Citrus Sinensis ID: 003694
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 802 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SW11 | 835 | U-box domain-containing p | yes | no | 0.973 | 0.935 | 0.559 | 0.0 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.957 | 0.908 | 0.511 | 0.0 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.951 | 0.958 | 0.495 | 0.0 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.943 | 0.924 | 0.490 | 0.0 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.594 | 0.595 | 0.493 | 1e-126 | |
| Q8GUH1 | 834 | U-box domain-containing p | no | no | 0.937 | 0.901 | 0.318 | 1e-102 | |
| Q94A51 | 805 | U-box domain-containing p | no | no | 0.526 | 0.524 | 0.376 | 2e-83 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.508 | 0.787 | 0.364 | 7e-71 | |
| Q9FID9 | 880 | Probable receptor-like pr | no | no | 0.367 | 0.335 | 0.374 | 6e-48 | |
| Q9FID8 | 873 | Putative receptor-like pr | no | no | 0.367 | 0.337 | 0.371 | 1e-46 |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 887 bits (2292), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/818 (55%), Positives = 585/818 (71%), Gaps = 37/818 (4%)
Query: 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDV 75
+V VA+ G+ KS+Y V WA+EKF EG FKLLH+ P ITSVPTPMGN IPI +VRDDV
Sbjct: 21 TVVVALSGSSKSKYVVTWAIEKFATEGNVGFKLLHIHPMITSVPTPMGNAIPISEVRDDV 80
Query: 76 AAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGA 135
AY+QE W+++ +L P+ + +R+V VEV VIESD+VA AIA+EV +I+++VIG
Sbjct: 81 VTAYRQEILWQSEEMLKPYTKLFVRRKVAVEVLVIESDNVAAAIAEEVTRDSIDRIVIGG 140
Query: 136 QSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKDDSSDTGC 195
S+ F+ +K ++ S IS +P+FCTVY V KGKLS VRPSD + ++D S+
Sbjct: 141 SSRSFFS---RKADICSVISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIREDGSERTN 197
Query: 196 SNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAV-NKTLLHLKPSSTEINHS 254
S+S SS S S + SA S S SLP +R+Q A+ + + ++ SS + +
Sbjct: 198 SSSGSSGPTSDSSDVMSSAHDS--QSRPLSLPVRRMQHFPAIAGQASVPMETSSVGSDET 255
Query: 255 RCQSFDVEEQKDASSSCLSGP--------------EVRQTVSRSSSYR------------ 288
RC S D EE +D SS S E ++ +S SSS R
Sbjct: 256 RCMSLDAEEARDVSSINRSSTDTTSRWTPRRRDYEERKEAMSSSSSNREYGNFGTRFSWS 315
Query: 289 --SMETENQDWSDQAST-TDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEAN 345
++T + S QAS +D L S +++QV++NFE+EKLR ELRHV+ MYA+AQ E
Sbjct: 316 GMGVDTTHSRASQQASNMSDALSEQSYTDNQVNLNFEVEKLRAELRHVQEMYAVAQTETF 375
Query: 346 DASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAA 405
DASRK+ +LN+ +LEE +L E++L E +A ELA++EK+ +E ARR+AE R AE+E A
Sbjct: 376 DASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMRERAEREIA 435
Query: 406 QRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVY 465
QR+EAE K+ + KEKE LE L +Y++ WEEI +AT SFSE L+IGMG YG VY
Sbjct: 436 QRREAERKSARDTKEKEKLEGTLGSPQLQYQHFAWEEIMAATSSFSEELKIGMGAYGAVY 495
Query: 466 KGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMEN 525
K HHT A VKVLQS N +KQF QELE+LSKIRHPHL+LLLGACP+ G LVYEYMEN
Sbjct: 496 KCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGALVYEYMEN 555
Query: 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 585
GSLEDRL++ NN+PP+PWFER+RIAWEVA+AL FLH +KPKPIIHRD+KP NILLDHN V
Sbjct: 556 GSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANILLDHNFV 615
Query: 586 SKIGDVGLSTMLNSDP-SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVIL 644
SK+GDVGLSTM+ DP S T YK T PVGTLCYIDPEYQRTG IS KSD+Y++GM++L
Sbjct: 616 SKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPEYQRTGRISSKSDIYSFGMILL 675
Query: 645 QLLTAKPAIAITHKVETAIDE-DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 703
QLLTAKPAIA+TH VE+A+D D +ILD +AG+WPI+ET+ELAAL L C ELR KDRP
Sbjct: 676 QLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCTELRGKDRP 735
Query: 704 DLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKA 763
DLK+Q+LP LE LK+VA++AR++ V PP HFICP+LK+VMNEPCVAADGYTYDR A
Sbjct: 736 DLKDQILPALENLKKVAEKARNSFSGVSTQPPTHFICPLLKDVMNEPCVAADGYTYDRHA 795
Query: 764 IEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 801
IEEWL+E++ SP+TD PL +KNLLPNYTL +AI++W+S
Sbjct: 796 IEEWLKEHNTSPMTDSPLHSKNLLPNYTLYTAIMEWRS 833
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 811 bits (2095), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/836 (51%), Positives = 568/836 (67%), Gaps = 68/836 (8%)
Query: 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVA 76
VAVA+ G +KS+Y V WALEKFIPEG FKLL+VRP ++ +PTPMG + + ++R+DV
Sbjct: 24 VAVAINGKKKSKYVVFWALEKFIPEGFTDFKLLYVRPPVSYIPTPMGIAVAVSELREDVV 83
Query: 77 AAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQ 136
+AYKQE W + +L P++ M +R+V+VEV +++S + A AIA+E+A + KLVIG
Sbjct: 84 SAYKQELDWSANEMLRPYKKMFERRKVQVEVLLLDSLEPAAAIAEEIAGTGVTKLVIGMS 143
Query: 137 SQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTK--------- 187
+G F+ +K ++SS I+ VP FCTVY + KGKL+SVRPS+ + GS +
Sbjct: 144 LRGFFS---RKIDMSSLIATAVPRFCTVYVISKGKLASVRPSESDASGSIRFERSSSTSG 200
Query: 188 ------------DDSSDTGCSNSSSSSHNSSSQTDLGS-AVASYTHSSSPSLPTQRLQAL 234
D S + S S + + + +GS AVA SSS T + +
Sbjct: 201 STDSPRLPPEYQDFLSAVSEAQSRVSPFSPALKHSMGSNAVAQMDTSSSG---TDQEEVS 257
Query: 235 SAVNKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETE- 293
+ ++H S E ++ +SF S+S G E ++S +S +R E
Sbjct: 258 TGRGMEIVH---SGIEGKKNKDESF--------SASFPMGTEAYNSMSWTSKWRDHEDRR 306
Query: 294 --------------NQDW-----------SDQAS--TTDVLPYDSSSESQVDVNFELEKL 326
N DW S AS + +L S +++QV++NFE+EKL
Sbjct: 307 EMRSSSSSNNHDLVNMDWGAVVPENYSWVSHTASHMSDGLLSVHSITDNQVNLNFEIEKL 366
Query: 327 RIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKY 386
R EL+HV+ MYA+AQ E AS+K+ +LN+ + EE +L E++ EE A + A +EK++Y
Sbjct: 367 RAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEVAKDTASKEKQRY 426
Query: 387 ETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESA 446
E A +EAE + KEA R+EAE KA+ +A+EK+ L+ +L +Y++ TWEEI +A
Sbjct: 427 EEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQYQHYTWEEIAAA 486
Query: 447 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL 506
T F+ENL+IG+G YG+VYK HHT AVKVL + +KQF QELE+LSKIRHPHL+
Sbjct: 487 TSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQELEILSKIRHPHLV 546
Query: 507 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
LLLGACP+ GCLVYEYM+NGSL+DRL N+TPPIPWFER+RIA EVASAL FLH +KP+
Sbjct: 547 LLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVASALVFLHKSKPR 606
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
PIIHRD+KPGNILLDHN VSK+GDVGLSTM+N D T +K T PVGTLCYIDPEYQR
Sbjct: 607 PIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSRTIFKQTSPVGTLCYIDPEYQR 666
Query: 627 TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED-NLAEILDAQAGDWPIKETK 685
TG+ISPKSDVY+ G+VILQL+TAKPAIAITH VE AI +D ILD +AG WPI +T+
Sbjct: 667 TGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAILDKKAGSWPISDTR 726
Query: 686 ELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKE 745
ELAALGL C E+RR+DRPDLK+Q++P LERL++VAD+A++ + PP+HFICP+LK
Sbjct: 727 ELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADKAQNLLSRTPSGPPSHFICPLLKG 786
Query: 746 VMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 801
VMNEPCVAADGYTYDR+AIEEWL++ D SP+T+LPLPNKNL+ NYTL SAI++WKS
Sbjct: 787 VMNEPCVAADGYTYDREAIEEWLRQKDTSPVTNLPLPNKNLIANYTLYSAIMEWKS 842
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 754 bits (1946), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/815 (49%), Positives = 544/815 (66%), Gaps = 52/815 (6%)
Query: 14 ALSVAVAVKGNR-KSRYAVLWALEKFIPEGINLFKLLHVRPRIT-SVPTPMGNFIPIEQV 71
AL VAVA+KGN K++ V WAL++F + +FKLLHV+PR + SV T
Sbjct: 5 ALIVAVAIKGNNSKTKGVVRWALQEFASQEHVVFKLLHVQPRDSNSVSTTR--------- 55
Query: 72 RDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKL 131
+D + YK++ KT +LLP R+M R V++++ V+ESDD+A AI+ V I++L
Sbjct: 56 KDLTTSVYKKDVDRKTREMLLPSRDMFVHREVQLDIMVLESDDIADAISKAVQDHGISEL 115
Query: 132 VIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKDDSS 191
VIGA S IF+WK K++NLSSRI+ P FC+V+ + KGKL +VR SD+ + S DD S
Sbjct: 116 VIGASSSIIFSWKLKRSNLSSRIADATPRFCSVHVISKGKLLNVRKSDMDTETSIADDRS 175
Query: 192 DTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTL------LHLK 245
+ S SS SH+ + S+ +S+ SS+P L QR+QAL+ VN+ + + +
Sbjct: 176 E---SRFSSDSHSGTV-----SSTSSHQFSSTPLL-FQRIQALTTVNQKVGTNIGKQNNE 226
Query: 246 PSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRS---SSYRSMETENQDWSDQAS 302
P N R S DV+E K + SS+RS + E +AS
Sbjct: 227 PHHHHHN--RAGSLDVDESKLLNQKGFYRTSSSGIGYGGSDISSWRSSQME------EAS 278
Query: 303 TTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEE 362
++ +SS SQ+ +FELEKL+IELRH++GMYA+AQ+E DAS+K+ DLN+ + EE
Sbjct: 279 SSSTYSDPTSSSSQIHKDFELEKLKIELRHIKGMYAVAQSEVIDASKKMQDLNQRRSEEA 338
Query: 363 TRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKE 422
TRL + + EE+A E+ + E+++ E A EAE R E+E +R EAE +A+ KEK+
Sbjct: 339 TRLKNLTIREEEADEVVEMERERQEDAENEAELVRECIERETEERLEAEARAEEVRKEKQ 398
Query: 423 MLERALNG---TFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVL 479
LE AL G Q+Y WEEI AT SFS+ L+IG+GGYG+VY+ HHT AVKVL
Sbjct: 399 RLEDALEGGPLQRQQYMKFEWEEIVEATSSFSDELKIGVGGYGSVYRCNLHHTTVAVKVL 458
Query: 480 QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKN--- 536
S + KQF QELE+LSKIRHPHLLLLLGACP+ G LVYEYM NGSLE+RL ++
Sbjct: 459 HSDKSSLTKQFHQELEILSKIRHPHLLLLLGACPERGSLVYEYMHNGSLEERLMKRRPNV 518
Query: 537 ---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593
PP+ WFER+RIAWE+ASAL FLH +P+PI+HRD+KP NILLD N VSKIGDVGL
Sbjct: 519 DTPQPPPLRWFERFRIAWEIASALYFLHTNEPRPIVHRDLKPANILLDRNNVSKIGDVGL 578
Query: 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 653
S M+N DPS ST + TGPVGT YIDPEYQRTG+++P+SD+YA+G+++LQL+TA+ A+
Sbjct: 579 SKMVNLDPSHASTVFNETGPVGTFFYIDPEYQRTGVVTPESDIYAFGIILLQLVTARSAM 638
Query: 654 AITHKVETAIDEDN--LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLP 711
+ H +E A+ + EILD AGDWP+KE KE+ +GL CAE+R++DRPDL ++LP
Sbjct: 639 GLAHSIEKALRDQTGKFTEILDKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPDLGKEILP 698
Query: 712 VLERLKEVADRAR----DTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEW 767
VLERLKEVA AR D + H P HF CPI K+VM PCVA+DGYTY+++AI+EW
Sbjct: 699 VLERLKEVASIARNMFADNLIDHHHNAPTHFYCPITKDVMENPCVASDGYTYEKRAIKEW 758
Query: 768 LQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 802
LQ+N KSP+TDLP P+ +LLPN++LLSAI +W+S+
Sbjct: 759 LQKNHKSPMTDLPFPSDSLLPNHSLLSAIKEWRSQ 793
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 728 bits (1879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/826 (49%), Positives = 548/826 (66%), Gaps = 69/826 (8%)
Query: 10 PNSPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIE 69
P+ P ++VA+A+ G+ KS+ + WAL KF + FKL+H+ P+IT++PT GN + I
Sbjct: 28 PSEP-MTVALAISGSIKSKNVIKWALNKFGSDKNVTFKLIHIHPKITTLPTASGNIVSIS 86
Query: 70 QVRDDVAAAYKQEEKWKTDRLLL-PFRNMCAQRR--------------VEVEVKVIESDD 114
+ ++VAAAY+Q+ +T LL PF+ MC +++ V VE++V+ES+
Sbjct: 87 EELEEVAAAYRQKVMQETKETLLKPFKKMCERKKLKIDETRFESSLTKVAVELQVLESNS 146
Query: 115 VAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSS 174
VA AI EV I+ L+IG SQ + + ++++ IS V + CTVY V G
Sbjct: 147 VAVAITKEVNQHLISNLIIGRSSQAASSRNY---DITASISASVSNLCTVYVVSNG---- 199
Query: 175 VRPSDLGSIGSTKDDSSDTGCSNSSSSS------HNSSSQTDLGSAVASYTHSSSP-SLP 227
+ D+SDT +++S S + SS + S V S S+P +L
Sbjct: 200 -------GVHILAKDTSDTERNDTSIESGFERTSSSCSSGSGANSDVMSNALKSNPHTLS 252
Query: 228 TQRLQALSAVNKTL-LHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSS 286
+R+Q L + + + + ++ SSTE + ++ +S D E+ +S S PE ++VS +
Sbjct: 253 NKRMQNLPTIVRGVSVPMETSSTESDETKKRSSDAAEE----ASKRSSPETSRSVSWNPQ 308
Query: 287 YRSMETENQDWSDQASTTD----VLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQN 342
+R + S +S + V P D E+ KLR ELRH MYA+AQ
Sbjct: 309 FRDFDERKDAMSSMSSNFEYGNVVTPLGHYFTDNQDTLNEISKLRAELRHAHEMYAVAQV 368
Query: 343 EANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEK 402
E DASRK+N+L + E+ LLE + +AK+E +K+E RRE E+
Sbjct: 369 ETLDASRKLNEL---------KFEELTLLEHETKGIAKKETEKFEQKRRE--------ER 411
Query: 403 EAAQRQEAEMKAKHEAKEKEMLERALNGTFQ-RYRNLTWEEIESATLSFSENLRIGMGGY 461
EAAQR+EAEMKA HEAKEKE LE + + +Y+ TWEEI +AT SFSE+L+IGMG Y
Sbjct: 412 EAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSFSEDLKIGMGAY 471
Query: 462 GTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYE 521
G VYK HHT AAVKVL S + +KQF QELE+LSKIRHPHL+LLLGACPDHG LVYE
Sbjct: 472 GDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLGACPDHGALVYE 531
Query: 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 581
YMENGSLEDRL++ N++ PIPWF R RIAWEVASAL FLH +KP PIIHRD+KP NILL+
Sbjct: 532 YMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIHRDLKPANILLN 591
Query: 582 HNLVSKIGDVGLSTMLN-SDP-SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAY 639
HN VSK+GDVGLSTM+ +DP S T YK T PVGTLCYIDPEYQRTG ISPKSDVYA+
Sbjct: 592 HNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTGRISPKSDVYAF 651
Query: 640 GMVILQLLTAKPAIAITHKVETAID---EDNLAEILDAQAGDWPIKETKELAALGLSCAE 696
GM+ILQLLT + A+A+T+ VETA++ +D L +ILD +AG+WPI+ET++LAAL L C E
Sbjct: 652 GMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETRQLAALALQCTE 711
Query: 697 LRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADG 756
LR KDRPDL++Q+LPVLE LK+VAD+AR+++ + PP+HF CP+LK+VM EPC+AADG
Sbjct: 712 LRSKDRPDLEDQILPVLESLKKVADKARNSLSAAPSQPPSHFFCPLLKDVMKEPCIAADG 771
Query: 757 YTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 802
YTYDR+AIEEW++ + SP+T+ PL N NLLPN+TL +AI++W+++
Sbjct: 772 YTYDRRAIEEWMENHRTSPVTNSPLQNVNLLPNHTLYAAIVEWRNR 817
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1168), Expect = e-126, Method: Compositional matrix adjust.
Identities = 236/478 (49%), Positives = 318/478 (66%), Gaps = 1/478 (0%)
Query: 325 KLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKK 384
+L+ EL+ Y A E KV L+ L E R++ EE A EK+
Sbjct: 317 RLKNELQSTVFKYKQACEELFSTQNKVKMLSTEYLNESKRVNNAVEKEELQRNTAALEKE 376
Query: 385 KYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIE 444
+Y A +E E A+A +E QRQ AE+ A EK+ + L GT RYR T EEI
Sbjct: 377 RYMKAVKEVETAKALLAREFCQRQIAEVNALRTYLEKKKVIDQLLGTDHRYRKYTIEEIV 436
Query: 445 SATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH 504
+AT FS IG GGYG VY+ + T AAVKV++ + ++FL+E+EVLS++RHPH
Sbjct: 437 TATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPH 496
Query: 505 LLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
++LLLGACP++GCLVYEY+ENGSLE+ ++ + N PP+PWF R+R+ +EVA LAFLH++K
Sbjct: 497 VVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSK 556
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
P+PI+HRD+KPGNILL+ N VSKI DVGL+ ++ T Y+N+ GTL YIDPEY
Sbjct: 557 PEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVTDVAPDNVTMYRNSVLAGTLHYIDPEY 616
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684
RTG I PKSD+YA+G++ILQLLTA+ I VE A+ + L E+LD DWP+ ET
Sbjct: 617 HRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAET 676
Query: 685 KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILK 744
+ELA +GL CAE R +DRPDLK++V+PVL+RL E A+ S A P+H+ CPIL+
Sbjct: 677 EELARIGLKCAEFRCRDRPDLKSEVIPVLKRLVETANSKVKKEGSNLRA-PSHYFCPILR 735
Query: 745 EVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 802
E+M EP +AADG+TY+RKAI WL++++ SP+T L + L PN+TL SAI DWKS+
Sbjct: 736 EIMEEPEIAADGFTYERKAILAWLEKHNISPVTRQKLDHFKLTPNHTLRSAIRDWKSR 793
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 374 bits (959), Expect = e-102, Method: Compositional matrix adjust.
Identities = 259/814 (31%), Positives = 427/814 (52%), Gaps = 62/814 (7%)
Query: 17 VAVAV-KGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDV 75
+ VAV K KS+ ++WAL+ G L+HV +P MG P+ V+++
Sbjct: 47 IFVAVDKHVAKSKSTLIWALQN---TGGKKICLIHVHQPSQMIPL-MGAKFPVGAVKEEE 102
Query: 76 AAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGA 135
++++E+ K +L + +C QR V E IE + + I ++ I KLV+GA
Sbjct: 103 VRVFREKEREKVHMILDDYLRICQQRGVRAEKMFIEMESIENGIVQLISELGIRKLVMGA 162
Query: 136 QSQGIFTWKFKKNNLSSRISICV----PSFCTVYGVEKGKLSSVRPSDLGSIGSTKDDSS 191
+ ++ + +L SR +I V P+ C ++ KG L R + T DD+
Sbjct: 163 AADRHYSRRM--TDLKSRKAIFVRREAPTLCQIWFTCKGYLIHTREA-------TMDDTE 213
Query: 192 DTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTLLHLKPSSTEI 251
+ +S S S +DL + +++ S R+Q+ +V + L+ S+ +
Sbjct: 214 -----SEYASPRPSISASDL---LQTFSTPESEHQHISRVQSTDSVQQ-LVSNGSSTEQS 264
Query: 252 NHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDWSDQASTTDVLPYDS 311
S + +E++ S G EV + + SS S + D D + + S
Sbjct: 265 GRVSDGSLNTDEEERESD----GSEVTGSATVMSSGHSSPSSFPDGVDDSFNVKIRKATS 320
Query: 312 SSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDAS-----RKVNDLNKCKLEEETRLS 366
+ S F E LR + + AI + + ++++ ++ D +E+ R
Sbjct: 321 EAHSSKQEAFA-ETLRRQKAEKNALDAIRRAKQSESAYSEELKRRKDTEIAVAKEKERFI 379
Query: 367 EIQ-----LLEEKAIELAKQEKKKYETARREAECARASAEKEAA---------QRQEAEM 412
I+ ++EE +A++ + + A+ + + + + + A +R+E +
Sbjct: 380 TIKNEQEVIMEELQSAMAQKAMLESQIAKSDGTMEKLNQKLDIAVKLLQKLRDEREELQT 439
Query: 413 KAKHEAKEKEMLE-RALNGTFQ---RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGT 468
+ +E E L A T Q + + ++ EIE AT F L+IG GGYG++Y G
Sbjct: 440 ERDRALREAEELRSHAETSTLQLPQYFTDFSFSEIEEATNHFDSTLKIGEGGYGSIYVGL 499
Query: 469 FHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSL 528
HT A+K+L + ++ QE++VLSK+RHP+++ L+GACP+ LVYEY+ GSL
Sbjct: 500 LRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNIITLIGACPEGWSLVYEYLPGGSL 559
Query: 529 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 588
EDRL K+N+PP+ W R RIA E+ +AL FLH+ K ++H D+KP NILLD NLVSK+
Sbjct: 560 EDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKAHSLVHGDLKPANILLDSNLVSKL 619
Query: 589 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
D G ++L+ + S T GT+ Y+DPE +G ++PKSDVY++G+++L+LLT
Sbjct: 620 SDFGTCSLLHPNGS----KSVRTDVTGTVAYLDPEASSSGELTPKSDVYSFGIILLRLLT 675
Query: 649 AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 708
+PA+ I+++V+ A+D L ++LD AGDWP + ++LA L L C E ++RPDL +
Sbjct: 676 GRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAEQLARLALRCCETVSENRPDLGTE 735
Query: 709 VLPVLE--RLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEE 766
V VLE R + + H P +FICPI +EVM +P VAADG+TY+ +AI
Sbjct: 736 VWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFICPIFQEVMQDPHVAADGFTYEAEAIRA 795
Query: 767 WL-QENDKSPITDLPLPNKNLLPNYTLLSAILDW 799
WL E+D SP+T++ L + +L+ N+ L SAI +W
Sbjct: 796 WLDSEHDTSPMTNVKLSHTSLIANHALRSAIQEW 829
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 171/454 (37%), Positives = 271/454 (59%), Gaps = 32/454 (7%)
Query: 365 LSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEA-EMKAKHE--AKEK 421
+ E+Q+++ + ++L Q +K + + E + E + RQ+ E++ HE KE
Sbjct: 367 MKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQKRDEIRIDHENAVKEV 426
Query: 422 EMLERALNG-----TFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAV 476
L R + G + + ++ EI AT F + ++G G YG+VYKG H AV
Sbjct: 427 NALRRLVKGETGESSGSEMLDYSFMEINEATNEFDPSWKLGEGKYGSVYKGNLQHLQVAV 486
Query: 477 KVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKN 536
K+L S G++ + +F + +E+LS++RHP+L+ L+GACP+ L+Y+Y+ NGSLED +N
Sbjct: 487 KMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQYIPNGSLEDCFSSEN 546
Query: 537 NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596
N P + W R RIA E+ SAL FLH+ P IIH ++KP ILLD NLV+KI D G+S +
Sbjct: 547 NVPALSWESRIRIASEICSALLFLHSNIP-CIIHGNLKPSKILLDSNLVTKINDYGISQL 605
Query: 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT 656
+ D + P ++DP Y + ++ +SD+YA+G+++LQLLT +P I
Sbjct: 606 IPID------GLDKSDP-----HVDPHYFVSREMTLESDIYAFGIILLQLLTRRPVSGIL 654
Query: 657 HKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716
V+ A++ DN++ +LD AGDWP+ K+LA + + C + +RPDL VL ++R+
Sbjct: 655 RDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCCKKNPMNRPDLA-VVLRFIDRM 713
Query: 717 K-------EVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQ 769
K E + A VP PP+H++CPI +EVM +P +AADG+TY+ +AI EWL
Sbjct: 714 KAPEVPSSETSSYANQNVPR---RPPSHYLCPIFQEVMKDPLIAADGFTYEAEAIREWLA 770
Query: 770 E-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 802
+D SP+T+L + + NL+PN+ L AI DW+++
Sbjct: 771 NGHDTSPMTNLKMEDCNLIPNHALHLAIQDWQNQ 804
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (687), Expect = 7e-71, Method: Compositional matrix adjust.
Identities = 163/447 (36%), Positives = 246/447 (55%), Gaps = 39/447 (8%)
Query: 358 KLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECA--RASAEKEAAQRQEAEMKAK 415
K EE R ++ +LEE+ + L K + Y + +A A + E++ A +Q E++
Sbjct: 83 KTYEEVR--KVHILEEEIVTL-KHQADTYLVQKEKAVTAYDQLKHERDNAVQQVNELR-- 137
Query: 416 HEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAA 475
+ +L+ F R +++E AT F +G YG YKG H+
Sbjct: 138 -DQSTHIILD------FSR------KDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVL 184
Query: 476 VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRK 535
+K+ S+ K F QE+ +L + RHP+++ +G C + LVYE++ NG+LEDR+
Sbjct: 185 IKLSSSQ-----KLFQQEVSILRQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICT 239
Query: 536 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595
NN+ P+ W+ R +I E+ AL FLH+ K ++H D++P NIL+D N SKI + G+S
Sbjct: 240 NNSAPLSWYNRTQIIGEICCALLFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSN 299
Query: 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI 655
+ +F L Y+DPE+ TG ++ SDVY+ G++IL+LLT P + +
Sbjct: 300 LFLQLGTFPPNL------TARLPYMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTL 353
Query: 656 THKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 715
+ KV A+ D+L ++D AGDWP E K+LA +GLSC + RK RPDL N+V V+E
Sbjct: 354 SEKVAEALGSDSLHLLIDKSAGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEP 413
Query: 716 LKEVADRARDTVPSVHPAP-----PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE 770
L A T P + A P FICPI E+M +P VA+DG+TY+ +AI W
Sbjct: 414 LTRKPPAA--TWPYLQSASGDSSVPAAFICPISMEIMKDPQVASDGFTYEAEAIRCWFDR 471
Query: 771 N-DKSPITDLPLPNKNLLPNYTLLSAI 796
+SP+T+L LPN NL+PN L S I
Sbjct: 472 GISRSPMTNLALPNLNLVPNRVLRSFI 498
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (489), Expect = 6e-48, Method: Compositional matrix adjust.
Identities = 119/318 (37%), Positives = 176/318 (55%), Gaps = 23/318 (7%)
Query: 436 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQE 493
R + EI+SAT F E L IG+GG+G+VYKG T AVK L+ N K+F E
Sbjct: 511 RRFSIYEIKSATNDFEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTE 570
Query: 494 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNT--PPIPWFERYRI 549
LE+LSK+RH HL+ L+G C D LVYEYM +G+L+D L+R++ PP+ W R I
Sbjct: 571 LEMLSKLRHVHLVSLIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLEI 630
Query: 550 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 609
A L +LH IIHRD+K NILLD N V+K+ D GLS + P+ S T+
Sbjct: 631 CIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVAKVSDFGLSRV---GPTSASQTHV 687
Query: 610 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA---------IAITHKVE 660
+T GT Y+DPEY R +++ KSDVY++G+V+L++L +P + V+
Sbjct: 688 STVVKGTFGYLDPEYYRRQILTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVK 747
Query: 661 TAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE---RL 716
+ ++ + +I+D+ D ++ + + C + R +RP + N V+ LE +L
Sbjct: 748 SNFNKRTVDQIIDSDLTADITSTSMEKFCEIAIRCVQDRGMERPPM-NDVVWALEFALQL 806
Query: 717 KEVADRARDTVPSVHPAP 734
E A + D V S+ P
Sbjct: 807 HETAKKKNDNVESLDLMP 824
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (479), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 118/318 (37%), Positives = 176/318 (55%), Gaps = 23/318 (7%)
Query: 436 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQE 493
R + EI+SAT F + L IG+GG+G+VYKG T AVK L+ N K+F E
Sbjct: 504 RRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFETE 563
Query: 494 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNT--PPIPWFERYRI 549
LE+LSK+RH HL+ L+G C + LVYEYM +G+L+D L+R++ T PP+ W R I
Sbjct: 564 LEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLEI 623
Query: 550 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 609
A L +LH IIHRD+K NILLD N V+K+ D GLS + P+ S T+
Sbjct: 624 CIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLSRV---GPTSASQTHV 680
Query: 610 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA---------IAITHKVE 660
+T GT Y+DPEY R +++ KSDVY++G+V+L++L +P + V+
Sbjct: 681 STVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVK 740
Query: 661 TAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE---RL 716
+ + +I+D+ + D ++ + + C + R +RP + N V+ LE +L
Sbjct: 741 SNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERPPM-NDVVWALEFALQL 799
Query: 717 KEVADRARDTVPSVHPAP 734
E A + D V S+ P
Sbjct: 800 HETAKKKNDNVESLDLMP 817
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 802 | ||||||
| 359490160 | 804 | PREDICTED: U-box domain-containing prote | 0.990 | 0.987 | 0.662 | 0.0 | |
| 147858097 | 804 | hypothetical protein VITISV_021538 [Viti | 0.990 | 0.987 | 0.663 | 0.0 | |
| 297745064 | 784 | unnamed protein product [Vitis vinifera] | 0.965 | 0.987 | 0.653 | 0.0 | |
| 357455815 | 809 | U-box domain-containing protein [Medicag | 0.970 | 0.961 | 0.618 | 0.0 | |
| 449451988 | 836 | PREDICTED: U-box domain-containing prote | 0.983 | 0.943 | 0.617 | 0.0 | |
| 357455813 | 797 | U-box domain-containing protein [Medicag | 0.973 | 0.979 | 0.604 | 0.0 | |
| 356508200 | 785 | PREDICTED: U-box domain-containing prote | 0.951 | 0.971 | 0.602 | 0.0 | |
| 449488729 | 1074 | PREDICTED: U-box domain-containing prote | 0.927 | 0.692 | 0.624 | 0.0 | |
| 42567138 | 835 | U-box domain-containing protein 35 [Arab | 0.973 | 0.935 | 0.559 | 0.0 | |
| 297799476 | 832 | kinase family protein [Arabidopsis lyrat | 0.970 | 0.935 | 0.553 | 0.0 |
| >gi|359490160|ref|XP_002266973.2| PREDICTED: U-box domain-containing protein 35-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1070 bits (2766), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/809 (66%), Positives = 644/809 (79%), Gaps = 15/809 (1%)
Query: 1 MEVKDIVELPNSPAL------SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPR 54
ME K+I+E AL ++AVA+ G +KS+Y V WALEKF+PEG+++FK+LHVRP+
Sbjct: 1 MEAKEIIEEKQELALALPLPSTIAVAINGKKKSKYVVRWALEKFVPEGLHMFKMLHVRPK 60
Query: 55 ITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDD 114
ITSVPTPMGN IP+ QVRDDVAAAY +E W+T +LLP++ M ++V+V+V VIESDD
Sbjct: 61 ITSVPTPMGNSIPLSQVRDDVAAAYLEEMGWQTSEMLLPYKTMFLHKKVQVDVVVIESDD 120
Query: 115 VAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSS 174
VAKAIA+E+A I+KLVIGA S G+F+ K K +LS RIS C PSFCTVY V KG+LSS
Sbjct: 121 VAKAIAEEIAKSTIHKLVIGASSSGMFSRKVKGQSLSLRISECTPSFCTVYTVSKGQLSS 180
Query: 175 VRPSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQAL 234
VRPSD GS K+DSSD +S++SS + +S GSA ASY+H SPSLP QR QAL
Sbjct: 181 VRPSDSDKNGSIKEDSSDA---SSTTSSSSHTSSPHAGSA-ASYSHFHSPSLPMQRFQAL 236
Query: 235 SAVNKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETEN 294
S +N+TLLH + S E N SR QS D+ E++ S C S ++ S+ SS RS T++
Sbjct: 237 STINRTLLHTRTGSIETNSSRRQSLDIREEESFMSPCPSNSDIGYAPSQVSSARSFLTDD 296
Query: 295 QDW-SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVND 353
Q W SDQAST+D +SSS SQV++NFELEKLR+ELRHVRG+YA+AQ+E DASRK+ND
Sbjct: 297 QSWISDQASTSDAFT-ESSSGSQVNINFELEKLRVELRHVRGIYAMAQSENIDASRKLND 355
Query: 354 LNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMK 413
L+K +LEE +L EI+L EE+A ELA++EK+KYE A+REAE AR AEKEA QR+EAE+K
Sbjct: 356 LSKRRLEEADKLKEIKLKEEEARELARKEKEKYEAAKREAEYARECAEKEALQRKEAEIK 415
Query: 414 AKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTF 473
A H+ KEKE LE AL G Q Y+ TWEEI SAT SFSENL+IG G +GTVY+ HHT
Sbjct: 416 ALHDVKEKEKLENALVGPVQSYQEFTWEEIVSATSSFSENLQIGKGAHGTVYRCNLHHTT 475
Query: 474 AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLY 533
AAVKVL SK + K+F QEL+VLSKIRHPHLLLLLGAC DHGCLVYEYMENGSLE+RL
Sbjct: 476 AAVKVLHSKEGHRTKEFQQELDVLSKIRHPHLLLLLGACSDHGCLVYEYMENGSLEERLL 535
Query: 534 RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593
+K NT PIPWFERYRIAWEVAS L FLHN+KPK IIHRD+KP NILLDHNLVSKIGDVGL
Sbjct: 536 QKYNTAPIPWFERYRIAWEVASTLVFLHNSKPKSIIHRDLKPANILLDHNLVSKIGDVGL 595
Query: 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 653
STMLN D S + NTGPVGTLCYIDPEYQRTGL+SPKSDVYA+GMV+LQLLTAKPAI
Sbjct: 596 STMLNLDSSICNI---NTGPVGTLCYIDPEYQRTGLVSPKSDVYAFGMVVLQLLTAKPAI 652
Query: 654 AITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713
A+ H VETAI +D L +ILD AG WP+KETKELA LGLSC ELRR+DRPDLK++VLP L
Sbjct: 653 ALAHLVETAIQDDQLMKILDPMAGQWPMKETKELALLGLSCLELRRRDRPDLKDEVLPAL 712
Query: 714 ERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDK 773
ERLK+ ADR+RD+ P V APPNHF+CPILK+VM++PCVAADGYTYDR+AIE+W++END
Sbjct: 713 ERLKDAADRSRDSAPKVQLAPPNHFVCPILKDVMHDPCVAADGYTYDRRAIEKWVEENDN 772
Query: 774 SPITDLPLPNKNLLPNYTLLSAILDWKSK 802
SP+T+L LPNKNL+PNYTLLSAI++WKS+
Sbjct: 773 SPMTNLALPNKNLIPNYTLLSAIMEWKSQ 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147858097|emb|CAN78862.1| hypothetical protein VITISV_021538 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1070 bits (2766), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 537/809 (66%), Positives = 644/809 (79%), Gaps = 15/809 (1%)
Query: 1 MEVKDIVELPNSPAL------SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPR 54
ME K+I+E AL ++AVA+ G +KS+Y V WALEKF+PEG+++FK+LHVRP+
Sbjct: 1 MEAKEIIEEKQELALALPLPSTIAVAINGKKKSKYVVRWALEKFVPEGLHMFKMLHVRPK 60
Query: 55 ITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDD 114
ITSVPTPMGN IP+ QVRDDVAAAY +E W+T +LLP++ M ++V+V+V VIESDD
Sbjct: 61 ITSVPTPMGNSIPLSQVRDDVAAAYLEEMGWQTSEMLLPYKTMFLHKQVQVDVVVIESDD 120
Query: 115 VAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSS 174
VAKAIA+E+A I+KLVIGA S G+F+ K K +LS RIS C PSFCTVY V KG+LSS
Sbjct: 121 VAKAIAEEIAKSTIHKLVIGASSSGMFSRKVKGQSLSLRISECTPSFCTVYTVSKGQLSS 180
Query: 175 VRPSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQAL 234
VRPSD GS K+DSSD +S++SS + +S GSA ASY+H SPSLP QR QAL
Sbjct: 181 VRPSDSDKNGSIKEDSSDA---SSTTSSSSHTSSPHAGSA-ASYSHFHSPSLPMQRFQAL 236
Query: 235 SAVNKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETEN 294
S +N+TLLH + S E N SR QS D+ E++ S C S ++ S+ SS RS T++
Sbjct: 237 STINRTLLHTRTGSIETNSSRRQSLDIREEESFMSPCPSNSDIGYAPSQVSSARSFLTDD 296
Query: 295 QDW-SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVND 353
Q W SDQAST+D +SSS SQV++NFELEKLR+ELRHVRG+YA+AQ+E DASRK+ND
Sbjct: 297 QSWISDQASTSDAFT-ESSSGSQVNINFELEKLRVELRHVRGIYAMAQSENIDASRKLND 355
Query: 354 LNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMK 413
L+K +LEE +L EI+L EE+A ELA++EK+KYE A+REA AR AEKEA QR+EAE+K
Sbjct: 356 LSKRRLEEADKLKEIKLKEEEARELARKEKEKYEAAKREAXYARECAEKEALQRKEAEIK 415
Query: 414 AKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTF 473
A H+ KEKE LE AL G Q Y+ TWEEI SAT SFSENL+IG G +GTVY+ HHT
Sbjct: 416 ALHDVKEKEKLENALVGPVQSYQEFTWEEIVSATSSFSENLQIGKGAHGTVYRCNLHHTT 475
Query: 474 AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLY 533
AAVKVL SK + K+F QELEVLSKIRHPHLLLLLGAC DHGCLVYEYMENGSLE+RL
Sbjct: 476 AAVKVLHSKEGHRTKEFQQELEVLSKIRHPHLLLLLGACSDHGCLVYEYMENGSLEERLL 535
Query: 534 RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593
+K NT PIPWFERYRIAWEVAS L FLHN+KP+ IIHRD+KP NILLDHNLVSKIGDVGL
Sbjct: 536 QKYNTAPIPWFERYRIAWEVASTLVFLHNSKPRSIIHRDLKPANILLDHNLVSKIGDVGL 595
Query: 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 653
STMLN D S + NTGPVGTLCYIDPEYQRTGL+SPKSDVYA+GMV+LQLLTAKPAI
Sbjct: 596 STMLNPDSSICNI---NTGPVGTLCYIDPEYQRTGLVSPKSDVYAFGMVVLQLLTAKPAI 652
Query: 654 AITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713
A+ H VETAI +D L EILD AG WP+KETKELA LGLSC ELRR+DRPDLK++VLP L
Sbjct: 653 ALAHLVETAIQDDQLMEILDPMAGQWPMKETKELALLGLSCLELRRRDRPDLKDEVLPAL 712
Query: 714 ERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDK 773
ERLK+VADR+RD+ P V APPNHF+CPILK+VM++PCVAADGYTYDR+AIE+W++END
Sbjct: 713 ERLKDVADRSRDSAPKVQLAPPNHFVCPILKDVMHDPCVAADGYTYDRRAIEKWVEENDN 772
Query: 774 SPITDLPLPNKNLLPNYTLLSAILDWKSK 802
SP+T+L LPNKNL+PNYTLLSAI++WKS+
Sbjct: 773 SPMTNLALPNKNLIPNYTLLSAIVEWKSQ 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745064|emb|CBI38656.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1047 bits (2708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/809 (65%), Positives = 633/809 (78%), Gaps = 35/809 (4%)
Query: 1 MEVKDIVELPNSPAL------SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPR 54
ME K+I+E AL ++AVA+ G +KS+Y V WALEKF+PEG+++FK+LHVRP+
Sbjct: 1 MEAKEIIEEKQELALALPLPSTIAVAINGKKKSKYVVRWALEKFVPEGLHMFKMLHVRPK 60
Query: 55 ITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDD 114
ITSVPTPMGN IP+ QVRDDVAAAY +E W+T +LLP++ M ++V+V+V VIESDD
Sbjct: 61 ITSVPTPMGNSIPLSQVRDDVAAAYLEEMGWQTSEMLLPYKTMFLHKKVQVDVVVIESDD 120
Query: 115 VAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSS 174
VAKAIA+E+A I+KLVIGA S G+F+ K K +LS RIS C PSFCTVY V KG+LSS
Sbjct: 121 VAKAIAEEIAKSTIHKLVIGASSSGMFSRKVKGQSLSLRISECTPSFCTVYTVSKGQLSS 180
Query: 175 VRPSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQAL 234
VRPSD GS K+DSSD +S++SS + +S GSA ASY+H SPSLP QR QAL
Sbjct: 181 VRPSDSDKNGSIKEDSSDA---SSTTSSSSHTSSPHAGSA-ASYSHFHSPSLPMQRFQAL 236
Query: 235 SAVNKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETEN 294
S +N+TLLH + S E N SR + S+ SS RS T++
Sbjct: 237 STINRTLLHTRTGSIETNSSR--------------------HIGYAPSQVSSARSFLTDD 276
Query: 295 QDW-SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVND 353
Q W SDQAST+D +SSS SQV++NFELEKLR+ELRHVRG+YA+AQ+E DASRK+ND
Sbjct: 277 QSWISDQASTSDAFT-ESSSGSQVNINFELEKLRVELRHVRGIYAMAQSENIDASRKLND 335
Query: 354 LNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMK 413
L+K +LEE +L EI+L EE+A ELA++EK+KYE A+REAE AR AEKEA QR+EAE+K
Sbjct: 336 LSKRRLEEADKLKEIKLKEEEARELARKEKEKYEAAKREAEYARECAEKEALQRKEAEIK 395
Query: 414 AKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTF 473
A H+ KEKE LE AL G Q Y+ TWEEI SAT SFSENL+IG G +GTVY+ HHT
Sbjct: 396 ALHDVKEKEKLENALVGPVQSYQEFTWEEIVSATSSFSENLQIGKGAHGTVYRCNLHHTT 455
Query: 474 AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLY 533
AAVKVL SK + K+F QEL+VLSKIRHPHLLLLLGAC DHGCLVYEYMENGSLE+RL
Sbjct: 456 AAVKVLHSKEGHRTKEFQQELDVLSKIRHPHLLLLLGACSDHGCLVYEYMENGSLEERLL 515
Query: 534 RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593
+K NT PIPWFERYRIAWEVAS L FLHN+KPK IIHRD+KP NILLDHNLVSKIGDVGL
Sbjct: 516 QKYNTAPIPWFERYRIAWEVASTLVFLHNSKPKSIIHRDLKPANILLDHNLVSKIGDVGL 575
Query: 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 653
STMLN D S + NTGPVGTLCYIDPEYQRTGL+SPKSDVYA+GMV+LQLLTAKPAI
Sbjct: 576 STMLNLDSSICNI---NTGPVGTLCYIDPEYQRTGLVSPKSDVYAFGMVVLQLLTAKPAI 632
Query: 654 AITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713
A+ H VETAI +D L +ILD AG WP+KETKELA LGLSC ELRR+DRPDLK++VLP L
Sbjct: 633 ALAHLVETAIQDDQLMKILDPMAGQWPMKETKELALLGLSCLELRRRDRPDLKDEVLPAL 692
Query: 714 ERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDK 773
ERLK+ ADR+RD+ P V APPNHF+CPILK+VM++PCVAADGYTYDR+AIE+W++END
Sbjct: 693 ERLKDAADRSRDSAPKVQLAPPNHFVCPILKDVMHDPCVAADGYTYDRRAIEKWVEENDN 752
Query: 774 SPITDLPLPNKNLLPNYTLLSAILDWKSK 802
SP+T+L LPNKNL+PNYTLLSAI++WKS+
Sbjct: 753 SPMTNLALPNKNLIPNYTLLSAIMEWKSQ 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357455815|ref|XP_003598188.1| U-box domain-containing protein [Medicago truncatula] gi|355487236|gb|AES68439.1| U-box domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 958 bits (2477), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/792 (61%), Positives = 613/792 (77%), Gaps = 14/792 (1%)
Query: 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVA 76
VA+A+KGN+KS+Y V WAL KF+PEG+ +FKL+HV I VPTPMGN +PI QVRDDVA
Sbjct: 24 VALAIKGNKKSKYVVQWALNKFVPEGMIIFKLIHVHAGIVGVPTPMGNMLPISQVRDDVA 83
Query: 77 AAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQ 136
AAYK+E + +T+++LLPF+ MC QR+V VEV VIESDDVA A+A+EV + KLV+GA
Sbjct: 84 AAYKKEIECETNQMLLPFKQMCEQRKVHVEVVVIESDDVASAVAEEVTKYAVTKLVVGAS 143
Query: 137 SQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKDDSSDTGCS 196
+ G+F K K +S++IS+C P FCTVY V KGKL +RPSD+ S DD+S+ S
Sbjct: 144 TGGLF--KSKHKGMSAKISVCTPRFCTVYAVSKGKLL-IRPSDVQIDESITDDTSEISFS 200
Query: 197 NSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTLLHLKPSSTEINHSRC 256
+SSSS++ S++QTD GS VASY S SL TQR QALS++N+ LL PS E NHSR
Sbjct: 201 SSSSSNYTSTTQTDSGS-VASYAALHSSSLATQRFQALSSMNQNLLSTNPSLNETNHSRG 259
Query: 257 QSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDW-SDQASTTDVLPYDS---S 312
QS D+ A+SS + + + +SR+SS+RS+ ++ W DQ S D P S S
Sbjct: 260 QSIDLGRGNVATSSARNS-DFDRGLSRASSFRSIVSDTDTWIYDQISLKDA-PLTSKLAS 317
Query: 313 SESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLE 372
Q + N ELEKLRIELRH +GM+A+AQ E DASRK+N+L+K + E ++ EI E
Sbjct: 318 PNRQENFNLELEKLRIELRHAQGMHAVAQTENIDASRKLNELSKRRSGESMKMKEIIAKE 377
Query: 373 EKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTF 432
E A ELA+QE +KYE A REA + AE+EA++R+E E+KA AKEK+ LE AL+G+
Sbjct: 378 EVAKELARQEIEKYEAAAREASYLKECAEREASERKETELKAIRAAKEKDKLEDALSGST 437
Query: 433 QRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQ 492
+YR TW+EI SAT SFSE+LRIGMG YG VYK T HHT AVKVL S G Q+KQF Q
Sbjct: 438 PQYRKFTWDEIVSATSSFSEDLRIGMGAYGMVYKCTLHHTTVAVKVLHSAGISQSKQFQQ 497
Query: 493 ELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 552
ELE+LS+IRHP+LLLLLGACPDHGCLVYEYMENGSLEDRL++KN+T PI WF+R+R+AWE
Sbjct: 498 ELEILSRIRHPNLLLLLGACPDHGCLVYEYMENGSLEDRLFQKNSTTPIRWFDRFRVAWE 557
Query: 553 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 612
+ASAL+FLH++KP+PIIHRD+KP NILL NLVSKIGD+GLST+LNSD +ST YK+T
Sbjct: 558 IASALSFLHSSKPQPIIHRDLKPANILLGGNLVSKIGDIGLSTVLNSDE--LSTMYKDTA 615
Query: 613 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 672
PVGTL YIDPEYQR+GLIS KSDVYA+G+V+LQLLTAKPA A+TH VETAI++ NL +IL
Sbjct: 616 PVGTLSYIDPEYQRSGLISTKSDVYAFGLVMLQLLTAKPATALTHVVETAIEDGNLTDIL 675
Query: 673 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARD--TVPSV 730
D +AG WP +ET +LA L LSCAELRR+DRPDL + VLP LERLKEVADRA ++ ++
Sbjct: 676 DPKAGLWPFQETLDLARLALSCAELRRRDRPDLLDHVLPTLERLKEVADRAHHSASMVAI 735
Query: 731 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNY 790
P PPNHFICPIL++VM++PCVAADGYTYDRKAIE+WL+E DKSP+T++PLP+K L+PNY
Sbjct: 736 KPKPPNHFICPILQDVMDDPCVAADGYTYDRKAIEKWLEEKDKSPMTNIPLPHKILIPNY 795
Query: 791 TLLSAILDWKSK 802
TLLSAIL+WKSK
Sbjct: 796 TLLSAILEWKSK 807
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449451988|ref|XP_004143742.1| PREDICTED: U-box domain-containing protein 35-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2457), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/797 (61%), Positives = 606/797 (76%), Gaps = 8/797 (1%)
Query: 9 LPNSPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPI 68
LP+S VAVA+ G + S+Y + W+LEKF+PEGI F+LLH PRITSVP +GN IPI
Sbjct: 15 LPSSSV--VAVAISGKKNSKYIIRWSLEKFLPEGIIDFRLLHFIPRITSVPNAVGNAIPI 72
Query: 69 EQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNI 128
QVR+DVAAAY++E W T LLPF+ M AQR+V ++V +E+DDVA AI +EV C+I
Sbjct: 73 SQVREDVAAAYRKEIWWHTSEKLLPFKKMFAQRKVHLDVVTLEADDVAGAIIEEVTKCSI 132
Query: 129 NKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKD 188
NKLVIG SQG+F+ K + LSSRIS P +CTVY + KGKL+S+RP D+ + S +D
Sbjct: 133 NKLVIGVSSQGLFSRKL--SGLSSRISALAPRYCTVYAISKGKLASIRPPDMDTNVSIRD 190
Query: 189 DSSDTGCSNSSSSSHNSSSQTDLGSAVASYTH--SSSPSLPTQRLQALSAVNKTLLHLKP 246
D+S+ ++S SS +SS S +SY+H S SPSLP QR QALS +N+ LL KP
Sbjct: 191 DASEESSASSYSSYTSSSLTDGSSSLTSSYSHFPSPSPSLPLQRFQALSTINQPLLTKKP 250
Query: 247 SSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDW-SDQASTTD 305
S + +HSRCQS D+E Q D S + QT+SR+SS +S EN+ W SD+AS++
Sbjct: 251 SPIKADHSRCQSVDIENQVDGVHSSSYVSDCIQTLSRASSSKSSPAENKSWNSDEASSSG 310
Query: 306 VLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRL 365
+ SS ESQ DV+FELEKLRIELRH RGM+AIAQ E DASR++N LN + EE +L
Sbjct: 311 MFNDYSSCESQADVSFELEKLRIELRHARGMFAIAQRETIDASRELNHLNNQRSEEARKL 370
Query: 366 SEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLE 425
EI A E A++E+ K+E RREA+ + AE+E R+EAEMKA AKEK E
Sbjct: 371 EEINNKAVAAKEFAREERVKHEALRREAKYVKERAEREGIYRKEAEMKALQNAKEKGKHE 430
Query: 426 RALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI 485
AL G Q+Y++ WE+I SAT SFSE+L+IGMG +GTVYK + HHT AVKVL S+ +
Sbjct: 431 NALQGPLQQYQHFQWEDIVSATSSFSEDLKIGMGAHGTVYKCSLHHTTVAVKVLHSRDSH 490
Query: 486 QNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE 545
+ Q LQELEVLS+I HPHLLLLLGACPD CLVYEYMENGSLEDRLYR+ NTP IPW+E
Sbjct: 491 KQMQLLQELEVLSRIHHPHLLLLLGACPDKNCLVYEYMENGSLEDRLYRRGNTPAIPWYE 550
Query: 546 RYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605
R+RIAWE+ASAL FLH++KPK IIHRD+KP NILLD NLVSKIGDVGLST+ NSDPS +S
Sbjct: 551 RFRIAWEIASALVFLHSSKPKSIIHRDLKPANILLDQNLVSKIGDVGLSTVFNSDPS-MS 609
Query: 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 665
T + N+GPVGTLCYIDPEYQRTGLISPKSDVYA+GMVILQLLTAKPA+A+TH VETAID
Sbjct: 610 TAFMNSGPVGTLCYIDPEYQRTGLISPKSDVYAFGMVILQLLTAKPAVALTHVVETAIDN 669
Query: 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARD 725
NL +LD +AG WP++ET ELA LGL CAE++RKDRPDLK+QVLP+L LK+VAD+AR+
Sbjct: 670 SNLINVLDIEAGHWPLEETYELARLGLRCAEMQRKDRPDLKDQVLPLLMTLKKVADKARN 729
Query: 726 TVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKN 785
V A PNHFICPIL++VMN+PCVAADGYTYDR+AIE+WLQ+ND SP+T LPLP+KN
Sbjct: 730 LASKVPAAIPNHFICPILQDVMNDPCVAADGYTYDRQAIEKWLQKNDNSPMTKLPLPDKN 789
Query: 786 LLPNYTLLSAILDWKSK 802
L+PNY+LLSAI++W SK
Sbjct: 790 LIPNYSLLSAIVEWNSK 806
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357455813|ref|XP_003598187.1| U-box domain-containing protein [Medicago truncatula] gi|355487235|gb|AES68438.1| U-box domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 941 bits (2432), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/798 (60%), Positives = 625/798 (78%), Gaps = 17/798 (2%)
Query: 11 NSPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQ 70
N+ + V +A+KGN+KS+Y V WAL+KF+ EGI++FKL+HVR IT VPTPMG +P+ Q
Sbjct: 10 NNKSSVVGLAIKGNKKSKYVVQWALDKFVHEGISIFKLIHVRAVITGVPTPMGEVLPLSQ 69
Query: 71 VRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINK 130
VR+DVA A+K+E +W+T+++LLPF+++C QR+V V+V VIESDDVA A+A+EVA I K
Sbjct: 70 VRNDVATAFKREVEWQTNQMLLPFKSLCEQRKVHVDVVVIESDDVATAVAEEVAREAITK 129
Query: 131 LVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKDDS 190
LV+GA S GIF K K +S++IS+C P FCTVY V KGKLS +RPSD GS D++
Sbjct: 130 LVLGASSSGIFRSKHK--GISAKISVCTPRFCTVYAVAKGKLS-IRPSDTEIDGSIIDNT 186
Query: 191 SDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTLLHLKPSSTE 250
S+T S+SSSS++ S+SQTD ++VAS S + TQR++A S++++TLL PS E
Sbjct: 187 SETSFSSSSSSNYTSTSQTD-SASVASCNALHSYAKETQRVRAHSSMDQTLLSTSPSLNE 245
Query: 251 INHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSM-ETEN----QDWSDQASTTD 305
NH R QS D+ +K+A++S ++ +S++SS S+ +TE+ Q+ + A+ +
Sbjct: 246 TNHFRGQSLDLG-RKNAAASSSRKSDIDHALSQASSCGSISDTESFFYEQNHAKDATRVN 304
Query: 306 VLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRL 365
LP S Q ++N ELEKLRIELRH +GM+A+AQ+E DAS+K+N+LNK +LEE ++
Sbjct: 305 RLP---PSNRQENINLELEKLRIELRHAQGMHAVAQSENVDASQKLNELNKRRLEESMKV 361
Query: 366 SEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLE 425
EI EE A+ELA QE++KYE A REA + AE+EAA+R+E E KA AKEKE LE
Sbjct: 362 KEIMAKEEMAMELANQEREKYEAAAREATYLKECAEREAAERKETEFKAIRAAKEKEKLE 421
Query: 426 RALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI 485
AL+G+ +YR TW+EI SAT SFSE+LR+GMG YG VYK T HHT AVKVL S GN
Sbjct: 422 DALSGSTPQYRIFTWDEIVSATSSFSEDLRLGMGAYGIVYKCTLHHTTVAVKVLHSTGNC 481
Query: 486 QNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE 545
+NKQF QELE+LS+I HP+LLLLLGACPDHGCLVYEYMENG+LEDRL +KN+ PIPWF
Sbjct: 482 KNKQFQQELEILSRIHHPNLLLLLGACPDHGCLVYEYMENGNLEDRLLQKNSNSPIPWFN 541
Query: 546 RYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605
R++IAWEVASAL+FLH++KP+PIIHRD+KP NILLD NLVSKIGDVGLST+L+SD +S
Sbjct: 542 RFQIAWEVASALSFLHSSKPQPIIHRDLKPANILLDGNLVSKIGDVGLSTILDSDE--LS 599
Query: 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 665
YK+T PVGTL YIDPEYQR+GLIS KSDVYA+G+VILQLLTAKPAIA+TH VETAID
Sbjct: 600 AMYKDTAPVGTLSYIDPEYQRSGLISTKSDVYAFGLVILQLLTAKPAIALTHIVETAIDG 659
Query: 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARD 725
NLA+ILD +AG WP++ET ++A L L CAE+RRKDRPDL + VLP+LERLKEVAD+A+
Sbjct: 660 GNLADILDPKAGSWPLQETLDIARLALGCAEMRRKDRPDLNDHVLPMLERLKEVADKAQH 719
Query: 726 --TVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPN 783
++ ++ PPNHFICPIL++VM++PCVAADGYTYDR AIE+WL+ENDKSP+T++ LP+
Sbjct: 720 SASIVTIKSRPPNHFICPILQDVMDDPCVAADGYTYDRNAIEKWLEENDKSPMTNMVLPH 779
Query: 784 KNLLPNYTLLSAILDWKS 801
K+L+PNYTLLSAIL+WK+
Sbjct: 780 KHLIPNYTLLSAILEWKT 797
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508200|ref|XP_003522847.1| PREDICTED: U-box domain-containing protein 35-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 929 bits (2400), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/797 (60%), Positives = 602/797 (75%), Gaps = 34/797 (4%)
Query: 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVA 76
VA+A+KGN+KS+Y V WAL KF+PEG+ +FKL+HV I VPTP +
Sbjct: 10 VALAIKGNKKSKYVVQWALNKFVPEGMIIFKLIHVHGGIKGVPTP--------------S 55
Query: 77 AAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQ 136
A+K+E +W+T+++LLPF+ MC QR+V V+V VIESDDVA AIADEVA I KLV+GA
Sbjct: 56 TAFKKEVEWQTNQMLLPFKRMCEQRKVHVDVIVIESDDVATAIADEVAKGAITKLVVGAS 115
Query: 137 SQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKDDSSDTGCS 196
S+G+F K K+ +S+RIS+ P FCT+Y + KGKLS +RPSD+ G+ DD+S++ S
Sbjct: 116 SRGLF--KSKQKGMSTRISVSTPRFCTIYAISKGKLS-IRPSDMPIDGNIIDDASESETS 172
Query: 197 NSSSSSHNSSSQTDLGSA-VASYTHSSSPSLPTQRLQALSAVNKTLLHLKPSSTEINHSR 255
S+SSS N +S + SA V+SY S SL TQR QALS++N LL PS + NHSR
Sbjct: 173 LSTSSSSNYTSTSQTESASVSSYAALQSSSLTTQRFQALSSINSALLSTNPSFADTNHSR 232
Query: 256 CQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDWS-DQASTTDV-----LPY 309
QS D+ + ASSS + ++ +SR SS +S ++ + W DQ S DV LP
Sbjct: 233 GQSLDLGRENTASSSARNS-DIDHALSRVSSCKSFISDTESWMYDQNSCKDVQLATTLP- 290
Query: 310 DSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQ 369
S Q N ELEKLRIELRH +G++A+AQ E +ASRK+NDL+K + EE R+ EI
Sbjct: 291 --SPNRQAKYNLELEKLRIELRHAQGLHAVAQTEKIEASRKLNDLSKRRSEETMRMKEII 348
Query: 370 LLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALN 429
EEKA ELAK E++KY+ A REAE + AE+EAA+++E E++A AKEKE LE AL+
Sbjct: 349 SKEEKAKELAKLEREKYQDASREAEYLKECAEREAAEKKEMELRAIRAAKEKEKLEDALS 408
Query: 430 GTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI--QN 487
G+ +YR TW+EI AT SFSE+L+IGMG YG VYK +HT AVKVL N+ +
Sbjct: 409 GSTPQYRKFTWDEIILATSSFSEDLKIGMGAYGVVYKCNLYHTTVAVKVLTLNTNVNSKR 468
Query: 488 KQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY 547
KQF QELE+LS+IRHP+LLLLLGACPDHGCLVYEYMENG+LEDRL RKNNT PIPWFER+
Sbjct: 469 KQFQQELEILSRIRHPNLLLLLGACPDHGCLVYEYMENGNLEDRLLRKNNTSPIPWFERF 528
Query: 548 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607
RIA EVAS+LAFLH++KP+PIIHRD+KP NILLD NLVSKIGD+GLST+LNSD +S
Sbjct: 529 RIALEVASSLAFLHSSKPEPIIHRDLKPANILLDRNLVSKIGDIGLSTVLNSDN--LSIM 586
Query: 608 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 667
K+T PVGTLCYIDPEYQRTGLISPKSD+YA+GMVILQLLTAKPAIA+ HKVETAID N
Sbjct: 587 SKDTAPVGTLCYIDPEYQRTGLISPKSDIYAFGMVILQLLTAKPAIALAHKVETAIDSGN 646
Query: 668 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRAR--D 725
L +ILD +AG WP +ET +LA LGLSCAELRR+DRPDL++ VLP LERLKEV DRA+
Sbjct: 647 LTDILDPEAGAWPYQETLDLALLGLSCAELRRRDRPDLQDHVLPTLERLKEVVDRAQCSA 706
Query: 726 TVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKN 785
++ ++ PPNHFICPIL++VM++PCVAADGYTYDRKAIE+WL+ENDKSP+T++ LP+K+
Sbjct: 707 SIVTIKSKPPNHFICPILQDVMDDPCVAADGYTYDRKAIEKWLEENDKSPMTNMALPHKH 766
Query: 786 LLPNYTLLSAILDWKSK 802
L+PNYTLLSAIL+WKS+
Sbjct: 767 LIPNYTLLSAILEWKSR 783
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449488729|ref|XP_004158155.1| PREDICTED: U-box domain-containing protein 35-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 905 bits (2338), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/750 (62%), Positives = 574/750 (76%), Gaps = 6/750 (0%)
Query: 56 TSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDV 115
T+VPTPMGN IPI QVR+DVAAAY++E W T LLPF+ M AQR+V ++V +E+DDV
Sbjct: 298 TTVPTPMGNAIPISQVREDVAAAYRKEIWWHTSEKLLPFKKMFAQRKVHLDVVTLEADDV 357
Query: 116 AKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSV 175
A AI +EV C+INKLVIG SQG+F+ K + LSSRIS P +CTVY + KGKL+S+
Sbjct: 358 AGAIIEEVTKCSINKLVIGVSSQGLFSRKL--SGLSSRISALAPRYCTVYAISKGKLASI 415
Query: 176 RPSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTH--SSSPSLPTQRLQA 233
RP D+ + S +DD+S+ ++S SS +SS S +SY+H S SPSLP QR QA
Sbjct: 416 RPPDMDTNVSIRDDASEESSASSYSSYTSSSLTDGSSSLTSSYSHFPSPSPSLPLQRFQA 475
Query: 234 LSAVNKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETE 293
LS +N+ LL KPS + +HSRCQS D+E Q D S + QT+SR+SS +S E
Sbjct: 476 LSTINQPLLTKKPSPIKADHSRCQSVDIENQVDGVHSSSYVSDCIQTLSRASSSKSSPAE 535
Query: 294 NQDW-SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVN 352
N+ W SD+AS++ + SS ESQ DV+FELEKLRIELRH RGM+AIAQ E DASR++N
Sbjct: 536 NKSWNSDEASSSGMFNDYSSCESQADVSFELEKLRIELRHARGMFAIAQRETIDASRELN 595
Query: 353 DLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEM 412
LN + EE +L EI A E A++E+ K+E RREA+ + AE+E R+EAEM
Sbjct: 596 HLNNQRSEEARKLEEINNKAVAAKEFAREERVKHEALRREAKYVKERAEREGIYRKEAEM 655
Query: 413 KAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHT 472
KA AKEK E AL G Q+Y++ WE+I SAT SFSE+L+IGMG +GTVYK + HHT
Sbjct: 656 KALQNAKEKGKHENALQGPLQQYQHFQWEDIVSATSSFSEDLKIGMGAHGTVYKCSLHHT 715
Query: 473 FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRL 532
AVKVL S+ + + Q LQELEVLS+I HPHLLLLLGACPD CLVYEYMENGSLEDRL
Sbjct: 716 TVAVKVLHSRDSHKQMQLLQELEVLSRIHHPHLLLLLGACPDKNCLVYEYMENGSLEDRL 775
Query: 533 YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 592
YR+ NTP IPW+ER+RIAWE+ASAL FLH++KPK IIHRD+KP NILLD NLVSKIGDVG
Sbjct: 776 YRRGNTPAIPWYERFRIAWEIASALVFLHSSKPKSIIHRDLKPANILLDQNLVSKIGDVG 835
Query: 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 652
LST+ NSDPS +ST + N+GPVGTLCYIDPEYQRTGLISPKSDVYA+GMVILQLLTAKPA
Sbjct: 836 LSTVFNSDPS-MSTAFMNSGPVGTLCYIDPEYQRTGLISPKSDVYAFGMVILQLLTAKPA 894
Query: 653 IAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPV 712
+A+TH VETAID NL +LD +AG WP++ET ELA LGL CAE++RKDRPDLK+QVLP+
Sbjct: 895 VALTHVVETAIDNSNLINVLDIEAGHWPLEETYELARLGLRCAEMQRKDRPDLKDQVLPL 954
Query: 713 LERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQEND 772
L LK+VAD+AR+ V A PNHFICPIL++VMN+PCVAADGYTYDR+AIE+WLQ+ND
Sbjct: 955 LMTLKKVADKARNLASKVPAAIPNHFICPILQDVMNDPCVAADGYTYDRQAIEKWLQKND 1014
Query: 773 KSPITDLPLPNKNLLPNYTLLSAILDWKSK 802
SP+T LPLP+KNL+PNY+LLSAI++W SK
Sbjct: 1015 NSPMTKLPLPDKNLIPNYSLLSAIVEWNSK 1044
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42567138|ref|NP_194246.2| U-box domain-containing protein 35 [Arabidopsis thaliana] gi|172044784|sp|Q9SW11.2|PUB35_ARATH RecName: Full=U-box domain-containing protein 35; AltName: Full=Plant U-box protein 35; Includes: RecName: Full=E3 ubiquitin ligase; Includes: RecName: Full=Serine/threonine-protein kinase gi|332659618|gb|AEE85018.1| U-box domain-containing protein 35 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2292), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/818 (55%), Positives = 585/818 (71%), Gaps = 37/818 (4%)
Query: 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDV 75
+V VA+ G+ KS+Y V WA+EKF EG FKLLH+ P ITSVPTPMGN IPI +VRDDV
Sbjct: 21 TVVVALSGSSKSKYVVTWAIEKFATEGNVGFKLLHIHPMITSVPTPMGNAIPISEVRDDV 80
Query: 76 AAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGA 135
AY+QE W+++ +L P+ + +R+V VEV VIESD+VA AIA+EV +I+++VIG
Sbjct: 81 VTAYRQEILWQSEEMLKPYTKLFVRRKVAVEVLVIESDNVAAAIAEEVTRDSIDRIVIGG 140
Query: 136 QSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKDDSSDTGC 195
S+ F+ +K ++ S IS +P+FCTVY V KGKLS VRPSD + ++D S+
Sbjct: 141 SSRSFFS---RKADICSVISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIREDGSERTN 197
Query: 196 SNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAV-NKTLLHLKPSSTEINHS 254
S+S SS S S + SA S S SLP +R+Q A+ + + ++ SS + +
Sbjct: 198 SSSGSSGPTSDSSDVMSSAHDS--QSRPLSLPVRRMQHFPAIAGQASVPMETSSVGSDET 255
Query: 255 RCQSFDVEEQKDASSSCLSGP--------------EVRQTVSRSSSYR------------ 288
RC S D EE +D SS S E ++ +S SSS R
Sbjct: 256 RCMSLDAEEARDVSSINRSSTDTTSRWTPRRRDYEERKEAMSSSSSNREYGNFGTRFSWS 315
Query: 289 --SMETENQDWSDQAST-TDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEAN 345
++T + S QAS +D L S +++QV++NFE+EKLR ELRHV+ MYA+AQ E
Sbjct: 316 GMGVDTTHSRASQQASNMSDALSEQSYTDNQVNLNFEVEKLRAELRHVQEMYAVAQTETF 375
Query: 346 DASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAA 405
DASRK+ +LN+ +LEE +L E++L E +A ELA++EK+ +E ARR+AE R AE+E A
Sbjct: 376 DASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMRERAEREIA 435
Query: 406 QRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVY 465
QR+EAE K+ + KEKE LE L +Y++ WEEI +AT SFSE L+IGMG YG VY
Sbjct: 436 QRREAERKSARDTKEKEKLEGTLGSPQLQYQHFAWEEIMAATSSFSEELKIGMGAYGAVY 495
Query: 466 KGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMEN 525
K HHT A VKVLQS N +KQF QELE+LSKIRHPHL+LLLGACP+ G LVYEYMEN
Sbjct: 496 KCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGALVYEYMEN 555
Query: 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 585
GSLEDRL++ NN+PP+PWFER+RIAWEVA+AL FLH +KPKPIIHRD+KP NILLDHN V
Sbjct: 556 GSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANILLDHNFV 615
Query: 586 SKIGDVGLSTMLNSDP-SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVIL 644
SK+GDVGLSTM+ DP S T YK T PVGTLCYIDPEYQRTG IS KSD+Y++GM++L
Sbjct: 616 SKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPEYQRTGRISSKSDIYSFGMILL 675
Query: 645 QLLTAKPAIAITHKVETAIDE-DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 703
QLLTAKPAIA+TH VE+A+D D +ILD +AG+WPI+ET+ELAAL L C ELR KDRP
Sbjct: 676 QLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCTELRGKDRP 735
Query: 704 DLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKA 763
DLK+Q+LP LE LK+VA++AR++ V PP HFICP+LK+VMNEPCVAADGYTYDR A
Sbjct: 736 DLKDQILPALENLKKVAEKARNSFSGVSTQPPTHFICPLLKDVMNEPCVAADGYTYDRHA 795
Query: 764 IEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 801
IEEWL+E++ SP+TD PL +KNLLPNYTL +AI++W+S
Sbjct: 796 IEEWLKEHNTSPMTDSPLHSKNLLPNYTLYTAIMEWRS 833
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297799476|ref|XP_002867622.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297313458|gb|EFH43881.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 881 bits (2277), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/818 (55%), Positives = 585/818 (71%), Gaps = 40/818 (4%)
Query: 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDV 75
+V VA+ G+ KS+Y V WALEKF PEG FKLLH+ P ITSVPTPMGN IPI +VRDDV
Sbjct: 21 TVVVALSGSSKSKYVVTWALEKFAPEGNVGFKLLHIHPMITSVPTPMGNAIPISEVRDDV 80
Query: 76 AAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGA 135
A++QE W+++ +L PF + +++V VEV VIESD++A AIA+EV +I+++VIG
Sbjct: 81 VTAFRQEILWQSEEMLKPFTKLFVRKKVAVEVLVIESDNLAAAIAEEVTRDSIDRIVIGG 140
Query: 136 QSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKDDSSDTGC 195
S+ F+ +K ++ S IS +P+FCTVY V KGKLS VRPSD + +DD G
Sbjct: 141 SSRSFFS---RKADMCSAISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIRDD----GS 193
Query: 196 SNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTL-LHLKPSSTEINHS 254
++SSS +S +D+ S+V + S + SLP +R+Q + + + ++ SS + +
Sbjct: 194 ERTNSSSGSSGPTSDVMSSVHD-SQSRALSLPVRRMQNFPTIARQASVPMETSSVGSDET 252
Query: 255 RCQSFDVEEQKDASSSCLSG--------PEVR------QTVSRSSSYR------------ 288
RC S D EE +D SS S P +R + +S SSS R
Sbjct: 253 RCMSLDAEEARDVSSINRSSTDTTSRWTPRLRDYEERKEAMSSSSSNREYGNIGSRFSWT 312
Query: 289 --SMETENQDWSDQAST-TDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEAN 345
++ + S QAS +D L S ++SQV++NFE+EKLR ELRHV+ MYA+AQ E
Sbjct: 313 GMGVDNTHSRASQQASNMSDALSEQSYTDSQVNLNFEVEKLRAELRHVQEMYAMAQTETF 372
Query: 346 DASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAA 405
DASRK+ +LN+ +LEE +L E++L E +A ELA++EK+ E ARR+AE R AE+E A
Sbjct: 373 DASRKLGELNQRRLEEAIKLEELKLKEYEARELAEREKQNVEKARRDAESMRERAEREIA 432
Query: 406 QRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVY 465
QR+E E K+ + KE+E L+ L +Y++ WEEI +AT SFSE L+IGMG YG VY
Sbjct: 433 QRREVERKSARDTKEREKLKGTLGSPQLQYQHFAWEEIMAATSSFSEELKIGMGAYGAVY 492
Query: 466 KGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMEN 525
K HHT AAVKVL S + +KQF QELE+LSKIRHPHL+LLLGACP+ G LVYEYMEN
Sbjct: 493 KCNLHHTTAAVKVLHSAESRLSKQFQQELEILSKIRHPHLVLLLGACPEQGALVYEYMEN 552
Query: 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 585
GSLEDRL++ NN+PP+PWFER+RIAWEVA+AL FLH +KPKPIIHRD+KP NILLD N V
Sbjct: 553 GSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANILLDQNFV 612
Query: 586 SKIGDVGLSTMLNSD-PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVIL 644
SK+GDVGLSTM+ D S T YK T PVGTLCYIDPEYQRTG+IS KSDVY++GM++L
Sbjct: 613 SKVGDVGLSTMVQVDLLSTKFTIYKQTSPVGTLCYIDPEYQRTGMISSKSDVYSFGMIVL 672
Query: 645 QLLTAKPAIAITHKVETAIDE-DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 703
QLLTAKPAIA+TH VE+A+D D +ILD +AG+WPI+ET+EL AL L C ELR KDRP
Sbjct: 673 QLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELTALALCCTELRGKDRP 732
Query: 704 DLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKA 763
DLKNQ+LP LE LK+VA+ AR+++ V PP HFICP+LK+VMNEPCVAADGYTYDR+A
Sbjct: 733 DLKNQILPALENLKKVAEMARNSLSGVSTQPPTHFICPLLKDVMNEPCVAADGYTYDRRA 792
Query: 764 IEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 801
IEEWL+E+D SP+TD PL +KNLLPNYTL +AI++W+S
Sbjct: 793 IEEWLEEHDTSPMTDSPLHSKNLLPNYTLYTAIMEWRS 830
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 802 | ||||||
| TAIR|locus:2117343 | 835 | AT4G25160 [Arabidopsis thalian | 0.709 | 0.681 | 0.547 | 7.2e-213 | |
| TAIR|locus:2151641 | 796 | AT5G61560 [Arabidopsis thalian | 0.461 | 0.464 | 0.583 | 7.2e-178 | |
| TAIR|locus:2176177 | 819 | AT5G51270 [Arabidopsis thalian | 0.460 | 0.450 | 0.641 | 2.5e-173 | |
| TAIR|locus:504954932 | 789 | AT5G57035 [Arabidopsis thalian | 0.458 | 0.466 | 0.508 | 3.2e-121 | |
| TAIR|locus:2047605 | 801 | AT2G19410 [Arabidopsis thalian | 0.635 | 0.636 | 0.435 | 7.6e-118 | |
| TAIR|locus:2061012 | 788 | AT2G24370 [Arabidopsis thalian | 0.566 | 0.576 | 0.436 | 1.2e-117 | |
| TAIR|locus:2015656 | 758 | AT1G16760 [Arabidopsis thalian | 0.365 | 0.386 | 0.547 | 2.2e-117 | |
| TAIR|locus:2128131 | 764 | AT4G31230 [Arabidopsis thalian | 0.531 | 0.557 | 0.426 | 7.8e-114 | |
| TAIR|locus:2063601 | 700 | AT2G07020 [Arabidopsis thalian | 0.578 | 0.662 | 0.429 | 1.7e-113 | |
| TAIR|locus:2143094 | 701 | AT5G12000 [Arabidopsis thalian | 0.776 | 0.888 | 0.358 | 1.6e-111 |
| TAIR|locus:2117343 AT4G25160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1561 (554.6 bits), Expect = 7.2e-213, Sum P(2) = 7.2e-213
Identities = 319/583 (54%), Positives = 403/583 (69%)
Query: 225 SLPTQRLQALSAVNKTLLHLKPSSTEINHSRC--QSFDVEEQKDASSSCLSGPEVRQTVS 282
SL + + +S++N+ SST+ SR + D EE+K+A SS S E +
Sbjct: 259 SLDAEEARDVSSINR-------SSTDTT-SRWTPRRRDYEERKEAMSSSSSNREYGNFGT 310
Query: 283 RSS-SYRSMETENQDWSDQAST-TDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIA 340
R S S ++T + S QAS +D L S +++QV++NFE+EKLR ELRHV+ MYA+A
Sbjct: 311 RFSWSGMGVDTTHSRASQQASNMSDALSEQSYTDNQVNLNFEVEKLRAELRHVQEMYAVA 370
Query: 341 QNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYXXXXXXXXXXXXXX 400
Q E DASRK+ +LN+ +LEE +L E++L E +A ELA++EK+ +
Sbjct: 371 QTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMRERA 430
Query: 401 XXXXXXXXXXXXXXXXXXXXXXXXXRALNGTFQRYRNLTWEEIESATLSFSENLRIGMGG 460
L +Y++ WEEI +AT SFSE L+IGMG
Sbjct: 431 EREIAQRREAERKSARDTKEKEKLEGTLGSPQLQYQHFAWEEIMAATSSFSEELKIGMGA 490
Query: 461 YGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVY 520
YG VYK HHT A VKVLQS N +KQF QELE+LSKIRHPHL+LLLGACP+ G LVY
Sbjct: 491 YGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGALVY 550
Query: 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 580
EYMENGSLEDRL++ NN+PP+PWFER+RIAWEVA+AL FLH +KPKPIIHRD+KP NILL
Sbjct: 551 EYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANILL 610
Query: 581 DHNLVSKIGDVGLSTMLNSDP-SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAY 639
DHN VSK+GDVGLSTM+ DP S T YK T PVGTLCYIDPEYQRTG IS KSD+Y++
Sbjct: 611 DHNFVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPEYQRTGRISSKSDIYSF 670
Query: 640 GMVILQLLTAKPAIAITHKVETAIDE-DNLAEILDAQAGDWPIKETKELAALGLSCAELR 698
GM++LQLLTAKPAIA+TH VE+A+D D +ILD +AG+WPI+ET+ELAAL L C ELR
Sbjct: 671 GMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCTELR 730
Query: 699 RKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYT 758
KDRPDLK+Q+LP LE LK+VA++AR++ V PP HFICP+LK+VMNEPCVAADGYT
Sbjct: 731 GKDRPDLKDQILPALENLKKVAEKARNSFSGVSTQPPTHFICPLLKDVMNEPCVAADGYT 790
Query: 759 YDRKAIEEWLQENDKSPITDXXXXXXXXXXXXXXXSAILDWKS 801
YDR AIEEWL+E++ SP+TD +AI++W+S
Sbjct: 791 YDRHAIEEWLKEHNTSPMTDSPLHSKNLLPNYTLYTAIMEWRS 833
|
|
| TAIR|locus:2151641 AT5G61560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1182 (421.1 bits), Expect = 7.2e-178, Sum P(2) = 7.2e-178
Identities = 223/382 (58%), Positives = 279/382 (73%)
Query: 433 QRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQ 492
Q+Y WEEI AT SFS+ L+IG+GGYG+VY+ HHT AVKVL S + KQF Q
Sbjct: 412 QQYMKFEWEEIVEATSSFSDELKIGVGGYGSVYRCNLHHTTVAVKVLHSDKSSLTKQFHQ 471
Query: 493 ELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLY-RKNNT-----PPIPWFER 546
ELE+LSKIRHPHLLLLLGACP+ G LVYEYM NGSLE+RL R+ N PP+ WFER
Sbjct: 472 ELEILSKIRHPHLLLLLGACPERGSLVYEYMHNGSLEERLMKRRPNVDTPQPPPLRWFER 531
Query: 547 YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606
+RIAWE+ASAL FLH +P+PI+HRD+KP NILLD N VSKIGDVGLS M+N DPS ST
Sbjct: 532 FRIAWEIASALYFLHTNEPRPIVHRDLKPANILLDRNNVSKIGDVGLSKMVNLDPSHAST 591
Query: 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 666
+ TGPVGT YIDPEYQRTG+++P+SD+YA+G+++LQL+TA+ A+ + H +E A+ +
Sbjct: 592 VFNETGPVGTFFYIDPEYQRTGVVTPESDIYAFGIILLQLVTARSAMGLAHSIEKALRDQ 651
Query: 667 N--LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRAR 724
EILD AGDWP+KE KE+ +GL CAE+R++DRPDL ++LPVLERLKEVA AR
Sbjct: 652 TGKFTEILDKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPDLGKEILPVLERLKEVASIAR 711
Query: 725 ----DTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDXX 780
D + H P HF CPI K+VM PCVA+DGYTY+++AI+EWLQ+N KSP+TD
Sbjct: 712 NMFADNLIDHHHNAPTHFYCPITKDVMENPCVASDGYTYEKRAIKEWLQKNHKSPMTDLP 771
Query: 781 XXXXXXXXXXXXXSAILDWKSK 802
SAI +W+S+
Sbjct: 772 FPSDSLLPNHSLLSAIKEWRSQ 793
|
|
| TAIR|locus:2176177 AT5G51270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1286 (457.8 bits), Expect = 2.5e-173, Sum P(2) = 2.5e-173
Identities = 240/374 (64%), Positives = 299/374 (79%)
Query: 434 RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQE 493
+Y+ TWEEI +AT SFSE+L+IGMG YG VYK HHT AAVKVL S + +KQF QE
Sbjct: 444 QYQEFTWEEIINATSSFSEDLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQE 503
Query: 494 LEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEV 553
LE+LSKIRHPHL+LLLGACPDHG LVYEYMENGSLEDRL++ N++ PIPWF R RIAWEV
Sbjct: 504 LEILSKIRHPHLVLLLGACPDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEV 563
Query: 554 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS-DP-SFVSTTYKNT 611
ASAL FLH +KP PIIHRD+KP NILL+HN VSK+GDVGLSTM+ + DP S T YK T
Sbjct: 564 ASALVFLHKSKPTPIIHRDLKPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQT 623
Query: 612 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---EDNL 668
PVGTLCYIDPEYQRTG ISPKSDVYA+GM+ILQLLT + A+A+T+ VETA++ +D L
Sbjct: 624 SPVGTLCYIDPEYQRTGRISPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDEL 683
Query: 669 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVP 728
+ILD +AG+WPI+ET++LAAL L C ELR KDRPDL++Q+LPVLE LK+VAD+AR+++
Sbjct: 684 IQILDEKAGNWPIEETRQLAALALQCTELRSKDRPDLEDQILPVLESLKKVADKARNSLS 743
Query: 729 SVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDXXXXXXXXXX 788
+ PP+HF CP+LK+VM EPC+AADGYTYDR+AIEEW++ + SP+T+
Sbjct: 744 AAPSQPPSHFFCPLLKDVMKEPCIAADGYTYDRRAIEEWMENHRTSPVTNSPLQNVNLLP 803
Query: 789 XXXXXSAILDWKSK 802
+AI++W+++
Sbjct: 804 NHTLYAAIVEWRNR 817
|
|
| TAIR|locus:504954932 AT5G57035 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 983 (351.1 bits), Expect = 3.2e-121, Sum P(2) = 3.2e-121
Identities = 188/370 (50%), Positives = 255/370 (68%)
Query: 434 RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQE 493
RYR T EEI +AT +FS IG GGYG VYK + HT A+KVL+ + ++FL+E
Sbjct: 409 RYRKYTKEEIAAATDNFSSRKIIGEGGYGKVYKCSLDHTPVALKVLKPDSVEKKEEFLKE 468
Query: 494 LEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEV 553
+ VLS++RHPH++LLLGACP++GCLVYEYMENGSL+ + K P + WF R+RI +E
Sbjct: 469 ISVLSQLRHPHVVLLLGACPENGCLVYEYMENGSLDCHISPKKGKPSLSWFIRFRIIYET 528
Query: 554 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
A LAFLHN+KP+PI+HRD+KPGNILLD N VSKIGDVGL+ +++ + T Y+N+
Sbjct: 529 ACGLAFLHNSKPEPIVHRDLKPGNILLDRNFVSKIGDVGLAKLMSDEAPDSVTVYRNSII 588
Query: 614 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673
GTL Y+DPEYQRTG I PKSD+YA+G++ILQLLTA+ + VE A+ ++LD
Sbjct: 589 AGTLYYMDPEYQRTGTIRPKSDLYAFGIIILQLLTARHPNGLLFCVEDAVKRGCFEDMLD 648
Query: 674 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPA 733
DWPI E KELA + + C++L+ +DRPDL QVLP L+R+ E A+ +R +
Sbjct: 649 GSVKDWPIAEAKELARIAIRCSQLKCRDRPDLSTQVLPALKRILESAN-SRLKTEQANAR 707
Query: 734 PPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQEN-DKSPITDXXXXXXXXXXXXXX 792
P H+ CPILKE+M +P +AADG+TY+RKAI+EW+Q++ D SP+T
Sbjct: 708 APTHYYCPILKEIMEDPQIAADGFTYERKAIKEWIQKHQDVSPVTKHRLKHSDLTPNHTL 767
Query: 793 XSAILDWKSK 802
SAI +W+S+
Sbjct: 768 RSAIREWRSR 777
|
|
| TAIR|locus:2047605 AT2G19410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1056 (376.8 bits), Expect = 7.6e-118, Sum P(2) = 7.6e-118
Identities = 226/519 (43%), Positives = 315/519 (60%)
Query: 285 SSYRSMETENQDWSDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEA 344
S+ ++ +E++D SD++ P S +V++ E+E+L+ EL+ Y A E
Sbjct: 283 SNVENIVSEHRD-SDRSP-----PETSRKSKKVEIEEEVERLKNELQSTVFKYKQACEEL 336
Query: 345 NDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYXXXXXXXXXXXXXXXXXX 404
KV L+ L E R++ EE A EK++Y
Sbjct: 337 FSTQNKVKMLSTEYLNESKRVNNAVEKEELQRNTAALEKERYMKAVKEVETAKALLAREF 396
Query: 405 XXXXXXXXXXXXXXXXXXXXXRALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTV 464
L GT RYR T EEI +AT FS IG GGYG V
Sbjct: 397 CQRQIAEVNALRTYLEKKKVIDQLLGTDHRYRKYTIEEIVTATEGFSPEKVIGEGGYGKV 456
Query: 465 YKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYME 524
Y+ + T AAVKV++ + ++FL+E+EVLS++RHPH++LLLGACP++GCLVYEY+E
Sbjct: 457 YQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPHVVLLLGACPENGCLVYEYLE 516
Query: 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 584
NGSLE+ ++ + N PP+PWF R+R+ +EVA LAFLH++KP+PI+HRD+KPGNILL+ N
Sbjct: 517 NGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSKPEPIVHRDLKPGNILLNRNY 576
Query: 585 VSKIGDVGLSTMLNS-DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 643
VSKI DVGL+ ++ P V T Y+N+ GTL YIDPEY RTG I PKSD+YA+G++I
Sbjct: 577 VSKIADVGLAKLVTDVAPDNV-TMYRNSVLAGTLHYIDPEYHRTGTIRPKSDLYAFGIII 635
Query: 644 LQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 703
LQLLTA+ I VE A+ + L E+LD DWP+ ET+ELA +GL CAE R +DRP
Sbjct: 636 LQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAETEELARIGLKCAEFRCRDRP 695
Query: 704 DLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKA 763
DLK++V+PVL+RL E A+ ++ + P+H+ CPIL+E+M EP +AADG+TY+RKA
Sbjct: 696 DLKSEVIPVLKRLVETAN-SKVKKEGSNLRAPSHYFCPILREIMEEPEIAADGFTYERKA 754
Query: 764 IEEWLQENDKSPITDXXXXXXXXXXXXXXXSAILDWKSK 802
I WL++++ SP+T SAI DWKS+
Sbjct: 755 ILAWLEKHNISPVTRQKLDHFKLTPNHTLRSAIRDWKSR 793
|
|
| TAIR|locus:2061012 AT2G24370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 1.2e-117, Sum P(2) = 1.2e-117
Identities = 200/458 (43%), Positives = 276/458 (60%)
Query: 270 SCLSGPEVRQTVSRSSSYRSMETENQDWSDQASTTDVLPYDSSSESQVDVNFELEKLRIE 329
S S + ++ +SS+Y + +D S + S+S+S DV E+ +L++E
Sbjct: 304 SNFSDMDYSSSLDQSSNYGRRSVDMNSPTDFESER----FSSASQSIDDVEAEMRRLKLE 359
Query: 330 LRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYXXX 389
L+ MY+ A EA A +K +L + KLEEE +L E + EE A+ +A++EK K
Sbjct: 360 LKQTMEMYSTACKEALTAKQKATELQRWKLEEERKLEEARNAEEAALAIAEKEKAKSKAA 419
Query: 390 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXRALNGTFQRYRNLTWEEIESATLS 449
AL + RYR + E+IE AT
Sbjct: 420 MEAAEAAQRIAELEAKKRVNAEMKALKESEEKTKALTALANSDVRYRKYSIEDIELATEF 479
Query: 450 FSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLL 509
F+E +IG GGYG VYK HT AVKVL+ QF QE+EVLS IRHP+++LLL
Sbjct: 480 FAEKYKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQQEVEVLSCIRHPNMVLLL 539
Query: 510 GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
GACP+ GCLVYE+M NGSLEDRL+R N+PP+ W R+RIA E+ + L FLH KP+P++
Sbjct: 540 GACPECGCLVYEFMANGSLEDRLFRLGNSPPLSWQMRFRIAAEIGTGLLFLHQAKPEPLV 599
Query: 570 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 629
HRD+KPGNILLD N VSKI DVGL+ ++ + T Y+ T GT CYIDPEYQ+TG+
Sbjct: 600 HRDLKPGNILLDRNFVSKISDVGLARLVPPTVADTVTQYRMTSTAGTFCYIDPEYQQTGM 659
Query: 630 ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAA 689
+ KSD+Y+ G++ LQL+TAKP + +TH VE A+++ L ++LD DWP+++T+E A
Sbjct: 660 LGVKSDIYSLGIMFLQLITAKPPMGLTHYVERALEKGTLVDLLDPVVSDWPMEDTEEFAK 719
Query: 690 LGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTV 727
L L CAELRRKDRPDL +LP L RL+ +AD + +V
Sbjct: 720 LALKCAELRRKDRPDLAKVILPELNRLRTLADESSHSV 757
|
|
| TAIR|locus:2015656 AT1G16760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 857 (306.7 bits), Expect = 2.2e-117, Sum P(3) = 2.2e-117
Identities = 161/294 (54%), Positives = 215/294 (73%)
Query: 434 RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQE 493
RYR + +EIE T +F+E+ ++G GGYG V++G HT AVKVL+ QF +E
Sbjct: 434 RYRKYSVQEIEEGTANFAESRKVGEGGYGPVFRGHLDHTSVAVKVLRPDAAQGRSQFHKE 493
Query: 494 LEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEV 553
+EVLS IRHP+++LLLGACP++G LVYEYM GSL+DRL+R+ NTPPI W R+RIA E+
Sbjct: 494 VEVLSCIRHPNMVLLLGACPEYGILVYEYMARGSLDDRLFRRGNTPPISWQLRFRIAAEI 553
Query: 554 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
A+ L FLH TKP+PI+HRD+KPGN+LLDHN VSKI DVGL+ ++ + V T Y+ T
Sbjct: 554 ATGLLFLHQTKPEPIVHRDLKPGNVLLDHNYVSKISDVGLARLVPAVAENV-TQYRVTSA 612
Query: 614 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673
GT CYIDPEYQ+TG++ KSDVY+ G+++LQLLTAK + + + VE AI+E L ++LD
Sbjct: 613 AGTFCYIDPEYQQTGMLGVKSDVYSLGIMLLQLLTAKQPMGLAYYVEQAIEEGTLKDMLD 672
Query: 674 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTV 727
DWP++E LA L L CAELRRKDRPDL +V+P L RL+E+ + + D+V
Sbjct: 673 PAVPDWPLEEALSLAKLSLQCAELRRKDRPDLGKEVMPELSRLREIGEESLDSV 726
|
|
| TAIR|locus:2128131 AT4G31230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 925 (330.7 bits), Expect = 7.8e-114, Sum P(2) = 7.8e-114
Identities = 182/427 (42%), Positives = 254/427 (59%)
Query: 309 YDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEI 368
+ S+S+ DV E+ +L++EL+ MY+ A EA A K +L + KL EE + E
Sbjct: 327 FSSASQGGDDVEAEMRRLKLELKQTMEMYSTACKEALTAKHKATELQRWKLAEERKFEEA 386
Query: 369 QLLEEKAIELAKQEKKKYXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXRAL 428
+L EE A+ +A++EK K AL
Sbjct: 387 KLAEEAALAIAEKEKAKSKAAMEAAEAAQRIADIESRKRVDAETKALKESEARTKAVNAL 446
Query: 429 NGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNK 488
RYR + EEIE AT F + +IG G YG VYK HT AVK L+
Sbjct: 447 AKDV-RYRKYSIEEIEDATEFFDDKYKIGEGSYGPVYKCYLDHTPVAVKALRPDAAQGRS 505
Query: 489 QFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 548
QF +E+EVL IRHP+++LLLGACP+ GCLVYE+M NGSLEDRL+R+ ++P + W R+R
Sbjct: 506 QFQKEVEVLCSIRHPNMVLLLGACPECGCLVYEFMANGSLEDRLFRQGDSPALSWQTRFR 565
Query: 549 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 608
IA E+ + L FLH TKP+P++HRD+KP NILLD N VSK+ DVGL+ ++ + T Y
Sbjct: 566 IAAEIGTVLLFLHQTKPEPLVHRDLKPANILLDRNFVSKLADVGLARLVPPSVANTVTQY 625
Query: 609 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 668
T GT CYIDPEYQ+TG++ KSD+Y+ G++ LQL+T KP + +TH VE A+++ NL
Sbjct: 626 HMTSTAGTFCYIDPEYQQTGMLGVKSDIYSLGIMFLQLITGKPPMGLTHYVERALEKGNL 685
Query: 669 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVP 728
++LD DWP+++T E A L L CAE+RRKDRPDL +LP L RL+ +A+ +
Sbjct: 686 KDLLDPAVSDWPVEDTTEFAKLALKCAEIRRKDRPDLSKVILPELNRLRVLAEESTQAAV 745
Query: 729 SVHPAPP 735
++ + P
Sbjct: 746 VINSSGP 752
|
|
| TAIR|locus:2063601 AT2G07020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 946 (338.1 bits), Expect = 1.7e-113, Sum P(3) = 1.7e-113
Identities = 203/473 (42%), Positives = 286/473 (60%)
Query: 258 SFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDWSDQASTTDVLPYDSSSESQV 317
S D E ++ + S +Q++ SSY + T +Q+ S + S+ + Y SQ
Sbjct: 235 SMDWFEDNRSNYATSSSSSEKQSIDLCSSYSAFSTSSQE-SGRLSSLSM--Y-----SQD 286
Query: 318 DVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIE 377
DV E+ +L++EL++ MY A EA A + +L+K K E + +L E L +E A+
Sbjct: 287 DVESEMRRLKLELKYTMDMYNSACKEAIAAKKTTIELHKWKEERKHKLEEAILAKEAAMA 346
Query: 378 LAKQEKKKYXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXRALNGTFQRYRN 437
+A+ EK K AL + + YR
Sbjct: 347 IAENEKAKSRAAMEALEAAHRMAETEAQKRKQIETAALREVEHENKAMHALPHSNRMYRK 406
Query: 438 LTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVL 497
T EEIE T FS++ +IG G YGTVYKGT +T A+KV++ QF QE+EVL
Sbjct: 407 YTIEEIEQGTTKFSDSHKIGEGSYGTVYKGTLDYTPVAIKVVRPDATQGRSQFQQEVEVL 466
Query: 498 SKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 557
+ IRHP+++LLLGAC ++GCLVYEYM NGSL+D L R+ N+P + W R+RIA E+A++L
Sbjct: 467 TCIRHPNMVLLLGACAEYGCLVYEYMSNGSLDDCLLRRGNSPVLSWQLRFRIAAEIATSL 526
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 617
FLH KP+P++HRD+KP NILLD ++VSKI DVGL+ ++ ++T Y+ T GTL
Sbjct: 527 NFLHQLKPEPLVHRDLKPANILLDQHMVSKISDVGLARLVPPTIDDIATHYRMTSTAGTL 586
Query: 618 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 677
CYIDPEYQ+TG++ KSD+Y++G+V+LQ+LTAK + +T++VE AI+E N A+ILD
Sbjct: 587 CYIDPEYQQTGMLGTKSDIYSFGIVLLQILTAKTPMGLTNQVEKAIEEGNFAKILDPLVT 646
Query: 678 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARD-TVPS 729
DWPI+E LA +GL CAELRRKDRPDL VLP L+RL +A+ T PS
Sbjct: 647 DWPIEEALILAKIGLQCAELRRKDRPDLGTVVLPGLKRLMNLAEENMSITRPS 699
|
|
| TAIR|locus:2143094 AT5G12000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1063 (379.3 bits), Expect = 1.6e-111, Sum P(2) = 1.6e-111
Identities = 234/653 (35%), Positives = 361/653 (55%)
Query: 88 DRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIF--TWKF 145
++L +P+R CA++ + + +++ DV+KA+ D V + + LV+G+ S+ F + KF
Sbjct: 69 NQLFVPYRGYCARKGISMMEVILDDTDVSKAVLDYVNNNLVTNLVLGSSSKSPFARSLKF 128
Query: 146 -KKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSD---LGSIGSTKXXXXXXXXXXXXXX 201
K ++++S + P FC+VY + KGK+ S R + ++ +
Sbjct: 129 TKSHDVASSVLKSTPEFCSVYVISKGKVHSSRTAQRPITNTLVPPRVPSSTFHLPDPDHD 188
Query: 202 XXXXXXQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTL---LHLKPSSTEINHSRCQS 258
+ + Y+H + P + + + N +L + + N + S
Sbjct: 189 RSPRSQRNGRNTVPERYSHENKGFKPVREMHKIPT-NGSLDFNYEFRQGKGQRNSTGRSS 247
Query: 259 FDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDWSDQASTTDVLPYDSSSESQVD 318
F +E D S + G ++ S+ EN D + ++D +S+S+S D
Sbjct: 248 FS-DESSDVGSMMMMG-----SIDLSA-------ENFDMVGGSGSSD----ESASQSTRD 290
Query: 319 VNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIEL 378
+ E+++L+IEL+ MY+ A EA +A +K N+LN+ K+EE R E + EE A+ +
Sbjct: 291 IEAEMKRLKIELKQTMDMYSSACKEALNAKKKANELNQWKMEEARRFEEARNAEEAALAV 350
Query: 379 AKQEKKKYXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXRALNGTFQRYRNL 438
A+ EK K AL RYR
Sbjct: 351 AEMEKAKCRAALEAAEKAQRMAELEGQRRKQAEMKARRESQEKDRALSALVQNDVRYRKY 410
Query: 439 TWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLS 498
+ +EIE AT F+ N +IG GGYG VY GT HT A+KVL+ KQF QE+EVLS
Sbjct: 411 SIDEIEVATERFANNRKIGEGGYGPVYHGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLS 470
Query: 499 KIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 558
IRHPH++LLLGACP++GCLVYE+M+NGSLEDRL+R+ N+PP+ W +R++IA E+A+AL+
Sbjct: 471 SIRHPHMVLLLGACPEYGCLVYEFMDNGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALS 530
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
FLH KP+P++HRD+KP NILLD N VSKI DVGL+ ++ + + T Y T GT C
Sbjct: 531 FLHQAKPEPLVHRDLKPANILLDKNYVSKISDVGLARLVPASVANTVTQYHMTSAAGTFC 590
Query: 619 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 678
YIDPEYQ+TG ++ KSD+++ G+++LQ++TAK + + H V AID+ ++LD D
Sbjct: 591 YIDPEYQQTGKLTTKSDIFSLGIMLLQIITAKSPMGLAHHVSRAIDKGTFKDMLDPVVPD 650
Query: 679 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVH 731
WP++E A L L CAELR++DRPDL +++P L RL+ + +D P H
Sbjct: 651 WPVEEALNFAKLCLRCAELRKRDRPDLGKEIVPELLRLRNLG---KDNEPGCH 700
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SW11 | PUB35_ARATH | 2, ., 7, ., 1, 1, ., - | 0.5599 | 0.9738 | 0.9353 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 6.3.2 | 0.691 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 802 | |||
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 1e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-39 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| smart00504 | 63 | smart00504, Ubox, Modified RING finger domain | 1e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-16 | |
| pfam04564 | 73 | pfam04564, U-box, U-box domain | 7e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-09 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 4e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-06 | |
| pfam13445 | 55 | pfam13445, zf-RING_LisH, RING-type zinc-finger, Li | 2e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-06 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 4e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 2e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-05 | |
| pfam00582 | 139 | pfam00582, Usp, Universal stress protein family | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-05 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 5e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-04 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 2e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 5e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 6e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-04 | |
| pfam03763 | 112 | pfam03763, Remorin_C, Remorin, C-terminal region | 8e-04 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 9e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.001 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.002 | |
| PRK00409 | 782 | PRK00409, PRK00409, recombination and DNA strand e | 0.002 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 0.003 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.003 | |
| COG3064 | 387 | COG3064, TolA, Membrane protein involved in colici | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.004 | |
| COG4942 | 420 | COG4942, COG4942, Membrane-bound metallopeptidase | 0.004 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.004 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 0.004 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 71/155 (45%), Positives = 97/155 (62%), Gaps = 9/155 (5%)
Query: 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDV 75
SVAVAV ++KS+ A+ WAL+ +G L+HV P ITS+P+ G +V
Sbjct: 1 SVAVAVDKDKKSKNALKWALDNLATKGQT-IVLVHVHPPITSIPSSSGKL--------EV 51
Query: 76 AAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGA 135
A+AYKQEE + LLLP+R C+++ V+ E V+E DDVAKAI + VA I KLV+GA
Sbjct: 52 ASAYKQEEDKEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGA 111
Query: 136 QSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKG 170
S F+ KFKK++++S + P FCTVY V KG
Sbjct: 112 SSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 73/198 (36%), Positives = 108/198 (54%), Gaps = 18/198 (9%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC 512
+G GG+GTVY T A+K+++ + + + L+E+E+L K+ HP+++ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 513 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
+H LV EY E GSL+D K N + E RI ++ L +LH+ IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKD--LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 571 RDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTG 628
RD+KP NILLD N K+ D GLS +L SD S + T VGT Y+ PE G
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI------VGTPAYMAPEVLLGKG 169
Query: 629 LISPKSDVYAYGMVILQL 646
S KSD+++ G+++ +L
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 8e-43
Identities = 76/204 (37%), Positives = 110/204 (53%), Gaps = 19/204 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVL--QSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
++G G +GTVYK T AVK+L +S+ + +++ +E+ +L ++ HP+++ L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 511 AC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
A DH LV EY E G L D L R P+ E +IA ++ L +LH+ I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRT 627
IHRD+KP NILLD N V KI D GL+ L S T VGT Y+ PE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS------SLTTFVGTPWYMAPEVLLGG 173
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
PK DV++ G+++ +LLT KP
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKP 197
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 29/260 (11%)
Query: 456 IGMGGYGTVYKGT------FHHTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLL 508
+G G +G VYKGT T AVK L+ + + ++ FL+E ++ K+ HP+++ L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 509 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
LG C +V EYM G L D L + + ++A ++A + +L + K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLES---K 121
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
+HRD+ N L+ NLV KI D GLS + D + P+ ++ PE +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG-GGKLPI---KWMAPESLK 177
Query: 627 TGLISPKSDVYAYGMVILQLLT--AKP-AIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683
G + KSDV+++G+++ ++ T +P +V +++ P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR--------PENC 229
Query: 684 TKELAALGLSCAELRRKDRP 703
EL L L C +DRP
Sbjct: 230 PDELYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 78/260 (30%), Positives = 121/260 (46%), Gaps = 29/260 (11%)
Query: 456 IGMGGYGTVYKGTF------HHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+G G +G VYKGT AVK L+ Q ++FL+E ++ K+ HP+++ L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 509 LGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
LG C + +V EYM G L D L RKN + + A ++A + +L + K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES---K 122
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
IHRD+ N L+ NLV KI D GLS L D YK G + ++ PE +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-----DYYKVKGGKLPIRWMAPESLK 177
Query: 627 TGLISPKSDVYAYGMVILQLLT--AKPAIAITHK-VETAIDEDNLAEILDAQAGDWPIKE 683
G + KSDV+++G+++ ++ T +P +++ V + + P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK--------PPNC 229
Query: 684 TKELAALGLSCAELRRKDRP 703
EL L L C +DRP
Sbjct: 230 PPELYKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 6e-39
Identities = 75/260 (28%), Positives = 120/260 (46%), Gaps = 30/260 (11%)
Query: 456 IGMGGYGTVYKGT------FHHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+G G +G VYKG AVK L+ Q ++FL+E ++ K+ HP+++ L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 509 LGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
LG C + +V EYME G L L + N P + + A ++A + +L + K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLES---K 121
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
IHRD+ N L+ NLV KI D GLS L D Y+ G + ++ PE +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-----DYYRKRGGKLPIRWMAPESLK 176
Query: 627 TGLISPKSDVYAYGMVILQLLT--AKPAIAITHK-VETAIDEDNLAEILDAQAGDWPIKE 683
G + KSDV+++G+++ ++ T +P ++++ V + P
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQ--------PPNC 228
Query: 684 TKELAALGLSCAELRRKDRP 703
EL L L C +DRP
Sbjct: 229 PPELYDLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 9e-39
Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
+G G +G VY T A+KV++ K ++ L+E+++L K++HP+++ L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 513 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAFLHNTKPKPII 569
D LV EY E G L D L ++ + R ++ SAL +LH+ K I+
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRGRLSE----DEARFYLRQILSALEYLHS---KGIV 119
Query: 570 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 629
HRD+KP NILLD + K+ D GL+ L+ T VGT Y+ PE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-------TTFVGTPEYMAPEVLLGKG 172
Query: 630 ISPKSDVYAYGMVILQLLTAKP 651
D+++ G+++ +LLT KP
Sbjct: 173 YGKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 456 IGMGGYGTVYKGTF-----HHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLL 509
+G G +G VYKG T AVK L+ + K FL+E V+ K+ HP+++ LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 510 GACPDHG--CLVYEYMENGSLEDRL------YRKNNTPPIPWFERYRIAWEVASALAFLH 561
G C + LV EYME G L D L + + + A ++A + +L
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
+ K +HRD+ N L+ +LV KI D GLS + D + T G I
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-------GGKLPIR 172
Query: 622 ---PEYQRTGLISPKSDVYAYGMVI 643
PE + G+ + KSDV+++G+++
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLL 197
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGA 511
+G G +G+VY T AVK ++ G+ + + +E+ +LS ++HP+++ G+
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 512 C----PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
+ + EY+ GSL L +K P P +Y ++ LA+LH+
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKY--TRQILEGLAYLHS---NG 121
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
I+HRD+K NIL+D + V K+ D G + L + T GT ++ PE R
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGD----IETGEGTGSVRGTPYWMAPEVIRG 177
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
+D+++ G ++++ T KP
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (323), Expect = 4e-32
Identities = 91/359 (25%), Positives = 144/359 (40%), Gaps = 28/359 (7%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHL---LLLL 509
+G G +G VY A+KVL K ++K +FL+E+++L+ + HP L
Sbjct: 8 LGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66
Query: 510 GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
LV EY++ GSLED L + P+ E I ++ SAL +LH K II
Sbjct: 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGII 123
Query: 570 HRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY---Q 625
HRD+KP NILLD + V K+ D GL+ +L S S + VGT Y+ PE
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKP------AIAITHKVETAIDEDNLAEILDAQAGDW 679
S SD+++ G+ + +LLT P + T + I E + +
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSN 243
Query: 680 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFI 739
P +K + L K+R + + L ++ + + + P
Sbjct: 244 PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLS 303
Query: 740 CPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILD 798
P + A + + AI + D S + PN + S +L
Sbjct: 304 --------LPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLS 354
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLLGAC 512
+G G G VYK T A+K + G+ + KQ L+EL+ L P+++ GA
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 513 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPI 568
G +V EYM+ GSL D L + IP E IA ++ L +LH + I
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKK---VGKIP--EPVLAYIARQILKGLDYLHTKRH--I 121
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
IHRD+KP N+L++ KI D G+S +L + + NT VGT+ Y+ PE +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLEN-----TLDQCNTF-VGTVTYMSPERIQGE 175
Query: 629 LISPKSDVYAYGMVILQLLTAK 650
S +D+++ G+ +L+ K
Sbjct: 176 SYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 455 RIGMGGYGTVYKGTFHHTF----AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+IG GG+G VYK H A+KV++ + + ++ + E+++L K +HP+++ G
Sbjct: 7 KIGKGGFGEVYKA--RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 511 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKP 565
+ D +V E+ GSL+D L + N +IA+ E+ L +LH+
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKD-LLKSTNQT----LTESQIAYVCKELLKGLEYLHSNG- 118
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
IIHRD+K NILL + K+ D GLS +S T VGT ++ PE
Sbjct: 119 --IIHRDIKAANILLTSDGEVKLIDFGLSA-------QLSDTKARNTMVGTPYWMAPEVI 169
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKP 651
K+D+++ G+ ++L KP
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 44/218 (20%)
Query: 456 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQF-LQELEVLSKIRHPHLLLLLGA 511
IG G +G VY + ++ S + + ++ L E+++L K+ HP+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII----K 63
Query: 512 C------PDHGCLVYEYMENGSLEDRL--YRKNNTPPIPWFERYRI-AW--EVASALAFL 560
C+V EY + G L ++ +K P F +I W ++ AL +L
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP----FPEEQILDWFVQLCLALKYL 119
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
H+ K I+HRD+KP NI L N + K+GD G+S +L+S T VGT Y+
Sbjct: 120 HSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV------VGTPYYL 170
Query: 621 DPE------YQRTGLISPKSDVYAYGMVILQLLTAKPA 652
PE Y + KSD+++ G V+ +L T K
Sbjct: 171 SPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 72/219 (32%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 456 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNI--QNKQ--FLQELEVLSKI-RHPHLLLL 508
IG G + TV T A+K+L K + + K E EVL+++ HP ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKIL-DKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 509 LGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
D L V EY NG L + RK + R+ A E+ AL +LH+ K
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCT-RFYAA-EILLALEYLHS---K 121
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP------------- 613
IIHRD+KP NILLD ++ KI D G + +L+ + S S T
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 614 -VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 651
VGT Y+ PE SD++A G +I Q+LT KP
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGAC 512
+G G G V K T AVK ++ + N KQ L+EL++L K P+++ GA
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 513 PDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
++G C+ EYM+ GSL+ K IP +IA V L +LH I
Sbjct: 69 YNNGDISICM--EYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--I 122
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
IHRD+KP NIL++ K+ D G+S L NS ++ T+ VGT Y+ PE +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTF-----VGTSSYMAPERIQG 173
Query: 628 GLISPKSDVYAYGMVILQLLTAK 650
S KSD+++ G+ +++L T +
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVK--VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
IG G +G VYKG T F A+K L+ K +QE+++L ++HP+++ +G+
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 512 CPDHGCL--VYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAWEVASALAFLHNTKPKPI 568
L + EY ENGSL + K P P Y + +V LA+LH +
Sbjct: 68 IETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVY-VY-QVLQGLAYLHEQG---V 120
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
IHRD+K NIL + V K+ D G++T LN + VGT ++ PE
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSK------DDASVVGTPYWMAPEVIEMS 174
Query: 629 LISPKSDVYAYGMVILQLLTAKP 651
S SD+++ G +++LLT P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|128780 smart00504, Ubox, Modified RING finger domain | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-23
Identities = 29/63 (46%), Positives = 41/63 (65%)
Query: 737 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAI 796
F+CPI EVM +P + G TY+R AIE+WL + P+T PL +++L+PN L SAI
Sbjct: 1 EFLCPISLEVMKDPVILPSGQTYERSAIEKWLLSHGTDPVTGQPLTHEDLIPNLALKSAI 60
Query: 797 LDW 799
+W
Sbjct: 61 QEW 63
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. Length = 63 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQFLQ---ELEVLSKIRHPHLLLL 508
+G G +G V K T +A +KVL+ K I+ K+ E +LS+I HP ++ L
Sbjct: 1 LGKGSFGKVLLVRKKDT-GKLYA-MKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 509 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
A + LV EY G L L K Y A E+ AL +LH+
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFY-AA-EIVLALEYLHS---L 112
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY-Q 625
II+RD+KP NILLD + K+ D GL+ L+S+ S +T GT Y+ PE
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT------FCGTPEYLAPEVLL 166
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKP 651
G D ++ G+++ ++LT KP
Sbjct: 167 GKG-YGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 74/259 (28%), Positives = 122/259 (47%), Gaps = 28/259 (10%)
Query: 455 RIGMGGYGTVYKGTFH---HTFAAVKV-LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+IG G +G V+K +A ++ L + ++ + E VL+K+ +++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 511 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
+ D G +V EY ENG L L + P+P + +R ++ LA LH+ K I
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---I 122
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
+HRD+K N+ LD KIGD+G++ +L+ + +F +T VGT Y+ PE
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI------VGTPYYLSPELCEDK 176
Query: 629 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP---IKETK 685
+ KSDV+A G+V+ + T K H + + A IL G +P ++
Sbjct: 177 PYNEKSDVWALGVVLYECCTGK------HPFDA---NNQGALILKIIRGVFPPVSQMYSQ 227
Query: 686 ELAALGLSCAELRRKDRPD 704
+LA L C + RPD
Sbjct: 228 QLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 80/272 (29%), Positives = 120/272 (44%), Gaps = 45/272 (16%)
Query: 455 RIGMGGYGTVYK------GTFHHTFAAVKVLQSK----GNIQNK---QFLQELEVLSKIR 501
IG G +GTV K G K+L K GN+ K Q + E+ +L +++
Sbjct: 7 TIGKGSFGTVRKVRRKSDG---------KILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 502 HPHLLLLLGACPDHGC----LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVAS 555
HP+++ D +V EY E G L + +K I +RI ++
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLL 116
Query: 556 ALAFLHN-TKPKP-IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
AL HN + P ++HRD+KP NI LD N K+GD GL+ +L D SF + TY
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF-AKTY----- 170
Query: 614 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE-IL 672
VGT Y+ PE KSD+++ G +I +L P TA ++ LA I
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-------TARNQLQLASKIK 223
Query: 673 DAQAGDWPIKETKELAALGLSCAELRRKDRPD 704
+ + P + + EL + S + RP
Sbjct: 224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 449 SFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 507
S ++G G +G V+ GT++ T AVK L+ G + + FLQE +++ K+RH L+
Sbjct: 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQ 65
Query: 508 LLGACPDHG--CLVYEYMENGSLEDRLY----RKNNTPPIPWFERYRIAWEVASALAFLH 561
L C + +V EYM GSL D L +K P + +A ++A +A+L
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-----VDMAAQIAEGMAYLE 120
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
+ IHRD+ NIL+ NLV KI D GL+ ++ D K P+ +
Sbjct: 121 SRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIK---WTA 172
Query: 622 PEYQRTGLISPKSDVYAYGMVILQLLT 648
PE G + KSDV+++G+++ +++T
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 456 IGMGGYGTVYKGTFHHTF--------AAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLL 506
+G G +G V + AVK L S F +E+E+L + H +++
Sbjct: 12 LGEGHFGKVELC--RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 507 LLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
G C G L+ EY+ +GSL D L R + + + + ++ + +L +
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF--SSQICKGMDYLGS 127
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
+ IHRD+ NIL++ + KI D GL+ +L D + P+ + P
Sbjct: 128 QR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI---FWYAP 181
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLT 648
E RT S SDV+++G+ + +L T
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR 501
I S L IG G +G V G + AVK L+ + FL E V++ +R
Sbjct: 2 AINSKELKLGA--TIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAA-QAFLAEASVMTTLR 58
Query: 502 HPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 559
HP+L+ LLG L V EYM GSL D L R I ++ A +V + +
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
L K +HRD+ N+L+ +LV+K+ D GL+ + + +
Sbjct: 118 LEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAK---------EASQGQDSGKLPVKW 165
Query: 620 IDPEYQRTGLISPKSDVYAYGMVI 643
PE R S KSDV+++G+++
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 69/229 (30%), Positives = 117/229 (51%), Gaps = 30/229 (13%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSK 499
E+E ++ L G G YG VY+G + + AVK L+ ++ ++FL+E V+ +
Sbjct: 2 EMERTDITMKHKL--GGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKE 58
Query: 500 IRHPHLLLLLGAC----PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 555
I+HP+L+ LLG C P + ++ E+M G+L D L R+ N + +A +++S
Sbjct: 59 IKHPNLVQLLGVCTREPPFY--IITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISS 115
Query: 556 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 615
A+ +L + K IHRD+ N L+ N + K+ D GLS ++ D TY T G
Sbjct: 116 AMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TY--TAHAG 164
Query: 616 T---LCYIDPEYQRTGLISPKSDVYAYGMVILQLLT----AKPAIAITH 657
+ + PE S KSDV+A+G+++ ++ T P I ++
Sbjct: 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 62/215 (28%), Positives = 110/215 (51%), Gaps = 22/215 (10%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-AVKVLQSKGNIQNKQFLQELEVLS 498
WE I+ ++ ++G G +G V++G +++T AVK L+ G + K FL E +++
Sbjct: 1 WE-IDRTSIQLLR--KLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMK 56
Query: 499 KIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 556
K+RHP L+ L C +V E M+ GSL + L + + + +A +VAS
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASG 115
Query: 557 LAFL--HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGP 613
+A+L N IHRD+ N+L+ N + K+ D GL+ ++ D Y+ G
Sbjct: 116 MAYLEAQN-----YIHRDLAARNVLVGENNICKVADFGLARVIKED------IYEAREGA 164
Query: 614 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
+ + PE S KSDV+++G+++ +++T
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 456 IGMGGYGTVYKGTFH------HTFAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+G G +GTVYKG + A+KVL + NK+ L E V++ + HPH++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 509 LGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNTKP 565
LG C L+ + M G L D Y +N+ I +Y + W ++A +++L
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLD--YVRNHKDNIG--SQYLLNWCVQIAKGMSYLEE--- 127
Query: 566 KPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
K ++HRD+ N+L+ V KI D GL+ +L+ D Y G + ++ E
Sbjct: 128 KRLVHRDLAARNVLVKTPQHV-KITDFGLAKLLDVD----EKEYHAEGGKVPIKWMALES 182
Query: 625 QRTGLISPKSDVYAYGMVILQLLT--AKP 651
+ + KSDV++YG+ + +L+T AKP
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 66/271 (24%), Positives = 119/271 (43%), Gaps = 41/271 (15%)
Query: 456 IGMGGYGTVYKGTFH-----HTF--AAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLL 507
+G G +G VY+G A+K + ++ + +FL E V+ + H++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 508 LLGACPD--HGCLVYEYMENGSLEDRLY------RKNNTPPIPWFER-YRIAWEVASALA 558
LLG +V E M G L+ L N P ++ ++A E+A +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG----PV 614
+L K +HRD+ N ++ +L KIGD G++ + + Y+ G PV
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE-----TDYYRKGGKGLLPV 185
Query: 615 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEIL 672
++ PE + G+ + KSDV+++G+V+ ++ T +P +++ E+ L ++
Sbjct: 186 R---WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------EEVLKFVI 235
Query: 673 DAQAGDWPIKETKELAALGLSCAELRRKDRP 703
D D P +L L C + K RP
Sbjct: 236 DGGHLDLPENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 456 IGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGA 511
IG G +G VY AVK ++ + N K+ E++VL ++HP+L+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 512 --CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
+ + EY G+LE+ L Y + ++ LA+LH+ I+
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEH-VIRVYTL--QLLEGLAYLHSHG---IV 121
Query: 570 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 629
HRD+KP NI LDHN V K+GD G + L ++ + + ++ GT Y+ PE G
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL--AGTPAYMAPEVITGGK 179
Query: 630 ISPK---SDVYAYGMVILQLLTAKP 651
+D+++ G V+L++ T K
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 68/229 (29%), Positives = 100/229 (43%), Gaps = 39/229 (17%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA- 511
IG G YG VYK T A+K++ + + ++ +E +L K HP++ GA
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 512 -------CPDHGCLVYEYMENGSLED---RLYRKNNTPPIPWFERYRIAW---EVASALA 558
D LV E GS+ D L +K W IA+ E LA
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGLA 127
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTL 617
+LH K +IHRD+K NILL N K+ D G+S L+ ST + NT +GT
Sbjct: 128 YLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNTF-IGTP 177
Query: 618 CYIDPE-----YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 661
++ PE Q +SDV++ G+ ++L KP + H +
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 70/203 (34%), Positives = 114/203 (56%), Gaps = 24/203 (11%)
Query: 456 IGMGGYGTVYKGTFH---HTFAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+G G G+V K H T A KV + +K +++ KQ L+EL+++ + R P+++ G
Sbjct: 13 LGAGNGGSVSK-VKHIPTGTVMAKKVVHIGAKSSVR-KQILRELQIMHECRSPYIVSFYG 70
Query: 511 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
A ++ C+ E+M+ GSL DR+Y+K PIP +IA V L +L+N I
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+HRD+KP NIL++ K+ D G+S ++NS ++ T+ VGT Y+ PE +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTF-----VGTSTYMSPERIQG 176
Query: 628 GLISPKSDVYAYGMVILQLLTAK 650
G + KSDV++ G+ I++L K
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 455 RIGMGGYGTVYKGT-----FHHTFAAVKVLQSKGNIQNKQ--FLQELEVLSKIRHPHLLL 507
++G G +G V +G AVK L+S + + FL+E ++ + H +L+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS-DKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 508 LLGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
L G H +V E GSL DRL RK+ A ++A+ + +L + K
Sbjct: 61 LYGVVLTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLES---K 116
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
IHRD+ NILL + KIGD GL L ++ +V + + PE
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV----PFAWCAPESL 172
Query: 626 RTGLISPKSDVYAYGMVILQLLT 648
RT S SDV+ +G+ + ++ T
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 491 LQELEVLSKIRHPHLLLLLGACPDHGCLV--YEYMENGSLEDRLYRKNNTPPIPWFERYR 548
L E+ +LS ++HP+++ D L+ EY G+L D++ R+ FE
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ----LFEEEM 102
Query: 549 IAW---EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605
+ W ++ SA++++H I+HRD+K NI L + K+GD G+S +L S+ S
Sbjct: 103 VLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159
Query: 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 665
T VGT Y+ PE + + KSD++A G V+ +LLT K D
Sbjct: 160 TV------VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK----------RTFDA 203
Query: 666 DNLAEILDA-QAGDW-PIKE--TKELAALGLSCAELRRKDRP 703
N ++ G++ P+ + EL +L S + + RP
Sbjct: 204 TNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 65/232 (28%), Positives = 112/232 (48%), Gaps = 40/232 (17%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTF-------HHTFAAVKVLQSKGNIQNKQ-FLQE 493
EI + + F E L G G +G VYKG T A+K L+ + +Q F QE
Sbjct: 1 EIPLSAVRFLEEL--GEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 494 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTP------------ 539
E++S ++HP+++ LLG C C+++EY+ +G L + L R N+P
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVR--NSPHSDVGAESGDET 116
Query: 540 ---PIPWFERYRIAWEVASALAFL--HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594
+ + IA ++A+ + +L H+ +HRD+ N L+ L KI D GLS
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL 646
+ S + K+ PV ++ PE G + +SD++++G+V+ ++
Sbjct: 172 RDIYSA-DYYRVQSKSLLPVR---WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 455 RIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 513
++G G +G V++G + + A+K+L+S ++ + F +E++ L ++RH HL+ L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 514 DHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
G VY E ME GSL L R +P +A +VA +A+L IH
Sbjct: 73 V-GEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIH 127
Query: 571 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 630
RD+ NIL+ +LV K+ D GL+ ++ D V + P + PE G
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKED---VYLSSDKKIPYK---WTAPEAASHGTF 181
Query: 631 SPKSDVYAYGMVILQLLT 648
S KSDV+++G+++ ++ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 75/266 (28%), Positives = 124/266 (46%), Gaps = 33/266 (12%)
Query: 456 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQF--LQELEVLSKIRHPHLLLLLGA 511
+G G +G V+ + +K + + ++++ E +VL + HP+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 512 CPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
+ L V EY G+L + + ++ N+ + I L LH+ K I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNS----LLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 570 HRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
HRD+K NILLD H +V KIGD G+S +L S+ K VGT CYI PE
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL-------SSKSKAYTVVGTPCYISPELCEGK 176
Query: 629 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL-AEILDAQAGDW-PIKE--T 684
+ KSD++A G V+ +L + ++ A + NL A +L +G + PI + +
Sbjct: 177 PYNQKSDIWALGCVLYELAS----------LKRAFEAANLPALVLKIMSGTFAPISDRYS 226
Query: 685 KELAALGLSCAELRRKDRPDLKNQVL 710
+L L LS L RP L +Q++
Sbjct: 227 PDLRQLILSMLNLDPSKRPQL-SQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF--------LQELEVLSKI-RHP 503
++G G +G+VY T A+K + K+F L+E++ L K+ HP
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 504 HLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 561
+++ L ++ L V+EYME G+L L + P I +++ LA +H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYME-GNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
HRD+KP N+L+ V KI D GL+ + S P + T Y V T Y
Sbjct: 117 KHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDY-----VSTRWYRA 166
Query: 622 PE-YQRTGLISPKSDVYAYGMVILQLLTAKP 651
PE R+ S D++A G ++ +L T +P
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-19
Identities = 73/259 (28%), Positives = 121/259 (46%), Gaps = 32/259 (12%)
Query: 475 AVKVLQS---KGNIQNKQFLQELEVLSKIRHPHLLLLL--GACPDHGCL--VYEYMENGS 527
A+K+L++ + Q +F +E + +++ HP+++ LL G P G L V+EY+ +
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGRT 65
Query: 528 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNL 584
L + L P E R+ +V ALA HN + I+HRD+KP NI++
Sbjct: 66 LREVLAADGALPAG---ETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRP 119
Query: 585 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPV-GTLCYIDPEYQRTGLISPKSDVYAYGMVI 643
+K+ D G+ T+L T T V GT Y PE R ++P SD+YA+G++
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 644 LQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 703
L+ LT + V+ A ++AEIL Q + +A L LR+
Sbjct: 180 LECLTGQRV------VQGA----SVAEILYQQLSPVDVSLPPWIAGHPLG-QVLRKALNK 228
Query: 704 DLKNQVLP---VLERLKEV 719
D + + + ER + +
Sbjct: 229 DPRQRAASAPALAERFRAL 247
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 456 IGMGGYGTVY---KGTFHHTFAAVKVLQSKGNIQNK----QFLQELEVLSKIRHPHLLLL 508
I G YG V+ K + +A +KV+ K ++ K Q L E ++LS+ + P+++ L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYA-IKVI-KKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 509 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
+ + LV EY+ G L L + R IA E+ AL +LH+
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDV-ARIYIA-EIVLALEYLHSNG-- 113
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTM-LNSDPSFVS-TTYKNTGPVGTLCYIDPEY 624
IIHRD+KP NIL+D N K+ D GLS + L ++ ++ VGT YI PE
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKP 651
S D ++ G ++ + L P
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKG----NIQNKQFLQELEVLSKIRHPHLLLLLG 510
+G G YG V K T V + + K K L+E++VL ++RH +++ L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 511 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
A G LV+EY+E LE PP W++ A+A+ H+ I
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPD---AVRSYIWQLLQAIAYCHSHN---I 121
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
IHRD+KP NIL+ + V K+ D G + L + P+ T Y V T Y PE
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY-----VATRWYRAPEL---- 172
Query: 629 LISPKS-----DVYAYGMVILQLLTAKP 651
L+ + DV+A G ++ +LL +P
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFL-QELEVLSKIRHPHLLLLLGACP 513
+IG G G VYK T T V + + + QNK+ + E+ ++ +HP+++ +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 514 DHGCL--VYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
L V EYM+ GSL D + + N P I + EV L +LH+ + +
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA-----YVCREVLQGLEYLHS---QNV 137
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
IHRD+K NILL + K+ D G + L + S K VGT ++ PE +
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS------KRNSVVGTPYWMAPEVIKRK 191
Query: 629 LISPKSDVYAYGMVILQLLTAKP 651
PK D+++ G++ +++ +P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 36/287 (12%)
Query: 437 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH---HTFA----AVKVLQSKGNIQNKQ 489
+L WE LSF + L G G +G V + T + + A AVK+L+ + ++
Sbjct: 27 DLKWE-FPRNNLSFGKTL--GAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE 83
Query: 490 FL-QELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFE 545
L EL+++S + H +++ LLGAC G ++ EY G L + L RK + F
Sbjct: 84 ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES-----FL 138
Query: 546 RYR----IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601
+++VA +AFL + K IHRD+ N+LL H + KI D GL+ + +D
Sbjct: 139 TLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195
Query: 602 SFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 660
++V N PV ++ PE + + +SDV++YG+++ ++ + +
Sbjct: 196 NYVVK--GNARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSNPYPG 246
Query: 661 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 707
+D I + P E+ + +C + RP K
Sbjct: 247 MPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQ 293
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLL 509
RIG G +G V+K T A+K + + G I N Q L+E++ L +HP+++ LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN-QALREIKALQACQHPYVVKLL 65
Query: 510 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
P LV EYM L + L + P + Y + +A++H
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMR--MLLKGVAYMHANG--- 119
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY--- 624
I+HRD+KP N+L+ + V KI D GL+ + + + + + V T Y PE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH-----QVATRWYRAPELLYG 174
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKP 651
R P D++A G + +LL P
Sbjct: 175 ARK--YDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 40/220 (18%)
Query: 456 IGMGGYGTVYKGTFHH-------TFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLL 507
+G G +G V+ G +H AVK L+ + N K F +E E+L+ +H +++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 508 LLGACPDHGCL--VYEYMENGSLEDRLYRKNN-------TPPIPWFERYR-----IAWEV 553
G C + V+EYME+G L ++ R + +P P E IA ++
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 554 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG- 612
AS + +L + +HRD+ N L+ ++LV KIGD G+S +T Y G
Sbjct: 132 ASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSR------DVYTTDYYRVGG 182
Query: 613 ----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
P+ ++ PE + +SDV+++G+V+ ++ T
Sbjct: 183 HTMLPIR---WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 25/203 (12%)
Query: 455 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
R+G G G+V K +T FA + KQ L+ELE+ + P+++ GA
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 512 CPD-HGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKP 565
D + EY E GSL D +Y+K E+ +IA V L++LH+ K
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK- 125
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTML-NS-DPSFVSTTYKNTGPVGTLCYIDPE 623
IIHRD+KP NILL K+ D G+S L NS +F T++ Y+ PE
Sbjct: 126 --IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF----------YMAPE 173
Query: 624 YQRTGLISPKSDVYAYGMVILQL 646
+ S SDV++ G+ +L++
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 72/224 (32%), Positives = 106/224 (47%), Gaps = 49/224 (21%)
Query: 445 SATLSFSENLR---IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEV 496
SA S SE R IG G GTVYK T A+KV+ GN ++ +Q +E+E+
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY--GNHEDTVRRQICREIEI 125
Query: 497 LSKIRHPHLLLLLGACPD---HGC---LVYEYMENGSLEDRLYRKNNTPPIPWFERY--R 548
L + HP+++ C D H ++ E+M+ GSLE E++
Sbjct: 126 LRDVNHPNVV----KCHDMFDHNGEIQVLLEFMDGGSLEGTHI---------ADEQFLAD 172
Query: 549 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS--DPSFVST 606
+A ++ S +A+LH I+HRD+KP N+L++ KI D G+S +L DP S
Sbjct: 173 VARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYA-----YGMVILQ 645
VGT+ Y+ PE T L D YA G+ IL+
Sbjct: 229 -------VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 66/230 (28%), Positives = 93/230 (40%), Gaps = 41/230 (17%)
Query: 456 IGMGGYGTVYKGTFHHT---FA-----AVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 507
IG G +G V T FA K + KG+++N L E +L ++ HP L+
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRN--VLNERRILQELNHPFLVN 64
Query: 508 LLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 562
L + D LV + + G L L +K F E+ + E+ AL +LH+
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK------FSEEQVKFWICEIVLALEYLHS 118
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
K IIHRD+KP NILLD I D ++T V+ T GT Y+ P
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATK-------VTPDTLTTSTSGTPGYMAP 168
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAK---------PAIAITHKVETAI 663
E S D ++ G+ + L K I K ETA
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD 218
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (211), Expect = 5e-18
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 37/213 (17%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLL 508
++G G YG VYK T A+K + + + + + L+E+ +L +++HP+++ L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALK--KIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 509 LGACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
L LV+EY + D + Y P+ I +++ LA+ H+ +
Sbjct: 64 LDVIHTERKLYLVFEYCDM----DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR- 118
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-- 623
I+HRD+KP NIL++ + V K+ D GL+ +F T V TL Y PE
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLAR------AFGIPLRTYTHEVVTLWYRAPEIL 170
Query: 624 -----YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y S D+++ G + +++T KP
Sbjct: 171 LGSKHY------STAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 443 IESATLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR 501
I + L+ + IG G +G V+ G + A+K ++ +G + + F++E +V+ K+
Sbjct: 1 IHPSELTLVQ--EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLS 57
Query: 502 HPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFER---YRIAWEVASA 556
HP L+ L G C + CLV+E+ME+G L D L + F + + +V
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-----FSQETLLGMCLDVCEG 112
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
+A+L ++ +IHRD+ N L+ N V K+ D G++ + D ST K PV
Sbjct: 113 MAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVK- 166
Query: 617 LCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
+ PE S KSDV+++G+++ ++ +
Sbjct: 167 --WSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 46/215 (21%)
Query: 456 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNI----QNKQFLQELEVLSKIRHPHLLL 507
+G G +G V +KG+ + A+K+L SK I Q + L E +L IRHP L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGK--YYALKIL-SKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 508 LLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
L G+ D L V EY+ G L L RK+ P P Y A +V AL +LH+
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFY--AAQVVLALEYLHS--- 119
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YID 621
I++RD+KP N+LLD + KI D G + + TY TLC Y+
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TY-------TLCGTPEYLA 166
Query: 622 PEYQRTGLISPK-----SDVYAYGMVILQLLTAKP 651
PE +I K D +A G++I ++L P
Sbjct: 167 PE-----IILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 30/273 (10%)
Query: 456 IGMGGYGTVYKGTF-----HHTFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLL 509
IG G +G V G A+K L++ Q + FL E ++ + HP+++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 510 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
G +V EYMENGSL D RK++ + + +AS + +L +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQ-FTVIQLVGMLRGIASGMKYLSDMG--- 126
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+HRD+ NIL++ NLV K+ D GLS +L DP TT P+ + PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR---WTAPEAIAY 183
Query: 628 GLISPKSDVYAYGMVILQLLT--AKPAIAITHK-VETAIDED-NLAEILDAQAGDWPIKE 683
+ SDV++YG+V+ ++++ +P ++++ V AI+E L +D A
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAA------ 237
Query: 684 TKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716
L L L C + R +RP Q++ +L++L
Sbjct: 238 ---LHQLMLDCWQKDRNERPKF-EQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 456 IGMGGYGTVYKG---TFHHTFAAVKV-LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
+G G YG+VYK + + +A +V L S + + + E+ +L+ + HP+++ A
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 512 CPDHG--CLVYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAWEVASALAFLHNTKPKPI 568
D C+V EY G L + ++ IP E +RI ++ L LH K I
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---I 124
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
+HRD+K NILL N + KIGD+G+S +L T +GT Y+ PE +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKK-------NMAKT-QIGTPHYMAPEVWKGR 176
Query: 629 LISPKSDVYAYGMVILQLLTAKP 651
S KSD+++ G ++ ++ T P
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 449 SFSENLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 507
S +++G G +G V+ GT++ T A+K L+ G + + FLQE +V+ K+RH L+
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 65
Query: 508 LLGACPDHGC-LVYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAWEVASALAFLHNTKP 565
L + +V EYM GSL D L + +P + +A ++AS +A++
Sbjct: 66 LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMN- 122
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
+HRD++ NIL+ NLV K+ D GL+ ++ D + + G + + PE
Sbjct: 123 --YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTA----RQGAKFPIKWTAPEAA 175
Query: 626 RTGLISPKSDVYAYGMVILQLLT 648
G + KSDV+++G+++ +L T
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLG 510
+IG G YG VYK T A K+ + K L+E+++L ++ HP+++ LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 511 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
G LV+E+M+ + L + + +++ LAF H+ I
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYK--LIKDRQRGLPESLIKS-YLYQLLQGLAFCHSHG---I 119
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRT 627
+HRD+KP N+L++ V K+ D GL+ S T Y V T Y PE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY-THY-----VVTRWYRAPELLLGD 173
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
S D+++ G + +LL+ +P
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 59/202 (29%), Positives = 109/202 (53%), Gaps = 12/202 (5%)
Query: 449 SFSENLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 507
S ++++G G +G V+ GT++ T A+K L+ G + + FLQE +++ K+RH L+
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 508 LLGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
L + +V E+M GSL D L ++ + + + +A ++A +A++
Sbjct: 66 LYAVVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMN-- 122
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
IHRD++ NIL+ NLV KI D GL+ ++ D + + G + + PE
Sbjct: 123 -YIHRDLRAANILVGDNLVCKIADFGLARLI-EDNEYTA----RQGAKFPIKWTAPEAAL 176
Query: 627 TGLISPKSDVYAYGMVILQLLT 648
G + KSDV+++G+++ +L+T
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
RIG G YG VYK T A+KV L+ + + Q QE+ +L + RHP+++ G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ--QEISMLKECRHPNIVAYFG 67
Query: 511 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKP 565
+ L V EY GSL+D +Y+ P +IA+ E LA+LH T
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGP----LSELQIAYVCRETLKGLAYLHETG- 121
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY- 624
IHRD+K NILL + K+ D G+S L +T K +GT ++ PE
Sbjct: 122 --KIHRDIKGANILLTEDGDVKLADFGVSAQLT------ATIAKRKSFIGTPYWMAPEVA 173
Query: 625 --QRTGLISPKSDVYAYGMVILQLLTAKP 651
+R G K D++A G+ ++L +P
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 14/209 (6%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKI 500
E+ TL + ++G G +G V+ G ++ HT A+K L+ G++ + FL E ++ ++
Sbjct: 2 EVPRETLKLVK--KLGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQL 58
Query: 501 RHPHLLLLLGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 559
+HP L+ L ++ EYMENGSL D L + + + +A ++A +AF
Sbjct: 59 QHPRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
+ K IHRD++ NIL+ L KI D GL+ ++ + K P+ +
Sbjct: 118 IER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIK---W 169
Query: 620 IDPEYQRTGLISPKSDVYAYGMVILQLLT 648
PE G + KSDV+++G+++ +++T
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 75/260 (28%), Positives = 121/260 (46%), Gaps = 27/260 (10%)
Query: 455 RIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLL 508
+G G +G+V KG + AVK L+ + K+ FL+E V++++ HP ++ L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 509 LGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
+G C LV E G L L ++ P E +A +VA +A+L +
Sbjct: 62 IGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYLESKH--- 115
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTLCYIDPEYQR 626
+HRD+ N+LL + +KI D G+S L + S Y+ T L + PE
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG----SDYYRATTAGRWPLKWYAPECIN 171
Query: 627 TGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684
G S KSDV++YG+ + + + AKP + A+ E E L P +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG--ERLPR-----PEECP 224
Query: 685 KELAALGLSCAELRRKDRPD 704
+E+ ++ LSC + R +DRP
Sbjct: 225 QEIYSIMLSCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 456 IGMGGYGTVYKGTFHH-----TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLL 509
IG G +G V +G F A+K L+S Q + FL E ++ + HP+++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 510 G----ACPDHGCLVYEYMENGSLEDRLYRKNNT--PPIPWFERYRIAWEVASALAFLHNT 563
G + P ++ E+MENG+L D R+N+ I R +A+ + +L
Sbjct: 72 GVVTKSRPV--MIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM 125
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG---TLCYI 620
+HRD+ NIL++ NLV K+ D GLS L D S TY T +G + +
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTY--TSSLGGKIPIRWT 178
Query: 621 DPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHK-VETAIDED-NLAEILDAQA 676
PE + SDV++YG+V+ ++++ +P ++++ V AI++D L +D
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238
Query: 677 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716
L L L C + R RP Q++ L+++
Sbjct: 239 A---------LHQLMLDCWQKDRNARPKFG-QIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 6e-17
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 46/219 (21%)
Query: 455 RIGMGGYGTVYKG--TFHHTFAAVKVLQSKGNIQNK------QFLQELEVLSKIRHPHLL 506
+IG G YG VYK A+K K ++N+ ++E+++L K+RHP+++
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALK----KIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 507 LLLGACPDHGC----LVYEYME---NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 559
L G +V+EYM+ G L+ + T + ++ L +
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKF--TES----QIKCYMKQLLEGLQY 115
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
LH+ I+HRD+K NIL++++ V K+ D GL+ S T + V TL Y
Sbjct: 116 LHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNR----VITLWY 167
Query: 620 IDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
PE Y P+ D+++ G ++ +L KP
Sbjct: 168 RPPELLLGATRY------GPEVDMWSVGCILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 72/264 (27%), Positives = 122/264 (46%), Gaps = 33/264 (12%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN------KQFLQELEVLSKIRHPHLLLLL 509
+G G YG V H + + K N++N K QE ++LS+++HP+++
Sbjct: 8 VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 510 GACPDHGCLVYEYM---ENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNTK 564
+ L+Y M E G L +L ++ +P E + W ++A AL +LH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLP--ENQVVEWFVQIAMALQYLHE-- 120
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
K I+HRD+K N+ L + K+GD+G++ +L + ST +GT Y+ PE
Sbjct: 121 -KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL------IGTPYYMSPEL 173
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA-EILDAQAGDWPIKE 683
+ KSDV+A G + ++ T K A A D ++L I++ + P
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAF-------NAKDMNSLVYRIIEGKLPPMPKDY 226
Query: 684 TKELAALGLSCAELRRKDRPDLKN 707
+ EL L + R + RP +K+
Sbjct: 227 SPELGELIATMLSKRPEKRPSVKS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 16/195 (8%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD 514
IG G +G V +G + AVK + K ++ + FL+E V++K+ H +L+ LLG
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 515 HGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDM 573
+G +V E M G+L + L R + + + + +VA + +L + K ++HRD+
Sbjct: 71 NGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDL 126
Query: 574 KPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPK 633
NIL+ + V+K+ D GL+ + V + PV + PE + S K
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL---PVK---WTAPEALKHKKFSSK 177
Query: 634 SDVYAYGMVILQLLT 648
SDV++YG+++ ++ +
Sbjct: 178 SDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 72/273 (26%), Positives = 125/273 (45%), Gaps = 49/273 (17%)
Query: 456 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQ------FLQELEVLSKIRHPHLLL 507
+G G + + Y + T AVK + N ++Q +E+ +++++ HPH++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 508 LLGA-CPD-HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNT 563
+LGA C D H L E+M GS+ L + + E I + ++ L++LH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN 122
Query: 564 KPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP-VGTLCY 619
+ IIHRD+K N+L+D L +I D G + L + + + G +GT+ +
Sbjct: 123 Q---IIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAK---GTGAGEFQGQLLGTIAF 174
Query: 620 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA---------IAITHKVETAIDEDNLAE 670
+ PE R DV++ G VI+++ TAKP +A+ K+ +A ++ E
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234
Query: 671 ILDAQAGDWPIKETKELAALGLSCAELRRKDRP 703
L D + L C EL+ +DRP
Sbjct: 235 HLSPGLRD-----------VTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 69/272 (25%), Positives = 130/272 (47%), Gaps = 28/272 (10%)
Query: 456 IGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLL 509
IG G +G V++G A+K L+ + +Q FL E ++ + H +++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 510 GACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
G ++ EYMENG+L D+ R ++ ++ + +A+ + +L +
Sbjct: 73 GVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSS-YQLVGMLRGIAAGMKYLSDMN--- 127
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+HRD+ NIL++ NL K+ D GLS +L DP TY +G + + PE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP---EGTYTTSGGKIPIRWTAPEAIAY 184
Query: 628 GLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVETAIDEDNLAEILDAQAGDWPIKET 684
+ SDV+++G+V+ ++++ +P ++ H+V AI++ L A P+
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND---GFRLPA-----PMDCP 236
Query: 685 KELAALGLSCAELRRKDRPDLKNQVLPVLERL 716
+ L L C + R RP + ++ +L++L
Sbjct: 237 SAVYQLMLQCWQQDRARRPRFVD-IVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 513
+G G YG+VYK T A+KV+ + ++Q ++E+ +L + P+++ G+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE--IIKEISILKQCDSPYIVKYYGSYF 68
Query: 514 DHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA---LAFLHNTKPKPI 568
+ L V EY GS+ D + N T IA + L +LH+ K
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKT-----LTEEEIAAILYQTLKGLEYLHSNK---K 120
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY-QRT 627
IHRD+K GNILL+ +K+ D G+S L + +NT +GT ++ PE Q
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNT-VIGTPFWMAPEVIQEI 174
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
G + K+D+++ G+ +++ KP
Sbjct: 175 GYNN-KADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 53/187 (28%), Positives = 95/187 (50%), Gaps = 21/187 (11%)
Query: 475 AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSL--- 528
AVK+L++ + FL+E++++S++++P+++ LLG C D C++ EYMENG L
Sbjct: 48 AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQF 107
Query: 529 ------EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 582
E NN P + +A ++AS + +L + +HRD+ N L+ +
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGN 164
Query: 583 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGM 641
+ KI D G+S L S Y+ G V + ++ E G + SDV+A+G+
Sbjct: 165 HYTIKIADFGMSRNLYS-----GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 642 VILQLLT 648
+ ++ T
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 68/263 (25%), Positives = 122/263 (46%), Gaps = 39/263 (14%)
Query: 456 IGMGGYGTVYKG--TFHHTFAAVKVL-------QSKGNIQNKQFLQELEVLSKIRHPHLL 506
+G G +G+VY+G F AVK + + + KQ QE+ +LSK++HP+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAV--KQLEQEIALLSKLQHPNIV 65
Query: 507 LLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
LG + + E + GSL +L +K + P P Y ++ L +LH+
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLY--TRQILLGLEYLHDRN 122
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS---TMLNSDPSFVSTTYKNTGPVGTLCYID 621
+HRD+K NIL+D N V K+ D G++ + SF + Y ++
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY----------WMA 169
Query: 622 PEY-QRTGLISPKSDVYAYGMVILQLLTAKP------AIAITHKVETAIDEDNLAEILDA 674
PE + G +D+++ G +L++ T KP +A K+ + + + + L
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229
Query: 675 QAGDWPIKETKELAALGLSCAEL 697
+A D+ +K + +L + AEL
Sbjct: 230 EAKDFILKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 456 IGMGGYGTVYKGTFHHTFA--------AVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLL 506
+G G +G VY+GT AVK L+ Q K +FL+E ++S HP+++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 507 LLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPP--IPWFERYRIAWEVASALAFL 560
LLG C + ++ E ME G L R R P + E I +VA +L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 561 HNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG--- 612
IHRD+ N L+ D + V KIGD GL+ + + S Y+ G
Sbjct: 123 EQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-----YKSDYYRKEGEGL 174
Query: 613 -PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
PV ++ PE G + +SDV+++G+++ ++LT
Sbjct: 175 LPVR---WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 12/196 (6%)
Query: 455 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 513
++G G +G V+ GT++ +T AVK L+ G + + FL+E +++ K+RH L+ L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 514 DHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRD 572
+ +V EYM GSL D L + + +A +VA+ +A++ IHRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 573 MKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP 632
++ NIL+ LV KI D GL+ ++ D + + G + + PE G +
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI-EDNEYTA----RQGAKFPIKWTAPEAALYGRFTI 182
Query: 633 KSDVYAYGMVILQLLT 648
KSDV+++G+++ +L+T
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 72/275 (26%), Positives = 124/275 (45%), Gaps = 35/275 (12%)
Query: 456 IGMGGYGTVYKGTFHHTF-----AAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLL 507
IG G +G V +G A+K L K +KQ FL E ++ + HP+++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 508 LLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
L G ++ EYMENGSL D+ R+N+ + + +AS + +L
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSL-DKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
+HRD+ NIL++ NLV K+ D GLS L TY G + + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLED----SEATYTTKGGKIPIRWTAPEAI 180
Query: 626 RTGLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVETAIDED-NLAEILDAQAGDWPI 681
+ SDV+++G+V+ ++++ +P ++ V A+++ L +D +
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSA---- 236
Query: 682 KETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716
L L L C + R +RP Q++ L+++
Sbjct: 237 -----LYQLMLDCWQKDRNERPTFS-QIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 50/163 (30%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 492 QELEVLSKIRHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI 549
+E+ VLS ++HP+++ + ++G L V +Y E G L ++ N + + E +
Sbjct: 48 KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI---NAQRGVLFPEDQIL 104
Query: 550 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 609
W V LA H + I+HRD+K NI L + K+GD G++ +LNS T
Sbjct: 105 DWFVQICLALKH-VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-- 161
Query: 610 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 652
+GT Y+ PE + KSD++A G V+ ++ T K A
Sbjct: 162 ----IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 443 IESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR 501
I+ + L+F + L G G +G V+ G + A+K+++ +G + F++E +V+ K+
Sbjct: 1 IDPSELTFLKEL--GSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLS 57
Query: 502 HPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW------EV 553
HP+L+ L G C +V EYM NG L + L + + W +V
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK--------GKLGTEWLLDMCSDV 109
Query: 554 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
A+ +L + IHRD+ N L+ + V K+ D GL+ + D S K P
Sbjct: 110 CEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--P 164
Query: 614 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
V + PE S KSDV+++G+++ ++ +
Sbjct: 165 VK---WAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 68/198 (34%), Positives = 101/198 (51%), Gaps = 27/198 (13%)
Query: 456 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGA 511
+G G GTVYK +H AVKV+ ++ KQ + ELE+L K P+++ GA
Sbjct: 9 LGHGNGGTVYK-AYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 512 --CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
+ + E+M+ GSL+ +YRK IP RIA V L +L + K I+
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRK-----IPEHVLGRIAVAVVKGLTYLWSLK---IL 117
Query: 570 HRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
HRD+KP N+L++ K+ D G+ST L NS ++ TY VGT Y+ PE
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTY-----VGTNAYMAPERISGE 168
Query: 629 LISPKSDVYAYGMVILQL 646
SDV++ G+ ++L
Sbjct: 169 QYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|203049 pfam04564, U-box, U-box domain | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 7e-16
Identities = 26/69 (37%), Positives = 35/69 (50%), Gaps = 1/69 (1%)
Query: 735 PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKS-PITDLPLPNKNLLPNYTLL 793
P+ F+ PI E+M +P + G TYDR IE L D + P T PL + L+PN L
Sbjct: 2 PDEFLDPITLELMKDPVILPSGITYDRSTIERHLLSVDPTDPFTREPLTHDQLIPNLELK 61
Query: 794 SAILDWKSK 802
I W +
Sbjct: 62 EKIDAWLEE 70
|
This domain is related to the Ring finger pfam00097 but lacks the zinc binding residues. Length = 73 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 53/283 (18%)
Query: 456 IGMGGYGTVYKGTF-------HHTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLL 507
IG G +G V++ T AVK+L+ + + F +E ++++ HP+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 508 LLGACPDHG--CLVYEYMENGSLEDRLYRKN-------------------NTPPIPWFER 546
LLG C CL++EYM G L + L ++ N P+ E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 547 YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606
IA +VA+ +A+L K +HRD+ N L+ N+V KI D GLS + S +
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYS-----AD 184
Query: 607 TYK-NTGPVGTLCYIDPE---YQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVE 660
YK + + ++ PE Y R + +SDV+AYG+V+ ++ + +P + H
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGMQPYYGMAH--- 238
Query: 661 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 703
E+ + + D P EL L C DRP
Sbjct: 239 ----EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP 277
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 456 IGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLL 507
+G G +G V K T T AVK+L+ + + + L E +L ++ HPH++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 508 LLGACPDHG--CLVYEYMENGSLED--RLYRK-------------------NNTPPIPWF 544
L GAC G L+ EY + GSL R RK + +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 545 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604
+ AW+++ + +L K ++HRD+ N+L+ KI D GLS + + S+V
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
+ K PV ++ E + + +SDV+++G+++ +++T
Sbjct: 185 KRS-KGRIPVK---WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 455 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC 512
+IG G +G VYKG +T AVK +S K+ FLQE E+L + HP+++ L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 513 PDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
+ V E + GSL L +K N + + +++ + A+ + +L + K IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLES---KNCIH 116
Query: 571 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 630
RD+ N L+ N V KI D G+S VS K P+ + PE G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-PIK---WTAPEALNYGRY 172
Query: 631 SPKSDVYAYGMVILQLLT 648
+ +SDV++YG+++ + +
Sbjct: 173 TSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 456 IGMGGYGTVYKGTF--HHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
IG+G VY ++ A+K + K + +E++ +S+ HP+++ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 513 PDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
L V Y+ GSL D + + + EV L +LH+ IH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIH 125
Query: 571 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--YQRTG 628
RD+K GNILL + KI D G+S L +D + + T VGT C++ PE Q G
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKT-FVGTPCWMAPEVMEQVHG 183
Query: 629 LISPKSDVYAYGMVILQLLTAKP 651
K+D++++G+ ++L T
Sbjct: 184 YDF-KADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 456 IGMGGYGTVY--KGTFHHTFAAVKVLQ-SKGNIQNKQFLQ-ELEVLSKIRHPHLLLLLGA 511
IG G +G +Y K +K + +K ++ K+ + E+ +L+K++HP+++ +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 512 CPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPI 568
++G L V EY + G L R+ R+ F +I +W V +L H + I
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGV----LFSEDQILSWFVQISLGLKH-IHDRKI 122
Query: 569 IHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+HRD+K NI L N +V+K+GD G++ LN T VGT Y+ PE +
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC------VGTPYYLSPEICQN 176
Query: 628 GLISPKSDVYAYGMVILQLLTAK 650
+ K+D+++ G V+ +L T K
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 456 IGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
+G G YG+VYK H T A ++ + Q + EL++L K P+++ GA
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 512 CPDHGCLVY--EYMENGSLEDRLY-RKNNTPPIPWFERYRIAWEVASALAFL---HNTKP 565
G + EYM+ GSL D+LY T IP RI + V L FL HN
Sbjct: 68 FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
IIHRD+KP N+L++ N K+ D G+S L V++ K +G Y+ PE
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTN--IGCQSYMAPERI 173
Query: 626 RTG------LISPKSDVYAYGMVILQL 646
++G + +SDV++ G+ IL++
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 28/209 (13%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 513
+G G +G VYK T FAA K++Q + + + F+ E+++LS+ +HP+++ L A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 514 DHGCL--VYEYMENGSLE---DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
L + E+ + G+L+ L R P I RY + ++ AL FLH+ K +
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQI----RY-VCRQMLEALNFLHSHK---V 124
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD----PSFVSTTYKNTGPVGTLC--YIDP 622
IHRD+K GNILL + K+ D G+S S +F+ T Y P C + D
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYW-MAPEVVACETFKDN 183
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y K+D+++ G+ +++L +P
Sbjct: 184 PYDY------KADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 58/210 (27%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKI 500
EI +L + ++G G +G V+ T++ HT AVK ++ G++ + FL E V+ +
Sbjct: 2 EIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTL 58
Query: 501 RHPHLLLLLGACPDHGC-LVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALA 558
+H L+ L ++ E+M GSL D L + + P+P + + ++A +A
Sbjct: 59 QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMA 116
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
F+ + IHRD++ NIL+ +LV KI D GL+ ++ D + + G +
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTA----REGAKFPIK 168
Query: 619 YIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
+ PE G + KSDV+++G+++++++T
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 456 IGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+G G +G V+ H+ AVK L+ + F +E E+L+ ++H H++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 509 LGACPDHGCL--VYEYMENGSLEDRLYRKNNTP-------------PIPWFERYRIAWEV 553
G C + L V+EYM +G L +R R + + + IA ++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 554 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
AS + +L + +HRD+ N L+ LV KIGD G+S ST Y G
Sbjct: 132 ASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR------DIYSTDYYRVGG 182
Query: 614 VGTLC--YIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
L ++ PE + +SD++++G+V+ ++ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 456 IGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLL 509
IG G +G VY GT AVK L +++ +QFL+E ++ HP++L LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 510 GAC-PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
G C P G +V YM++G L + + + + P + + +VA + +L + K
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK--DLIGFGLQVAKGMEYLASKK-- 118
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG--PVGTLCYIDPEY 624
+HRD+ N +LD + K+ D GL+ + D + S PV ++ E
Sbjct: 119 -FVHRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGAKLPVK---WMALES 173
Query: 625 QRTGLISPKSDVYAYGMVILQLLT 648
+T + KSDV+++G+++ +L+T
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 38/230 (16%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTF----HHTFAAVKVLQSKGNIQN-KQFLQEL 494
WE+I+ + IG G +G V + AA+K+L+ + + + F EL
Sbjct: 1 WEDIKFEDV-------IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGEL 53
Query: 495 EVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFER----- 546
EVL K+ HP+++ LLGAC + G L EY G+L D L + P F +
Sbjct: 54 EVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTA 113
Query: 547 --------YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598
+ A +VA+ + +L K IHRD+ N+L+ NL SKI D GLS
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLS---R 167
Query: 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
+ +V T PV + Y + + KSDV+++G+++ ++++
Sbjct: 168 GEEVYVKKTMGRL-PVRWMAIESLNYS---VYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 78/284 (27%), Positives = 123/284 (43%), Gaps = 51/284 (17%)
Query: 447 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHL 505
TL F N+R G AVK+L+ N + FL+E+++LS+++ P++
Sbjct: 34 TLQFPFNVRKG------------RPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81
Query: 506 LLLLGAC--PDHGCLVYEYMENGS---------LEDRLYRKNNT-------PPIPWFERY 547
+ LLG C D C++ EYMENG L+D+ N+ P I +
Sbjct: 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL 141
Query: 548 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607
+A ++AS + +L + +HRD+ N L+ NL KI D G+S L +
Sbjct: 142 HVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNL-----YAGDY 193
Query: 608 YKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMV---ILQLLTAKPAIAITHKVETAI 663
Y+ G V + ++ E G + SDV+A+G+ IL L +P +T E I
Sbjct: 194 YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD--EQVI 251
Query: 664 DEDNLAEILDAQAGD----WPIKETKELAALGLSCAELRRKDRP 703
+N E Q P + L L L C ++RP
Sbjct: 252 --ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP 293
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVK-VLQSKGNIQNKQ--------FLQELEVLSKIRHPH 504
IG G +G+VY G + AVK V + +K +E+ +L +++H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 505 LLLLLGACPD--HGCLVYEYMENGSLEDRL--YRKNNTPPIPWFERYRIAWEVASALAFL 560
++ LG+ D H + EY+ GS+ L Y + F R ++ L +L
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR-----QILKGLNYL 122
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
HN + IIHRD+K NIL+D+ KI D G+S L ++ T G++ ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 621 DPEYQRTGLISPKSDVYAYGMVILQLLTAK 650
PE + + K+D+++ G +++++LT K
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA-CPD 514
IG G +G V G + AVK +++ Q FL E V++++RH +L+ LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 515 HGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRD 572
G L V EYM GSL D L R + + + +V A+ +L +HRD
Sbjct: 72 KGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127
Query: 573 MKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP 632
+ N+L+ + V+K+ D GL+ +S K T PE R S
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA---------PEALREKKFST 178
Query: 633 KSDVYAYGMVILQL 646
KSDV+++G+++ ++
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVK--VLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLL 508
+G G Y VYK T A+K L + + N L+E+++L +++HP+++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 509 LGACPDHG--CLVYEYMENGSLEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTK 564
L LV+E+ME LE + K+ TP + L +LH+
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA----DIKSYMLMTLRGLEYLHS-- 120
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE- 623
I+HRD+KP N+L+ + V K+ D GL+ SF S K T V T Y PE
Sbjct: 121 -NWILHRDLKPNNLLIASDGVLKLADFGLAR------SFGSPNRKMTHQVVTRWYRAPEL 173
Query: 624 ------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y D+++ G + +LL P
Sbjct: 174 LFGARHY------GVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 513
+G G +G VYK T AA KV+++K + + ++ E+E+L+ HP+++ LLGA
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 514 DHGCL--VYEYMENGSLED---RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
G L + E+ G+++ L R P I I ++ AL +LH+ K I
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VICRQMLEALQYLHSMK---I 131
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLST----MLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
IHRD+K GN+LL + K+ D G+S L SF+ T Y P +C E
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYW-MAPEVVMC----ET 186
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKP 651
+ K+D+++ G+ ++++ +P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 67/265 (25%), Positives = 110/265 (41%), Gaps = 36/265 (13%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNK-------QFLQELEVLSKIRHPHLLLL 508
+G G +G VY T + V Q + + E+++L ++H ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 509 LGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
G + + EYM GS++D+L K R + ++ + +LH+
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEYLHSNM-- 124
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--- 623
I+HRD+K NIL D K+GD G S L + S S T + GT ++ PE
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS--SGTGMKS-VTGTPYWMSPEVIS 180
Query: 624 ---YQRTGLISPKSDVYAYGMVILQLLTAKP------AIAITHKVETAIDEDNLAEILDA 674
Y R K+DV++ G ++++LT KP A+A K+ T L +
Sbjct: 181 GEGYGR------KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP 234
Query: 675 QAGDWPIKETKELAALGLSCAELRR 699
A ++ + E A S EL R
Sbjct: 235 DARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 66/257 (25%), Positives = 107/257 (41%), Gaps = 32/257 (12%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ----FLQELEVLSKIRHPHLLLLL 509
+G GG+G V T A K L K ++ ++ L E ++L K+ ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKK-RLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 510 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALAFLHNTK 564
A D CLV M G L+ +Y P F R A ++ L LH +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
I++RD+KP N+LLD + +I D+GL+ L K G GT Y+ PE
Sbjct: 116 ---IVYRDLKPENVLLDDHGNVRISDLGLAVEL-------KGGKKIKGRAGTPGYMAPEV 165
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684
+ + D +A G + +++ + K ++++ L A ++P K +
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFR-QRK--EKVEKEELKRRTLEMAVEYPDKFS 222
Query: 685 KELAALGLSCAELRRKD 701
E L C L +KD
Sbjct: 223 PEAKDL---CEALLQKD 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 26/214 (12%)
Query: 443 IESATLSFSENLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQNKQFLQELEVLSKIR 501
I+ L+F + L G G +G V G + + A+K+++ +G++ +F++E +V+ K+
Sbjct: 1 IDPKDLTFLKEL--GTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLS 57
Query: 502 HPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVASAL 557
H L+ L G C +V EYM NG L + R + K P + + +V +
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPS----QLLEMCKDVCEGM 113
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT- 616
A+L + K IHRD+ N L+D K+ D GLS + D + T VG+
Sbjct: 114 AYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--------EYTSSVGSK 162
Query: 617 --LCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
+ + PE S KSDV+A+G+++ ++ +
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 456 IGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+G G +G V+ ++ AVK L+ + K F +E E+L+ ++H H++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 509 LGAC--PDHGCLVYEYMENGSLE--------DRLYRKNNTPP--IPWFERYRIAWEVASA 556
G C D +V+EYM++G L D + P + + IA ++A+
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
+ +L + + +HRD+ N L+ NL+ KIGD G+S ST Y G
Sbjct: 133 MVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSR------DVYSTDYYRVGGHTM 183
Query: 617 LC--YIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
L ++ PE + +SDV++ G+V+ ++ T
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-14
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 443 IESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH 502
I S E I G G YKG ++ + + N N E+ + K++H
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKN--GMQFVVKEINDVNSIPSSEIADMGKLQH 742
Query: 503 PHLLLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL 560
P+++ L+G C L++EY+E +L + L N + W R +IA +A AL FL
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL---RN---LSWERRRKIAIGIAKALRFL 796
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS-FVSTTYKNTGPVGTLCY 619
H ++ ++ P I++D + + L +L +D F+S+ Y
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISSAY----------- 844
Query: 620 IDPEYQRTGLISPKSDVYAYGMVILQLLTAK 650
+ PE + T I+ KSD+Y +G+++++LLT K
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 36/275 (13%)
Query: 449 SFSENLRIGMGGYGTVYKG-------TFHHTFAAVKVLQS-KGNIQNKQFLQELEVLSKI 500
+ E +G G +G V+ T VK LQ K +F +EL++ K+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 501 RHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRL------YRKNNTPPIPWFERYRIAWE 552
H +++ LLG C + ++ EY + G L+ L K PP+ ++ + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 553 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 612
+A + L N + +HRD+ N L+ K+ + LS + + + +N
Sbjct: 126 IALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY---KLRNA- 178
Query: 613 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 672
+ L ++ PE + S KSDV+++G+++ ++ T + + DE+ L
Sbjct: 179 -LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG---ELPFYGLS--DEEVLN--- 229
Query: 673 DAQAGD--WPIKET--KELAALGLSCAELRRKDRP 703
QAG P+ E L L C + KDRP
Sbjct: 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 52/224 (23%)
Query: 452 ENL-RIGMGGYGTVYKGTFHHT--FAAVKV-LQSKGN-IQNKQFLQELEVLSKIRHPHLL 506
ENL +G G YG V K T A+K L+S+ + + K ++E+ +L ++RH +L+
Sbjct: 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 507 LLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY----------RIAWEVA 554
L+ LV+E++++ L+D E+Y + +++
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDD-------------LEKYPNGLDESRVRKYLFQIL 110
Query: 555 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 614
+ F H+ IIHRD+KP NIL+ + V K+ D G + L + P V T Y V
Sbjct: 111 RGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDY-----V 161
Query: 615 GTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
T Y PE Y R D++A G ++ ++LT +P
Sbjct: 162 ATRWYRAPELLVGDTKYGRA------VDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 58/222 (26%)
Query: 456 IGMGGYGTVYKGTFHH---TFAAVKVLQSKGNI----QNKQFLQELEVLSKIRHP----- 503
+G+GG+G V TFA V K +I Q + E E+L + HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV--KKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 504 --------HLLLLLGACPDHGCLVYEYM-ENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 554
++ +L+ C G ++ + + G ++ + R+ IA V
Sbjct: 59 YRTFKDKKYIYMLMEYCL--GGELWTILRDRGLFDE------------YTARFYIA-CVV 103
Query: 555 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 614
A +LHN + II+RD+KP N+LLD N K+ D G + L T+
Sbjct: 104 LAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTF---C 153
Query: 615 GTLCYIDPEYQRTGLISPK-----SDVYAYGMVILQLLTAKP 651
GT Y+ PE +I K D ++ G+++ +LLT +P
Sbjct: 154 GTPEYVAPE-----IILNKGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 450 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPH 504
F++ RIG G +G VYKG + T A+K++ +++ I++ Q QE+ VLS+ P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63
Query: 505 LLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFL 560
+ G+ L + EY+ GS D L P P E Y I E+ L +L
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYL 117
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
H+ + IHRD+K N+LL K+ D G++ L T K VGT ++
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT------DTQIKRNTFVGTPFWM 168
Query: 621 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 657
PE + K+D+++ G+ ++L +P + H
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 456 IGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLL 509
IG G +G V K AA+K ++ + + + F ELEVL K+ HP+++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 510 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFER-------------YRIAWEVA 554
GAC G L EY +G+L D L + P F A +VA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 555 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 614
+ +L K IHRD+ NIL+ N V+KI D GLS +V T PV
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGRL-PV 175
Query: 615 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
+ Y + + SDV++YG+++ ++++
Sbjct: 176 RWMAIESLNYS---VYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 475 AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLE 529
AVK L+ + QN + +E+ +L + H +++ G C + G L+ EY+ GSL
Sbjct: 37 AVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLR 96
Query: 530 DRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 588
D L + N + F A ++ +A+LH+ + IHRD+ N+LLD++ + KI
Sbjct: 97 DYLPKHKLNLAQLLLF-----AQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKI 148
Query: 589 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
GD GL+ + + PV + E + S SDV+++G+ + +LLT
Sbjct: 149 GDFGLAKAVPEGHEYYRVREDGDSPV---FWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 55/186 (29%), Positives = 94/186 (50%), Gaps = 20/186 (10%)
Query: 475 AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDR 531
AVK+L+ N + FL+E++++S+++ P+++ LL C D C++ EYMENG L
Sbjct: 50 AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109
Query: 532 LYR--------KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN 583
L R K + I + +A ++AS + +L + +HRD+ N L+ N
Sbjct: 110 LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKN 166
Query: 584 LVSKIGDVGLSTMLNSDPSFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 642
KI D G+S L S Y+ G V + ++ E G + SDV+A+G+
Sbjct: 167 YTIKIADFGMSRNLYS-----GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 643 ILQLLT 648
+ ++LT
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 54/186 (29%), Positives = 94/186 (50%), Gaps = 20/186 (10%)
Query: 475 AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEYMENGSLEDR 531
AVKVL+ + ++ FL+E+++LS++ P++ LLG C C++ EYMENG L
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 532 LYR--------KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN 583
L + N+ + + +A ++AS + +L + +HRD+ N L+ N
Sbjct: 110 LQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKN 166
Query: 584 LVSKIGDVGLSTMLNSDPSFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 642
KI D G+S L + S Y+ G + ++ E G + KSDV+A+G+
Sbjct: 167 YTIKIADFGMSRNL-----YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221
Query: 643 ILQLLT 648
+ ++LT
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 455 RIGMGGYGTVYKG--TFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLL 509
+IG G + VYK A+K +Q + K L+E+++L ++ HP+++ L
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 510 GACPDHGCL--VYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
+ ++ L V E + G L R+ + K IP ++ ++ SAL +H+
Sbjct: 69 ASFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--- 124
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
K I+HRD+KP N+ + V K+GD+GL F S T VGT Y+ PE
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAAHSLVGTPYYMSPERI 178
Query: 626 RTGLISPKSDVY-----AYGMVILQ 645
+ KSD++ Y M LQ
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 72/284 (25%), Positives = 126/284 (44%), Gaps = 41/284 (14%)
Query: 456 IGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLL 507
+G G +G VY+G T AVK + +++ + +FL E V+ H++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 508 LLGACP--DHGCLVYEYMENGSLEDRLY-----RKNNT--PPIPWFERYRIAWEVASALA 558
LLG +V E M +G L+ L +NN PP E ++A E+A +A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL- 617
+L+ K +HRD+ N ++ H+ KIGD G++ T Y G G L
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR------DIYETDYYRKGGKGLLP 184
Query: 618 -CYIDPEYQRTGLISPKSDVYAYGMVILQL--LTAKPAIAITHKVETAIDEDNLAEILDA 674
++ PE + G+ + SD++++G+V+ ++ L +P ++ +E L ++D
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVLKFVMDG 237
Query: 675 QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718
D P + + L C + K RP L ++ LK+
Sbjct: 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTF----LEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
RIG G YG VYK +T AA+KV++ + QE+ ++ +H +++ G+
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 513 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
D + E+ GSL+D +Y + T P+ + ++ E L +LH+ K +H
Sbjct: 76 LRRDKLWICMEFCGGGSLQD-IY--HVTGPLSESQIAYVSRETLQGLYYLHS---KGKMH 129
Query: 571 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQRT 627
RD+K NILL N K+ D G+S + +T K +GT ++ PE +R
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQIT------ATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 628 GLISPKSDVYAYGMVILQLLTAKPAIAITH 657
G + D++A G+ ++L +P + H
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 509
IG G +G VYK T A+KV+ +++ I++ Q QE++ LS+ R P++
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ--QEIQFLSQCRSPYITKYY 65
Query: 510 GACPDHGC---LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTK 564
G G ++ EY GS D L P E Y I EV L +LH
Sbjct: 66 G-SFLKGSKLWIIMEYCGGGSCLDLL------KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
IHRD+K NILL K+ D G+S L ST K VGT ++ PE
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLT------STMSKRNTFVGTPFWMAPEV 169
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKP 651
+ K+D+++ G+ ++L +P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 450 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPH 504
F++ IG G +G VY T A+K + G N+++ ++E+ L ++RHP+
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 505 LLLLLGAC--PDHGC-LVYEYMENGSLEDRL--YRKNNTPPIPWFERYRIAWEVASALAF 559
+ G C +H LV EY GS D L ++K P+ E I LA+
Sbjct: 77 TIEYKG-CYLREHTAWLVMEYCL-GSASDILEVHKK----PLQEVEIAAICHGALQGLAY 130
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
LH+ + IHRD+K GNILL K+ D G +++++ SFV T Y V +
Sbjct: 131 LHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEV--ILA 185
Query: 620 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 651
+D E Q G K DV++ G+ ++L KP
Sbjct: 186 MD-EGQYDG----KVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 60/209 (28%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 456 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
+G G +G V KGT AVKVL+ +Q+ + E VL+ L
Sbjct: 3 LGKGSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 509 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 564
L +C D V EY+ G L + R R R A E+ L FLH
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE----PRARFYAAEIVLGLQFLHE-- 114
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLST--MLNSDPSFVSTTYKNTGPVGTLCYIDP 622
+ II+RD+K N+LLD KI D G+ +L ++T+ GT YI P
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTF-----CGTPDYIAP 165
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAKP 651
E P D +A G+++ ++L +
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 456 IGMGGYGTVYKG-------TFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+G G +G V+ T AVK L+ K F +E E+L+ ++H H++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 509 LGACPDHGCL--VYEYMENGSLE--------DRLYRKNNTP-----PIPWFERYRIAWEV 553
G C D L V+EYM++G L D + + P + + IA ++
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 554 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
AS + +L + + +HRD+ N L+ NL+ KIGD G+S ST Y G
Sbjct: 133 ASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSR------DVYSTDYYRVGG 183
Query: 614 VGTLC--YIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
L ++ PE + +SDV+++G+++ ++ T
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF-LQELEVLSKIRHPHLLLLLG 510
+IG G YG V+K T V K ++S+ + K+ L+E+ +L +++HP+L+ L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 511 ACPD----HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
H LV+EY ++ ++ + L + N +P +I W+ A+ F H
Sbjct: 68 VFRRKRKLH--LVFEYCDH-TVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHN-- 120
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
IHRD+KP NIL+ K+ D G + +L P T Y V T Y PE
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDY-----VATRWYRAPE--- 170
Query: 627 TGLI------SPKSDVYAYGMVILQLLTAKP 651
L+ P DV+A G V +LLT +P
Sbjct: 171 --LLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 56/230 (24%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKGNIQN-KQFLQEL 494
E+ + + F E L G +G +YKG H A+K L+ N Q +F QE
Sbjct: 1 ELPLSAVRFMEEL--GECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 495 EVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNN--------------T 538
+++++ HP+++ LLG C+++EY+ G L + L ++
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 539 PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598
+ + IA ++A+ + +L + +H+D+ NIL+ L KI D+GLS +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
S + K+ P+ ++ PE G S SD++++G+V+ ++ +
Sbjct: 176 S-ADYYRVQPKSLLPIR---WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 55/191 (28%), Positives = 88/191 (46%), Gaps = 42/191 (21%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ------FLQELEVLSKIR---HP 503
IG G YGTVYK +T F A+K K + + L+E+ +L ++ HP
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALK----KVRVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 504 HLLLLLGACPDHGC---------LVYEYMENGSLED-RLYRKNNTPP-IPWFERYRIAWE 552
+++ LL C HG LV+E+++ +D Y P +P + +
Sbjct: 62 NIVRLLDVC--HGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 553 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 612
+ + FLH+ + I+HRD+KP NIL+ + KI D GL+ + + + + S
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV------ 166
Query: 613 PVGTLCYIDPE 623
V TL Y PE
Sbjct: 167 -VVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 32/214 (14%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQ----SKGNIQNKQ------FLQELEVLSKIRHP 503
IG G YG VY T AVK ++ G ++Q E+E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 504 HLLLLLG--ACPDHGCLVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVASALAF 559
+++ LG ++ + EY+ GS+ R Y + + +F +V LA+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVLEGLAY 123
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
LH+ K I+HRD+K N+L+D + + KI D G+S SD + + +N G++ +
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDN--DQNMSMQGSVFW 176
Query: 620 IDPEY---QRTGLISPKSDVYAYGMVILQLLTAK 650
+ PE G S K D+++ G V+L++ +
Sbjct: 177 MAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 45/290 (15%)
Query: 455 RIGMGGYGTVYKGTF-------HHTFAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHL 505
+G G +G V K + AVK+L+ ++ + E+E++ I +H ++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 506 LLLLGACPDHGCL--VYEYMENGSLEDRLYRK----------NNTPPIPWFERYRI---A 550
+ LLG C G L V EY +G+L D L + + PP + + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 610
++VA + FL + K IHRD+ N+L+ + V KI D GL+ ++ Y+
Sbjct: 139 YQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHH-----IDYYRK 190
Query: 611 TG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 666
T PV ++ PE + + +SDV+++G+++ ++ T + VE
Sbjct: 191 TTNGRLPVK---WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--K 245
Query: 667 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716
L E + P T+EL L C RP K Q++ L+R+
Sbjct: 246 LLKE---GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFK-QLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 50/197 (25%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 455 RIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 513
++G G +G V+ G +++ T AVK L+ G + + FL+E ++ ++H L+ L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 514 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 571
++ EYM GSL D L + + + + + ++A +A++ K IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127
Query: 572 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 631
D++ N+L+ +L+ KI D GL+ ++ + G + + PE G +
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDN-----EYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 632 PKSDVYAYGMVILQLLT 648
KSDV+++G+++ +++T
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 68/205 (33%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 456 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNI---QNKQFLQELEVLSK-IRHPHLLLLL 509
IG G +G V K F AVKVLQ K + + K + E VL K ++HP L+ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 510 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPK 566
+ D V +Y+ G L L R+ + P R R A E+ASAL +LH+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPE----PRARFYAAEIASALGYLHSLN-- 116
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
II+RD+KP NILLD + D GL + S ++T+ GT Y+ PE R
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTF-----CGTPEYLAPEVLR 169
Query: 627 TGLISPKSDVYAYGMVILQLLTAKP 651
D + G V+ ++L P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 448 LSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQN-KQFLQELEVLSKIRH- 502
L E L G G YG V K H T AVK +++ N Q K+ L +L++ +
Sbjct: 3 LEVIEEL--GRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC 59
Query: 503 PHLLLLLGACPDHGCLVYEYME--NGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALA 558
P+ + GA G V+ ME + SL D+ Y+K + E +IA + AL
Sbjct: 60 PYTVTFYGALFREGD-VWICMEVMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
+LH +K +IHRD+KP N+L++ N K+ D G+S L S T P
Sbjct: 118 YLH-SKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPE 173
Query: 619 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 650
I+PE + G KSDV++ G+ +++L T +
Sbjct: 174 RINPELNQKGY-DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 450 FSENLRIGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPH 504
FS+ IG G +G VY + + A+K + G N+++ ++E+ L K+RHP+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 505 LLLLLGA-CPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
+ G +H LV EY GS D L + + P+ E + LA+LH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
+IHRD+K GNILL + K+GD G ++++ FV T Y ++ P
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPY----------WMAP 180
Query: 623 EY---QRTGLISPKSDVYAYGMVILQLLTAKPAI 653
E G K DV++ G+ ++L KP +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 72/283 (25%), Positives = 129/283 (45%), Gaps = 39/283 (13%)
Query: 456 IGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLL 508
+G G +GTVYKG + A+KVL+ + + NK+ L E V++ + P++ L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 509 LGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNTKP 565
LG C LV + M G L D Y + N I + + W ++A +++L +
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLD--YVRENKDRIG--SQDLLNWCVQIAKGMSYLEEVR- 129
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
++HRD+ N+L+ KI D GL+ +L+ D T Y G + ++ E
Sbjct: 130 --LVHRDLAARNVLVKSPNHVKITDFGLARLLDID----ETEYHADGGKVPIKWMALESI 183
Query: 626 RTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIK 682
+ +SDV++YG+ + +L+T AKP I + + ++L+ + P
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGERLPQPPI 235
Query: 683 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARD 725
T ++ + + C + + RP + E + E + ARD
Sbjct: 236 CTIDVYMIMVKCWMIDSECRPRFR-------ELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 456 IGMGGYGTVYKG-TFHHTFAAVKVL------QSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+G G YGTVY G T AVK + + ++ +E+++L ++H +++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 509 LGACPDHGCLVYEYME---NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
LG C D + +ME GS+ L R P P F +Y ++ +A+LHN
Sbjct: 68 LGTCLDD-NTISIFMEFVPGGSISSILNRFGPLPE-PVFCKY--TKQILDGVAYLHNNC- 122
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
++HRD+K N++L N + K+ D G + L + + GT ++ PE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKPAIA 654
KSD+++ G + ++ T KP +A
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLA 209
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 456 IGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLL 508
+G G +GTVYKG + A+K L+ + + NK+ L E V++ + +PH+ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 509 LGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNTKP 565
LG C L+ + M G L D Y + + I +Y + W ++A + +L
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLD--YVREHKDNIG--SQYLLNWCVQIAKGMNYLEE--- 127
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
+ ++HRD+ N+L+ KI D GL+ +L +D Y G + ++ E
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD----EKEYHAEGGKVPIKWMALESI 183
Query: 626 RTGLISPKSDVYAYGMVILQLLT--AKP 651
+ + +SDV++YG+ + +L+T +KP
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 51/176 (28%), Positives = 87/176 (49%), Gaps = 24/176 (13%)
Query: 479 LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKN 536
L+ K I+N Q ++EL+VL + P+++ GA G + E+M+ GSL+ L +
Sbjct: 36 LEIKPAIRN-QIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 94
Query: 537 NTPPIPWFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594
P E +I+ V L +L I+HRD+KP NIL++ K+ D G+S
Sbjct: 95 RIP-----ENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 147
Query: 595 TML-NS-DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
L +S SF VGT Y+ PE + + +SD+++ G+ ++++
Sbjct: 148 GQLIDSMANSF----------VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 450 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPH 504
F++ RIG G +G V+KG + T A+K++ +++ I++ Q QE+ VLS+ P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63
Query: 505 LLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
+ G+ L + EY+ GS D L P F+ + E+ L +LH+
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
K IHRD+K N+LL K+ D G++ L T K VGT ++ P
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT------DTQIKRNTFVGTPFWMAP 170
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 657
E + K+D+++ G+ ++L +P + H
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 60/204 (29%), Positives = 81/204 (39%), Gaps = 46/204 (22%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLL 508
+G G G V+ KGT A+KVL K I+ K+ L E E+L+ + HP L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGK--LFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 509 LG--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE----RYRIAWEVASALAFLHN 562
+ CLV +Y G L +R P R+ A EV AL +LH
Sbjct: 67 YASFQTETYLCLVMDYCPGGEL----FRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHL 121
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP--------- 613
I++RD+KP NILL + + D LS + +P VS +
Sbjct: 122 ---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 614 --------------VGTLCYIDPE 623
VGT YI PE
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPE 202
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 62/209 (29%), Positives = 87/209 (41%), Gaps = 27/209 (12%)
Query: 455 RIGMGGYGTVYKG---TFHHTFAAVKVL--QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 509
RIG G YG VY+ T A KV + I L+E+ +L +RHP+++ L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLNLRHPNIVELK 72
Query: 510 ----GACPDHGCLVYEYMEN--GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
G D LV EY E SL D N P + + ++ L +LH
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQLLRGLQYLHE- 126
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
IIHRD+K N+LL KI D GL+ ++ V TL Y PE
Sbjct: 127 --NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK------VVTLWYRAPE 178
Query: 624 YQRTGLISPKS-DVYAYGMVILQLLTAKP 651
+ D++A G ++ +LL KP
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA- 511
R+G G YG VYK HT AAVK+++ + QE+ ++ + +H +++ G+
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 512 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
+ + EY GSL+D +Y + T P+ + + E LA+LH +K K +H
Sbjct: 76 LSREKLWICMEYCGGGSLQD-IY--HVTGPLSELQIAYVCRETLQGLAYLH-SKGK--MH 129
Query: 571 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQRT 627
RD+K NILL N K+ D G++ + +T K +GT ++ PE ++
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKIT------ATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 628 GLISPKSDVYAYGMVILQLLTAKPAIAITH 657
G + D++A G+ ++L +P + H
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 16/175 (9%)
Query: 477 KVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC-PDHGCLVYEYMENGSLEDRLYRK 535
KVL S + F + ++S++ H HL+ L G C D +V EY++ G L+ L+R+
Sbjct: 36 KVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHRE 94
Query: 536 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595
N + W +A ++ASAL +L + K ++H GN+ + LV++ G
Sbjct: 95 KNNVSLHWK--LDVAKQLASALHYLEDKK---LVH-----GNVCGKNILVARYGLNEGYV 144
Query: 596 MLN--SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS--DVYAYGMVILQL 646
SDP T V + +I PE R G S D +++G +L++
Sbjct: 145 PFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 455 RIGMGGYGTVY--KGTFHHTFAAVKVLQ--SKGNIQNKQFLQ---ELEVLSKIRHPHLLL 507
R+G G +GTVY K +KVL+ G + + +Q E ++LSK+ HP ++
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 508 LLGAC--PDHGCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTK 564
+ D C++ EY E L+ +L K+ + E W + L +H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLS--ENQVCEWFIQLLLG-VHYMH 123
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
+ I+HRD+K NI L +NL+ KIGD G+S +L +T GT Y+ PE
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTF------TGTPYYMSPEA 176
Query: 625 QRTGLISPKSDVYAYGMVILQL 646
+ KSD+++ G ++ ++
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 456 IGMGGYGTVYKGTFH------HTFAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+G G +GTVYKG + A+K+L ++ G N +F+ E +++ + HPHL+ L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 509 LGACPDHGC-LVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAW--EVASALAFLHNTK 564
LG C LV + M +G L D ++ K+N + + W ++A + +L +
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIG-----SQLLLNWCVQIAKGMMYLEERR 129
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
++HRD+ N+L+ KI D GL+ +L D Y G + ++ E
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD----EKEYNADGGKMPIKWMALEC 182
Query: 625 QRTGLISPKSDVYAYGMVILQLLT 648
+ +SDV++YG+ I +L+T
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 456 IGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLL 507
+G G +G VY+G T A+K + +++ + +FL E V+ + H++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 508 LLGACPDH--GCLVYEYMENGSLEDRLY----RKNNTP---PIPWFERYRIAWEVASALA 558
LLG ++ E M G L+ L N P P + ++A E+A +A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
+L+ K +HRD+ N ++ + KIGD G++ T Y G G L
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETDYYRKGGKGLLP 184
Query: 619 --YIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
++ PE + G+ + SDV+++G+V+ ++ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 456 IGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLGACP 513
+G G +G V+KGT T AVK + + K +FL E +L + HP+++ L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 514 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 571
+V E + G L +K + ++ A + A+ +A+L + K IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLES---KNCIHR 117
Query: 572 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 631
D+ N L+ N V KI D G+S D S++ P+ + PE G S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIK---WTAPEALNYGRYS 172
Query: 632 PKSDVYAYGMVILQLLT 648
+SDV++YG+++ + +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQELEVLSK 499
E E E + +G G YG VY T A+K + + + + +E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 500 IRHPHLLLLLGACPDHGCLVYEYMEN---GSLEDRLYRK-----NNTPPIPWFERYRIAW 551
++H +++ LG+ ++G +ME GSL L K +N I ++ +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKI-FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK----- 115
Query: 552 EVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNS-DPSFVSTTYK 609
++ L +LH+ + I+HRD+K N+L++ ++ V KI D G S L +P + T+
Sbjct: 116 QILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFT 170
Query: 610 NTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKP 651
GTL Y+ PE G +D+++ G I+++ T KP
Sbjct: 171 -----GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 510
IG G +G VY T HT AVK + G N+++ ++E++ L +++HP+ + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 511 A-CPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
+H LV EY GS D L + + P+ E I LA+LH+ +
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHS---HNM 142
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY---Q 625
IHRD+K GNILL K+ D G ++ + SFV T Y ++ PE
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY----------WMAPEVILAM 192
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKPAI 653
G K DV++ G+ ++L KP +
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 27/204 (13%)
Query: 456 IGMGGYGTVYKGTFHHTF-----AAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLL 509
IG G +G VY+G + AVK ++ + ++ FLQE ++ + HPH++ L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 510 GACPDHGCLVYEYMENGSL-EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
G ++ V+ ME L E R Y + N + ++++++ALA+L + +
Sbjct: 74 GVITENP--VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---F 128
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC--YIDPE--- 623
+HRD+ N+L+ K+GD GLS L + + YK + G L ++ PE
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE-----SYYKAS--KGKLPIKWMAPESIN 181
Query: 624 YQRTGLISPKSDVYAYGMVILQLL 647
++R + SDV+ +G+ + ++L
Sbjct: 182 FRR---FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 50/219 (22%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQ------SKGNIQNKQFLQELEVLSKIRHPHLLL 507
IG G YG VY+G T A+K++ +IQ +E+ +LS++R
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ-----REVALLSQLRQ----- 58
Query: 508 LLGACPD----HGCL--------VYEYMENGSLEDRLYRKNNTPPIPWFERYR--IAWEV 553
P+ +G + EY E GS+ + P E+Y I EV
Sbjct: 59 --SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM------KAGPIAEKYISVIIREV 110
Query: 554 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
AL ++H +IHRD+K NIL+ + K+ D G++ +LN + K +
Sbjct: 111 LVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN------QNSSKRSTF 161
Query: 614 VGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKP 651
VGT ++ PE G K+D+++ G+ I ++ T P
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 51/227 (22%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF--------------LQELEVLSKIR 501
IG G YG VYK A K + K+F +E+ +L +++
Sbjct: 8 IGRGTYGRVYK-------AKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 502 HPHLLLLLGACPDHGC----LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASA 556
H +++ L+ +H L+++Y E+ + + +R+ IP + W++ +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 557 LAFLHNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 611
+ +LH+ ++HRD+KP NIL+ + +V KIGD+GL+ + N+
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVV-KIGDLGLARLFNAPL---KPLADLD 173
Query: 612 GPVGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
V T+ Y PE Y + D++A G + +LLT +P
Sbjct: 174 PVVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 475 AVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLED 530
AVK LQ + F +E+E+L ++H +++ G C G LV EY+ GSL D
Sbjct: 37 AVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRD 96
Query: 531 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 590
Y + + + + A ++ + +L + K +HRD+ NIL++ KIGD
Sbjct: 97 --YLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGD 151
Query: 591 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
GL+ +L D + P+ + PE S SDV+++G+V+ +L T
Sbjct: 152 FGLTKVLPQDKEYYKVREPGESPI---FWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 450 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPH 504
F++ +IG G +G V+KG + T A+K++ +++ I++ Q QE+ VLS+ P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63
Query: 505 LLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
+ G+ L + EY+ GS D L P+ + I E+ L +LH+
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS 119
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
K IHRD+K N+LL + K+ D G++ L T K VGT ++ P
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT------DTQIKRNTFVGTPFWMAP 170
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 660
E + K+D+++ G+ ++L +P + H ++
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 50/231 (21%)
Query: 456 IGMGGYGTVYKG--TFHHTFAAVKVLQ----SKGNIQNKQF----------LQELEVLSK 499
+G G YG V K T A+K ++ S +++Q L+EL+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 500 IRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR--IAWEVAS 555
I+H +++ L+ + LV + M L+ + RK I E I ++ +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILN 130
Query: 556 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY------- 608
L LH +HRD+ P NI ++ + KI D GL+ P + +
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 609 -KNTGPVGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
+ T V TL Y PE Y D+++ G + +LLT KP
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKY------HFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 64/263 (24%), Positives = 117/263 (44%), Gaps = 25/263 (9%)
Query: 454 LRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLL 507
+ +G G +G V KG + A+KVL++ N ++ + ++E E++ ++ +P+++
Sbjct: 1 VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKN-ENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 508 LLGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
++G C LV E G L L K + I + +V+ + +L K
Sbjct: 60 MIGVCEAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEG---K 114
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
+HRD+ N+LL + +KI D GLS L +D S+ P L + PE
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP---LKWYAPECIN 171
Query: 627 TGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684
S +SDV++YG+ + + + KP + + ++ I + D P +
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-------GPEVMSFIEQGKRLDCPAECP 224
Query: 685 KELAALGLSCAELRRKDRPDLKN 707
E+ AL C + +DRP+
Sbjct: 225 PEMYALMKDCWIYKWEDRPNFAK 247
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 57/204 (27%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 456 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLL 509
I G +G+VY K + A+KVL+ I Q + ++ + P++ L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 510 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
+ D+ LV EY+ G L + P W ++Y EV + LH +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQY--IAEVVLGVEDLHQ---RG 117
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
IIHRD+KP N+L+D K+ D GLS + F VGT Y+ PE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF----------VGTPDYLAPETILG 167
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
SD ++ G VI + L P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA- 511
+G G YG VYKG T AA+KV+ G+ + ++ QE+ +L K H ++ GA
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 512 -------CPDHGCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNT 563
D LV E+ GS+ D + K NT W I E+ L+ LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD----PSFVSTTYKNTGPVGTLCY 619
K +IHRD+K N+LL N K+ D G+S L+ +F+ T Y P C
Sbjct: 131 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW-MAPEVIACD 186
Query: 620 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 657
+P+ KSD+++ G+ +++ P + H
Sbjct: 187 ENPD----ATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 456 IGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLG 510
IG G +G V G H VK L++ + FLQE++ ++ HP++L LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 511 ACPDHG--CLVYEYMENGSLEDRLYRKNNT----PPIPWFERYRIAWEVASALAFLHNTK 564
C + LV E+ G L++ L R N + R+A EVAS L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQ-RMACEVASGLLWLHQAD 120
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
IH D+ N L +L KIGD GL+ + +++ L ++ PE
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH----AVPLRWLAPEL 173
Query: 625 Q-------RTGLISPKSDVYAYGMVILQLLTA 649
+ KS++++ G+ + +L TA
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 37/209 (17%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQEL-------EVLSKIRHPHLL 506
+G G +G V + T A+K L+ KG+I + ++ L E + RHP L+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALK-KGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 507 LLLGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
L AC DH C V EY G L ++ + P F Y A V L +LH
Sbjct: 66 NLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF--Y--AACVVLGLQYLHEN 120
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
K I++RD+K N+LLD KI D GL F T T C PE
Sbjct: 121 K---IVYRDLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRT-------STFCGT-PE 166
Query: 624 YQRTGLISPKS-----DVYAYGMVILQLL 647
+ +++ S D + G++I ++L
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 4e-11
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 49/222 (22%)
Query: 455 RIGMGGYGTVYKGT---FHHTFAAVKVLQSKGNIQNKQ-------FLQELEVLSKIRHPH 504
++G G YG V+K A K+ + N + Q FLQEL HP+
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPN 68
Query: 505 LLLLLG---ACPDHGC-LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVASALA 558
++ LL A D LV+EYME D + R N + +RY I +++ AL
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYMET----DLHAVIRANILEDV--HKRY-IMYQLLKALK 121
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL----STMLNSDPSFVSTTYKNTGPV 614
++H+ +IHRD+KP NILL+ + K+ D GL S + + + V T Y V
Sbjct: 122 YIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY-----V 173
Query: 615 GTLCYIDPEYQRTGLISPKS-----DVYAYGMVILQLLTAKP 651
T Y PE L+ D+++ G ++ ++L KP
Sbjct: 174 ATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 66/205 (32%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 456 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSK-IRHPHLLLLL 509
IG G +G V K +F AVKVLQ K ++ K+ + E VL K ++HP L+ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 510 GA--CPDHGCLVYEYMENGSLEDRLYRKNN-TPPIPWFERYRIAWEVASALAFLHNTKPK 566
+ + V +Y+ G L L R+ P F A EVASA+ +LH+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF----YAAEVASAIGYLHSLN-- 116
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
II+RD+KP NILLD + D GL +P ++T+ GT Y+ PE R
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTF-----CGTPEYLAPEVLR 169
Query: 627 TGLISPKSDVYAYGMVILQLLTAKP 651
D + G V+ ++L P
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC- 512
+G G +G VYK T AA KV+ +K + + ++ E+++L+ HP+++ LL A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 513 -PDHGCLVYEYMENGSLED---RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
++ ++ E+ G+++ L R P I + + AL +LH K I
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIR-----VVCKQTLEALNYLHENK---I 124
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLST----MLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
IHRD+K GNIL + K+ D G+S + SF+ T Y P +C E
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW-MAPEVVMC----ET 179
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKP 651
+ K+DV++ G+ ++++ +P
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 48/218 (22%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNI-QNKQFLQELEVLSKIRH--PHLLLLLG 510
IG G G VYK F T AVK ++ GN +NK+ L +L+V+ K H P+++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYIV---- 77
Query: 511 ACPDHGCLVYEY-----ME-NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL---H 561
C +G + + ME + D+L ++ P IP ++ + AL +L H
Sbjct: 78 KC--YGYFITDSDVFICMELMSTCLDKLLKRIQGP-IPEDILGKMTVAIVKALHYLKEKH 134
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
+IHRD+KP NILLD + K+ D G+S L + T G Y+
Sbjct: 135 G-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-------KTRSAGCAAYMA 182
Query: 622 PEYQRTGLISPK---------SDVYAYGMVILQLLTAK 650
PE I P +DV++ G+ +++L T +
Sbjct: 183 PER-----IDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFL--QELEVLSKIRHPHLLLLLGA- 511
+IG G GTVY T V + Q Q K+ L E+ V+ + +HP+++ L +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 512 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKP 567
D +V EY+ GSL D + + +IA E AL FLH+ +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSNQ--- 135
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+IHRD+K NILL + K+ D G + + S K + VGT ++ PE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS------KRSTMVGTPYWMAPEVVTR 189
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
PK D+++ G++ ++++ +P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 20/141 (14%)
Query: 452 ENLRIGMGGYGTVYKGT---------FHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH 502
E+L G G + ++KG H T +KVL ++ F + ++S++ H
Sbjct: 1 ESL--GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH 58
Query: 503 PHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF- 559
HL+L G C D +V EY++ GSL+ L + N I W EVA LA+
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW------KLEVAKQLAWA 112
Query: 560 LHNTKPKPIIHRDMKPGNILL 580
LH + K + H ++ N+LL
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 38/235 (16%)
Query: 435 YRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQN-KQ 489
Y L W +I+ + IG G +G V K AA+K ++ + + +
Sbjct: 1 YPVLEWNDIKFQDV-------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 53
Query: 490 FLQELEVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWF-- 544
F ELEVL K+ HP+++ LLGAC G L EY +G+L D L + P F
Sbjct: 54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 113
Query: 545 -----------ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593
+ A +VA + +L K IHRD+ NIL+ N V+KI D GL
Sbjct: 114 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 170
Query: 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
S +V T PV + Y + + SDV++YG+++ ++++
Sbjct: 171 S---RGQEVYVKKTMGRL-PVRWMAIESLNYS---VYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLL---- 506
RI G YG VY+ T V + + K + + F L+E+ +L K++HP+++
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 507 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
+++G+ D +V EY+E+ L+ + + P E + ++ S +A LH+
Sbjct: 72 VVVGSNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCLMLQLLSGVAHLHD---N 125
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--- 623
I+HRD+K N+LL++ + KI D GL+ + S T V TL Y PE
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAR------EYGSPLKPYTQLVVTLWYRAPELLL 179
Query: 624 ----YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y S D+++ G + +LLT KP
Sbjct: 180 GAKEY------STAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 456 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 510
+G G +G V+ + + A+KV+ I+ KQ E VL ++ HP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 511 ACPDHGCL--VYEYMENGSLEDRLY---RKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
D L + EY+ G L L R +N+ + + A E+ AL +LH+
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY------ASEIVCALEYLHS--- 119
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YID 621
K I++RD+KP NILLD K+ D G + L T+ TLC Y+
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTW-------TLCGTPEYLA 166
Query: 622 PE-YQRTGLISPKSDVYAYGMVILQLLTAKP 651
PE Q G + D +A G++I ++L P
Sbjct: 167 PEVIQSKGH-NKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 449 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNK---QFLQELEVLSKIRHP 503
+F +IG G + VY+ T A+K +Q + K ++E+++L ++ HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 504 HLLLLLGACPDHGCL--VYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFL 560
+++ + + L V E + G L + + K IP ++ ++ SAL +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
H+ + ++HRD+KP N+ + V K+GD+GL F S T VGT Y+
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAAHSLVGTPYYM 173
Query: 621 DPEYQRTGLISPKSDVYAYGMVILQL 646
PE + KSD+++ G ++ ++
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 443 IESATLSFSENLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQNKQFLQELEVLSKIR 501
I + L+F + L G G +G V+ G + A+K + +G + + F++E +V+ K+
Sbjct: 1 INPSELTFMKEL--GSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLS 57
Query: 502 HPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFER---YRIAWEVASA 556
HP L+ L G C L V E+MENG L + L ++ + + +V
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-----LSKDMLLSMCQDVCEG 112
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
+ +L IHRD+ N L+ V K+ D G++ + D S+ K PV
Sbjct: 113 MEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--PVK- 166
Query: 617 LCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
+ PE S KSDV+++G+++ ++ T
Sbjct: 167 --WSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 476 VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLY 533
+++ +S +++ + +E +L+K++HP+++ + G L V EY + G L ++
Sbjct: 33 IRLPKSSSAVEDSR--KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIK 90
Query: 534 RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593
+ + E + W V L H + K ++HRD+K NI L N K+GD G
Sbjct: 91 LQRGKL---FPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNGKVKLGDFGS 146
Query: 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 650
+ +L + P + TY VGT Y+ PE + KSD+++ G ++ +L T K
Sbjct: 147 ARLL-TSPGAYACTY-----VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 72/255 (28%), Positives = 109/255 (42%), Gaps = 51/255 (20%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
+G G +G V KGT A+K+L+ IQ+ + E VL+ P L
Sbjct: 8 LGKGSFGKVMLAERKGT--DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQ 65
Query: 509 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYR------IAWEVASALAF 559
L +C D V EY+ G L +Y I +++ A E+A L F
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDL---MYH------IQQVGKFKEPHAVFYAAEIAIGLFF 116
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
LH+ K II+RD+K N++LD KI D G+ N + T+ GT Y
Sbjct: 117 LHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTF-----CGTPDY 167
Query: 620 IDPE---YQRTGLISPKS-DVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675
I PE YQ G KS D +A+G+++ ++L +P DED L + +
Sbjct: 168 IAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQPPF-------DGEDEDELFQSIMEH 216
Query: 676 AGDWPIKETKELAAL 690
+P +KE ++
Sbjct: 217 NVSYPKSLSKEAVSI 231
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 449 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHP 503
+F + +G GG+G V T A K L+ K + K L E ++L K+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 504 HLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 561
++ L A D CLV M G L+ +Y N P FE R + A L L
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLE 116
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
+ + ++RD+KP NILLD +I D+GL+ + S G VGT+ Y+
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI-------RGRVGTVGYMA 169
Query: 622 PEY---QRTGLISPKSDVYAYGMVILQLLTAK 650
PE QR L SP D + G +I +++ +
Sbjct: 170 PEVLNNQRYTL-SP--DYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLGA 511
RIG G +G V+ G +T AVK + K +FLQE +L + HP+++ L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 512 CPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
C +V E ++ G L + P + E ++ A+ + +L + K I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLES---KHCI 116
Query: 570 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 629
HRD+ N L+ V KI D G+S D + ST PV + PE G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVK---WTAPEALNYGR 172
Query: 630 ISPKSDVYAYGMVILQL--LTAKPAIAITHK 658
S +SDV+++G+++ + L A P ++++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 456 IGMGGYGTVYKGTFHH---TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRH-PHLLLLLG 510
IG G +GTV K H T AVK ++S + K+ L +L+V+ + P+++ G
Sbjct: 12 IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 511 ACPDHG-CLV-YEYMENGSLEDRLYR-----KNNTPPIPWFERY--RIAWEVASALAFLH 561
A G C + E M+ SL D+ Y+ + P E +IA AL +L
Sbjct: 71 ALFREGDCWICMELMDI-SL-DKFYKYVYEVLKSVIP----EEILGKIAVATVKALNYLK 124
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
IIHRD+KP NILLD N K+ D G+S L V + K T G Y+
Sbjct: 125 EELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL------VDSIAK-TRDAGCRPYMA 175
Query: 622 PEYQRTGLISP---KSDVYAYGMVILQLLTAK 650
PE +SDV++ G+ + ++ T K
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 455 RIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLL 509
+IG G + VY+ T V++ + + ++E+++L ++ HP+++ L
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 510 GACPDHGCL--VYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
+ + L V E + G L + Y K IP ++ ++ SA+ +H+ +
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-- 126
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
++HRD+KP N+ + V K+GD+GL F S T VGT Y+ PE
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAAHSLVGTPYYMSPERIH 179
Query: 627 TGLISPKSDVYAYGMVILQL 646
+ KSD+++ G ++ ++
Sbjct: 180 ENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 16/195 (8%)
Query: 456 IGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQ--NKQFLQELEVLSKIRHPHLLLLL 509
+G G +GTV KG + AVK+L++ N + L+E V+ ++ +P+++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 510 GACP-DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
G C + LV E E G L L + + E + +V+ + +L T
Sbjct: 63 GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETN---F 116
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
+HRD+ N+LL +KI D GLS L +D ++ PV + PE
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK---WYAPECMNYY 173
Query: 629 LISPKSDVYAYGMVI 643
S KSDV+++G+++
Sbjct: 174 KFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 67/226 (29%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 456 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 510
+G G +G V + AVKVL+ +Q+ + E +LS R+ L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 511 AC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALAFLHNTK 564
C PD V E++ G L + + F+ R A E+ SAL FLH+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR------FDEARARFYAAEITSALMFLHD-- 114
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
K II+RD+K N+LLDH K+ D G+ + ST GT YI PE
Sbjct: 115 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF------CGTPDYIAPEI 167
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 670
+ L P D +A G+++ ++L H A +ED+L E
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG-------HAPFEAENEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 48/204 (23%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ----FLQELEVLSKIRHPHLLLLLG 510
+IG G G V T T V V K +++ +Q E+ ++ +HP+++ +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAV--KKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 511 A--CPDHGCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
+ D +V E++E G+L D + N I V AL+FLH
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLA-----VLKALSFLHAQG--- 135
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+IHRD+K +ILL + K+ D G ++ + + VGT ++ PE
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------VPRRKSLVGTPYWMAPEVISR 189
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
+ D+++ G+++++++ +P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 456 IGMGGYGTVY--KGTFHHTFAAVKVLQSK---GNIQNKQFLQELEVLSK-IRHPHLLLLL 509
IG G +G V K AVKVLQ K + K + E VL K ++HP L+ L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 510 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
+ + V +++ G L L ++ + P P Y A E+ASAL +LH+
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL-QRERSFPEPRARFY--AAEIASALGYLHSIN--- 116
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
I++RD+KP NILLD + D GL ++ + T GT Y+ PE R
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK------EGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
D + G V+ ++L P
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 6e-10
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 450 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPH 504
F++ IG G +G VY T A+K + G N+++ ++E++ L +I+HP+
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 505 LLLLLGA-CPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
+ G +H LV EY GS D L + + P+ E I LA+LH+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
+IHRD+K GNILL K+ D G +++ + SFV T Y ++ P
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPY----------WMAP 190
Query: 623 EY---QRTGLISPKSDVYAYGMVILQLLTAKPAI 653
E G K DV++ G+ ++L KP +
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 46/211 (21%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 456 IGMGGYGTVYKGTFHH---TF--AAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLL 508
+G G +G+V +G + AVK ++ + + ++FL E + HP+++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 509 LGAC--------PDHGCLVYEYMENGSLEDRLYR---KNNTPPIPWFERYRIAWEVASAL 557
+G C ++ +M++G L L +P + ++A +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 617
+L N + IHRD+ N +L ++ + D GLS + S + PV
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPVK-- 180
Query: 618 CYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
+I E + + KSDV+A+G+ + ++ T
Sbjct: 181 -WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 456 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSK-IRHPHLLLLL 509
IG G +G V + F AVKVLQ K ++ K+ + E VL K ++HP L+ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 510 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE-RYRI-AWEVASALAFLHNTKP 565
+ D V +Y+ G L L R+ + E R R A E+ASAL +LH+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERC-----FLEPRARFYAAEIASALGYLHSLN- 116
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
I++RD+KP NILLD + D GL N + + ++T+ GT Y+ PE
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTF-----CGTPEYLAPEVL 168
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKP 651
D + G V+ ++L P
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 455 RIGMGGYGTVYK------GTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+IG G + V K G ++ K +S + N + +Q L LS HP++L L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP--HPNILRL 63
Query: 509 LGACPD--HGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
+ D G LV+E M+ +L + K P+P +++ +L +H
Sbjct: 64 IEVLFDRKTGRLALVFELMD-MNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-- 118
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
I HRD+KP NIL+ +++ K+ D G + S P + T Y + T Y PE
Sbjct: 119 -NGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPY--TEY-----ISTRWYRAPEC 169
Query: 625 QRT-GLISPKSDVYAYGMVILQLLTAKP 651
T G PK D++A G V ++L+ P
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ--FLQELEVLSKIRHPHLLLLLGA- 511
+IG G GTVY T V + Q Q K+ + E+ V+ + ++P+++ L +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 512 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
D +V EY+ GSL D + + + + E AL FLH+ + +IH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 571 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 630
RD+K NILL + K+ D G + + S K + VGT ++ PE
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS------KRSTMVGTPYWMAPEVVTRKAY 193
Query: 631 SPKSDVYAYGMVILQLLTAKP 651
PK D+++ G++ ++++ +P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 40/219 (18%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLLGA 511
IG G YG VYK T V + + + + + + F ++E+++L ++ H +++ L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 512 CPDHGC------------LVYEYMEN---GSLEDRLYRKNNTPPIPWFERYRIAWEVASA 556
D LV+EYM++ G LE L + + + ++
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK------QLLEG 128
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
L + H K +HRD+K NILL++ K+ D GL+ + NS+ S Y N V T
Sbjct: 129 LNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE---SRPYTNK--VIT 180
Query: 617 LCYIDPEY----QRTGLISPKSDVYAYGMVILQLLTAKP 651
L Y PE +R G P DV++ G ++ +L T KP
Sbjct: 181 LWYRPPELLLGEERYG---PAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ--FLQELEVLSKIRHPHLLLLLGA- 511
+IG G GTVY T V + Q Q K+ + E+ V+ + ++P+++ L +
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 512 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
D +V EY+ GSL D + + + + E AL FLH+ + +IH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSNQ---VIH 138
Query: 571 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 630
RD+K NILL + K+ D G + + S ST VGT ++ PE
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------VGTPYWMAPEVVTRKAY 192
Query: 631 SPKSDVYAYGMVILQLLTAKP 651
PK D+++ G++ ++++ +P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ--FLQELEVLSKIRHPHLLLLLGA- 511
+IG G GTV+ T V + Q Q K+ + E+ V+ ++++P+++ L +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 512 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKP 567
D +V EY+ GSL D + + +IA E AL FLH +
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHANQ--- 135
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+IHRD+K N+LL + K+ D G + + S ST VGT ++ PE
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM------VGTPYWMAPEVVTR 189
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
PK D+++ G++ ++++ +P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLLGA 511
+G G YG V K T V + + K + +N++ L+EL++L ++ +++ L A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 512 CPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAFLHNTKPKPI 568
G LV+EY+E LE N PP E+ R +++ A+ + H I
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPP----EKVRSYIYQLIKAIHWCHKND---I 121
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
+HRD+KP N+L+ HN V K+ D G + L+ + T Y V T Y PE
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY-----VATRWYRSPELLLGA 176
Query: 629 LISPKSDVYAYGMVILQLLTAKP 651
D+++ G ++ +L +P
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 54/235 (22%), Positives = 106/235 (45%), Gaps = 30/235 (12%)
Query: 449 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQ---SKGNIQNKQFLQELEVLSKIRHP 503
+F + ++G G Y TVYKG T A+K + +G ++E+ ++ +++H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA--IREISLMKELKHE 58
Query: 504 HLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 561
+++ L + LV+EYM+ L+ + + +++ +AF H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
+ ++HRD+KP N+L++ K+ D GL+ +F + V TL Y
Sbjct: 118 ENR---VLHRDLKPQNLLINKRGELKLADFGLAR------AFGIPVNTFSNEVVTLWYRA 168
Query: 622 PEY---QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673
P+ RT S D+++ G ++ +++T +P T+ +ED L +I
Sbjct: 169 PDVLLGSRT--YSTSIDIWSVGCIMAEMITGRPLFPGTN------NEDQLLKIFR 215
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 38/248 (15%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGN-----IQNKQFLQELEVLSKIRHPHLLLL 508
IG+G YGTVYK H+ F A+K ++ + N + + + L+ L HP+++ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 509 LGACPD-------HGCLVYEYMENGSLEDRLYRKNNTPP-IPWFERYRIAWEVASALAFL 560
+ C LV+E+++ + R Y PP +P + + L FL
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
H I+HRD+KP NIL+ K+ D GL+ + + + T V TL Y
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL-------TPVVVTLWYR 174
Query: 621 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD----AQA 676
PE + D+++ G + ++ KP + D L +I D
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS------EADQLGKIFDLIGLPPE 228
Query: 677 GDWPIKET 684
DWP T
Sbjct: 229 DDWPRDVT 236
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 31/203 (15%)
Query: 493 ELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRL--YRKNNTPPIPWFER 546
E+++L ++H ++ G D + EYM GS++D+L Y + R
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 547 YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG----LSTMLNSDPS 602
++ +++LH+ I+HRD+K NIL D K+GD G L T+ S
Sbjct: 114 -----QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP------AIAIT 656
S T GT ++ PE K+DV++ G ++++LT KP A+A
Sbjct: 166 IRSVT-------GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI 218
Query: 657 HKVETAIDEDNLAEILDAQAGDW 679
K+ T L + A D+
Sbjct: 219 FKIATQPTNPQLPSHISEHARDF 241
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 66/263 (25%), Positives = 118/263 (44%), Gaps = 38/263 (14%)
Query: 475 AVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLED 530
AVK+L+ ++ + E+E++ I +H +++ LLGAC G L + EY G+L +
Sbjct: 51 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 110
Query: 531 RL-----------YRKNNTP--PIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 577
L Y P + + + ++VA + +L + K IHRD+ N
Sbjct: 111 YLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN 167
Query: 578 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVY 637
+L+ N V KI D GL+ +N+ + TT PV ++ PE + + +SDV+
Sbjct: 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL-PVK---WMAPEALFDRVYTHQSDVW 223
Query: 638 AYGMVILQLLT----AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLS 693
++G+++ ++ T P I + E+ + + D P T EL +
Sbjct: 224 SFGVLMWEIFTLGGSPYPGIPV---------EELFKLLKEGHRMDKPANCTNELYMMMRD 274
Query: 694 CAELRRKDRPDLKNQVLPVLERL 716
C RP K Q++ L+R+
Sbjct: 275 CWHAIPSHRPTFK-QLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 456 IGMGGYGTV--YKGTFHHTFAAVKVLQS--KGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
+GMG +G V + A+K + + K+ +EL++L +RH +++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 512 CPDHGCLVYEYMENGSLEDRLYRKNNTPPI-PWFERYRIAWEVASALAFLHNTKPKPIIH 570
+Y E L L+R + P+ F +Y +++ L ++H+ ++H
Sbjct: 78 FISPLEDIYFVTE--LLGTDLHRLLTSRPLEKQFIQY-FLYQILRGLKYVHSAG---VVH 131
Query: 571 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE----YQR 626
RD+KP NIL++ N KI D GL+ + DP TG V T Y PE +Q+
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARI--QDPQM-------TGYVSTRYYRAPEIMLTWQK 182
Query: 627 TGLISPKSDVYAYGMVILQLLTAKP 651
+ + D+++ G + ++L KP
Sbjct: 183 YDV---EVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA- 511
+G G YG VYKG T AA+KV+ + + ++ E+ +L K H ++ GA
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 512 ---CP----DHGCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNT 563
P D LV E+ GS+ D + K N W I E+ LA LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD----PSFVSTTYKNTGPVGTLCY 619
K +IHRD+K N+LL N K+ D G+S L+ +F+ T Y P C
Sbjct: 141 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW-MAPEVIACD 196
Query: 620 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 657
+P+ +SD+++ G+ +++ P + H
Sbjct: 197 ENPD----ATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 48/183 (26%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 475 AVKVL--QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGC----LVYEYMENGSL 528
AVK L +S GN +E+E+L + H +++ G C + G L+ E++ +GSL
Sbjct: 37 AVKSLKPESGGN-HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 95
Query: 529 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 588
++ L R N + +Y A ++ + +L + + +HRD+ N+L++ KI
Sbjct: 96 KEYLPRNKNKINLKQQLKY--AVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKI 150
Query: 589 GDVGLSTMLNSDPSFVSTTYKNTGPV---GTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 645
GD GL+ + +D + + PV C I ++ SDV+++G+ + +
Sbjct: 151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA------SDVWSFGVTLYE 204
Query: 646 LLT 648
LLT
Sbjct: 205 LLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 479 LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKN 536
L+ K I+N Q ++EL+VL + P+++ GA G + E+M+ GSL D++ ++
Sbjct: 40 LEIKPAIRN-QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEA 97
Query: 537 NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596
P + IA V LA+L + I+HRD+KP NIL++ K+ D G+S
Sbjct: 98 KRIPEEILGKVSIA--VLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153
Query: 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 653
L ++ ++ VGT Y+ PE + S +SD+++ G+ +++L + I
Sbjct: 154 LIDS---MANSF-----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 50/214 (23%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNK---QFLQELE----VLSKIRHPHLLLL 508
+G G +GTV+KG + ++K+ + IQ++ Q QE+ + + H +++ L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 509 LGACPDHGC-LVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAW--EVASALAFLHNTK 564
LG CP LV + GSL D + +++ P + + W ++A + +L +
Sbjct: 75 LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDP-----QRLLNWCVQIAKGMYYLEEHR 129
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTLCYIDPE 623
++HR++ NILL + + +I D G++ +L D + + +K + ++ E
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT-----PIKWMALE 181
Query: 624 YQRTGLISPKSDVYAYGMVILQLLT--AKPAIAI 655
G + +SDV++YG+ + ++++ A+P +
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ----FLQELEVLSKIRHPHLLLLL 509
+G GG+G V T A K L+ K I+ ++ L E ++L K+ ++ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKK-RIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 510 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
A D CLV M G L+ +Y N P F+ R + A L + +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRER 122
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
I++RD+KP NILLD +I D+GL+ + + G VGT+ Y+ PE +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI-------RGRVGTVGYMAPEVVKN 175
Query: 628 GLISPKSDVYAYGMVILQLLTAK 650
+ D + G +I +++ K
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 31/123 (25%), Positives = 49/123 (39%), Gaps = 19/123 (15%)
Query: 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVA 76
+ VAV G+ +S A+ WA G L LLHV A
Sbjct: 2 ILVAVDGSEESERALRWAARLARRLGAELV-LLHVVDP-----------------PPSSA 43
Query: 77 AAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQ 136
A + + + LL R A+ V+VE V+E D A+AI + + +V+G++
Sbjct: 44 AELAELLEEEARALLEALREALAEAGVKVETVVLE-GDPAEAILEAAEELGADLIVMGSR 102
Query: 137 SQG 139
+
Sbjct: 103 GRS 105
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 46/237 (19%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA----------AVKVLQSKGNIQ-NKQF 490
EI +T+ F E L G +G VYKG H F A+K L+ K ++F
Sbjct: 1 EINLSTVRFMEEL--GEDRFGKVYKG---HLFGTAPGEQTQAVAIKTLKDKAEGPLREEF 55
Query: 491 LQELEVLSKIRHPHLLLLLGA-------------CPD---HGCLVYE--YMENGSLEDRL 532
E + S+++HP+++ LLG C H LV + + GS +D
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 533 YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 592
K+ P + I ++A+ + FL + ++H+D+ N+L+ L KI D+G
Sbjct: 116 TVKSTLEPADFVH---IVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLG 169
Query: 593 LSTMLNSDPSFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
L + + + YK G + + ++ PE G S SD+++YG+V+ ++ +
Sbjct: 170 LFREV-----YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 450 FSENLRIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHL 505
F + +G G G V+K + + A K+ L+ K I+N Q ++EL+VL + P++
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN-QIIRELQVLHECNSPYI 65
Query: 506 LLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
+ GA G + E+M+ GSL D++ +K P + IA V L +L
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIA--VIKGLTYLR-- 120
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
+ I+HRD+KP NIL++ K+ D G+S L ++ ++ VGT Y+ PE
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF-----VGTRSYMSPE 172
Query: 624 YQRTGLISPKSDVYAYGMVILQLLTAKPAI 653
+ S +SD+++ G+ ++++ + I
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 46/229 (20%)
Query: 475 AVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG----------------CL 518
AVK + K L+E++++ ++ H +++ + G +
Sbjct: 34 AVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYI 93
Query: 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNI 578
V EYME L P+ +++ L ++H+ ++HRD+KP N+
Sbjct: 94 VQEYMETD-----LANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANV 145
Query: 579 LLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS--- 634
++ +LV KIGD GL+ ++ DP + Y + G V T Y P L+SP +
Sbjct: 146 FINTEDLVLKIGDFGLARIV--DPHYSHKGYLSEGLV-TKWYRSPRL----LLSPNNYTK 198
Query: 635 --DVYAYGMVILQLLTAKPAIAITHKVE---------TAIDEDNLAEIL 672
D++A G + ++LT KP A H++E + E++ E+L
Sbjct: 199 AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 5e-09
Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 456 IGMGGYGTVYKGTFHHTFA--AVK----VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLL 509
IG G YG V T A+K V I K+ L+E+++L +RH +++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL--IDAKRILREIKLLRHLRHENIIGLL 65
Query: 510 GACPDHGC-------LVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFL 560
+V E ME D L++ K+ P +Y +++ L +L
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602
H+ +IHRD+KP NIL++ N KI D GL+ ++ D
Sbjct: 120 HSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 28/207 (13%)
Query: 456 IGMGGYGTVYKGTFHHT---FAAVKV----LQSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+G GG+G V +T +A K+ L+ K K L E E+L K+ P ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG--EKMALLEKEILEKVNSPFIVNL 58
Query: 509 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNT 563
A H CLV M G L+ +Y E R+ ++ + LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHSM 114
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
I++RDMKP N+LLD ++ D+GL+ L + T + GT Y+ PE
Sbjct: 115 D---IVYRDMKPENVLLDDQGNCRLSDLGLAVEL---KDGKTITQR----AGTNGYMAPE 164
Query: 624 YQRTGLISPKSDVYAYGMVILQLLTAK 650
+ S D +A G I +++ +
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 67/264 (25%), Positives = 124/264 (46%), Gaps = 34/264 (12%)
Query: 475 AVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLED 530
AVK+L+ ++ + E+E++ I +H +++ LLGAC G L + EY G+L +
Sbjct: 48 AVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLRE 107
Query: 531 RLYRKNNTPPIPW-FERYRI-------------AWEVASALAFLHNTKPKPIIHRDMKPG 576
L R P + + F+ ++ A++VA + +L + K IHRD+
Sbjct: 108 YL-RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163
Query: 577 NILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDV 636
N+L+ + V KI D GL+ +++ + TT PV ++ PE + + +SDV
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL-PVK---WMAPEALFDRVYTHQSDV 219
Query: 637 YAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQAGDWPIKETKELAALGLSCA 695
+++G+++ ++ T + I + L ++L + D P T EL + C
Sbjct: 220 WSFGVLLWEIFTLGGS------PYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECW 273
Query: 696 ELRRKDRPDLKNQVLPVLERLKEV 719
RP K Q++ L+R+ V
Sbjct: 274 HAVPSQRPTFK-QLVEDLDRVLTV 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 67/244 (27%), Positives = 102/244 (41%), Gaps = 46/244 (18%)
Query: 439 TWEEIESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEV 496
TWE IE+ IG G YG VYK T + AAVK+L ++ +++ E +
Sbjct: 23 TWEIIET----------IGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNI 71
Query: 497 LSKI-RHPHLLLLLGAC--PDHGC-----LVYEYMENGSLED------RLYRKNNTPPIP 542
L + HP+++ G D LV E GS+ + ++ + I
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 543 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602
+ I + L LHN + IIHRD+K NILL K+ D G+S L
Sbjct: 132 Y-----ILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLT---- 179
Query: 603 FVSTTYKNTGPVGTLCYIDPEY-----QRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 657
ST + VGT ++ PE Q + DV++ G+ ++L P + H
Sbjct: 180 --STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237
Query: 658 KVET 661
V+T
Sbjct: 238 PVKT 241
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 449 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHP 503
+F + +G GG+G V T A K L+ K + K L E ++L K+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 504 HLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 561
++ L A D CLV M G L+ +Y FE R + A L
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGRAVFYAAEICCGLE 116
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
+ + I++RD+KP NILLD + +I D+GL+ + + G VGT+ Y+
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI-------KGRVGTVGYMA 169
Query: 622 PEYQRTGLISPKSDVYAYGMVILQLLTAK 650
PE + + D +A G ++ +++ +
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 456 IGMGGYGTVYKGTFHHTFA-------AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLL 507
+G G +G VY+G + AVK L + Q++ FL E ++SK H +++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 508 LLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR----IAWEVASALAFLH 561
L+G + ++ E M G L+ L P P + A +VA +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 562 NTKPKPIIHRDMKPGNILLDH---NLVSKIGDVGLSTMLNSDPSFVSTTYKNTG----PV 614
IHRD+ N LL V+KI D G++ + + ++ Y+ G P+
Sbjct: 134 E---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-----YRASYYRKGGRAMLPI 185
Query: 615 GTLCYIDPEYQRTGLISPKSDVYAYGMVI 643
++ PE G+ + K+DV+++G+++
Sbjct: 186 K---WMPPEAFLDGIFTSKTDVWSFGVLL 211
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIR-HPHLLL 507
+G G +G V KGT A+KVL+ +Q+ + E +L+ HP L
Sbjct: 3 LGKGSFGKVMLAELKGT--DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 508 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYR---IAWEVASALAFLHN 562
L D V EY+ G L ++ R F+ R A EV AL FLH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK------FDEPRSRFYAAEVTLALMFLHR 114
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
+I+RD+K NILLD K+ D G+ +TT+ GT YI P
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTF-----CGTPDYIAP 165
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 670
E + P D +A G+++ +++ +P A +ED+L E
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPF-------EADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV--GTL 617
+H+ K +IHRD+K NILL N + K+GD G S M + +T + G GT
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM------YAATVSDDVGRTFCGTP 209
Query: 618 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 650
Y+ PE R S K+D+++ G+++ +LLT K
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 63/215 (29%), Positives = 93/215 (43%), Gaps = 34/215 (15%)
Query: 456 IGMGGYGTVY---KGTFHH--TFAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRH-PHL 505
+G G YG V+ K H A+KVL+ +Q + + E +VL +R P L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 506 LLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFE----RYRIAWEVASALAF 559
+ L A L + +Y+ G L LY++ + F R IA E+ AL
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH------FTESEVRVYIA-EIVLALDH 120
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
LH II+RD+K NILLD + D GLS ++ + GT+ Y
Sbjct: 121 LHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-----EEERAYSFCGTIEY 172
Query: 620 IDPEYQRTGLISPKS--DVYAYGMVILQLLT-AKP 651
+ PE R G D ++ G++ +LLT A P
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 36/190 (18%)
Query: 455 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLL 507
+IG G +G V+K T A KVL + + F L+E+++L ++H +++
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKILQLLKHENVVN 75
Query: 508 LLGAC-----PDHGC-----LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 557
L+ C P + LV+E+ E+ L L KN + E ++ + + L
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS--EIKKVMKMLLNGL 132
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL----STMLNSDPSFVSTTYKNTGP 613
++H K I+HRDMK NIL+ + + K+ D GL S NS P+ + T
Sbjct: 133 YYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN------RYTNR 183
Query: 614 VGTLCYIDPE 623
V TL Y PE
Sbjct: 184 VVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 18/199 (9%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLLG 510
+G GG+G V T A K L+ K + K L E +L K+ ++ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 511 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
A D CLV M G L+ +Y N P F+ R + A L + + + I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
++RD+KP NILLD +I D+GL+ + + G VGT+ Y+ PE
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV-------RGRVGTVGYMAPEVINNE 176
Query: 629 LISPKSDVYAYGMVILQLL 647
+ D + G +I +++
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 42/268 (15%)
Query: 472 TFAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGS 527
T AVK+L+S ++ + E+E++ I +H +++ LLGAC G L + EY G+
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 528 LEDRLYRKNNTPP---------------IPWFERYRIAWEVASALAFLHNTKPKPIIHRD 572
L R Y + PP + + + A++VA + +L + K IHRD
Sbjct: 111 L--REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRD 165
Query: 573 MKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP 632
+ N+L+ + V KI D GL+ ++ + TT PV ++ PE + +
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL-PVK---WMAPEALFDRIYTH 221
Query: 633 KSDVYAYGMVILQLLT----AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 688
+SDV+++G+++ ++ T P + + E+ + + D P T EL
Sbjct: 222 QSDVWSFGVLLWEIFTLGGSPYPGVPV---------EELFKLLKEGHRMDKPSNCTNELY 272
Query: 689 ALGLSCAELRRKDRPDLKNQVLPVLERL 716
+ C RP K Q++ L+R+
Sbjct: 273 MMMRDCWHAVPSQRPTFK-QLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 556 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 615
AL +LH K K I+HRD+ P NI+L + I D GL+ + K T VG
Sbjct: 125 ALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-------KLTSVVG 175
Query: 616 TLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675
T+ Y PE + K+DV+A+G ++ Q+ T +P T+ + A +I++A
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT------KIVEAV 229
Query: 676 AGDWPIKE---TKELAALGLSCAELRRKDRPDL 705
P+ E ++++ + SC + RPD+
Sbjct: 230 YE--PLPEGMYSEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 577
+V EYM G L + + N P W R+ A EV AL +H+ IHRD+KP N
Sbjct: 120 MVMEYMPGGDLVNLM--SNYDIPEKW-ARFYTA-EVVLALDAIHSMG---FIHRDVKPDN 172
Query: 578 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT----GLISPK 633
+LLD + K+ D G ++++ T VGT YI PE ++ G +
Sbjct: 173 MLLDKSGHLKLADFGTCMKMDANGMVRCDT-----AVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 634 SDVYAYGMVILQLLTAKP---AIAITHKVETAIDEDNLAEILDAQAGDWPI-KETKELAA 689
D ++ G+ + ++L A ++ +D N D D I K+ K+L
Sbjct: 228 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD----DIEISKQAKDLIC 283
Query: 690 LGLSCAELR--RKDRPDLKNQVLPVLERLKEVADRARDTVPSVHP 732
L+ E+R R ++K+ P + + D R+TV V P
Sbjct: 284 AFLTDREVRLGRNGVDEIKSH--PFFKNDQWTFDNIRETVAPVVP 326
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 43/272 (15%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNI------QNKQFLQELEVLSKIRHPHLLLLL 509
+G G +G+V +G + + +KV I + + FL E + + HP+++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 510 GACPDHG--------CLVYEYMENGSLEDRLY--RKNNTPP-IPWFERYRIAWEVASALA 558
G C ++ +M++G L L R + P +P + ++AS +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTL 617
+L + K IHRD+ N +L+ N+ + D GLS + N D Y G + +
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD-------YYRQGRIAKM 176
Query: 618 C--YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675
+I E + + KSDV+++G+ + ++ T + +T +EI D
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT---------RGQTPYPGVENSEIYDYL 227
Query: 676 AGDWPIKETKE----LAALGLSCAELRRKDRP 703
+K+ + L +L SC L KDRP
Sbjct: 228 RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRP 259
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 66/248 (26%), Positives = 104/248 (41%), Gaps = 31/248 (12%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ----FLQE---LEVLSKIRHPHLL 506
IG GG+G VY T A+K L K I+ KQ L E L ++S P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKK-RIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 507 LLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
+ A PD + + M G L Y + E A E+ L +HN
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEAEMRFYAAEIILGLEHMHN-- 115
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
+ +++RD+KP NILLD + +I D+GL+ + S VGT Y+ PE
Sbjct: 116 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMAPEV 166
Query: 625 QRTGLISPKS-DVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683
+ G+ S D ++ G ++ +LL HK + + D + + + P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVE---LPDSF 222
Query: 684 TKELAALG 691
+ EL +L
Sbjct: 223 SPELRSLL 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 29/210 (13%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+IG G YG VYKG T A+K L+S+ ++E+ +L +++HP+++ L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 511 AC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA---WEVASALAFLHNTKP 565
L++E++ S++ + Y ++ P + + + +++ + F H+ +
Sbjct: 67 VLMQESRLYLIFEFL---SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSRR- 121
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY- 624
++HRD+KP N+L+D+ V K+ D GL+ +F T V TL Y PE
Sbjct: 122 --VLHRDLKPQNLLIDNKGVIKLADFGLAR------AFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 625 ---QRTGLISPKSDVYAYGMVILQLLTAKP 651
R S D+++ G + ++ T KP
Sbjct: 174 LGSPR---YSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 67/244 (27%), Positives = 103/244 (42%), Gaps = 28/244 (11%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ----FLQELEVLSKIRH---PHLL 506
IG GG+G VY T A+K L K I+ KQ L E +LS + P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKK-RIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 507 LLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
+ A PD C + + M G L Y + E A E+ L +HN
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLH---YHLSQHGVFSEKEMRFYATEIILGLEHMHN-- 115
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
+ +++RD+KP NILLD + +I D+GL+ + S VGT Y+ PE
Sbjct: 116 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMAPEV 166
Query: 625 QRTGLISPKS-DVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683
+ G S D ++ G ++ +LL HK + + D + ++ + D E
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTVNVELPDSFSPE 225
Query: 684 TKEL 687
K L
Sbjct: 226 LKSL 229
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 510
+G GG+G V T A K L K + K + + E +L+K+ ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 511 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
A CLV M G L +Y + P F R + A ++ L + + I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
I+RD+KP N+LLD++ +I D+GL+ L S K G GT ++ PE +
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS------KTKGYAGTPGFMAPELLQGE 172
Query: 629 LISPKSDVYAYGMVILQLLTAK-PAIAITHKVE 660
D +A G+ + +++ A+ P A KVE
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-08
Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 44/227 (19%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSK------GN-IQNKQFLQELEVLSKIRHPHLLLL 508
IG GG G VY + + +V K N + K+FL+E ++ + + HP ++ +
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 509 LGACPDHGCLVY---EYMENGSLEDRL---YRKNNTP-------PIPWFERYRIAWEVAS 555
C D G VY Y+E +L+ L ++K + + F I ++ +
Sbjct: 68 YSICSD-GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF--LSIFHKICA 124
Query: 556 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK--IGDVGLSTMLN---SDPSFVSTTYKN 610
+ ++H+ K ++HRD+KP NILL L + I D G + D + +N
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 611 ------TGP---VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
T P VGT Y+ PE S +D+YA G+++ Q+LT
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 67/240 (27%), Positives = 98/240 (40%), Gaps = 46/240 (19%)
Query: 439 TWEEIESATLSFSENLRIGMGGYGTVYK--GTFHHTFAAVKVLQSKGNIQNKQFLQELEV 496
TWE IE+ IG G YG V+K + + AAVK+L +I +++ E +
Sbjct: 19 TWEIIET----------IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-DEEIEAEYNI 67
Query: 497 LSKIR-HPHLLLLLG-------ACPDHGCLVYEYMENGSLED------RLYRKNNTPPIP 542
L + HP+++ G D LV E GS+ D + + P I
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA 127
Query: 543 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602
+ I E L LH K IHRD+K NILL K+ D G+S L
Sbjct: 128 Y-----ILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT---- 175
Query: 603 FVSTTYKNTGPVGTLCYIDPEY-----QRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 657
ST + VGT ++ PE Q + DV++ G+ ++L P +A H
Sbjct: 176 --STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 67/280 (23%), Positives = 122/280 (43%), Gaps = 42/280 (15%)
Query: 460 GYGTVYKGTFHHTFAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLLGACPDHGC 517
YG AVK+L+ ++ + E+E++ I +H +++ LLG C G
Sbjct: 33 AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92
Query: 518 L--VYEYMENGSLEDRLYRKNNTPPIP--WFERYRI-------------AWEVASALAFL 560
L + EY G+L R + + PP P F+ ++ A++VA + +L
Sbjct: 93 LYVIVEYAAKGNL--REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
+ + IHRD+ N+L+ + V KI D GL+ ++ D + T PV ++
Sbjct: 151 ESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVH-DIDYYKKTSNGRLPVK---WM 203
Query: 621 DPEYQRTGLISPKSDVYAYGMVILQLLT----AKPAIAITHKVETAIDEDNLAEILDAQA 676
PE + + +SDV+++G+++ ++ T P I + E+ + +
Sbjct: 204 APEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---------EELFKLLREGHR 254
Query: 677 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716
D P T EL L C RP K Q++ L+++
Sbjct: 255 MDKPSNCTHELYMLMRECWHAVPTQRPTFK-QLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 456 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 508
+G G +G V +KGT + A+K L+ + ++ KQ QE +L ++ HP ++ +
Sbjct: 26 LGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 509 LGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
+ + D + + E++ G L L RK P + Y E+ A +LH+ K
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHA--ELVLAFEYLHS---K 137
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
II+RD+KP N+LLD+ K+ D G + + D +F TLC PEY
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTF------------TLCGT-PEYLA 183
Query: 627 TGLISPKS-----DVYAYGMVILQLLTAKP 651
+I K D + G+++ + + P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 69/250 (27%), Positives = 106/250 (42%), Gaps = 41/250 (16%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
+G G +G V KGT A+K+L+ IQ+ + E VL+ P L
Sbjct: 8 LGKGSFGKVMLAERKGT--DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQ 65
Query: 509 LGAC---PDHGCLVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNT 563
L +C D V EY+ G L + + K P ++ A E++ L FLH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY-----AAEISVGLFFLHR- 119
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
+ II+RD+K N++LD KI D G+ D + T+ GT YI PE
Sbjct: 120 --RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTTRTF-----CGTPDYIAPE 171
Query: 624 ---YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680
YQ G D +AYG+++ ++L +P DED L + + +P
Sbjct: 172 IIAYQPYGK---SVDWWAYGVLLYEMLAGQPPF-------DGEDEDELFQSIMEHNVSYP 221
Query: 681 IKETKELAAL 690
+KE ++
Sbjct: 222 KSLSKEAVSI 231
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 15/154 (9%)
Query: 475 AVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYMENGSLE 529
A+KV++ F +E ++LS P + L A D + LV EY G L
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 530 DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 589
L R + F+ + +A + +H+ +HRD+KP N+L+D K+
Sbjct: 90 SLLNRYEDQ-----FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLA 144
Query: 590 DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
D G + L ++ S PVGT YI PE
Sbjct: 145 DFGSAARLTANKMVNSKL-----PVGTPDYIAPE 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 47/270 (17%)
Query: 459 GGYGTVYKGTFHHTF------AAVK-VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
G +G ++ G VK V IQ LQE +L + H ++L +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 512 C---PDHGCLVYEYMENGSLED-----RLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
C + ++Y YM G+L+ RL NN + + +A ++A +++LH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG-----PVGTLC 618
+ +IH+D+ N ++D L KI D LS L F Y G PV
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDL-----FPM-DYHCLGDNENRPVK--- 184
Query: 619 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD----- 673
++ E S SDV+++G+++ +L+T + T VE ID +A L
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMT----LGQTPYVE--IDPFEMAAYLKDGYRL 238
Query: 674 AQAGDWPIKETKELAALGLSCAELRRKDRP 703
AQ PI EL A+ C L ++RP
Sbjct: 239 AQ----PINCPDELFAVMACCWALDPEERP 264
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 48/150 (32%), Positives = 69/150 (46%), Gaps = 16/150 (10%)
Query: 456 IGMGGYGTVYKGT----FHHTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLG 510
IG G +G V G + VK L+ ++Q + +FL+E + ++H +LL LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 511 ACPDHG--CLVYEYMENGSLEDRLYR----KNNTPPIPWFERYRIAWEVASALAFLHNTK 564
C + LV E+ G L+ L + TP +R +A E+A L LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLHLHKNN 120
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594
IH D+ N LL +L KIGD GLS
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 46/203 (22%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 454 LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
++IG G G V T + AVK + + + + E+ ++ +H +++ + +
Sbjct: 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 512 --CPDHGCLVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
D +V E++E G+L D + + + N I + V AL+ LH + +
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGV 137
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
IHRD+K +ILL H+ K+ D G ++ + + VGT ++ PE
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------VPRRKSLVGTPYWMAPELISRL 191
Query: 629 LISPKSDVYAYGMVILQLLTAKP 651
P+ D+++ G+++++++ +P
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 476 VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGSLEDRLY 533
+KVL + F + ++ ++ H H++LL G C +V E++E G L+ ++
Sbjct: 37 LKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH 96
Query: 534 RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593
RK++ PW ++++A ++ASAL++L + K ++H ++ NILL + G+ G
Sbjct: 97 RKSDVLTTPW--KFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGID--GECGP 149
Query: 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTGLISPKSDVYAYGMVILQLLTAKPA 652
L SDP T V + +I PE + + +S +D +++G + +
Sbjct: 150 FIKL-SDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE------- 201
Query: 653 IAITHKVETAIDEDNLAEILDAQAGDWPI--KETKELAALGLSCAELRRKDRP 703
I + E + + LAE G + KELA L C RP
Sbjct: 202 --ICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 456 IGMGGYGTVYK-----GTFHHTFAAVKVLQSKGNIQNKQ----FLQELEVLSKIRHPHLL 506
+G GGYG V++ G A+KVL+ ++N++ E +L ++HP ++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 507 LLLGACPDHG--CLVYEYMENGSLEDRLYRK----NNTPPIPWFERYRIAWEVASALAFL 560
L+ A G L+ EY+ G L L R+ +T + ++ E++ AL L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA------CFYLS-EISLALEHL 116
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
H + II+RD+KP NILLD K+ D GL + + V+ T+ GT+ Y+
Sbjct: 117 HQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTF-----CGTIEYM 167
Query: 621 DPE-YQRTGLISPKSDVYAYGMVILQLLTAKP 651
PE R+G D ++ G ++ +LT P
Sbjct: 168 APEILMRSGH-GKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 456 IGMGGYGTV--YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 510
+G G +G V + + A+K+L+ + I + L E VL RHP L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 511 A--CPDHGCLVYEYMENGSL-----EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
+ D C V EY+ G L +R++ ++ T R+ A E+ SAL +LH+
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT-------RFYGA-EIVSALDYLHSG 114
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
K I++RD+K N++LD + KI D GL +D + + T GT Y+ PE
Sbjct: 115 K---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF------CGTPEYLAPE 165
Query: 624 YQRTGLISPKSDVYAYGMVILQLLTAK 650
D + G+V+ +++ +
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 59/200 (29%), Positives = 82/200 (41%), Gaps = 38/200 (19%)
Query: 455 RIGMGGYGTVY---KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 508
IG G +G V+ +A +KVL+ I+ Q E ++L+ P ++ L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYA-MKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 509 LGACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
+ D H LV EYM G L + L RK+ P R+ IA E+ AL +H
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE--TARFYIA-ELVLALDSVHKLG-- 121
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS--DPSFVSTTYKNTG------------ 612
IHRD+KP NIL+D + K+ D GL +N D + N
Sbjct: 122 -FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 613 ---------PVGTLCYIDPE 623
VGT YI PE
Sbjct: 181 KQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 50/239 (20%)
Query: 445 SATLSFSENLRIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF----LQELEVL 497
S + ++G G +G VYK T V K+L + F L+E+++L
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKIL 61
Query: 498 SKIRHPHLLLLL--------GACPDHGC--LVYEYME---NGSLEDRLYRKNNTPPIPWF 544
K++HP+++ L+ + G +V YM+ +G LE+ T
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--SVKLTES---- 115
Query: 545 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL-------STML 597
+ ++ + +LH I+HRD+K NIL+D+ + KI D GL
Sbjct: 116 QIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 598 NSDPSFVSTTYKNTGPVGTLCYIDPEY-----QRTGLISPKSDVYAYGMVILQLLTAKP 651
+ Y T V T Y PE + T + D++ G V ++ T +P
Sbjct: 173 KGGGGGGTRKY--TNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 15/156 (9%)
Query: 550 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 609
+++VA + FL + K IHRD+ NILL N V KI D GL+ + DP +V +
Sbjct: 179 SFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----R 231
Query: 610 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDN 667
L ++ PE + + +SDV+++G+++ ++ + A P + IDE+
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ------IDEEF 285
Query: 668 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 703
+ + P T E+ ++ L C +DRP
Sbjct: 286 CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNI----QNKQFLQELEVLSKIRHPHLLL 507
I G YG VY K T FA K+ +K N+ Q +Q E ++L+ +P ++
Sbjct: 9 ISNGAYGAVYLVRHKET-RQRFAMKKI--NKQNLILRNQIQQVFVERDILTFAENPFVVS 65
Query: 508 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW-EVASALAFLHNTK 564
+ + H C+V EY+E G L N +P + R+ + E AL +LHN
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLL---KNIGALP-VDMARMYFAETVLALEYLHNYG 121
Query: 565 PKPIIHRDMKPGNILL---------DHNLVSKIGDVGLSTMLNSDPSFVST-TYKNTGPV 614
I+HRD+KP N+L+ D L SKIG + L+T L T + +
Sbjct: 122 ---IVHRDLKPDNLLITSMGHIKLTDFGL-SKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 615 GTLCYIDPEY-QRTGLISPKSDVYAYGMVILQLL 647
GT YI PE R G P D +A G+++ + L
Sbjct: 178 GTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 15/156 (9%)
Query: 550 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 609
+++VA + FL + K IHRD+ NILL N V KI D GL+ + DP +V K
Sbjct: 180 SFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR---K 233
Query: 610 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL--LTAKPAIAITHKVETAIDEDN 667
+ + L ++ PE + + +SDV+++G+++ ++ L A P + I+E+
Sbjct: 234 GSARL-PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ------INEEF 286
Query: 668 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 703
+ D P T E+ + L+C + K+RP
Sbjct: 287 CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 64/236 (27%), Positives = 113/236 (47%), Gaps = 37/236 (15%)
Query: 456 IGMGGYGTVY-----KGTFHHTFAAVKVLQSKGNIQNKQFLQ---ELEVLSKIRHPHLLL 507
+G G +G V+ G A+KVL+ K ++ + ++ E ++L+++ HP ++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLK-KATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 508 LLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFE---RYRIAWEVASALAFLHN 562
L A G L+ +++ G L RL ++ + + E ++ +A E+A AL LH+
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLA-ELALALDHLHS 116
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
II+RD+KP NILLD K+ D GLS + K GT+ Y+ P
Sbjct: 117 LG---IIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGTVEYMAP 167
Query: 623 E-YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 677
E R G + +D +++G+++ ++LT + ET + IL A+ G
Sbjct: 168 EVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMILKAKLG 216
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 37/188 (19%)
Query: 493 ELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRL-----YRKNNTPPIPW 543
E+++L +RH ++ G D + EYM GS++D+L +N T
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVT----- 108
Query: 544 FERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS----TMLNS 599
R ++ +++LH+ I+HRD+K NIL D K+GD G S T+ S
Sbjct: 109 ---RRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162
Query: 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP------AI 653
S T GT ++ PE K+DV++ ++++LT KP A+
Sbjct: 163 GTGIKSVT-------GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215
Query: 654 AITHKVET 661
A K+ T
Sbjct: 216 AAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 456 IGMGGYGTV--YKGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 510
IG G +G V + A+K+L I+ F +E ++++ P ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 511 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
A D L V EYM G L + + N P W R+ A EV AL +H+
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHSMG---F 163
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT- 627
IHRD+KP N+LLD + K+ D G +N + T VGT YI PE ++
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-----AVGTPDYISPEVLKSQ 218
Query: 628 ---GLISPKSDVYAYGMVILQLLTA 649
G + D ++ G+ + ++L
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 40/160 (25%), Positives = 78/160 (48%), Gaps = 11/160 (6%)
Query: 490 FLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY 547
F + ++S++ H HL + G C +V E++E+G L+ L ++ P+ W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 548 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607
+A ++ASAL++L + K ++H ++ NILL + + + SDP T
Sbjct: 121 TVAQQLASALSYLED---KNLVHGNVCAKNILLAR---LGLAEGTSPFIKLSDPGVSFTA 174
Query: 608 YKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQL 646
V + +I PE G +S +D +++G +L++
Sbjct: 175 LSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 32/212 (15%)
Query: 456 IGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLG 510
IG G +G V + VK L++ + + + +FLQ+ + ++HP++L LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 511 ACPDH--GCLVYEYMENGSL------EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
C + LV+EY E G L E R + R+A E+A+ + +H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL-----LLLQRMACEIAAGVTHMHK 117
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
+H D+ N L +L K+GD G+ ++ T P L ++ P
Sbjct: 118 HN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVP---LRWLAP 170
Query: 623 EY---QRTGLISPK----SDVYAYGMVILQLL 647
E GLI+ + S+V+A G+ + +L
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-07
Identities = 56/181 (30%), Positives = 82/181 (45%), Gaps = 42/181 (23%)
Query: 549 IAWEVASALAFLHNTKPKP----IIHRDMKPGNILLD-------------HNL----VSK 587
I ++ ALA+ HN K P ++HRD+KP NI L +NL ++K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 588 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--YQRTGLISPKSDVYAYGMVILQ 645
IGD GLS + + S VGT Y PE T KSD++A G +I +
Sbjct: 183 IGDFGLSKNIGIESMAHSC-------VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 646 LLTAKPAIAITHKVETAIDEDNLAEILD--AQAGDWPIK-ETKELAALGLSCAELRRKDR 702
L + K HK +N ++++ + D PIK ++KEL L + L K+R
Sbjct: 236 LCSGKTPF---HKA------NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKER 286
Query: 703 P 703
P
Sbjct: 287 P 287
|
Length = 1021 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 66/245 (26%), Positives = 100/245 (40%), Gaps = 31/245 (12%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
+G G +G V KGT A+K+L+ IQ+ + E VL+ P L
Sbjct: 8 LGKGSFGKVMLAERKGT--DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQ 65
Query: 509 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
L +C D V EY+ G L +Y+ A E+A L FLH+
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS--- 119
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
K II+RD+K N++LD KI D G+ N + T+ GT YI PE
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTF-----CGTPDYIAPEII 173
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 685
D +A+G+++ ++L + DED L + + +P +K
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPF-------EGEDEDELFQSIMEHNVAYPKSMSK 226
Query: 686 ELAAL 690
E A+
Sbjct: 227 EAVAI 231
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKV----LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+IG G YG VYK T + + L+ + ++E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 511 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFER-YRIA----WEVASALAFLHNT 563
LV+EY++ L K + P F + R+ +++ +A+ H+
Sbjct: 69 VVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 564 KPKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
+ ++HRD+KP N+L+D + K+ D GL+ +F T V TL Y P
Sbjct: 122 R---VLHRDLKPQNLLIDRRTNALKLADFGLAR------AFGIPVRTFTHEVVTLWYRAP 172
Query: 623 EY---QRTGLISPKSDVYAYGMVILQLLTAKP 651
E R S D+++ G + +++ KP
Sbjct: 173 EILLGSRH--YSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 44/199 (22%), Positives = 86/199 (43%), Gaps = 27/199 (13%)
Query: 464 VYKGTFHHTFAAVKVLQ--SKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------ 514
+YKG F++ ++ + KG + E++ L +I ++L + G D
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 515 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 574
L+ EY G L + L ++ + + + + +A + L L+ KP ++++
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 575 PGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP-- 632
+ L+ N KI GL +L+S P +KN V + Y + + S
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPP------FKN---VNFMVYFSYKML-NDIFSEYT 200
Query: 633 -KSDVYAYGMVILQLLTAK 650
K D+Y+ G+V+ ++ T K
Sbjct: 201 IKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 454 LRIGMGGYGTVYKGTFHHTF--AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
++IG G G V T HT AVK + + + + E+ ++ H +++ + +
Sbjct: 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 512 --CPDHGCLVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
D +V E++E G+L D + + + N I + V AL++LHN + +
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN---QGV 139
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
IHRD+K +ILL + K+ D G ++ + K VGT ++ PE
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE------VPKRKSLVGTPYWMAPEVISRL 193
Query: 629 LISPKSDVYAYGMVILQLLTAKP 651
+ D+++ G+++++++ +P
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 456 IGMGGYGTV--YKGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 510
IG G +G V + A+K+L I+ F +E ++++ P ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 511 ACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
A D + +V EYM G L + + N P W + Y EV AL +H+ +
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTA--EVVLALDAIHSMG---L 163
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT- 627
IHRD+KP N+LLD + K+ D G ++ T VGT YI PE ++
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-----AVGTPDYISPEVLKSQ 218
Query: 628 ---GLISPKSDVYAYGMVILQLLTA 649
G + D ++ G+ + ++L
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 27/159 (16%)
Query: 475 AVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL- 528
A+K+L+ + I + L E VL RHP L L + H C V EY G L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 529 ----EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 584
+R++ ++ R+ A E+ SAL +LH+ +++RD+K N++LD +
Sbjct: 84 FHLSRERVFSEDRA-------RFYGA-EIVSALGYLHSCD---VVYRDLKLENLMLDKDG 132
Query: 585 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
KI D GL SD + + T GT Y+ PE
Sbjct: 133 HIKITDFGLCKEGISDGATMKTF------CGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 34/210 (16%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
+G G +G V K T + A+K+L+ + + + L E VL RHP L L
Sbjct: 3 LGKGTFGKVILVKEKATGR--YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 509 LGACPDHG--CLVYEYMENGSL-----EDRLYRKNNTPPIPWFERYRI-AWEVASALAFL 560
+ H C V EY G L +R++ + +R R E+ SAL +L
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE---------DRARFYGAEIVSALDYL 111
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
H+ K +++RD+K N++LD + KI D GL D + + T GT Y+
Sbjct: 112 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF------CGTPEYL 163
Query: 621 DPEYQRTGLISPKSDVYAYGMVILQLLTAK 650
PE D + G+V+ +++ +
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 51/217 (23%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 456 IGMGGYGTVYK-------GTFHHTFAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLL 506
+G G +G+V + G+F AVK+L++ + ++FL+E + + HP+++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKV--AVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 507 LLLGACPDHGC--------LVYEYMENGSLE-----DRLYRKNNTPPIPWFERYRIAWEV 553
L+G ++ +M++G L R+ + T P+ R+ I ++
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI--DI 122
Query: 554 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
AS + +L + K IHRD+ N +L+ N+ + D GLS + S Y G
Sbjct: 123 ASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKI------YSGDYYRQGC 173
Query: 614 VGTLC--YIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
L ++ E + + SDV+A+G+ + +++T
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 473 FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 527
+ A+K+L+ + I + + E VL RHP L L A H C V EY G
Sbjct: 22 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81
Query: 528 LEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 586
L L R+ + ER R E+ SAL +LH+ + +++RD+K N++LD +
Sbjct: 82 LFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHI 134
Query: 587 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL 646
KI D GL SD + + T GT Y+ PE D + G+V+ ++
Sbjct: 135 KITDFGLCKEGISDGATMKTF------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 647 LTAK 650
+ +
Sbjct: 189 MCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 40/216 (18%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF-----LQELEVLSKIRHPHLLLLLG 510
IG G YG V T T VKV K + Q L+E+++L + +H +++ +L
Sbjct: 13 IGEGAYGMVCSATHKPT--GVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 511 A-CPDHGC------LVYEYMENGSLEDRLYRKNNTPP-----IPWFERYRIAWEVASALA 558
P +V E ME LY+ T I +F +++ L
Sbjct: 71 IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYF-----LYQILRGLK 120
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL--STMLNSDPSFVSTTYKNTGPVGT 616
++H+ ++HRD+KP N+LL+ N KI D GL D + T Y V T
Sbjct: 121 YIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY-----VAT 172
Query: 617 LCYIDPEYQRTGLISPKS-DVYAYGMVILQLLTAKP 651
Y PE K+ D+++ G ++ ++L+ +P
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|222135 pfam13445, zf-RING_LisH, RING-type zinc-finger, LisH dimerisation motif | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-06
Identities = 17/41 (41%), Positives = 23/41 (56%), Gaps = 4/41 (9%)
Query: 737 HFICPILKEVM----NEPCVAADGYTYDRKAIEEWLQENDK 773
F+CPI KEVM N P + G+ Y RKA+E+ + K
Sbjct: 10 IFVCPISKEVMTDEENPPVMLPCGHVYSRKALEKLAKNGGK 50
|
This zinc-finger is the dimerisation motif for LisH proteins, and is also a typical RING-type of plant ubiquitin ligases. Length = 55 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 46/190 (24%), Positives = 79/190 (41%), Gaps = 43/190 (22%)
Query: 456 IGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLL-- 509
IG G YG V + V K+ + K+ L+EL++L +H +++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 510 ----GACPDHGCLVYEYME---------NGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 556
GA +V + ME + L + R + Y++
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIR---------YFLYQLL----RG 119
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP---SFVSTTYKNTGP 613
L ++H+ +IHRD+KP N+L++ + +IGD G++ L+S P + T Y
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY----- 171
Query: 614 VGTLCYIDPE 623
V T Y PE
Sbjct: 172 VATRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 37/244 (15%)
Query: 456 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQF--LQELEVLSKIR---HPHLLL 507
IG G YG V+K F A+K ++ + + ++E+ VL + HP+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 508 LLGACP-------DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL 560
L C LV+E+++ L L K P +P + +++ L FL
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
H+ + ++HRD+KP NIL+ + K+ D GL+ + SF T V TL Y
Sbjct: 127 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMAL---TSVVVTLWYR 176
Query: 621 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA----QA 676
PE + D+++ G + ++ KP + D D L +ILD
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF------RGSSDVDQLGKILDVIGLPGE 230
Query: 677 GDWP 680
DWP
Sbjct: 231 EDWP 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 35/243 (14%)
Query: 455 RIGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLL 506
++G GGYG V+ K T A+K + K + + L E ++L+ + L+
Sbjct: 8 QVGQGGYGQVFLAKKKDT--GEIVALKRM-KKSLLFKLNEVRHVLTERDILTTTKSEWLV 64
Query: 507 LLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE-RYRIAWEVASALAFLHNT 563
LL A ++ L EY+ G L NN + R+ +A E+ A+ LH
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMA-EMFEAVDALHEL 120
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
IHRD+KP N L+D + K+ D GLS V TY N+ VG+ Y+ PE
Sbjct: 121 G---YIHRDLKPENFLIDASGHIKLTDFGLSK------GIV--TYANS-VVGSPDYMAPE 168
Query: 624 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683
R D ++ G ++ + L P + + ET + E L P+ +
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL-----QRPVYD 223
Query: 684 TKE 686
Sbjct: 224 DPR 226
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 38/147 (25%), Positives = 71/147 (48%), Gaps = 15/147 (10%)
Query: 455 RIGMGGYGTVYKG---TFHHTFAAVKV-LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+IG G YG VYK A K+ L+++ ++E+ +L ++ HP+++ LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 511 ACPDHGCL--VYEY--MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
L V+E+ ++ D PP+ + Y +++ +A+ H+ +
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPL--IKSY--LYQLLQGIAYCHSHR-- 119
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGL 593
++HRD+KP N+L+D K+ D GL
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 341 QNEANDASRKVNDLNKCKLEEETRLSEI--QLLEEKAIELAKQEKKKYETARREAECARA 398
Q ++ + K + E+ R E+ + EKA + A+Q K+ E +++AE A+A
Sbjct: 67 QERQKKLEQQAEEAEKQRAAEQARQKELEQRAAAEKAAKQAEQAAKQAEEKQKQAEEAKA 126
Query: 399 SAEKEAAQRQEA--EMKAKHEAKEKEMLERA 427
EA + EA E KAK EAK++ E
Sbjct: 127 KQAAEAKAKAEAEAEKKAKEEAKKQAEEEAK 157
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 41/218 (18%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN----KQFLQELEVLSKIRHP------HL 505
IG G YG V HT V + + ++ + L+E+++L +RHP H+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 506 LLLLGACPDHG-----CLVYEYMENGSLEDRLYRKNN--TPPIPWFERYRI-AWEVASAL 557
+L P +V+E ME S ++ + N+ TP E ++ +++ AL
Sbjct: 68 ML----PPSRREFKDIYVVFELME--SDLHQVIKANDDLTP-----EHHQFFLYQLLRAL 116
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVS-TTYKNTGPVG 615
++H + HRD+KP NIL + + KI D GL+ N P+ + T Y V
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-----VA 168
Query: 616 TLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKP 651
T Y PE + +P D+++ G + ++LT KP
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 46/228 (20%)
Query: 452 ENLRIGMGGYGTVYK-----GTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL 506
E ++G G YG VYK G +A + Q +G + +E+ +L +++HP+++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYA---LKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 507 LLLGACPDHG----CLVYEYMENGSLE----DRLYRKNNTP-PIPWFERYRIAWEVASAL 557
L H L+++Y E+ R + N P +P + +++ +
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 558 AFLHNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNS--------DPSFV 604
+LH ++HRD+KP NIL+ + V KI D+G + + NS DP V
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLADLDPVVV 177
Query: 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKS-DVYAYGMVILQLLTAKP 651
T Y PE K+ D++A G + +LLT++P
Sbjct: 178 -----------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 15/148 (10%)
Query: 456 IGMGGYGTVY---KGTFHHTFAAVKVLQSKGNIQNKQFLQ---ELEVLSKIRHPHLLLLL 509
IG+G +G V K + +A +K L+ + Q E ++L++ + ++ L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYA-MKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 510 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
+ D L V +Y+ G + L R R+ IA E+ A+ +H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED--LARFYIA-ELTCAIESVHKMG--- 121
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLST 595
IHRD+KP NIL+D + K+ D GL T
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 42/228 (18%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSK-----IRHPHLLLLLG 510
IG G +G V AV ++ I + L + E+L + R +L+ G
Sbjct: 9 IGRGAFGEV----------AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG 58
Query: 511 AC------------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 558
C ++ LV +Y G L L + + P Y +A +
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVL 113
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
+H+ +HRD+KP N+LLD N ++ D G +N D T +++ VGT
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD-----GTVQSSVAVGTPD 168
Query: 619 YIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 661
YI PE + G P+ D ++ G+ + ++L + VET
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 456 IGMGGYGTV----YKGTFHHTFAAVK----VLQSKGNIQNKQFLQELEVLSKIR-HPHLL 506
+G G YG V T A+K V K I K+ L+EL++L R H ++
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK--ILAKRALRELKLLRHFRGHKNIT 65
Query: 507 LLLG---ACPDHGCLVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLH 561
L P + +Y Y E +E L++ ++ P + I +++ L ++H
Sbjct: 66 CLYDMDIVFPGNFNELYLYEE--LMEADLHQIIRSGQPLTDAHFQSFI-YQILCGLKYIH 122
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
+ ++HRD+KPGN+L++ + KI D GL+ + + T V T Y
Sbjct: 123 SAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS--ENPGENAGFMTEYVATRWYRA 177
Query: 622 PE----YQRTGLISPKSDVYAYGMVILQLLTAKP 651
PE +Q + DV++ G ++ +LL KP
Sbjct: 178 PEIMLSFQS---YTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 29/168 (17%)
Query: 493 ELEVLSKIRHPHLLLLLGA-------C---PDHGCLVYEYMENGSLEDRLYRKNNTPPIP 542
E+++L I H ++ L+ A C P + C ++ Y++ P+P
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG------------PLP 183
Query: 543 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602
+ I + ALA+LH + IIHRD+K NI LD + +GD G + L++ P
Sbjct: 184 LEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240
Query: 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 650
T + G GTL PE K+D+++ G+V+ ++
Sbjct: 241 ----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 455 RIGMGGYGTVYKGT--FHHTFAAVKVLQSKGNIQNKQF--LQELEVLSKIRHPHLLLLLG 510
++G G Y TVYKG + A+KV+ K + F ++E +L ++H +++LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 511 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
L V+EYM + Y + + + +++ LA++H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQ---YMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---I 124
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
+HRD+KP N+L+ + K+ D GL+ S S TY + V TL Y P+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLA----RAKSIPSQTY--SSEVVTLWYRPPDVLLGA 178
Query: 629 L-ISPKSDVYAYGMVILQLLTAKPAIA 654
S D++ G + +++L +PA
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 449 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPH 504
+F + +IG G YG VYK T V + + + + + + ++E+ +L ++ HP+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 505 LLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTP----PIPWFERYRIAWEVASALA 558
++ LL LV+E++ +D + +P P+P + Y +++ LA
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASPLSGIPLPLIKSY--LFQLLQGLA 114
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
F H+ + ++HRD+KP N+L++ K+ D GL+ +F T V TL
Sbjct: 115 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR------AFGVPVRTYTHEVVTLW 165
Query: 619 YIDPE-YQRTGLISPKSDVYAYGMVILQLLTAK 650
Y PE S D+++ G + +++T +
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 30/99 (30%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 550 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 609
+++VA ++FL + K IHRD+ NILL H ++KI D GL+ + +D ++V
Sbjct: 220 SYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 610 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
PV ++ PE + + +SDV++YG+++ ++ +
Sbjct: 277 RL-PVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 14/156 (8%)
Query: 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPIIHRDMKPG 576
LV EY+ G L + R+ P E R A E+ AL FLH + II+RD+K
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPE----EHARFYAAEICIALNFLHE---RGIIYRDLKLD 125
Query: 577 NILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDV 636
N+LLD + K+ D G+ P ++T+ GT YI PE R D
Sbjct: 126 NVLLDADGHIKLTDYGMCKE-GLGPGDTTSTF-----CGTPNYIAPEILRGEEYGFSVDW 179
Query: 637 YAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 672
+A G+++ +++ + I ED L +++
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 46/228 (20%)
Query: 452 ENLRIGMGGYGTVYK-----GTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL 506
E ++G G YG VYK G +A + Q +G + +E+ +L +++HP+++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYA---LKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 507 LLLGACPDHG----CLVYEYMENGSLE----DRLYRKNNTP-PIPWFERYRIAWEVASAL 557
L H L+++Y E+ R + N P +P + +++ +
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 558 AFLHNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNS--------DPSFV 604
+LH ++HRD+KP NIL+ + V KI D+G + + NS DP V
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLADLDPVVV 177
Query: 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKS-DVYAYGMVILQLLTAKP 651
T Y PE K+ D++A G + +LLT++P
Sbjct: 178 -----------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 28/180 (15%)
Query: 514 DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALAFLHNTKPKPIIH 570
+H V E++ G L + K F+ YR A E+ L FLH+ K II+
Sbjct: 69 EHLFFVMEFLNGGDLMFHIQDKGR------FDLYRATFYAAEIVCGLQFLHS---KGIIY 119
Query: 571 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 630
RD+K N++LD + KI D G+ V + + GT YI PE +
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCK------ENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 631 SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP---IKETKEL 687
+ D +++G+++ ++L + DED L E + +P KE+K++
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFH-------GDDEDELFESIRVDTPHYPRWITKESKDI 226
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRH-PHLLLLL 509
+IG G YG VYK +T V + +++ + + L+E+ +L + +++ LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 510 GACPDHG---------CLVYEYMENG--SLEDRLYRKNNTP-PIPWFERYRIAWEVASAL 557
+H LV+EY+++ D R P P + + +++ +
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF--MYQLLKGV 123
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
A H ++HRD+KP N+L+D + KI D+GL +F T + T
Sbjct: 124 AHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSIPVKSYTHEIVT 174
Query: 617 LCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKP 651
L Y PE S D+++ G + ++ +P
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 34/227 (14%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQE-------LEVLSKIRHPHLLLL 508
+G G +G VY T + V Q + + ++ + +E +++L + H ++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 509 LGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
G D + E+M GS++D+L K+ R + ++ +++LH+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGVSYLHSNM 126
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVG----LSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
I+HRD+K NIL D K+GD G L T+ S S T GT ++
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-------GTPYWM 176
Query: 621 DPEYQRTGLISPKSDVYAYGMVILQLLTAKP------AIAITHKVET 661
PE K+D+++ G ++++LT KP A+A K+ T
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 456 IGMGGYGTVY---KGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRH-PHL 505
+G G YG V+ K T H T A+KVLQ +Q + ++ E VL +R P L
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 506 LLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHN 562
+ L A L+ +Y+ G + LY+++N + R + E+ AL LH
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE----DEVRFYSGEIILALEHLHK 123
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP-VGTLCYID 621
I++RD+K NILLD + D GLS F+S + T GT+ Y+
Sbjct: 124 LG---IVYRDIKLENILLDSEGHVVLTDFGLSK------EFLSEEKERTYSFCGTIEYMA 174
Query: 622 PEYQRTGLISPKS-DVYAYGMVILQLLT-AKP 651
PE R K+ D ++ G++I +LLT A P
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 10/133 (7%)
Query: 518 LVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPG 576
L+ EY G L ++ R P +E + +++ AL +H+ K ++HRD+K
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSA 198
Query: 577 NILLDHNLVSKIGDVGLSTMLNSDPSF-VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSD 635
NI L + K+GD G S + S V++++ GT Y+ PE S K+D
Sbjct: 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF-----CGTPYYLAPELWERKRYSKKAD 253
Query: 636 VYAYGMVILQLLT 648
+++ G+++ +LLT
Sbjct: 254 MWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 340 AQNEANDASRKVNDLNKCKLE---EETRLSEIQLLEEKAIELAKQEKKKYETARREAECA 396
+ A A+++ K E + Q E KA A+ EKK E A+++AE
Sbjct: 96 QRAAAEKAAKQAEQAAKQAEEKQKQAEEAKAKQAAEAKAKAEAEAEKKAKEEAKKQAEEE 155
Query: 397 RASAEKEAAQRQEAEMKAKHEAKEKE 422
+ A+++ AE K K EA+ K
Sbjct: 156 AKAKAAAEAKKKAAEAKKKAEAEAKA 181
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 60/252 (23%), Positives = 98/252 (38%), Gaps = 45/252 (17%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 513
+G G +G V T F A+K L+ L++ +V + +L L P
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALK------KDVVLEDDDVECTMVERRVLALAWEHP 56
Query: 514 ------------DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALA 558
+H V EY+ G L + F+ R A E+ L
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR------FDEARARFYAAEIICGLQ 110
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
FLH K II+RD+K N+LLD + KI D G+ N + ++T+ GT
Sbjct: 111 FLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTF-----CGTPD 161
Query: 619 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 678
YI PE + + D +++G+++ ++L + DED L + +
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF-------HGEDEDELFDSILNDRPH 214
Query: 679 WPIKETKELAAL 690
+P +KE
Sbjct: 215 FPRWISKEAKDC 226
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLLGA 511
IG G +G V+ T V + + QN K+ +EL++L +H ++L L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 512 C--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPI 568
P Y+ ++ L++ +P + ++ +++ L +LH+ I
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---I 124
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602
+HRD+KPGN+L++ N V KI D GL+ + D S
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 57/271 (21%), Positives = 112/271 (41%), Gaps = 28/271 (10%)
Query: 456 IGMGGYGTVYKGTF-----HHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLL 509
+G G +G + +G A+ L+ + Q + FL E L + H +++ L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 510 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
G + V EYM NG+L+ L + + + + +AS + +L
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYLSEMG--- 127
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+H+ + +L++ +LV KI G + + TT PV + PE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPV---LWAAPEAIQY 182
Query: 628 GLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 685
S SDV+++G+V+ ++++ +P ++ +D + + D P
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKAVEDGFRLPAPRNCPN 235
Query: 686 ELAALGLSCAELRRKDRPDLKNQVLPVLERL 716
L L L C + R +RP +Q+ +L ++
Sbjct: 236 LLHQLMLDCWQKERGERPRF-SQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 18/100 (18%)
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
L ++H+ ++HRD+KP N+LL+ N KI D GL+ + F+ T Y V T
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEY-----VVT 171
Query: 617 LCYIDPEY-----QRTGLISPKSDVYAYGMVILQLLTAKP 651
Y PE + T I DV++ G + +LL KP
Sbjct: 172 RWYRAPELLLNCSEYTTAI----DVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|216006 pfam00582, Usp, Universal stress protein family | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 28/123 (22%), Positives = 47/123 (38%), Gaps = 14/123 (11%)
Query: 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVA 76
+ VAV G+ +S A+ WALE G L LLHV S E+ ++
Sbjct: 5 ILVAVDGSEESERALEWALELAKRRGAELI-LLHVIDPEPSGAASEALEEEEEEELEEEE 63
Query: 77 AAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQ 136
A + A+ V V+ D A+AI + + + +V+G++
Sbjct: 64 AEAEALAA-------------AAEAGGVVVEVVVRGGDPAEAILEVAEEEDADLIVMGSR 110
Query: 137 SQG 139
+
Sbjct: 111 GRS 113
|
The universal stress protein UspA is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, though UspA lacks ATP-binding activity. Length = 139 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 450 FSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHL 505
+ + ++G G YGTV T A V + + Q++ F +EL +L ++H ++
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 506 LLLLGA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 557
+ LL PD LV +M G+ +L + RI + V L
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEK------LSEDRIQFLVYQML 128
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 617
L IIHRD+KPGN+ ++ + KI D GL+ +S+ TG V T
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---------MTGYVVTR 179
Query: 618 CYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y PE Y +T D+++ G ++ ++LT KP
Sbjct: 180 WYRAPEVILNWMHYTQT------VDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 22/91 (24%)
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---- 623
IIHRD+KP NI ++ + KI D GL+ + + TG V T Y PE
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDD---------EMTGYVATRWYRAPEIMLN 189
Query: 624 ---YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y +T D+++ G ++ +LLT K
Sbjct: 190 WMHYNQT------VDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 15/162 (9%)
Query: 550 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 609
+++VA + FL + K IHRD+ NILL N V KI D GL+ + DP +V +
Sbjct: 185 SFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----R 237
Query: 610 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL--LTAKPAIAITHKVETAIDEDN 667
L ++ PE + + +SDV+++G+++ ++ L A P + IDE+
Sbjct: 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDEEF 291
Query: 668 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 709
+ + P T E+ L C RP V
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 15/130 (11%)
Query: 535 KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594
++ P+ + R + +VA + FL K IHRD+ N+LL V+KI D GL+
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 595 TMLNSDPSFVSTTYKNTG--PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL----LT 648
+ +D ++V K PV ++ PE + + +SDV++YG+++ ++ +
Sbjct: 260 RDIMNDSNYV---VKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
Query: 649 AKPAIAITHK 658
P I + K
Sbjct: 314 PYPGILVNSK 323
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 51/207 (24%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLLLL 509
++G G Y TV+KG T V + + + +++++ ++E+ +L ++H +++ L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 510 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPK 566
CL V+EY+++ D +N + +I +++ L++ H K
Sbjct: 70 DIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK-- 123
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--Y 624
I+HRD+KP N+L++ K+ D GL+ S + TY N V TL Y P+
Sbjct: 124 -ILHRDLKPQNLLINEKGELKLADFGLARA----KSVPTKTYSNE--VVTLWYRPPDVLL 176
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKP 651
T +P D++ G ++ ++ T +P
Sbjct: 177 GSTEYSTP-IDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 50/204 (24%), Positives = 81/204 (39%), Gaps = 29/204 (14%)
Query: 459 GGYGTVYKGTFHHTFAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG 516
+ K +T AVK L S K QE+ +++HP++L + +
Sbjct: 13 LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS 72
Query: 517 CL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKPIIHR 571
L V M GS ED L K + P IA+ +V +AL ++H+ K IHR
Sbjct: 73 ELYVVSPLMAYGSCEDLL--KTHFPE--GLPELAIAFILKDVLNALDYIHS---KGFIHR 125
Query: 572 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG-------TLCYIDPE- 623
+K +ILL + + GL + S + + L ++ PE
Sbjct: 126 SVKASHILLSGDGKVVLS--GLRYSV----SMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 624 -YQRTGLISPKSDVYAYGMVILQL 646
Q + KSD+Y+ G+ +L
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 33/209 (15%)
Query: 456 IGMGGYGTVYKGTF---HHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLL 509
+G G +G V T+ A+K + I+ KQ E ++L+ I HP + L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 510 GACPDHGCL--VYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAWEVASALAFLHNTKPK 566
G+ D L V E++ G L R P + F A ++ +L +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF----YAAQIVLIFEYLQSLN-- 151
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YIDP 622
I++RD+KP N+LLD + K+ D G + +++ + TY TLC YI P
Sbjct: 152 -IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTY-------TLCGTPEYIAP 197
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAKP 651
E +D + G+ I ++L P
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 42/311 (13%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLS-KIRHPHL--LL 507
+G G +G V+ T F A+K L+ + + + E VLS HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 508 LLGACPDHGCLVYEYMENGSLEDRLY--RKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
++ V EY+ G L + K + P ++ A E+ L FLH+
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY-----AAEIICGLQFLHS--- 114
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGL--STMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
K I++RD+K NILLD + KI D G+ ML K GT YI PE
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--------KTCTFCGTPDYIAPE 166
Query: 624 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL---DAQAGDWP 680
+ D +++G+++ ++L + DE+ L + + + W
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH-------GHDEEELFQSIRMDNPCYPRWL 219
Query: 681 IKETKE-LAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFI 739
+E K+ L L + E R + D++ P + A R+ P P +
Sbjct: 220 TREAKDILVKLFVREPERRLGVKGDIRQH--PFFREIDWSALEEREIEPPFKPKVKSAND 277
Query: 740 CPIL-KEVMNE 749
C KE +NE
Sbjct: 278 CSNFDKEFLNE 288
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 28/158 (17%)
Query: 502 HPHLLLLLGACPDHGC--------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWE 552
HP L+ L H C V E++ G L + R+ P E R + E
Sbjct: 55 HPFLVGL------HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPE----EHARFYSAE 104
Query: 553 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 612
++ AL FLH + II+RD+K N+LLD K+ D G+ P ++T+
Sbjct: 105 ISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTF---- 156
Query: 613 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 650
GT YI PE R D +A G+++ +++ +
Sbjct: 157 -CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 456 IGMGGYGTVYKGTFH---HTFA----AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLL 507
+G G +G V + T H H+ + AVK+L+S KQ + EL+++S + PHL +
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHL-GPHLNI 103
Query: 508 --LLGACPDHG--CLVYEYMENGSLEDRLYRKNNT 538
LLGAC G ++ EY G L D L+R +T
Sbjct: 104 VNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHT 138
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 39/135 (28%), Positives = 62/135 (45%), Gaps = 15/135 (11%)
Query: 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 577
LV +Y G L L + + P R+ +A E+ A+ +H +HRD+KP N
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLP-EDMARFYLA-EMVLAIDSVHQLG---YVHRDIKPDN 132
Query: 578 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISP 632
+LLD N ++ D G L +D + S VGT YI PE + G P
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLADGTVQSNV-----AVGTPDYISPEILQAMEDGKGRYGP 187
Query: 633 KSDVYAYGMVILQLL 647
+ D ++ G+ + ++L
Sbjct: 188 ECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 31/93 (33%), Positives = 40/93 (43%), Gaps = 7/93 (7%)
Query: 338 AIAQNEAN-DASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECA 396
A+ +A +A K K K E + +E E KA AK K K E A+ +AE A
Sbjct: 146 EEAKKQAEEEAKAKAAAEAKKKAAEAKKKAEA---EAKAKAEAK-AKAKAEEAKAKAEAA 201
Query: 397 RASAEKEAAQ--RQEAEMKAKHEAKEKEMLERA 427
+A A EAA EA A EA+ K
Sbjct: 202 KAKAAAEAAAKAEAEAAAAAAAEAERKADEAEL 234
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 31/115 (26%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 533 YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 592
Y + P+P + I ++ L +LH + IIHRD+K NI ++ IGD+G
Sbjct: 146 YLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLG 202
Query: 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLL 647
+ P+F+ G GT+ PE + K+D+++ G+V+ ++L
Sbjct: 203 AAQFPVVAPAFL-------GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 16/148 (10%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKV----LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+IG G YGTV+K T V + L L+E+ +L +++H +++ L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 511 ACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
H LV+EY + L+ N + + +++ LAF H+
Sbjct: 67 VL--HSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSF--MFQLLKGLAFCHSHN-- 119
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLS 594
++HRD+KP N+L++ N K+ D GL+
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 59/258 (22%), Positives = 102/258 (39%), Gaps = 29/258 (11%)
Query: 446 ATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNI-----QNKQFLQELE 495
A+L+ R G+ G TF FA + ++ ++ Q E
Sbjct: 77 ASLALCAEARAGIEKAGFSILETFTPGAEGFAFACIDN-KTCEHVVIKAGQRGGTATEAH 135
Query: 496 VLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEV 553
+L I HP ++ L G + CL+ + L L K N I + I V
Sbjct: 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRN---IAICDILAIERSV 191
Query: 554 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
A+ +LH + IIHRD+K NI ++H +GD G + P + K G
Sbjct: 192 LRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF----PVDI-NANKYYGW 243
Query: 614 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673
GT+ PE P D+++ G+V+ ++ T ++ ++ D D +++
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303
Query: 674 AQAG----DWPIKETKEL 687
++G ++PI L
Sbjct: 304 RRSGTHPNEFPIDAQANL 321
|
Length = 391 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 43/203 (21%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 454 LRIGMGGYGTVYKGTFHHTF--AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
++IG G G V H+ AVK++ + + + E+ ++ +H +++ + +
Sbjct: 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 512 --CPDHGCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
+ ++ E+++ G+L D + + + N I + V AL +LH+ + +
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-----TVCESVLQALCYLHS---QGV 138
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
IHRD+K +ILL + K+ D G ++ D K VGT ++ PE
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKD------VPKRKSLVGTPYWMAPEVISRT 192
Query: 629 LISPKSDVYAYGMVILQLLTAKP 651
+ D+++ G+++++++ +P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 29/85 (34%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 340 AQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYET--ARREAECAR 397
Q +A +A K K K E E + +E+A + A++E K A+++A A+
Sbjct: 117 KQKQAEEAKAKQAAEAKAKAEAE----AEKKAKEEAKKQAEEEAKAKAAAEAKKKAAEAK 172
Query: 398 ASAEKEAAQRQEAEMKAKHE-AKEK 421
AE EA + EA+ KAK E AK K
Sbjct: 173 KKAEAEAKAKAEAKAKAKAEEAKAK 197
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 48/178 (26%), Positives = 71/178 (39%), Gaps = 22/178 (12%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 510
IG G +G VY+ T A+KVL K + K+ + E +L + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 511 -----ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
LV +YM G L L ++ F R + +A + L +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR------FSEDRAKFYIAELVLALEHLHK 114
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
I++RD+KP NILLD + D GLS + NT GT Y+ PE
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSK-----ANLTDNKTTNTF-CGTTEYLAPE 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 456 IGMGGYGTVY---KGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRHPHLL 506
+G G YG V+ K + H + A+KVL+ +Q + + E +VL IR L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 507 LLLGACPDHGC---LVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALAFL 560
+ L L+ +Y+ G L L ++ F+ + + E+ AL L
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRER------FKEQEVQIYSGEIVLALEHL 121
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
H II+RD+K NILLD N + D GLS + D + ++ GT+ Y+
Sbjct: 122 HKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF-----CGTIEYM 173
Query: 621 DPEYQRTGLISPKS--DVYAYGMVILQLLTA 649
P+ R G D ++ G+++ +LLT
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 48/205 (23%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLLLL 509
++G G Y TVYKG T V + + + +++++ ++E+ +L ++H +++ L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 510 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
LV+EY++ + + Y + I +++ L + H K
Sbjct: 71 DIIHTEKSLTLVFEYLDK---DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--- 124
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
++HRD+KP N+L++ K+ D GL+ S + TY N V TL Y P+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYSNE--VVTLWYRPPDILLG 178
Query: 628 GL-ISPKSDVYAYGMVILQLLTAKP 651
S + D++ G + ++ T +P
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 577
LV +Y G L L + + P R+ +A E+ A+ +H +HRD+KP N
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA-EMVIAIDSVHQLH---YVHRDIKPDN 132
Query: 578 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISP 632
IL+D N ++ D G L D T +++ VGT YI PE + G P
Sbjct: 133 ILMDMNGHIRLADFGSCLKLMED-----GTVQSSVAVGTPDYISPEILQAMEDGKGKYGP 187
Query: 633 KSDVYAYGMVILQLLTAKPAIAITHKVET 661
+ D ++ G+ + ++L + VET
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 48/206 (23%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLLL- 508
++G G Y TV+KG T V + + + +++++ ++E+ +L ++H +++ L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 509 -LGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPK 566
+ LV+EY++ +D ++ I +I +++ LA+ H K
Sbjct: 71 DIVHTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK-- 124
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
++HRD+KP N+L++ K+ D GL+ S + TY N V TL Y P+
Sbjct: 125 -VLHRDLKPQNLLINERGELKLADFGLARA----KSVPTKTYSNE--VVTLWYRPPDVLL 177
Query: 627 -TGLISPKSDVYAYGMVILQLLTAKP 651
+ S + D++ G + ++ + +P
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK----QFLQELEVLSKIRHPHLLLLL 509
IG G +G V + T A+K ++ K +I ++ L E VL+++ P ++ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 510 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
+ P+ LV ++ G L L R+ F+ R + A L L N
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGR------FDLSRARFYTAELLCALENLHKFN 113
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+I+RD+KP NILLD+ + D GL LN + T+ GT Y+ PE
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTF-----CGTPEYLAPELLLG 167
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
+ D + G+++ ++LT P
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 11/100 (11%)
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS--TTY 608
++VA + FL + K +HRD+ N+LL + KI D GL+ + D ++VS +T+
Sbjct: 244 YQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 609 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
PV ++ PE L + SDV++YG+++ ++ +
Sbjct: 301 L---PVK---WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 52/221 (23%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 507
++G G Y TVYKG T A+K ++ +++++ ++E +L ++H +++
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIR----LEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 508 LLGACPDHG--------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALA 558
L H LV+EY++ D ++ R+ +++ LA
Sbjct: 68 L------HDIIHTKKTLTLVFEYLDT----DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
+ H + ++HRD+KP N+L+ K+ D GL+ S S TY N V TL
Sbjct: 118 YCHQRR---VLHRDLKPQNLLISERGELKLADFGLARA----KSVPSKTYSNE--VVTLW 168
Query: 619 YIDP-------EYQRTGLISPKSDVYAYGMVILQLLTAKPA 652
Y P EY S D++ G + ++ T +P
Sbjct: 169 YRPPDVLLGSTEY------STSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 29/115 (25%), Positives = 62/115 (53%), Gaps = 11/115 (9%)
Query: 536 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595
N +P + + + +++VA+ + FL + K +HRD+ N+L+ + KI D GL+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 596 MLNSDPSFVS--TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
+ D +++S +T+ L ++ PE L + SDV+++G+++ ++ T
Sbjct: 288 DIMRDSNYISKGSTFL------PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 488 KQFLQELEVLSKIRHPHLLL--LLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPW 543
+E+ +L + L + +L + G L+ E++E +L++
Sbjct: 36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SE 85
Query: 544 FERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 581
E+ IA ++A LA LH + H D+ PGNIL+D
Sbjct: 86 EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD 123
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 27/75 (36%), Positives = 39/75 (52%), Gaps = 3/75 (4%)
Query: 356 KCKLEEETRLSEIQL---LEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEM 412
+ K E+ RL+ + EE A + A ++K+ E A + A A+A AE EA + A
Sbjct: 102 RLKQLEKERLAAQEQKKQAEEAAKQAALKQKQAEEAAAKAAAAAKAKAEAEAKRAAAAAK 161
Query: 413 KAKHEAKEKEMLERA 427
KA EAK+K E A
Sbjct: 162 KAAAEAKKKAEAEAA 176
|
Length = 387 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 6e-04
Identities = 28/74 (37%), Positives = 42/74 (56%), Gaps = 1/74 (1%)
Query: 349 RKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQ 408
+K ++ K K EE + E + E+A + A KKK E A++ AE A+A AE A + +
Sbjct: 1302 KKADEAKK-KAEEAKKADEAKKKAEEAKKKADAAKKKAEEAKKAAEAAKAEAEAAADEAE 1360
Query: 409 EAEMKAKHEAKEKE 422
AE KA+ K+KE
Sbjct: 1361 AAEEKAEAAEKKKE 1374
|
Length = 2084 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 47/181 (25%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 449 SFSENLRIGMGGYGTVYKGT--FHHTFAAVKVLQSKGNIQNKQF--LQELEVLSKIRHPH 504
S+ + ++G G Y TVYKG + A+KV++ + + F ++E +L ++H +
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHAN 64
Query: 505 LLLL--LGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
++LL + + LV+EY+ + Y + + +++ L+++H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQ---YMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
+ I+HRD+KP N+L+ K+ D GL+ S S TY N V TL Y P
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLARA----KSVPSHTYSNE--VVTLWYRPP 172
Query: 623 E 623
+
Sbjct: 173 D 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|190741 pfam03763, Remorin_C, Remorin, C-terminal region | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 25/67 (37%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 353 DLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEM 412
+ K K E E + E +L ++KA K K K A ++AE RA+AE A+R E E
Sbjct: 37 NKKKAKAEAELKKIERKLEKKKAEAAEKL-KNKLAAAHKKAEEKRATAE---AKRGEEEA 92
Query: 413 KAKHEAK 419
KA+ +A
Sbjct: 93 KAEEKAA 99
|
Remorins are plant-specific plasma membrane-associated proteins. In tobacco remorin co-purifies with lipid rafts. Most remorins have a variable, proline-rich C-half and a more conserved N-half that is predicted to form coiled coils. Consistent with this, circular dichroism studies have demonstrated that much of the protein is alpha-helical. Remorins exist in plasma membrane preparations as oligomeric structures and form filaments in vitro. The proteins can bind polyanions including the extracellular matrix component oligogalacturonic acid (OGA). In vitro, remorin in plasma membrane preparations is phosphorylated (principally on threonine residues) in the presence of OGA and thus co-purifies with a protein kinases(s). The biological functions of remorins are unknown but roles as components of the membrane/cytoskeleton are possible. Length = 112 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 29/103 (28%), Positives = 45/103 (43%), Gaps = 13/103 (12%)
Query: 338 AIAQNEANDASRKVNDLNKCKLEEETRLSEI---QLLEE-KAIELAKQEKKKYETARREA 393
A+ Q +A +A+ K K K E E + + + E K A+ KK A+++A
Sbjct: 128 ALKQKQAEEAAAKAAAAAKAKAEAEAKRAAAAAKKAAAEAKKKAEAEAAKKAAAEAKKKA 187
Query: 394 EC---------ARASAEKEAAQRQEAEMKAKHEAKEKEMLERA 427
E A+ AE EA ++ AE K K A+ K +A
Sbjct: 188 EAEAAAKAAAEAKKKAEAEAKKKAAAEAKKKAAAEAKAAAAKA 230
|
Length = 387 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 29/87 (33%), Positives = 40/87 (45%), Gaps = 14/87 (16%)
Query: 518 LVYEYMENGSLEDRLYRKNNTPPIPWFE----RYRIAWEVASALAFLHNTKPKPIIHRDM 573
L+ EY+ G + L +K+ F R+ IA E A+ +H IHRD+
Sbjct: 78 LIMEYLPGGDMMTLLMKKDT------FTEEETRFYIA-ETILAIDSIHKLG---YIHRDI 127
Query: 574 KPGNILLDHNLVSKIGDVGLSTMLNSD 600
KP N+LLD K+ D GL T L
Sbjct: 128 KPDNLLLDAKGHIKLSDFGLCTGLKKS 154
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 49/153 (32%), Positives = 74/153 (48%), Gaps = 27/153 (17%)
Query: 456 IGMGGYGTVY---KGTFHHTFAAVKVLQSKGNIQNK----QFLQELEVLSKIRHP---HL 505
I G +G VY K +A VKV++ K ++ NK Q E + L+ + P HL
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYA-VKVVK-KADMINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 506 LLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE----RYRIAWEVASALAFLH 561
L + ++ LV EY+ G ++ L+ +F+ I+ EVA AL +LH
Sbjct: 70 YYSLQSA-NNVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYIS-EVALALDYLH 121
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594
IIHRD+KP N+L+ + K+ D GLS
Sbjct: 122 R---HGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 28/163 (17%)
Query: 502 HPHLLLLLGACPDHGCL--------VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWE 552
HP L+ L H C V EY+ G L + R+ P E R + E
Sbjct: 55 HPFLVGL------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAE 104
Query: 553 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 612
++ AL +LH + II+RD+K N+LLD K+ D G+ P ++T+
Sbjct: 105 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTF---- 156
Query: 613 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI 655
GT YI PE R D +A G+++ +++ + I
Sbjct: 157 -CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (97), Expect = 0.002
Identities = 28/84 (33%), Positives = 48/84 (57%), Gaps = 1/84 (1%)
Query: 343 EANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEK 402
+A + +KV L K + EE+ + E++ EE+ A +E KK E +++AE A+ AE+
Sbjct: 1627 KAEEEKKKVEQLKKKEAEEKKKAEELKKAEEENKIKAAEEAKKAEEDKKKAEEAK-KAEE 1685
Query: 403 EAAQRQEAEMKAKHEAKEKEMLER 426
+ + EA K EAK+ E L++
Sbjct: 1686 DEKKAAEALKKEAEEAKKAEELKK 1709
|
Length = 2084 |
| >gnl|CDD|234750 PRK00409, PRK00409, recombination and DNA strand exchange inhibitor protein; Reviewed | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.002
Identities = 30/113 (26%), Positives = 49/113 (43%), Gaps = 26/113 (23%)
Query: 323 LEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQE 382
LE+L E + +A +A + + K K E LEEK +L ++E
Sbjct: 525 LEELERE----------LEQKAEEAEALLKEAEKLKEE----------LEEKKEKLQEEE 564
Query: 383 KKKYETARREAECARASAEKEAAQ----RQEAEMKAKHEAKEKEMLE--RALN 429
K E A +EA+ A A+KEA + ++ + K E++E + LN
Sbjct: 565 DKLLEEAEKEAQQAIKEAKKEADEIIKELRQLQKGGYASVKAHELIEARKRLN 617
|
Length = 782 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 20/86 (23%), Positives = 40/86 (46%), Gaps = 5/86 (5%)
Query: 341 QNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASA 400
Q + A++K + K ++ + + E+ + +Q + A++ + A+ +
Sbjct: 56 QQQKKPAAKKEQERQKKLEQQAEEAEKQRAAEQARQKELEQRAAAEKAAKQAEQAAKQAE 115
Query: 401 EK-----EAAQRQEAEMKAKHEAKEK 421
EK EA +Q AE KAK EA+ +
Sbjct: 116 EKQKQAEEAKAKQAAEAKAKAEAEAE 141
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 31/132 (23%), Positives = 61/132 (46%), Gaps = 19/132 (14%)
Query: 519 VYEYMENGSLE--DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPG 576
+Y +M + + + DR P+ R I ++ A+ ++H+ K +IHRD+K
Sbjct: 249 LYSFMYDEAFDWKDR--------PLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLE 296
Query: 577 NILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDV 636
NI L+ + +GD G + + + G VGT+ PE +D+
Sbjct: 297 NIFLNCDGKIVLGDFGTAMPFEKE-----REAFDYGWVGTVATNSPEILAGDGYCEITDI 351
Query: 637 YAYGMVILQLLT 648
++ G+++L +L+
Sbjct: 352 WSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 63/264 (23%), Positives = 106/264 (40%), Gaps = 36/264 (13%)
Query: 452 ENLR-IGMGGYGTV---YKGTFHHTFAAVKVLQS-KGNIQNKQFLQELEVLSKIRHPHLL 506
+NL+ IG G G V Y A K+ + + K+ +EL ++ + H +++
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 507 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPW-FERYRIAWEVASALAFLHNTKP 565
LL L E ++ L L N I + R+++ + L + +
Sbjct: 80 SLLNVFTPQKSL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
IIHRD+KP NI++ + KI D GL+ + SF+ T Y V T Y PE
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPY-----VVTRYYRAPEVI 190
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 685
D+++ G ++ +++ K I ID+ N K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWN-----------------K 229
Query: 686 ELAALGLSCAELRRKDRPDLKNQV 709
+ LG C E +K +P ++N V
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYV 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|225606 COG3064, TolA, Membrane protein involved in colicin uptake [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 24/63 (38%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 361 EETRLSEIQLLEEKAIELAKQEKKKYETARRE--AECARASAEKEAAQRQEAEMKAKHEA 418
E+ E + EE+A + A ++KKK E A+ + AE A+ A EA ++ E KA EA
Sbjct: 124 EKQAQLEQKQQEEQARKAAAEQKKKAEAAKAKAAAEAAKLKAAAEAKKKAEEAAKAAEEA 183
Query: 419 KEK 421
K K
Sbjct: 184 KAK 186
|
Length = 387 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 456 IGMGGYGTV--YKGTFHHTFAAVKVLQSKGNIQNKQFLQ---ELEVLSKIRHPHLLLLLG 510
+G+G +G V H A+K L+ K + Q E ++L++ + ++ L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 511 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
+ D L V +Y+ G + L R P + R+ IA E+ A+ +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV--LARFYIA-ELTLAIESVHKMG---F 122
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLST 595
IHRD+KP NIL+D + K+ D GL T
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.004
Identities = 27/86 (31%), Positives = 46/86 (53%), Gaps = 4/86 (4%)
Query: 340 AQNEANDASRKVNDLNKCKLEEETRLSEIQLLEE--KAIELAK-QEKKKYETARREAECA 396
A+ +A +A +K ++ K E + + E + EE KA E K +E KK + A++ E
Sbjct: 1488 AKKKAEEAKKKADEAKK-AAEAKKKADEAKKAEEAKKADEAKKAEEAKKADEAKKAEEKK 1546
Query: 397 RASAEKEAAQRQEAEMKAKHEAKEKE 422
+A K+A + ++AE K K E +K
Sbjct: 1547 KADELKKAEELKKAEEKKKAEEAKKA 1572
|
Length = 2084 |
| >gnl|CDD|227278 COG4942, COG4942, Membrane-bound metallopeptidase [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 29/110 (26%), Positives = 40/110 (36%), Gaps = 9/110 (8%)
Query: 322 ELEKLRIELRHVRGMYAIAQNE---ANDASRKVNDLNKCKLEEETRL-----SEIQLLEE 373
L+ +L VR A Q E R LEE + SE+ ++
Sbjct: 165 ALKATLKQLAAVRAEIAAEQAELTTLLSEQRAQQAKLAQLLEERKKTLAQLNSELSADQK 224
Query: 374 KAIELAKQEKK-KYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKE 422
K EL E + K E A EA A+A AA+ A +A + E
Sbjct: 225 KLEELRANESRLKNEIASAEAAAAKAREAAAAAEAAAARARAAEAKRTGE 274
|
Length = 420 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 25/64 (39%), Positives = 33/64 (51%), Gaps = 10/64 (15%)
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
LH+ IIHRD+KP NI++ + KI D GL+ + SF+ T Y V T Y
Sbjct: 134 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPY-----VVTRYY 183
Query: 620 IDPE 623
PE
Sbjct: 184 RAPE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.004
Identities = 28/126 (22%), Positives = 44/126 (34%), Gaps = 10/126 (7%)
Query: 322 ELEKLRIELRHVRGMYAIAQNEANDASRKVN----DLNKCKLEEETRLSEIQLLE----- 372
L +LR EL + + E + SR+++ DL + + E E I L
Sbjct: 699 ALAELRKELEELEEELEQLRKELEELSRQISALRKDLARLEAEVEQLEERIAQLSKELTE 758
Query: 373 -EKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGT 431
E IE ++ ++ E EAE E + Q +E + E LN
Sbjct: 759 LEAEIEELEERLEEAEEELAEAEAEIEELEAQIEQLKEELKALREALDELRAELTLLNEE 818
Query: 432 FQRYRN 437
R
Sbjct: 819 AANLRE 824
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 802 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.68 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.67 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.64 | |
| PF04564 | 73 | U-box: U-box domain; InterPro: IPR003613 Quality c | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.56 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.49 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| smart00504 | 63 | Ubox Modified RING finger domain. Modified RING fi | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.43 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.35 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 98.32 | |
| KOG4642 | 284 | consensus Chaperone-dependent E3 ubiquitin protein | 98.27 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.95 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.94 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.91 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.83 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.75 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.7 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.68 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 97.66 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.62 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.6 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.53 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.29 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.24 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.2 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.19 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.19 | |
| PLN02236 | 344 | choline kinase | 97.06 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.88 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-51 Score=449.33 Aligned_cols=275 Identities=43% Similarity=0.746 Sum_probs=237.2
Q ss_pred ccccCCHHHHHHhhcCCcccceecCCCcEEEEEEEECC-eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeccee
Q 003694 434 RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512 (802)
Q Consensus 434 ~~~~~~~~ei~~~~~~f~~~~~iG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~ 512 (802)
..+.|++.++..+|++|+..+.||+||||.||+|.+.+ +.||||.+.........+|.+|+++|++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46779999999999999999999999999999999987 79999988776543145599999999999999999999999
Q ss_pred cCC---CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEe
Q 003694 513 PDH---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 589 (802)
Q Consensus 513 ~~~---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~ 589 (802)
.+. .+||||||++|+|.++|+..... +++|..|++|+.++|+||.|||...+++||||||||+|||||.++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 644 48999999999999999876654 79999999999999999999999887899999999999999999999999
Q ss_pred eecccccccC-CCCcccccccccCC-ccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccc---------cch
Q 003694 590 DVGLSTMLNS-DPSFVSTTYKNTGP-VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI---------THK 658 (802)
Q Consensus 590 DFGla~~~~~-~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~---------~~~ 658 (802)
|||+|+..+. .... ... .||.+|+||||..++.++.++|||||||+|+||+||++|... ..+
T Consensus 220 DFGLa~~~~~~~~~~-------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV-------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CccCcccCCccccce-------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 9999976554 2111 111 799999999999999999999999999999999999988863 233
Q ss_pred hhhhhchhhhHHHhhhhCC--CCCh-HHHHHHHHHHHHhhccccCCCCccccchhhHHHHHH
Q 003694 659 VETAIDEDNLAEILDAQAG--DWPI-KETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 659 ~~~~~~~~~l~~~ld~~~~--~~p~-~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
....+..+.+.+++|+... ..+. .....+..++.+|++.+|..||+|.+ |+..|+.+.
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~-Vv~~L~~~~ 353 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ-VVKELEGIL 353 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH-HHHHHHhhc
Confidence 4455667789999999863 5554 67888999999999999999999994 666765443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=405.93 Aligned_cols=253 Identities=34% Similarity=0.516 Sum_probs=213.4
Q ss_pred cceecCCCcEEEEEEEECCeE-EEEEEEcccCccc--hHHHHHHHHHHHhcCCCceeeecceecCC---CeEEEEEccCC
Q 003694 453 NLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQ--NKQFLQELEVLSKIRHPHLLLLLGACPDH---GCLVYEYMENG 526 (802)
Q Consensus 453 ~~~iG~G~~g~Vy~~~~~~~~-vavK~l~~~~~~~--~~~~~~Ei~il~~l~Hpniv~l~g~~~~~---~~lV~Ey~~~g 526 (802)
...||.|+||+||+|.++++. ||||++....... .+.|.+|+.+|.+++|||||+|+|+|.+. .+||||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 345999999999999999998 9999997653222 56899999999999999999999999776 48999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCc-eeEEeeecccccccCCCCccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~ 605 (802)
+|.++|+.. ....+++..+++|+.|||.||.|||+.++ ||||||||+||||+.++ ++||||||+++......
T Consensus 126 sL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---- 198 (362)
T KOG0192|consen 126 SLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---- 198 (362)
T ss_pred cHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc----
Confidence 999999875 34569999999999999999999999886 99999999999999997 99999999998866432
Q ss_pred ccccccCCccCcccCCccccc--cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQR--TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||.....+..+. .-+.....+..|..+
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~-----~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS-----AVVVGGLRPPIPKEC 271 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH-----HHHhcCCCCCCCccC
Confidence 1234578999999999999 5689999999999999999999999997554422211 111233345667778
Q ss_pred HHHHHHHHHHhhccccCCCCccccchhhHHHHHHHhh
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVA 720 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~~ 720 (802)
+..+..|+.+||..+|..||++. +++..|+.+....
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~-ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFL-EIVSRLESIMSHI 307 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHH-HHHHHHHHHHHhh
Confidence 99999999999999999999999 6888888776543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=375.60 Aligned_cols=239 Identities=31% Similarity=0.401 Sum_probs=201.2
Q ss_pred ceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCC---CeEEEEEccCCC
Q 003694 454 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---GCLVYEYMENGS 527 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~---~~lV~Ey~~~gs 527 (802)
..||+|..|+|||+.+. +..+|+|++.... ....+++.+|+++|..++|||||.+||+|... .+|+||||++||
T Consensus 85 ~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGS 164 (364)
T KOG0581|consen 85 GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGS 164 (364)
T ss_pred hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCC
Confidence 46999999999999997 5689999995443 34567899999999999999999999998543 479999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 528 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 528 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
|++++...+ .+++....+|+.+|++||.|||. .+ ||||||||+|||++..|.+||||||.++.+....
T Consensus 165 Ld~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~----- 233 (364)
T KOG0581|consen 165 LDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI----- 233 (364)
T ss_pred HHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhhh-----
Confidence 999987653 48899999999999999999996 67 9999999999999999999999999999876542
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH-HHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK-ETK 685 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~-~~~ 685 (802)
..+.+||..|||||.+.+..|+.++||||||+.++|+.+|+-||........ --...+..+++...+..|.. .++
T Consensus 234 ---a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 234 ---ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-DIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred ---cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-CHHHHHHHHhcCCCCCCCcccCCH
Confidence 2456999999999999999999999999999999999999999965411000 01123344444445566665 889
Q ss_pred HHHHHHHHhhccccCCCCcccc
Q 003694 686 ELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 686 ~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
++..++..||+.||.+||++.+
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~q 331 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQ 331 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHH
Confidence 9999999999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=370.25 Aligned_cols=240 Identities=30% Similarity=0.478 Sum_probs=194.8
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
..+|....+||+|+||+||+|++. ++.||||.+... .....+.+..|+.+|+.|+|||||.|++++.+.. ||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888888999999999999985 569999998765 3444566789999999999999999999996554 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC------ceeEEeeeccc
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN------LVSKIGDVGLS 594 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~------~~~kl~DFGla 594 (802)
|||.||+|.++|...+. ++......++.||+.||++||+++ ||||||||+||||+.+ -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999987663 888999999999999999999999 9999999999999764 56899999999
Q ss_pred ccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 674 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~ 674 (802)
+.+.... .....+|++.|||||++...+|+.|+|+||+|+|||+|++|++||......+-.. .+..
T Consensus 163 R~L~~~~-------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-------~~~k 228 (429)
T KOG0595|consen 163 RFLQPGS-------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL-------YIKK 228 (429)
T ss_pred hhCCchh-------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-------HHhc
Confidence 9987432 2345699999999999999999999999999999999999999997443322211 1111
Q ss_pred h---CCCCChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 675 Q---AGDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 675 ~---~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
. .+..+......+.+|+...+..+|.+|-++.
T Consensus 229 ~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~ 263 (429)
T KOG0595|consen 229 GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFE 263 (429)
T ss_pred cccccCchhhhccCchhhhhhHHHhcCccccCchH
Confidence 1 1223334445566777777777777776655
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=382.16 Aligned_cols=242 Identities=27% Similarity=0.424 Sum_probs=206.2
Q ss_pred cCCcccceecCCCcEEEEEEEE--CCeEEEEEEEccc---CccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
..|...+.||+|||+.||.+++ .+..||+|++... .....+.+.+||+|.+.|.|||||+|+++|.|.. |||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4588889999999999999998 3669999998764 2345677899999999999999999999998876 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
|+|.+|+|..++.+ ..++++.++..++.||+.||.|||+.+ |||||||..||||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999998863 345999999999999999999999999 999999999999999999999999999988754
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
.. +..+.+|||.|+|||++....++..+||||+|||||.||+|+|||..... + +.+ .-+....-..|
T Consensus 172 ~E------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-k-----ety-~~Ik~~~Y~~P 238 (592)
T KOG0575|consen 172 GE------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-K-----ETY-NKIKLNEYSMP 238 (592)
T ss_pred cc------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-H-----HHH-HHHHhcCcccc
Confidence 32 23556999999999999999999999999999999999999999953321 1 111 12222234456
Q ss_pred hHHHHHHHHHHHHhhccccCCCCccccc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKNQ 708 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~~ 708 (802)
...+.+.++||.++|+.+|.+||++.++
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~v 266 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSLDEV 266 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 7788899999999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=353.97 Aligned_cols=246 Identities=25% Similarity=0.399 Sum_probs=201.5
Q ss_pred CCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeecce-ecCC---CeEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGA-CPDH---GCLVY 520 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~-~~~~---~~lV~ 520 (802)
+|.+.++||+|.||.||++.. ++..+|.|.++..... ..+....|+.+|++|+|||||+++++ +.+. .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 577788999999999999875 5779999998865432 34568899999999999999999994 4333 27999
Q ss_pred EEccCCCHHHHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 521 EYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTKP-KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 521 Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~-~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
|||.+|+|...+.. +....-+++..+++++.|++.||..+|+.-+ ..|+||||||.||+|+.+|.+||+||||++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999998875 3344568999999999999999999999432 249999999999999999999999999999987
Q ss_pred CCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh-CC
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AG 677 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~-~~ 677 (802)
....+ .++.+|||.||+||.+...+|+.+|||||+||++|||..-++||......+ +..-+... .+
T Consensus 180 s~~tf------A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~~ 246 (375)
T KOG0591|consen 180 SKTTF------AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGDYP 246 (375)
T ss_pred chhHH------HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCCCC
Confidence 65433 356799999999999999999999999999999999999999997542211 11111111 12
Q ss_pred CCC-hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 678 DWP-IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 678 ~~p-~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..| .-++..+..|+..|+..||..||+...
T Consensus 247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~ 277 (375)
T KOG0591|consen 247 PLPDEHYSTDLRELINMCIAVDPEQRPDTVP 277 (375)
T ss_pred CCcHHHhhhHHHHHHHHHccCCcccCCCcch
Confidence 233 567899999999999999999999653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=378.27 Aligned_cols=249 Identities=29% Similarity=0.452 Sum_probs=206.8
Q ss_pred cccceecCCCcEEEEEEEECCe-EEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCC
Q 003694 451 SENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 527 (802)
Q Consensus 451 ~~~~~iG~G~~g~Vy~~~~~~~-~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gs 527 (802)
...+.||+|-||.||.|.++++ .||+|.++.. ....+.|.+|+++|.+|+|+|||+|+|+|.... |||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3346799999999999999987 9999999876 345678999999999999999999999997644 99999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccc
Q 003694 528 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607 (802)
Q Consensus 528 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 607 (802)
|.++|.. .....+...+.+.++.|||+|++||++.+ +|||||...||||+++..+||+|||||+...++...
T Consensus 288 Ll~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~---- 359 (468)
T KOG0197|consen 288 LLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT---- 359 (468)
T ss_pred HHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee----
Confidence 9999986 23445888899999999999999999998 999999999999999999999999999955443211
Q ss_pred ccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 608 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 608 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
...+..-...|.|||.+..+.++.+||||||||+||||+| |+.|+......+ .+..+-.......|..++..
T Consensus 360 -~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e------v~~~le~GyRlp~P~~CP~~ 432 (468)
T KOG0197|consen 360 -ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE------VLELLERGYRLPRPEGCPDE 432 (468)
T ss_pred -ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH------HHHHHhccCcCCCCCCCCHH
Confidence 1233455678999999999999999999999999999999 888886443221 12222223345678889999
Q ss_pred HHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 687 LAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
+.+|+..||..+|++|||+. .+...|+.+
T Consensus 433 vY~lM~~CW~~~P~~RPtF~-~L~~~l~~~ 461 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFE-TLREVLEDF 461 (468)
T ss_pred HHHHHHHHhhCCcccCCCHH-HHHHHHHHh
Confidence 99999999999999999998 455555544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=362.24 Aligned_cols=240 Identities=27% Similarity=0.313 Sum_probs=201.6
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccc---hHHHHHHHHHHHhcCCCceeeecceecCCC--eEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~---~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
..+|...+.||+|+||.||.++.. ++.+|+|+++...... .+....|..||.+++||+||.|+..|++.. |||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 457999999999999999999875 5589999998764333 355788999999999999999999998766 999
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
+||+.||.|..+|.+.+. +++..+.-++.+|+.||.|||+.+ ||||||||+|||||..|+++|+|||||+..-.
T Consensus 104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999987664 788888889999999999999999 99999999999999999999999999996543
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
.... ....+||+.|||||++.+..|+..+|+|||||++|||+||.+||...+... ....++.......
T Consensus 178 ~~~~------t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~~k~~~~ 245 (357)
T KOG0598|consen 178 DGDA------TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILKGKLPLP 245 (357)
T ss_pred CCCc------cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhcCcCCCC
Confidence 3221 234699999999999999999999999999999999999999997554322 1222333333344
Q ss_pred ChHHHHHHHHHHHHhhccccCCCCc
Q 003694 680 PIKETKELAALGLSCAELRRKDRPD 704 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~ 704 (802)
|.-.+....+|+.+.+..+|++|-.
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhcC
Confidence 4446788999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=359.29 Aligned_cols=243 Identities=23% Similarity=0.336 Sum_probs=192.1
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccc-------hHHHHHHHHHHHhcCCCceeeecceecC--C
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ-------NKQFLQELEVLSKIRHPHLLLLLGACPD--H 515 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~-------~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~ 515 (802)
.+.|-..+.||+|+||.|-+|... ++.||||+++...... .....+|++||++|+|||||+++++|.. .
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 445777889999999999999876 4599999997643222 2235799999999999999999999954 4
Q ss_pred CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC---ceeEEeeec
Q 003694 516 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVG 592 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~---~~~kl~DFG 592 (802)
.||||||++||+|.+.+..++. +....-.-++.|++.||.|||+.| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 4899999999999999876543 555556778999999999999999 9999999999999765 889999999
Q ss_pred ccccccCCCCcccccccccCCccCcccCCccccccCCC---CCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhH
Q 003694 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI---SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 669 (802)
Q Consensus 593 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~ 669 (802)
+|+..... + .+.+.+|||.|.|||++.++.+ ..++|+||+||+||-+|+|.+||....... .-..
T Consensus 325 lAK~~g~~-s------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-----sl~e 392 (475)
T KOG0615|consen 325 LAKVSGEG-S------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-----SLKE 392 (475)
T ss_pred hhhccccc-e------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----cHHH
Confidence 99987632 2 2356799999999999976653 347899999999999999999996321100 0111
Q ss_pred HHhhhhCCCCC---hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 670 EILDAQAGDWP---IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 670 ~~ld~~~~~~p---~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+++...-...| ...+.+..+||.++|..||+.||++.+
T Consensus 393 QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~e 433 (475)
T KOG0615|consen 393 QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADE 433 (475)
T ss_pred HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHH
Confidence 22222222222 256788999999999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=363.96 Aligned_cols=247 Identities=28% Similarity=0.353 Sum_probs=206.8
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccc---hHHHHHHHHHHHhc-CCCceeeecceecCCC--eE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ---NKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~---~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~l 518 (802)
..+|..++.||+|+|++||+|+.. ++.||||++....... .+-+..|-++|.+| .||.|++||..|+|.. |+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 347888889999999999999886 4599999987653322 23467899999999 7999999999998876 89
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
|+||++||+|.++|.+.+. |+......++.+|+.||+|||++| ||||||||+|||||.||++||+|||.|+.++
T Consensus 152 vLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999987654 788888889999999999999999 9999999999999999999999999999987
Q ss_pred CCCCc-------ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHH
Q 003694 599 SDPSF-------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 671 (802)
Q Consensus 599 ~~~~~-------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ 671 (802)
+.... .........++||..|.+||++..+..++.+|+|+||||||+|+.|+|||...+..- .+..+
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------iFqkI 299 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------IFQKI 299 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------HHHHH
Confidence 54322 111222366899999999999999999999999999999999999999996543221 22233
Q ss_pred hhhhCCCCChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 672 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 672 ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
+ ...-.||...++.+.+|+.+.|..||.+|++..
T Consensus 300 ~-~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~ 333 (604)
T KOG0592|consen 300 Q-ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQ 333 (604)
T ss_pred H-HhcccCCCCCCHHHHHHHHHHHccCccccccHH
Confidence 3 234567777788999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=355.77 Aligned_cols=249 Identities=24% Similarity=0.298 Sum_probs=199.7
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccch---HHHHHHHHHHHhcCCCceeeecceecCCC--eE
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~---~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~l 518 (802)
..++|.....||+|+||.||+|.-+ |..+|+|+++....... .....|-.+|...++|+||+||..|++.. ||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4567888889999999999999875 55999999987655444 44678999999999999999999998765 89
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
||||++||++..+|.+.+ .|+......++.+++.|+..||+.| ||||||||+|+|||..|++||+|||||.-+.
T Consensus 219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999998755 4888888889999999999999999 9999999999999999999999999996543
Q ss_pred CCC---------------------Cccc--cc------------------ccccCCccCcccCCccccccCCCCCcccch
Q 003694 599 SDP---------------------SFVS--TT------------------YKNTGPVGTLCYIDPEYQRTGLISPKSDVY 637 (802)
Q Consensus 599 ~~~---------------------~~~~--~~------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~ 637 (802)
... .+.. +. ......+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 210 0000 00 001235999999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCc
Q 003694 638 AYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPD 704 (802)
Q Consensus 638 SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~ 704 (802)
|||||+||||.|.|||......+..-.--++...+.... ......+..+||.+||. ||.+|-.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999986665554333223332222111 12345889999999999 9999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=353.02 Aligned_cols=247 Identities=27% Similarity=0.429 Sum_probs=200.7
Q ss_pred cCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecce--ecCC--CeEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA--CPDH--GCLVYE 521 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~--~~~~--~~lV~E 521 (802)
.+|...+.||+|+||.||++.... ...|||..........+.+.+|+.+|++++|||||+++|. ..+. .++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456777889999999999999874 7899998776533335678999999999999999999996 3443 579999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC-CceeEEeeecccccccCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~-~~~~kl~DFGla~~~~~~ 600 (802)
|+++|+|.+++.+.+. .++...+.+++.||+.||.|||+++ ||||||||+||||+. ++.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999987664 5999999999999999999999988 999999999999999 799999999999877641
Q ss_pred CCcccccccccCCccCcccCCccccccCC-CCCcccchhHHHHHHHHHhCCCCcccc-chhhhhhchhhhHHHhhhhCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAIT-HKVETAIDEDNLAEILDAQAGD 678 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDv~SlGvil~elltg~~p~~~~-~~~~~~~~~~~l~~~ld~~~~~ 678 (802)
.. .........||+.|||||++..+. ..+++|||||||+++||+||++||... ..... .+........+.
T Consensus 172 ~~---~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~-----~~~ig~~~~~P~ 243 (313)
T KOG0198|consen 172 GT---KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA-----LLLIGREDSLPE 243 (313)
T ss_pred cc---cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH-----HHHHhccCCCCC
Confidence 11 111234568999999999998643 345999999999999999999999642 11111 111111222457
Q ss_pred CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+|...+....+++.+|+..+|..||++.+
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~e 272 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEE 272 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 78888899999999999999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.98 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=196.0
Q ss_pred CCcccceecCCCcEEEEEEEECC--eEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
.|+...++|+|+||.||+++++. ..||||++.... ....+..++|+.+|++++|||+|.|+.+|.... +||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 46667789999999999999864 589999986543 234456789999999999999999999997655 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
|+. ++.+.|.+..+ .++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+.....
T Consensus 83 ~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 83 CDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred cch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 986 44455655443 3888899999999999999999999 99999999999999999999999999999875322
Q ss_pred cccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch----hh----hHHHhh
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE----DN----LAEILD 673 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~----~~----l~~~ld 673 (802)
. .+..+.|.+|.|||.+.+ .+|++.+||||+||++.||+||.|-|...+.+++..-- |. ...++.
T Consensus 157 -~-----YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 157 -N-----YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred -h-----hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 2 255689999999998877 78999999999999999999999999877666654311 11 111111
Q ss_pred hh-------CCC----CC-----hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 674 AQ-------AGD----WP-----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ~~-------~~~----~p-----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.. .+. .| +....-+.+|+.+|+++||.+|++-.+
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~q 280 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQ 280 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHH
Confidence 11 000 01 133557889999999999999999774
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.42 Aligned_cols=257 Identities=19% Similarity=0.279 Sum_probs=205.8
Q ss_pred cccCCHHHHHHhhcCCcccceecCCCcEEEEEEEECCeEEEEEEEcccCccc---hHHHHHHHHHHHhcCCCceeeecce
Q 003694 435 YRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGA 511 (802)
Q Consensus 435 ~~~~~~~ei~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~---~~~~~~Ei~il~~l~Hpniv~l~g~ 511 (802)
.+.++.++| +......||+|++|.||+|.++++.||||++....... .+.|.+|+.+|.+++||||++++|+
T Consensus 12 ~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 12 IKCIESDDI-----DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred ceecCHHHc-----CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 344555555 33334679999999999999999999999987653322 4668899999999999999999999
Q ss_pred ecC------CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCeEecCCc
Q 003694 512 CPD------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNL 584 (802)
Q Consensus 512 ~~~------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILl~~~~ 584 (802)
|.+ ..++||||+++|+|.+++.... .+++.....++.+++.||.|||+. + ++||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENY 160 (283)
T ss_pred EEecccCCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCC
Confidence 865 2379999999999999986543 488999999999999999999985 6 88999999999999999
Q ss_pred eeEEeeecccccccCCCCcccccccccCCccCcccCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCccccchhhhh
Q 003694 585 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA 662 (802)
Q Consensus 585 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~ 662 (802)
.+||+|||+++.+.... ....||..|+|||++.+ ..++.++|||||||++|||+||+.||......
T Consensus 161 ~~kl~dfg~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--- 228 (283)
T PHA02988 161 KLKIICHGLEKILSSPP---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--- 228 (283)
T ss_pred cEEEcccchHhhhcccc---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---
Confidence 99999999998764321 23468999999999876 67999999999999999999999999643211
Q ss_pred hchhhhHHHhhh-hCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHH
Q 003694 663 IDEDNLAEILDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 663 ~~~~~l~~~ld~-~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
..+..++.. .....|..++..+.+|+.+||+.+|.+||++. +++..|+.+..
T Consensus 229 ---~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ell~~l~~~~~ 281 (283)
T PHA02988 229 ---EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIK-EILYNLSLYKF 281 (283)
T ss_pred ---HHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHH-HHHHHHHHHHh
Confidence 111111111 12234445788999999999999999999999 68788777653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.15 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=202.2
Q ss_pred hcCCcccceecCCCcEEEEEEEEC-------CeEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeecceecCC--
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH-- 515 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~-- 515 (802)
.++|...++||+|+||.||+|.+. +..||||++..... .....+.+|+.+|..+ +||||++++|+|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 457888899999999999999752 24799999875432 2345689999999999 899999999998643
Q ss_pred -CeEEEEEccCCCHHHHhhhcCC---------------------------------------------------------
Q 003694 516 -GCLVYEYMENGSLEDRLYRKNN--------------------------------------------------------- 537 (802)
Q Consensus 516 -~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 537 (802)
.++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 3799999999999999875321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccccccCCcc
Q 003694 538 --TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 615 (802)
Q Consensus 538 --~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~g 615 (802)
..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......... ......+
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~----~~~~~~~ 238 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----RKGSARL 238 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchh----cccCCCC
Confidence 134788889999999999999999988 9999999999999999999999999998764332211 1123356
Q ss_pred CcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHh
Q 003694 616 TLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSC 694 (802)
Q Consensus 616 t~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~C 694 (802)
++.|+|||++.+..++.++|||||||+||||+| |.+||......+. ....+.+......|...+..+.+|+.+|
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~c 313 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQRLKDGTRMRAPENATPEIYRIMLAC 313 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 788999999988899999999999999999997 9999964322111 1111112212223445667899999999
Q ss_pred hccccCCCCccccchhhHHHHHH
Q 003694 695 AELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 695 l~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
|+.+|.+||++. +++..|+.+.
T Consensus 314 l~~dp~~RPs~~-el~~~l~~~~ 335 (338)
T cd05102 314 WQGDPKERPTFS-ALVEILGDLL 335 (338)
T ss_pred ccCChhhCcCHH-HHHHHHHHHH
Confidence 999999999998 5777777654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=328.57 Aligned_cols=234 Identities=26% Similarity=0.358 Sum_probs=201.6
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccch---HHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~---~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
.+|.....||.|+||.|.+++.+ +..+|+|++........ +...+|..+|+.+.||++++|++.|.+.. +|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778889999999999999886 45899999987654433 34678999999999999999999998766 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||++||.|..+|.+.+. ++.....-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999977554 888899999999999999999999 999999999999999999999999999987653
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
....+|||.|+|||.+....|+.++|+|||||++|||+.|.+||.....+. .+..++.. .-.+|
T Consensus 198 ---------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------iY~KI~~~-~v~fP 261 (355)
T KOG0616|consen 198 ---------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------IYEKILEG-KVKFP 261 (355)
T ss_pred ---------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------HHHHHHhC-cccCC
Confidence 245699999999999999999999999999999999999999998665422 23334333 23567
Q ss_pred hHHHHHHHHHHHHhhccccCCCC
Q 003694 681 IKETKELAALGLSCAELRRKDRP 703 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP 703 (802)
.-....+.+|+.+.++.|-.+|-
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhhh
Confidence 77788999999999999999983
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=351.87 Aligned_cols=240 Identities=25% Similarity=0.392 Sum_probs=204.5
Q ss_pred cCCcccceecCCCcEEEEEEEECCe--EEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
++|-....||+|+||.||||+-+.+ .||+|.+...... ..+.+.+|++|++.++|||||.++.+|.... ++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 3566667899999999999987654 8999998765432 3456899999999999999999999997655 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+.| +|..+|...+. +++..+..|+.+++.||.|||+++ |+|||+||.||||+.+|.+|+||||+|+.+....
T Consensus 82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9986 99999976543 899999999999999999999998 9999999999999999999999999999876532
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
...+...|||.|||||...+..|+..+|+||+|||||||++|+|||..... -.+.+.+-.....||.
T Consensus 155 ------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-------~~Lv~~I~~d~v~~p~ 221 (808)
T KOG0597|consen 155 ------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-------TQLVKSILKDPVKPPS 221 (808)
T ss_pred ------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-------HHHHHHHhcCCCCCcc
Confidence 234677999999999999999999999999999999999999999953221 1223333334467888
Q ss_pred HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+..++...+..||.+|.+..+
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~ 247 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTD 247 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHH
Confidence 99999999999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=353.01 Aligned_cols=240 Identities=27% Similarity=0.413 Sum_probs=203.6
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceec--CCCeEEEEEcc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEYME 524 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~--~~~~lV~Ey~~ 524 (802)
.|....+||+|..|.||.+... +..||||.+........+-+.+|+.+|+..+|+|||.++..|. +..++|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 3555678999999999999875 4589999998777667777899999999999999999999874 45589999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
||+|.|.+.... +++.++..|+.+++.||.|||..+ |||||||.+||||+.+|.+||+|||+|..+.....
T Consensus 354 ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 354 GGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 999999886433 888899999999999999999999 99999999999999999999999999998876543
Q ss_pred cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC--CCCChH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPIK 682 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~--~~~p~~ 682 (802)
+....+|||+|||||+.....|+++.||||||++++||+-|.|||........ +..+.+... ...|..
T Consensus 425 ----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA------lyLIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 425 ----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGTPKLKNPEK 494 (550)
T ss_pred ----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH------HHHHhhcCCCCcCCccc
Confidence 34566999999999999999999999999999999999999999964333221 122222222 234567
Q ss_pred HHHHHHHHHHHhhccccCCCCcccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..|.+|+.+||+.|+.+||++.+
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHH
Confidence 7899999999999999999999985
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=355.47 Aligned_cols=255 Identities=32% Similarity=0.480 Sum_probs=199.9
Q ss_pred cCCcccceecCCCcEEEEEEEECCeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEEEEcc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYME 524 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~Ey~~ 524 (802)
..+....+||+|.||+||+|.|.| .||||+++.... ...+.|.+|+.+|++-+|.||+-|+|+|.... .+|..+|+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwCe 470 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWCE 470 (678)
T ss_pred HHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhcc
Confidence 345566789999999999999987 599999987643 34577999999999999999999999996655 78999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
|-+|..+|+-.. ..|.....+.|+.||++|+.|||..+ |||||||..||||.+++.|||+||||+.....-.
T Consensus 471 GsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~--- 542 (678)
T KOG0193|consen 471 GSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS--- 542 (678)
T ss_pred Cchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeec---
Confidence 999999998654 34888899999999999999999998 9999999999999999999999999997543211
Q ss_pred cccccccCCccCcccCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCccccchhhhh-hchhhhHHHhhhhCCCCC
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-IDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~-~~~~~l~~~ld~~~~~~p 680 (802)
.........|...|||||+++. .+|++.+|||||||++|||+||..||.+ ...++. +..|.- .+.+......
T Consensus 543 -g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifmVGrG--~l~pd~s~~~ 618 (678)
T KOG0193|consen 543 -GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFMVGRG--YLMPDLSKIR 618 (678)
T ss_pred -cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEEeccc--ccCccchhhh
Confidence 1111234578899999998753 4689999999999999999999999973 222221 111111 0011111122
Q ss_pred hHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
..++.++.+|+..||..++++||.+.+ |+..|+.+
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~-il~~l~~l 653 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQ-LLSKLEEL 653 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHH-HHHHHHHh
Confidence 356789999999999999999999994 55544433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=367.31 Aligned_cols=254 Identities=28% Similarity=0.495 Sum_probs=210.6
Q ss_pred cccceecCCCcEEEEEEEECC-------eEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 451 SENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 451 ~~~~~iG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
.....||+|.||.||+|...+ +.||||.++..... ...+|++|+++|..|+|||||+|+|+|.+.. |+|+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 444579999999999998643 48999999987665 7789999999999999999999999997665 9999
Q ss_pred EEccCCCHHHHhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEe
Q 003694 521 EYMENGSLEDRLYRKNN-----------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 589 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~ 589 (802)
|||..|+|..+|..... .++|+..+.+.||.|||.|+.||-++. +|||||-..|+||+++..+||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEec
Confidence 99999999999975321 234888999999999999999999998 9999999999999999999999
Q ss_pred eecccccccCCCCccccccccc-CCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhh
Q 003694 590 DVGLSTMLNSDPSFVSTTYKNT-GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 667 (802)
Q Consensus 590 DFGla~~~~~~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 667 (802)
||||++.+-..+- |+.. ...-...||+||.+..+.||++||||||||+|||++| |+.||..... .+-
T Consensus 646 DfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------~EV 714 (774)
T KOG1026|consen 646 DFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------QEV 714 (774)
T ss_pred ccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch------HHH
Confidence 9999986643321 1211 2345788999999999999999999999999999998 8888864322 122
Q ss_pred hHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHHh
Q 003694 668 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 719 (802)
Q Consensus 668 l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~ 719 (802)
+..+-.......|..++..+.+|+..||+.+|++||+++ +|-..|+.+...
T Consensus 715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~-eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 715 IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFK-EIHSRLQAWAQA 765 (774)
T ss_pred HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHH-HHHHHHHHHHhc
Confidence 233333444567888999999999999999999999999 587777766543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=342.77 Aligned_cols=248 Identities=24% Similarity=0.312 Sum_probs=195.3
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCC----CeEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVY 520 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~~lV~ 520 (802)
.|+...+||+|.||.||+|++. +..||+|.+..+.. ....-..+||.||++|+||||++|.+...+. .|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 4666678999999999999985 45799999887652 2334457899999999999999999988655 28999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
|||+. +|..++...+ -.|+..++..++.||+.||.|||..| |+|||||.+|||||.+|.+||+|||||+++...
T Consensus 198 eYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred ecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99985 8888775433 34888999999999999999999999 999999999999999999999999999988765
Q ss_pred CCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch--------hhhHHH
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE--------DNLAEI 671 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~--------~~l~~~ 671 (802)
... ..|..+-|++|.|||.+.+ ..|++.+|+||.||||.||++|+|.|.....+++.-.. +..+..
T Consensus 272 ~~~-----~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 272 GSA-----PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred CCc-----ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 432 2467789999999998765 45999999999999999999999999876665543110 111111
Q ss_pred hhhh-----CCCCC--h-------HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 672 LDAQ-----AGDWP--I-------KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 672 ld~~-----~~~~p--~-------~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+-. .+..+ . ..+....+|+..+|.+||.+|.++.+
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~ 396 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS 396 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence 1100 00000 0 12455678999999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=336.88 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=195.6
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
+|...+.||+|+||.||+|.+. ++.||+|++..... .....+.+|+.+|.+++||||+.++++|.+.. ++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677789999999999999874 67999998865422 22345789999999999999999999986544 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998876433 235889999999999999999999988 9999999999999999999999999998754322
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
. .....||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ...+...+.......+.
T Consensus 157 ~-------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 226 (285)
T cd05631 157 T-------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQEEYSE 226 (285)
T ss_pred e-------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcccccCCc
Confidence 1 1344799999999999999999999999999999999999999964322110 01111111112233445
Q ss_pred HHHHHHHHHHHHhhccccCCCCccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
..+..+.+|+.+||..+|.+||+..
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCR 251 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCC
Confidence 5678899999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.29 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=202.0
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccc-hHHHHHHHHHHHhcC-CCceeeecceecCCC---eEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIR-HPHLLLLLGACPDHG---CLV 519 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~-~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~---~lV 519 (802)
.+.|...++||.|.||+||+|+-. +..||||.++...... ...-++|+..|++|+ |||||+|..++.|.. ++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 346777889999999999999875 5589999887654322 222468999999999 999999999997655 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
||||+ .+|..++..+ ...++...+..|+.||++||+|+|.+| +.||||||+|||+..+..+||+|||||+.+..
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99997 6999988665 457999999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCcccccccccCCccCcccCCcccc-ccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch-------------
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQ-RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE------------- 665 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~------------- 665 (802)
... .|..+.|.+|.|||++ +.+.|+.+.|+||+|||++|+.+-+|-|.+...+++...-
T Consensus 163 kpP-------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 163 KPP-------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred CCC-------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 543 2567899999999965 6788999999999999999999999999877665554321
Q ss_pred --hhhHHHhhhhCCCC--------ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 --DNLAEILDAQAGDW--------PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 --~~l~~~ld~~~~~~--------p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+...+....+.. -..++.++.+|+.+||..||.+||++.+
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~ 287 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ 287 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence 12222222221111 1136788999999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=345.96 Aligned_cols=244 Identities=24% Similarity=0.315 Sum_probs=200.1
Q ss_pred HhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEccc----Cc-cchHHHHHHHHHHHhcC-CCceeeecceecCC-
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK----GN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDH- 515 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~----~~-~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~- 515 (802)
.....|...+.||+|+||.||.|.+. +..||+|++... .. ...+.+.+|+.++++++ ||||++++.++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34567899999999999999999875 569999977653 12 23455678999999999 99999999998544
Q ss_pred -CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC-ceeEEeeecc
Q 003694 516 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGL 593 (802)
Q Consensus 516 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~-~~~kl~DFGl 593 (802)
.++||||+.||+|.+++...+ .+......+++.|+++|+.|||+.+ |+||||||+|||||.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 489999999999999998733 3777889999999999999999999 9999999999999999 9999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCC-CC-CcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHH
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL-IS-PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 671 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~-~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ 671 (802)
+........ .....+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||....... +...
T Consensus 168 s~~~~~~~~------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~k 234 (370)
T KOG0583|consen 168 SAISPGEDG------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRK 234 (370)
T ss_pred ccccCCCCC------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHH
Confidence 998742111 124569999999999998866 75 88999999999999999999997532211 1111
Q ss_pred hhhhCCCCChHH-HHHHHHHHHHhhccccCCCCcccc
Q 003694 672 LDAQAGDWPIKE-TKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 672 ld~~~~~~p~~~-~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+.......|... +..+..|+.+|+..+|..|+++.+
T Consensus 235 i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~ 271 (370)
T KOG0583|consen 235 IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLE 271 (370)
T ss_pred HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 333333445555 899999999999999999999984
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=339.95 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=196.6
Q ss_pred cCCcccceecCCCcEEEEEEEEC------------------CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeee
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH------------------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLL 508 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~------------------~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l 508 (802)
+.|....+||+|+||.||+|.+. +..||+|++..... .....|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46778889999999999999753 23699999876532 234679999999999999999999
Q ss_pred cceecCCC--eEEEEEccCCCHHHHhhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 003694 509 LGACPDHG--CLVYEYMENGSLEDRLYRKN----------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570 (802)
Q Consensus 509 ~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH 570 (802)
+++|.+.. ++||||+++|+|.+++.... ....+++..+.+|+.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 99986544 89999999999999886432 1234788899999999999999999988 999
Q ss_pred cCCCCCCeEecCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh--
Q 003694 571 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-- 648 (802)
Q Consensus 571 rDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-- 648 (802)
|||||+|||++.++.+||+|||+++.+....... ......++..|+|||++.++.++.++||||||+++|+|++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR----IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeE----ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999999999999999998654332111 1123456889999999988899999999999999999987
Q ss_pred CCCCccccchhhhhhchhhhHHHhhhh----CCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 649 AKPAIAITHKVETAIDEDNLAEILDAQ----AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 649 g~~p~~~~~~~~~~~~~~~l~~~ld~~----~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
+..||........ + ......+... ....|..++..+.+|+.+||+.+|.+||++. +|...|+
T Consensus 238 ~~~p~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~-~i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTDEQV-I--ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS-DIHAFLT 303 (304)
T ss_pred CCCCCCcCCHHHH-H--HHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH-HHHHHHh
Confidence 5567753322111 0 0111111111 1122345567899999999999999999998 4655553
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=343.78 Aligned_cols=235 Identities=27% Similarity=0.439 Sum_probs=195.1
Q ss_pred ceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCHHHH
Q 003694 454 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDR 531 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL~~~ 531 (802)
.-||.|+.|-||+|.+++..||||+++.- -..+|.-|++|+||||+.|.|+|.... |||||||..|-|...
T Consensus 130 eWlGSGaQGAVF~Grl~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeeccCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 34999999999999999999999986532 134788899999999999999997766 799999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccccccc
Q 003694 532 LYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 611 (802)
Q Consensus 532 l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 611 (802)
|.... ++.......|..+||.|+.|||.++ |||||||.-||||..+..+||+|||.++.+.... .+-
T Consensus 203 Lka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-------TkM 269 (904)
T KOG4721|consen 203 LKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-------TKM 269 (904)
T ss_pred HhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh-------hhh
Confidence 96543 3666678899999999999999999 9999999999999999999999999998776432 234
Q ss_pred CCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHHHHH
Q 003694 612 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALG 691 (802)
Q Consensus 612 ~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li 691 (802)
.++||..|||||++++.+.+.|+|||||||+|||||||..||.......-.+.-|. ..+ ....|..++..|.-|+
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs--NsL---~LpvPstcP~GfklL~ 344 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS--NSL---HLPVPSTCPDGFKLLL 344 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC--Ccc---cccCcccCchHHHHHH
Confidence 67999999999999999999999999999999999999999964433221111111 111 1345778899999999
Q ss_pred HHhhccccCCCCccccchhhHHH
Q 003694 692 LSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 692 ~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
..||.-.|+.||+++ +|+.-|+
T Consensus 345 Kqcw~sKpRNRPSFr-qil~Hld 366 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFR-QILLHLD 366 (904)
T ss_pred HHHHhcCCCCCccHH-HHHHHHh
Confidence 999999999999999 4555443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=349.63 Aligned_cols=241 Identities=23% Similarity=0.299 Sum_probs=200.5
Q ss_pred hhcCCcccceecCCCcEEEEEEEECCe--EEEEEEEcccCccch---HHHHHHHHHHHhcC-CCceeeecceecCC--Ce
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIR-HPHLLLLLGACPDH--GC 517 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~~---~~~~~Ei~il~~l~-Hpniv~l~g~~~~~--~~ 517 (802)
...+|.....||+|+||+|+++.++++ .+|||+++....... +..+.|..|+.... ||.++.|+++|+.. .|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 446799999999999999999998754 899999998755443 45678888888775 99999999999654 48
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~ 597 (802)
+||||+.||++..+. ....++.....-++.+|+.||.|||.++ |||||||.+|||||.+|++||+|||+|+..
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999954333 2234888888999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCC
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 677 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~ 677 (802)
-...+ ...+.+|||.|||||++....|+..+|+|||||+|||||+|.+||...+. +.+.+.+-....
T Consensus 519 m~~g~------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-------ee~FdsI~~d~~ 585 (694)
T KOG0694|consen 519 MGQGD------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-------EEVFDSIVNDEV 585 (694)
T ss_pred CCCCC------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCCC
Confidence 43222 23567999999999999999999999999999999999999999965432 222222222235
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
.+|...+.+...|+.+.+..+|.+|-...
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~~ 614 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGSG 614 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCCC
Confidence 57888899999999999999999998873
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=338.47 Aligned_cols=234 Identities=24% Similarity=0.304 Sum_probs=194.9
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
+|.....||+|+||.||+|... +..||+|++.... ......+.+|+.+|++++||||+++++++.+.. ++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6788899999999999999986 6789999986432 123456889999999999999999999987655 79999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+++|+|.+++.... .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 82 YVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999999986543 4888899999999999999999998 9999999999999999999999999998764321
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
....||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .+..+ ......+|.
T Consensus 156 ---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i-~~~~~~~~~ 219 (291)
T cd05612 156 ---------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKI-LAGKLEFPR 219 (291)
T ss_pred ---------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhCCcCCCc
Confidence 23478999999999998889999999999999999999999996433211 11112 222234555
Q ss_pred HHHHHHHHHHHHhhccccCCCCc
Q 003694 682 KETKELAALGLSCAELRRKDRPD 704 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~ 704 (802)
..+..+.+|+.+|++.||.+||+
T Consensus 220 ~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 220 HLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred cCCHHHHHHHHHHcCCCHHHccC
Confidence 56788999999999999999997
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=312.20 Aligned_cols=242 Identities=26% Similarity=0.339 Sum_probs=204.7
Q ss_pred hcCCcccceecCCCcEEEEEEEECCe--EEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~~--~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
.++|+.++.||+|.||.||.|+.+.+ .||+|++.... .....++.+|++|-+.|+||||+++||+|.+.. ||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 45789999999999999999998754 89999986542 223467899999999999999999999998766 999
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
+||.++|+|...|..... ..++......++.|+|.||.|+|..+ ||||||||+|+|++..+..||+|||.+..-+.
T Consensus 101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999974432 34777778889999999999999988 99999999999999999999999999976542
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
. +....+||+.|.+||...+..++..+|+|++|++.||++.|.+||.... ....+..+. ......
T Consensus 177 ~--------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~------~~etYkrI~-k~~~~~ 241 (281)
T KOG0580|consen 177 N--------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS------HSETYKRIR-KVDLKF 241 (281)
T ss_pred C--------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh------hHHHHHHHH-HccccC
Confidence 2 3456799999999999999999999999999999999999999995332 223333333 333455
Q ss_pred ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
|...+...+++|.+|+..+|.+|..+.+
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l~~ 269 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLALTE 269 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccHHH
Confidence 6778899999999999999999999874
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=343.23 Aligned_cols=236 Identities=21% Similarity=0.305 Sum_probs=195.3
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
.+|...+.||+|+||.||+|.+. +..||+|++.... ......+.+|+.+|++++||||+++++++.+.. ++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999985 5689999986532 223456889999999999999999999986655 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999987543 4788888899999999999999998 999999999999999999999999999876432
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
. ....||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .+..+.. .....|
T Consensus 172 ~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~-~~~~~p 235 (329)
T PTZ00263 172 T---------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IYEKILA-GRLKFP 235 (329)
T ss_pred c---------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HHHHHhc-CCcCCC
Confidence 1 23479999999999999889999999999999999999999996443221 1111222 122344
Q ss_pred hHHHHHHHHHHHHhhccccCCCCcc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDL 705 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~ 705 (802)
...+..+.+|+.+||+.||.+||+.
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 4456789999999999999999985
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.03 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=199.5
Q ss_pred hcCCcccceecCCCcEEEEEEEEC-------CeEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeecceecCCC-
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG- 516 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~-------~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~- 516 (802)
.++|...++||+|+||.||+|++. +..||||+++... ......+.+|+.+|..+ +||||++++|+|.+..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 346888999999999999999742 3489999987543 23345688999999999 8999999999996654
Q ss_pred -eEEEEEccCCCHHHHhhhcCC----------------------------------------------------------
Q 003694 517 -CLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 537 (802)
Q Consensus 517 -~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 537 (802)
++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 899999999999999864321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 538 --------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 538 --------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788899999999999999999988 999999999999999999999999999876543221
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhh-CCCCCh
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPI 681 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p~ 681 (802)
. ......++..|+|||++.+..++.++|||||||++|||+| |.+||...... ..+...+... ....|.
T Consensus 271 ~----~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~ 340 (375)
T cd05104 271 V----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEGYRMLSPE 340 (375)
T ss_pred c----ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhCccCCCCC
Confidence 1 1122345678999999999999999999999999999998 88898533211 1112222221 122233
Q ss_pred HHHHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
..+.++.+|+.+||+.+|.+||++. +|+..|++
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~-eil~~l~~ 373 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFK-QIVQLIEQ 373 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHH-HHHHHHHh
Confidence 4467899999999999999999999 56666654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.00 Aligned_cols=232 Identities=24% Similarity=0.295 Sum_probs=189.8
Q ss_pred ecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCH
Q 003694 456 IGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 528 (802)
Q Consensus 456 iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL 528 (802)
||+|+||.||+|... +..||+|++.... ......+.+|+.+|.+++||||++++++|.+.. ++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999985 4589999986432 233456788999999999999999999986554 899999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccc
Q 003694 529 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 608 (802)
Q Consensus 529 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 608 (802)
.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------ 148 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------ 148 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------
Confidence 99987543 4888999999999999999999988 99999999999999999999999999986432211
Q ss_pred cccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHH
Q 003694 609 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 688 (802)
Q Consensus 609 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 688 (802)
......||+.|+|||++.+..++.++|||||||++|+|+||++||......+ .+..++. ....+|...+..+.
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~ 221 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQ-EPLRFPDGFDRDAK 221 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHc-CCCCCCCcCCHHHH
Confidence 1234579999999999999999999999999999999999999996432211 1111221 12344556678899
Q ss_pred HHHHHhhccccCCCCccc
Q 003694 689 ALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 689 ~li~~Cl~~~p~~RP~~~ 706 (802)
+++.+||..+|.+||++.
T Consensus 222 ~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred HHHHHHcCCCHHHcCCCC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.49 Aligned_cols=232 Identities=25% Similarity=0.304 Sum_probs=189.8
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 527 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gs 527 (802)
.||+|+||.||++... +..||+|++.... ......+.+|+.+|.+++||||+++++++.+.. |+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 6999999999999874 5689999987542 223356788999999999999999999986655 89999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccc
Q 003694 528 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607 (802)
Q Consensus 528 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 607 (802)
|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~----- 150 (323)
T cd05571 82 LFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-----
Confidence 999886543 4889999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHH
Q 003694 608 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687 (802)
Q Consensus 608 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 687 (802)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .+...+.......|...+..+
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~~~~p~~~~~~~ 222 (323)
T cd05571 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEEIRFPRTLSPEA 222 (323)
T ss_pred -cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------HHHHHHHcCCCCCCCCCCHHH
Confidence 123457999999999999899999999999999999999999999643221 111222222234555677889
Q ss_pred HHHHHHhhccccCCCCcc
Q 003694 688 AALGLSCAELRRKDRPDL 705 (802)
Q Consensus 688 ~~li~~Cl~~~p~~RP~~ 705 (802)
.+|+.+||+.||.+||+.
T Consensus 223 ~~li~~~L~~dP~~R~~~ 240 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGG 240 (323)
T ss_pred HHHHHHHccCCHHHcCCC
Confidence 999999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.39 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=200.6
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
...|.....||.|..++||+|... +..||||++..+... ..+.+.+|+..|+.++||||+.++..|.... ++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 457888889999999999999874 679999999865433 3477899999999999999999999985444 88999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
||.+||+.+++...-. ..+++..+..|+++++.||.|||.+| .||||||+.||||+.+|.+||+|||.+-.+....
T Consensus 105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999876543 34889999999999999999999999 9999999999999999999999999987776544
Q ss_pred CcccccccccCCccCcccCCcccc--ccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCC--
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQ--RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG-- 677 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~-- 677 (802)
... .++....+||++|||||++ .-..|+.|+|||||||+.+||.+|..||.....++..+ .-+....+
T Consensus 181 ~R~--~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl------~tLqn~pp~~ 252 (516)
T KOG0582|consen 181 DRQ--VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL------LTLQNDPPTL 252 (516)
T ss_pred cee--eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH------HHhcCCCCCc
Confidence 222 2222677999999999984 33569999999999999999999999997544433211 11111110
Q ss_pred ---C----CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 678 ---D----WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 678 ---~----~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. ........+.+++..|+..||.+||++.+
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAsk 289 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASK 289 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHH
Confidence 1 11234568999999999999999999985
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=329.03 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=199.7
Q ss_pred cCCcccceecCCCcEEEEEEEEC-----CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~-----~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
.+|.....||+|+||.||+|.+. +..||+|.++.... .....|.+|+.+|.+++||||++++|++.... ++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788889999999999999864 35899999876533 23456899999999999999999999986544 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999986543 35889999999999999999999988 99999999999999999999999998765432
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 678 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~ 678 (802)
... +......++..|+|||++.++.++.++|||||||++|||++ |.+||....... .+..+.+.....
T Consensus 160 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~~~~~~~~~~~~ 228 (266)
T cd05064 160 EAI-----YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIKAVEDGFRLP 228 (266)
T ss_pred cch-----hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHCCCCCC
Confidence 111 11123345678999999999999999999999999999775 999996432211 111111211223
Q ss_pred CChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
.|..++..+.+++.+||+.+|.+||++. ++...|.++
T Consensus 229 ~~~~~~~~~~~li~~c~~~~p~~RP~~~-~i~~~l~~~ 265 (266)
T cd05064 229 APRNCPNLLHQLMLDCWQKERGERPRFS-QIHSILSKM 265 (266)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCCCHH-HHHHHHHhh
Confidence 3455678899999999999999999998 577666543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=345.99 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=200.9
Q ss_pred hcCCcccceecCCCcEEEEEEEECC-------eEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeecceecCCC-
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG- 516 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~-------~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~- 516 (802)
.++|...+.||+|+||.||+|...+ ..||||++.... ......+.+|+.+|+.+ +|||||+++|+|.+..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 4468889999999999999987532 379999987543 22345688999999999 8999999999997654
Q ss_pred -eEEEEEccCCCHHHHhhhcCC----------------------------------------------------------
Q 003694 517 -CLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 537 (802)
Q Consensus 517 -~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 537 (802)
++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 899999999999998864211
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccc
Q 003694 538 ---------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 608 (802)
Q Consensus 538 ---------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 608 (802)
..++++..+.+|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~---- 269 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---- 269 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee----
Confidence 124788889999999999999999988 9999999999999999999999999998664332111
Q ss_pred cccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhh-CCCCChHHHHH
Q 003694 609 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKE 686 (802)
Q Consensus 609 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~ 686 (802)
......++..|+|||++.+..++.++|||||||++|+|++ |+.||...... ..+...+... ....|...+..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN------SKFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc------HHHHHHHHcccCccCCCCCCHH
Confidence 1122345678999999988899999999999999999997 99999643211 1122222211 12233344678
Q ss_pred HHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 687 LAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
+.+++.+||+.+|.+||++. +|+..|+++
T Consensus 344 l~~li~~cl~~dp~~RPs~~-~l~~~l~~~ 372 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFS-QISQLIQRQ 372 (374)
T ss_pred HHHHHHHHcCCChhhCcCHH-HHHHHHHHH
Confidence 99999999999999999999 577777765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.55 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=193.7
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc--------------cchHHHHHHHHHHHhcCCCceeeec
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--------------IQNKQFLQELEVLSKIRHPHLLLLL 509 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--------------~~~~~~~~Ei~il~~l~Hpniv~l~ 509 (802)
..++|.....||+|.||.|-+|... ++.||||++..... ...+...+||.||++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3467888889999999999999874 67999999865321 1125688999999999999999999
Q ss_pred ceecCC----CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCce
Q 003694 510 GACPDH----GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 585 (802)
Q Consensus 510 g~~~~~----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~ 585 (802)
.+..+. .|||+|||..|.+.. .....+.++..+..+++.++..||+|||.+| ||||||||+|+||+.+|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 998543 499999999887744 2333334899999999999999999999999 999999999999999999
Q ss_pred eEEeeecccccccCCCCcccccccccCCccCcccCCccccccCC----CCCcccchhHHHHHHHHHhCCCCccccchhhh
Q 003694 586 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL----ISPKSDVYAYGMVILQLLTAKPAIAITHKVET 661 (802)
Q Consensus 586 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~sDv~SlGvil~elltg~~p~~~~~~~~~ 661 (802)
+||+|||.+............ -.....+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||......+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d-~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~- 326 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSD-DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE- 326 (576)
T ss_pred EEeeccceeeecccCCccccH-HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-
Confidence 999999999877543211111 1123369999999999876633 3568899999999999999999996443222
Q ss_pred hhchhhhHHHhhhhCCCCCh--HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 662 AIDEDNLAEILDAQAGDWPI--KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 662 ~~~~~~l~~~ld~~~~~~p~--~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..++... ..+|. ++.+.+.+||.++|+.||.+|.++.+
T Consensus 327 -----l~~KIvn~p-L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ 368 (576)
T KOG0585|consen 327 -----LFDKIVNDP-LEFPENPEINEDLKDLIKRLLEKDPEQRITLPD 368 (576)
T ss_pred -----HHHHHhcCc-ccCCCcccccHHHHHHHHHHhhcChhheeehhh
Confidence 122232222 22232 46789999999999999999998874
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=335.38 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=201.4
Q ss_pred cCCcccceecCCCcEEEEEEEEC--Ce----EEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC-eEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HT----FAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~----~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV 519 (802)
.+|+....||+|+||.||+|.+. +. .||+|++.... ......|.+|+.+++.++||||++++|+|.... ++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 46888899999999999999863 22 48999987543 334567899999999999999999999986544 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
+||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 87 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999987543 34788899999999999999999988 99999999999999999999999999987754
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhh-CC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AG 677 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~-~~ 677 (802)
.... .......++..|+|||++.+..++.++|||||||++|||+| |+.||...... .+..++... ..
T Consensus 162 ~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~ 230 (316)
T cd05108 162 DEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKGERL 230 (316)
T ss_pred CCcc----eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHhCCCCC
Confidence 3221 11123345778999999999999999999999999999998 99999643211 112222211 12
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHH
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
..+..++..+.+++.+||..+|.+||++. +++..|..+.
T Consensus 231 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~l~~~l~~~~ 269 (316)
T cd05108 231 PQPPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMA 269 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHH
Confidence 23445567899999999999999999999 5666666554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=307.41 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=195.4
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
.|...++||+|.||.||+|++. ++.||||.++..... ......+|+..|+.++||||+.|+++|+... .||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4566678999999999999986 559999998765322 2345689999999999999999999997655 799999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
|+ .+|+..+..+. ..++-.++..++.++++||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 83 m~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 97 69999886543 45888899999999999999999999 99999999999999999999999999999875442
Q ss_pred cccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhh-hhCCCCC
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAGDWP 680 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld-~~~~~~p 680 (802)
. .+..+-|.+|.|||.+-+ ..|+..+|+||.|||+.||+-|.|-|....++++... +...+- +....||
T Consensus 157 ~------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~---If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 157 I------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK---IFRALGTPTPDQWP 227 (318)
T ss_pred c------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH---HHHHcCCCCcccCc
Confidence 2 123378999999997654 5699999999999999999999999887666554311 000010 1111222
Q ss_pred -----------------------hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 -----------------------IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 -----------------------~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..++..+.+|+.+++.+||.+|+++.+
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q 277 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ 277 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence 134567799999999999999999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=341.90 Aligned_cols=236 Identities=25% Similarity=0.365 Sum_probs=202.3
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
-|..++.||.|+.|.|..|++. |..+|||++..... .....+.+|+-||+-|.|||+++||++|.++. |||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4677888999999999999985 56899999876532 23456789999999999999999999997665 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+++|-|.++|.+++. ++..+..++++||+.|+.|+|..+ |+||||||+|+|||..+.+||+|||+|.+...+.
T Consensus 93 yv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred ecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 9999999999987664 888999999999999999999999 9999999999999999999999999998865443
Q ss_pred CcccccccccCCccCcccCCccccccCCC-CCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh---CC
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ---AG 677 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~---~~ 677 (802)
- -.+.||.|.|.+||++.+.+| +.++||||.|||||.||||+.||+. +++..++... .-
T Consensus 167 l-------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----------dNir~LLlKV~~G~f 229 (786)
T KOG0588|consen 167 L-------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----------DNIRVLLLKVQRGVF 229 (786)
T ss_pred c-------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----------ccHHHHHHHHHcCcc
Confidence 1 234589999999999999887 4799999999999999999999962 3333333322 34
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+.|...+.+.++|+.+|+..||..|.++.+
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~e 259 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEE 259 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHH
Confidence 567788999999999999999999999985
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.62 Aligned_cols=246 Identities=33% Similarity=0.575 Sum_probs=192.4
Q ss_pred cceecCCCcEEEEEEEEC------CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 453 NLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 453 ~~~iG~G~~g~Vy~~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
...||.|.||.||+|.+. +..|+||++...... ..+.|.+|+++|++++||||++++|+|.... ++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999998 568999999664332 4678999999999999999999999997433 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++|+|.++|... ....+++..+..|+.||+.||.|||+.+ |+|+||+|+|||++.++.+||+|||++.........
T Consensus 84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999876 2345899999999999999999999988 999999999999999999999999999877322211
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChH
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 682 (802)
.......+...|+|||++....++.++||||||+++|||+| |+.||..... ......+.+......+..
T Consensus 160 ----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~ 229 (259)
T PF07714_consen 160 ----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKLKQGQRLPIPDN 229 (259)
T ss_dssp ----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHHHTTEETTSBTT
T ss_pred ----cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccccceeccc
Confidence 12234467889999999999989999999999999999999 7788753321 111222333333444556
Q ss_pred HHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
++..+.+++.+||..+|.+||++. +++..|
T Consensus 230 ~~~~~~~li~~C~~~~p~~RPs~~-~i~~~L 259 (259)
T PF07714_consen 230 CPKDIYSLIQQCWSHDPEKRPSFQ-EILQEL 259 (259)
T ss_dssp SBHHHHHHHHHHT-SSGGGS--HH-HHHHHH
T ss_pred hhHHHHHHHHHHcCCChhhCcCHH-HHHhcC
Confidence 678899999999999999999998 455443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=344.50 Aligned_cols=257 Identities=23% Similarity=0.399 Sum_probs=202.3
Q ss_pred hcCCcccceecCCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhcC-CCceeeecceecCCC-
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG- 516 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~- 516 (802)
...|...++||+|+||.||+|++.+ ..||||++..... ...+.|.+|+.+|+++. ||||++++|+|.+..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4578888999999999999998642 3699999875433 23457899999999996 999999999997654
Q ss_pred -eEEEEEccCCCHHHHhhhcCC----------------------------------------------------------
Q 003694 517 -CLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 537 (802)
Q Consensus 517 -~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 537 (802)
+|||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 899999999999998865311
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC
Q 003694 538 -----------------------------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 582 (802)
Q Consensus 538 -----------------------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~ 582 (802)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788889999999999999999988 999999999999999
Q ss_pred CceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhh
Q 003694 583 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVET 661 (802)
Q Consensus 583 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~ 661 (802)
++.+||+|||+++.+....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~- 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYV----SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS- 347 (400)
T ss_pred CCEEEEEeCCcceecccccccc----ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence 9999999999998765332211 1123457788999999988889999999999999999997 889985321111
Q ss_pred hhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 662 AIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 662 ~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
.....+........+...+..+.+++.+||..+|.+||++. .|.+.|+++
T Consensus 348 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-~l~~~l~~l 397 (400)
T cd05105 348 ----TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFL-HLSDIVESL 397 (400)
T ss_pred ----HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHH-HHHHHHHHH
Confidence 00111111112233445678899999999999999999998 577777765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.68 Aligned_cols=235 Identities=23% Similarity=0.310 Sum_probs=193.9
Q ss_pred cCCcccceecCCCcEEEEEEEECC---eEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH---TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~---~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
++|....+||+|+||.||+|.+.+ ..||+|++.... ......+.+|+.++..++||||+++++++.+.. ++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998643 479999886432 223456889999999999999999999997665 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999987543 4888899999999999999999998 99999999999999999999999999987543
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
.. ....||+.|+|||++.+..++.++|||||||++|+|+||++||....... ....+.. ....+
T Consensus 184 ~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i~~-~~~~~ 247 (340)
T PTZ00426 184 RT---------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKILE-GIIYF 247 (340)
T ss_pred Cc---------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHHhc-CCCCC
Confidence 21 23479999999999998889999999999999999999999996543221 1112222 12234
Q ss_pred ChHHHHHHHHHHHHhhccccCCCCc
Q 003694 680 PIKETKELAALGLSCAELRRKDRPD 704 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~ 704 (802)
|...+..+.+++.+|++.+|.+|++
T Consensus 248 p~~~~~~~~~li~~~l~~dp~~R~~ 272 (340)
T PTZ00426 248 PKFLDNNCKHLMKKLLSHDLTKRYG 272 (340)
T ss_pred CCCCCHHHHHHHHHHcccCHHHcCC
Confidence 5556678899999999999999974
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=336.72 Aligned_cols=232 Identities=25% Similarity=0.301 Sum_probs=188.8
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 527 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gs 527 (802)
.||+|+||.||++... +..||+|++.... ......+.+|+.++..++||||++++++|.+.. |+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 6999999999999874 5689999987542 223346778999999999999999999986554 89999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccc
Q 003694 528 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607 (802)
Q Consensus 528 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 607 (802)
|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 82 LFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-----
Confidence 998886543 4889999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHH
Q 003694 608 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687 (802)
Q Consensus 608 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 687 (802)
......||+.|+|||++.++.++.++|||||||++|+|+||+.||...... .+...+.......|...+..+
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~~~~~~~p~~~~~~~ 222 (323)
T cd05595 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEIRFPRTLSPEA 222 (323)
T ss_pred -ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCCCCCCCCCHHH
Confidence 113457999999999999899999999999999999999999999643221 111111122234455667889
Q ss_pred HHHHHHhhccccCCCCcc
Q 003694 688 AALGLSCAELRRKDRPDL 705 (802)
Q Consensus 688 ~~li~~Cl~~~p~~RP~~ 705 (802)
.+|+.+||..+|.+||+.
T Consensus 223 ~~li~~~L~~dP~~R~~~ 240 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGG 240 (323)
T ss_pred HHHHHHHccCCHHHhCCC
Confidence 999999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=328.39 Aligned_cols=251 Identities=25% Similarity=0.463 Sum_probs=200.8
Q ss_pred CCcccceecCCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~l 518 (802)
+|.....||+|+||.||+|.+.+ ..||+|.+..... .....|.+|+.++..++||||+++++++.+.. ++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57778889999999999998743 3689998875432 33456899999999999999999999986544 89
Q ss_pred EEEEccCCCHHHHhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCce
Q 003694 519 VYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 585 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~ 585 (802)
+|||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999875422 135788899999999999999999998 999999999999999999
Q ss_pred eEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhc
Q 003694 586 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAID 664 (802)
Q Consensus 586 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~ 664 (802)
+||+|||+++........ .......+++.|+|||++.++.++.++|||||||++|||+| |..||......
T Consensus 163 ~~L~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----- 233 (283)
T cd05048 163 VKISDFGLSRDIYSADYY----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----- 233 (283)
T ss_pred EEECCCcceeeccccccc----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence 999999999865432211 11233467889999999988899999999999999999998 99998643221
Q ss_pred hhhhHHHh-hhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 665 EDNLAEIL-DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 665 ~~~l~~~l-d~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
.+...+ .......|..++..+.+|+.+||+.+|.+||++. +|+..|+
T Consensus 234 --~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~-~i~~~l~ 281 (283)
T cd05048 234 --EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFK-DIHTRLR 281 (283)
T ss_pred --HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHH-HHHHHHh
Confidence 112222 2222334556788999999999999999999999 5666554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=338.48 Aligned_cols=243 Identities=23% Similarity=0.272 Sum_probs=195.4
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|....+||+|+||.||+|.+. +..||||++.... ......+.+|+.+|..++||||+++++++.+.. ||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999985 5689999987542 223456889999999999999999999987654 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999986543 4788899999999999999999998 99999999999999999999999999986543
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
......||+.|+|||++.+..++.++|||||||++|||+||++||......+...........+.. +.+.
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~ 223 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR--PVYD 223 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC--CCCC
Confidence 123457999999999999889999999999999999999999999644322211000000000110 1111
Q ss_pred ---hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 ---IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ---~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+..+.+|+.+|+..+|.+||++.+
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ 253 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLED 253 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHH
Confidence 134678999999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=352.11 Aligned_cols=248 Identities=20% Similarity=0.283 Sum_probs=201.1
Q ss_pred CCcccceecCCCcEEEEEEEEC---CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~---~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
.|.....||+|+||.||+|... +..||+|.+..........+.+|+.+|+.++|||||+++++|.+.. ||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999999999999764 4578888776555545566888999999999999999999986554 8999999
Q ss_pred cCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 524 ENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 524 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
++|+|.++|... ....++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 23446888899999999999999999988 99999999999999999999999999987654321
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 682 (802)
. .......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... ..+..++.......|..
T Consensus 225 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~~~~~~ 294 (478)
T PTZ00267 225 L----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLYGKYDPFPCP 294 (478)
T ss_pred c----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCCCcc
Confidence 1 1123457999999999999999999999999999999999999999643221 11222222222334455
Q ss_pred HHHHHHHHHHHhhccccCCCCccccch
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
.+..+.+|+.+||..+|.+||++.+.+
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 678899999999999999999998543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=335.64 Aligned_cols=231 Identities=25% Similarity=0.300 Sum_probs=188.8
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 527 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gs 527 (802)
.||+|+||.||++... +..||+|++.... ......+.+|+.+|+.++||||+++++++.+.. ++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 6999999999999875 5699999987542 223456788999999999999999999986554 89999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccc
Q 003694 528 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607 (802)
Q Consensus 528 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 607 (802)
|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 82 LFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-----
Confidence 998886543 4889999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHH
Q 003694 608 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687 (802)
Q Consensus 608 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 687 (802)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... +...+.......|...+..+
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~~~~p~~~~~~~ 222 (328)
T cd05593 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEDIKFPRTLSADA 222 (328)
T ss_pred -ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-------HHHHhccCCccCCCCCCHHH
Confidence 1234579999999999998899999999999999999999999996432211 11112222234455667889
Q ss_pred HHHHHHhhccccCCCCc
Q 003694 688 AALGLSCAELRRKDRPD 704 (802)
Q Consensus 688 ~~li~~Cl~~~p~~RP~ 704 (802)
.+|+.+||..+|.+||+
T Consensus 223 ~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 223 KSLLSGLLIKDPNKRLG 239 (328)
T ss_pred HHHHHHHcCCCHHHcCC
Confidence 99999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=334.29 Aligned_cols=234 Identities=26% Similarity=0.329 Sum_probs=189.3
Q ss_pred ceecCCCcEEEEEEEE-----CCeEEEEEEEcccC----ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 454 LRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~-----~~~~vavK~l~~~~----~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
++||+|+||.||++.. .+..||||++.... ......+.+|+.+|+.++||||++++++|.+.. ++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4799999999999875 35689999987532 123345788999999999999999999986654 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999886543 3778888889999999999999988 99999999999999999999999999875432221
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 682 (802)
......||+.|+|||++.+..++.++|||||||++|+|+||++||....... .+..++.. ....|..
T Consensus 156 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~~-~~~~~~~ 222 (323)
T cd05584 156 ------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILKG-KLNLPPY 222 (323)
T ss_pred ------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHcC-CCCCCCC
Confidence 1233579999999999998889999999999999999999999996543221 12222222 2334555
Q ss_pred HHHHHHHHHHHhhccccCCCCccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
.+..+.+|+.+||+.+|.+||+..
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~ 246 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAG 246 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCC
Confidence 678899999999999999999644
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.21 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=207.9
Q ss_pred HhhcCCcccceecCCCcEEEEEEEECC-----eE-EEEEEEccc---CccchHHHHHHHHHHHhcCCCceeeecceecCC
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFHH-----TF-AAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH 515 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~~-----~~-vavK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~ 515 (802)
....+....++||+|.||.||+|.+.- .. ||||..+.. ......+|.+|..+|+.++|||||+|||++.+.
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 334455556899999999999998742 13 899988753 345667899999999999999999999998544
Q ss_pred C--eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 516 G--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 516 ~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
. +||||+|.||+|.++|.+... .++..++++++.++|.||.|||+.+ +|||||-..|+|++.++.+||+||||
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccc
Confidence 3 899999999999999987654 4889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHH-
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEI- 671 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~- 671 (802)
++...... . ......-...|+|||.+.++.|+.++|||||||++||+++ |..||......+. ...+
T Consensus 309 s~~~~~~~---~---~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v------~~kI~ 376 (474)
T KOG0194|consen 309 SRAGSQYV---M---KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV------KAKIV 376 (474)
T ss_pred ccCCccee---e---ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH------HHHHH
Confidence 87654111 0 0111234678999999999999999999999999999999 7889865443211 1222
Q ss_pred hhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHHhhh
Q 003694 672 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 721 (802)
Q Consensus 672 ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~~~ 721 (802)
........|...+..+..++.+||..+|.+||+|. .+...|+.+.....
T Consensus 377 ~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~-~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 377 KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMS-TIKKKLEALEKKKE 425 (474)
T ss_pred hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHH-HHHHHHHHHHhccc
Confidence 22223445556788899999999999999999999 68888887765433
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=362.91 Aligned_cols=255 Identities=27% Similarity=0.499 Sum_probs=207.8
Q ss_pred CCcccceecCCCcEEEEEEEECCe-------EEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHHT-------FAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~~-------~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~l 518 (802)
+......||+|.||.||.|.+.+. .||||.+.... .....+|++|..+|++++|||||+|+|.|.+.. +|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 344566799999999999987432 48999887653 445678999999999999999999999997654 89
Q ss_pred EEEEccCCCHHHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccc
Q 003694 519 VYEYMENGSLEDRLYRKN----NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla 594 (802)
++|||++|+|..+|.... ....+...+.+.|+.|||+|+.||++.+ +|||||...|+||+....+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998652 2345888999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCC-ccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHh
Q 003694 595 TMLNSDPSFVSTTYKNTGP-VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 672 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~l 672 (802)
+.+-.... |+.... .-...|||||.+..+.++.|+|||||||+|||++| |..||+..+..+- +..++
T Consensus 850 rDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~ 918 (1025)
T KOG1095|consen 850 RDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVL 918 (1025)
T ss_pred Hhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHH
Confidence 94433221 222222 34567999999999999999999999999999999 8899975543322 22233
Q ss_pred hhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHH
Q 003694 673 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 673 d~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
.....+.|..++..+.+++..||+.+|.+||++. .++..+..+..
T Consensus 919 ~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~-~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 919 EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFR-TIVEQDPAISN 963 (1025)
T ss_pred hCCccCCCCCCChHHHHHHHHHccCChhhCccHH-HHHhhhhhhhh
Confidence 3445667888999999999999999999999999 56665555543
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.64 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=204.2
Q ss_pred cCCcccceecCCCcEEEEEEEEC-------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~l 518 (802)
.+|...+.||+|+||.||++... +..+|+|.+..........|.+|+++|.+++||||++++++|.+.. ++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888889999999999999752 2468999887655555677999999999999999999999986544 89
Q ss_pred EEEEccCCCHHHHhhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEE
Q 003694 519 VYEYMENGSLEDRLYRKN----------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 588 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl 588 (802)
||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1234899999999999999999999988 999999999999999999999
Q ss_pred eeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhh
Q 003694 589 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 667 (802)
Q Consensus 589 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 667 (802)
+|||+++........ .......+++.|+|||++.+..++.++|||||||++|+|+| |.+||....... .
T Consensus 162 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~ 231 (288)
T cd05093 162 GDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------V 231 (288)
T ss_pred ccCCccccccCCcee----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------H
Confidence 999999866432211 11223456788999999998889999999999999999999 999986432211 1
Q ss_pred hHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHH
Q 003694 668 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 668 l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
+..+........+...+..+.+|+.+||+.+|.+||++. ++...|+.+..
T Consensus 232 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~-~v~~~l~~~~~ 281 (288)
T cd05093 232 IECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIK-EIHSLLQNLAK 281 (288)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHHHHH
Confidence 111222112223334567899999999999999999999 57777776653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=326.50 Aligned_cols=254 Identities=23% Similarity=0.390 Sum_probs=199.2
Q ss_pred hhcCCcccceecCCCcEEEEEEEECC-------eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC-
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 516 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~~-------~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~- 516 (802)
..++|+....||+|+||.||+|.+.+ ..||+|++.... ......|.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678999999999999999998643 479999886432 223456889999999999999999999987554
Q ss_pred -eEEEEEccCCCHHHHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEE
Q 003694 517 -CLVYEYMENGSLEDRLYRKNN-------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 588 (802)
Q Consensus 517 -~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl 588 (802)
++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 899999999999999865321 234678889999999999999999988 999999999999999999999
Q ss_pred eeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhh
Q 003694 589 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 667 (802)
Q Consensus 589 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 667 (802)
+|||+++......... ......+++.|+|||++.++.++.++|||||||++|||+| |.+||...... ..
T Consensus 161 ~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~ 230 (277)
T cd05062 161 GDFGMTRDIYETDYYR----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QV 230 (277)
T ss_pred CCCCCccccCCcceee----cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HH
Confidence 9999998654322111 1122356788999999998889999999999999999999 78888533211 11
Q ss_pred hHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 668 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 668 l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
+..+........+...+..+.+++.+||+.+|.+||++. +++..|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-e~l~~l 275 (277)
T cd05062 231 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSI 275 (277)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHh
Confidence 111222222334445667899999999999999999998 455444
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=333.28 Aligned_cols=236 Identities=24% Similarity=0.304 Sum_probs=188.7
Q ss_pred eecCCCcEEEEEEEECC--eEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||+|.+.+ ..||+|+++... ......+..|..++..+ +||||+++++++.... ++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 69999999999999864 579999987542 22334456677777654 7999999999986554 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++.... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---- 151 (316)
T cd05592 82 DLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---- 151 (316)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC----
Confidence 9999886543 4888899999999999999999988 99999999999999999999999999976432221
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+ +...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~ 222 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILNDRPHFPRWISKE 222 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCCCCCCCHH
Confidence 1234579999999999998889999999999999999999999996433211 1111222233445556788
Q ss_pred HHHHHHHhhccccCCCCccccch
Q 003694 687 LAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
+.+|+.+||+.+|.+||++.+.+
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHH
Confidence 99999999999999999986433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.62 Aligned_cols=243 Identities=24% Similarity=0.422 Sum_probs=195.4
Q ss_pred eecCCCcEEEEEEEEC----CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEEEEccCCC
Q 003694 455 RIGMGGYGTVYKGTFH----HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGS 527 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~----~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~Ey~~~gs 527 (802)
.||+|+||.||+|.+. +..+|+|++..... ...+.|.+|+.++..++||||++++|++.+.. ++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 5899999999999763 46899999865432 23467899999999999999999999986544 89999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccc
Q 003694 528 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607 (802)
Q Consensus 528 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 607 (802)
|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||.|||++.++.+||+|||+++.+........
T Consensus 82 L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~-- 153 (257)
T cd05116 82 LNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-- 153 (257)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee--
Confidence 999986433 4888999999999999999999988 99999999999999999999999999987654332111
Q ss_pred ccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhh-hCCCCChHHHH
Q 003694 608 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIKETK 685 (802)
Q Consensus 608 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~~~ 685 (802)
......++..|+|||.+....++.++|||||||++|||+| |++||...... .+...+.. .....|...+.
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~i~~~~~~~~~~~~~~ 225 (257)
T cd05116 154 -AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------EVTQMIESGERMECPQRCPP 225 (257)
T ss_pred -ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHCCCCCCCCCCCCH
Confidence 1122345688999999988889999999999999999998 99999643211 12222222 22345566788
Q ss_pred HHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 686 ELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 686 ~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
.+.+|+.+||+.+|.+||++. .|...|+
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~-~i~~~l~ 253 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFA-VVELRLR 253 (257)
T ss_pred HHHHHHHHHhccCchhCcCHH-HHHHHHh
Confidence 999999999999999999998 5666554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=333.11 Aligned_cols=240 Identities=23% Similarity=0.261 Sum_probs=193.8
Q ss_pred CCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCc---cchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN---IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~---~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~ 520 (802)
+|.....||+|+||.||+|...+ ..||+|++..... .....+..|..++..+ +||+|+.+++++.+.. ++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788899999999999998864 4899999875422 2234567788888877 5899999999886554 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999886543 4888899999999999999999988 999999999999999999999999999754322
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .+...+......+|
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------~~~~~i~~~~~~~p 221 (323)
T cd05616 155 GV------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEHNVAYP 221 (323)
T ss_pred CC------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCC
Confidence 11 123457999999999999999999999999999999999999999644321 11112222223456
Q ss_pred hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+..+.+|+.+|++.+|.+|++...
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~~ 248 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCGP 248 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCCC
Confidence 667788999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=333.06 Aligned_cols=242 Identities=23% Similarity=0.256 Sum_probs=193.6
Q ss_pred CCcccceecCCCcEEEEEEEECC--eEEEEEEEcccC---ccchHHHHHHHHHHHhcCCC-ceeeecceecCC--CeEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHP-HLLLLLGACPDH--GCLVY 520 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hp-niv~l~g~~~~~--~~lV~ 520 (802)
+|...+.||+|+||.||+|...+ ..||||++.... ......+..|+.++..+.|+ +|+.+++++.+. .++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788899999999999999864 489999987532 23345678899999999765 578888887554 48999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999886543 4788899999999999999999988 999999999999999999999999998753221
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||++||....... +...+.......|
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~~~~ 221 (324)
T cd05587 155 GK------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNVSYP 221 (324)
T ss_pred CC------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCCC
Confidence 11 1134579999999999999999999999999999999999999996433211 1111222233455
Q ss_pred hHHHHHHHHHHHHhhccccCCCCccccch
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
...+..+.+++.+||..+|.+||+.....
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~ 250 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCGPTG 250 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCC
Confidence 56678899999999999999999975433
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.94 Aligned_cols=248 Identities=27% Similarity=0.354 Sum_probs=195.7
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
.++|....+||+|+||.||++.+. +..+|+|++..... .....|.+|+++|.+++||||+++++++.+.. ++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357888999999999999999986 55899999876432 33467899999999999999999999986544 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999886543 4788899999999999999999853 29999999999999999999999999997654321
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhh--hhch--------------
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET--AIDE-------------- 665 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~--~~~~-------------- 665 (802)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||......+. .+..
T Consensus 159 --------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 159 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred --------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 1334799999999999988999999999999999999999999963321110 0000
Q ss_pred --------------------hhhHHHhhh----hCCCCC-hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 --------------------DNLAEILDA----QAGDWP-IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 --------------------~~l~~~ld~----~~~~~p-~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+++. .....+ ...+..+.+|+.+||+.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~e 297 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKM 297 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHH
Confidence 000111111 111111 135678999999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=333.15 Aligned_cols=241 Identities=25% Similarity=0.380 Sum_probs=200.1
Q ss_pred cCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
..|+....||+|.||.||+|.+.. ..||+|++..+.. ....++++|+.+|..+++|||.++||.+..+. .++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 346666789999999999999875 4899999987643 34577899999999999999999999986554 789999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
|.||++.+.|.... .+......-|+.+++.||.|||..+ .+|||||+.||||..+|.+||+|||.+-.+....
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 99999999886433 2466677788999999999999998 9999999999999999999999999998876543
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh-hCCCCCh
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGDWPI 681 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~-~~~~~p~ 681 (802)
.+...++||+.|||||++....|+.++||||||++.+||++|.||+...+.+...+ ++.. ..+....
T Consensus 166 -----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------lIpk~~PP~L~~ 233 (467)
T KOG0201|consen 166 -----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------LIPKSAPPRLDG 233 (467)
T ss_pred -----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------eccCCCCCcccc
Confidence 23366799999999999998899999999999999999999999997665533211 1111 1122223
Q ss_pred HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..++.|.+|+..|+..+|+.||++.+
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKE 259 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 56788999999999999999999985
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.83 Aligned_cols=243 Identities=24% Similarity=0.360 Sum_probs=191.8
Q ss_pred ecCCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCH
Q 003694 456 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 528 (802)
Q Consensus 456 iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL 528 (802)
||+|+||.||++.+. +..||+|++...... ....+..|+.+|+.++||||+++++++.... ++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 568999998654221 2345778999999999999999999886544 899999999999
Q ss_pred HHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccc
Q 003694 529 EDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607 (802)
Q Consensus 529 ~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 607 (802)
.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----
Confidence 98875432 3346899999999999999999999988 99999999999999999999999999986653321
Q ss_pred ccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHH
Q 003694 608 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687 (802)
Q Consensus 608 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 687 (802)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ .......++. .....|...+..+
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~ 228 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILN-DSVTYPDKFSPAS 228 (280)
T ss_pred -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcc-cCCCCcccCCHHH
Confidence 12345789999999999999999999999999999999999999964321110 0011111111 1123445567889
Q ss_pred HHHHHHhhccccCCCCccccchh
Q 003694 688 AALGLSCAELRRKDRPDLKNQVL 710 (802)
Q Consensus 688 ~~li~~Cl~~~p~~RP~~~~~v~ 710 (802)
.+++.+||+.+|.+||++.+...
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~ 251 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNC 251 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCH
Confidence 99999999999999998765333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.41 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=202.4
Q ss_pred cCCcccceecCCCcEEEEEEEEC-----CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~-----~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
++|.....||+|+||.||+|.+. ...||||++..... .....|..|+.++.+++||||+++++++.+.. ++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 46888899999999999999874 23789998875432 33467899999999999999999999986554 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999865432 5899999999999999999999988 99999999999999999999999999998753
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 678 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~ 678 (802)
..... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... .....+.......
T Consensus 159 ~~~~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~ 228 (266)
T cd05033 159 SEATY----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DVIKAVEDGYRLP 228 (266)
T ss_pred cccce----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HHHHHHHcCCCCC
Confidence 22111 1123345778999999998899999999999999999998 99998532211 1111122222223
Q ss_pred CChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
.+..++..+.+|+.+|++.+|.+||++. +++..|+++
T Consensus 229 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~-ei~~~l~~~ 265 (266)
T cd05033 229 PPMDCPSALYQLMLDCWQKDRNERPTFS-QIVSTLDKM 265 (266)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 3455678899999999999999999999 577776654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=333.42 Aligned_cols=243 Identities=21% Similarity=0.285 Sum_probs=192.3
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHH---HhcCCCceeeecceecCCC--eEE
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVL---SKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il---~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
|.....||+|+||.||+|.+. ++.||||++.... ....+.+.+|+.++ +.++||||+++++++.+.. |+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566788999999999999885 5689999987542 22234566676665 5668999999999986554 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|||+++|+|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999887753 24899999999999999999999988 99999999999999999999999999875432
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+..+.. .....
T Consensus 154 ~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~~-~~~~~ 220 (324)
T cd05589 154 FGD------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVN-DEVRY 220 (324)
T ss_pred CCC------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCCCC
Confidence 211 1234579999999999998899999999999999999999999996433211 1111211 12334
Q ss_pred ChHHHHHHHHHHHHhhccccCCCCccccchhhH
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKNQVLPV 712 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~ 712 (802)
|...+..+.+++.+||..+|.+||+..+..+..
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 253 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGSGEKDAED 253 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 555678899999999999999999876543333
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=346.60 Aligned_cols=257 Identities=27% Similarity=0.460 Sum_probs=216.9
Q ss_pred cccceecCCCcEEEEEEEEC--C---eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 451 SENLRIGMGGYGTVYKGTFH--H---TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 451 ~~~~~iG~G~~g~Vy~~~~~--~---~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
.+.+.||.|.||.||+|+++ + ..||||.|+.... ..+.+|+.|..||.+++||||++|.|+..... .+|.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 45678999999999999985 2 3899999998754 35578999999999999999999999987655 789999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
|+||+|+.+|..+.+. +.+.+..-+++.|+.|+.||-..+ +|||||...|||++.|..+||+||||++.+.++..
T Consensus 712 MENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 9999999999876643 889999999999999999999988 99999999999999999999999999998876552
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
. .|...+..-...|.|||.+...++|.+||||||||+|||.++ |..||... ...+-+..+-+......|+
T Consensus 787 ~---~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm------SNQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 787 A---AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM------SNQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred c---cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc------chHHHHHHHHhccCCCCCC
Confidence 2 222233344678999999999999999999999999999776 88888422 2334445555555667789
Q ss_pred HHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHHhhhc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADR 722 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~~~~ 722 (802)
+++..|.+|++.||++|...||.+. +|+..|++|......
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~-qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFA-QIVSTLDKLIRNPNS 897 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHH-HHHHHHHHHhcCchh
Confidence 9999999999999999999999999 688899988654443
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.99 Aligned_cols=244 Identities=25% Similarity=0.301 Sum_probs=192.3
Q ss_pred CCcccceecCCCcEEEEEEEE-----CCeEEEEEEEcccC----ccchHHHHHHHHHHHhcC-CCceeeecceecCCC--
Q 003694 449 SFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG-- 516 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~-----~~~~vavK~l~~~~----~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~-- 516 (802)
+|...++||+|+||.||++.. .+..||+|++.... ....+.+..|+.+|..++ ||||+.+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477888999999999999876 35689999986432 223456788999999995 999999999886554
Q ss_pred eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 79999999999999986543 4888899999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCCcccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~ 675 (802)
+...... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||........ ...+...+...
T Consensus 155 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~ 226 (332)
T cd05614 155 FLSEEKE-----RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILKC 226 (332)
T ss_pred ccccCCC-----ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhcC
Confidence 5432211 11345799999999998764 478899999999999999999999964321110 01111111112
Q ss_pred CCCCChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 676 AGDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 676 ~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
....|...+..+.+++.+||..+|.+||+..
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 2334455678899999999999999999765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.04 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=196.9
Q ss_pred cCCcccceecCCCcEEEEEEEECC-eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEcc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
++|...+.||+|+||.||++.+.. ..+|+|.+... ......|.+|+.+|++++||||++++++|.+.. ++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357777889999999999998865 48999987643 334567899999999999999999999986554 89999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999886533 24889999999999999999999988 999999999999999999999999999865432211
Q ss_pred cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
......++..|+|||++.+..++.++||||||+++|+|+| |++||......+ .+..+........|...
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~------~~~~i~~~~~~~~~~~~ 226 (256)
T cd05114 157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE------VVEMISRGFRLYRPKLA 226 (256)
T ss_pred ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCCCCCCCCCCC
Confidence 1123345678999999988889999999999999999999 899996433211 11112221122234445
Q ss_pred HHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
+..+.+++.+||..+|.+||++.+ ++..|
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~-l~~~l 255 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAE-LLRAI 255 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHH-HHHhh
Confidence 678999999999999999999984 54443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.97 Aligned_cols=246 Identities=25% Similarity=0.428 Sum_probs=194.7
Q ss_pred eecCCCcEEEEEEEEC----CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEEEEccCCCH
Q 003694 455 RIGMGGYGTVYKGTFH----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSL 528 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~----~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~Ey~~~gsL 528 (802)
.||+|+||.||+|.+. +..||+|++..... ...+.|.+|+.++++++||||++++++|.... ++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999764 34689999876533 23456899999999999999999999986544 899999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccc
Q 003694 529 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 608 (802)
Q Consensus 529 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 608 (802)
.+++.... ..+++..+.+++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--- 153 (257)
T cd05115 82 NKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--- 153 (257)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcccee---
Confidence 99886433 35899999999999999999999988 99999999999999999999999999986654332111
Q ss_pred cccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHH
Q 003694 609 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687 (802)
Q Consensus 609 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 687 (802)
......+++.|+|||++.+..++.++|||||||++|+|++ |.+||....... ....+........|..++..+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l 227 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMSFIEQGKRLDCPAECPPEM 227 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHCCCCCCCCCCCCHHH
Confidence 1122344678999999988889999999999999999996 999996432211 111111222234555667899
Q ss_pred HHHHHHhhccccCCCCccccchhhHHHH
Q 003694 688 AALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 688 ~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
.+++.+||..+|.+||++. .|...|+.
T Consensus 228 ~~li~~c~~~~~~~Rp~~~-~i~~~l~~ 254 (257)
T cd05115 228 YALMKDCWIYKWEDRPNFA-KVEERMRT 254 (257)
T ss_pred HHHHHHHcCCChhhCcCHH-HHHHHHhh
Confidence 9999999999999999998 46655543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.38 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=200.4
Q ss_pred cCCcccceecCCCcEEEEEEEEC-------CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecCCC--e
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--C 517 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~ 517 (802)
.+|.....||+|+||.||+|... +..||||++...... ....|.+|+++|.+++||||+++++++.+.. +
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 35777788999999999999763 257999998765443 4568999999999999999999999986554 8
Q ss_pred EEEEEccCCCHHHHhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCcee
Q 003694 518 LVYEYMENGSLEDRLYRKNN-----------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 586 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~ 586 (802)
+||||+++|+|.+++...+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999975431 234788899999999999999999988 9999999999999999999
Q ss_pred EEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhch
Q 003694 587 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 665 (802)
Q Consensus 587 kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~ 665 (802)
||+|||++.......... ......+++.|+|||++.++.++.++|||||||++|+|++ |..||.......
T Consensus 162 kl~d~g~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----- 232 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYR----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----- 232 (280)
T ss_pred EECCcccceecccCccee----cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----
Confidence 999999997654322110 1123356788999999999999999999999999999999 999985332211
Q ss_pred hhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 666 ~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
....+........+...+..+.+++.+||..+|.+||++. +|+..|+
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-eil~~l~ 279 (280)
T cd05049 233 -VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIK-DIHERLQ 279 (280)
T ss_pred -HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHhh
Confidence 1111122222233445678899999999999999999998 4655553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.34 Aligned_cols=253 Identities=21% Similarity=0.351 Sum_probs=198.2
Q ss_pred cCCcccceecCCCcEEEEEEEEC--Ce----EEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC-eEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HT----FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~----~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV 519 (802)
.+|.....||+|+||.||+|.+. +. .+++|.+..... .....+..|+.++.+++||||++++|++.+.. +++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 35677788999999999999873 33 477787754322 22356778888999999999999999986554 799
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
+||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999987543 34899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhh-CC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AG 677 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~-~~ 677 (802)
.... .......++..|++||++.++.++.++|||||||++|||+| |+.||...... .+.+++... ..
T Consensus 162 ~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~ 230 (279)
T cd05111 162 DDKK----YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERL 230 (279)
T ss_pred CCcc----cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcC
Confidence 3211 11233467788999999998899999999999999999998 99999643221 112222221 11
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHH
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
..+..++..+..++.+||..+|.+||++. +++..|..+.
T Consensus 231 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~-el~~~l~~~~ 269 (279)
T cd05111 231 AQPQICTIDVYMVMVKCWMIDENVRPTFK-ELANEFTRMA 269 (279)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHH
Confidence 22333456788999999999999999998 5666666554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.12 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=204.0
Q ss_pred CCcccceecCCCcEEEEEEEEC-------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
+|.....||+|+||.||+|... ...+++|.+........+.|.+|+.++++++||||+++++++.+.. ++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4667788999999999999753 2368889887665555677999999999999999999999996554 899
Q ss_pred EEEccCCCHHHHhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCcee
Q 003694 520 YEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 586 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~ 586 (802)
|||+++++|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 999999999999875321 234889999999999999999999998 9999999999999999999
Q ss_pred EEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhch
Q 003694 587 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 665 (802)
Q Consensus 587 kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~ 665 (802)
||+|||++......... .......++..|+|||++.+..++.++|||||||++|+|+| |++||.......
T Consensus 163 ~l~dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----- 233 (291)
T cd05094 163 KIGDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----- 233 (291)
T ss_pred EECCCCcccccCCCcee----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 99999999865432211 11233467889999999988889999999999999999999 999985432211
Q ss_pred hhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHH
Q 003694 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 666 ~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
.+..+........+...+..+.+++.+||+.+|.+||++. +|+..|+.+..
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~-~v~~~l~~~~~ 284 (291)
T cd05094 234 -VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIK-EIYKILHALGK 284 (291)
T ss_pred -HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHHh
Confidence 1111112222233444567899999999999999999999 67777777643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.76 Aligned_cols=244 Identities=23% Similarity=0.326 Sum_probs=196.1
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCC--CeEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYE 521 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~lV~E 521 (802)
+|+..++||+|+||.||++... ++.||+|++..... .....+.+|+.+++.++||||+.+++++.+. .++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777889999999999999874 56999999865322 2234578899999999999999999998654 489999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886543 245899999999999999999999988 9999999999999999999999999998754322
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+...+.......+.
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05605 157 T-------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQEEYSE 226 (285)
T ss_pred c-------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcccccCc
Confidence 1 123478999999999988889999999999999999999999996432111 001112222222234455
Q ss_pred HHHHHHHHHHHHhhccccCCCCccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
..+..+.+|+.+||..||.+||+..
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCR 251 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCC
Confidence 5678899999999999999999655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.15 Aligned_cols=240 Identities=23% Similarity=0.282 Sum_probs=190.5
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||++.+. +..||+|+++... ......+..|..++..+ +||||++++++|.+.. +|||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6999999999999885 5589999987542 22335578899999998 6999999999986654 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---- 151 (329)
T cd05588 82 DLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---- 151 (329)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC----
Confidence 9998886543 4899999999999999999999998 99999999999999999999999999875322111
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhh--hhchhhhHHHhhhhCCCCChHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET--AIDEDNLAEILDAQAGDWPIKET 684 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~--~~~~~~l~~~ld~~~~~~p~~~~ 684 (802)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ......+...+.......|...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 229 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS 229 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCC
Confidence 12345799999999999999999999999999999999999999963221110 00111122222222233455567
Q ss_pred HHHHHHHHHhhccccCCCCccc
Q 003694 685 KELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
..+.+++.+||..+|.+||+..
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~ 251 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCH 251 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCC
Confidence 7899999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=334.85 Aligned_cols=240 Identities=25% Similarity=0.298 Sum_probs=193.5
Q ss_pred ceecCCCcEEEEEEEE-----CCeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEcc
Q 003694 454 LRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~-----~~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
+.||+|+||.||++.. .++.||+|++..... .....+.+|+.+|.+++||||+++++++.+.. |+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999865 357899999875322 23345778999999999999999999986655 89999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999999886533 4889999999999999999999998 99999999999999999999999999986543211
Q ss_pred cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 684 (802)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .+..+.. .....|...+
T Consensus 154 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~i~~-~~~~~p~~~~ 222 (318)
T cd05582 154 ----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTMILK-AKLGMPQFLS 222 (318)
T ss_pred ----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHHHHc-CCCCCCCCCC
Confidence 1134579999999999988889999999999999999999999996443211 1111211 1223455567
Q ss_pred HHHHHHHHHhhccccCCCCccccchhhH
Q 003694 685 KELAALGLSCAELRRKDRPDLKNQVLPV 712 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~~~v~~~ 712 (802)
..+.+|+.+||+.+|.+||++.++.+..
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~ 250 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGPDGVEE 250 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 8899999999999999999987644333
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=334.37 Aligned_cols=231 Identities=25% Similarity=0.311 Sum_probs=187.6
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 527 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gs 527 (802)
.||+|+||.||++... +..||+|++.... ......+..|+.++..++||||+++++++.+.. |+||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 5999999999999874 5689999987542 223356788999999999999999999886555 89999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 528 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 528 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
|.+++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 82 LFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc----
Confidence 998886543 48899999999999999999997 57 99999999999999999999999999875432211
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
......||+.|+|||++.+..++.++|||||||+||+|+||+.||..... ..+...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-------~~~~~~i~~~~~~~p~~~~~~ 222 (325)
T cd05594 152 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEIRFPRTLSPE 222 (325)
T ss_pred --ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-------HHHHHHHhcCCCCCCCCCCHH
Confidence 11234799999999999989999999999999999999999999964322 111222222223345556788
Q ss_pred HHHHHHHhhccccCCCCc
Q 003694 687 LAALGLSCAELRRKDRPD 704 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~ 704 (802)
+.+|+.+||+.+|.+|++
T Consensus 223 ~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred HHHHHHHHhhcCHHHhCC
Confidence 999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.31 Aligned_cols=251 Identities=23% Similarity=0.395 Sum_probs=199.7
Q ss_pred cCCcccceecCCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEcc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
++|...++||+|+||.||+|.+. ++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.. ++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46888899999999999999875 4579999876543 24567899999999999999999999886554 79999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 999999886543 335888899999999999999999988 999999999999999999999999999876532211
Q ss_pred cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
......++..|+|||++..+.++.++|||||||++|+|+| |+.||....... ....+........+...
T Consensus 160 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 229 (261)
T cd05072 160 ----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD------VMSALQRGYRMPRMENC 229 (261)
T ss_pred ----ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH------HHHHHHcCCCCCCCCCC
Confidence 1123356778999999988889999999999999999998 999995322111 11111111111122345
Q ss_pred HHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
+..+.+++.+|+..+|.+||++. ++...|+.
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 260 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFD-YLQSVLDD 260 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHH-HHHHHHhc
Confidence 67899999999999999999998 67777664
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=330.06 Aligned_cols=236 Identities=24% Similarity=0.302 Sum_probs=188.8
Q ss_pred eecCCCcEEEEEEEECC--eEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||+|.+.+ ..||||++.... ......+..|..++..+ +||||+++++++.+.. ++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 69999999999999864 589999987542 22334567788888764 8999999999986654 7999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 151 (316)
T cd05619 82 DLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---- 151 (316)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC----
Confidence 999988653 24788899999999999999999988 99999999999999999999999999875332111
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .+...+.......|......
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~ 222 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMDNPCYPRWLTRE 222 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCCccCCHH
Confidence 113357899999999999889999999999999999999999999643321 11111222223344456678
Q ss_pred HHHHHHHhhccccCCCCccccch
Q 003694 687 LAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
+.+|+.+||+.+|.+||++.+.+
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHH
Confidence 99999999999999999987433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=318.83 Aligned_cols=250 Identities=27% Similarity=0.463 Sum_probs=200.8
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEcc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
+|...++||+|+||.||+|.+. ++.+|+|++... ......+.+|+.+|..++||||++++++|.... ++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 5777889999999999999885 568999988754 334567899999999999999999999986544 89999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 86 YGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 999999886543 345899999999999999999999988 999999999999999999999999999876532211
Q ss_pred cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhh-hhCCCCChH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAGDWPIK 682 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~ 682 (802)
......++..|+|||++.+..++.++|||||||++|+|+| |..||...... .+...+. ......|..
T Consensus 161 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~ 229 (263)
T cd05052 161 ----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKGYRMERPEG 229 (263)
T ss_pred ----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCCCCCCCC
Confidence 1112234678999999998899999999999999999998 99998543211 1111121 112344555
Q ss_pred HHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
.+..+.+++.+||..+|.+||++. +++..|+.+
T Consensus 230 ~~~~~~~li~~cl~~~p~~Rp~~~-~l~~~l~~~ 262 (263)
T cd05052 230 CPPKVYELMRACWQWNPSDRPSFA-EIHQAFETM 262 (263)
T ss_pred CCHHHHHHHHHHccCCcccCCCHH-HHHHHHHhh
Confidence 678899999999999999999999 576666543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.14 Aligned_cols=240 Identities=24% Similarity=0.291 Sum_probs=189.6
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||++... +..||+|++.... ......+..|+.++.++ +||||+++++++.+.. ++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 6999999999999885 4589999987542 22334577899988877 7999999999986554 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|..++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---- 151 (329)
T cd05618 82 DLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---- 151 (329)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC----
Confidence 9998876543 4889999999999999999999998 99999999999999999999999999975432211
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhh--hhchhhhHHHhhhhCCCCChHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET--AIDEDNLAEILDAQAGDWPIKET 684 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~--~~~~~~l~~~ld~~~~~~p~~~~ 684 (802)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ......+...+.......|...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~ 229 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCC
Confidence 11345799999999999999999999999999999999999999953211100 00111122222222334555667
Q ss_pred HHHHHHHHHhhccccCCCCccc
Q 003694 685 KELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
..+.+|+.+||..+|.+||+..
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~ 251 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCH 251 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCC
Confidence 8899999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.78 Aligned_cols=237 Identities=23% Similarity=0.295 Sum_probs=189.9
Q ss_pred ceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEEEEccC
Q 003694 454 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMEN 525 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~Ey~~~ 525 (802)
+.||+|+||.||+|.+. +..||+|++.... ......+..|..++..+ +||||+++++++.+.. ++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999985 4589999987542 22344567788888764 8999999999987655 899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 151 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--- 151 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---
Confidence 99999886543 4788899999999999999999998 99999999999999999999999999875322111
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 685 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~ 685 (802)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .+.+.+.......|.....
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~ 221 (316)
T cd05620 152 ---RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRVDTPHYPRWITK 221 (316)
T ss_pred ---ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCCCCCCH
Confidence 123457999999999999999999999999999999999999999643321 1122222222334445677
Q ss_pred HHHHHHHHhhccccCCCCccccch
Q 003694 686 ELAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 686 ~l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
.+.+|+.+||+.||.+||++.+++
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHH
Confidence 899999999999999999986444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.00 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=192.1
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
++|.....||+|+||.||+|++. +..||+|++.... ......+.+|+.+++.++||||++++++|.+.. ++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999986 4589999987542 223456889999999999999999999986554 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+++++|..+.. . ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~-~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE-M--PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh-c--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999877765432 2 234888899999999999999999988 9999999999999999999999999998765322
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchh---------hhHHHh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------NLAEIL 672 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~---------~l~~~l 672 (802)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|++||............. .+....
T Consensus 155 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 155 NA-----NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cc-----cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 11 1133578999999999988889999999999999999999999997543222111000 000000
Q ss_pred -hhh--CCCC-------------ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 673 -DAQ--AGDW-------------PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 673 -d~~--~~~~-------------p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+.. ...+ ....+..+.+|+.+|++.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~ 280 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQ 280 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHH
Confidence 000 0000 1124567999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.17 Aligned_cols=236 Identities=28% Similarity=0.352 Sum_probs=186.9
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHH-HHHhcCCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELE-VLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~-il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||+|.+. +..||+|++..... .....+..|.. +++.++||||+++++++.+.. ++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 6999999999999984 66899999865321 12234555555 467899999999999886544 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 151 (323)
T cd05575 82 ELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---- 151 (323)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC----
Confidence 9999886533 4888889999999999999999998 99999999999999999999999999875432211
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
......||+.|+|||++.+..++.++|||||||++|+|+||++||......+ .+..++.. ....+...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~-~~~~~~~~~~~ 222 (323)
T cd05575 152 --TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILNK-PLRLKPNISVS 222 (323)
T ss_pred --ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHcC-CCCCCCCCCHH
Confidence 1234579999999999999999999999999999999999999996432211 11122221 12233445788
Q ss_pred HHHHHHHhhccccCCCCccccch
Q 003694 687 LAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
+.+++.+|++.+|.+||++.+.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCCCCH
Confidence 99999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=330.55 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=189.6
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecC-------CCe
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------HGC 517 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-------~~~ 517 (802)
.|....+||+|+||.||+|... +..||||++.... ......+.+|+.+|+.++||||+++++++.. ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3777889999999999999875 5689999986432 2234568899999999999999999998732 138
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~ 597 (802)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68988886433 4889999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCCcccccccccCCccCcccCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCccccchhhhh-------------
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA------------- 662 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~------------- 662 (802)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||.........
T Consensus 154 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPT---AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCc---cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 432211 111234579999999998865 67899999999999999999999999643321110
Q ss_pred ----hchhhhHHHhhhhCCCCC-------hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 663 ----IDEDNLAEILDAQAGDWP-------IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 663 ----~~~~~l~~~ld~~~~~~p-------~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+........+.......+ ...+..+.+++.+||..+|.+||++.+
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e 286 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHH
Confidence 000111111111111111 123466789999999999999999885
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=322.21 Aligned_cols=251 Identities=23% Similarity=0.423 Sum_probs=197.2
Q ss_pred CCcccceecCCCcEEEEEEEE------CCeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
+|+...+||+|+||.||+|.+ .+..+++|.+..... .....|.+|+.+++.++||||+++++++.... ++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 567778999999999999985 235889998875332 33467889999999999999999999986544 899
Q ss_pred EEEccCCCHHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCce
Q 003694 520 YEYMENGSLEDRLYRKNN--------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 585 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~ 585 (802)
|||+++|+|.+++..... ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCc
Confidence 999999999999864321 224788889999999999999999988 999999999999999999
Q ss_pred eEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhc
Q 003694 586 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAID 664 (802)
Q Consensus 586 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~ 664 (802)
+||+|||+++......... ......++..|+|||++.++.++.++|||||||++|||+| |.+||.....
T Consensus 163 ~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------ 232 (283)
T cd05090 163 VKISDLGLSREIYSADYYR----VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------ 232 (283)
T ss_pred EEeccccccccccCCccee----cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 9999999998764332111 1123356778999999988889999999999999999999 9999854321
Q ss_pred hhhhHHHhhhh-CCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 665 EDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 665 ~~~l~~~ld~~-~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
..+.+.+... ....+...+..+.+++.+|+..+|.+||++. .+...|.
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~i~~~l~ 281 (283)
T cd05090 233 -QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFK-DIHTRLR 281 (283)
T ss_pred -HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHH-HHHHHhh
Confidence 1112222211 2234445678899999999999999999998 4655553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.29 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=200.3
Q ss_pred cCCcccceecCCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeecceecCC---
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH--- 515 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~--- 515 (802)
..|...+.||+|+||.||+|...+ +.||+|++..... .....+..|+.++.++ +||||++++++|...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 367888999999999999997532 4799999875432 2335678899999999 799999999988543
Q ss_pred CeEEEEEccCCCHHHHhhhcCC----------------------------------------------------------
Q 003694 516 GCLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 537 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 537 (802)
.+++|||+++|+|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 3789999999999998864321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccccccCCccCc
Q 003694 538 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 617 (802)
Q Consensus 538 ~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~ 617 (802)
..+++|..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....... ......++.
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~----~~~~~~~~~ 239 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----RKGDARLPL 239 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchh----hccCCCCCc
Confidence 125899999999999999999999988 9999999999999999999999999998765332111 123345678
Q ss_pred ccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhh-CCCCChHHHHHHHHHHHHhh
Q 003694 618 CYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCA 695 (802)
Q Consensus 618 ~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~li~~Cl 695 (802)
.|+|||++.+..++.++|||||||+||+|+| |..||...... ..+...+... ....|......+.+++.+||
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 313 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------EEFCRRLKEGTRMRAPEYATPEIYSIMLDCW 313 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc------HHHHHHHhccCCCCCCccCCHHHHHHHHHHc
Confidence 8999999999999999999999999999998 99999542211 1111122111 12223445678999999999
Q ss_pred ccccCCCCccccchhhHHHHHH
Q 003694 696 ELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 696 ~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
+.+|.+||++. +++..|+++.
T Consensus 314 ~~~p~~RPs~~-ell~~l~~~~ 334 (337)
T cd05054 314 HNNPEDRPTFS-ELVEILGDLL 334 (337)
T ss_pred cCChhhCcCHH-HHHHHHHHHH
Confidence 99999999999 6777777654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=331.98 Aligned_cols=246 Identities=25% Similarity=0.404 Sum_probs=207.3
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeecceecCCC---eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG---CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~---~lV~ 520 (802)
.+|...+.||+|+||.++..+.+ .+.+++|.+...... .+....+|+.++++++|||||.+.+.|.+.. ||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46777889999999999987654 568999988765433 3345789999999999999999999997655 7899
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
+|++||+|.+.+.+.. +.-++...+++++.|++.|+.|||+.. |+|||||+.|||++.++.+||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998765 445899999999999999999999887 999999999999999999999999999998876
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
.+.. ...+||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+... -...+........|
T Consensus 160 ~~~a------~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~~~~~Plp 227 (426)
T KOG0589|consen 160 DSLA------STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINRGLYSPLP 227 (426)
T ss_pred hhhh------heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhhccCCCCC
Confidence 5332 45699999999999999999999999999999999999999996443221 12223333335567
Q ss_pred hHHHHHHHHHHHHhhccccCCCCccccch
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
..+..++..|+..|+..+|..||++.+.+
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL 256 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELL 256 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHh
Confidence 78899999999999999999999998533
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=317.68 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=198.8
Q ss_pred CcccceecCCCcEEEEEEEECC-----eEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecC--C-----
Q 003694 450 FSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPD--H----- 515 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~~-----~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~----- 515 (802)
|...+.||+|+||.||+|.+.. ..||+|.++.... .....+.+|+.+|+.++||||+++++++.+ .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567789999999999998742 4799999875432 234578999999999999999999998732 1
Q ss_pred -CeEEEEEccCCCHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeee
Q 003694 516 -GCLVYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 591 (802)
Q Consensus 516 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DF 591 (802)
.++||||+++|+|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 379999999999999886532 2235899999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHH
Q 003694 592 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAE 670 (802)
Q Consensus 592 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~ 670 (802)
|+++.+....... ......++..|+|||++.+..++.++|||||||++|||++ |.+||...... ..+..
T Consensus 158 g~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~ 227 (273)
T cd05035 158 GLSKKIYSGDYYR----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDY 227 (273)
T ss_pred cceeecccccccc----ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 9998765432211 1122345678999999988889999999999999999999 88998543221 11222
Q ss_pred HhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 671 ILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 671 ~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
+........|...+..+.+++.+||..+|.+||++. +++..|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-e~~~~l~~~ 272 (273)
T cd05035 228 LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFT-KLREVLENI 272 (273)
T ss_pred HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 222222334556678899999999999999999998 576666543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=348.85 Aligned_cols=255 Identities=23% Similarity=0.275 Sum_probs=204.3
Q ss_pred HHHHHhhcCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCC-
Q 003694 441 EEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH- 515 (802)
Q Consensus 441 ~ei~~~~~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~- 515 (802)
..+.....+|.....||+|+||.||+|.. .+..||||++.... ......+.+|+.+|..++|+||+++++.+...
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34455667899999999999999999987 46799999986543 23345688999999999999999998776321
Q ss_pred ---------CeEEEEEccCCCHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCce
Q 003694 516 ---------GCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 585 (802)
Q Consensus 516 ---------~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~ 585 (802)
.++||||+++|+|.++|.... ....+++..+..|+.|++.||.|||+.+ |+||||||+||||+.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 268999999999999986532 2346889999999999999999999988 999999999999999999
Q ss_pred eEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch
Q 003694 586 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 665 (802)
Q Consensus 586 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~ 665 (802)
+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||+||+.||......
T Consensus 182 vkL~DFGls~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------ 251 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSD----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------ 251 (496)
T ss_pred EEEEecccCeeccccccc----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------
Confidence 999999999876532211 1123457999999999999999999999999999999999999999643221
Q ss_pred hhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccc
Q 003694 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 708 (802)
Q Consensus 666 ~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~ 708 (802)
..+..++.......|...+..+.+|+.+||..+|.+||++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~el 294 (496)
T PTZ00283 252 EVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKL 294 (496)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 1112222222233455667889999999999999999999853
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=330.29 Aligned_cols=233 Identities=24% Similarity=0.307 Sum_probs=189.0
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||+|.+. ++.||||++.... ......+..|..++..+ +||||+++++++.+.. ++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999885 5689999987532 22345677899998876 6999999999986654 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---- 151 (320)
T cd05590 82 DLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---- 151 (320)
T ss_pred hHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC----
Confidence 9999886543 4888899999999999999999988 99999999999999999999999999875432211
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... +...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~ 222 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVVYPTWLSQD 222 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCCCCCCCCCHH
Confidence 1234579999999999998899999999999999999999999996443211 1111222222344456778
Q ss_pred HHHHHHHhhccccCCCCccc
Q 003694 687 LAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~ 706 (802)
+.+|+.+|++.+|.+||+..
T Consensus 223 ~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred HHHHHHHHcccCHHHCCCCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=311.21 Aligned_cols=245 Identities=26% Similarity=0.346 Sum_probs=192.9
Q ss_pred cCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccc--hHHHHHHHHHHHhcCCCceeeeccee----cCCCeEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQ--NKQFLQELEVLSKIRHPHLLLLLGAC----PDHGCLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~--~~~~~~Ei~il~~l~Hpniv~l~g~~----~~~~~lV 519 (802)
++|...++|++|+||.||+|++.. ..||+|.++.+.... .-.-++||.+|.+++|||||.+-.+. .+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 357778899999999999999864 589999987654211 12347999999999999999886654 4556999
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
||||+. +|..++.... .++...++.-+..|++.||.|||.+. |+||||||+|+|+.+.|.+||+|||+|+.+..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999985 8998887654 45888889999999999999999999 99999999999999999999999999998875
Q ss_pred CCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh-hCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAG 677 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~-~~~ 677 (802)
.. ...+..+-|.+|.|||.+.+ ..|++..|+||+|||+.||++++|-|.....+.+.-. +..++.. ...
T Consensus 230 p~------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~---If~llGtPte~ 300 (419)
T KOG0663|consen 230 PL------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK---IFKLLGTPSEA 300 (419)
T ss_pred Cc------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH---HHHHhCCCccc
Confidence 43 23467789999999998765 4599999999999999999999999976544433211 1111100 001
Q ss_pred CCC-----------------h---------H-HHHHHHHHHHHhhccccCCCCcccc
Q 003694 678 DWP-----------------I---------K-ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 678 ~~p-----------------~---------~-~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.|| . . ....-.+|+...+.+||++|.++.+
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~ 357 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED 357 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence 111 1 1 2356678999999999999999885
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=336.81 Aligned_cols=247 Identities=27% Similarity=0.328 Sum_probs=197.3
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|.....||+|+||.||+|... +..||||++.... ......+..|+.+|..++||||+++++++.+.. ++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999986 6799999987542 233456889999999999999999999987655 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998765 34888899999999999999999988 999999999999999999999999999876543
Q ss_pred CCc-----------------------ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccc
Q 003694 601 PSF-----------------------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 657 (802)
Q Consensus 601 ~~~-----------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~ 657 (802)
... ...........||+.|+|||++.+..++.++|||||||+||+|+||+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 200 000011234579999999999999999999999999999999999999997544
Q ss_pred hhhhhhchhhhHHHhhh-hCCCCCh--HHHHHHHHHHHHhhccccCCCCc-ccc
Q 003694 658 KVETAIDEDNLAEILDA-QAGDWPI--KETKELAALGLSCAELRRKDRPD-LKN 707 (802)
Q Consensus 658 ~~~~~~~~~~l~~~ld~-~~~~~p~--~~~~~l~~li~~Cl~~~p~~RP~-~~~ 707 (802)
.... +..+... .....|. ..+..+.+|+.+|+. +|.+||+ +.+
T Consensus 235 ~~~~------~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ 281 (350)
T cd05573 235 LQET------YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEE 281 (350)
T ss_pred HHHH------HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHH
Confidence 2211 1112220 0011121 247889999999997 9999999 663
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.65 Aligned_cols=240 Identities=24% Similarity=0.271 Sum_probs=190.4
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||+|... +..+|+|++..... .....+.+|+.++.++ +||||+.+++++.+.. |+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999875 46899999875422 2335578899999888 5999999999986554 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|..++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---- 151 (327)
T cd05617 82 DLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---- 151 (327)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC----
Confidence 9998886543 4899999999999999999999988 99999999999999999999999999875332111
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
......||+.|+|||++.+..++.++|||||||+||+|+||+.||..............+...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 229 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK 229 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 113457999999999999999999999999999999999999999532211111011112222222223455556788
Q ss_pred HHHHHHHhhccccCCCCccc
Q 003694 687 LAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~ 706 (802)
+.+++.+||..+|.+||+..
T Consensus 230 ~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHHHHhccCHHHcCCCC
Confidence 99999999999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.80 Aligned_cols=241 Identities=26% Similarity=0.415 Sum_probs=188.8
Q ss_pred CCcccceecCCCcEEEEEEEEC---CeEEEEEEEcccCc--cchHHHHHHHHHHHhc---CCCceeeecceec-------
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGN--IQNKQFLQELEVLSKI---RHPHLLLLLGACP------- 513 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~---~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l---~Hpniv~l~g~~~------- 513 (802)
+|.....||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5788889999999999999873 46899998865432 2234567788887766 6999999999874
Q ss_pred CCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 514 DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 514 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
...++||||+. ++|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 12389999996 68999886543 234889999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhh
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld 673 (802)
++...... ......||+.|+|||++....++.++|||||||++|+|++|++||......+. +..+++
T Consensus 157 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~------~~~i~~ 223 (290)
T cd07862 157 ARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ------LGKILD 223 (290)
T ss_pred eEeccCCc-------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH------HHHHHH
Confidence 98764321 12345789999999999888899999999999999999999999975433221 111111
Q ss_pred hhC----CCC----------------------ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 674 AQA----GDW----------------------PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ~~~----~~~----------------------p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
... ..| ....+..+.+|+.+|++.+|++||++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 283 (290)
T cd07862 224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 283 (290)
T ss_pred HhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH
Confidence 100 001 0123567789999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=336.00 Aligned_cols=238 Identities=26% Similarity=0.402 Sum_probs=185.1
Q ss_pred cccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccC
Q 003694 451 SENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 525 (802)
Q Consensus 451 ~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~ 525 (802)
...++||+|+||.||+|.+. ++.||||++..... .....|.+|+.+|+.++||||+++++++.+.. ++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 34567999999999999885 57999999865432 33467899999999999999999999996654 899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|.+.. ...+..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 157 ~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--- 223 (353)
T PLN00034 157 GSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--- 223 (353)
T ss_pred Ccccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc---
Confidence 9986532 2456677889999999999999998 99999999999999999999999999987653221
Q ss_pred ccccccCCccCcccCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
......||..|+|||++.. ...+.++|||||||++|||++|+.||........ ......+........+
T Consensus 224 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 297 (353)
T PLN00034 224 ---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASLMCAICMSQPPEAP 297 (353)
T ss_pred ---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHHhccCCCCCC
Confidence 1134579999999998743 2345689999999999999999999963221110 0001111111122334
Q ss_pred hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+..+.+|+.+||..+|.+||++.+
T Consensus 298 ~~~~~~l~~li~~~l~~~P~~Rpt~~e 324 (353)
T PLN00034 298 ATASREFRHFISCCLQREPAKRWSAMQ 324 (353)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHH
Confidence 456788999999999999999999884
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=322.01 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=200.1
Q ss_pred cCCcccceecCCCcEEEEEEEEC------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecC----CCe
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD----HGC 517 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~----~~~ 517 (802)
.+|.....||+|+||.||+|.+. +..||+|.+..........|.+|+.+|++++||||+++++++.. ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46777889999999999999752 45899999877665556789999999999999999999998742 237
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~ 597 (802)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999986543 34889999999999999999999988 999999999999999999999999999877
Q ss_pred cCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchh-hhhhch--------hhh
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKV-ETAIDE--------DNL 668 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~-~~~~~~--------~~l 668 (802)
........ ......++..|+|||++.+..++.++|||||||++|||++|..|+...... ...+.. ..+
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYYK---VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCccee---ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 54332111 111223456699999998888999999999999999999988766422111 000000 111
Q ss_pred HHHhhhh-CCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 669 AEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 669 ~~~ld~~-~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
.+.+... ....+...+..+.+|+.+||..+|.+||++. +++..|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS-ELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHhc
Confidence 1222211 1122334567899999999999999999999 577766643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=329.80 Aligned_cols=233 Identities=25% Similarity=0.318 Sum_probs=188.0
Q ss_pred eecCCCcEEEEEEEECC--eEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||+|...+ ..||+|++.... ......+..|..++..+ +||||+++++++.+.. |+||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 59999999999999864 589999987542 22345577899999876 7999999999986654 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---- 151 (321)
T cd05591 82 DLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---- 151 (321)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc----
Confidence 9998886543 4888899999999999999999998 99999999999999999999999999876432211
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
......||+.|+|||++.+..++.++|||||||++|+|+||++||....... .+..+.. .....|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~-~~~~~p~~~~~~ 222 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILH-DDVLYPVWLSKE 222 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHc-CCCCCCCCCCHH
Confidence 1234579999999999998899999999999999999999999996443211 1112221 112334445678
Q ss_pred HHHHHHHhhccccCCCCccc
Q 003694 687 LAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~ 706 (802)
+.+|+.+|+..+|.+||+..
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~ 242 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCV 242 (321)
T ss_pred HHHHHHHHhccCHHHcCCCC
Confidence 99999999999999999654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.33 Aligned_cols=253 Identities=26% Similarity=0.467 Sum_probs=206.4
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
...+|...++||.|+||.||+|.+. +..+++|++..........+..|+.+++.++||||+++++++.+.. ++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3456888889999999999999875 4689999988766555677999999999999999999999986554 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++|+|.+++.... ...+++..+..++.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999987543 345899999999999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
......++..|++||++..+.++.++||||||+++|+|++ |+.||..... ...+..+........+.
T Consensus 160 ------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~ 227 (261)
T cd05148 160 ------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN------HEVYDQITAGYRMPCPA 227 (261)
T ss_pred ------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHHhCCcCCCCC
Confidence 1123456788999999988889999999999999999998 8999954321 11222222222233445
Q ss_pred HHHHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
..+..+.+++.+||..+|.+||++. +++..|+.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~-~l~~~L~~ 260 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFK-ALREELDN 260 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHhc
Confidence 6678899999999999999999999 57766654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=319.16 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=194.7
Q ss_pred cccceecCCCcEEEEEEEECCe----EEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecC--------CC
Q 003694 451 SENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--------HG 516 (802)
Q Consensus 451 ~~~~~iG~G~~g~Vy~~~~~~~----~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--------~~ 516 (802)
....+||+|+||.||+|.+... .+|+|.+.... ......|..|+.++..++||||++++++|.. ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999987543 58999876542 3335678899999999999999999998732 23
Q ss_pred eEEEEEccCCCHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 517 CLVYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
+++|||+++|+|.+++.... ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 79999999999998875321 2335889999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHh
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 672 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~l 672 (802)
++.+....... ......+++.|++||++....++.++||||||+++|+|++ |++||....... ....+.
T Consensus 159 ~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~ 228 (272)
T cd05075 159 SKKIYNGDYYR----QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------IYDYLR 228 (272)
T ss_pred ccccCccccee----cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHH
Confidence 98765432110 1122346778999999998899999999999999999999 889985432111 111111
Q ss_pred hhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 673 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 673 d~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
.......+...+..+.+++.+||..+|.+||++. +++..|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~l~~~l~~ 270 (272)
T cd05075 229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFE-TLRCELEK 270 (272)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHh
Confidence 1111223345567899999999999999999998 56666654
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=319.12 Aligned_cols=241 Identities=24% Similarity=0.323 Sum_probs=188.3
Q ss_pred ecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCH
Q 003694 456 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 528 (802)
Q Consensus 456 iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL 528 (802)
||+|+||.||++... +..||+|.+..... .....+..|+++|++++||||+++++++.+.. ++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 67899998864321 12344567999999999999999999986554 899999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccc
Q 003694 529 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 608 (802)
Q Consensus 529 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 608 (802)
.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce------
Confidence 98886543 234888899999999999999999988 99999999999999999999999999987653221
Q ss_pred cccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHH
Q 003694 609 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 688 (802)
Q Consensus 609 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 688 (802)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ........+...........+..+.
T Consensus 151 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05607 151 -ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDEVKFEHQNFTEESK 227 (277)
T ss_pred -eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccccccccccCCHHHH
Confidence 1234789999999999988899999999999999999999999964321100 0111111111111111123567899
Q ss_pred HHHHHhhccccCCCCccccch
Q 003694 689 ALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 689 ~li~~Cl~~~p~~RP~~~~~v 709 (802)
+|+.+||+.+|.+||++.+.+
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHhccCHhhCCCCccch
Confidence 999999999999999998533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=316.61 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=199.7
Q ss_pred hcCCcccceecCCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
..+|...+.||+|+||.||+|.+. ++.||+|.+.... ...+.|.+|+.++++++||||+++++++.... ++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 456888899999999999999875 4579999987543 34567899999999999999999999986554 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986543 345899999999999999999999988 999999999999999999999999999877532110
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhh-CCCCCh
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPI 681 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p~ 681 (802)
......++..|+|||++.+..++.++||||||+++|+|+| |+.||...... .+...+... ....+.
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~ 227 (261)
T cd05068 160 -----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQGYRMPCPP 227 (261)
T ss_pred -----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCCCCCC
Confidence 1112233568999999998889999999999999999999 99999543211 111111111 122344
Q ss_pred HHHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
..+..+.+++.+|++.+|.+||++. .+...|+
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~-~l~~~l~ 259 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFE-TLQWKLE 259 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHH-HHHHHHh
Confidence 5578899999999999999999998 4655554
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=316.02 Aligned_cols=246 Identities=28% Similarity=0.470 Sum_probs=196.2
Q ss_pred ceecCCCcEEEEEEEECC-----eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEEEEccCC
Q 003694 454 LRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENG 526 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~-----~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~Ey~~~g 526 (802)
++||+|+||.||+|.+.. ..+|+|.+..... .....+.+|+.+++.+.||||+++++++.... ++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 369999999999998632 4799999876543 24567899999999999999999999986444 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++.... .+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~- 153 (257)
T cd05060 81 PLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR- 153 (257)
T ss_pred cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc-
Confidence 9999997543 5889999999999999999999988 99999999999999999999999999987654332111
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhh-hCCCCChHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIKET 684 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~~ 684 (802)
......++..|+|||.+.+..++.++|||||||++|+|+| |.+||...... .+...+.. .....|...+
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 224 (257)
T cd05060 154 --ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-------EVIAMLESGERLPRPEECP 224 (257)
T ss_pred --cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcCCcCCCCCCCC
Confidence 1122334578999999998899999999999999999998 99999643221 11111111 1123444566
Q ss_pred HHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 685 KELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
..+.+++.+||..+|.+||++. +++..|+.+
T Consensus 225 ~~l~~li~~cl~~~p~~Rp~~~-~l~~~l~~~ 255 (257)
T cd05060 225 QEIYSIMLSCWKYRPEDRPTFS-ELESTFRRD 255 (257)
T ss_pred HHHHHHHHHHhcCChhhCcCHH-HHHHHHHhc
Confidence 8899999999999999999999 577776654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=317.50 Aligned_cols=246 Identities=24% Similarity=0.412 Sum_probs=196.7
Q ss_pred CCcccceecCCCcEEEEEEEECCe-EEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccC
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 525 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~~-~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~ 525 (802)
+|.....||+|+||.||+|.+.+. .+|+|.+.... .....|.+|+.++.+++||||++++++|.+.. ++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 467778899999999999988654 69999876543 34567999999999999999999999986544 899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|.+++..... .+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++........
T Consensus 84 ~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-- 156 (256)
T cd05113 84 GCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-- 156 (256)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee--
Confidence 999998865432 5899999999999999999999988 999999999999999999999999999866432211
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 684 (802)
......++..|++||++.+..++.++|||||||++|+|+| |..||....... ....+........+...+
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05113 157 ---SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKVSQGLRLYRPHLAS 227 (256)
T ss_pred ---ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHhcCCCCCCCCCCC
Confidence 1123356778999999988889999999999999999999 999986432211 111122222222334456
Q ss_pred HHHHHHHHHhhccccCCCCccccchhhH
Q 003694 685 KELAALGLSCAELRRKDRPDLKNQVLPV 712 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~~~v~~~ 712 (802)
..+.+++.+||+.+|.+||++. +++..
T Consensus 228 ~~~~~li~~cl~~~p~~Rp~~~-~ll~~ 254 (256)
T cd05113 228 EKVYAIMYSCWHEKAEERPTFQ-QLLSS 254 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHH-HHHHh
Confidence 8899999999999999999998 45443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=319.93 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=198.3
Q ss_pred CcccceecCCCcEEEEEEEE------CCeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCC----CeE
Q 003694 450 FSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCL 518 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~~l 518 (802)
|.....||+|+||.||++.+ .+..||+|++..... .....|.+|+++|++++||||++++++|... .++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 36778899999999988764 245899999876432 3456788999999999999999999987542 379
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
||||+++|+|.+++... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999988643 3899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccch-hhhhh-------chhhhHH
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHK-VETAI-------DEDNLAE 670 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~-~~~~~-------~~~~l~~ 670 (802)
....... ......++..|++||++....++.++||||||+++|+|+||..||..... ..... ....+..
T Consensus 159 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 159 EGHEYYR---VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred Ccchhhc---cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 4321100 01223456779999999888899999999999999999999999853321 11110 0111122
Q ss_pred Hhhhh-CCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHH
Q 003694 671 ILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 671 ~ld~~-~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
.++.. ....+...+..+.+++.+||+.+|.+||++. .++..|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR-SLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHH-HHHHHHHHhh
Confidence 22211 1122344568899999999999999999999 5777776653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.59 Aligned_cols=238 Identities=28% Similarity=0.332 Sum_probs=187.3
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHH-HHHhcCCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELE-VLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~-il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||+|... +..||+|++..... .....+..|.. +++.++||||+++++++.+.. ++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999984 56899999865321 22334555554 578899999999999886554 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|...+.... .++...+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 82 ELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC----
Confidence 9998886432 4778888899999999999999988 99999999999999999999999999875322111
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
......||+.|+|||++.+..++.++|||||||++|+|++|++||...+... .+..++. .....|......
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~-~~~~~~~~~~~~ 222 (321)
T cd05603 152 --TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNILH-KPLQLPGGKTVA 222 (321)
T ss_pred --ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHhc-CCCCCCCCCCHH
Confidence 1234579999999999998889999999999999999999999996442211 1111221 123344556778
Q ss_pred HHHHHHHhhccccCCCCccccchhh
Q 003694 687 LAALGLSCAELRRKDRPDLKNQVLP 711 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~~~v~~ 711 (802)
+.+++.+|++.+|.+||+....+.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~ 247 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAKADFLE 247 (321)
T ss_pred HHHHHHHHccCCHhhcCCCCCCHHH
Confidence 9999999999999999997644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=314.97 Aligned_cols=247 Identities=26% Similarity=0.323 Sum_probs=201.0
Q ss_pred CCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccc---hHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~---~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
.|...++||.|.-|+||++.+.+ ..+|+|++....... ..+.+.|-+||+.++||.++.||..|.... |||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 35556789999999999999987 589999998764433 345677999999999999999999996554 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
||+||+|..+++++. ...++...+.-++.+++.||+|||-.| ||+|||||+||||.++|++.|+||.|+......+
T Consensus 158 yCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999877654 456899999999999999999999999 9999999999999999999999999986553211
Q ss_pred Ccc--------------------------------------------------cccccccCCccCcccCCccccccCCCC
Q 003694 602 SFV--------------------------------------------------STTYKNTGPVGTLCYIDPEYQRTGLIS 631 (802)
Q Consensus 602 ~~~--------------------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 631 (802)
... .+..+....+||-.|+|||++.+..++
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011223456999999999999999999
Q ss_pred CcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC--CCCChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 632 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 632 ~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~--~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
.++|+|+|||+|||||.|..||-.... +..+..++.... ++.| ..+..+.+||.+.|..||.+|-...
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~------~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNN------KETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCc------hhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccc
Confidence 999999999999999999999975543 233455544332 2333 5678899999999999999998854
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=329.16 Aligned_cols=248 Identities=26% Similarity=0.371 Sum_probs=193.8
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
.++|+...+||+|+||.||++.+. +..+|+|++.... ......+.+|+.+|..++||||++++++|.+.. ++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367888999999999999999986 5588999887543 233467899999999999999999999986654 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+++|+|.+++.... .+++.....++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999986533 4788888999999999999999742 29999999999999999999999999997654321
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhh--hc---h-----------
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA--ID---E----------- 665 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~--~~---~----------- 665 (802)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||......... +. .
T Consensus 159 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 159 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred --------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 12347899999999999888999999999999999999999998643211100 00 0
Q ss_pred ------------------hhhHHHhhhh----CCCCCh-HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 ------------------DNLAEILDAQ----AGDWPI-KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 ------------------~~l~~~ld~~----~~~~p~-~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.....+.+.. .+..+. ..+.++.+|+.+||+.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~e 295 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQ 295 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHH
Confidence 0000111111 011111 23567899999999999999999885
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=316.30 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=200.1
Q ss_pred cCCcccceecCCCcEEEEEEEECC-eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEEEEccC
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 525 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~Ey~~~ 525 (802)
..|....+||+|+||.||+|.+.+ ..||+|++.... .....|.+|+.+++.++||||+++++++.+.. ++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 458888999999999999998764 479999987533 24567899999999999999999999875544 899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-- 158 (262)
T cd05071 85 GSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-- 158 (262)
T ss_pred CcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc--
Confidence 99999987532 235789999999999999999999988 999999999999999999999999999876543211
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 684 (802)
......++..|++||+..++.++.++||||||+++|+|+| |.+||...... ..+..+........+...+
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd05071 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYRMPCPPECP 229 (262)
T ss_pred ---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHHhcCCCCCCccccC
Confidence 1123456788999999988889999999999999999999 88888533211 1111111111122234567
Q ss_pred HHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 685 KELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
..+.+|+.+|++.+|.+||++. +++..|+.
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~-~~~~~l~~ 259 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFE-YLQAFLED 259 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHH-HHHHHHHH
Confidence 8899999999999999999998 56666654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=322.79 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=203.2
Q ss_pred HhhcCCcccceecCCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeecceecCC
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH 515 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~ 515 (802)
...++|.....||+|+||.||++...+ ..+|+|.+..... .....+.+|++++.++ +||||++++++|.+.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344568888899999999999998642 4789998875432 2345688999999999 799999999998665
Q ss_pred C--eEEEEEccCCCHHHHhhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEe
Q 003694 516 G--CLVYEYMENGSLEDRLYRK-------------NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 580 (802)
Q Consensus 516 ~--~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl 580 (802)
. +++|||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 4 8999999999999998643 22345889999999999999999999988 9999999999999
Q ss_pred cCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchh
Q 003694 581 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 659 (802)
Q Consensus 581 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~ 659 (802)
+.++.+||+|||+++.+....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYR----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred cCCCeEEeCcccccccccccccee----ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 999999999999998765432111 1122345678999999988889999999999999999998 99998533211
Q ss_pred hhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 660 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 660 ~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
+ .+..+........+...+..+.+|+.+||..+|.+||++. +++..|+.+
T Consensus 242 ~------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-eil~~l~~~ 291 (293)
T cd05053 242 E------LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFK-QLVEDLDRM 291 (293)
T ss_pred H------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHH-HHHHHHHHh
Confidence 1 1111111222344556678899999999999999999998 577776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.92 Aligned_cols=253 Identities=25% Similarity=0.461 Sum_probs=199.5
Q ss_pred CCcccceecCCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~l 518 (802)
+|.....||+|+||.||+|.... ..+++|.+..... .....+.+|+.+|+.++||||+++++.|.... ++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46677889999999999998642 4688888765432 23457889999999999999999999986544 89
Q ss_pred EEEEccCCCHHHHhhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 003694 519 VYEYMENGSLEDRLYRKN---------------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 577 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~N 577 (802)
||||+.+|+|.+++.... ...++++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999886421 1235889999999999999999999988 9999999999
Q ss_pred eEecCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcccc
Q 003694 578 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAIT 656 (802)
Q Consensus 578 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~ 656 (802)
||++.++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|+|+| |..||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYV----KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchh----cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999998664332211 1123356778999999988889999999999999999999 99998533
Q ss_pred chhhhhhchhhhHHHhhhh-CCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 657 HKVETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 657 ~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
.. ..+...+... ....|...+..+.+++.+|++.+|.+||++. +++..|+.+
T Consensus 234 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~-~i~~~l~~~ 286 (290)
T cd05045 234 AP-------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA-DISKELEKM 286 (290)
T ss_pred CH-------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHH-HHHHHHHHH
Confidence 21 1222222221 2233445667899999999999999999999 576766655
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=331.36 Aligned_cols=251 Identities=24% Similarity=0.447 Sum_probs=207.8
Q ss_pred CCcccceecCCCcEEEEEEEECC------eEEEEEEEccc-CccchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVY 520 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~------~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~ 520 (802)
......+||.|-||.||+|++.. -.||||..+.+ .....+.|++|..+|++++|||||+|+|.|.+.. .+||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wivm 469 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVM 469 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEE
Confidence 34456689999999999998842 26889988764 3445678999999999999999999999998877 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
|.++.|.|..+|..+... ++......++.||+.||.|||+.. +|||||...|||+..+-.+||+||||++.+.++
T Consensus 470 EL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred ecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 999999999999876544 888888999999999999999988 999999999999999999999999999998765
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
.- |+.+...-...|||||-+.-..++.+||||-|||++||+|. |..||.....-+ -+..+-.......
T Consensus 545 ~y-----YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------VI~~iEnGeRlP~ 613 (974)
T KOG4257|consen 545 AY-----YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------VIGHIENGERLPC 613 (974)
T ss_pred ch-----hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc------eEEEecCCCCCCC
Confidence 42 33344455678999999999999999999999999999886 999996443211 1111222334567
Q ss_pred ChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
|..+++.|..|+.+||.++|.+||.+. ++...|..+
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrft-ei~~~lsdv 649 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFT-EIKAILSDV 649 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHH-HHHHHHHHH
Confidence 889999999999999999999999998 465555444
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.10 Aligned_cols=234 Identities=25% Similarity=0.287 Sum_probs=189.6
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||+|.+. +..||||++.... ......+..|..++..+ +||||+++++++.+.. |+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999885 4589999987542 22345577899999888 6999999999986554 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 151 (318)
T cd05570 82 DLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---- 151 (318)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC----
Confidence 9998886543 4899999999999999999999988 99999999999999999999999999875322211
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .+...+.......|...+..
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~ 222 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------ELFQSILEDEVRYPRWLSKE 222 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCCCCCcCCHH
Confidence 112346899999999999999999999999999999999999999643321 11111222223345556788
Q ss_pred HHHHHHHhhccccCCCCcccc
Q 003694 687 LAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+.+|+.+||..+|.+||++..
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~ 243 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLP 243 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCC
Confidence 999999999999999999843
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.31 Aligned_cols=252 Identities=24% Similarity=0.417 Sum_probs=199.4
Q ss_pred CCcccceecCCCcEEEEEEEEC-------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
+|....+||+|+||.||++... +..+++|.+..........|.+|+++++.++||||+++++++.+.. ++|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 5666788999999999999642 3478999887665556678999999999999999999999987544 899
Q ss_pred EEEccCCCHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeE
Q 003694 520 YEYMENGSLEDRLYRKNN------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK 587 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~k 587 (802)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEE
Confidence 999999999999875431 134789999999999999999999988 99999999999999999999
Q ss_pred EeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchh
Q 003694 588 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDED 666 (802)
Q Consensus 588 l~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~ 666 (802)
|+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|+| |.+||.......
T Consensus 163 L~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------ 232 (280)
T cd05092 163 IGDFGMSRDIYSTDYYR----VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------ 232 (280)
T ss_pred ECCCCceeEcCCCceee----cCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------
Confidence 99999997654322110 1122345788999999998899999999999999999998 999985332211
Q ss_pred hhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 667 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 667 ~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
.+..+........+..++..+.+|+.+||..+|.+||++. +|+..|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~-~l~~~l~ 279 (280)
T cd05092 233 AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIK-DIHSRLQ 279 (280)
T ss_pred HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHh
Confidence 1122222222233445677899999999999999999998 4655553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=316.50 Aligned_cols=240 Identities=22% Similarity=0.351 Sum_probs=197.4
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccch---HHHHHHHHHHHhcCCCceeeecceecCCC--eEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~---~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
...|++...||+|.||.|-++..+ ++.||||.++.+..... -.+.+||+||+.|+||||+.+|.+|.... .||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 345777889999999999999764 67999999887654433 34789999999999999999999996544 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|||..+|.|.|++...+. |+......+++||.+|+.|+|.++ ++|||||.+|||||.|+++||+||||+.++..
T Consensus 132 MEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999987654 899999999999999999999998 99999999999999999999999999998865
Q ss_pred CCCcccccccccCCccCcccCCccccccCCC-CCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 678 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~ 678 (802)
.. + .+.++|+|.|.+||+..+.+| ++.+|-|||||+||.|+.|.-||+..+. ..+..-+.....
T Consensus 206 ~k-f------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lvrQIs~GaY- 270 (668)
T KOG0611|consen 206 KK-F------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLVRQISRGAY- 270 (668)
T ss_pred cc-H------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHHHHhhcccc-
Confidence 43 2 245699999999999998887 5889999999999999999999975432 111111111111
Q ss_pred CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+....-||..|+..+|..|.++.+
T Consensus 271 rEP~~PSdA~gLIRwmLmVNP~RRATieD 299 (668)
T KOG0611|consen 271 REPETPSDASGLIRWMLMVNPERRATIED 299 (668)
T ss_pred cCCCCCchHHHHHHHHHhcCcccchhHHH
Confidence 11223455678899999999999999774
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=315.75 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=197.8
Q ss_pred cCCcccceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceec-C--CCeEEEEEcc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP-D--HGCLVYEYME 524 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~-~--~~~lV~Ey~~ 524 (802)
.+|.....||+|+||.||++...+..+++|.+.... ..+.|.+|+.++++++|||++++++++. + ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 367778899999999999999999999999986543 3467899999999999999999999763 2 2389999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 84 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 999999886543 234889999999999999999999988 9999999999999999999999999988654321
Q ss_pred cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ....+........+..+
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 224 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPDGC 224 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhcCCCCCCCCCC
Confidence 12245678999999998889999999999999999998 999985332111 01111111122334456
Q ss_pred HHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
+..+.+++.+|++.+|.+||++. +++..|+.
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~~ 255 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFL-QLREQLEH 255 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHH-HHHHHHhc
Confidence 78899999999999999999999 46665543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=328.25 Aligned_cols=243 Identities=23% Similarity=0.284 Sum_probs=194.0
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcC-CCceeeecceecCCC--eEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~lV~ 520 (802)
+|+....||+|+||.||+|... +..||+|++.... ......+..|..++..+. ||+|+.+++++.+.. ++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677789999999999999875 5689999987542 223355778999998886 577888888876544 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999886543 4889999999999999999999988 999999999999999999999999998754322
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||++||...... ..+..++. ....+|
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~-~~~~~p 221 (323)
T cd05615 155 GV------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIME-HNVSYP 221 (323)
T ss_pred Cc------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCCCCC
Confidence 11 113456999999999999889999999999999999999999999644221 11122222 223455
Q ss_pred hHHHHHHHHHHHHhhccccCCCCccccchh
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKNQVL 710 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~ 710 (802)
...+..+.+++.+||+.+|.+|++..+...
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 251 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCGPEGE 251 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCCCCCH
Confidence 566788999999999999999999764333
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=336.58 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=186.9
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
.+|...++||+|+||.||++.+. +..||+|... ...+.+|+.+|++++||||++++++|.... |+||||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 46888999999999999999885 4589999643 235788999999999999999999886444 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
. ++|..++.... .+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 166 K-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred C-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 5 78888876543 4889999999999999999999988 99999999999999999999999999975432211
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhh----------h----------
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA----------I---------- 663 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~----------~---------- 663 (802)
.......||+.|+|||++.+..++.++|||||||+||+|+||+.||......... +
T Consensus 238 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 238 ----NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ----cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 1123457999999999999889999999999999999999999887432111000 0
Q ss_pred ---chhhhHHHh----hhh---CCCCC-----hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 664 ---DEDNLAEIL----DAQ---AGDWP-----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 664 ---~~~~l~~~l----d~~---~~~~p-----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
....+.... ... ....| ...+..+.+|+.+||+.||.+||++.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~e 372 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA 372 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHH
Confidence 000011111 000 00111 134567899999999999999999984
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=319.23 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=199.6
Q ss_pred cCCcccceecCCCcEEEEEEEEC--Ce----EEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC-eEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HT----FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~----~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV 519 (802)
.+|....+||.|+||.||+|.+. +. .||+|++..... .....+.+|+.++..++||||+.++++|.... +++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 46778889999999999999863 22 489999875433 33567889999999999999999999986544 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999886533 34889999999999999999999988 99999999999999999999999999987754
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhh-CC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AG 677 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~-~~ 677 (802)
.... .......+++.|++||+..+..++.++|||||||++|||+| |.+||..... ..+...+... ..
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~ 230 (279)
T cd05109 162 DETE----YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-------REIPDLLEKGERL 230 (279)
T ss_pred ccce----eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCcC
Confidence 3221 11123345788999999988889999999999999999998 8999853221 1122222221 12
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
..+...+..+.+++.+||..+|.+||++.+ ++..|+.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~-l~~~l~~~ 268 (279)
T cd05109 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRE-LVDEFSRM 268 (279)
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHh
Confidence 233456778999999999999999999994 66665544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=336.82 Aligned_cols=247 Identities=24% Similarity=0.334 Sum_probs=190.5
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
.|.....||+|+||.||+|... +..||||++.... ......+.+|+.+|.+++||||+++++++.+.. ++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778889999999999999885 4589999987542 223456889999999999999999999997655 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987543 4788888899999999999999988 9999999999999999999999999986542110
Q ss_pred Ccc-----------------------------------------cccccccCCccCcccCCccccccCCCCCcccchhHH
Q 003694 602 SFV-----------------------------------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYG 640 (802)
Q Consensus 602 ~~~-----------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlG 640 (802)
... ..........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 000 000011235799999999999888899999999999
Q ss_pred HHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh-CCCCC--hHHHHHHHHHHHH--hhccccCCCCcccc
Q 003694 641 MVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWP--IKETKELAALGLS--CAELRRKDRPDLKN 707 (802)
Q Consensus 641 vil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p--~~~~~~l~~li~~--Cl~~~p~~RP~~~~ 707 (802)
|++|||+||++||........ ...++... ....| ...+.++.+|+.+ |+..+|..||++.+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTET------QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHH------HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 999999999999965432221 11122111 11122 2346788889988 55566667999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=323.97 Aligned_cols=285 Identities=23% Similarity=0.362 Sum_probs=211.4
Q ss_pred cCCcccceecCCCcEEEEEEEEC--Ce----EEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCC-CeEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HT----FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~----~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-~~lV 519 (802)
.+|...+.||+|+||.||+|.+. +. .+|+|.+..... .....+.+|+.+++.++||||++++|+|... .+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 35677788999999999999873 32 578888765432 2234688999999999999999999998654 4799
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
+||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999986543 24788899999999999999999988 99999999999999999999999999987654
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhC-C
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQA-G 677 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~-~ 677 (802)
.... .......++..|++||++.+..++.++|||||||++|||+| |..||..... ..+..++.... .
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~ 230 (303)
T cd05110 162 DEKE----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGERL 230 (303)
T ss_pred cccc----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCCC
Confidence 3211 11223456788999999988889999999999999999997 8889853211 11122222111 1
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHHhhhccccCCCCCCCCCCCCccCccchhcccC
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNE 749 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~~~~~~~~~~~~~~~~P~~f~cPi~~evm~d 749 (802)
..+..++..+.+++.+||..+|.+||++. +++..|..+..-........+......|.....|.+++.|.+
T Consensus 231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (303)
T cd05110 231 PQPPICTIDVYMVMVKCWMIDADSRPKFK-ELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLLDE 301 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHhchhhheeeccCCcCCCCCCchhhHHhccccc
Confidence 12234567889999999999999999998 577777766443322221111223334555555666665554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=316.94 Aligned_cols=255 Identities=24% Similarity=0.445 Sum_probs=200.7
Q ss_pred hcCCcccceecCCCcEEEEEEEECC-----eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~-----~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~l 518 (802)
.++|+..+.||+|+||.||+|.+.. ..+++|.+.... ......|.+|+.++.+++|||++++++++.+.. ++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3477888999999999999998742 268999886543 334567899999999999999999999986544 89
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999886533 35889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCC
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAG 677 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~ 677 (802)
...... ........++.|+|||++.+..++.++|||||||++|+|+| |+.||...... .....+......
T Consensus 159 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~~~~~~ 229 (268)
T cd05063 159 DDPEGT---YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAINDGFRL 229 (268)
T ss_pred cccccc---eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhcCCCC
Confidence 432111 11122234567999999988889999999999999999998 99999533211 111112111122
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
..+...+..+.+++.+||..+|.+||++. .|+..|+++
T Consensus 230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~-~i~~~l~~~ 267 (268)
T cd05063 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFV-DIVNLLDKL 267 (268)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 33445678899999999999999999999 576666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=324.10 Aligned_cols=247 Identities=21% Similarity=0.341 Sum_probs=189.5
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
.++|...++||+|+||.||+|... +..||||++..... .....+.+|+.+++.++||||+++++++.+.. ++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357888999999999999999985 56899999875432 22345788999999999999999999986554 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+. ++|.+++.... ..++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 68888776533 34788889999999999999999998 9999999999999999999999999997643221
Q ss_pred CcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh-hCCCC
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGDW 679 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~-~~~~~ 679 (802)
. ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||.........+.. +...+.. ....|
T Consensus 158 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~ 229 (303)
T cd07869 158 H------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER--IFLVLGTPNEDTW 229 (303)
T ss_pred c------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhCCCChhhc
Confidence 1 1234578999999998765 45888999999999999999999999754332221110 0000000 00000
Q ss_pred ------------------Ch---------HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 680 ------------------PI---------KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 680 ------------------p~---------~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+. .....+.+|+.+|++.||.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~ 284 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQA 284 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHH
Confidence 00 12356789999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.99 Aligned_cols=244 Identities=24% Similarity=0.293 Sum_probs=192.0
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|...+.||+|+||.||+|... ++.||||++.... ......+.+|+.+|..++||||++++++|.+.. +|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888899999999999999885 5689999987532 223355788999999999999999999987655 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987543 4889999999999999999999998 999999999999999999999999999765422
Q ss_pred CCccc--------------------------------ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh
Q 003694 601 PSFVS--------------------------------TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648 (802)
Q Consensus 601 ~~~~~--------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt 648 (802)
..... ........+||+.|+|||++....++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 11000 0001123479999999999998899999999999999999999
Q ss_pred CCCCccccchhhhhhchhhhHHHhhhhC-CCCC--hHHHHHHHHHHHHhhccccCCCCc
Q 003694 649 AKPAIAITHKVETAIDEDNLAEILDAQA-GDWP--IKETKELAALGLSCAELRRKDRPD 704 (802)
Q Consensus 649 g~~p~~~~~~~~~~~~~~~l~~~ld~~~-~~~p--~~~~~~l~~li~~Cl~~~p~~RP~ 704 (802)
|.+||........ +..++.... ...| ...+..+.+|+.+|+. +|.+|++
T Consensus 235 G~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 235 GYPPFCSDNPQET------YRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred CCCCCCCCCHHHH------HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 9999975433221 111211110 1111 1346788899999996 9999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.62 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=199.6
Q ss_pred cCCcccceecCCCcEEEEEEEECC-eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEEEEccC
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 525 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~Ey~~~ 525 (802)
++|...++||+|+||.||+|...+ ..+|+|.+..... ....|.+|+.++++++|||++++++++.+.. ++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 357778899999999999998754 5789998876433 4567999999999999999999999886544 899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05070 85 GSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc--
Confidence 99999886532 335889999999999999999999988 999999999999999999999999999876532211
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 684 (802)
......++..|+|||++.+..++.++||||||+++|+|++ |.+||......+ .+..+........+...+
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 229 (260)
T cd05070 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------VLEQVERGYRMPCPQDCP 229 (260)
T ss_pred ---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCCCCCcCC
Confidence 1122345678999999988889999999999999999999 899995432211 111122221233445567
Q ss_pred HHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 685 KELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
..+.+|+.+|+..+|.+||++. .+...|+
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~ 258 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFE-YLQSFLE 258 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHH-HHHHHHh
Confidence 8899999999999999999998 4655554
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=335.98 Aligned_cols=247 Identities=23% Similarity=0.261 Sum_probs=189.5
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|...++||.|+||.||++... +..||||++.... ......+.+|+.+|..++||||++++++|.+.. ||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999874 5689999986432 223456788999999999999999999997654 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999988653 34788888899999999999999998 999999999999999999999999999643211
Q ss_pred CCcc----------cc-------------------------------cccccCCccCcccCCccccccCCCCCcccchhH
Q 003694 601 PSFV----------ST-------------------------------TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAY 639 (802)
Q Consensus 601 ~~~~----------~~-------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~Sl 639 (802)
.... .. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0000 00 000012479999999999998889999999999
Q ss_pred HHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh-CCCCCh--HHHHHHHHHHHHhhccccCCCC---cccc
Q 003694 640 GMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPI--KETKELAALGLSCAELRRKDRP---DLKN 707 (802)
Q Consensus 640 Gvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p~--~~~~~l~~li~~Cl~~~p~~RP---~~~~ 707 (802)
||+||||+||++||....... .+..++... ...+|. ..+..+.+|+.+|+. +|.+|+ ++.+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE------TYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH------HHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 999999999999996433211 111122110 111221 346788999999997 777664 6553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.46 Aligned_cols=243 Identities=28% Similarity=0.420 Sum_probs=199.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|...+.||+|+||.||+|... +..|++|.+... .......+.+|+.+++.++||||+++++++.+.. ++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999884 568999988643 2334567889999999999999999999987654 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999987642 345889999999999999999999988 99999999999999999999999999987654321
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 682 (802)
. .....|++.|+|||++.++.++.++|+||||+++|+|+||+.||....... ....+........+..
T Consensus 157 ~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~ 224 (256)
T cd08529 157 F------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA------LILKIIRGVFPPVSQM 224 (256)
T ss_pred h------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCCCCccc
Confidence 1 133468899999999999999999999999999999999999996443211 1122222222333335
Q ss_pred HHHHHHHHHHHhhccccCCCCcccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..+.+++.+||+.+|.+||++.+
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHH
Confidence 6788999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=321.80 Aligned_cols=252 Identities=22% Similarity=0.359 Sum_probs=198.8
Q ss_pred CCcccceecCCCcEEEEEEEEC-------CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecCCC--eE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~l 518 (802)
.|....+||.|+||.||+|.+. +..||+|++...... ....|.+|+.++..++||||+++++++.+.. ++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556678999999999999864 257999998755332 2456889999999999999999999986544 89
Q ss_pred EEEEccCCCHHHHhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCce
Q 003694 519 VYEYMENGSLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 585 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~ 585 (802)
++||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1234788889999999999999999988 999999999999999999
Q ss_pred eEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhc
Q 003694 586 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAID 664 (802)
Q Consensus 586 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~ 664 (802)
+||+|||+++........ .......+++.|+|||++.++.++.++|||||||++|||+| |.+||.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------ 232 (283)
T cd05091 163 VKISDLGLFREVYAADYY----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------ 232 (283)
T ss_pred eEecccccccccccchhe----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999998876432211 11123456789999999988889999999999999999998 8888853321
Q ss_pred hhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 665 EDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 665 ~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
.+.+..+........+..++..+.+|+.+||+.+|.+||++. +|+..|+
T Consensus 233 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~-~i~~~l~ 281 (283)
T cd05091 233 QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFK-DIHSRLR 281 (283)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHH-HHHHHhh
Confidence 112223333333444566788899999999999999999998 4655553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=322.44 Aligned_cols=254 Identities=27% Similarity=0.406 Sum_probs=197.4
Q ss_pred cCCcccceecCCCcEEEEEEEECCe----EEEEEEEccc-CccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSK-GNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~~----~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV 519 (802)
++|.....||+|+||.||+|.+... .+++|.++.. .......|.+|+.++.++ +||||+++++++.+.. ++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 4678888999999999999987532 4688877643 233446789999999999 7999999999986654 899
Q ss_pred EEEccCCCHHHHhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCcee
Q 003694 520 YEYMENGSLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 586 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~ 586 (802)
|||+++|+|.+++.... ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986532 1234888999999999999999999988 9999999999999999999
Q ss_pred EEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhch
Q 003694 587 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 665 (802)
Q Consensus 587 kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~ 665 (802)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|+|+| |..||.......
T Consensus 159 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----- 226 (297)
T cd05089 159 KIADFGLSRGEEVYV-------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----- 226 (297)
T ss_pred EECCcCCCcccccee-------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 999999986432110 0111233567999999988889999999999999999998 999995332211
Q ss_pred hhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHH
Q 003694 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 666 ~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
.+..+........|..++..+.+|+.+||+.+|.+||++. +++..|+.+..
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~~~~ 277 (297)
T cd05089 227 -LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFA-QISVQLSRMLE 277 (297)
T ss_pred -HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHH
Confidence 1111221112233445677899999999999999999999 46666665543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=328.67 Aligned_cols=237 Identities=27% Similarity=0.340 Sum_probs=186.2
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHH-HHHhcCCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELE-VLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~-il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||+|.+. +..||+|++..... .....+..|.. +++.++||||+++++++.+.. ++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6999999999999885 45899999865321 12233444444 567889999999999986554 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++.... .++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 82 ELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC----
Confidence 9999886543 3777788889999999999999998 99999999999999999999999999975432211
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
......||+.|+|||++.+..++.++|||||||++|+|++|++||......+ .+..+... ....+...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~-~~~~~~~~~~~ 222 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNK-PLQLKPNITNS 222 (325)
T ss_pred --CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHhC-CcCCCCCCCHH
Confidence 1234579999999999999999999999999999999999999996433211 11122211 12233456778
Q ss_pred HHHHHHHhhccccCCCCccccchh
Q 003694 687 LAALGLSCAELRRKDRPDLKNQVL 710 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~~~v~ 710 (802)
+.+++.+|++.+|.+||+..+.+.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCCHH
Confidence 999999999999999999886443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=313.73 Aligned_cols=243 Identities=24% Similarity=0.366 Sum_probs=192.0
Q ss_pred eecCCCcEEEEEEEE--CCeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCHH
Q 003694 455 RIGMGGYGTVYKGTF--HHTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLE 529 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL~ 529 (802)
.||+|+||.||+|++ +++.+|+|.+.... ......|.+|+++|+.++||||++++++|.+.. ++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 589999999999987 46789999876433 233467899999999999999999999986554 8999999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccccc
Q 003694 530 DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 609 (802)
Q Consensus 530 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 609 (802)
+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... . .
T Consensus 82 ~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~--~ 152 (252)
T cd05084 82 TFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--S--T 152 (252)
T ss_pred HHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc--c--c
Confidence 9986433 35889999999999999999999988 999999999999999999999999998765432110 0 0
Q ss_pred ccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhh-hCCCCChHHHHHH
Q 003694 610 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIKETKEL 687 (802)
Q Consensus 610 ~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~~~~l 687 (802)
.....++..|+|||++.++.++.++||||||+++|+|++ |.+||...... .....+.. .....+...+..+
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 225 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQGVRLPCPELCPDAV 225 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCCCCCCcccCCHHH
Confidence 111233567999999998999999999999999999998 88888533211 11112211 1233445567889
Q ss_pred HHHHHHhhccccCCCCccccchhhHHH
Q 003694 688 AALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 688 ~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
.+|+.+|+..+|.+||++. +++..|+
T Consensus 226 ~~li~~~l~~~p~~Rps~~-~~~~~l~ 251 (252)
T cd05084 226 YRLMERCWEYDPGQRPSFS-TVHQELQ 251 (252)
T ss_pred HHHHHHHcCCChhhCcCHH-HHHHHHh
Confidence 9999999999999999999 4655553
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=318.77 Aligned_cols=253 Identities=22% Similarity=0.372 Sum_probs=198.5
Q ss_pred hhcCCcccceecCCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCC--
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH-- 515 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-- 515 (802)
.+++|...+.||+|+||.||+|.+.. ..|++|.+..... .....|.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678888999999999999998854 4788888764432 2345689999999999999999999988654
Q ss_pred CeEEEEEccCCCHHHHhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCc---eeEE
Q 003694 516 GCLVYEYMENGSLEDRLYRKNN----TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL---VSKI 588 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~---~~kl 588 (802)
.++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 4899999999999999876432 235899999999999999999999998 99999999999998654 6899
Q ss_pred eeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhh
Q 003694 589 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 667 (802)
Q Consensus 589 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 667 (802)
+|||+++.+....... ......++..|+|||++.++.++.++|||||||++|+|+| |..||..... ..
T Consensus 161 ~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-------~~ 229 (277)
T cd05036 161 ADFGMARDIYRASYYR----KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-------QE 229 (277)
T ss_pred ccCccccccCCcccee----cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence 9999998764322110 1122244578999999998999999999999999999997 9999864321 11
Q ss_pred hHHHhh-hhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 668 LAEILD-AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 668 l~~~ld-~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
+...+. ......|...+..+.+++.+|++.+|.+||++.+ |+..|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~-vl~~l 275 (277)
T cd05036 230 VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT-ILERI 275 (277)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHh
Confidence 122222 2223445566788999999999999999999984 55444
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=329.41 Aligned_cols=236 Identities=28% Similarity=0.322 Sum_probs=186.5
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHH-HHHhcCCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELE-VLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~-il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||+|... +..+|+|++.... ......+..|.. +++.++||||+++++++.+.. ++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 5999999999999874 5689999986542 122344556655 467789999999999886544 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---- 151 (325)
T cd05604 82 ELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---- 151 (325)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC----
Confidence 9998886433 4889999999999999999999988 99999999999999999999999999875432211
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
......||+.|+|||++.+..++.++|||||||++|+|++|++||......+ .+..++... ...+...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~~~-~~~~~~~~~~ 222 (325)
T cd05604 152 --TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILHKP-LVLRPGASLT 222 (325)
T ss_pred --CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHcCC-ccCCCCCCHH
Confidence 1234579999999999999999999999999999999999999996432211 111222211 1223345678
Q ss_pred HHHHHHHhhccccCCCCccccch
Q 003694 687 LAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
+.+++.+|++.+|.+||++.+.+
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCCCH
Confidence 89999999999999999997533
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=318.90 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=200.4
Q ss_pred hcCCcccceecCCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 516 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-- 516 (802)
.++|.....||+|+||.||+|.+.+ ..||+|.+..... .....|.+|+.+|..++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3467888899999999999998753 5799999865432 33456889999999999999999999986544
Q ss_pred eEEEEEccCCCHHHHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEe
Q 003694 517 CLVYEYMENGSLEDRLYRKNN-------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 589 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~ 589 (802)
++||||+++|+|.+++..... ...+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 899999999999999875322 234788899999999999999999988 9999999999999999999999
Q ss_pred eecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhh
Q 003694 590 DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNL 668 (802)
Q Consensus 590 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l 668 (802)
|||+++.+....... ......++..|+|||++.++.++.++|||||||++|||+| |.+||....... .+
T Consensus 162 dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~ 231 (277)
T cd05032 162 DFGMTRDIYETDYYR----KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VL 231 (277)
T ss_pred CcccchhhccCcccc----cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------HH
Confidence 999998665432111 1123456889999999988889999999999999999998 999985332111 11
Q ss_pred HHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 669 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 669 ~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
..+........|...+..+.+++.+||..+|.+||++. +++..|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~l~~~l 275 (277)
T cd05032 232 KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFL-EIVSSL 275 (277)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHH-HHHHHh
Confidence 11222222334555678899999999999999999998 455544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=333.88 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=202.1
Q ss_pred hhcCCcccceecCCCcEEEEEEEECC-------eEEEEEEEcccCcc-chHHHHHHHHHHHhcC-CCceeeecceecCCC
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNI-QNKQFLQELEVLSKIR-HPHLLLLLGACPDHG 516 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~ 516 (802)
...+|...++||+|+||.||+|++.+ ..||||++...... ....+.+|+.+|.++. |||||+++|+|....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 34467778899999999999998643 47999999754322 2346889999999997 999999999997654
Q ss_pred --eEEEEEccCCCHHHHhhhcCC---------------------------------------------------------
Q 003694 517 --CLVYEYMENGSLEDRLYRKNN--------------------------------------------------------- 537 (802)
Q Consensus 517 --~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 537 (802)
++||||+++|+|.++|.....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 899999999999999975321
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeE
Q 003694 538 --------------------------------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 579 (802)
Q Consensus 538 --------------------------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NIL 579 (802)
...+++..+..|+.||+.||.|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 124677888999999999999999987 999999999999
Q ss_pred ecCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccch
Q 003694 580 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHK 658 (802)
Q Consensus 580 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~ 658 (802)
++.++.+||+|||+++......... ......++..|+|||++....++.++|||||||++|||++ |..||.....
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYI----SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EeCCCEEEEEecCcceecccccccc----cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999998754322111 1123357889999999988889999999999999999998 8889854321
Q ss_pred hhhhhchhhhHHHhhhh-CCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 659 VETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 659 ~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
.+ .+...+... ....|...+..+.+|+.+||..+|.+||++. +|+..|+.+
T Consensus 348 ~~------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~-ell~~L~~~ 399 (401)
T cd05107 348 NE------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFS-QLVHLVGDL 399 (401)
T ss_pred hH------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHH
Confidence 11 111112111 1233445678899999999999999999999 577777765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.31 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=201.7
Q ss_pred cCCcccceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCC--CeEEEEEccC
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMEN 525 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~lV~Ey~~~ 525 (802)
.+|.....||.|+||.||+|...+..||+|.+..... ..+.+.+|+.++.+++||||+++++++.+. .++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4677888999999999999999999999999976654 567799999999999999999999998643 3899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 85 GSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 999998865432 35899999999999999999999998 9999999999999999999999999998764321
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhh-hhCCCCChHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAGDWPIKE 683 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~~ 683 (802)
....++..|+|||++.++.++.++||||||+++|+|++ |..||...... .+...+. ......+...
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKGYRMEAPEGC 224 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCCCCccCC
Confidence 12245678999999988899999999999999999997 99998533211 1111111 1112234445
Q ss_pred HHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
+..+.+++.+||..+|.+||++. +++..|+.
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~~ 255 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFK-QLREQLAL 255 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHH-HHHHHHhc
Confidence 68899999999999999999998 56666653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=321.28 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=189.8
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
.+|....+||.|+||.||+|... +..||+|++..... .....+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 35888889999999999999875 56899999865432 23456789999999999999999999987654 799999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
++ |+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 97 58988886543 34788899999999999999999988 99999999999999999999999999976543221
Q ss_pred cccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhh------------------
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI------------------ 663 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~------------------ 663 (802)
......||+.|+|||++.+ ..++.++|||||||++|+|+||++||......+...
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred ------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 1234478999999998765 568999999999999999999999996432211100
Q ss_pred chhhhHHHhhhhCCC-----CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 664 DEDNLAEILDAQAGD-----WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 664 ~~~~l~~~ld~~~~~-----~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
....+...+.+.... .....+..+.+|+.+|+..||.+||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~ 281 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA 281 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 000000000000000 00123567889999999999999999884
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=342.14 Aligned_cols=259 Identities=24% Similarity=0.309 Sum_probs=205.0
Q ss_pred hcCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeecceec-----CC-C-
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACP-----DH-G- 516 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~-----~~-~- 516 (802)
..++++.+.|.+|||+.||.+.+.+ +.||+|++-.......+.+.+||++|++|. |||||.+++.+. .. .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 4556778889999999999999853 699999988777777888999999999997 999999999431 11 1
Q ss_pred --eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccc
Q 003694 517 --CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594 (802)
Q Consensus 517 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla 594 (802)
.|.||||.||+|-|++..+.... |+..++++|+.|+|+|+.+||..+ .||||||||-+||||+.+|..||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 58999999999999998665544 999999999999999999999998 58999999999999999999999999999
Q ss_pred ccccCCCCccc-ccc--cccCCccCcccCCccc---cccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhh
Q 003694 595 TMLNSDPSFVS-TTY--KNTGPVGTLCYIDPEY---QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 668 (802)
Q Consensus 595 ~~~~~~~~~~~-~~~--~~~~~~gt~~Y~aPE~---~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l 668 (802)
........... ..+ ..-...-|+.|++||. +.+...+.|+|||+|||+||-|+....||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 76543321000 000 0112256999999995 4677799999999999999999999999963311
Q ss_pred HHHhhhhCCCCC-hHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHH
Q 003694 669 AEILDAQAGDWP-IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 669 ~~~ld~~~~~~p-~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
..|+...-.-.| ..+...|..||..||+.+|.+||++. +|+..+-+|..
T Consensus 264 laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~-Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIY-QVLEEIFELAN 313 (738)
T ss_pred eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHH-HHHHHHHHHhc
Confidence 123332211112 47899999999999999999999998 46666555543
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=353.38 Aligned_cols=264 Identities=22% Similarity=0.250 Sum_probs=202.7
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|...++||+|+||.||+|.+. ++.||+|++..... ...++|.+|+.++++++||||+++++++.+.. ++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999875 56899999875422 23467899999999999999999999987654 8999
Q ss_pred EEccCCCHHHHhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeec
Q 003694 521 EYMENGSLEDRLYRKN--------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 592 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFG 592 (802)
||++||+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1234567788999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCCCcc------------cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhh
Q 003694 593 LSTMLNSDPSFV------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 660 (802)
Q Consensus 593 la~~~~~~~~~~------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~ 660 (802)
+++......... ..........||+.|+|||++.+..++.++|||||||++|||+||++||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998763211100 00011123579999999999999999999999999999999999999996422111
Q ss_pred hhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHH
Q 003694 661 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 661 ~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
.. ... .+..+.........+..+.+++.+|+..+|.+||+..++++..|+....
T Consensus 239 i~-~~~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 IS-YRD---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh-hhh---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 000 0111100001123467789999999999999999887778777776643
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.83 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=196.8
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
|...+.||+|+||.||+|.+. ++.+|+|.+..... .....+.+|+.+|+.++|+||+.+++++.+.. |+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666788999999999999885 56899999865432 22345788999999999999999998886554 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998886543 235899999999999999999999988 99999999999999999999999999976543211
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 682 (802)
.....|++.|+|||++.+..++.++|+|||||++|+|+||..||........ ...+...+......++..
T Consensus 158 -------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05632 158 -------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETEEVYSAK 227 (285)
T ss_pred -------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccccccCcc
Confidence 1234789999999999888999999999999999999999999964322111 011111111111233445
Q ss_pred HHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
.+..+.+|+.+|++.+|.+||+..+..+..|
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l 258 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEV 258 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHH
Confidence 5678899999999999999999765433333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.39 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=201.9
Q ss_pred cCCcccceecCCCcEEEEEEEECC-----eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~-----~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~ 520 (802)
.+|....+||+|+||.||+|.+.. ..|+||...... ....+.|.+|+.++++++||||++++++|.+.. ++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 457778899999999999998743 268999887654 344567999999999999999999999986554 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 86 ELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999986543 24899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
.. +..+...++..|+|||++....++.++||||||+++|+|++ |.+||......+. +..+........
T Consensus 161 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~~ 229 (270)
T cd05056 161 SY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGRIENGERLPM 229 (270)
T ss_pred cc-----eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHcCCcCCC
Confidence 21 11223345678999999988889999999999999999996 9999964432211 111111111223
Q ss_pred ChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHH
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
|...+..+.+++.+|+..+|.+||++. +++..|+.+.
T Consensus 230 ~~~~~~~~~~li~~~l~~~P~~Rpt~~-~~~~~l~~~~ 266 (270)
T cd05056 230 PPNCPPTLYSLMTKCWAYDPSKRPRFT-ELKAQLSDIL 266 (270)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHH
Confidence 445678899999999999999999998 5777776654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.48 Aligned_cols=254 Identities=27% Similarity=0.474 Sum_probs=199.8
Q ss_pred cCCcccceecCCCcEEEEEEEEC-----CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~-----~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
.+|...+.||+|+||.||+|.+. ...+|+|.+.... ......|.+|+.++.+++||||+++++++.+.. ++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46777889999999999999863 2378999886543 223467899999999999999999999986544 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|||+++|+|.+++.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999987543 34889999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 678 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~ 678 (802)
..... .......++..|++||++.+..++.++|+||||+++|++++ |..||......+ ....+.+.....
T Consensus 159 ~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~------~~~~~~~~~~~~ 229 (267)
T cd05066 159 DPEAA---YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD------VIKAIEEGYRLP 229 (267)
T ss_pred cccee---eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH------HHHHHhCCCcCC
Confidence 32211 11122344678999999998889999999999999999886 999985332111 111122221223
Q ss_pred CChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
.+...+..+.+++.+|++.+|.+||++. +++..|+.+
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~~ 266 (267)
T cd05066 230 APMDCPAALHQLMLDCWQKDRNERPKFE-QIVSILDKL 266 (267)
T ss_pred CCCCCCHHHHHHHHHHcccCchhCCCHH-HHHHHHHhh
Confidence 3445577899999999999999999998 577666643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.35 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=204.2
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC---------CeEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeecceecC
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPD 514 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~---------~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~ 514 (802)
...+|.....||+|+||.||+|... ...||+|++.... ......+.+|+.+++.+ +||||++++++|..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3457888899999999999999752 2368999886543 23446788999999999 79999999999865
Q ss_pred CC--eEEEEEccCCCHHHHhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeE
Q 003694 515 HG--CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 579 (802)
Q Consensus 515 ~~--~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NIL 579 (802)
.. ++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 54 899999999999999875421 235788899999999999999999988 999999999999
Q ss_pred ecCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccch
Q 003694 580 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHK 658 (802)
Q Consensus 580 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~ 658 (802)
++.++.+||+|||+++.+....... ......+++.|+|||++.+..++.++||||||+++|+|+| |..||.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYK----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccc----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999998765432211 1123356788999999988889999999999999999998 7888853321
Q ss_pred hhhhhchhhhHHHhh-hhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHHh
Q 003694 659 VETAIDEDNLAEILD-AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 719 (802)
Q Consensus 659 ~~~~~~~~~l~~~ld-~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~ 719 (802)
. .+...+. ......+..++..+.+|+.+||..+|.+||++. +++..|+++...
T Consensus 246 ~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-e~l~~l~~~~~~ 299 (304)
T cd05101 246 E-------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFK-QLVEDLDRILTL 299 (304)
T ss_pred H-------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHH-HHHHHHHHHHHh
Confidence 1 1111111 112233445678899999999999999999998 688888777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.64 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=203.2
Q ss_pred hcCCcccceecCCCcEEEEEEEECC---------eEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeecceecCC
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH 515 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~---------~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~ 515 (802)
..+|...+.||+|+||.||++.+.+ ..+|+|++.... ......+..|+.++.++ +||||++++++|.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3568889999999999999997632 369999987543 23445688899999999 799999999998655
Q ss_pred C--eEEEEEccCCCHHHHhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEe
Q 003694 516 G--CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 580 (802)
Q Consensus 516 ~--~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl 580 (802)
. ++||||+++|+|.+++..... ...+++..++.|+.|++.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 4 899999999999999975421 124889999999999999999999988 9999999999999
Q ss_pred cCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchh
Q 003694 581 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 659 (802)
Q Consensus 581 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~ 659 (802)
+.++.+||+|||+++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhh----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-
Confidence 999999999999998664322111 1122234578999999988889999999999999999998 8888853321
Q ss_pred hhhhchhhhHHHhhhh-CCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHHh
Q 003694 660 ETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 719 (802)
Q Consensus 660 ~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~ 719 (802)
. .+...+... ....|...+..+.+|+.+||..+|.+||++. +++..|+++...
T Consensus 249 ~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-evl~~l~~~~~~ 302 (307)
T cd05098 249 E------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRILAL 302 (307)
T ss_pred H------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHHHH
Confidence 1 111122111 2234455678899999999999999999999 687887776554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.10 Aligned_cols=247 Identities=25% Similarity=0.412 Sum_probs=196.0
Q ss_pred CCcccceecCCCcEEEEEEEECC-eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccC
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 525 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~ 525 (802)
+|...+.||+|+||.||+|.+.. ..+|+|++.... .....|.+|+.+++.++||||+++++++.+.. ++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 46777889999999999998864 479999876432 24457889999999999999999999986554 899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
++|.+++..... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-- 156 (256)
T cd05059 84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-- 156 (256)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc--
Confidence 999999875432 5889999999999999999999998 999999999999999999999999999866432111
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 684 (802)
......++..|+|||++.+..++.++||||||+++|+|+| |+.||......+. ...+........|...+
T Consensus 157 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~ 227 (256)
T cd05059 157 ---SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV------VESVSAGYRLYRPKLAP 227 (256)
T ss_pred ---ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH------HHHHHcCCcCCCCCCCC
Confidence 1122234568999999988899999999999999999999 8999864322111 11111111223445567
Q ss_pred HHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 685 KELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
..+.+++.+||..+|.+||++.+ ++..|
T Consensus 228 ~~~~~li~~cl~~~p~~Rpt~~~-~l~~l 255 (256)
T cd05059 228 TEVYTIMYSCWHEKPEDRPAFKK-LLSQL 255 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHH-HHHHh
Confidence 88999999999999999999984 54443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=320.92 Aligned_cols=259 Identities=23% Similarity=0.399 Sum_probs=195.5
Q ss_pred cCCcccceecCCCcEEEEEEEECC----------------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH----------------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLG 510 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~----------------~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g 510 (802)
..|...++||+|+||.||++...+ ..||+|.+..... .....|.+|+++|.+++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467888899999999999987642 2589999876432 33457899999999999999999999
Q ss_pred eecCCC--eEEEEEccCCCHHHHhhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeE
Q 003694 511 ACPDHG--CLVYEYMENGSLEDRLYRKN---------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 579 (802)
Q Consensus 511 ~~~~~~--~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NIL 579 (802)
++.... ++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 986544 89999999999999886432 1234788899999999999999999988 999999999999
Q ss_pred ecCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh--CCCCccccc
Q 003694 580 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITH 657 (802)
Q Consensus 580 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt--g~~p~~~~~ 657 (802)
++.++.+||+|||++..+...... .......++..|+|||++.++.++.++|||||||++|+|+| |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY----RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcce----eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999865432211 11123355788999999988889999999999999999998 567775432
Q ss_pred hhhhhhchhhhHHHh-hhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 658 KVETAIDEDNLAEIL-DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 658 ~~~~~~~~~~l~~~l-d~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
............... .......+...+..+.+|+.+||+.+|.+||++. +|+..|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~i~~~l~ 294 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN-KIHHFLR 294 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHh
Confidence 211100000000000 0001112333567899999999999999999998 5665553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.14 Aligned_cols=253 Identities=27% Similarity=0.406 Sum_probs=195.7
Q ss_pred cCCcccceecCCCcEEEEEEEECC--e--EEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH--T--FAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~--~--~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV 519 (802)
++|.....||+|+||.||+|.+.. . .+++|.+.... ......|.+|+.++.++ +||||++++++|.+.. ++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 467888899999999999998743 3 45777665432 23445788999999999 8999999999986654 899
Q ss_pred EEEccCCCHHHHhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCcee
Q 003694 520 YEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 586 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~ 586 (802)
|||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999875431 235789999999999999999999988 9999999999999999999
Q ss_pred EEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhch
Q 003694 587 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 665 (802)
Q Consensus 587 kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~ 665 (802)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|+| |.+||......+
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----- 231 (303)
T cd05088 164 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 231 (303)
T ss_pred EeCccccCcccchhh-------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----
Confidence 999999986432111 0112234678999999988889999999999999999998 999995332211
Q ss_pred hhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHH
Q 003694 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 666 ~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
....+........+...+..+.+|+.+||..+|.+||++. +++..|..+.
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~il~~l~~~~ 281 (303)
T cd05088 232 -LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRML 281 (303)
T ss_pred -HHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHH
Confidence 1111111111223344567899999999999999999998 4666665543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.13 Aligned_cols=263 Identities=21% Similarity=0.270 Sum_probs=204.8
Q ss_pred hhcCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecC-------CC
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------HG 516 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-------~~ 516 (802)
..+.|.+.+.||+|||+-||.+.. .+..||+|++......+.+..++|++..++++|||+++++.++.. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 345688999999999999999874 456899999888777788889999999999999999999998721 13
Q ss_pred eEEEEEccCCCHHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccc
Q 003694 517 CLVYEYMENGSLEDRLYRKNN-TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~ 595 (802)
||++.|...|||.+.+..... +..++..+.++|+.+|++||.+||...| |+.||||||.|||+.+.+.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence 899999999999999976433 3468999999999999999999999984 89999999999999999999999999998
Q ss_pred cccCCC---CcccccccccCCccCcccCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhH
Q 003694 596 MLNSDP---SFVSTTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 669 (802)
Q Consensus 596 ~~~~~~---~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~ 669 (802)
...-.. ..............|..|.|||.+.- ...+.++|||||||+||.|+.|..||.-.-. ..+.+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----~GgSla 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----QGGSLA 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----cCCeEE
Confidence 765221 11111122344578999999998753 4578999999999999999999999952110 112221
Q ss_pred HHhhhhCCCCC--hHHHHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 670 EILDAQAGDWP--IKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 670 ~~ld~~~~~~p--~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
-.+....-.|| ...++.+.+|+..|++.||.+||++.+ ++..++.
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~-ll~~~d~ 299 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPE-LLSKLDD 299 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHH-HHHHHHh
Confidence 11111111122 126889999999999999999999984 5544443
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=316.81 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=196.0
Q ss_pred hhcCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecC---C--C--
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD---H--G-- 516 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~---~--~-- 516 (802)
.+..|...+.+|.|+||.||+|.... ..||||..-.+.... .+|+.+|++++|||||+|+-+|.. . .
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 44568888999999999999999864 489999876554322 369999999999999999988731 1 2
Q ss_pred eEEEEEccCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC-ceeEEeeeccc
Q 003694 517 CLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLS 594 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~-~~~kl~DFGla 594 (802)
.||||||+ .+|...+... .....++...+.-+.+||++||.|||+.+ |+||||||.|||+|.+ |.+||||||.|
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 58999998 4898888642 12234777788889999999999999988 9999999999999976 99999999999
Q ss_pred ccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch--------
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-------- 665 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~-------- 665 (802)
+.+...... .+...|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+.+.+...-
T Consensus 174 K~L~~~epn-------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 174 KVLVKGEPN-------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred eeeccCCCc-------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 998765543 23467899999997654 56999999999999999999999999865544433211
Q ss_pred -hhhHHHhh-------hhC--CC----CChHHHHHHHHHHHHhhccccCCCCccccchh-hHHHHHHHh
Q 003694 666 -DNLAEILD-------AQA--GD----WPIKETKELAALGLSCAELRRKDRPDLKNQVL-PVLERLKEV 719 (802)
Q Consensus 666 -~~l~~~ld-------~~~--~~----~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~-~~L~~l~~~ 719 (802)
+.+..+-- +.. .. +....++++.+|+.+++.++|..|.+..+.+. +..+.|++.
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 00000000 000 11 22345788999999999999999999875332 345555543
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.90 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=203.3
Q ss_pred hcCCcccceecCCCcEEEEEEEECC------eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecC---CC
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD---HG 516 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~------~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~---~~ 516 (802)
.++|.....||+|+||.||+|.+.. ..|++|.+.... ......+.+|+.+|++++||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888899999999999999754 588999876543 2335668899999999999999999998754 34
Q ss_pred eEEEEEccCCCHHHHhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeee
Q 003694 517 CLVYEYMENGSLEDRLYRKNNT-----PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 591 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DF 591 (802)
+++++|+++|+|.+++...... ..+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998754322 46899999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHH
Q 003694 592 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAE 670 (802)
Q Consensus 592 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~ 670 (802)
|+++.+....... ......++..|+|||++.+..++.++||||||+++|++++ |++||....... +..
T Consensus 162 g~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~ 230 (280)
T cd05043 162 ALSRDLFPMDYHC----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAA 230 (280)
T ss_pred CCcccccCCceEE----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------HHH
Confidence 9998664332111 1122356778999999988889999999999999999999 999996432211 111
Q ss_pred Hh-hhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHH
Q 003694 671 IL-DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 671 ~l-d~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
.+ +......+..++..+.+++.+||..+|.+||++. +++..|+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~~~~l~~~~ 277 (280)
T cd05043 231 YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFS-QLVQCLTDFH 277 (280)
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHH
Confidence 11 1112223445567899999999999999999998 5777776654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.76 Aligned_cols=256 Identities=24% Similarity=0.417 Sum_probs=198.9
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC-------CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC-
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 516 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~- 516 (802)
...+|....+||+|+||.||+|... +..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999999753 23799998764432 23346889999999999999999999986544
Q ss_pred -eEEEEEccCCCHHHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEE
Q 003694 517 -CLVYEYMENGSLEDRLYRKN-------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 588 (802)
Q Consensus 517 -~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl 588 (802)
++||||+++|+|.+++.... ..+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 89999999999999997532 1244677788999999999999999988 999999999999999999999
Q ss_pred eeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhh
Q 003694 589 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 667 (802)
Q Consensus 589 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 667 (802)
+|||+++......... ......++..|+|||++.++.++.++|||||||++|||++ |.+||...... +.
T Consensus 161 ~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~ 230 (288)
T cd05061 161 GDFGMTRDIYETDYYR----KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QV 230 (288)
T ss_pred CcCCcccccccccccc----ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HH
Confidence 9999998654322111 1122345778999999998899999999999999999999 78888543211 11
Q ss_pred hHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 668 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 668 l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
+..+.+......+...+..+.+++.+|++.+|.+||++. +++..|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~ll~~l~~ 277 (288)
T cd05061 231 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFL-EIVNLLKD 277 (288)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHh
Confidence 112222222333445568899999999999999999998 45555443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.76 Aligned_cols=250 Identities=27% Similarity=0.433 Sum_probs=199.5
Q ss_pred cCCcccceecCCCcEEEEEEEECCe-EEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEEEEccC
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 525 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~~-~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~Ey~~~ 525 (802)
..|....+||+|+||.||+|.+.+. .+|+|.+.... .....|.+|+.++++++|||++++++++.+.. ++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 3577788999999999999988653 78999876543 34567899999999999999999999886544 899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05069 85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc--
Confidence 99999987543 345889999999999999999999988 999999999999999999999999999876432211
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 684 (802)
......++..|+|||+..++.++.++||||||+++|+|+| |+.||....... .+..+........+...+
T Consensus 159 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 229 (260)
T cd05069 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------VLEQVERGYRMPCPQGCP 229 (260)
T ss_pred ---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCcccC
Confidence 1123356788999999988889999999999999999999 899986432211 111121111222344567
Q ss_pred HHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 685 KELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
..+.+++.+||..+|.+||++. .|.+.|+
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~ 258 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFE-YIQSFLE 258 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHH-HHHHHHh
Confidence 8899999999999999999998 5666654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.53 Aligned_cols=255 Identities=22% Similarity=0.373 Sum_probs=201.6
Q ss_pred cCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
.+|.....||+|+||.||+|+. .++.||||.+.... ......|.+|+.+++.++||||+++++++.+.. ++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688889999999999999987 46799999876432 223456889999999999999999999886543 8999
Q ss_pred EEccCCCHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 521 EYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
||+++|+|.+++.... ....++...+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886422 2345788899999999999999999988 99999999999999999999999999987653
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh-hCCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGD 678 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~-~~~~ 678 (802)
... ......|++.|+|||++.+..++.++|+||||+++|+|+||+.||...... ...+...+.. ..+.
T Consensus 159 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~ 227 (267)
T cd08228 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LFSLCQKIEQCDYPP 227 (267)
T ss_pred hhH------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-----HHHHHHHHhcCCCCC
Confidence 221 112346889999999998888999999999999999999999998533211 0111111111 1111
Q ss_pred C-ChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHH
Q 003694 679 W-PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 679 ~-p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
. +...+..+.+++.+||..+|.+||++. +|+..|+.++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~vl~~~~~~~ 266 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIG-YVHQIAKQMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHH-HHHHHHHHhc
Confidence 1 224567899999999999999999999 6877777653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.07 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=198.0
Q ss_pred cCCcccceecCCCcEEEEEEEECC------------------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeee
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH------------------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLL 508 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~------------------~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l 508 (802)
..|....+||+|+||.||++.+.. ..||+|++..... .....|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467888899999999999988643 3589999876543 345678999999999999999999
Q ss_pred cceecCCC--eEEEEEccCCCHHHHhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCe
Q 003694 509 LGACPDHG--CLVYEYMENGSLEDRLYRKN--------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNI 578 (802)
Q Consensus 509 ~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NI 578 (802)
+++|.+.. ++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 99986543 89999999999999987543 1235899999999999999999999988 99999999999
Q ss_pred EecCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh--CCCCcccc
Q 003694 579 LLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT 656 (802)
Q Consensus 579 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt--g~~p~~~~ 656 (802)
|++.++.++|+|||+++......... ......+++.|+|||++.++.++.++|||||||++|+|++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYR----VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eecCCCceEEccccceeecccCccee----ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 99999999999999998654332111 1233456789999999988889999999999999999998 67777533
Q ss_pred chhhhhhchhhhHHHhh----hhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 657 HKVETAIDEDNLAEILD----AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 657 ~~~~~~~~~~~l~~~ld----~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
...+. +. ....... ......+...+..+.+|+.+|++.+|.+||++. +++..|+
T Consensus 238 ~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~-el~~~L~ 295 (296)
T cd05051 238 TDQQV-IE--NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR-EIHLFLQ 295 (296)
T ss_pred ChHHH-HH--HHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHH-HHHHHhc
Confidence 21111 00 0000100 001122334567899999999999999999998 4655553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=304.76 Aligned_cols=256 Identities=29% Similarity=0.420 Sum_probs=203.8
Q ss_pred hcCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCccc-------hHHHHHHHHHHHhcCCCceeeeccee---cC
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQ-------NKQFLQELEVLSKIRHPHLLLLLGAC---PD 514 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~-------~~~~~~Ei~il~~l~Hpniv~l~g~~---~~ 514 (802)
...|-....||+|||+.||++.+ .++.||||+-..+.... .+...+|..|-+.|+||.||++|++| .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 34566677899999999999986 46799999866543221 12357899999999999999999998 34
Q ss_pred CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC---CceeEEeee
Q 003694 515 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDV 591 (802)
Q Consensus 515 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~---~~~~kl~DF 591 (802)
..|-|+|||+|.+|+-+|.... .++......|+.||+.||.||...+ .||||-||||.||||-. -|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 5599999999999998886543 3888999999999999999999988 58999999999999944 488999999
Q ss_pred cccccccCCCCc-ccccccccCCccCcccCCccccccC----CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchh
Q 003694 592 GLSTMLNSDPSF-VSTTYKNTGPVGTLCYIDPEYQRTG----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 666 (802)
Q Consensus 592 Gla~~~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~ 666 (802)
||++++.++... ...........||.+|++||++.-+ ..+.++||||.|||+|+.|.|+.||+........+..+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 999999865433 2222234567999999999987644 47889999999999999999999999776666666665
Q ss_pred hhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 667 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 667 ~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+........+..| ....+...+|.+||++..++|.+..+
T Consensus 698 TIlkAtEVqFP~KP-vVsseAkaFIRRCLaYRKeDR~DV~q 737 (775)
T KOG1151|consen 698 TILKATEVQFPPKP-VVSSEAKAFIRRCLAYRKEDRIDVQQ 737 (775)
T ss_pred chhcceeccCCCCC-ccCHHHHHHHHHHHHhhhhhhhhHHH
Confidence 54443333223222 45678899999999999999988763
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=311.86 Aligned_cols=251 Identities=26% Similarity=0.428 Sum_probs=200.1
Q ss_pred hcCCcccceecCCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCC-CeEEEEEcc
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYME 524 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-~~lV~Ey~~ 524 (802)
.++|...++||+|+||.||+|... +..||+|.+..... ....|.+|+.++++++||||+++++++.+. .++||||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCC
Confidence 356788899999999999999874 46899999875433 456789999999999999999999988544 489999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05067 84 NGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-
Confidence 999999886543 345889999999999999999999988 999999999999999999999999999876532211
Q ss_pred cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
......++..|+|||++.++.++.++||||||+++|+|++ |++||....... ....+........+...
T Consensus 159 ----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 228 (260)
T cd05067 159 ----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------VIQNLERGYRMPRPDNC 228 (260)
T ss_pred ----cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------HHHHHHcCCCCCCCCCC
Confidence 1123356788999999998889999999999999999999 999996432211 11111111112223345
Q ss_pred HHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
+..+.+++.+|+..+|.+||++. .+...|+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~ 258 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFE-YLRSVLE 258 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHH-HHHHHhh
Confidence 67899999999999999999998 4665554
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=336.43 Aligned_cols=243 Identities=23% Similarity=0.285 Sum_probs=188.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
+|...++||+|+||.||++... +..||||++.... ......+.+|+.+|.+++||||+++++.+.+.. |+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888899999999999999875 5689999986432 223456789999999999999999999987655 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+++|+|.+++...+ .++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999986543 4788888889999999999999988 9999999999999999999999999985432100
Q ss_pred Cc-------------------------------------ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHH
Q 003694 602 SF-------------------------------------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVIL 644 (802)
Q Consensus 602 ~~-------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ 644 (802)
.. ...........||+.|+|||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00 00000112457999999999999889999999999999999
Q ss_pred HHHhCCCCccccchhhhhhchhhhHHHhhhh---CCCCChHHHHHHHHHHHHhhccccCCCCc
Q 003694 645 QLLTAKPAIAITHKVETAIDEDNLAEILDAQ---AGDWPIKETKELAALGLSCAELRRKDRPD 704 (802)
Q Consensus 645 elltg~~p~~~~~~~~~~~~~~~l~~~ld~~---~~~~p~~~~~~l~~li~~Cl~~~p~~RP~ 704 (802)
+|+||+.||......+.. ..+.... ........+..+.+++.+|+ .+|.+|+.
T Consensus 236 ell~G~~Pf~~~~~~~~~------~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 236 EMLVGQPPFLADTPAETQ------LKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred ehhhCCCCCCCCCHHHHH------HHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 999999999754432211 1111100 00111234667888888876 49999994
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.34 Aligned_cols=257 Identities=25% Similarity=0.378 Sum_probs=197.8
Q ss_pred cCCcccceecCCCcEEEEEEEE-------CCeEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeecceecCC---
Q 003694 448 LSFSENLRIGMGGYGTVYKGTF-------HHTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH--- 515 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~-------~~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~--- 515 (802)
.+|...+.||+|+||.||+|.+ .++.||||+++.... .....+.+|+.+|.++ +||||++++++|...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688889999999999999974 245899999875432 2345688999999999 689999999988543
Q ss_pred CeEEEEEccCCCHHHHhhhcCC----------------------------------------------------------
Q 003694 516 GCLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 537 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 537 (802)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 3799999999999999864321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccccccc
Q 003694 538 ------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 611 (802)
Q Consensus 538 ------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 611 (802)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~----~~~ 239 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----RKG 239 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchh----hcC
Confidence 123678888999999999999999988 9999999999999999999999999998764332111 112
Q ss_pred CCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHHHH
Q 003694 612 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAAL 690 (802)
Q Consensus 612 ~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~l 690 (802)
...+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ....+........|...+..+.++
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 314 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTRMRAPDYTTPEMYQT 314 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-----HHHHHhccCCCCCCCCCCHHHHHH
Confidence 2346678999999988889999999999999999997 9999854321111 111111111122233345679999
Q ss_pred HHHhhccccCCCCccccchhhHHHHHH
Q 003694 691 GLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 691 i~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
+.+||+.+|.+||++. +++..|+.+.
T Consensus 315 ~~~cl~~~p~~Rps~~-eil~~l~~~~ 340 (343)
T cd05103 315 MLDCWHGEPSQRPTFS-ELVEHLGNLL 340 (343)
T ss_pred HHHHccCChhhCcCHH-HHHHHHHHHH
Confidence 9999999999999999 5777776654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=329.96 Aligned_cols=240 Identities=26% Similarity=0.392 Sum_probs=203.7
Q ss_pred cceecCCCcEEEEEEEECC-----eEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecCCC-eEEEEEccC
Q 003694 453 NLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 525 (802)
Q Consensus 453 ~~~iG~G~~g~Vy~~~~~~-----~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~Ey~~~ 525 (802)
.++||+|.||.|++|.|+. -.||||.+..+... ...+|++|+.+|.+|+|||+++|||...+.. .||||+++.
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELapl 194 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPL 194 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhccc
Confidence 3569999999999999963 37999999887654 5678999999999999999999999998765 799999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|||.++|.+ .....|.....+.++.|||.|+.||.+.+ +|||||-..||||-....+|||||||.+-+....+..
T Consensus 195 GSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y- 269 (1039)
T KOG0199|consen 195 GSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY- 269 (1039)
T ss_pred chHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcce-
Confidence 999999987 44566888899999999999999999988 9999999999999999999999999999998766543
Q ss_pred cccccc-CCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhh-hCCCCChH
Q 003694 606 TTYKNT-GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIK 682 (802)
Q Consensus 606 ~~~~~~-~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~ 682 (802)
.+. ...-.+.|+|||.++...++.++|||+|||+||||+| |.-||.... .-.+.+.+|. .....|..
T Consensus 270 ---vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-------g~qIL~~iD~~erLpRPk~ 339 (1039)
T KOG0199|consen 270 ---VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-------GIQILKNIDAGERLPRPKY 339 (1039)
T ss_pred ---EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-------HHHHHHhccccccCCCCCC
Confidence 222 2244678999999999999999999999999999999 677774332 2223334442 23567888
Q ss_pred HHHHHHHHHHHhhccccCCCCcccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+++.+++++..||..+|.+||++..
T Consensus 340 csedIY~imk~cWah~paDRptFsa 364 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSA 364 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHH
Confidence 9999999999999999999999994
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.08 Aligned_cols=245 Identities=31% Similarity=0.537 Sum_probs=199.9
Q ss_pred eecCCCcEEEEEEEEC-----CeEEEEEEEcccCccc-hHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~-----~~~vavK~l~~~~~~~-~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||+|... +..+++|++....... ...+.+|+.++..++||||+++++++.+.. ++||||+++|
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 6999999999999886 6689999988664433 677899999999999999999999987644 8999999999
Q ss_pred CHHHHhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 527 SLEDRLYRKNN------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 527 sL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999876421 256899999999999999999999988 999999999999999999999999999887654
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
... .......+++.|+|||.+....++.++||||||+++|+|++ |..||...... ..+..+........
T Consensus 159 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~ 228 (262)
T cd00192 159 DYY----RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLEYLRKGYRLPK 228 (262)
T ss_pred ccc----ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCCCC
Confidence 321 11234567899999999988889999999999999999999 69999644221 11222222223344
Q ss_pred ChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
|...+..+.+++.+|+..+|.+||++. +++..|
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~-~l~~~l 261 (262)
T cd00192 229 PEYCPDELYELMLSCWQLDPEDRPTFS-ELVERL 261 (262)
T ss_pred CccCChHHHHHHHHHccCCcccCcCHH-HHHHhh
Confidence 556678999999999999999999998 454443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=334.33 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=188.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
.|...++||+|+||.||+|... +..||+|++.... ......+.+|+.+|++++||||++++++|.+.. +||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999875 5689999987542 223456889999999999999999999997655 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+++|+|.+++.+.+ .++......++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999886543 4788888899999999999999998 9999999999999999999999999986432110
Q ss_pred Ccc-----------------------------------------cccccccCCccCcccCCccccccCCCCCcccchhHH
Q 003694 602 SFV-----------------------------------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYG 640 (802)
Q Consensus 602 ~~~-----------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlG 640 (802)
... ..........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 000 000011234799999999999988999999999999
Q ss_pred HHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh-CCCCC--hHHHHHHHHHHHHhhccccCCCCc
Q 003694 641 MVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWP--IKETKELAALGLSCAELRRKDRPD 704 (802)
Q Consensus 641 vil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p--~~~~~~l~~li~~Cl~~~p~~RP~ 704 (802)
|+||||+||++||......+. ...++... ....| ...+..+.+++.+|+. +|.+|++
T Consensus 236 vil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~ 295 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLET------QMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLG 295 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHH------HHHHHccCCCcCCCCcccCCHHHHHHHHHHcc-CHhHcCC
Confidence 999999999999975433221 11111110 01111 2346778888888764 9999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=309.84 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=202.2
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|...+.||+|+||.||+|... +..||+|.++... ......+.+|+.++++++|+|++++++++.+.. ++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999985 6789999876422 223567899999999999999999999986554 8999
Q ss_pred EEccCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 521 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
||+++|+|.+++... .....+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988643 22345889999999999999999999998 99999999999999999999999999886543
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
.... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||........ .....+........
T Consensus 159 ~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~ 228 (267)
T cd08224 159 KTTA------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCKKIEKCDYPPL 228 (267)
T ss_pred CCcc------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH----HHHhhhhcCCCCCC
Confidence 2211 1234688999999999888899999999999999999999999853321000 00011111111222
Q ss_pred Ch-HHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 680 PI-KETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 680 p~-~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
|. ..+..+.+++.+||..+|.+||++. .|+..|+.+
T Consensus 229 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~-~il~~~~~~ 265 (267)
T cd08224 229 PADHYSEELRDLVSRCINPDPEKRPDIS-YVLQVAKEM 265 (267)
T ss_pred ChhhcCHHHHHHHHHHcCCCcccCCCHH-HHHHHHHHh
Confidence 33 4567899999999999999999998 577776655
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.99 Aligned_cols=245 Identities=26% Similarity=0.376 Sum_probs=195.9
Q ss_pred eecCCCcEEEEEEEECC---e--EEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEEEEccCCC
Q 003694 455 RIGMGGYGTVYKGTFHH---T--FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGS 527 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~---~--~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~Ey~~~gs 527 (802)
+||+|+||.||+|.+.. + .||+|.+..... ...+.|.+|+.++++++||||+++++.+.+.. ++||||+++|+
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~ 81 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGS 81 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCc
Confidence 68999999999998743 2 689999887655 55678999999999999999999999987633 89999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccc
Q 003694 528 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607 (802)
Q Consensus 528 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 607 (802)
|.+++..... ..+++.....++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++..+........
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~-- 155 (257)
T cd05040 82 LLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV-- 155 (257)
T ss_pred HHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee--
Confidence 9999876543 46899999999999999999999988 99999999999999999999999999988764322111
Q ss_pred ccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHh-hhhCCCCChHHHH
Q 003694 608 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL-DAQAGDWPIKETK 685 (802)
Q Consensus 608 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~l-d~~~~~~p~~~~~ 685 (802)
......++..|+|||++.+..++.++|||||||++|+|+| |+.||......+. +..+. .......+...+.
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 228 (257)
T cd05040 156 -MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI------LKKIDKEGERLERPEACPQ 228 (257)
T ss_pred -cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhcCCcCCCCccCCH
Confidence 1123467889999999998889999999999999999999 9999953322111 11111 1111223344567
Q ss_pred HHHHHHHHhhccccCCCCccccchhhHH
Q 003694 686 ELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 686 ~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
.+.+++.+|+..+|.+||++.+ ++..|
T Consensus 229 ~~~~li~~~l~~~p~~Rps~~~-~~~~l 255 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTFAA-LREFL 255 (257)
T ss_pred HHHHHHHHHCCCCcccCCCHHH-HHHHh
Confidence 8999999999999999999984 54443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.32 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=200.8
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC-------CeEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeecceecCCC
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 516 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~-------~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~ 516 (802)
..++|...+.||+|+||.||++... ...+|||++.... ......+.+|+.+++++ +||||++++++|....
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457888999999999999999752 2378999887543 23345789999999999 7999999999986554
Q ss_pred --eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccc
Q 003694 517 --CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594 (802)
Q Consensus 517 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla 594 (802)
++||||+++|+|.+++..... ..+++..+..|+.+++.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 899999999999999875432 34899999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhh
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD 673 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld 673 (802)
+......... ......++..|+|||++..+.++.++|||||||++|+|+| |.+||...... ..+...+.
T Consensus 189 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~~~~~~ 258 (302)
T cd05055 189 RDIMNDSNYV----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKFYKLIK 258 (302)
T ss_pred ccccCCCcee----ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHHHHHHH
Confidence 8665432111 1122356788999999988889999999999999999998 99998533211 11112222
Q ss_pred hh-CCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 674 AQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 674 ~~-~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
.. ....+...+..+.+++.+|+..+|.+||++. +++..|+.
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ell~~l~~ 300 (302)
T cd05055 259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFK-QIVQLIGK 300 (302)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHHh
Confidence 11 1122334467899999999999999999999 57666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.64 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=199.5
Q ss_pred hcCCcccceecCCCcEEEEEEEEC-------CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 516 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-- 516 (802)
.++|.....||+|+||.||++... +..||+|++..... .....|.+|+.+++.++||||++++++|.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888899999999999999863 46899999875432 33467899999999999999999999986544
Q ss_pred eEEEEEccCCCHHHHhhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 003694 517 CLVYEYMENGSLEDRLYRKN-------------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 577 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~N 577 (802)
++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 89999999999999986421 1234788899999999999999999988 9999999999
Q ss_pred eEecCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCcccc
Q 003694 578 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAIT 656 (802)
Q Consensus 578 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~ 656 (802)
||++.++.+||+|||++..+....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYK----ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCcccc----ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999987654322110 0122245678999999988899999999999999999998 88888533
Q ss_pred chhhhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 657 HKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 657 ~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
... ..+..+.+......|...+..+.+|+.+|++.+|.+||++. +++..|+
T Consensus 237 ~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~-el~~~l~ 287 (288)
T cd05050 237 AHE------EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFA-SINRILQ 287 (288)
T ss_pred CHH------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHH-HHHHHhh
Confidence 211 11122222222223445568899999999999999999998 4666664
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.62 Aligned_cols=248 Identities=23% Similarity=0.287 Sum_probs=188.2
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|+..+.||+|+||.||++... +..||||++.... ......+.+|+.++..++||||+++++.+.+.. ||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888899999999999999875 5689999987532 223356788999999999999999999997655 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999987543 4889999999999999999999988 999999999999999999999999999865421
Q ss_pred CCcc-----------------------------cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCC
Q 003694 601 PSFV-----------------------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 651 (802)
Q Consensus 601 ~~~~-----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~ 651 (802)
.... .........+||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1000 00000124579999999999998899999999999999999999999
Q ss_pred CccccchhhhhhchhhhHHHhhhh-CCCCC--hHHHHHHHHHHHHhhc--cccCCCCcccc
Q 003694 652 AIAITHKVETAIDEDNLAEILDAQ-AGDWP--IKETKELAALGLSCAE--LRRKDRPDLKN 707 (802)
Q Consensus 652 p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p--~~~~~~l~~li~~Cl~--~~p~~RP~~~~ 707 (802)
||......+. +..+.... ....| ......+.+++.+++. .++..||++.+
T Consensus 235 Pf~~~~~~~~------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~e 289 (363)
T cd05628 235 PFCSETPQET------YKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEE 289 (363)
T ss_pred CCCCCCHHHH------HHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHH
Confidence 9964432211 11121110 01111 1235677788877443 23335677663
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.15 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=198.7
Q ss_pred HHHhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eE
Q 003694 443 IESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 443 i~~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~l 518 (802)
++.+++++.....||+|+||.||+|.+. +..|++|.+..........+.+|+.++++++||||++++++|.+.. ++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4556778888889999999999999875 4579999887666556678999999999999999999999986654 89
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC-CceeEEeeecccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTML 597 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~-~~~~kl~DFGla~~~ 597 (802)
||||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999875432211277788899999999999999988 999999999999976 689999999999766
Q ss_pred cCCCCcccccccccCCccCcccCCccccccCC--CCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~ 675 (802)
..... ......|++.|+|||++.+.. ++.++||||||+++|+|++|++||.......... ........
T Consensus 160 ~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~~~~~~~ 229 (268)
T cd06624 160 AGINP------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FKVGMFKI 229 (268)
T ss_pred ccCCC------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hhhhhhcc
Confidence 43221 112346889999999986544 7889999999999999999999996332111110 00011112
Q ss_pred CCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 676 AGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 676 ~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..|......+.+++.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 261 (268)
T cd06624 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHD 261 (268)
T ss_pred CCCCCcccCHHHHHHHHHHcCCCchhCCCHHH
Confidence 23445566788999999999999999999984
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.82 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=190.4
Q ss_pred eecCCCcEEEEEEEEC-----CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecC-C--CeEEEEEccC
Q 003694 455 RIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD-H--GCLVYEYMEN 525 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~-----~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~--~~lV~Ey~~~ 525 (802)
.||+|+||.||+|.+. ...+|+|.+.... ......|.+|+.+++.++||||++++++|.. . .++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5899999999999863 2479999875432 2345678899999999999999999998742 2 3899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+........
T Consensus 82 ~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 82 GDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999865432 3677788899999999999999988 99999999999999999999999999986543221100
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhC-CCCccccchhhhhhchhhhHHHhhhhCCCCChHHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 684 (802)
.......+++.|+|||++.+..++.++|||||||++|||+|| .+||....... ....+........+...+
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 228 (262)
T cd05058 157 --HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD------ITVYLLQGRRLLQPEYCP 228 (262)
T ss_pred --cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHhcCCCCCCCCcCC
Confidence 111234567889999999888899999999999999999995 66664322111 111111211222333446
Q ss_pred HHHHHHHHHhhccccCCCCccccchhhHHHHHH
Q 003694 685 KELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
..+.+++.+||..+|.+||++. +++..|+.+.
T Consensus 229 ~~~~~li~~cl~~~p~~Rp~~~-~il~~l~~~~ 260 (262)
T cd05058 229 DPLYEVMLSCWHPKPEMRPTFS-ELVSRIEQIF 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHh
Confidence 7899999999999999999998 5777776553
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.05 Aligned_cols=247 Identities=23% Similarity=0.364 Sum_probs=193.3
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCc-eeeecceecC--------
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPH-LLLLLGACPD-------- 514 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~Hpn-iv~l~g~~~~-------- 514 (802)
..|....+||+|.||+||+|+.. +..||+|++...... ......+|+.+|++++|+| ||.|++++..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34666678999999999999875 568999998765442 3345689999999999999 9999999854
Q ss_pred CCeEEEEEccCCCHHHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 515 HGCLVYEYMENGSLEDRLYRKNNT-PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 515 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
..+|||||++ .+|.+++...... ..++...+..++.||+.||+|||+++ |+||||||.||||+.+|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 2368999996 6999998765422 34666789999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHh
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 672 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~l 672 (802)
|+...-... ..+..++|..|.|||++.+. .|++..||||+|||+.||+++++-|......++... +.+++
T Consensus 167 Ara~~ip~~------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~---If~~l 237 (323)
T KOG0594|consen 167 ARAFSIPMR------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR---IFRLL 237 (323)
T ss_pred HHHhcCCcc------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH---HHHHc
Confidence 996652221 13556899999999988766 699999999999999999999999976655443211 11111
Q ss_pred hhh-CCCCCh------------------H-------HHHHHHHHHHHhhccccCCCCcccc
Q 003694 673 DAQ-AGDWPI------------------K-------ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 673 d~~-~~~~p~------------------~-------~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
... ...||. . ......+++.+|++.+|.+|.++..
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~ 298 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKG 298 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHH
Confidence 111 011221 1 1147889999999999999999874
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.37 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=197.8
Q ss_pred CCcccceecCCCcEEEEEEEECC-----eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~-----~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
.|...+.||+|+||.||+|.+.. ..||||++.... ......|..|+.+++.++||||+++++++.+.. ++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999998753 369999987542 334567999999999999999999999986554 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999886543 34889999999999999999999988 999999999999999999999999999876543
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
...... ........+..|+|||++.++.++.++|||||||++|||++ |..||....... ....+........
T Consensus 160 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~------~~~~i~~~~~~~~ 232 (269)
T cd05065 160 TSDPTY-TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VINAIEQDYRLPP 232 (269)
T ss_pred cccccc-ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH------HHHHHHcCCcCCC
Confidence 221110 00111123467999999998999999999999999999887 999985432211 1111111111223
Q ss_pred ChHHHHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
+...+..+.+++.+||..+|.+||++. .++..|+.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 267 (269)
T cd05065 233 PMDCPTALHQLMLDCWQKDRNARPKFG-QIVSTLDK 267 (269)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHh
Confidence 445567899999999999999999998 56666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=319.49 Aligned_cols=258 Identities=22% Similarity=0.390 Sum_probs=201.2
Q ss_pred cCCcccceecCCCcEEEEEEEEC---------CeEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeecceecCCC
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 516 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~---------~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~ 516 (802)
.+|...++||+|+||.||++... ...+|+|++.... ......+.+|+.++..+ +||||++++++|.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778889999999999999752 2468999887543 23345688999999999 6999999999987554
Q ss_pred --eEEEEEccCCCHHHHhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEec
Q 003694 517 --CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 581 (802)
Q Consensus 517 --~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~ 581 (802)
++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 899999999999999965321 235889999999999999999999988 99999999999999
Q ss_pred CCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhh
Q 003694 582 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVE 660 (802)
Q Consensus 582 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~ 660 (802)
.++.+||+|||+++......... ......++..|+|||++.++.++.++|||||||++|+|+| |..||......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~- 243 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYK----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE- 243 (314)
T ss_pred CCCcEEEcccccccccccccccc----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999998765322111 0112234568999999988889999999999999999999 88888533211
Q ss_pred hhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHHh
Q 003694 661 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 719 (802)
Q Consensus 661 ~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~ 719 (802)
. .+..+........+..++..+.+++.+|+..+|.+||++. +++..|+.+...
T Consensus 244 ~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~ll~~l~~~~~~ 296 (314)
T cd05099 244 E-----LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK-QLVEALDKVLAA 296 (314)
T ss_pred H-----HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHHHH
Confidence 1 1111111112233455677899999999999999999998 577787776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=314.45 Aligned_cols=258 Identities=21% Similarity=0.366 Sum_probs=197.5
Q ss_pred CCcccceecCCCcEEEEEEEEC------CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCC----Ce
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GC 517 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~~ 517 (802)
.|...+.||+|+||.||++.++ +..||+|.+.... ......|.+|+.+|+.++||||++++++|.+. .+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4677889999999999999753 4589999987543 33346789999999999999999999998653 37
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~ 597 (802)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 9999999999999886543 34899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhh--------hchhhhH
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA--------IDEDNLA 669 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~--------~~~~~l~ 669 (802)
........ ......++..|+|||++.+..++.++|||||||++|+|+|++.|+......... .......
T Consensus 160 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 160 ETDKEYYT---VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccCcccee---ecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 54322110 112345778899999998888999999999999999999988765322110000 0000111
Q ss_pred HHhhh-hCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 670 EILDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 670 ~~ld~-~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
..+.. .....+...+..+.+|+.+||+.+|.+||++. .++..|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il~~l~~ 282 (284)
T cd05079 237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQ-NLIEGFEA 282 (284)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHH-HHHHHHHh
Confidence 11111 11122334578899999999999999999998 46666554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=315.69 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=192.8
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
|...+.||+|+||.||++.+. ++.||||.+...... ....+.+|+.++.+++|+|++.+++.+.+.. |+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999886 458999988654322 2345778999999999999999999986544 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999998865432 35888999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 682 (802)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .......++.......+..
T Consensus 158 -------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05630 158 -------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEVERLVKEVQEEYSEK 227 (285)
T ss_pred -------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHHHhhhhhhhhhcCcc
Confidence 123478999999999998999999999999999999999999996432110 1111122222212223344
Q ss_pred HHHHHHHHHHHhhccccCCCCcc
Q 003694 683 ETKELAALGLSCAELRRKDRPDL 705 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~ 705 (802)
.+..+.+|+.+||+.+|.+||++
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCC
Confidence 56778999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=322.40 Aligned_cols=243 Identities=25% Similarity=0.281 Sum_probs=186.6
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|...+.||+|+||.||++... ++.||+|++.... ......|.+|+.++..++||||+.++++|.+.. |+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888899999999999999875 5689999986421 223455889999999999999999999987654 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999986533 34888899999999999999999998 999999999999999999999999999765433
Q ss_pred CCcccccccccCCccCcccCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~ 675 (802)
... ......||+.|+|||++.. +.++.++|||||||++|+|++|+.||......+. +..++...
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~ 224 (331)
T cd05597 156 GTV-----QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHK 224 (331)
T ss_pred CCc-----cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCC
Confidence 211 1123469999999998863 4578899999999999999999999964332211 11111111
Q ss_pred ----CCCCChHHHHHHHHHHHHhhcccc--CCCCccc
Q 003694 676 ----AGDWPIKETKELAALGLSCAELRR--KDRPDLK 706 (802)
Q Consensus 676 ----~~~~p~~~~~~l~~li~~Cl~~~p--~~RP~~~ 706 (802)
........+..+.+++.+|+..++ ..||++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~ 261 (331)
T cd05597 225 EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQ 261 (331)
T ss_pred CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 011112346778889988776433 3366665
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=312.26 Aligned_cols=245 Identities=28% Similarity=0.438 Sum_probs=190.4
Q ss_pred eecCCCcEEEEEEEECCe----EEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMGGYGTVYKGTFHHT----FAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~~----~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||+|+||.||+|.+.++ .+++|.+.... ......|.+|+.++.++ +||||++++++|.... ++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 589999999999987542 46888776432 33446788999999999 7999999999996654 8999999999
Q ss_pred CHHHHhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 527 SLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 527 sL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 9999986532 1234789999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHh
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 672 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~l 672 (802)
+....... .......++.|+|||++....++.++|||||||++|+|+| |..||...... ..+..+.
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~ 225 (270)
T cd05047 159 SRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLP 225 (270)
T ss_pred ccccchhh-------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHHh
Confidence 86432110 1112234677999999988889999999999999999997 99999533211 1111111
Q ss_pred hhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 673 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 673 d~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
.......+...+..+.+|+.+|+..+|.+||++. +++..|+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~l~~~ 268 (270)
T cd05047 226 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRM 268 (270)
T ss_pred CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHH-HHHHHHHHh
Confidence 1111223344567899999999999999999999 566666654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=328.65 Aligned_cols=243 Identities=24% Similarity=0.291 Sum_probs=194.6
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|....+||+|+||.||++... +..||+|++..... .....+..|+.++..++||||+++++++.+.. ++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999875 56899999875422 23456889999999999999999999986554 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999987642 34889999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcccccccccCCccCcccCCccccc------cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQR------TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 674 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~ 674 (802)
... ......||+.|+|||++. ...++.++|||||||++|+|+||+.||....... .+..++..
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~ 224 (330)
T cd05601 156 KMV-----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNF 224 (330)
T ss_pred Cce-----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcC
Confidence 211 123347899999999886 4567899999999999999999999996443221 11222221
Q ss_pred h-CCCCC--hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 675 Q-AGDWP--IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 675 ~-~~~~p--~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. ...+| ...+..+.+|+.+|+. +|.+||++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~ 259 (330)
T cd05601 225 QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEG 259 (330)
T ss_pred CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHH
Confidence 1 11122 2356788999999998 9999999884
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=322.00 Aligned_cols=243 Identities=24% Similarity=0.320 Sum_probs=187.6
Q ss_pred cCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|....+||+|+||.||++.+.+ ..+|+|++.... ......|..|+.++..++||||+.+++++.+.. ++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368888999999999999999864 589999986421 222345788999999999999999999986554 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999997533 24888889999999999999999988 999999999999999999999999999765432
Q ss_pred CCcccccccccCCccCcccCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~ 675 (802)
... ......||+.|+|||++. .+.++.++|||||||+||||++|+.||......+. +..++...
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~ 224 (332)
T cd05623 156 GTV-----QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHK 224 (332)
T ss_pred Ccc-----eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCC
Confidence 211 113357999999999875 35688999999999999999999999964432221 11222111
Q ss_pred -CCCCC---hHHHHHHHHHHHHhhccccCC--CCccc
Q 003694 676 -AGDWP---IKETKELAALGLSCAELRRKD--RPDLK 706 (802)
Q Consensus 676 -~~~~p---~~~~~~l~~li~~Cl~~~p~~--RP~~~ 706 (802)
...+| ...+..+.+|+.+|+..++.. ||++.
T Consensus 225 ~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~ 261 (332)
T cd05623 225 ERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIE 261 (332)
T ss_pred ccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHH
Confidence 01122 245678899999988654433 56655
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.75 Aligned_cols=246 Identities=23% Similarity=0.334 Sum_probs=193.2
Q ss_pred cCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
.+|....+||+|+||.||+|.. .+..||+|++..........+.+|+.++.+++||||+++++++.+.. ++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999987 45689999987655445567889999999999999999999986554 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++|+|.+++.... ++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 9999999886432 4788999999999999999999988 99999999999999999999999999987643211
Q ss_pred ccccccccCCccCcccCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
......|++.|+|||.+. ...++.++|||||||++|+|++|++||.............. ..+.......+
T Consensus 162 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~ 234 (267)
T cd06646 162 -----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK--SNFQPPKLKDK 234 (267)
T ss_pred -----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec--CCCCCCCCccc
Confidence 123346889999999874 44578899999999999999999999853322211100000 00000000111
Q ss_pred hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+..+.+++.+||..+|.+||++.+
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~ 261 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAER 261 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 234578999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=329.10 Aligned_cols=242 Identities=26% Similarity=0.368 Sum_probs=197.8
Q ss_pred eecCCCcEEEEEEEECCe--EEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCCe--EEEEEccCCCHHH
Q 003694 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGC--LVYEYMENGSLED 530 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~--lV~Ey~~~gsL~~ 530 (802)
.||+|.||+||-|++..+ ..|||-+........+-+..||.+-+.|+|.|||+++|.|.++++ +.||.++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 599999999999999876 568888877666666678899999999999999999999988885 6899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEec-CCceeEEeeecccccccCCCCccccccc
Q 003694 531 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYK 609 (802)
Q Consensus 531 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~ 609 (802)
+|..+=+.-.-++.+.--+..||+.||.|||.+. |||||||-+|||++ -.|.+||+|||-++.+..-.. .
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP------~ 732 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP------C 732 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc------c
Confidence 9875432212267777888999999999999999 99999999999996 579999999999998765432 1
Q ss_pred ccCCccCcccCCccccccCC--CCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHH
Q 003694 610 NTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687 (802)
Q Consensus 610 ~~~~~gt~~Y~aPE~~~~~~--~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 687 (802)
...+.||..|||||++..|+ |+.++|||||||++.||.||+|||.-......++-.-.+ -..-+..|...+.+.
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm----yKvHP~iPeelsaea 808 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM----YKVHPPIPEELSAEA 808 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc----eecCCCCcHHHHHHH
Confidence 24568999999999987654 899999999999999999999999633333322211111 112356788899999
Q ss_pred HHHHHHhhccccCCCCccccch
Q 003694 688 AALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 688 ~~li~~Cl~~~p~~RP~~~~~v 709 (802)
..+|++|+..+|.+||++.+.+
T Consensus 809 k~FilrcFepd~~~R~sA~~LL 830 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLL 830 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhc
Confidence 9999999999999999998633
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=309.73 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=199.2
Q ss_pred HhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEc--ccCccchHHHHHHHHHHHhcCCCceeeecceecC------
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQ--SKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------ 514 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~--~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~------ 514 (802)
.....|.....||.|+||.|+.+.+. +..||||++. .......++-.+|+.+|+.++|+||+.++..+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34455666778999999999999885 5699999987 4555566788999999999999999999998743
Q ss_pred -CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 515 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 515 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
..|+|+|+|+ .+|...+.... .++.....-++.||++||.|+|+.+ |+||||||+|+|++.+..+||||||+
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 1289999994 68888776433 3788888889999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCcccc-ccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhh----------
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ-RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA---------- 662 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~---------- 662 (802)
|+..... .....+|..+.|.+|.|||.+ ....|+...||||.||||.|||+|++-|.+.+.+.+.
T Consensus 172 AR~~~~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 172 ARYLDKF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred eeecccc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 9988654 222345778999999999965 4567999999999999999999999999865544332
Q ss_pred -------hchhhhHHHhhhhC--CCCCh-----HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 663 -------IDEDNLAEILDAQA--GDWPI-----KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 663 -------~~~~~l~~~ld~~~--~~~p~-----~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+........+.... +..|. ...+...+|+.+||..||.+|+|..+
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 11112222222111 11121 34677889999999999999999885
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.46 Aligned_cols=235 Identities=23% Similarity=0.385 Sum_probs=183.1
Q ss_pred eecCCCcEEEEEEEECC--------------eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCC--CeE
Q 003694 455 RIGMGGYGTVYKGTFHH--------------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCL 518 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~--------------~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~l 518 (802)
.||+|+||.||+|++.. ..+++|++..........|..|+.++..++||||++++++|.+. .++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998532 25888988765555556788999999999999999999998654 489
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCce-------eEEeee
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV-------SKIGDV 591 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~-------~kl~DF 591 (802)
||||+++|+|..++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +|++||
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999988876433 34888999999999999999999988 999999999999987654 899999
Q ss_pred cccccccCCCCcccccccccCCccCcccCCccccc-cCCCCCcccchhHHHHHHHHH-hCCCCccccchhhhhhchhhhH
Q 003694 592 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLL-TAKPAIAITHKVETAIDEDNLA 669 (802)
Q Consensus 592 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDv~SlGvil~ell-tg~~p~~~~~~~~~~~~~~~l~ 669 (802)
|++...... ....++..|+|||++. +..++.++|||||||++|+|+ +|..||......+. .
T Consensus 157 g~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~ 219 (262)
T cd05077 157 GIPITVLSR----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------E 219 (262)
T ss_pred CCCccccCc----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------H
Confidence 998765321 2236788999999886 466899999999999999998 58888753221110 0
Q ss_pred HHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 670 EILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 670 ~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
...... ..........+.+|+.+||+.+|.+||++. +++..|
T Consensus 220 ~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~-~il~~~ 261 (262)
T cd05077 220 RFYEGQ-CMLVTPSCKELADLMTHCMNYDPNQRPFFR-AIMRDI 261 (262)
T ss_pred HHHhcC-ccCCCCChHHHHHHHHHHcCCChhhCcCHH-HHHHhc
Confidence 111111 111122356789999999999999999998 455443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.80 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=202.1
Q ss_pred CCcccceecCCCcEEEEEEEEC------CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecC----CCe
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPD----HGC 517 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~----~~~ 517 (802)
.|.....||+|+||.||+|.++ +..+|||++...... ....|.+|+.+++.+.||||+++++++.. ..+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4566678999999999999874 458999998765443 45679999999999999999999999865 348
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~ 597 (802)
+||||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999875432 4899999999999999999999988 999999999999999999999999999887
Q ss_pred cCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhh--------hchhhhH
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA--------IDEDNLA 669 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~--------~~~~~l~ 669 (802)
........ ......++..|++||++.+..++.++||||||+++|+|+||+.|+......... .....+.
T Consensus 160 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 160 PEDKDYYY---VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccCCccee---ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 63322111 112234567799999998889999999999999999999999988532211100 0011222
Q ss_pred HHhhhh-CCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 670 EILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 670 ~~ld~~-~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
..+... ....+..++..+.+|+.+||..+|.+||++. +|+.+|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFA-DLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHH-HHHHHHhhc
Confidence 222221 1122334567899999999999999999999 577777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=309.59 Aligned_cols=246 Identities=23% Similarity=0.370 Sum_probs=196.2
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccc---------hHHHHHHHHHHHhcCCCceeeecceecCCC--
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ---------NKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 516 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~---------~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-- 516 (802)
|.....||.|+||.||+|... +..+|+|.+....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566778999999999999874 5689999886543221 245788999999999999999999986544
Q ss_pred eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 8999999999999998654 34788889999999999999999988 99999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 676 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~ 676 (802)
..................|+..|+|||++.++.++.++|||||||++|+|+||+.||........ +..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~ 229 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFKIGENAS 229 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHHHhccCC
Confidence 75322111111112234688999999999888899999999999999999999999964332221 112222222
Q ss_pred CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 677 GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 677 ~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...|...+..+.+++.+||+.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAE 260 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHH
Confidence 3445566788999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=316.06 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=195.5
Q ss_pred cCCcccceecCCCcEEEEEEEEC------------------CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeee
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH------------------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLL 508 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~------------------~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l 508 (802)
++|+...+||+|+||.||++... ...+|+|++.... ......|.+|+.+|+.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998543 2368999987543 2344679999999999999999999
Q ss_pred cceecCCC--eEEEEEccCCCHHHHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCe
Q 003694 509 LGACPDHG--CLVYEYMENGSLEDRLYRKNN--------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNI 578 (802)
Q Consensus 509 ~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NI 578 (802)
++++.+.. ++||||+++|+|.+++..... ...+++.....++.|++.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99986544 899999999999999875331 124778889999999999999999988 99999999999
Q ss_pred EecCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh--CCCCcccc
Q 003694 579 LLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT 656 (802)
Q Consensus 579 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt--g~~p~~~~ 656 (802)
|++.++.++|+|||+++.+....... ......+++.|++||+..++.++.++|||||||++|||+| |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYR----IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCccee----ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999998654322110 1122345678999999888889999999999999999998 67888533
Q ss_pred chhhhhhchhhhHH-HhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 657 HKVETAIDEDNLAE-ILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 657 ~~~~~~~~~~~l~~-~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
...+.....+.+.. .........+..++..+.+|+.+||+.+|.+||++. +|...|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~i~~~l~ 295 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ-EIHATLL 295 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHHh
Confidence 22111100000000 000001122334568899999999999999999999 4655553
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=310.50 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=200.9
Q ss_pred cCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
.+|...+.||.|+||.||+|.. ++..++||.+.... ......|.+|+.+++.++||||++++++|.+.. +++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788899999999999986 46799999876432 223457889999999999999999999986544 8999
Q ss_pred EEccCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 521 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 22345899999999999999999999988 99999999999999999999999999887653
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHh-hhhCCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQAGD 678 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~l-d~~~~~ 678 (802)
.... .....|+..|+|||++.+..++.++||||||+++|+|++|..||.....-. ..+...+ ....+.
T Consensus 159 ~~~~------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~ 227 (267)
T cd08229 159 KTTA------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKKIEQCDYPP 227 (267)
T ss_pred CCcc------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-----HHHhhhhhcCCCCC
Confidence 3211 123468999999999988889999999999999999999999985322110 0111111 111111
Q ss_pred C-ChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 679 W-PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 679 ~-p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
. +...+..+.+++.+||..+|.+||++. .|+..+.++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~i~~~~~~~ 265 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDIT-YVYDVAKRM 265 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCHH-HHHHHHhhh
Confidence 1 224577899999999999999999999 677777665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.14 Aligned_cols=243 Identities=25% Similarity=0.418 Sum_probs=197.0
Q ss_pred cCCcccceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEEEEccCC
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENG 526 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~Ey~~~g 526 (802)
.+|.....||+|+||.||+|...+..+|+|.+.... ....|.+|+.++.+++|||++++++++.... ++||||+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence 357788899999999999999989999999986543 3467899999999999999999999986544 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 84 NLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 9999987543 235788999999999999999999988 9999999999999999999999999987643221
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhh-hCCCCChHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIKET 684 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~~ 684 (802)
.....+..|+|||++.++.++.++|+|||||++|+|++ |++||......+ +...+.. .....+...+
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 223 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRMEPPEGCP 223 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCCCCCCCcCC
Confidence 12234678999999988899999999999999999998 999996433211 1111111 1122334556
Q ss_pred HHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 685 KELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
..+.+++.+||+.+|..||++. .++..|
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~-~l~~~l 251 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFH-KLREKL 251 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHH-HHHHHH
Confidence 7899999999999999999998 455444
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=312.57 Aligned_cols=241 Identities=29% Similarity=0.374 Sum_probs=189.8
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
+|.....||+|+||.||+|.+. +..||+|++.... ......|.+|+.+|.+++||||++++++|.... ++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5677788999999999999874 5689999986542 233456889999999999999999999986544 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++|+|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999996542 3678888999999999999999988 9999999999999999999999999998654321
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhh-chhhhHHHhhhhCCCCC-h
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI-DEDNLAEILDAQAGDWP-I 681 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~-~~~~l~~~ld~~~~~~p-~ 681 (802)
.....||..|+|||++.+..++.++||||||+++|+|+||+.||.......... .......+.+......+ .
T Consensus 150 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (279)
T cd06619 150 ------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223 (279)
T ss_pred ------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC
Confidence 133578999999999998889999999999999999999999996322111110 01111111111112211 2
Q ss_pred HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+.+++.+|++.+|.+||++.+
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~e 249 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPEN 249 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 34568999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=351.35 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=194.6
Q ss_pred HhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCC----C
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 516 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~ 516 (802)
....+|.+..+||.|+||.||++.+. +..+|+|++.... ......|..|+.+|..|+|||||+++++|.+. .
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999986 4588999886542 22346789999999999999999999987432 3
Q ss_pred eEEEEEccCCCHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEEcCCCCCCeEecC---------
Q 003694 517 CLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKP----KPIIHRDMKPGNILLDH--------- 582 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~----~~ivHrDLKp~NILl~~--------- 582 (802)
||||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.++ .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999987532 23458999999999999999999998652 35999999999999964
Q ss_pred --------CceeEEeeecccccccCCCCcccccccccCCccCcccCCcccccc--CCCCCcccchhHHHHHHHHHhCCCC
Q 003694 583 --------NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPA 652 (802)
Q Consensus 583 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDv~SlGvil~elltg~~p 652 (802)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||+|+||+.|
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~-------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM-------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc-------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 34589999999987643221 134579999999998853 4588999999999999999999999
Q ss_pred ccccchhhhhhchhhhHHHhhhhCCCCC-hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 653 IAITHKVETAIDEDNLAEILDAQAGDWP-IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 653 ~~~~~~~~~~~~~~~l~~~ld~~~~~~p-~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
|......... ...+... +..| ...+..+.+|+..||..+|.+||++.+
T Consensus 243 F~~~~~~~ql------i~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 243 FHKANNFSQL------ISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred CCcCCcHHHH------HHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence 9643322211 1111111 1222 234678999999999999999999985
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=306.96 Aligned_cols=245 Identities=23% Similarity=0.313 Sum_probs=196.6
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-----cchHHHHHHHHHHHhcCCCceeeecceecCCC--eE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-----IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-----~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~l 518 (802)
.+|...+.||+|+||.||+|... +..+|+|.+..... .....+.+|+.++++++||||+++++++.+.. ++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 47888999999999999999864 56999998764321 12346889999999999999999999986655 89
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
||||+++++|.+++.... .+++.....++.|++.||.|||..+ |+||||+|+|||++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999886543 4788889999999999999999998 9999999999999999999999999997654
Q ss_pred CCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHh-hhhCC
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQAG 677 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~l-d~~~~ 677 (802)
..... ........|+..|+|||++.+..++.++||||||+++|+|++|++||......... .... .....
T Consensus 156 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~~ 226 (263)
T cd06625 156 TICSS---GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQPTNP 226 (263)
T ss_pred ccccc---cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhccCCCC
Confidence 32111 00112346889999999999888999999999999999999999999643222111 1111 11123
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..|...+..+.+++.+||..+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEE 256 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 345566788999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=329.97 Aligned_cols=244 Identities=24% Similarity=0.321 Sum_probs=193.7
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eE
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~l 518 (802)
...+|....+||+|+||.||++... +..||+|++.... ......+.+|+.+++.++||||+++++++.+.. ++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3457888999999999999999885 5689999986431 223345788999999999999999999987654 89
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
||||+++|+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988543 3777788889999999999999988 9999999999999999999999999998764
Q ss_pred CCCCcccccccccCCccCcccCCccccccC----CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTG----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 674 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~ 674 (802)
..... ......||+.|+|||++.+. .++.++|||||||+||||+||++||...... +.+..++..
T Consensus 194 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~ 262 (370)
T cd05596 194 ANGMV-----RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDH 262 (370)
T ss_pred CCCcc-----cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcC
Confidence 32211 12345799999999987643 4789999999999999999999999654322 122233322
Q ss_pred h-CCCCCh--HHHHHHHHHHHHhhccccCC--CCcccc
Q 003694 675 Q-AGDWPI--KETKELAALGLSCAELRRKD--RPDLKN 707 (802)
Q Consensus 675 ~-~~~~p~--~~~~~l~~li~~Cl~~~p~~--RP~~~~ 707 (802)
. ...+|. ..+..+.+|+.+|+..+|.+ ||++.+
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~e 300 (370)
T cd05596 263 KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDE 300 (370)
T ss_pred CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHH
Confidence 1 122232 35788999999999988887 998874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=322.58 Aligned_cols=250 Identities=27% Similarity=0.461 Sum_probs=208.5
Q ss_pred CCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEcc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
+.....+||.|-||.||.|.|+. -.||||.++.+.. ..++|+.|..+|+.|+|||+|+|+|+|.... |||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 44556789999999999999975 4899999987644 5678999999999999999999999996544 89999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+|+|.++|..... ..++-...+.++.||++|+.||...+ +|||||...|.|+.++..+||+||||++++..+...
T Consensus 347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT- 421 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT- 421 (1157)
T ss_pred CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee-
Confidence 9999999986553 34666678899999999999999988 999999999999999999999999999998765311
Q ss_pred cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhh-CCCCChH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIK 682 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~ 682 (802)
...+......|.|||-+....++.|+|||+|||+|||+.| |..||...+ ......++... ..+.|..
T Consensus 422 ----AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------lSqVY~LLEkgyRM~~PeG 490 (1157)
T KOG4278|consen 422 ----AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYGLLEKGYRMDGPEG 490 (1157)
T ss_pred ----cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHHHHhccccccCCCC
Confidence 1123345678999999999999999999999999999998 888886442 23334444433 3566888
Q ss_pred HHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
|++.+.+|++.||+.+|.+||+++ ++-..++.+
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFa-eiHqafEtm 523 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFA-EIHQAFETM 523 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHH-HHHHHHHHH
Confidence 999999999999999999999999 576666655
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=337.49 Aligned_cols=246 Identities=19% Similarity=0.295 Sum_probs=185.2
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecC--------C-
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--------H- 515 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--------~- 515 (802)
..+|...++||+|+||.||+|... +..||||++.... ....+|+.+|+.++|||||++++++.. .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 346888999999999999999874 5689999875432 234579999999999999999887622 1
Q ss_pred -CeEEEEEccCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC-ceeEEeeec
Q 003694 516 -GCLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVG 592 (802)
Q Consensus 516 -~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~-~~~kl~DFG 592 (802)
.++||||++ ++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 258999997 4777766532 23345889999999999999999999998 9999999999999866 479999999
Q ss_pred ccccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch------
Q 003694 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE------ 665 (802)
Q Consensus 593 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~------ 665 (802)
+++.+..... .....||+.|+|||++.+ ..++.++|||||||+||||+||.+||......+.....
T Consensus 217 la~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 217 SAKNLLAGQR-------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred cchhccCCCC-------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 9987653221 133578999999998765 46899999999999999999999999754332211100
Q ss_pred hhhHHH--hhhh--------C------CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 DNLAEI--LDAQ--------A------GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 ~~l~~~--ld~~--------~------~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.....+ ..+. . ..+|...+.++.+|+.+||..+|.+||++.+
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e 347 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE 347 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 000000 0000 0 0112234568899999999999999999985
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=309.28 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=195.8
Q ss_pred CCcccceecCCCcEEEEEEEE-CCeEEEEEEEcccCc------cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGN------IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~-~~~~vavK~l~~~~~------~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
+|.....||.|+||.||+|.. .+..+|+|.+..... .....+.+|+++|+.++||||++++++|.+.. ++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367778999999999999987 456899998865421 12245889999999999999999999997655 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|||+++|+|.+++.+.. ++++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999986543 4788899999999999999999988 99999999999999999999999999987643
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh--hCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA--QAG 677 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~--~~~ 677 (802)
...............|+..|+|||++.+..++.++||||||+++|+|+||..||......... ..+... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~ 228 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIGAHRGLMP 228 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhhhccCCCC
Confidence 221111111123456899999999999888999999999999999999999999643322211 111111 112
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+...+..+.+++.+||..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 258 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQ 258 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 334456788999999999999999999974
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=322.71 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=200.9
Q ss_pred CcccceecCCCcEEEEEEEECC-eEEEEEEEcccCccc-hHHHHHHHHHHHhcCCCceeeecceec--CCCeEEEEEccC
Q 003694 450 FSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEYMEN 525 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~-~~~~~~Ei~il~~l~Hpniv~l~g~~~--~~~~lV~Ey~~~ 525 (802)
..+.++||+|-||.|..+...+ ..||||.++...... +..|..|+.+|.+++|||||.|+|+|. +..|+|+|||++
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 3456789999999999999987 899999999876554 488999999999999999999999994 444999999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|..+|...... .+.-....+|+.||++|++||.+.. +|||||.+.|+|+|.++++||+|||+++.+-..+....
T Consensus 620 GDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 620 GDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred CcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999999765321 1334455679999999999999998 99999999999999999999999999996654332211
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh--CCCCccccchhhhhhchhhhHHHhhhh----CCCC
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDAQ----AGDW 679 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt--g~~p~~~~~~~~~~~~~~~l~~~ld~~----~~~~ 679 (802)
....+-...|||||.+..+++++++|||+||++|||+++ ...||...+.-+- .++...+++.. ....
T Consensus 696 ----qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 696 ----QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred ----ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcceeccC
Confidence 122355788999999999999999999999999999875 6788863322111 12223333332 2345
Q ss_pred ChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
|.-++..+.+++++||..+-.+||++.+ +...|
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~-lh~~l 801 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQ-LHLFL 801 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHH-HHHHH
Confidence 7778899999999999999999999985 43333
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=312.95 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=196.1
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
+|+....||+|+||.||++.+. +..||+|.+.... ......+.+|+.++.+++||||+++++++.... ++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677788999999999999986 6799999886542 233467889999999999999999999886544 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
++++|..++........+++..+..++.+++.||.|||+ .+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999888654333468999999999999999999996 46 9999999999999999999999999997654321
Q ss_pred cccccccccCCccCcccCCccccccCC------CCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGL------ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 676 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~ 676 (802)
.....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||....... ....+..+.....
T Consensus 158 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 227 (286)
T cd06622 158 -------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIVDGDP 227 (286)
T ss_pred -------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHhhcCC
Confidence 12346888999999885443 5889999999999999999999995332111 1112223333333
Q ss_pred CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 677 GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 677 ~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...|...+..+.+++.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (286)
T cd06622 228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQ 258 (286)
T ss_pred CCCCcccCHHHHHHHHHHcccCcccCCCHHH
Confidence 4455667889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.83 Aligned_cols=235 Identities=24% Similarity=0.406 Sum_probs=182.1
Q ss_pred eecCCCcEEEEEEEEC--------------------------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeee
Q 003694 455 RIGMGGYGTVYKGTFH--------------------------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 508 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--------------------------~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l 508 (802)
+||+|+||.||+|.+. ...|++|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999999742 12588998876544445678899999999999999999
Q ss_pred cceecCCC--eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCc--
Q 003694 509 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-- 584 (802)
Q Consensus 509 ~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~-- 584 (802)
+|+|.+.. ++||||+++|+|..++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99996554 89999999999998886533 34788899999999999999999988 99999999999997643
Q ss_pred -----eeEEeeecccccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHH-HhCCCCccccc
Q 003694 585 -----VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQL-LTAKPAIAITH 657 (802)
Q Consensus 585 -----~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~el-ltg~~p~~~~~ 657 (802)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++||| ++|+.||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCccceeeecCCccccccccc----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4799999988654321 22357888999998865 5689999999999999998 47999986432
Q ss_pred hhhhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 658 KVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 658 ~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
... ....+... ...|......+.+++.+||+.+|.+||++. +|+..|
T Consensus 227 ~~~-------~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~il~~L 273 (274)
T cd05076 227 PSE-------KERFYEKK-HRLPEPSCKELATLISQCLTYEPTQRPSFR-TILRDL 273 (274)
T ss_pred hHH-------HHHHHHhc-cCCCCCCChHHHHHHHHHcccChhhCcCHH-HHHHhh
Confidence 211 11111111 112222346789999999999999999998 454443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=327.55 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=191.2
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eE
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~l 518 (802)
...+|....+||+|+||.||++... +..+|+|++.... ......+.+|+.+++.++||||+++++++.+.. ++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467888999999999999999986 4589999986421 223345789999999999999999999987654 89
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
||||+++|+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999988543 3778888999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcccccccccCCccCcccCCccccccC----CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTG----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 674 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~ 674 (802)
.... .......||+.|+|||++.+. .++.++|||||||+||+|+||++||...... +.+..+++.
T Consensus 194 ~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~ 262 (370)
T cd05621 194 ETGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDH 262 (370)
T ss_pred cCCc-----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhC
Confidence 3221 112345799999999988653 3789999999999999999999999644321 222333332
Q ss_pred h-CCCCCh--HHHHHHHHHHHHhhccccC--CCCcccc
Q 003694 675 Q-AGDWPI--KETKELAALGLSCAELRRK--DRPDLKN 707 (802)
Q Consensus 675 ~-~~~~p~--~~~~~l~~li~~Cl~~~p~--~RP~~~~ 707 (802)
. ...+|. ..+..+.+++.+|+..++. .||++.+
T Consensus 263 ~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e 300 (370)
T cd05621 263 KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEE 300 (370)
T ss_pred CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHH
Confidence 2 122333 3467788999999975443 2677663
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=315.14 Aligned_cols=241 Identities=22% Similarity=0.349 Sum_probs=196.6
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCC--CeEEEEEc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~lV~Ey~ 523 (802)
..|.....||+|+||.||+|... +..+++|.+..........+.+|+.+++.++||||+++++.|.+. .++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46888889999999999999864 568999998776555567789999999999999999999988654 38999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 999999988532 3788899999999999999999988 999999999999999999999999998865433211
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHh-hhh-CCCCCh
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQ-AGDWPI 681 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~l-d~~-~~~~p~ 681 (802)
.....|++.|+|||++.+..++.++|||||||++|+|+||++||......... .... ... ....+.
T Consensus 173 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~~~~~~ 240 (296)
T cd06654 173 ------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGTPELQNPE 240 (296)
T ss_pred ------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH------HHHhcCCCCCCCCcc
Confidence 12347899999999998888999999999999999999999999644321111 1111 110 111234
Q ss_pred HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+.+++.+||..+|.+||++.+
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~e 266 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKE 266 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHH
Confidence 45678999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=311.84 Aligned_cols=241 Identities=23% Similarity=0.383 Sum_probs=192.1
Q ss_pred CcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccC
Q 003694 450 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 525 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~ 525 (802)
|+...+||.|+||.||+|.+.. ..+++|.+..........+.+|+.+++.++||||++++++|.+.. ++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4556789999999999999864 578888886655555677899999999999999999999886554 899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|..++.... .++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc---
Confidence 99998876432 35899999999999999999999988 99999999999999999999999999876543211
Q ss_pred ccccccCCccCcccCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC--CC
Q 003694 606 TTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GD 678 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~--~~ 678 (802)
......|++.|+|||++. +..++.++|||||||++|+|++|++||........ ...+..... ..
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~ 229 (282)
T cd06643 159 ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSEPPTLA 229 (282)
T ss_pred ---ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhcCCCCCC
Confidence 123346899999999873 44578899999999999999999999964332221 111111111 11
Q ss_pred CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.|...+..+.+|+.+||+.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 23345678999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=310.92 Aligned_cols=253 Identities=25% Similarity=0.426 Sum_probs=200.7
Q ss_pred cCCcccceecCCCcEEEEEEEECC------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC-eEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~------~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV 519 (802)
..|...+.||+|+||.||+|.+.. ..+|+|++..... .....+.+|+.++.+++||||++++++|.... ++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 356777899999999999998742 2689998775543 34467889999999999999999999986543 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999875432 4899999999999999999999988 99999999999999999999999999987753
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhh-hCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAG 677 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~-~~~ 677 (802)
.... +......++..|++||.+....++.++||||||+++|||+| |+.||...... .+...+.. ...
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~ 230 (279)
T cd05057 162 DEKE----YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-------EIPDLLEKGERL 230 (279)
T ss_pred cccc----eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHhCCCCC
Confidence 3221 11122344678999999988889999999999999999999 99999643221 11122221 112
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHH
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
..|..++..+.+++.+||..+|..||++. .++..|+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~-~l~~~l~~~~ 269 (279)
T cd05057 231 PQPPICTIDVYMVLVKCWMIDAESRPTFK-ELINEFSKMA 269 (279)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHH
Confidence 23444567899999999999999999999 5777776653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=327.28 Aligned_cols=246 Identities=22% Similarity=0.279 Sum_probs=191.2
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|...+.||+|+||.||++... +..||+|++.... ......+.+|+.++..++||||+++++.+.+.. +|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999885 5689999987432 223456788999999999999999999987655 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999986543 4888899999999999999999998 999999999999999999999999998765321
Q ss_pred CCcc-----------------------------cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCC
Q 003694 601 PSFV-----------------------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 651 (802)
Q Consensus 601 ~~~~-----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~ 651 (802)
.... .........+||+.|+|||++.+..++.++|||||||++|||+||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 1000 00000123579999999999999999999999999999999999999
Q ss_pred CccccchhhhhhchhhhHHHhhhh-CCCCCh--HHHHHHHHHHHHhhccccCCCCccc
Q 003694 652 AIAITHKVETAIDEDNLAEILDAQ-AGDWPI--KETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 652 p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p~--~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
||........ +..++... ....|. ..+..+.+|+.+|+. +|.+|++..
T Consensus 235 Pf~~~~~~~~------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 235 PFCSETPQET------YRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCHHHH------HHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 9964432211 11122111 011121 245678889988774 999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=309.12 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=184.2
Q ss_pred eecCCCcEEEEEEEECC----eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCC
Q 003694 455 RIGMGGYGTVYKGTFHH----TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 527 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~----~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gs 527 (802)
.||+|+||.||+|.+.+ ..+|+|.+..... .....|.+|+.++++++||||++++|+|.+.. ++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 3689998765443 23356889999999999999999999986544 89999999999
Q ss_pred HHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 528 LEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 528 L~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 9999875332 234567778889999999999999988 999999999999999999999999999754332211
Q ss_pred ccccccCCccCcccCCccccccC-------CCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCC
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTG-------LISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAG 677 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~-------~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~ 677 (802)
.......++..|+|||++... .++.++||||||+++|||++ |++||......+.. .............+
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (269)
T cd05087 157 --VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL-TYTVREQQLKLPKP 233 (269)
T ss_pred --ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH-HHHhhcccCCCCCC
Confidence 111234678899999987532 35789999999999999996 99999643222110 00000000000011
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
.........+.+++.+|+ .+|.+||++. +|+..|
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~-~l~~~l 267 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAE-EVHLLL 267 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHH-HHHHHh
Confidence 112234567888999999 6899999999 455544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=304.92 Aligned_cols=242 Identities=24% Similarity=0.379 Sum_probs=190.8
Q ss_pred eecCCCcEEEEEEEEC-CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCHHH
Q 003694 455 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED 530 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL~~ 530 (802)
+||+|+||.||+|... ++.+|+|++..... .....|.+|+.++..++||||++++++|.+.. ++||||+++|+|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6899999999999874 46899998875532 22346889999999999999999999986544 89999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccccc
Q 003694 531 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 610 (802)
Q Consensus 531 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 610 (802)
++.... ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++......... ..
T Consensus 82 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-----~~ 151 (250)
T cd05085 82 FLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-----SS 151 (250)
T ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-----cC
Confidence 886543 34789999999999999999999988 999999999999999999999999999764432110 01
Q ss_pred cCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHHH
Q 003694 611 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAA 689 (802)
Q Consensus 611 ~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~ 689 (802)
....+++.|+|||++.++.++.++||||||+++|+|++ |..||........ ...+........+...+..+.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------REQVEKGYRMSCPQKCPDDVYK 225 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH------HHHHHcCCCCCCCCCCCHHHHH
Confidence 12244678999999998899999999999999999998 9999954322111 1111111112334456788999
Q ss_pred HHHHhhccccCCCCccccchhhHH
Q 003694 690 LGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 690 li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
++.+|+..+|.+||++. +++..|
T Consensus 226 li~~~l~~~p~~Rp~~~-~l~~~l 248 (250)
T cd05085 226 VMQRCWDYKPENRPKFS-ELQKEL 248 (250)
T ss_pred HHHHHcccCcccCCCHH-HHHHHh
Confidence 99999999999999998 455544
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=320.08 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=202.3
Q ss_pred cCCcccceecCCCcEEEEEEEEC---------CeEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeecceecCCC
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 516 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~---------~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~ 516 (802)
..|...+.||+|+||.||++... ...||+|++.... ......+.+|+.++.++ +||||++++++|.+..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46788899999999999999752 1268999887543 22346789999999999 7999999999996654
Q ss_pred --eEEEEEccCCCHHHHhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEec
Q 003694 517 --CLVYEYMENGSLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 581 (802)
Q Consensus 517 --~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~ 581 (802)
+++|||+++|+|.+++.... ....+++..+..++.|++.||.|||..+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 89999999999999987532 1234788999999999999999999988 99999999999999
Q ss_pred CCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhh
Q 003694 582 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVE 660 (802)
Q Consensus 582 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~ 660 (802)
.++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYK----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred CCCcEEECCcccceecccccccc----cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999998765322111 1122345678999999988889999999999999999998 888885332111
Q ss_pred hhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHHh
Q 003694 661 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 719 (802)
Q Consensus 661 ~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~ 719 (802)
.+..+........+...+..+.+|+.+||+.+|.+||++. +++..|+.+...
T Consensus 245 ------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-ell~~l~~~~~~ 296 (334)
T cd05100 245 ------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFK-QLVEDLDRVLTV 296 (334)
T ss_pred ------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHhhh
Confidence 1111222222334455677899999999999999999998 577777766543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=311.58 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=194.2
Q ss_pred HhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeecceecC-------
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPD------- 514 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~------- 514 (802)
.++..|.....||+|+||.||+|... +..||+|++.... .....+.+|+.++.++ +||||++++++|..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35667888889999999999999875 5689999986543 3446788999999998 69999999999853
Q ss_pred -CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 515 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 515 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 2379999999999999887532 235889999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhh
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 668 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l 668 (802)
+........ ......|++.|+|||++. ...++.++|||||||++|+|++|++||..........
T Consensus 158 ~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~----- 226 (272)
T cd06637 158 SAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----- 226 (272)
T ss_pred ceecccccc------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----
Confidence 986543221 123457899999999875 3458889999999999999999999996433221111
Q ss_pred HHHhhhh-CCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 669 AEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 669 ~~~ld~~-~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...... ....+...+..+.+|+.+||..+|.+||++.+
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 265 (272)
T cd06637 227 -LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQ 265 (272)
T ss_pred -HHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence 111111 11112234568999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=319.29 Aligned_cols=239 Identities=25% Similarity=0.321 Sum_probs=186.4
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|...++||+|+||.||++... +..||+|++.... ......+.+|+.++..++||||+.+++++.+.. |+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999875 4589999986422 222345788999999999999999999987655 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||++||+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997533 24888889999999999999999988 999999999999999999999999999876543
Q ss_pred CCcccccccccCCccCcccCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~ 675 (802)
... ......||+.|+|||++.+ +.++.++|||||||+||+|+||+.||......+ .+..+....
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~ 224 (331)
T cd05624 156 GTV-----QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHE 224 (331)
T ss_pred Cce-----eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCC
Confidence 211 1123579999999998865 568899999999999999999999996443221 111222111
Q ss_pred -CCCCC---hHHHHHHHHHHHHhhccccCCCC
Q 003694 676 -AGDWP---IKETKELAALGLSCAELRRKDRP 703 (802)
Q Consensus 676 -~~~~p---~~~~~~l~~li~~Cl~~~p~~RP 703 (802)
...+| ...+..+.+|+.+|+..++ +|+
T Consensus 225 ~~~~~p~~~~~~~~~~~~li~~ll~~~~-~~~ 255 (331)
T cd05624 225 ERFQFPSHITDVSEEAKDLIQRLICSRE-RRL 255 (331)
T ss_pred CcccCCCccccCCHHHHHHHHHHccCch-hhc
Confidence 11122 2346788999999998654 443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=309.40 Aligned_cols=244 Identities=27% Similarity=0.383 Sum_probs=183.0
Q ss_pred eecCCCcEEEEEEEEC----CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCC
Q 003694 455 RIGMGGYGTVYKGTFH----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 527 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~----~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gs 527 (802)
.||+|+||.||+|... ...+++|.+..... .....|.+|+.+++.++||||+++++.|.+.. ++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999753 23678887654332 23456889999999999999999999986554 89999999999
Q ss_pred HHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 528 LEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 528 L~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|.+++..... ....++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~- 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI- 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence 9999876432 223467778899999999999999998 9999999999999999999999999987543322111
Q ss_pred ccccccCCccCcccCCccccc-------cCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhh--
Q 003694 606 TTYKNTGPVGTLCYIDPEYQR-------TGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-- 675 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~-- 675 (802)
......+++.|+|||++. ...++.++|||||||++|||++ |..||......+ .+...+...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~~ 228 (269)
T cd05042 158 ---TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQDI 228 (269)
T ss_pred ---ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccCc
Confidence 112345678899999864 2456889999999999999999 788885432211 111111111
Q ss_pred ---CCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 676 ---AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 676 ---~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
.+..+...+..+.+++..|+ .+|.+||++. +|+..|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~-~v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAE-EVHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHH-HHHHHh
Confidence 12233345677888889998 5999999998 455544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.35 Aligned_cols=251 Identities=29% Similarity=0.467 Sum_probs=200.4
Q ss_pred hcCCcccceecCCCcEEEEEEEECC-eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCC--CeEEEEEc
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 523 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~lV~Ey~ 523 (802)
.++|....+||.|+||.||+|.+.+ ..+|||.+.... .....+.+|+.++++++||||+++++++.+. .++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4578888999999999999998764 578999887543 3456799999999999999999999998653 38999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 9999999986543 235899999999999999999999988 99999999999999999999999999987653211
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChH
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 682 (802)
.......++..|+|||.+.+..++.++||||||+++|+|+| |+.||..... ...+..+........+..
T Consensus 159 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~ 228 (261)
T cd05034 159 ----TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN------REVLEQVERGYRMPRPPN 228 (261)
T ss_pred ----hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCCCCCCC
Confidence 01122345678999999998889999999999999999999 9999853321 111122222112223444
Q ss_pred HHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
.+..+.+++.+|+..+|.+||++. ++...|+
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rp~~~-~l~~~l~ 259 (261)
T cd05034 229 CPEELYDLMLQCWDKDPEERPTFE-YLQSFLE 259 (261)
T ss_pred CCHHHHHHHHHHcccCcccCCCHH-HHHHHHh
Confidence 577899999999999999999998 5666654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=309.93 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=192.7
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
++|....+||+|+||.||+|... +..||+|+++.........+.+|+.++..++||||+++++.+.+.. ++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777888999999999999874 5689999987665445566889999999999999999999986544 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 9999999886543 4889999999999999999999998 99999999999999999999999999876643211
Q ss_pred ccccccccCCccCcccCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
......|++.|+|||++. .+.++.++|||||||++|+|++|.+||............ . ............
T Consensus 162 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~ 234 (267)
T cd06645 162 -----KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-T-KSNFQPPKLKDK 234 (267)
T ss_pred -----ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh-h-ccCCCCCccccc
Confidence 123457899999999874 456889999999999999999999998533221110000 0 000000000011
Q ss_pred hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+..+.+++.+|+..+|.+||++.+
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ 261 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEK 261 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 124567899999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=309.24 Aligned_cols=246 Identities=26% Similarity=0.456 Sum_probs=192.7
Q ss_pred eecCCCcEEEEEEEECC--------eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 455 RIGMGGYGTVYKGTFHH--------TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~--------~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
.||+|+||.||+|.+.. ..+++|.+.... ......|.+|+.+++.++||||++++++|.+.. ++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998753 468999876543 234567899999999999999999999986544 8999999
Q ss_pred cCCCHHHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCc-----eeEEeeeccc
Q 003694 524 ENGSLEDRLYRKN----NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-----VSKIGDVGLS 594 (802)
Q Consensus 524 ~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~-----~~kl~DFGla 594 (802)
++|+|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999997532 2234788999999999999999999988 99999999999999877 8999999999
Q ss_pred ccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhh
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD 673 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld 673 (802)
.......... ......++..|+|||++.++.++.++|||||||++|+|+| |+.||....... ....+..
T Consensus 159 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~ 228 (269)
T cd05044 159 RDIYKSDYYR----KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE------VLQHVTA 228 (269)
T ss_pred cccccccccc----cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH------HHHHHhc
Confidence 8664322111 1122356788999999999999999999999999999998 999985332211 1111111
Q ss_pred hhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHH
Q 003694 674 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 674 ~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
......+...+..+.+++.+||..+|.+||++. +++..|+
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~ 268 (269)
T cd05044 229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFD-RIQEILQ 268 (269)
T ss_pred CCccCCcccchHHHHHHHHHHcCCCcccCCCHH-HHHHHHh
Confidence 112233445678899999999999999999998 4665553
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.84 Aligned_cols=246 Identities=27% Similarity=0.367 Sum_probs=191.7
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
++|...++||+|+||.||++.+. +..+|+|.+..... ....++.+|++++.+++||||++++++|.+.. ++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999885 45788888765422 23456889999999999999999999986554 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
+++|+|.+++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999998654 348888999999999999999997 45 9999999999999999999999999987653321
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhh--hch--------------
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA--IDE-------------- 665 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~--~~~-------------- 665 (802)
.....|+..|+|||++.+..++.++||||||+++|+|+||+.||......... +..
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 12347899999999998888999999999999999999999998532211100 000
Q ss_pred ----------hhhHHHhhhh----CCCCC-hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 ----------DNLAEILDAQ----AGDWP-IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 ----------~~l~~~ld~~----~~~~p-~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
....+..+.. .+..| ...+..+.+|+.+|+..+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 283 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence 0000111111 01111 124567999999999999999999884
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=322.97 Aligned_cols=246 Identities=21% Similarity=0.250 Sum_probs=189.0
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCC------
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 515 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------ 515 (802)
...+|.....||+|+||.||++... +..||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3568999999999999999999875 5689999986432 23345688999999999999999999988422
Q ss_pred --CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 516 --GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 516 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
.|+||||+.+ +|...+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 3899999975 56665532 3778888899999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhh---c---h--
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI---D---E-- 665 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~---~---~-- 665 (802)
++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.......... . .
T Consensus 170 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 170 ARTACTNF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ccccccCc-------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 97643321 1234578999999999999999999999999999999999999996443211100 0 0
Q ss_pred --------hhhHHHhhhh-----------CCCC--------ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 --------DNLAEILDAQ-----------AGDW--------PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 --------~~l~~~ld~~-----------~~~~--------p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.......... ...| +......+.+|+.+||..||.+||++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 311 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHH
Confidence 0000000000 0001 0112467899999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=312.28 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=190.9
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|.....||+|+||.||+|+.. +..||+|++.... ......+.+|+.+++.++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999885 5689999886542 223456889999999999999999999986544 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
++ |+|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 689888865544456899999999999999999999988 99999999999999999999999999976543211
Q ss_pred cccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch---------h------
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------D------ 666 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~---------~------ 666 (802)
......+++.|+|||++.+. .++.++|||||||++|+|+||++||............ .
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 157 ------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred ------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 11234678999999987654 4788999999999999999999999644322211100 0
Q ss_pred ---hhHHHhhhhC----CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 667 ---NLAEILDAQA----GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 667 ---~l~~~ld~~~----~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+........ .......+.++.+++.+||..||.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ 278 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 0000000000 0001124567889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=307.48 Aligned_cols=234 Identities=26% Similarity=0.451 Sum_probs=185.2
Q ss_pred eecCCCcEEEEEEEECCe------------EEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecC-CCeEEEE
Q 003694 455 RIGMGGYGTVYKGTFHHT------------FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-HGCLVYE 521 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~~------------~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~~~lV~E 521 (802)
.||+|+||.||+|.+..+ .+++|++...... ...|.+|+.+|+.++||||++++|+|.. ..++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 689999999999998643 3788877654433 6778999999999999999999998864 3489999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCc-------eeEEeeeccc
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-------VSKIGDVGLS 594 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~-------~~kl~DFGla 594 (802)
|+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 81 YVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred cCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999876443 5888999999999999999999988 99999999999999887 8999999999
Q ss_pred ccccCCCCcccccccccCCccCcccCCccccccC--CCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHH
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEI 671 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ 671 (802)
...... ....++..|+|||++... .++.++||||||+++|+|++ |..||........ ...
T Consensus 156 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-------~~~ 218 (259)
T cd05037 156 ITVLSR----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERF 218 (259)
T ss_pred cccccc----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------HHH
Confidence 865431 223567889999998776 78999999999999999999 5777753321110 000
Q ss_pred hhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 672 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 672 ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
.. .....+......+.+++.+||..+|.+||++. +++..|
T Consensus 219 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il~~l 258 (259)
T cd05037 219 YQ-DQHRLPMPDCAELANLINQCWTYDPTKRPSFR-AILRDL 258 (259)
T ss_pred Hh-cCCCCCCCCchHHHHHHHHHhccChhhCCCHH-HHHHhc
Confidence 00 11122222237899999999999999999998 454443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.13 Aligned_cols=194 Identities=25% Similarity=0.408 Sum_probs=157.3
Q ss_pred cceecCCCcEEEEEEEEC----CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCC----CeEEEEEcc
Q 003694 453 NLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVYEYME 524 (802)
Q Consensus 453 ~~~iG~G~~g~Vy~~~~~----~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~~lV~Ey~~ 524 (802)
..+||+|+||.||+|... +..||+|.+.... ....+.+|+.+|++++||||+++++++.+. .++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 3589999886542 234578899999999999999999988432 379999986
Q ss_pred CCCHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEe----cCCceeEEeeeccc
Q 003694 525 NGSLEDRLYRKN------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL----DHNLVSKIGDVGLS 594 (802)
Q Consensus 525 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl----~~~~~~kl~DFGla 594 (802)
++|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888765321 1235888899999999999999999988 9999999999999 45689999999999
Q ss_pred ccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccc
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAI 655 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~ 655 (802)
+........ ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||..
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCcc---ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 876543211 111234578999999998876 4589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.89 Aligned_cols=237 Identities=22% Similarity=0.253 Sum_probs=182.8
Q ss_pred ecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhc---CCCceeeecceecCCC--eEEEEEccC
Q 003694 456 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKI---RHPHLLLLLGACPDHG--CLVYEYMEN 525 (802)
Q Consensus 456 iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l---~Hpniv~l~g~~~~~~--~lV~Ey~~~ 525 (802)
||+|+||.||+|... +..||||++..... .....+..|..++.++ +||||+.+++++.+.. ++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 56999999864321 1223455677777665 6999999999886554 899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--- 151 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--- 151 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---
Confidence 99999886543 4888999999999999999999998 99999999999999999999999999875432221
Q ss_pred ccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh-HH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI-KE 683 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~-~~ 683 (802)
......||+.|+|||++.+. .++.++|||||||++|+|+||+.||......+ .+..+... ....|. ..
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i~~~-~~~~~~~~~ 221 (330)
T cd05586 152 ---TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNIAFG-KVRFPKNVL 221 (330)
T ss_pred ---CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHHHcC-CCCCCCccC
Confidence 12345799999999988654 48999999999999999999999996432211 11111111 111221 24
Q ss_pred HHHHHHHHHHhhccccCCCCccccchhh
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLP 711 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~ 711 (802)
+..+.+|+.+||..+|.+||+....+.+
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ 249 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVE 249 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHH
Confidence 6788999999999999999987643333
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=325.71 Aligned_cols=245 Identities=24% Similarity=0.333 Sum_probs=191.1
Q ss_pred HHHhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC-
Q 003694 443 IESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 516 (802)
Q Consensus 443 i~~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~- 516 (802)
+....++|.....||+|+||.||++.+. +..+|+|++.... ......+.+|+.++..++||||+++++++.+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3445578999999999999999999986 4589999986422 223345788999999999999999999987655
Q ss_pred -eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccc
Q 003694 517 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 517 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~ 595 (802)
++||||+++|+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 8999999999999988543 3777888899999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCccCcccCCccccccC----CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHH
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 671 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ 671 (802)
.+...... ......||+.|+|||++... .++.++|||||||+||+|++|++||....... .+..+
T Consensus 191 ~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i 259 (371)
T cd05622 191 KMNKEGMV-----RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKI 259 (371)
T ss_pred EcCcCCcc-----cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 76532211 12345799999999988643 37899999999999999999999997543221 12222
Q ss_pred hhhh-CCCCC--hHHHHHHHHHHHHhhccccCC---CCccc
Q 003694 672 LDAQ-AGDWP--IKETKELAALGLSCAELRRKD---RPDLK 706 (802)
Q Consensus 672 ld~~-~~~~p--~~~~~~l~~li~~Cl~~~p~~---RP~~~ 706 (802)
+... ...+| ...+..+.+|+.+|+. +|.. ||++.
T Consensus 260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ 299 (371)
T cd05622 260 MNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVE 299 (371)
T ss_pred HcCCCcccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHH
Confidence 2211 11222 2457788999999998 5555 45554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.16 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=198.2
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
++|....+||.|+||.||+|... ++.+++|++........+.+.+|+.++++++||||++++|++.+.. +++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 46888899999999999999875 4689999988665556678999999999999999999999986554 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++++|.+++.... ..++...+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 9999999886542 34888999999999999999999988 99999999999999999999999999987553211
Q ss_pred ccccccccCCccCcccCCccccccC---CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTG---LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
......++..|+|||.+.+. .++.++||||||+++|+|+||++||............. ...+.......+
T Consensus 157 -----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~ 229 (262)
T cd06613 157 -----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--KSNFPPPKLKDK 229 (262)
T ss_pred -----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCCCccccch
Confidence 12335788999999998776 78999999999999999999999996543322211000 000011111123
Q ss_pred hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+..+.+++.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATK 256 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHH
Confidence 345678999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=334.35 Aligned_cols=249 Identities=20% Similarity=0.271 Sum_probs=186.4
Q ss_pred HHHHhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCC------Cceeeecceec
Q 003694 442 EIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH------PHLLLLLGACP 513 (802)
Q Consensus 442 ei~~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H------pniv~l~g~~~ 513 (802)
++...+.+|....+||+|+||.||+|.+. +..||||+++... .....+..|+.++..++| ++++.++++|.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 44456778999999999999999999874 5689999986432 223456678888877754 45888888885
Q ss_pred CC---CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEecCCc-----
Q 003694 514 DH---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNL----- 584 (802)
Q Consensus 514 ~~---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl~~~~----- 584 (802)
.. .|+||+++ +++|.+++...+ .+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 43 38999988 678988886543 48899999999999999999997 47 99999999999998765
Q ss_pred -----------eeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCc
Q 003694 585 -----------VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 653 (802)
Q Consensus 585 -----------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~ 653 (802)
.+||+|||++...... .+...||+.|+|||++.+..++.++|||||||+||||+||++||
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~---------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERHS---------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccCCCCceEEECCCCccccCccc---------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4999999988643221 23458999999999999999999999999999999999999999
Q ss_pred cccchhhhhhch----h-------------hhHHHhhhhCC---C------------C---ChHHHHHHHHHHHHhhccc
Q 003694 654 AITHKVETAIDE----D-------------NLAEILDAQAG---D------------W---PIKETKELAALGLSCAELR 698 (802)
Q Consensus 654 ~~~~~~~~~~~~----~-------------~l~~~ld~~~~---~------------~---p~~~~~~l~~li~~Cl~~~ 698 (802)
......+..... + ....+.+.... . . .......+.+|+.+||..|
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 644322111000 0 00001100000 0 0 0012356789999999999
Q ss_pred cCCCCcccc
Q 003694 699 RKDRPDLKN 707 (802)
Q Consensus 699 p~~RP~~~~ 707 (802)
|.+||++.+
T Consensus 426 P~~R~ta~e 434 (467)
T PTZ00284 426 RQKRLNARQ 434 (467)
T ss_pred hhhCCCHHH
Confidence 999999985
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.59 Aligned_cols=240 Identities=28% Similarity=0.358 Sum_probs=196.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
+|.....||.|+||.||+|.+. +..+|+|++.... ......+.+|+.+++.++||||+++++++.+.. ++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777788999999999999875 5689999987543 333456889999999999999999999986554 7999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++++|.+++... ++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||+++.+.....
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 999999988643 5889999999999999999999988 99999999999999999999999999988764321
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH-
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK- 682 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~- 682 (802)
......|++.|++||++.+..++.++||||||+++|+|+||++||...+... ....+........+..
T Consensus 154 -----~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 222 (274)
T cd06609 154 -----KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLIPKNNPPSLEGNK 222 (274)
T ss_pred -----ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHhhhcCCCCCcccc
Confidence 1234578899999999998889999999999999999999999996443211 1111111112222222
Q ss_pred HHHHHHHHHHHhhccccCCCCcccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..+.+++.+||..+|.+||++.+
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~ 247 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKE 247 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHH
Confidence 5678999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.37 Aligned_cols=243 Identities=21% Similarity=0.322 Sum_probs=196.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEccc-CccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
+|...++||.|+||.||++... +..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.. ++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999875 568999988643 2334567889999999999999999999986654 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++|+|.+++.... ...++......++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 9999999886432 335788899999999999999999988 999999999999999999999999999876533211
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHH
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
.....|++.|+|||++.+..++.++|+||||+++|+|++|++||........ ...+........|...
T Consensus 157 ------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 224 (255)
T cd08219 157 ------ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKVCQGSYKPLPSHY 224 (255)
T ss_pred ------cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHHhcCCCCCCCccc
Confidence 1234789999999999988899999999999999999999999964332111 1111112122234455
Q ss_pred HHHHHHHHHHhhccccCCCCcccc
Q 003694 684 TKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+..+.+|+.+||+.+|.+||++.+
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHH
Confidence 678999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.39 Aligned_cols=241 Identities=22% Similarity=0.363 Sum_probs=198.0
Q ss_pred cCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
.+|....+||.|+||.||+|.. .+..|++|.+..........+.+|+.+++.++||||+.+++++.+.. ++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688888999999999999986 46789999987665555677899999999999999999999986544 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++|+|..++... .+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999987532 4889999999999999999999998 999999999999999999999999998876543211
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh--CCCCCh
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ--AGDWPI 681 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~--~~~~p~ 681 (802)
.....|++.|+|||.+.+..++.++|||||||++|+|+||++||......... ..+.... ....+.
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~~~~~~~~~~ 239 (296)
T cd06655 172 ------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGTPELQNPE 239 (296)
T ss_pred ------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcCCcccCCcc
Confidence 12346889999999998888999999999999999999999999654432221 1111111 112234
Q ss_pred HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+.+++.+||..+|.+||++.+
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~ 265 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKE 265 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHH
Confidence 45678999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.66 Aligned_cols=235 Identities=23% Similarity=0.380 Sum_probs=184.6
Q ss_pred eecCCCcEEEEEEEECC---------eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecC--CCeEEEEEc
Q 003694 455 RIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYM 523 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~---------~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~lV~Ey~ 523 (802)
.||.|+||.||+|.... ..+++|.+........+.|..|+.+++.++||||+++++++.. ..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999999997642 2488888765544455678899999999999999999999865 448999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCce--------eEEeeecccc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV--------SKIGDVGLST 595 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~--------~kl~DFGla~ 595 (802)
++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. ++++|||++.
T Consensus 82 ~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999875433 5888999999999999999999988 999999999999987664 6999999886
Q ss_pred cccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCC-CCccccchhhhhhchhhhHHHhh
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDEDNLAEILD 673 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~l~~~ld 673 (802)
..... ....+++.|+|||++.+ ..++.++|||||||++|+|++|. +||........ .....
T Consensus 157 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-------~~~~~ 219 (258)
T cd05078 157 TVLPK----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-------LQFYE 219 (258)
T ss_pred ccCCc----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-------HHHHH
Confidence 54321 22467889999999876 45789999999999999999994 66643322111 11111
Q ss_pred hhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 674 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 674 ~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
.....|......+.+|+.+||+.+|.+||++.+ ++..|
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-il~~l 257 (258)
T cd05078 220 -DRHQLPAPKWTELANLINQCMDYEPDFRPSFRA-IIRDL 257 (258)
T ss_pred -ccccCCCCCcHHHHHHHHHHhccChhhCCCHHH-HHHhc
Confidence 122334444578999999999999999999994 55544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.79 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=187.0
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhc---CCCceeeecceecCC------
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKI---RHPHLLLLLGACPDH------ 515 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~il~~l---~Hpniv~l~g~~~~~------ 515 (802)
+|.....||+|+||.||+|... +..||+|.+...... ....+.+|+.++..+ +||||++++++|.+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999885 568999988754221 233566788877765 699999999987532
Q ss_pred -CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccc
Q 003694 516 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594 (802)
Q Consensus 516 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla 594 (802)
.++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 379999997 58888876543 245899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhh-
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD- 673 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld- 673 (802)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.......... .+...+.
T Consensus 156 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~---~~~~~~~~ 225 (288)
T cd07863 156 RIYSCQMA-------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG---KIFDLIGL 225 (288)
T ss_pred ccccCccc-------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH---HHHHHhCC
Confidence 87653221 133478999999999988889999999999999999999999996432211100 0000000
Q ss_pred ------------------hhCC----CCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 674 ------------------AQAG----DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ------------------~~~~----~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.... ......+..+.+|+.+|++.||.+||++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ 281 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR 281 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHH
Confidence 0000 001134567899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.26 Aligned_cols=246 Identities=29% Similarity=0.417 Sum_probs=195.1
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
++|...++||+|+||.||++... +..+|+|++.... ......|.+|++++..++||||+++++++.+.. ++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777788999999999999886 6789999876543 334567899999999999999999999986655 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
+++|+|.+++... ..+++.....++.+++.||.|||+ .+ |+||||||+|||++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999987653 248899999999999999999997 45 9999999999999999999999999987543221
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhh-hch----hhhHHHhhhhC
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-IDE----DNLAEILDAQA 676 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~-~~~----~~l~~~ld~~~ 676 (802)
.....|+..|+|||++.++.++.++|||||||++|+|+||+.||......... ... +.+..++....
T Consensus 159 --------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd06620 159 --------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230 (284)
T ss_pred --------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence 12347899999999998888999999999999999999999999743221000 000 11122222222
Q ss_pred CCCCh-HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 677 GDWPI-KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 677 ~~~p~-~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+. ..+..+.+|+.+|+..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e 262 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQ 262 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHH
Confidence 22222 25678999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.83 Aligned_cols=241 Identities=25% Similarity=0.404 Sum_probs=197.0
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
++|....+||.|+||.||+|... +..+++|.+..... ...|.+|++++++++||||+++++++.+.. +++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888889999999999999986 46899999875533 678999999999999999999999986554 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999886433 35899999999999999999999988 99999999999999999999999999987654321
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC--CCCCh
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPI 681 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~--~~~p~ 681 (802)
......|+..|+|||++.+..++.++||||||+++|+|+||++||........... +..... ...+.
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~ 223 (256)
T cd06612 155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------IPNKPPPTLSDPE 223 (256)
T ss_pred -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------hccCCCCCCCchh
Confidence 11234588999999999888899999999999999999999999964332221110 000000 11233
Q ss_pred HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.....+.+++.+||+.+|.+||++.+
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~ 249 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQ 249 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHH
Confidence 45578999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=313.55 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=197.7
Q ss_pred hcCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
..+|...++||.|+||.||+|.. .+..||+|.+........+.+.+|+.+++.++||||++++++|.... ++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35788889999999999999986 46799999987665555677899999999999999999999986554 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++++|.+++.. ..+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998854 23788899999999999999999988 99999999999999999999999999987543321
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 682 (802)
. .....+++.|++||++.+..++.++|||||||++|+|+||++||.............. ........|..
T Consensus 171 ~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~ 240 (297)
T cd06656 171 K------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----NGTPELQNPER 240 (297)
T ss_pred C------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc----CCCCCCCCccc
Confidence 1 1234688999999999888899999999999999999999999964432221110000 00001123344
Q ss_pred HHHHHHHHHHHhhccccCCCCcccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..+.+|+.+||..+|.+||++.+
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~ 265 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKE 265 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHH
Confidence 5677899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.73 Aligned_cols=243 Identities=24% Similarity=0.386 Sum_probs=194.0
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
..|....+||.|+||.||+|... +..+++|++..........+.+|+.+++.++||||+++++++.... ++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45778889999999999999885 4689999987766556677899999999999999999999875444 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++++|..++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 9999988775433 34889999999999999999999988 99999999999999999999999999876432211
Q ss_pred ccccccccCCccCcccCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCC-
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG- 677 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~- 677 (802)
......+++.|+|||++. ...++.++|||||||++|+|+||.+||........ +..+......
T Consensus 166 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~ 234 (292)
T cd06644 166 -----RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSEPPT 234 (292)
T ss_pred -----ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHhcCCCcc
Confidence 123446889999999874 34578899999999999999999999964432211 1111111111
Q ss_pred -CCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 678 -DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 678 -~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+...+..+.+++.+||..+|.+||++.+
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 265 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQ 265 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence 123345568899999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=301.45 Aligned_cols=243 Identities=25% Similarity=0.373 Sum_probs=196.7
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecC-C--CeEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD-H--GCLVYE 521 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-~--~~lV~E 521 (802)
+|...+.||.|+||.||++... +..+|+|.+.... ......+.+|+.++++++|||++++++.+.. . .++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778889999999999999875 4589999986542 2334568899999999999999999988753 2 379999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999887532 345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+........+.
T Consensus 157 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~ 224 (257)
T cd08223 157 D------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRIIEGKLPPMPK 224 (257)
T ss_pred C------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHhcCCCCCcc
Confidence 1 1233468999999999998889999999999999999999999996432111 111122222233445
Q ss_pred HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+.+++.+|+..+|.+||++.+
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rp~~~~ 250 (257)
T cd08223 225 DYSPELGELIATMLSKRPEKRPSVKS 250 (257)
T ss_pred ccCHHHHHHHHHHhccCcccCCCHHH
Confidence 56788999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.64 Aligned_cols=247 Identities=22% Similarity=0.287 Sum_probs=189.4
Q ss_pred CCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCC-------Ce
Q 003694 449 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------GC 517 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-------~~ 517 (802)
+|+..++||+|+||.||++.. .++.||||++.... ......+.+|+.+|+.++||||+++++++.+. .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477888999999999999986 46799999886432 22345788999999999999999999998543 38
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~ 597 (802)
+||||+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 6788877543 34889999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCcccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhh------chh----
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI------DED---- 666 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~------~~~---- 666 (802)
...... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||.........- ...
T Consensus 154 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 154 EPDESK-----HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ccCccc-----cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 433211 12344789999999988764 47899999999999999999999996443221100 000
Q ss_pred ------hhHHHhhhhCC---------CCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 667 ------NLAEILDAQAG---------DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 667 ------~l~~~ld~~~~---------~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.....+..... ......+..+.+|+.+|++.||.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 284 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD 284 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHH
Confidence 00000100000 011123567889999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.29 Aligned_cols=250 Identities=24% Similarity=0.409 Sum_probs=197.1
Q ss_pred cCCcccceecCCCcEEEEEEEEC-------CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecCC--Ce
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDH--GC 517 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~ 517 (802)
.+|.....||.|+||.||+|+.. ...+++|.+...... ....|.+|+.+|++++||||++++++|.+. .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788889999999999999864 347899988654433 456799999999999999999999999764 48
Q ss_pred EEEEEccCCCHHHHhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeee
Q 003694 518 LVYEYMENGSLEDRLYRKNNT------PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 591 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DF 591 (802)
+||||+++|+|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998754422 25899999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHH
Q 003694 592 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAE 670 (802)
Q Consensus 592 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~ 670 (802)
|++........ .......+++.|++||.+.+..++.++||||||+++|+|++ |..||...... .+..
T Consensus 162 ~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------~~~~ 229 (275)
T cd05046 162 SLSKDVYNSEY-----YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------EVLN 229 (275)
T ss_pred ccccccCcccc-----cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-------HHHH
Confidence 99875432211 12233467888999999888888999999999999999999 78888532211 1111
Q ss_pred HhhhhCCCC--ChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 671 ILDAQAGDW--PIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 671 ~ld~~~~~~--p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
........+ +...+..+.+++.+||..+|.+||++. +++..|
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~-~~l~~l 273 (275)
T cd05046 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFS-ELVSAL 273 (275)
T ss_pred HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHh
Confidence 111111111 234567899999999999999999998 455544
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.75 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=192.5
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-----cchHHHHHHHHHHHhcCCCceeeecceecCC----C
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-----IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 516 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-----~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~ 516 (802)
.+|.....||+|+||.||+|... +..|++|++..... .....+.+|+.+++.++||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999874 56899998764321 2234688899999999999999999988542 2
Q ss_pred eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
+++|||+++++|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 78999999999999886533 3788899999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhh-hh
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQ 675 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld-~~ 675 (802)
+....... .......++..|+|||++.+..++.++|||||||++|+|+||++||........ +..... ..
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~~ 226 (266)
T cd06651 156 LQTICMSG---TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQPT 226 (266)
T ss_pred cccccccC---CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCCC
Confidence 54321110 011234688999999999888899999999999999999999999964322211 111111 11
Q ss_pred CCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 676 AGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 676 ~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..|......+..++ +||..+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~e 257 (266)
T cd06651 227 NPQLPSHISEHARDFL-GCIFVEARHRPSAEE 257 (266)
T ss_pred CCCCchhcCHHHHHHH-HHhcCChhhCcCHHH
Confidence 2344555667778887 788899999999884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=326.72 Aligned_cols=244 Identities=23% Similarity=0.317 Sum_probs=187.3
Q ss_pred cCCcccceecCCCcEEEEEEEECC----eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
..|....+||.|+||.||++...+ ..|++|.+... ..+.+|+.+|++++||||+++++++.... |+|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 468888999999999999997643 47888887543 23568999999999999999999886543 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+. ++|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 167 ~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 167 KYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 995 688888843 245899999999999999999999988 9999999999999999999999999998765432
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhh------hhhc----------h
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE------TAID----------E 665 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~------~~~~----------~ 665 (802)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.||....... ..+. .
T Consensus 240 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 240 DT----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cc----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 11 11234579999999999999999999999999999999999999995332110 0000 0
Q ss_pred ---hhh----HHHhhhhCCCCC-------hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 ---DNL----AEILDAQAGDWP-------IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 ---~~l----~~~ld~~~~~~p-------~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+ ..........++ ......+.+++.+||..+|.+||++.+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e 371 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQD 371 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHH
Confidence 000 000000001111 112457889999999999999999985
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.91 Aligned_cols=241 Identities=24% Similarity=0.359 Sum_probs=203.0
Q ss_pred hhcCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCcc---chHHHHHHHHHHHhcC-CCceeeecceecCCC--e
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNI---QNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--C 517 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~---~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~ 517 (802)
....|.....||.|.||.||+++... +.+|+|++...... ....+.+|+.||+++. |||||.++++|.+.. +
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34568888899999999999999864 58999998765443 3357899999999998 999999999997766 8
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC----CceeEEeeecc
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH----NLVSKIGDVGL 593 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~----~~~~kl~DFGl 593 (802)
+|||++.||.|.+.+... .++......++.||+.++.|||+.| |+||||||+|||+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999876 2889999999999999999999988 999999999999953 35899999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhh
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld 673 (802)
+...... ......+||+.|+|||++....|+..+||||+||++|.|++|.+||......... ..++.
T Consensus 186 a~~~~~~-------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~------~~i~~ 252 (382)
T KOG0032|consen 186 AKFIKPG-------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF------LAILR 252 (382)
T ss_pred ceEccCC-------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH------HHHHc
Confidence 9987752 1335679999999999999999999999999999999999999999755433222 12222
Q ss_pred h----hCCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 674 A----QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ~----~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. ..+.|+ .....+.+++.+|+..||..|+++.+
T Consensus 253 ~~~~f~~~~w~-~is~~akd~i~~ll~~dp~~R~ta~~ 289 (382)
T KOG0032|consen 253 GDFDFTSEPWD-DISESAKDFIRKLLEFDPRKRLTAAQ 289 (382)
T ss_pred CCCCCCCCCcc-ccCHHHHHHHHHhcccCcccCCCHHH
Confidence 2 234454 34888999999999999999999984
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.46 Aligned_cols=248 Identities=26% Similarity=0.458 Sum_probs=195.2
Q ss_pred cCCcccceecCCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEcc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
.+|.....||.|+||.||+|.+. +..+|+|.+.... .....|.+|++++++++|||++++++++.+.. ++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35677789999999999999875 6789999876443 23467899999999999999999999986544 89999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 999999886543 34789999999999999999999988 999999999999999999999999999865432110
Q ss_pred cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCChHH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
......++..|+|||++.++.++.++||||||+++|+|++ |+.||....... .+..+........|...
T Consensus 157 ----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 226 (256)
T cd05112 157 ----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETINAGFRLYKPRLA 226 (256)
T ss_pred ----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHhCCCCCCCCCCC
Confidence 1123345678999999998889999999999999999998 999985332111 11111111111123334
Q ss_pred HHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
+..+.+|+.+||..+|.+||++. +++..|
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~-~~l~~l 255 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFS-LLLHQL 255 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHH-HHHHhh
Confidence 67899999999999999999998 454443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.72 Aligned_cols=246 Identities=18% Similarity=0.220 Sum_probs=189.6
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCC------
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 515 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------ 515 (802)
..++|.....||+|+||.||++... +..||||++.... ......+.+|+.+++.++||||+.+++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4568999999999999999999875 5689999987532 23345688999999999999999999987432
Q ss_pred --CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 516 --GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 516 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
.|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 389999997 467776642 3778888999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch--------
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-------- 665 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~-------- 665 (802)
++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||............
T Consensus 173 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 173 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred ccccCCCC-------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98654321 123457899999999999999999999999999999999999999644322110000
Q ss_pred hhh--------HHHhhhhC-------------------CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 DNL--------AEILDAQA-------------------GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 ~~l--------~~~ld~~~-------------------~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+ ........ ..........+.+|+.+|++.||.+||++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e 314 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence 000 00000000 0001112357889999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.64 Aligned_cols=194 Identities=25% Similarity=0.406 Sum_probs=156.6
Q ss_pred cceecCCCcEEEEEEEECC----eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecC----CCeEEEEEcc
Q 003694 453 NLRIGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD----HGCLVYEYME 524 (802)
Q Consensus 453 ~~~iG~G~~g~Vy~~~~~~----~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~----~~~lV~Ey~~ 524 (802)
..+||+|+||.||+|.... ..||+|.+.... ....+.+|+.+|++++||||++++++|.. ..++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999998642 579999886543 23457899999999999999999998843 2379999987
Q ss_pred CCCHHHHhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEe----cCCceeEEeeeccc
Q 003694 525 NGSLEDRLYRK------NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL----DHNLVSKIGDVGLS 594 (802)
Q Consensus 525 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl----~~~~~~kl~DFGla 594 (802)
++|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5787776422 11235888899999999999999999988 9999999999999 56789999999999
Q ss_pred ccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccc
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAI 655 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~ 655 (802)
+........ ........||+.|+|||++.+ ..++.++|||||||++|||+||++||..
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCccc---ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876543211 111234578999999998876 4589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=302.89 Aligned_cols=250 Identities=26% Similarity=0.447 Sum_probs=198.8
Q ss_pred cCCcccceecCCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEEEEccC
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 525 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~Ey~~~ 525 (802)
..|...++||+|+||.||++.+. +..+++|.+.... .....|.+|+.++++++|+||+++++++.+.. +++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence 46788899999999999999865 4579999876542 24567899999999999999999999987644 899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 158 (260)
T cd05073 85 GSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-- 158 (260)
T ss_pred CcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc--
Confidence 99999987643 345788899999999999999999988 999999999999999999999999999876432211
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhh-hhCCCCChHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAGDWPIKE 683 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~~ 683 (802)
......++..|+|||++..+.++.++|+|||||++|+|+| |+.||....... +...+. ......+...
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~ 228 (260)
T cd05073 159 ---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRMPRPENC 228 (260)
T ss_pred ---cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCCCCCcccC
Confidence 1122346678999999998889999999999999999999 999996432211 111111 1111223345
Q ss_pred HHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
+..+.+++.+|+..+|.+||++. ++...|+.
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~-~l~~~L~~ 259 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFE-YIQSVLDD 259 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHH-HHHHHHhc
Confidence 67899999999999999999998 56666653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=315.43 Aligned_cols=248 Identities=19% Similarity=0.308 Sum_probs=188.7
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
.+|...++||+|+||.||+|+.. +..||+|.+..... .....+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999875 45899999875432 23346788999999999999999999986544 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LD-KDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 97 48888776543 34788889999999999999999988 99999999999999999999999999976543221
Q ss_pred cccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhc---------hhhhHHH-
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---------EDNLAEI- 671 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~---------~~~l~~~- 671 (802)
......+|+.|+|||++.+ ..++.++|||||||++|+|+||++||......+.... ...+..+
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 160 ------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 1123467999999998754 4588999999999999999999999964332111000 0000000
Q ss_pred -----hhhhCCC--------CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 672 -----LDAQAGD--------WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 672 -----ld~~~~~--------~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+...+. .....+..+.+|+.+|+..+|.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 282 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE 282 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHH
Confidence 0000000 01123567889999999999999999884
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=321.38 Aligned_cols=246 Identities=19% Similarity=0.223 Sum_probs=189.6
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecC-------
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------- 514 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~------- 514 (802)
...+|...+.||+|+||.||++... +..||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999874 5689999987542 2234567889999999999999999998742
Q ss_pred -CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 515 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 515 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 23899999975 67666632 3788888999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhh---c------
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI---D------ 664 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~---~------ 664 (802)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .
T Consensus 166 ~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 166 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred cccCCCcc-------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98654321 1234578999999999998889999999999999999999999996433211100 0
Q ss_pred -------hhhhHHHhhhhC-------------------CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 665 -------EDNLAEILDAQA-------------------GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 665 -------~~~l~~~ld~~~-------------------~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+...++... ...+......+.+|+.+|+..||.+||++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~e 307 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHH
Confidence 000001110000 0011123467899999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=305.21 Aligned_cols=253 Identities=21% Similarity=0.373 Sum_probs=196.0
Q ss_pred CcccceecCCCcEEEEEEEEC-----CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCC-------
Q 003694 450 FSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 515 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~-----~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------- 515 (802)
|...+.||+|+||.||+|.+. +..+|||++.... ....+.+.+|+.+|+.++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999863 4589999987543 23456788999999999999999999987432
Q ss_pred -CeEEEEEccCCCHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeee
Q 003694 516 -GCLVYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 591 (802)
Q Consensus 516 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DF 591 (802)
.+++++|+.+|+|.+++.... ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 268899999999998875422 2224788899999999999999999988 999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHH
Q 003694 592 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAE 670 (802)
Q Consensus 592 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~ 670 (802)
|+++......... ......+++.|++||.+....++.++||||||+++|+|++ |++||....... ....
T Consensus 158 g~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~------~~~~ 227 (273)
T cd05074 158 GLSKKIYSGDYYR----QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------IYNY 227 (273)
T ss_pred cccccccCCccee----cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH------HHHH
Confidence 9998764332111 1123345678999999988889999999999999999999 889986432211 1111
Q ss_pred HhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 671 ILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 671 ~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
+........+...+..+.+++.+||..+|.+||++. +++..|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~-~~~~~l~~~ 272 (273)
T cd05074 228 LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQ-HLRDQLELI 272 (273)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 111112223345567899999999999999999998 576666643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.01 Aligned_cols=239 Identities=22% Similarity=0.364 Sum_probs=202.7
Q ss_pred CCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecC--CCeEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~lV~Ey 522 (802)
-|...+.||+|.|..|-++++ .|..||||++.... ......+.+|+.-|+-++|||||+||.+... ..|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 466777899999999998865 67899999997653 2344568899999999999999999999754 45999999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEe-cCCceeEEeeecccccccCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL-DHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl-~~~~~~kl~DFGla~~~~~~~ 601 (802)
-++|+|.|+|.+...+ +.+....+++.||+.|+.|+|+.+ +|||||||+||.+ ..-|.+||.|||++..+.+..
T Consensus 99 GD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999876543 888889999999999999999999 9999999999877 566999999999998776543
Q ss_pred CcccccccccCCccCcccCCccccccCCCC-CcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLIS-PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
. .+..+|++.|.|||++.+..|+ +++||||||||||-|++|++||.-.+ +.+.+..++|. ....|
T Consensus 174 k-------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN------DSETLTmImDC-KYtvP 239 (864)
T KOG4717|consen 174 K-------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN------DSETLTMIMDC-KYTVP 239 (864)
T ss_pred h-------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc------chhhhhhhhcc-cccCc
Confidence 2 3556999999999999998886 68899999999999999999996443 34455556654 34567
Q ss_pred hHHHHHHHHHHHHhhccccCCCCccc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
...+.+..+||..|+..||++|.++.
T Consensus 240 shvS~eCrdLI~sMLvRdPkkRAslE 265 (864)
T KOG4717|consen 240 SHVSKECRDLIQSMLVRDPKKRASLE 265 (864)
T ss_pred hhhhHHHHHHHHHHHhcCchhhccHH
Confidence 88899999999999999999999876
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.72 Aligned_cols=243 Identities=26% Similarity=0.414 Sum_probs=196.3
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
++|....+||.|+||.||+|.+. +..+|+|++..........|.+|+.++++++||||+++++++.+.. ++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46788889999999999999885 5689999987665556677999999999999999999999986554 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 85 DGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999886543 34889999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccccCCccCcccCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC--
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-- 676 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~-- 676 (802)
......|++.|++||++. +..++.++||||||+++|+|++|++||........ +..+.....
T Consensus 159 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~ 227 (280)
T cd06611 159 -----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------LLKILKSEPPT 227 (280)
T ss_pred -----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------HHHHhcCCCCC
Confidence 123457899999999864 34577899999999999999999999964432211 111111111
Q ss_pred CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 677 GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 677 ~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...|...+..+.+++.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAE 258 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 1123345678999999999999999999884
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.86 Aligned_cols=235 Identities=27% Similarity=0.413 Sum_probs=193.0
Q ss_pred CcccceecCCCcEEEEEEEECC--eEEEEEEEcccCcc---chHHHHHHHHHHHhcCCCceeeecceecCC-C-eEEEEE
Q 003694 450 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDH-G-CLVYEY 522 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~---~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-~-~lV~Ey 522 (802)
|...+.||.|+||-||-+++.. ..||||.+.....+ ...++..|+..|.+++|||+|.+-|||... . +|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 6667789999999999998754 48999998765544 346789999999999999999999998533 3 799999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
|- ||-.|+|.-.. +++....+..|+.+.+.||.|||+++ .||||||..||||.++|.|||+|||.|....+..
T Consensus 108 Cl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn- 180 (948)
T KOG0577|consen 108 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN- 180 (948)
T ss_pred Hh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh-
Confidence 95 78888775432 45888889999999999999999999 9999999999999999999999999999876543
Q ss_pred cccccccccCCccCcccCCcccc---ccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQ---RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~---~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
+++|||+|||||++ ..|.|+-++|||||||+..||.-.+||+...+.+... ..+.....+..
T Consensus 181 ---------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL------YHIAQNesPtL 245 (948)
T KOG0577|consen 181 ---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNESPTL 245 (948)
T ss_pred ---------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH------HHHHhcCCCCC
Confidence 45899999999976 4688999999999999999999999998755433321 12222211221
Q ss_pred -ChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 680 -PIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 680 -p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
....+..|..|+..|++.-|.+||+..
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse 273 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSE 273 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHH
Confidence 235678899999999999999999976
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.82 Aligned_cols=241 Identities=26% Similarity=0.385 Sum_probs=193.8
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEcc
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
|.....||.|+||.||+|.+. +..||+|.+.... ......+.+|+.++++++||||++++++|.+.. ++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 555667999999999999874 5689999887443 334457889999999999999999999986554 89999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 86 ~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 86 GGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 9999998753 34888999999999999999999988 99999999999999999999999999987653221
Q ss_pred cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 684 (802)
......|+..|+|||++.+..++.++|||||||++|+|+||+.||........ ...+........+...+
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~ 226 (277)
T cd06642 157 ----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFLIPKNSPPTLEGQYS 226 (277)
T ss_pred ----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------HhhhhcCCCCCCCcccC
Confidence 11234688999999999988899999999999999999999999853322111 11111111223334566
Q ss_pred HHHHHHHHHhhccccCCCCccccch
Q 003694 685 KELAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
..+.+++.+||..+|.+||++.+.+
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il 251 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELL 251 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHH
Confidence 7899999999999999999999533
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.06 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=181.8
Q ss_pred eecCCCcEEEEEEEECC----eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCC
Q 003694 455 RIGMGGYGTVYKGTFHH----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 527 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~----~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gs 527 (802)
.||+|+||.||+|.... ..+++|.+.... ......|.+|+.+++.++||||++++++|.+.. ++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 59999999999997532 245677665443 234567999999999999999999999997554 89999999999
Q ss_pred HHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 528 LEDRLYRKNN-TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 528 L~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 9999875432 234667778899999999999999988 99999999999999999999999999864322110
Q ss_pred cccccCCccCcccCCcccccc-------CCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhh---
Q 003694 607 TYKNTGPVGTLCYIDPEYQRT-------GLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ--- 675 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~--- 675 (802)
........++..|+|||++.. ..++.++|||||||++|||++ |.+||......+ .+..++...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~~~ 228 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIKDQQVK 228 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhhcccc
Confidence 001134568899999998743 245789999999999999997 577875332211 111111111
Q ss_pred --CCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 676 --AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 676 --~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
.+..+......+.+++..|| .+|.+||++. +|++.|
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~-~i~~~l 266 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAE-EVHRLL 266 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHH-HHHHHh
Confidence 12233345678889999999 6899999999 465554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=301.04 Aligned_cols=242 Identities=29% Similarity=0.506 Sum_probs=195.0
Q ss_pred cccceecCCCcEEEEEEEECC------eEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 451 SENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 451 ~~~~~iG~G~~g~Vy~~~~~~------~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
.....||.|+||.||++.+.. ..+|+|++...... ....+.+|+.++..++||||+++++++.+.. +++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999865 67999999765443 5668999999999999999999999987644 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999865332 12899999999999999999999998 9999999999999999999999999998776442
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
... .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...... ..+..+........+
T Consensus 158 ~~~-----~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~ 226 (258)
T smart00219 158 YYK-----KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE------EVLEYLKKGYRLPKP 226 (258)
T ss_pred ccc-----cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHhcCCCCCCC
Confidence 211 112347889999999988889999999999999999998 88888542111 111111112222334
Q ss_pred hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+..+.+++.+|+..+|.+||++.+
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (258)
T smart00219 227 ENCPPEIYKLMLQCWAEDPEDRPTFSE 253 (258)
T ss_pred CcCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 446788999999999999999999984
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=301.16 Aligned_cols=244 Identities=22% Similarity=0.271 Sum_probs=193.6
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-----ccchHHHHHHHHHHHhcCCCceeeecceecCC----C
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 516 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-----~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~ 516 (802)
.+|.....||+|+||.||+|... +..||+|.+.... ......+.+|+.++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999875 5689999875432 12235688899999999999999999998653 2
Q ss_pred eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
++||||+++|+|.+++.... .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 68999999999999886543 3778888999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHh-hhh
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQ 675 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~l-d~~ 675 (802)
........ .......|+..|+|||++.+..++.++|||||||++|+|++|+.||........ +.... ...
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~ 226 (265)
T cd06652 156 LQTICLSG---TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQPT 226 (265)
T ss_pred cccccccc---cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHHhcCCC
Confidence 54321110 011334689999999999888899999999999999999999999964322211 11111 122
Q ss_pred CCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 676 AGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 676 ~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..|......+.+++.+|+. +|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~ 257 (265)
T cd06652 227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADE 257 (265)
T ss_pred CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence 234556667788999999995 9999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=299.14 Aligned_cols=242 Identities=27% Similarity=0.428 Sum_probs=192.2
Q ss_pred eecCCCcEEEEEEEEC-CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCHHH
Q 003694 455 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED 530 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL~~ 530 (802)
+||.|+||.||++.+. +..|++|.+...... ....|.+|+.++++++||||+.+++++.+.. ++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 6999999999999886 689999988765433 4567899999999999999999999986554 89999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccccc
Q 003694 531 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 610 (802)
Q Consensus 531 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 610 (802)
++..... .+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......... ..
T Consensus 82 ~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~----~~ 152 (251)
T cd05041 82 FLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV----SD 152 (251)
T ss_pred HHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCccee----cc
Confidence 9865432 4788899999999999999999988 9999999999999999999999999998654221100 00
Q ss_pred cCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhh-CCCCChHHHHHHH
Q 003694 611 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKELA 688 (802)
Q Consensus 611 ~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~ 688 (802)
....++..|+|||++.++.++.++||||||+++|+|+| |..||..... ......+... ....|...+..+.
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 225 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-------QQTRERIESGYRMPAPQLCPEEIY 225 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-------HHHHHHHhcCCCCCCCccCCHHHH
Confidence 12234677999999988899999999999999999999 8888853321 1111222211 1223345567899
Q ss_pred HHHHHhhccccCCCCccccchhhHH
Q 003694 689 ALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 689 ~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
+++.+|+..+|.+||++. +++..|
T Consensus 226 ~li~~~l~~~p~~Rp~~~-ell~~l 249 (251)
T cd05041 226 RLMLQCWAYDPENRPSFS-EIYNEL 249 (251)
T ss_pred HHHHHHhccChhhCcCHH-HHHHHh
Confidence 999999999999999998 455544
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.56 Aligned_cols=244 Identities=30% Similarity=0.482 Sum_probs=191.8
Q ss_pred CcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccchH--HHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 450 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNK--QFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~--~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
|...++||+|+||.||++...+ ..+|+|++......... ...+|+.++.+++||||+++++++.+.. ++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5667899999999999999965 47999999876544332 3456999999999999999999996544 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++++|.+++... ..+++..+..++.||+.||.+||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~- 153 (260)
T PF00069_consen 81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE- 153 (260)
T ss_dssp TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS-
T ss_pred cccccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 999999999733 34889999999999999999999998 99999999999999999999999999986521111
Q ss_pred ccccccccCCccCcccCCccccc-cCCCCCcccchhHHHHHHHHHhCCCCccccchhh--hhhchhhhHHHhhhhCCCCC
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE--TAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~--~~~~~~~l~~~ld~~~~~~p 680 (802)
......++..|+|||++. +..++.++||||||+++|+|++|..||....... ..+....... +.... ...
T Consensus 154 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~ 226 (260)
T PF00069_consen 154 -----NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP-LPSSS-QQS 226 (260)
T ss_dssp -----EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH-HHHHT-TSH
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc-ccccc-ccc
Confidence 124457899999999988 8889999999999999999999999997541111 1111111101 11111 111
Q ss_pred hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
......+.+++.+||+.+|.+||++.+
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~ 253 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEE 253 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHH
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHH
Confidence 112388999999999999999999884
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=327.24 Aligned_cols=191 Identities=25% Similarity=0.344 Sum_probs=161.9
Q ss_pred hcCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
..+|.....||+|+||.||+|.+.. ..||||... ...+.+|+.+|++++|||||++++++.... +|||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578889999999999999999864 579999532 234678999999999999999999886544 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+. |+|.+++.... ..++|..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 78888876533 35899999999999999999999988 99999999999999999999999999987653321
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCc
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 653 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~ 653 (802)
. .......||+.|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 316 ~----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 T----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred c----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 1 1113457999999999999999999999999999999999988655
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.36 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=196.9
Q ss_pred HHHHHHhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeecceec---
Q 003694 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACP--- 513 (802)
Q Consensus 440 ~~ei~~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~--- 513 (802)
++.+..+.++|.....||+|+||.||++... ++.+|+|++.... .....+.+|+.++.++ +||||++++++|.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455667889999999999999999999874 5689999876532 2345688899999999 6999999999873
Q ss_pred --C--CCeEEEEEccCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEE
Q 003694 514 --D--HGCLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 588 (802)
Q Consensus 514 --~--~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl 588 (802)
+ ..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 1 238999999999999987642 22345888889999999999999999988 999999999999999999999
Q ss_pred eeecccccccCCCCcccccccccCCccCcccCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhh
Q 003694 589 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI 663 (802)
Q Consensus 589 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~ 663 (802)
+|||++..+..... ......|++.|+|||++.. ..++.++|||||||++|+|+||+.||..........
T Consensus 166 ~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~ 239 (286)
T cd06638 166 VDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239 (286)
T ss_pred ccCCceeecccCCC------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence 99999987643211 1233478999999998753 447889999999999999999999996443322111
Q ss_pred chhhhHHHhhhhC--CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 664 DEDNLAEILDAQA--GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 664 ~~~~l~~~ld~~~--~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
....... ...|...+..+.+|+.+||+.+|.+||++.+
T Consensus 240 ------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 279 (286)
T cd06638 240 ------KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSD 279 (286)
T ss_pred ------hccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHH
Confidence 1111100 0112234567999999999999999999984
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=291.11 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=194.8
Q ss_pred hcCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCcc--------chHHHHHHHHHHHhc-CCCceeeecceecCC
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNI--------QNKQFLQELEVLSKI-RHPHLLLLLGACPDH 515 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~--------~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~ 515 (802)
-..|.....||.|+.++|.++..+. ..+|+|++...... ..+.-.+|++||+++ .||||++|.+++...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 3456777789999999999998864 47888887543211 123346799999998 599999999999776
Q ss_pred C--eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 516 G--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 516 ~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
. ++|+|.|+.|.|.|+|...- .++.....+|+.|+..|+.|||... ||||||||+|||+|+|.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 6 78999999999999997543 4889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCcccccc------CCCCCcccchhHHHHHHHHHhCCCCccccchhh--hhhch
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT------GLISPKSDVYAYGMVILQLLTAKPAIAITHKVE--TAIDE 665 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~--~~~~~ 665 (802)
++.+..... -...+|||+|+|||.+.. ..|+..+|+|++|||+|.||.|.+||.....+- ..+..
T Consensus 170 a~~l~~Gek-------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 170 ACQLEPGEK-------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred eeccCCchh-------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 998876542 356799999999997653 347889999999999999999999995322111 11111
Q ss_pred hhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccch
Q 003694 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 666 ~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
|.+ ....++|. +.+....+|+.+|++.||.+|.+..+.+
T Consensus 243 Gky----qF~speWa-dis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 243 GKY----QFRSPEWA-DISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred ccc----ccCCcchh-hccccHHHHHHHHHeeCchhcccHHHHh
Confidence 111 11223442 4577889999999999999999998644
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=304.27 Aligned_cols=240 Identities=26% Similarity=0.390 Sum_probs=195.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
.|+...+||.|+||.||+|.+. +..||+|++.... ......+.+|+.+++.++||||+++++++.+.. ++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666778999999999999874 5689999887543 334567889999999999999999999987654 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++|+|.+++.. .++++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999998853 24788899999999999999999988 99999999999999999999999999977653221
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHH
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
......++..|+|||++.+..++.++|+|||||++|+|+||.+||........ ...+........+...
T Consensus 157 -----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 225 (277)
T cd06640 157 -----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------LFLIPKNNPPTLTGEF 225 (277)
T ss_pred -----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------hhhhhcCCCCCCchhh
Confidence 11334688899999999888899999999999999999999999964322111 0111111123334467
Q ss_pred HHHHHHHHHHhhccccCCCCcccc
Q 003694 684 TKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+..+.+++.+||+.+|.+||++.+
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKE 249 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHH
Confidence 788999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=298.94 Aligned_cols=243 Identities=25% Similarity=0.359 Sum_probs=196.9
Q ss_pred CCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|+..+.||.|+||.||.+.. ++..+++|.+.... ......+.+|+.+|++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477888999999998888776 45689999876442 334567889999999999999999999997655 789999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999887543 345889999999999999999999988 99999999999999999999999999987654331
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 682 (802)
......|++.|+|||++.+..++.++||||||+++|+|++|..||......+ ....+........+..
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~ 224 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIVQGNYTPVVSV 224 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCCCCCccc
Confidence 1234578999999999988888999999999999999999999996432211 1122222222223344
Q ss_pred HHHHHHHHHHHhhccccCCCCcccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..+.+++.+||..+|.+||++.+
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~ 249 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADE 249 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHH
Confidence 5678999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=306.59 Aligned_cols=255 Identities=27% Similarity=0.341 Sum_probs=200.8
Q ss_pred cCCHHHHHHhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeecceec
Q 003694 437 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACP 513 (802)
Q Consensus 437 ~~~~~ei~~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~ 513 (802)
.++..++..++++|.....||+|+||.||++... ++.+|+|++.... .....+.+|+.++.++ +|||+++++++|.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3556677778899999999999999999999884 5689999986532 2345678899999999 7999999999884
Q ss_pred C-------CCeEEEEEccCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCce
Q 003694 514 D-------HGCLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 585 (802)
Q Consensus 514 ~-------~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~ 585 (802)
. ..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 2 248999999999999988642 22345889999999999999999999988 999999999999999999
Q ss_pred eEEeeecccccccCCCCcccccccccCCccCcccCCccccccCC-----CCCcccchhHHHHHHHHHhCCCCccccchhh
Q 003694 586 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL-----ISPKSDVYAYGMVILQLLTAKPAIAITHKVE 660 (802)
Q Consensus 586 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~~~~sDv~SlGvil~elltg~~p~~~~~~~~ 660 (802)
+||+|||++........ ......|+..|+|||++.... ++.++|||||||++|+|++|++||.......
T Consensus 167 ~kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred EEEeecccchhcccccc------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 99999999987653221 112346899999999876443 6889999999999999999999996443222
Q ss_pred hhhchhhhHHHhhhhCC--CCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 661 TAIDEDNLAEILDAQAG--DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 661 ~~~~~~~l~~~ld~~~~--~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. +..+...... ..+......+.+++.+||+.+|.+||++.+
T Consensus 241 ~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 283 (291)
T cd06639 241 T------LFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTH 283 (291)
T ss_pred H------HHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHH
Confidence 1 1111111111 113344567999999999999999999884
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=316.15 Aligned_cols=244 Identities=20% Similarity=0.286 Sum_probs=187.4
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecC-------
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------- 514 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~------- 514 (802)
..+.|.....||.|+||.||+|... +..||||++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3457888889999999999999875 4589999986532 2234567889999999999999999998742
Q ss_pred -CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 515 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 515 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
..+++++++ +++|.+++.. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 237899988 7899887743 24889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhh---------
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI--------- 663 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~--------- 663 (802)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 165 ~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 165 ARQADDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred ceecCCC---------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9875432 134578999999998876 568999999999999999999999996433221100
Q ss_pred --------chhhhHHHhhhhCCCCCh--------HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 664 --------DEDNLAEILDAQAGDWPI--------KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 664 --------~~~~l~~~ld~~~~~~p~--------~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
........+.. .+..+. ...+.+.+|+.+|+..||.+||++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~e 294 (343)
T cd07878 236 SPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE 294 (343)
T ss_pred CHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 00000000000 011111 12345789999999999999999884
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=300.30 Aligned_cols=244 Identities=27% Similarity=0.402 Sum_probs=197.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecC--C--CeEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--H--GCLVY 520 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~--~~lV~ 520 (802)
+|.....||.|+||.||++... +..+|+|++.... ......+..|+.++++++||||+++++++.. . .+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677789999999999999874 4689999886532 2334568899999999999999999997743 2 27999
Q ss_pred EEccCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEEcCCCCCCeEecCCceeEEeeeccc
Q 003694 521 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLH-----NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH-----~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla 594 (802)
||+++++|.+++... ....++++..+..++.+|+.||.||| +.+ |+|+||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998653 22346899999999999999999999 655 999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 674 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~ 674 (802)
......... .....|++.|++||++.+..++.++|+||||+++|+|++|+.||...... .....+...
T Consensus 158 ~~~~~~~~~------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~ 225 (265)
T cd08217 158 KILGHDSSF------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------QLASKIKEG 225 (265)
T ss_pred ccccCCccc------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------HHHHHHhcC
Confidence 877543321 12346899999999998888999999999999999999999999644311 111122222
Q ss_pred hCCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 675 QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 675 ~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.....+...+..+.+++.+|++.+|.+||++.+
T Consensus 226 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 258 (265)
T cd08217 226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258 (265)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 233455567789999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=309.40 Aligned_cols=260 Identities=24% Similarity=0.383 Sum_probs=208.6
Q ss_pred ccccCCHHHHHHhh-cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceee
Q 003694 434 RYRNLTWEEIESAT-LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLL 507 (802)
Q Consensus 434 ~~~~~~~~ei~~~~-~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~ 507 (802)
+|-...|-|....+ +.|+.-+.||+||||.||-+... ++-+|.|.+.... ..+....++|-.||.+++.|.||.
T Consensus 170 rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVs 249 (591)
T KOG0986|consen 170 RFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVS 249 (591)
T ss_pred HHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEE
Confidence 33334444554444 45888899999999999988765 5578888876543 223345688999999999999999
Q ss_pred ecceec--CCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCce
Q 003694 508 LLGACP--DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 585 (802)
Q Consensus 508 l~g~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~ 585 (802)
|-.+|. +..||||..|.||+|.-+|...++ +.++.....-++.+|+.||.+||+.. ||+|||||+|||||+.|+
T Consensus 250 laYAfeTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~Gh 325 (591)
T KOG0986|consen 250 LAYAFETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGH 325 (591)
T ss_pred EeeeecCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCC
Confidence 988884 556999999999999998887664 67999999999999999999999988 999999999999999999
Q ss_pred eEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch
Q 003694 586 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 665 (802)
Q Consensus 586 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~ 665 (802)
++|+|.|||..+..... .+..+||.+|||||++.++.|+...|+|||||+||||+.|+.||.... .....
T Consensus 326 vRISDLGLAvei~~g~~-------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K---eKvk~ 395 (591)
T KOG0986|consen 326 VRISDLGLAVEIPEGKP-------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK---EKVKR 395 (591)
T ss_pred eEeeccceEEecCCCCc-------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh---hhhhH
Confidence 99999999998876543 245599999999999999999999999999999999999999995321 11122
Q ss_pred hhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 ~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+.+...+......+|...+++...|....|..||.+|-.-..
T Consensus 396 eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg 437 (591)
T KOG0986|consen 396 EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRG 437 (591)
T ss_pred HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCC
Confidence 222333323234566677888999999999999999977653
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=305.75 Aligned_cols=237 Identities=27% Similarity=0.349 Sum_probs=194.8
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|.....||+|+||.||++.+. +..+|+|++.... ......+.+|+++|++++||||+++++++.+.. ++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788889999999999999885 5689999986532 223456889999999999999999999986655 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... .++...+..++.||+.||.|||+.+ |+|+||+|.|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999987653 4888899999999999999999988 999999999999999999999999999876543
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
.....|++.|+|||++.+...+.++||||||+++|+|+||+.||....... ....+. ......|
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~ 218 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEKIL-EGKVRFP 218 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHh-cCCccCC
Confidence 123468999999999988888999999999999999999999996443211 111112 1122344
Q ss_pred hHHHHHHHHHHHHhhccccCCCCccc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
...+..+.+++.+||..+|.+||+..
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~ 244 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNL 244 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcc
Confidence 45578899999999999999999654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=318.73 Aligned_cols=187 Identities=25% Similarity=0.382 Sum_probs=158.4
Q ss_pred cCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
.+|.....||+|+||.||+|...+ ..||+|+.... .+..|+.+|++++||||++++++|.+.. ++||||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 368888999999999999999864 48899975332 2456999999999999999999986554 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
. |+|.+++.... ..+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++......
T Consensus 140 ~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 140 S-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred C-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 5 68888886533 35899999999999999999999998 9999999999999999999999999997543221
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCc
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 653 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~ 653 (802)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 113457999999999999999999999999999999999865444
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=309.00 Aligned_cols=248 Identities=27% Similarity=0.341 Sum_probs=197.6
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
+|...+.||+|+||.||+|... +..+|+|.+...... ....+..|+++|..++||||+++++.+.+.. ++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6788889999999999999885 469999998764322 3456889999999999999999999986655 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999886432 345889999999999999999999988 9999999999999999999999999988664322
Q ss_pred Ccccc-----------------------cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccch
Q 003694 602 SFVST-----------------------TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHK 658 (802)
Q Consensus 602 ~~~~~-----------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~ 658 (802)
..... ........||..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 11100 0111234789999999999988899999999999999999999999964432
Q ss_pred hhhhhchhhhHHHhhhhCCCCChH--HHHHHHHHHHHhhccccCCCCcccc
Q 003694 659 VETAIDEDNLAEILDAQAGDWPIK--ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 659 ~~~~~~~~~l~~~ld~~~~~~p~~--~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. ..+..++... ..++.. .+..+.+++.+|+..+|.+||+...
T Consensus 238 ~------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~ 281 (316)
T cd05574 238 D------ETFSNILKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKR 281 (316)
T ss_pred H------HHHHHHhcCC-ccCCCccccCHHHHHHHHHHccCCHhHCCCchh
Confidence 2 1122222221 122222 5788999999999999999999654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=305.07 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=197.6
Q ss_pred CHHHHHHhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeecceecC-
Q 003694 439 TWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPD- 514 (802)
Q Consensus 439 ~~~ei~~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~- 514 (802)
+..++......|+....||.|+||.||+|.+. +..+|+|++.... .....+..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 55566667788999999999999999999984 5689999886543 2345688899999998 69999999999832
Q ss_pred -------CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeE
Q 003694 515 -------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK 587 (802)
Q Consensus 515 -------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~k 587 (802)
..+++|||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 2389999999999999886533 234788888999999999999999988 99999999999999999999
Q ss_pred EeeecccccccCCCCcccccccccCCccCcccCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhh
Q 003694 588 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA 662 (802)
Q Consensus 588 l~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~ 662 (802)
|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|+|+||++||.........
T Consensus 162 l~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred EeeCcchhhhhcccc------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 999999886543211 123357899999999875 345788999999999999999999999643322211
Q ss_pred hchhhhHHHhhhhCCC-CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 663 IDEDNLAEILDAQAGD-WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 663 ~~~~~l~~~ld~~~~~-~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. .+....... .+...+..+.+|+.+||..+|.+||++.+
T Consensus 236 ~------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~e 275 (282)
T cd06636 236 F------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQ 275 (282)
T ss_pred h------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHH
Confidence 1 111111111 11235678999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=309.74 Aligned_cols=237 Identities=19% Similarity=0.315 Sum_probs=190.8
Q ss_pred ccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCC--CeEEEEEccCCC
Q 003694 452 ENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGS 527 (802)
Q Consensus 452 ~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~lV~Ey~~~gs 527 (802)
...+||+|+||.||++... +..||+|++..........+.+|+.++..++||||++++++|... .++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3447999999999999874 679999998765555566788999999999999999999988544 389999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccc
Q 003694 528 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607 (802)
Q Consensus 528 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 607 (802)
|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----- 172 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 172 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-----
Confidence 9987743 24788999999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC--CCCChHHHH
Q 003694 608 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPIKETK 685 (802)
Q Consensus 608 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~--~~~p~~~~~ 685 (802)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||........ +..+..... ...+...+.
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 245 (297)
T cd06659 173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MKRLRDSPPPKLKNAHKISP 245 (297)
T ss_pred -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhccCCCCccccCCCCH
Confidence 11335689999999999888899999999999999999999999964332211 111111100 111223456
Q ss_pred HHHHHHHHhhccccCCCCcccc
Q 003694 686 ELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 686 ~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+.+++.+|+..+|.+||++.+
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ 267 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQE 267 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHH
Confidence 7899999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=299.09 Aligned_cols=239 Identities=25% Similarity=0.372 Sum_probs=194.4
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-----cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-----IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-----~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
|.....||+|+||.||+|... +..|++|.+..... .....+.+|+.+++.++||||+++++++.+.. ++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566778999999999999885 67999998865431 23457889999999999999999999987654 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 999999999988654 24788999999999999999999988 999999999999999999999999999876433
Q ss_pred CCcccccccccCCccCcccCCccccccCC-CCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhh-hhCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAGD 678 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld-~~~~~ 678 (802)
. ......|++.|++||.+.... ++.++|+||||+++|+|++|++||.......... .... .....
T Consensus 156 ~-------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~~~~~~~~ 222 (258)
T cd06632 156 S-------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF------KIGRSKELPP 222 (258)
T ss_pred c-------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH------HHHhcccCCC
Confidence 2 113456899999999887766 8999999999999999999999996543222111 1111 11223
Q ss_pred CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+......+.+++.+||..+|.+||++.+
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 251 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAE 251 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHH
Confidence 34456788999999999999999999884
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=304.88 Aligned_cols=248 Identities=29% Similarity=0.344 Sum_probs=194.4
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCC----CeEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~~lV~ 520 (802)
++|....+||.|+||.||+|.+. ++.+|+|.+..... .....+.+|++++++++||||++++++|.+. .++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788889999999999999984 56899998875433 3456789999999999999999999998542 38999
Q ss_pred EEccCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 521 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
||+++++|.+++... .....++......|+.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987642 23345888899999999999999999988 99999999999999999999999999876542
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC---
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--- 676 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~--- 676 (802)
.. .....++..|++||.+.+..++.++||||||+++|+|+||+.||..... ...........+.....
T Consensus 158 ~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd06621 158 SL--------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE-PPLGPIELLSYIVNMPNPEL 228 (287)
T ss_pred cc--------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC-CCCChHHHHHHHhcCCchhh
Confidence 21 1234578899999999988999999999999999999999999975422 00000111111111110
Q ss_pred CCCC---hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 677 GDWP---IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 677 ~~~p---~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+ ...+..+.+++.+||..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e 262 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHH
Confidence 1111 134678999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=302.98 Aligned_cols=245 Identities=29% Similarity=0.386 Sum_probs=196.9
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
+|+...+||.|+||.||++.+. +..+++|.+..... .....+.+|++++++++||||++++++|.... ++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677788999999999999986 56899998876532 34567899999999999999999999986554 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
++++|.+++.... ..++......++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999887543 458888999999999999999999 77 99999999999999999999999999876543211
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 682 (802)
....++..|+|||++.+..++.++||||||+++|+|++|+.||......... ....+..++.......+..
T Consensus 157 --------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 227 (265)
T cd06605 157 --------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIVNEPPPRLPSG 227 (265)
T ss_pred --------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHhcCCCCCCChh
Confidence 1157889999999998889999999999999999999999999643211000 0111222222222233333
Q ss_pred -HHHHHHHHHHHhhccccCCCCcccc
Q 003694 683 -ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 683 -~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..+.+++.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKE 253 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHH
Confidence 6778999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=306.74 Aligned_cols=246 Identities=23% Similarity=0.289 Sum_probs=192.5
Q ss_pred cCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|...+.||+|+||.||++.... ..|++|.+..... .....+.+|+.+++.++||||+++++.+.+.. ++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368888999999999999998864 5899998875432 23456889999999999999999999987655 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||++||+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999986543 4888999999999999999999988 999999999999999999999999998742211
Q ss_pred CCc---------ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHH
Q 003694 601 PSF---------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 671 (802)
Q Consensus 601 ~~~---------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ 671 (802)
... ...........|+..|+|||++.+..++.++|+|||||++|+|+||..||......+ .+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 100 000111223467889999999988889999999999999999999999996332111 11111
Q ss_pred hhhhCCCCC---hHHHHHHHHHHHHhhccccCCCCccc
Q 003694 672 LDAQAGDWP---IKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 672 ld~~~~~~p---~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
... ...+| ...+..+.+++.+||+.+|.+||+..
T Consensus 229 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 229 ISD-DIEWPEGDEALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred Hhc-ccCCCCccccCCHHHHHHHHHHhccChhhccCcc
Confidence 111 11111 13467799999999999999999976
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=299.31 Aligned_cols=243 Identities=23% Similarity=0.360 Sum_probs=197.3
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
.|+...+||+|+||.||++... +..|++|.+.... ......+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4777889999999999999874 5689999886432 223457899999999999999999999986654 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999886533 234788899999999999999999988 99999999999999999999999999987653221
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 682 (802)
......|++.|+|||++.+..++.++|+|||||++|+|+||+.||...... .....++.......+..
T Consensus 157 ------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 224 (256)
T cd08218 157 ------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIRGSYPPVSSH 224 (256)
T ss_pred ------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhcCCCCCCccc
Confidence 112346889999999998888999999999999999999999998643211 11222222223334455
Q ss_pred HHHHHHHHHHHhhccccCCCCcccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..+.+++.+||+.+|.+||++.+
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNS 249 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHH
Confidence 6788999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=310.18 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=189.4
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
..|....+||.|+||.||+|... +..||+|.+.... ......+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 35788889999999999999875 5689999886443 223456788999999999999999999986554 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
++ ++|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 68988886543 34788899999999999999999988 99999999999999999999999999976543221
Q ss_pred cccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhh---------chhhhHHHh
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI---------DEDNLAEIL 672 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~---------~~~~l~~~l 672 (802)
......+++.|+|||++.+ ..++.++|||||||++|+|+||++||......+... ....+..++
T Consensus 160 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 160 ------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred ------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 1123467899999998765 457889999999999999999999996433211100 000111111
Q ss_pred hhh------CCCC--------ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 673 DAQ------AGDW--------PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 673 d~~------~~~~--------p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
... .+.+ ....+..+.+|+.+|+..+|.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~e 282 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE 282 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 100 0000 1123567899999999999999999884
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=299.06 Aligned_cols=245 Identities=28% Similarity=0.402 Sum_probs=201.4
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
++|...+.||.|+||.||++... +..++||++..... .....+.+|+.++.+++||||+++++++.... ++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999886 56899999876544 34577999999999999999999999986654 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
+++++|.+++... .+++...+..++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998754 458899999999999999999999 88 9999999999999999999999999998765432
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
.. .....++..|+|||.+.+..++.++|+||||+++|+|+||+.||....... .......+........+.
T Consensus 155 ~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 225 (264)
T cd06623 155 DQ------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAICDGPPPSLPA 225 (264)
T ss_pred Cc------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHhcCCCCCCCc
Confidence 21 123468899999999999999999999999999999999999996543100 011122222222333444
Q ss_pred H-HHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 K-ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~-~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. .+..+.+++.+|+..+|.+||++.+
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ 252 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAE 252 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 4 6788999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=334.26 Aligned_cols=242 Identities=25% Similarity=0.307 Sum_probs=198.9
Q ss_pred HhhcCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--e
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--C 517 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~ 517 (802)
....+|.+.+.||+|+||.|..+++.+ +.||+|++..... ....-|..|-+||..-+.+.|+.|..+|+|.. |
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 344578888999999999999999875 4899999876432 23456899999999999999999999998876 8
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~ 597 (802)
||||||+||+|..+|.+.. .+|..-...++.+|+.||.-||+.| +|||||||+|||||..|++||+|||.|-.+
T Consensus 152 lVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred EEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhc
Confidence 9999999999999887655 4777777788999999999999999 999999999999999999999999999888
Q ss_pred cCCCCcccccccccCCccCcccCCccccc----c-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHh
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQR----T-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 672 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~l 672 (802)
..+... .....+|||.|++||+++ + +.|++.+|+||+||++||||.|..||.....+++. ..++
T Consensus 226 ~~dG~V-----~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY------~KIm 294 (1317)
T KOG0612|consen 226 DADGTV-----RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY------GKIM 294 (1317)
T ss_pred CCCCcE-----EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH------HHHh
Confidence 765432 335679999999999874 2 67999999999999999999999999876666543 3343
Q ss_pred hhh-CCCCC--hHHHHHHHHHHHHhhccccCCCCc
Q 003694 673 DAQ-AGDWP--IKETKELAALGLSCAELRRKDRPD 704 (802)
Q Consensus 673 d~~-~~~~p--~~~~~~l~~li~~Cl~~~p~~RP~ 704 (802)
+.. ...+| ...+.+..+||.+.+. +|..|-.
T Consensus 295 ~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 295 NHKESLSFPDETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred chhhhcCCCcccccCHHHHHHHHHHhc-Chhhhcc
Confidence 332 23344 4578889999988775 5556654
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=320.03 Aligned_cols=234 Identities=23% Similarity=0.375 Sum_probs=186.4
Q ss_pred ceecCCCcEEEEEEEECCeEEEEEEE--cc----cCccchHHHHHHHHHHHhcCCCceeeecceecCCC----eEEEEEc
Q 003694 454 LRIGMGGYGTVYKGTFHHTFAAVKVL--QS----KGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYM 523 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~~~vavK~l--~~----~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~----~lV~Ey~ 523 (802)
..||+|.|-+||+|.+..+.+.|..- +. ......++|..|+.+|+.|+|||||++|.+|.+.. .+|.|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 36999999999999997665554431 11 12334478999999999999999999999986543 5899999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC-ceeEEeeecccccccCCCC
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~-~~~kl~DFGla~~~~~~~~ 602 (802)
..|+|..|+.+.+. ++...+..|++||+.||.|||++. +||||||||.+||+|+.+ |.+||+|+|||..+....
T Consensus 126 TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred cCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 99999999987654 777889999999999999999998 489999999999999876 999999999999877543
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh-
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI- 681 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~- 681 (802)
.....|||.|||||.+. ..|+..+||||||++++||+|+.-||.-.....+ .+..++. |..|.
T Consensus 201 -------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-----IYKKV~S---GiKP~s 264 (632)
T KOG0584|consen 201 -------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-----IYKKVTS---GIKPAA 264 (632)
T ss_pred -------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-----HHHHHHc---CCCHHH
Confidence 23469999999999887 7799999999999999999999999953222111 1111211 11111
Q ss_pred ---HHHHHHHHHHHHhhccccCCCCccccch
Q 003694 682 ---KETKELAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 682 ---~~~~~l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
-..+++.+||.+|+.. ..+||++.+.+
T Consensus 265 l~kV~dPevr~fIekCl~~-~~~R~sa~eLL 294 (632)
T KOG0584|consen 265 LSKVKDPEVREFIEKCLAT-KSERLSAKELL 294 (632)
T ss_pred hhccCCHHHHHHHHHHhcC-chhccCHHHHh
Confidence 1146899999999999 99999998533
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=299.94 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=195.9
Q ss_pred CCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCc------cchHHHHHHHHHHHhcCCCceeeecceecCCC--eE
Q 003694 449 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGN------IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~------~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~l 518 (802)
+|+....||+|+||.||+|.. .+..+|+|++..... .....+.+|+.+|++++||||+++++++.+.. ++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999986 456899999865331 12456889999999999999999999997655 89
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCc-eeEEeeecccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTML 597 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~-~~kl~DFGla~~~ 597 (802)
||||+++++|.+++.... ++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999886533 5888999999999999999999998 99999999999998775 6999999999877
Q ss_pred cCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhh-hhC
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQA 676 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld-~~~ 676 (802)
........ .......|+..|+|||++.+..++.++||||||+++|+|++|..||........ ...+..... ...
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~ 229 (268)
T cd06630 155 AAKGTGAG--EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATTA 229 (268)
T ss_pred ccccccCC--ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccCCC
Confidence 54321111 111234688999999999888899999999999999999999999963321110 001111111 112
Q ss_pred CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 677 GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 677 ~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...|...+..+.+++.+|+..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 260 (268)
T cd06630 230 PSIPEHLSPGLRDVTLRCLELQPEDRPPSRE 260 (268)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCcCHHH
Confidence 3455567788999999999999999999884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.24 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=198.3
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
++|+..+.||.|+||.||+|... +..+++|++.... ......+.+|+.+|+.++||||+++++.+.+.. ++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36888899999999999999874 5689999986543 234567899999999999999999999886544 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++++|.+++........+++.....++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999876543345899999999999999999999988 99999999999999999999999999987765432
Q ss_pred cccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC-
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP- 680 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p- 680 (802)
... .......|+..|++||++... .++.++|+|||||++|+|++|+.||........ +...+.......+
T Consensus 158 ~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~ 229 (267)
T cd06610 158 RTR--KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQNDPPSLET 229 (267)
T ss_pred ccc--cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcCCCCCcCC
Confidence 110 112334689999999988776 789999999999999999999999964432211 1111111111111
Q ss_pred ----hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 ----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+..+.+++.+|+..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 245678999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.93 Aligned_cols=243 Identities=24% Similarity=0.357 Sum_probs=191.6
Q ss_pred ecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCH
Q 003694 456 IGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 528 (802)
Q Consensus 456 iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL 528 (802)
||+|+||.||++... +..+|+|++.... ......+..|+.+|++++||||+++++.+.... |+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 5689999886532 223445778999999999999999999886544 899999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccc
Q 003694 529 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 608 (802)
Q Consensus 529 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 608 (802)
.+++..... ..+++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++........
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~------ 150 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK------ 150 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc------
Confidence 998876543 45899999999999999999999988 99999999999999999999999999986543211
Q ss_pred cccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHH
Q 003694 609 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 688 (802)
Q Consensus 609 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 688 (802)
.....++..|++||++.++.++.++|||||||++|+|++|+.||....... ....+...........+...+..+.
T Consensus 151 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (277)
T cd05577 151 -IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV---EKEELKRRTLEMAVEYPDKFSPEAK 226 (277)
T ss_pred -cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc---cHHHHHhccccccccCCccCCHHHH
Confidence 123467889999999988889999999999999999999999996433210 0111111111112233445578899
Q ss_pred HHHHHhhccccCCCCccccchhhH
Q 003694 689 ALGLSCAELRRKDRPDLKNQVLPV 712 (802)
Q Consensus 689 ~li~~Cl~~~p~~RP~~~~~v~~~ 712 (802)
+++.+||+.+|.+||++.+.....
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ 250 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADE 250 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHH
Confidence 999999999999999887633333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.99 Aligned_cols=248 Identities=24% Similarity=0.420 Sum_probs=193.4
Q ss_pred CCcccceecCCCcEEEEEEEECC---eEEEEEEEcccC----------ccchHHHHHHHHHHHh-cCCCceeeecceecC
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH---TFAAVKVLQSKG----------NIQNKQFLQELEVLSK-IRHPHLLLLLGACPD 514 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~---~~vavK~l~~~~----------~~~~~~~~~Ei~il~~-l~Hpniv~l~g~~~~ 514 (802)
+|.....||+|+||.||+|.+.. ..+|+|.+.... ......+.+|+.++.+ ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778889999999999999864 689999875432 1223457789988875 799999999999866
Q ss_pred CC--eEEEEEccCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEecCCceeEEee
Q 003694 515 HG--CLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGD 590 (802)
Q Consensus 515 ~~--~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl~~~~~~kl~D 590 (802)
.. ++||||+++++|.+++... .....+++..++.++.|++.||.|||. .+ |+|+||+|+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 55 8999999999999988542 233458899999999999999999996 55 99999999999999999999999
Q ss_pred ecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHH
Q 003694 591 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 670 (802)
Q Consensus 591 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~ 670 (802)
||++....... ......|+..|++||++.++.++.++||||||+++|+|++|++||......... ..
T Consensus 158 fg~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~------~~ 224 (269)
T cd08528 158 FGLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA------TK 224 (269)
T ss_pred ccceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH------HH
Confidence 99998765432 123457899999999999888999999999999999999999999643322110 11
Q ss_pred HhhhhCCCCC-hHHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 671 ILDAQAGDWP-IKETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 671 ~ld~~~~~~p-~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
+........+ ...+..+.+++.+||+.+|.+||++.+ +...+
T Consensus 225 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e-~~~~~ 267 (269)
T cd08528 225 IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQ-VSAMI 267 (269)
T ss_pred HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHH-HHHHh
Confidence 1111111111 134678999999999999999999984 44443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=308.03 Aligned_cols=240 Identities=19% Similarity=0.293 Sum_probs=190.9
Q ss_pred cccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCC
Q 003694 451 SENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 451 ~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
....+||+|+||.||++... +..||||.+........+.+.+|+.+++.++||||+++++.+.... ++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33457999999999999874 5689999987655555667899999999999999999999886544 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 105 ~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--- 174 (292)
T cd06658 105 ALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--- 174 (292)
T ss_pred cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc---
Confidence 999987432 3788899999999999999999988 999999999999999999999999999765432211
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHH
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 686 (802)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||......... ..+...+... .......+..
T Consensus 175 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~ 247 (292)
T cd06658 175 ---RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---RRIRDNLPPR-VKDSHKVSSV 247 (292)
T ss_pred ---CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcCCCc-cccccccCHH
Confidence 12346899999999998888999999999999999999999999643322110 0011111111 1112234667
Q ss_pred HHHHHHHhhccccCCCCcccc
Q 003694 687 LAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+..++.+|+..+|.+||++.+
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~ 268 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQE 268 (292)
T ss_pred HHHHHHHHccCChhHCcCHHH
Confidence 899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.49 Aligned_cols=242 Identities=26% Similarity=0.393 Sum_probs=195.1
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|.....||+|+||.||++... +..+|+|.+.... ......+.+|+.+|++++||||+++++.+.... ++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777889999999999998874 5689999886542 234567889999999999999999999886544 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC-ceeEEeeecccccccCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~-~~~kl~DFGla~~~~~~~ 601 (802)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999987543 335889999999999999999999988 9999999999999854 568999999998765432
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ ............+.
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 223 (256)
T cd08220 157 K-------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKIMSGTFAPISD 223 (256)
T ss_pred c-------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHHHhcCCCCCCC
Confidence 1 1234688999999999888899999999999999999999999964332111 11122222223344
Q ss_pred HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+.+++.+||..+|.+||++.+
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ 249 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQ 249 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHH
Confidence 56778999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=299.52 Aligned_cols=240 Identities=25% Similarity=0.273 Sum_probs=197.5
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
+|.....||.|+||.||+|.+. +..||+|++..... ...+.+.+|+.++++++||||+++++++.+.. ++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778889999999999999986 67899999875432 23567899999999999999999999986544 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|+.+++|.+++... .++++..+..|+.||+.||.|||..+ |+|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998654 35888999999999999999999988 9999999999999999999999999998765432
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
......|+..|++||++.+..++.++|+||||+++|+|++|+.||...... ....+...........|.
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~ 223 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETADVLYPA 223 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccccccCcc
Confidence 113346889999999998888999999999999999999999999644321 011112222212234455
Q ss_pred HHHHHHHHHHHHhhccccCCCCcc
Q 003694 682 KETKELAALGLSCAELRRKDRPDL 705 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~ 705 (802)
..+..+.+++.+||..+|.+||++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCc
Confidence 567899999999999999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=294.08 Aligned_cols=249 Identities=25% Similarity=0.276 Sum_probs=206.1
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHH---HHHHHHHHhcCCCceeeecceecC--CCeEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGACPD--HGCLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~---~~Ei~il~~l~Hpniv~l~g~~~~--~~~lV~ 520 (802)
++|...+.||+|.||.|.+++-+ ++.+|+|+++.......++. +.|-.+|...+||.+..|-..|+. ..|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 46778889999999999999875 56999999998766665554 568899999999999999887754 449999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||..||.|.-+|.+.. .++.....-+-.+|+.||.|||+.+ ||+||||.+|+|||.+|++||+|||||+.--..
T Consensus 248 eyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999988886643 3666666678899999999999988 999999999999999999999999999864332
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
.. .....+|||.|+|||++....|+..+|+|.+||++|||++|+.||... +.+.+.+++-...-.+|
T Consensus 322 g~------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~-------dh~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 322 GD------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK-------DHEKLFELILMEDLKFP 388 (516)
T ss_pred cc------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc-------chhHHHHHHHhhhccCC
Confidence 22 235679999999999999999999999999999999999999999533 45566666666556678
Q ss_pred hHHHHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
...+++...|+.-.+..||++|-.-...=..++.+
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 88889999999999999999996654333333333
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=305.95 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=190.5
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|+..++||+|+||.||+|.+. +..||+|++..... ...+.+.+|+++++.++||||++++++|.+.. ++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 6778899999999999999985 56899998764332 23456889999999999999999999996654 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++++|..+.... ..+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++..+.....
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 82 VDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 9999888765432 23889999999999999999999988 99999999999999999999999999987644321
Q ss_pred cccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchh--------hhHHHhh
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--------NLAEILD 673 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~l~~~ld 673 (802)
......++..|+|||++.+ ..++.++||||||+++|+|+||++||......+...... ......+
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 156 ------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred ------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence 1133468899999998765 447889999999999999999999996433221100000 0000000
Q ss_pred ------hh-CCC---------CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 674 ------AQ-AGD---------WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ------~~-~~~---------~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.. ... .....+..+.+|+.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 279 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHH
Confidence 00 000 01134677999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.75 Aligned_cols=246 Identities=26% Similarity=0.393 Sum_probs=195.1
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
.|.....||+|+||.||+|... +..+++|++...... ....+..|+.++++++||||+++++++.+.. ++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3677789999999999999874 568999998765443 5567899999999999999999999986544 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++++|.+++.... .+++..+..|+.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999886532 3788889999999999999999988 99999999999999999999999999988764432
Q ss_pred cccccccccCCccCcccCCccccccCC---CCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGL---ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
.... ......++..|++||++.+.. ++.++||||||+++|+|++|+.||........ ....+........
T Consensus 155 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~ 227 (264)
T cd06626 155 TMGE--EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMFHVGAGHKPPI 227 (264)
T ss_pred cccc--cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HHHHHhcCCCCCC
Confidence 1111 012356889999999988766 88999999999999999999999963321110 0011111111223
Q ss_pred ChH--HHHHHHHHHHHhhccccCCCCcccc
Q 003694 680 PIK--ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 680 p~~--~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
|.. .+..+.+++.+||+.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 257 (264)
T cd06626 228 PDSLQLSPEGKDFLDRCLESDPKKRPTASE 257 (264)
T ss_pred CcccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 332 3678899999999999999999884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=300.85 Aligned_cols=247 Identities=27% Similarity=0.381 Sum_probs=196.0
Q ss_pred HhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeecceecCC------
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH------ 515 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~------ 515 (802)
..+++|.....||.|+||.||+|... +..+++|++..... ....|.+|+.+++++ +||||++++++|.+.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35678999999999999999999985 45899998876543 346789999999999 699999999998432
Q ss_pred --CeEEEEEccCCCHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeec
Q 003694 516 --GCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 592 (802)
Q Consensus 516 --~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFG 592 (802)
.++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 379999999999999886532 2345889999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCccCcccCCcccccc-----CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhh
Q 003694 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 667 (802)
Q Consensus 593 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~ 667 (802)
++........ ......|++.|+|||++.. ..++.++|||||||+||+|+||++||...+... .
T Consensus 159 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~ 226 (275)
T cd06608 159 VSAQLDSTLG------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------A 226 (275)
T ss_pred cceecccchh------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------H
Confidence 9986543221 1234578999999998753 346789999999999999999999996432221 1
Q ss_pred hHHHhhhhCCC--CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 668 LAEILDAQAGD--WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 668 l~~~ld~~~~~--~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+..+....... .+...+..+.+|+.+||..+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ 268 (275)
T cd06608 227 LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE 268 (275)
T ss_pred HHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHH
Confidence 11222211111 12235678999999999999999999984
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=288.84 Aligned_cols=243 Identities=22% Similarity=0.364 Sum_probs=192.8
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
+++|+.-..||+|.|+.||++... +..+|+|++... .....+.+.+|+.|-..|+|||||+|.....+.. |||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 346667778999999999998775 447788876533 2335677889999999999999999999886655 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEec---CCceeEEeeecccccc
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTML 597 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~---~~~~~kl~DFGla~~~ 597 (802)
|+|.||+|..-+.... .+++...-..+.||+.+|.|+|.++ |||||+||.|+||. ..--+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999977665432 2667778889999999999999999 99999999999994 3456799999999988
Q ss_pred cCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccc--hhhhhhchhhhHHHhhhh
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH--KVETAIDEDNLAEILDAQ 675 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~--~~~~~~~~~~l~~~ld~~ 675 (802)
.+.. ...+.+|||+|||||+++..+|+..+|||+.|||||-||.|.+||.... ..-..+..+ -.|..
T Consensus 164 ~~g~-------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g----~yd~~ 232 (355)
T KOG0033|consen 164 NDGE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG----AYDYP 232 (355)
T ss_pred CCcc-------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc----ccCCC
Confidence 7321 2467799999999999999999999999999999999999999996421 111111111 11222
Q ss_pred CCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 676 AGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 676 ~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+.|+ ...++..+|+.+|+..||.+|.+..+
T Consensus 233 ~~~w~-~is~~Ak~LvrrML~~dP~kRIta~E 263 (355)
T KOG0033|consen 233 SPEWD-TVTPEAKSLIRRMLTVNPKKRITADE 263 (355)
T ss_pred CcccC-cCCHHHHHHHHHHhccChhhhccHHH
Confidence 23444 35788899999999999999999885
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=303.85 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=189.3
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|+....||.|+||.||+|... +..||||.+.... ......+.+|++++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5788889999999999999884 5689999886543 223357889999999999999999999986554 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+. ++|..++.... ...+++..+..++.|++.||.|||..+ ++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68988876543 345899999999999999999999988 99999999999999999999999999986643221
Q ss_pred cccccccccCCccCcccCCccccccCC-CCCcccchhHHHHHHHHHhCCCCccccchhhhhhchh--------hh----H
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--------NL----A 669 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~l----~ 669 (802)
. .....+++.|+|||++.+.. ++.++||||||+++|+|+||+.||............. .+ .
T Consensus 156 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 T------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred c------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 1 12335788999999876544 6889999999999999999999996443222111000 00 0
Q ss_pred HHhh--hhCCCC--------ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 670 EILD--AQAGDW--------PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 670 ~~ld--~~~~~~--------p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+.. .....+ .......+.+++.+|++.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 277 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKA 277 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHH
Confidence 0000 000001 1123466789999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.13 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=190.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|+....||+|+||.||+|.+. +..||+|++.... ....+.+.+|+.+++.++|||++++++++.+.. ++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5778889999999999999985 5689999876432 223456889999999999999999999986554 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 82 CDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred cCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9998887765432 24899999999999999999999988 99999999999999999999999999987654321
Q ss_pred cccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchh-hhH-------HHhh
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED-NLA-------EILD 673 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~-~l~-------~~ld 673 (802)
. .....++..|+|||++.+ ..++.++||||||+++|+|+||++||......+...... .+. .+.+
T Consensus 156 ~------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 156 D------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred c------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 1 123467889999998765 457899999999999999999999996443322111000 000 0000
Q ss_pred h----------hC-CCCC-----hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 674 A----------QA-GDWP-----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ~----------~~-~~~p-----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. .. ...+ ...+..+.+|+.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 279 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE 279 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHH
Confidence 0 00 0000 123567899999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.19 Aligned_cols=237 Identities=25% Similarity=0.316 Sum_probs=192.7
Q ss_pred ecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCH
Q 003694 456 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 528 (802)
Q Consensus 456 iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL 528 (802)
||.|+||.||++.+. +..+++|++..... ...+.+.+|+.+++.++||||+++++++.+.. ++||||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999997 67999999865432 23467899999999999999999999986554 899999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccc
Q 003694 529 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 608 (802)
Q Consensus 529 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 608 (802)
.+++.+.. .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------- 147 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------- 147 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------
Confidence 99986543 3788899999999999999999988 9999999999999999999999999998765432
Q ss_pred cccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhh-hhCCCCChHHHHHH
Q 003694 609 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAGDWPIKETKEL 687 (802)
Q Consensus 609 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~~~~~l 687 (802)
......|++.|++||++....++.++|+||||+++|+|++|..||...... ....+..+.. ......|...+..+
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNGKLEFPNYIDKAA 223 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCCCCCCCcccCHHH
Confidence 112346889999999998888999999999999999999999999754310 0111222221 22234455557899
Q ss_pred HHHHHHhhccccCCCCccccch
Q 003694 688 AALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 688 ~~li~~Cl~~~p~~RP~~~~~v 709 (802)
.+++.+||..+|.+||++.+..
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~ 245 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGG 245 (262)
T ss_pred HHHHHHHccCChhhCcCCcccC
Confidence 9999999999999999965433
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.31 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=188.5
Q ss_pred hcCCcccceecCCCcEEEEEEEEC-CeEEEEEEEccc--CccchHHHHHHHHHHHhcC-CCceeeecceecCCC--eEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~lV~ 520 (802)
...|++.++||+||.+.||++... .+.||+|.+... .......|.+|+.+|.+|+ |.+||+||+|-...+ ||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 345888899999999999999875 457777765433 3445677999999999996 999999999864333 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||=+ .+|..+|...... ...| -+..+..|++.++.++|.+| |||.||||.|+|+- .|.+||+|||+|.-+..+
T Consensus 440 E~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 9864 6899988765543 2334 56678899999999999999 99999999999995 468999999999988765
Q ss_pred CCcccccccccCCccCcccCCccccccCC-----------CCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhH
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGL-----------ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 669 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----------~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~ 669 (802)
. +.......+||+.||+||.+.... .+.++||||||||||+|+.|++||+...... ..+.
T Consensus 513 T----TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~-----aKl~ 583 (677)
T KOG0596|consen 513 T----TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI-----AKLH 583 (677)
T ss_pred c----cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-----HHHH
Confidence 3 223345679999999999764322 5678999999999999999999997433222 2344
Q ss_pred HHhhhhC----CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 670 EILDAQA----GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 670 ~~ld~~~----~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+.++.. ++.|. ..++.+++..||..||++||+..+
T Consensus 584 aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~e 623 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPE 623 (677)
T ss_pred hhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHH
Confidence 5555532 22222 233999999999999999999884
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.41 Aligned_cols=241 Identities=24% Similarity=0.371 Sum_probs=195.4
Q ss_pred cCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCC--CeEEEEEc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~lV~Ey~ 523 (802)
.+|...+.||+|+||.||+|.. ++..+++|.+........+.+.+|+.++++++||||+++++.|.+. .++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788889999999999999986 4568999998765555567789999999999999999999998544 48999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++|+|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999988543 3788899999999999999999998 99999999999999999999999999876654321
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCC--CCh
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD--WPI 681 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~--~p~ 681 (802)
......|++.|++||++..+.++.++||||||+++|+|++|+.||.......... .+.....+. .+.
T Consensus 171 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~~~~~~~~ 239 (293)
T cd06647 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGTPELQNPE 239 (293)
T ss_pred -----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCCCCCCCcc
Confidence 1123468899999999988889999999999999999999999996443221110 000011111 122
Q ss_pred HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+.+++.+||..+|.+||++.+
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~ 265 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKE 265 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHH
Confidence 34667999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.80 Aligned_cols=251 Identities=17% Similarity=0.206 Sum_probs=184.7
Q ss_pred cceecCC--CcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEcc
Q 003694 453 NLRIGMG--GYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 453 ~~~iG~G--~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
..+||+| +||+||++... +..||+|.+.... ......+.+|+.+++.++||||++++++|.+.. ++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3579999 78999999875 5689999987543 223355778999999999999999999986544 89999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++.... ...+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+..........
T Consensus 83 ~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999886533 234889999999999999999999988 9999999999999999999999998765443211100
Q ss_pred c-ccccccCCccCcccCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhh--chhhhHHHhhh-----
Q 003694 605 S-TTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI--DEDNLAEILDA----- 674 (802)
Q Consensus 605 ~-~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~--~~~~l~~~ld~----- 674 (802)
. .........++..|+|||++.+ ..++.++|||||||++|+|+||+.||.......... ..+.....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 0 0001122357788999999875 458999999999999999999999996322111000 00000000000
Q ss_pred ------------------------hC--------CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 675 ------------------------QA--------GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 675 ------------------------~~--------~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.. ..........+.+|+.+||+.||.+||++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e 303 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAST 303 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHH
Confidence 00 0011123568999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.43 Aligned_cols=239 Identities=26% Similarity=0.400 Sum_probs=192.8
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEcc
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
|....+||.|+||.||+|.+. +..+|+|++.... ......|.+|+.++.+++||||+++++++.+.. ++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 566778999999999999874 5689999876432 233457889999999999999999999986544 89999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 86 ~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 86 GGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 9999998853 24889999999999999999999988 99999999999999999999999999876643211
Q ss_pred cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 684 (802)
......|+..|++||++.+..++.++|+|||||++|+|+||..||........ ...+........+...+
T Consensus 157 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~ 226 (277)
T cd06641 157 ----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFLIPKNNPPTLEGNYS 226 (277)
T ss_pred ----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HHHHhcCCCCCCCcccC
Confidence 12334688999999999888899999999999999999999999964322111 11111111222344567
Q ss_pred HHHHHHHHHhhccccCCCCcccc
Q 003694 685 KELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+.+++.+|+..+|.+||++.+
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~ 249 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKE 249 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHH
Confidence 78999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=300.02 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=198.9
Q ss_pred HhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
..+++|.....||.|+||.||+|.+. +..+++|++..... ....+.+|++++..++|||++++++++.... ++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35567888889999999999999986 67899999876544 5667889999999999999999999986544 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999997654 35899999999999999999999988 999999999999999999999999998765533
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCC--
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD-- 678 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~-- 678 (802)
.. ......++..|++||++.+..++.++|||||||++|+|+||+.||......... ..+.......
T Consensus 170 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~~ 237 (286)
T cd06614 170 KS------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL------FLITTKGIPPLK 237 (286)
T ss_pred hh------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcCCCCCc
Confidence 21 112345788999999998888999999999999999999999999643322111 1111111111
Q ss_pred CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+...+..+.+++.+|++.+|..||++.+
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 266 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEE 266 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHH
Confidence 12225678999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.95 Aligned_cols=240 Identities=26% Similarity=0.412 Sum_probs=192.0
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcC---CCceeeecceecCCC--eEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIR---HPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~---Hpniv~l~g~~~~~~--~lV~ 520 (802)
.|+....||.|+||.||+|.+. +..+|+|.+.... ......+.+|+.++++++ |||+++++++|.+.. ++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4667788999999999999974 5689999987543 334567889999999997 999999999986554 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++++|.+++... .+++.....++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999987542 5889999999999999999999988 999999999999999999999999999876543
Q ss_pred CCcccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
.. ......|+..|+|||++.++ .++.++|+|||||++|+|++|.+||.......... .+........
T Consensus 155 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------~~~~~~~~~~ 222 (277)
T cd06917 155 SS------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------LIPKSKPPRL 222 (277)
T ss_pred cc------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------ccccCCCCCC
Confidence 21 12334789999999988654 46899999999999999999999996443221110 0001111122
Q ss_pred Ch-HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 680 PI-KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 680 p~-~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+. ..+..+.+++.+||+.+|.+||++.+
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 251 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEE 251 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 22 25678999999999999999999884
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=291.12 Aligned_cols=241 Identities=27% Similarity=0.435 Sum_probs=197.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEcc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
.|.....||.|+||.||++... +..+++|++..........+.+|+.++++++|||++++++++.... ++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677789999999999999986 6789999987765545678999999999999999999999986544 89999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+++|.+++.... ..+++..+..++.+++.||.|||..+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999886543 35899999999999999999999988 99999999999999999999999999987664321
Q ss_pred cccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC--ChH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW--PIK 682 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~--p~~ 682 (802)
.....++..|++||++....++.++||||||+++|+|++|++||.......... .......... +..
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~ 222 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KIATNGPPGLRNPEK 222 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHHhcCCCCcCcccc
Confidence 133478899999999988889999999999999999999999996432211111 0111111112 222
Q ss_pred HHHHHHHHHHHhhccccCCCCcccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..+.+++.+|+..+|.+||++.+
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHH
Confidence 3678999999999999999999974
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=300.12 Aligned_cols=239 Identities=20% Similarity=0.309 Sum_probs=192.2
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCC--CeEEEEEccC
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMEN 525 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~lV~Ey~~~ 525 (802)
|....+||+|+||.||++... +..+++|++........+.+.+|+.+++.++||||+++++++... .++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999864 568999988765555556788999999999999999999987543 4899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc---
Confidence 999998865 24788899999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh--CCCCChHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ--AGDWPIKE 683 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~--~~~~p~~~ 683 (802)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||........ +..+.... ....+...
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 241 (285)
T cd06648 171 ---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRDNLPPKLKNLHKV 241 (285)
T ss_pred ---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHhcCCCCCcccccC
Confidence 11234689999999999888899999999999999999999999864332211 11111111 11112235
Q ss_pred HHHHHHHHHHhhccccCCCCcccc
Q 003694 684 TKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+..+.+++.+||..+|.+||++.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHH
Confidence 678999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=295.01 Aligned_cols=243 Identities=23% Similarity=0.398 Sum_probs=195.3
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|...+.||.|+||.||+|... +..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.+.. ++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999885 5689999886542 223456889999999999999999999986654 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCc-eeEEeeecccccccCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~-~~kl~DFGla~~~~~~~ 601 (802)
+++++|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999998865432 35789999999999999999999988 99999999999998885 56999999998765432
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
.. .....|++.|+|||++.+..++.++|+||||+++|+|++|..||....... .............+.
T Consensus 157 ~~------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~ 224 (257)
T cd08225 157 EL------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQGYFAPISP 224 (257)
T ss_pred cc------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhcccCCCCCC
Confidence 11 122468999999999988889999999999999999999999996433211 112222222222333
Q ss_pred HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+.+++.+||..+|.+||++.+
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHH
Confidence 45678999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.59 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=190.1
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc-----chHHHHHHHHHHHhcCCCceeeecceecCCC--eEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-----QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~-----~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
+|.....||.|+||.||+|.+. ++.|+||.+...... ....+..|++++++++||||+++++++.+.. ++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667788999999999999875 569999998755332 2345678999999999999999999997654 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|||+ +|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999986543 35899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch---------hhhH
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLA 669 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~---------~~l~ 669 (802)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||............ ..+.
T Consensus 155 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 155 PNR------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred CCc------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 321 1123357889999998754 45789999999999999999998888643322110000 0000
Q ss_pred ------HHhhhh-CCC-----CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 670 ------EILDAQ-AGD-----WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 670 ------~~ld~~-~~~-----~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...... ... .....+..+.+++.+||..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 000000 000 01223578899999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=298.60 Aligned_cols=244 Identities=26% Similarity=0.375 Sum_probs=188.4
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHH-HHhcCCCceeeecceecCCC--eEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEV-LSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~i-l~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
++|.....||+|+||.||++.+. +..||+|.+..... .....+..|+.+ ++.++||||+++++++.+.. ++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999985 67999998875432 233456667776 55668999999999986544 89999
Q ss_pred EccCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 522 YMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 522 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|++ |+|.+++... .....+++..+..++.||+.||.|||+. + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 7888877642 2335689999999999999999999986 6 99999999999999999999999999986543
Q ss_pred CCCcccccccccCCccCcccCCcccccc----CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRT----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~ 675 (802)
.. ..+...|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||...... ...+...+...
T Consensus 157 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~ 224 (283)
T cd06617 157 SV-------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVEEP 224 (283)
T ss_pred cc-------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHhcC
Confidence 21 1123468899999998754 45688999999999999999999999532111 11122222222
Q ss_pred CCCCC-hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 676 AGDWP-IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 676 ~~~~p-~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
....| ...+..+.+++.+||..+|.+||++.+
T Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 257 (283)
T cd06617 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPE 257 (283)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 22222 234678999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.34 Aligned_cols=249 Identities=20% Similarity=0.323 Sum_probs=192.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
+|+..++||.|+||.||+|++. +..||||++...... ....+.+|+.++++++||||++++++|.+.. ++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999985 668999998765332 3456788999999999999999999986554 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
+ |+|.+++........+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 8 589888876554456899999999999999999999988 99999999999999999999999999976543211
Q ss_pred ccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhc---------hhhhHHHhh
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---------EDNLAEILD 673 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~---------~~~l~~~ld 673 (802)
......+++.|++||++.+ ..++.++|||||||++|+|++|++||......+.... ...+..+..
T Consensus 156 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1123467889999998765 3578899999999999999999999964432221100 000000000
Q ss_pred h--hCCC-----------CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 674 A--QAGD-----------WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ~--~~~~-----------~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. .... .....+..+.+++.+|++.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 277 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence 0 0000 11133567889999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=297.52 Aligned_cols=243 Identities=23% Similarity=0.347 Sum_probs=190.0
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc----------chHHHHHHHHHHHhcCCCceeeecceecCCC
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI----------QNKQFLQELEVLSKIRHPHLLLLLGACPDHG 516 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~----------~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~ 516 (802)
+|.....||.|+||.||+|... +..+|+|.+...... ..+.+..|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667788999999999999764 568999987532110 1245788999999999999999999986544
Q ss_pred --eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccc
Q 003694 517 --CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594 (802)
Q Consensus 517 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla 594 (802)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 8999999999999998654 35888899999999999999999988 999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccCcccCCccccccCC--CCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHh
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 672 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~l 672 (802)
......... .......|+..|+|||++.... ++.++|+||||+++|+|++|..||.......... ++.
T Consensus 156 ~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~ 225 (272)
T cd06629 156 KKSDDIYDN----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF------KLG 225 (272)
T ss_pred ccccccccc----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH------Hhh
Confidence 765432111 1123456889999999887654 7899999999999999999999996433222111 111
Q ss_pred hh-hCCCCC----hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 673 DA-QAGDWP----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 673 d~-~~~~~p----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.. .....+ ...+..+.+++.+||..+|.+||++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (272)
T cd06629 226 NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265 (272)
T ss_pred ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 00 011111 234678999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=301.75 Aligned_cols=238 Identities=26% Similarity=0.399 Sum_probs=188.8
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
..|.....||+|+||.||+|... +..||+|++..... .....+.+|+.+++.++||||++++++|.+.. ++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34777889999999999999874 67899998864322 23356889999999999999999999986544 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+. |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 67777765433 34899999999999999999999988 999999999999999999999999998765432
Q ss_pred CCcccccccccCCccCcccCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 677 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~ 677 (802)
....|++.|+|||++. .+.++.++||||||+++|+|+||++||......... ..+......
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~~~~~~~ 232 (307)
T cd06607 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNDSP 232 (307)
T ss_pred ----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHHhcCCCC
Confidence 2346788999999874 456889999999999999999999999644322211 111111111
Q ss_pred CC-ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 678 DW-PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 678 ~~-p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.. +...+..+.+++.+||..+|.+||++.+
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 263 (307)
T cd06607 233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEE 263 (307)
T ss_pred CCCchhhCHHHHHHHHHHhcCChhhCcCHHH
Confidence 11 2235678999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.56 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=191.9
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|.....||.|+||.||+|.+. ++.|++|++.... ......+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999874 6799999987643 223467899999999999999999999986554 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+ +++|.+++.... .++++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886544 45899999999999999999999988 99999999999999999999999999987654321
Q ss_pred cccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhh---c---h---hhhH---
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI---D---E---DNLA--- 669 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~---~---~---~~l~--- 669 (802)
. ......|+..|+|||++.+. .++.++||||||+++|+|+||.+||.......... . . ..+.
T Consensus 155 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 R-----LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred C-----ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 0 11334789999999987654 46899999999999999999988885433211100 0 0 0000
Q ss_pred ------HHhhhhCC-----CCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 670 ------EILDAQAG-----DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 670 ------~~ld~~~~-----~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+...... ......+..+.+++.+|+..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 278 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE 278 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHH
Confidence 00000000 001133578899999999999999999884
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.31 Aligned_cols=247 Identities=22% Similarity=0.311 Sum_probs=187.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|....+||.|+||.||+|.+. +..+|+|.+..... .....+.+|+.++++++||||+++++++.+.. ++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677789999999999999985 56899998865322 22356788999999999999999999986554 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 58888776433 34899999999999999999999988 99999999999999999999999999986543221
Q ss_pred cccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch----------hhh---
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE----------DNL--- 668 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~----------~~l--- 668 (802)
......+++.|+|||++.+. .++.++|||||||++|+|+||..|+.........+.. ..+
T Consensus 155 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 155 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred ------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 11234678999999987664 4789999999999999999998886432221111100 000
Q ss_pred HHHhhhh-CCCC---------ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 669 AEILDAQ-AGDW---------PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 669 ~~~ld~~-~~~~---------p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
....+.. .... ....+..+.+|+.+||+.+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 277 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH
Confidence 0000000 0000 1123567889999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.41 Aligned_cols=256 Identities=16% Similarity=0.194 Sum_probs=181.4
Q ss_pred hcCCcccceecCCCcEEEEEEEECCe-----EEEEEEEcccCccch-----------HHHHHHHHHHHhcCCCceeeecc
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHHT-----FAAVKVLQSKGNIQN-----------KQFLQELEVLSKIRHPHLLLLLG 510 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~~-----~vavK~l~~~~~~~~-----------~~~~~Ei~il~~l~Hpniv~l~g 510 (802)
...|...++||+|+||.||+|.+.++ .+++|+......... .....+...+..+.|+|++.+++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35788999999999999999987544 567776443322111 11122334455678999999998
Q ss_pred eecCCC------eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCc
Q 003694 511 ACPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 584 (802)
Q Consensus 511 ~~~~~~------~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~ 584 (802)
++.... +++++++. .++.+.+... ...++..+..|+.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 764332 56777764 4666665432 22567788899999999999999988 99999999999999999
Q ss_pred eeEEeeecccccccCCCCccc-ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhh-
Q 003694 585 VSKIGDVGLSTMLNSDPSFVS-TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA- 662 (802)
Q Consensus 585 ~~kl~DFGla~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~- 662 (802)
.++|+|||+++.+........ .........||+.|+|||++.+..++.++|||||||+||||+||++||.........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987653321111 011123347999999999999999999999999999999999999999644211111
Q ss_pred --hchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhH
Q 003694 663 --IDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPV 712 (802)
Q Consensus 663 --~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~ 712 (802)
...+.+..+..... .+...+..+.+++..|+..+|.+||++. ++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~-~l~~~ 292 (294)
T PHA02882 244 HAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYD-ALIKI 292 (294)
T ss_pred HHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHH-HHHHh
Confidence 11111122221111 1223467899999999999999999998 45443
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=300.02 Aligned_cols=248 Identities=20% Similarity=0.336 Sum_probs=187.9
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
++|....+||.|+||.||+|... ++.||+|.+..... .....+.+|++++++++||||+++++++.+.. ++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 46888899999999999999874 57899999865432 22345778999999999999999999987654 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+. ++|.+++..... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 98 599998865432 5888999999999999999999988 99999999999999999999999999875432111
Q ss_pred cccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhc----------hhhhHHH
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID----------EDNLAEI 671 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~----------~~~l~~~ 671 (802)
......++..|+|||++.+ ..++.++||||||+++|+|++|++||.........+. ...+...
T Consensus 159 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred ------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence 0122357889999998765 4588999999999999999999999964431111100 0000000
Q ss_pred hhh------hCCCC----------ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 672 LDA------QAGDW----------PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 672 ld~------~~~~~----------p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
... ....+ .......+.+++.+|++.+|.+||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e 284 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE 284 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHH
Confidence 000 00000 0111267789999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.79 Aligned_cols=248 Identities=26% Similarity=0.373 Sum_probs=192.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|+...+||+|+||.||+|.+. +..|++|++.... ......+.+|++++++++||||++++++|.+.. ++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6788899999999999999885 4589999876532 233467899999999999999999999986544 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
++++.|..++... ..+++..+..++.+|+.||.|||..+ |+||||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9987776554332 34888999999999999999999988 99999999999999999999999999987664332
Q ss_pred cccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhh--------HHHhh
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL--------AEILD 673 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l--------~~~ld 673 (802)
. ......++..|+|||++.+. .++.++||||||+++|+|++|++||............... .....
T Consensus 156 ~-----~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 156 S-----PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred c-----cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 1 11335688999999999887 7899999999999999999999999644322211100000 00000
Q ss_pred ------------hh-----CCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 674 ------------AQ-----AGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ------------~~-----~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.. ...++...+..+.+|+.+||..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 281 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHH
Confidence 00 00112233688999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=301.42 Aligned_cols=241 Identities=23% Similarity=0.276 Sum_probs=189.9
Q ss_pred CCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccchH---HHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~---~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
-|...+.||-|.||.|.++.-.. ..||+|.|.......+. ....|-+||..-+.+.||+||..|+|.. |+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 46777889999999999987544 47899988776544443 3577999999999999999999998765 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|++||++..+|.+.+- |++.....++.++.+|+++.|..| +|||||||+|||||.+|++||.|||||.-+....
T Consensus 710 YIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999987664 677777778899999999999999 9999999999999999999999999997654221
Q ss_pred Cccc------------------------------------ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHH
Q 003694 602 SFVS------------------------------------TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 645 (802)
Q Consensus 602 ~~~~------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~e 645 (802)
+... ........+||+.|+|||++....|+..||+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1000 0011234589999999999999999999999999999999
Q ss_pred HHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHH-hhccc
Q 003694 646 LLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLS-CAELR 698 (802)
Q Consensus 646 lltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~-Cl~~~ 698 (802)
|+.|++||......++...-.++...++... -.+.+.+...||.+ |+..+
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~---~~~ls~e~~~li~kLc~sad 914 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPY---QGNLSKEALDLIQKLCCSAD 914 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhcccccc---ccccCHHHHHHHHHHhcChh
Confidence 9999999987777666666666666665431 12234455555554 55443
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.90 Aligned_cols=247 Identities=20% Similarity=0.311 Sum_probs=188.8
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
|+...+||.|++|.||+|.+. ++.||+|++..... .....+.+|+++++.++|||++++++++.+.. ++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566778999999999999874 67999999875432 23356889999999999999999999987655 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
+ ++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 689998865432 35899999999999999999999988 99999999999999999999999999976543211
Q ss_pred ccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch---------hh---h--
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DN---L-- 668 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~---------~~---l-- 668 (802)
......+++.|+|||++.+. .++.++||||||+++|+|+||++||............ .. .
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 11233578999999987654 5788999999999999999999999644332211100 00 0
Q ss_pred -HHHhhh-------hCCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 669 -AEILDA-------QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 669 -~~~ld~-------~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...... .........+..+.+++.+|++.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 276 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 000000 000111223467899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.68 Aligned_cols=241 Identities=24% Similarity=0.405 Sum_probs=197.6
Q ss_pred CcccceecCCCcEEEEEEEECCe--EEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeccee--cCCCeEEEEEccC
Q 003694 450 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMEN 525 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~--~~~~~lV~Ey~~~ 525 (802)
|.+...||.|+||.||++..+.+ ..|.|++........++|+-||+||..++||+||+|+++| .....+..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 44455699999999999988765 5678888877777788999999999999999999999865 3444889999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|-.+..+..-+. +|...++.-++.|++.||.|||+.. |||||||..|||++.+|.++|+|||.+.... .
T Consensus 114 GAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~------~ 182 (1187)
T KOG0579|consen 114 GAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK------S 182 (1187)
T ss_pred chHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch------h
Confidence 999888766543 5888899999999999999999998 9999999999999999999999999986533 2
Q ss_pred ccccccCCccCcccCCccccc-----cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC--CC
Q 003694 606 TTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GD 678 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~--~~ 678 (802)
+..+...+.|||+|||||+.. ..+|+.++|||||||+|.||..+.||....+.+...+ .+..... .-
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll------KiaKSePPTLl 256 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKSEPPTLL 256 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH------HHhhcCCCccc
Confidence 233456789999999999754 4679999999999999999999999986444333221 1111111 12
Q ss_pred CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.|..+...|.+++.+||..+|..||++.+
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaq 285 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQ 285 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHH
Confidence 45677899999999999999999999884
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=298.60 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=188.6
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++.+|...+.||+|+||.||+|... +..||+|++...... ....+.+|+.+|+.++||||+++++++.+.. ++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3567889999999999999999874 679999998654322 2346788999999999999999999986654 8999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+. ++|.+.+.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 67777665432 34778888899999999999999988 999999999999999999999999999764332
Q ss_pred CCcccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchh----------hhH
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED----------NLA 669 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~----------~l~ 669 (802)
.. ......+++.|+|||++.+. .++.++|||||||++|+|+||++||.........+... ...
T Consensus 157 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 157 SQ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CC------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 11 11234578999999988653 47889999999999999999999996433221111000 000
Q ss_pred HHh--hhhCCC-----CC---------hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 670 EIL--DAQAGD-----WP---------IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 670 ~~l--d~~~~~-----~p---------~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+. ...... .+ ......+.+++.+|+..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~ 284 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQD 284 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHH
Confidence 000 000000 00 012467889999999999999999885
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=292.88 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=194.5
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-----ccchHHHHHHHHHHHhcCCCceeeecceecCC----C
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 516 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-----~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~ 516 (802)
.+|...+.||+|+||.||+|.+. +..||+|.+.... ......|.+|+.++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999874 5689999875321 22335788999999999999999999998543 3
Q ss_pred eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
++||||+++++|.+++.... .+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 78999999999999886543 3788889999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhh-hh
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQ 675 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld-~~ 675 (802)
....... ........|+..|+|||++.+..++.++|+|||||++|+|++|++||........ +..... +.
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~ 226 (264)
T cd06653 156 IQTICMS---GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFKIATQPT 226 (264)
T ss_pred ccccccc---CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHHHHcCCC
Confidence 5432110 0111334689999999999888899999999999999999999999964322211 111111 11
Q ss_pred CCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 676 AGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 676 ~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
....|......+.+++.+||. +|..||+..+
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~ 257 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEF 257 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHH
Confidence 233466677889999999999 5799999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.51 Aligned_cols=237 Identities=27% Similarity=0.395 Sum_probs=190.4
Q ss_pred ceecCCCcEEEEEEEECC--eEEEEEEEcccCc-cchHHHHHHHHHHHhcC-CCceeeecceecCCC--eEEEEEccCCC
Q 003694 454 LRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYMENGS 527 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~lV~Ey~~~gs 527 (802)
..||.|+.|.|+++++.. ...|||.+..... ...++++..+.++..-+ .|+||+.+|+|.... .+.||.|. ..
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TC 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HH
Confidence 349999999999999976 6889999876543 34567888898887765 999999999996544 67888884 45
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccc
Q 003694 528 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607 (802)
Q Consensus 528 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 607 (802)
++.+|.+.. .++++...-++..-+..||.||...+ +|||||+||+|||||..|++||||||++-.+.++...
T Consensus 177 ~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---- 248 (391)
T KOG0983|consen 177 AEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---- 248 (391)
T ss_pred HHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc----
Confidence 666665543 35888888899999999999998764 5999999999999999999999999999887765432
Q ss_pred ccccCCccCcccCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh--H
Q 003694 608 YKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI--K 682 (802)
Q Consensus 608 ~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~--~ 682 (802)
+..+|-+.|||||.+.. ..|+.++|||||||.|+||.||+-||.... .+.+.+..+++...+..|. .
T Consensus 249 ---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-----tdFe~ltkvln~ePP~L~~~~g 320 (391)
T KOG0983|consen 249 ---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK-----TDFEVLTKVLNEEPPLLPGHMG 320 (391)
T ss_pred ---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC-----ccHHHHHHHHhcCCCCCCcccC
Confidence 44589999999998753 458999999999999999999999997532 1334455566543333332 3
Q ss_pred HHHHHHHHHHHhhccccCCCCcccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.++.+.+++..||..|+.+||...+
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~ 345 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNK 345 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHH
Confidence 5789999999999999999999873
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=302.97 Aligned_cols=200 Identities=26% Similarity=0.401 Sum_probs=164.6
Q ss_pred CCcccceecCCCcEEEEEEEEC----CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCC----Ce
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GC 517 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~----~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~~ 517 (802)
.|....+||+|+||.||+|... +..||+|.+.... ......+.+|+.++..++||||++++++|.+. .+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677788999999999999984 4799999988643 33346678899999999999999999999765 38
Q ss_pred EEEEEccCCCHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC----CceeEEeee
Q 003694 518 LVYEYMENGSLEDRLYRKN--NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH----NLVSKIGDV 591 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~----~~~~kl~DF 591 (802)
+||||+++ +|.+.+.... ....++...+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999974 6777664322 2235888899999999999999999988 999999999999999 999999999
Q ss_pred cccccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccc
Q 003694 592 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAI 655 (802)
Q Consensus 592 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~ 655 (802)
|++......... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||..
T Consensus 157 g~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 157 GLARLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred ccccccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 999876543221 112234578999999998765 4578999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=297.65 Aligned_cols=244 Identities=24% Similarity=0.298 Sum_probs=191.7
Q ss_pred CCcccceecCCCcEEEEEEEE-----CCeEEEEEEEcccCc----cchHHHHHHHHHHHhc-CCCceeeecceecCCC--
Q 003694 449 SFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGN----IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG-- 516 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~-----~~~~vavK~l~~~~~----~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~-- 516 (802)
+|+....||.|+||.||++.. ++..||+|++..... ...+.+.+|+.+|.++ +||||+.+++++....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477788999999999999986 467899999875322 2345678899999999 5999999999886654
Q ss_pred eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
++||||+++|+|.+++.... ++++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 79999999999999987543 4788888999999999999999988 99999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccCcccCCccccccC--CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 674 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~ 674 (802)
....... ......|+..|+|||++... .++.++||||||+++|+|+||..||....... ....+...+..
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~~~~~ 226 (290)
T cd05613 155 FHEDEVE-----RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRILK 226 (290)
T ss_pred ccccccc-----ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHHHHHHhhc
Confidence 6432211 11234689999999988653 46789999999999999999999996322110 01111122222
Q ss_pred hCCCCChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 675 QAGDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 675 ~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
....+|...+..+.+++.+|++.+|.+||+..
T Consensus 227 ~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~ 258 (290)
T cd05613 227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCG 258 (290)
T ss_pred cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 22344556678899999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=292.52 Aligned_cols=238 Identities=28% Similarity=0.335 Sum_probs=190.9
Q ss_pred ecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCH
Q 003694 456 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 528 (802)
Q Consensus 456 iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL 528 (802)
||.|+||.||++.+. +..+++|++..... .....+.+|+.++.+++||||+++++.+.+.. |+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 67999999875533 34467889999999999999999999886554 899999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc--cc
Q 003694 529 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV--ST 606 (802)
Q Consensus 529 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~--~~ 606 (802)
.+++.+.. .+++..+..|+.||+.||.|||..+ |+|+||+|+|||++.++.++|+|||++.......... ..
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99987643 4889999999999999999999988 9999999999999999999999999987654321100 00
Q ss_pred cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHH--H
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE--T 684 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~--~ 684 (802)
........++..|++||+.....++.++||||||+++|+|+||..||....... .+..+.. ....+|... +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~~~~~~~~~ 227 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNILN-GKIEWPEDVEVS 227 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhc-CCcCCCccccCC
Confidence 111234568889999999988889999999999999999999999996443211 1111111 223344444 7
Q ss_pred HHHHHHHHHhhccccCCCCccc
Q 003694 685 KELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
..+.+++.+|++.+|.+||++.
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~~ 249 (265)
T cd05579 228 DEAIDLISKLLVPDPEKRLGAK 249 (265)
T ss_pred HHHHHHHHHHhcCCHhhcCCCc
Confidence 8899999999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=290.07 Aligned_cols=244 Identities=24% Similarity=0.378 Sum_probs=200.2
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCC----CeEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVY 520 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~~lV~ 520 (802)
+|...+.||+|+||.||+|... ++.+++|++..... ...+.+.+|+.++++++||||+++++.+.+. .++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677789999999999999986 67899999876543 3456789999999999999999999998765 37999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987543 5899999999999999999999988 999999999999999999999999999887654
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhh-hhCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAGDW 679 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld-~~~~~~ 679 (802)
... .......++..|++||++.+...+.++||||||+++|+|++|..||....... ..+..+.. ......
T Consensus 155 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~ 225 (260)
T cd06606 155 ETG----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIGSSGEPPEI 225 (260)
T ss_pred ccc----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhccccCCCcCC
Confidence 321 01234578899999999988889999999999999999999999996543111 11111111 112334
Q ss_pred ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
|...+..+.+++.+|+..+|.+||++.+
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ 253 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADE 253 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHH
Confidence 5556789999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=310.68 Aligned_cols=193 Identities=25% Similarity=0.361 Sum_probs=165.4
Q ss_pred CCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcC-C-----Cceeeeccee--cCCCeE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIR-H-----PHLLLLLGAC--PDHGCL 518 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H-----pniv~l~g~~--~~~~~l 518 (802)
.|.+...||+|+||.|.+|.+.+ ..||||++++.... ..+-..|+.||..|+ | -|+|+++++| ..+.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 67889999999999999999875 48999999876442 344567999999997 3 3899999997 456699
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC--ceeEEeeeccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN--LVSKIGDVGLSTM 596 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~--~~~kl~DFGla~~ 596 (802)
|+|.+. .+|.++|.... ..+++...+..|+.||+.||.+||..+ ||||||||+||||... ..+||+|||+++.
T Consensus 266 VfELL~-~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999995 69999887544 456999999999999999999999998 9999999999999653 4789999999998
Q ss_pred ccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCcccc
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT 656 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~ 656 (802)
..... .....+..|.|||++.+.+|+.+.||||||||+.||+||.|-|...
T Consensus 341 ~~q~v---------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 341 ESQRV---------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cCCcc---------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 76532 1347789999999999999999999999999999999999888643
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=299.27 Aligned_cols=248 Identities=24% Similarity=0.295 Sum_probs=189.4
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeecceecC----CCeEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPD----HGCLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~----~~~lV 519 (802)
++|.....||.|+||.||+|.+. ++.+++|.+...... ....+.+|+.++.+++||||+++++++.+ ..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788889999999999999986 568999988654322 23456789999999999999999998753 34899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|||+. ++|.+++..... .+++..+..|+.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 599998865432 5899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCcccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch---------hhhH
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLA 669 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~---------~~l~ 669 (802)
.... .....+++.|+|||++.+. .++.++||||||+++|+|++|.+||............ ..+.
T Consensus 159 ~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 159 PLKP------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred Cccc------cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 3211 1234678999999988654 4689999999999999999999999643221110000 0000
Q ss_pred ---HHhh------------hhCCCCChH-HHHHHHHHHHHhhccccCCCCcccc
Q 003694 670 ---EILD------------AQAGDWPIK-ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 670 ---~~ld------------~~~~~~p~~-~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+.. .....++.. ....+.+++.+||+.+|++||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~e 286 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHH
Confidence 0000 000111111 3677899999999999999999885
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=293.84 Aligned_cols=241 Identities=22% Similarity=0.352 Sum_probs=202.2
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecC--CCeEEEEEccC
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYMEN 525 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~lV~Ey~~~ 525 (802)
|.+..+||+|+||.||++.++ |..+|+|.+..+. ..+++..|+.||.+++.|++|++||.+-. ..++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 677789999999999999886 5588999877654 46678999999999999999999998744 34899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|++.|.+..+. ++|+...+..|+...+.||.|||-.. -||||||..||||+-+|.+||+|||.|..+.+..
T Consensus 113 GSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM---- 183 (502)
T KOG0574|consen 113 GSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM---- 183 (502)
T ss_pred CcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH----
Confidence 99999886543 46999999999999999999999988 8999999999999999999999999998776543
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 685 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~ 685 (802)
.+.....|||.|||||++..-.|+.+.||||||+...||.-|+|||...|.+...+.-.. -.+..-..|...+.
T Consensus 184 --AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT----~PPPTF~KPE~WS~ 257 (502)
T KOG0574|consen 184 --AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT----KPPPTFKKPEEWSS 257 (502)
T ss_pred --HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC----CCCCCCCChHhhhh
Confidence 234567999999999999999999999999999999999999999987777654321100 00001123567789
Q ss_pred HHHHHHHHhhccccCCCCcccc
Q 003694 686 ELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 686 ~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
++.+++.+|+-..|++|-++..
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~ 279 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALR 279 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHH
Confidence 9999999999999999988763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=344.86 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=194.0
Q ss_pred cCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 448 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
..|.....||+|+||.||+|.+ .+..||||.+...... ...|+.++++++|||||+++|+|.+.. ++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577778999999999999986 4679999988643221 235688999999999999999996544 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++|+|.+++. .++|..+.+|+.||+.||.|||.....+|+||||||+|||++.++..++. ||........
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999984 28899999999999999999996644569999999999999999888875 6665443211
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccc--------hhhhhhchhhhHHHhhhh
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH--------KVETAIDEDNLAEILDAQ 675 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~--------~~~~~~~~~~l~~~ld~~ 675 (802)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ++...........++++.
T Consensus 836 -------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 836 -------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred -------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 22368999999999999999999999999999999999999985221 111111122233333333
Q ss_pred CC---CCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHH
Q 003694 676 AG---DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 676 ~~---~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
.. ..+.....++.+++.+||+.+|.+||++. +++..|+.+..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN-DVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHH-HHHHHHHHhhc
Confidence 21 23345667889999999999999999999 57777776543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=304.74 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=189.2
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCC-------C
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------G 516 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-------~ 516 (802)
..+|....+||+|+||.||+|.+. +..||+|++.... ......+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467899999999999999999874 5689999986432 23345688899999999999999999986432 3
Q ss_pred eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 79999996 588777643 24889999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhh------hc---hh
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA------ID---ED 666 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~------~~---~~ 666 (802)
......... ......||+.|+|||.+.+ ..++.++|||||||++|+|+||++||......... +. .+
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTG---FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccC---CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 654322111 1234578999999998654 56889999999999999999999999643221100 00 01
Q ss_pred hhHHHhhhh--------C--CCCC-----hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 667 NLAEILDAQ--------A--GDWP-----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 667 ~l~~~ld~~--------~--~~~p-----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..+.+.. . ...+ ...+..+.+++.+||+.+|.+||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e 288 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHH
Confidence 111111100 0 0001 123567899999999999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.32 Aligned_cols=241 Identities=29% Similarity=0.456 Sum_probs=198.3
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|.....||+|+||.||++... +..|++|.+..... .....+.+|++++++++|||++++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999875 46899999876543 34567899999999999999999999986554 799999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988654 35899999999999999999999988 99999999999999999999999999987764332
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 682 (802)
. .....++..|++||+..+..++.++||||||+++|+|++|+.||........ +...........+..
T Consensus 155 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~ 222 (254)
T cd06627 155 D------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFRIVQDDHPPLPEG 222 (254)
T ss_pred c------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhccCCCCCCCC
Confidence 1 1334689999999998888889999999999999999999999964332111 111222222334445
Q ss_pred HHHHHHHHHHHhhccccCCCCcccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..+.+++.+||..+|++||++.+
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHH
Confidence 6788999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.11 Aligned_cols=236 Identities=21% Similarity=0.237 Sum_probs=181.8
Q ss_pred hhcCCccccee--cCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eE
Q 003694 446 ATLSFSENLRI--GMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 446 ~~~~f~~~~~i--G~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~l 518 (802)
..++|...+.+ |.|+||.||++... +..+|+|++....... .|+.+...+ +||||+++++.|.... ++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34455555555 99999999999875 4588999876532211 133333223 6999999999985544 89
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCc-eeEEeeecccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTML 597 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~-~~kl~DFGla~~~ 597 (802)
||||+++|+|.+++.... ++++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999986543 5899999999999999999999998 99999999999999998 9999999999866
Q ss_pred cCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCC
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 677 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~ 677 (802)
... ....|+..|+|||++.+..++.++||||||+++|+|+||+.||...... .+....+..... ...
T Consensus 161 ~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-~~~ 227 (267)
T PHA03390 161 GTP----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--ELDLESLLKRQQ-KKL 227 (267)
T ss_pred CCC----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc--hhhHHHHHHhhc-ccC
Confidence 432 1236889999999999889999999999999999999999999633211 111111222221 111
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCcc
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDL 705 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~ 705 (802)
..+...+..+.+++.+||+.+|.+||+.
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~ 255 (267)
T PHA03390 228 PFIKNVSKNANDFVQSMLKYNINYRLTN 255 (267)
T ss_pred CcccccCHHHHHHHHHHhccChhhCCch
Confidence 2233567889999999999999999964
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.78 Aligned_cols=233 Identities=24% Similarity=0.311 Sum_probs=179.2
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHh---cCCCceeeecceecCC--CeEEEEEcc
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSK---IRHPHLLLLLGACPDH--GCLVYEYME 524 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~---l~Hpniv~l~g~~~~~--~~lV~Ey~~ 524 (802)
.||+|+||.||++... ++.+|+|.+..... .....+.+|..++.. .+||||+.+++++... .++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 56899998865422 122334455544443 4799999999988654 489999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999886543 4899999999999999999999998 9999999999999999999999999987554321
Q ss_pred cccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
.....||+.|+|||.+.+ ..++.++|||||||++|+|+||..||....... ...+...........|...
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~ 222 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLTVNVELPDSF 222 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC----HHHHHHHhhcCCcCCcccc
Confidence 123468999999998864 558899999999999999999999996332111 0111111111122344556
Q ss_pred HHHHHHHHHHhhccccCCCCcc
Q 003694 684 TKELAALGLSCAELRRKDRPDL 705 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~ 705 (802)
+..+.+++.+|+..+|.+||+-
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~ 244 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGC 244 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCC
Confidence 7889999999999999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=313.46 Aligned_cols=195 Identities=29% Similarity=0.496 Sum_probs=169.1
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeecceecC--------CCeE
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPD--------HGCL 518 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--------~~~l 518 (802)
|.....||+|+||.||+|+++ |..||||.++.... ...+...+|+++|++++|||||++++.-.+ ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 444567999999999999976 56899999876543 345667899999999999999999987533 3379
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEec--CCc--eeEEeeeccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--HNL--VSKIGDVGLS 594 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~--~~~--~~kl~DFGla 594 (802)
|||||.||||...|.+-.+...|+....+.++.+++.||.|||.++ |+||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998777888999999999999999999999999 99999999999993 333 4599999999
Q ss_pred ccccCCCCcccccccccCCccCcccCCccccc-cCCCCCcccchhHHHHHHHHHhCCCCcc
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIA 654 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDv~SlGvil~elltg~~p~~ 654 (802)
+-++++. ..++.+||..|.+||.+. .+.|+.-+|.|||||++|+++||..||.
T Consensus 172 rel~d~s-------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 172 RELDDNS-------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ccCCCCC-------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9988654 236679999999999887 4889999999999999999999999995
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=297.95 Aligned_cols=236 Identities=27% Similarity=0.414 Sum_probs=187.7
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
|.....||+|+||.||+|.+. +..+|+|++..... .....+.+|+.++++++|||+++++++|.+.. ++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667788999999999999874 56899999864422 22346889999999999999999999986543 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+. |+|.+.+.... .++++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 97 57877775432 34899999999999999999999988 999999999999999999999999998764432
Q ss_pred cccccccccCCccCcccCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCC-
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD- 678 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~- 678 (802)
....|++.|+|||++. .+.++.++|||||||++|+|++|++||....... .+..+.......
T Consensus 179 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~ 244 (317)
T cd06635 179 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNESPTL 244 (317)
T ss_pred --------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhccCCCC
Confidence 2346889999999873 4668899999999999999999999986432111 111222221111
Q ss_pred CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+...+..+.+++.+||+.+|.+||++.+
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 273 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEE 273 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHH
Confidence 12245677999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=288.02 Aligned_cols=244 Identities=28% Similarity=0.459 Sum_probs=199.9
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|.....||.|+||.||++.+. +..+++|++..... .....+.+|+++++.++|||++++++.+.+.. ++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777789999999999999986 67999999876533 45567889999999999999999999886544 899999
Q ss_pred ccCCCHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 523 MENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 523 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999887642 2356899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
. ......|++.|+|||++....++.++|+||||+++|+|++|+.||...... ..............|.
T Consensus 158 ~------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~ 225 (258)
T cd08215 158 D------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILKGQYPPIPS 225 (258)
T ss_pred c------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhcCCCCCCCC
Confidence 1 123347899999999998888999999999999999999999999543211 1111222222333444
Q ss_pred HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+.+++.+||..+|.+||++.+
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 56788999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.35 Aligned_cols=244 Identities=25% Similarity=0.316 Sum_probs=191.2
Q ss_pred CCcccceecCCCcEEEEEEEE-----CCeEEEEEEEcccC----ccchHHHHHHHHHHHhc-CCCceeeecceecCCC--
Q 003694 449 SFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG-- 516 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~-----~~~~vavK~l~~~~----~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~-- 516 (802)
+|.....||+|+||.||++.. +++.+|||++.... ......+.+|+.++.++ +||||+.+++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467778999999999999875 34689999986432 22345688999999999 5999999999886554
Q ss_pred eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||.|||++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 7999999999999988653 24888899999999999999999988 99999999999999999999999999877
Q ss_pred ccCCCCcccccccccCCccCcccCCccccccCC--CCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 674 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~ 674 (802)
....... ......|+..|++||++.+.. .+.++||||||+++|+|+||..||......... ..+...+..
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~ 226 (288)
T cd05583 155 FLAEEEE-----RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ---SEISRRILK 226 (288)
T ss_pred ccccccc-----ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH---HHHHHHHHc
Confidence 5533211 112346899999999887655 788999999999999999999999633211110 111111112
Q ss_pred hCCCCChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 675 QAGDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 675 ~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
.....|...+..+.+++.+||+.+|.+||++.
T Consensus 227 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~ 258 (288)
T cd05583 227 SKPPFPKTMSAEARDFIQKLLEKDPKKRLGAN 258 (288)
T ss_pred cCCCCCcccCHHHHHHHHHHhcCCHhhccCcc
Confidence 22334445667899999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=298.31 Aligned_cols=252 Identities=19% Similarity=0.200 Sum_probs=189.9
Q ss_pred ccceecCCCcEEEEEEEECCeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCC
Q 003694 452 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 527 (802)
Q Consensus 452 ~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gs 527 (802)
..+.+|.|+++.||++...++.||||++... .......+.+|+.+++.++||||+++++++.+.. +++|||+++|+
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 4455677788888888888899999998764 2334567899999999999999999999986544 89999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc-ccc
Q 003694 528 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF-VST 606 (802)
Q Consensus 528 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~ 606 (802)
|.+++..... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+..+...... ...
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9998875432 34788889999999999999999988 999999999999999999999999998766432211 001
Q ss_pred cccccCCccCcccCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch--hhhHHHhh---------
Q 003694 607 TYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE--DNLAEILD--------- 673 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~--~~l~~~ld--------- 673 (802)
........++..|+|||++.. ..++.++|||||||++|+|++|+.||............ +.....++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 111234467889999998865 35889999999999999999999999744322211110 00000000
Q ss_pred ----------------hhCCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 674 ----------------AQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ----------------~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
......+......+.+|+.+||..+|.+||++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 291 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence 0000112234567899999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=297.41 Aligned_cols=250 Identities=20% Similarity=0.264 Sum_probs=188.6
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcC-CCceeeecceecC--C-----
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIR-HPHLLLLLGACPD--H----- 515 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~--~----- 515 (802)
++|.....||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.+. ||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888889999999999999985 56899998765432 23356888999999995 6999999998743 2
Q ss_pred CeEEEEEccCCCHHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC-CceeEEeeec
Q 003694 516 GCLVYEYMENGSLEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVG 592 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~-~~~~kl~DFG 592 (802)
.++||||+++ +|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 3899999985 88888765432 346899999999999999999999988 999999999999998 8999999999
Q ss_pred ccccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhh----
Q 003694 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN---- 667 (802)
Q Consensus 593 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~---- 667 (802)
++..+..... ......+++.|+|||++.+ ..++.++||||||+++|+|+||.+||...........-..
T Consensus 157 ~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPVK------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred cceecCCCcc------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9986543211 1123357889999998754 4578999999999999999999999965433222110000
Q ss_pred -----hHHHhhhh----CCC--------CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 668 -----LAEILDAQ----AGD--------WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 668 -----l~~~ld~~----~~~--------~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+....... ... .....+..+.+++.+||..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e 287 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHH
Confidence 00000000 000 01134677899999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.08 Aligned_cols=242 Identities=26% Similarity=0.384 Sum_probs=189.3
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcC-CCceeeecceecCCC--eEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~lV~E 521 (802)
++|....+||+|+||.||+|.+. +..||||.+.... ......+..|+.++.+.. ||||++++++|.+.. ++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 56788889999999999999997 7799999987543 223455777888777775 999999999997655 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
|+. ++|.+++.... ..+++..+..|+.||+.||.|||+ .+ |+||||+|+|||++.++.+||+|||++..+...
T Consensus 95 ~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 57877665533 268999999999999999999997 46 999999999999999999999999999766432
Q ss_pred CCcccccccccCCccCcccCCccccccCC----CCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGL----ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 676 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~ 676 (802)
.. .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...... ...+..++....
T Consensus 169 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~ 236 (296)
T cd06618 169 KA-------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP 236 (296)
T ss_pred Cc-------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC
Confidence 21 12335788999999887553 788999999999999999999999642211 111222233222
Q ss_pred CCCCh--HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 677 GDWPI--KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 677 ~~~p~--~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..++. ..+..+.+|+.+||..+|.+||++.+
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 269 (296)
T cd06618 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRE 269 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 22222 35678999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=296.44 Aligned_cols=243 Identities=28% Similarity=0.351 Sum_probs=185.7
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcC-CCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|.....||+|+||.||++.+. +..+|+|.+.... ......+.+|+.++.++. ||||+++++++.+.. +++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445567999999999999885 5689999886543 234557889999999996 999999999885543 799999
Q ss_pred ccCCCHHHHhhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 523 MENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 523 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
+. ++|.++... ......+++..+..++.+++.||.|||+. + |+||||||+|||++.++.+||+|||++..+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 466554321 11224589999999999999999999975 6 99999999999999999999999999976543
Q ss_pred CCCcccccccccCCccCcccCCccccccC---CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG---LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 676 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~ 676 (802)
... .....|++.|+|||++.+. .++.++|||||||++|+|++|++||....... ..+..+.....
T Consensus 161 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~ 228 (288)
T cd06616 161 SIA-------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-----DQLTQVVKGDP 228 (288)
T ss_pred CCc-------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-----HHHhhhcCCCC
Confidence 221 1233688999999998766 68999999999999999999999996432111 11111111111
Q ss_pred ----CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 677 ----GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 677 ----~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+...+..+.+|+.+||+.+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 263 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKE 263 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 1112246778999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=291.62 Aligned_cols=244 Identities=24% Similarity=0.393 Sum_probs=184.8
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcC-CCceeeecceecCC----CeEEEE
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDH----GCLVYE 521 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~----~~lV~E 521 (802)
|....+||+|+||.||+|... +..+|+|+++... ........+|+.++.++. |||+++++++|.+. .++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456778999999999999874 6789999987542 222234557999999985 99999999998654 389999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|++ |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++. +.+||+|||++..+....
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 58888776433 35899999999999999999999988 999999999999999 999999999998765332
Q ss_pred CcccccccccCCccCcccCCccccc-cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhc--------hhhhHHHh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--------EDNLAEIL 672 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~--------~~~l~~~l 672 (802)
.. ....++..|+|||++. ++.++.++|||||||++|+|++|.+||...+..+.... ...+...+
T Consensus 154 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 154 PY-------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred Cc-------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 21 2346789999999764 45578999999999999999999999964432221000 00000000
Q ss_pred hhh---CCCCC-----------hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 673 DAQ---AGDWP-----------IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 673 d~~---~~~~p-----------~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
... ...+| ...+..+.+|+.+||..+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 275 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQ 275 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHH
Confidence 000 00111 134688999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=296.02 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=187.9
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCC-------
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 515 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------- 515 (802)
.++|....+||+|+||.||+|... +..||||.+..... .....+.+|+.++++++||||++++++|...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346888999999999999999885 56899998764322 2234567899999999999999999987432
Q ss_pred ---CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeec
Q 003694 516 ---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 592 (802)
Q Consensus 516 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFG 592 (802)
.++||||+. ++|.+.+.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 289999996 58888775433 34889999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHH
Q 003694 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 671 (802)
Q Consensus 593 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ 671 (802)
++..+........ .......++..|+|||++.+. .++.++||||||+++|+|+||++||.......... .+..+
T Consensus 165 ~~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~---~~~~~ 239 (310)
T cd07865 165 LARAFSLSKNSKP--NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT---LISQL 239 (310)
T ss_pred CcccccCCcccCC--CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHH
Confidence 9987654322111 112344678999999987654 37889999999999999999999996433211100 00000
Q ss_pred h-----------------hhh-CC----------CCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 672 L-----------------DAQ-AG----------DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 672 l-----------------d~~-~~----------~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. +.. .+ .++......+.+|+.+||..+|.+||++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e 303 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 0 000 00 001112456779999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=292.12 Aligned_cols=246 Identities=29% Similarity=0.373 Sum_probs=198.7
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcC-CCceeeecceecCCC--eEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~lV 519 (802)
++|.....||.|+||.||+|... +..|++|++.... ......+..|+.++.+++ ||||+++++++.+.. ++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788889999999999999884 6799999986532 223456889999999998 999999999986554 899
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
|||+++++|.+++.... .+++..+..|+.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999986543 5899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCccc--------------ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch
Q 003694 600 DPSFVS--------------TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 665 (802)
Q Consensus 600 ~~~~~~--------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~ 665 (802)
...... .........|+..|++||++....++.++||||||+++++|++|+.||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----- 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----- 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-----
Confidence 331100 0112234568899999999988889999999999999999999999996443211
Q ss_pred hhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 666 ~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
.+..+. ......|...+..+.+++.+||+.+|.+||++.
T Consensus 230 -~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 268 (280)
T cd05581 230 -TFQKIL-KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVN 268 (280)
T ss_pred -HHHHHH-hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcc
Confidence 111221 122334555678899999999999999999995
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=329.99 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=198.0
Q ss_pred HHhhcCCcccceecCCCcEEEEEEEECCe--EEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeccee--cCCCe
Q 003694 444 ESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGAC--PDHGC 517 (802)
Q Consensus 444 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~--~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~--~~~~~ 517 (802)
...+-+|....+||.|.||.||.|....+ ..|+|-+..... .......+|+.+|..|+|||+|+.||+- .+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34566788889999999999999987644 678887654432 2335578899999999999999999985 44558
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~ 597 (802)
|.||||++|+|.+.+...+. .++.....+..|++.||.|||++| ||||||||+||||+.+|.+|++|||.|..+
T Consensus 1311 IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 99999999999998865433 455566678899999999999999 999999999999999999999999999888
Q ss_pred cCCCCcccccccccCCccCcccCCccccccC---CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG---LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 674 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~ 674 (802)
....... ...-....||+.|||||++.+. ...-+.|||||||+++||+||+.||...+.-+. .+..+--.
T Consensus 1385 ~~~~~~~--~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-----IMy~V~~g 1457 (1509)
T KOG4645|consen 1385 KNNAQTM--PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-----IMYHVAAG 1457 (1509)
T ss_pred cCchhcC--CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-----HHhHHhcc
Confidence 7553111 1223456999999999988643 356789999999999999999999964332221 22233333
Q ss_pred hCCCCChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 675 QAGDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 675 ~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
..+..|...+.+-.+++.+|++.||++|.++.
T Consensus 1458 h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1458 HKPQIPERLSSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred CCCCCchhhhHhHHHHHHHHHhcCchhhhHHH
Confidence 44677878888999999999999999997665
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=292.72 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=188.9
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCC----CeEEEE
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVYE 521 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~~lV~E 521 (802)
|....+||.|+||.||+|... +..+|+|++.... ......+.+|+.+++.++|||++++++++.+. .++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999886 4789999988653 33345688999999999999999999998755 489999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 997 58888876543 35889999999999999999999988 9999999999999999999999999998775432
Q ss_pred CcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch---------hhhHHH
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLAEI 671 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~---------~~l~~~ 671 (802)
.. ..+...++..|+|||.+.+ ..++.++||||||+++|+|+||++||............ ..+..+
T Consensus 155 ~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 155 SA-----DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred cc-----cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 11 1133467889999997654 45789999999999999999999999643321110000 000000
Q ss_pred hh-----hhCC--CCC-------hH-HHHHHHHHHHHhhccccCCCCcccc
Q 003694 672 LD-----AQAG--DWP-------IK-ETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 672 ld-----~~~~--~~p-------~~-~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+ .... ..+ .. ++..+.+++.+|+..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 280 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQ 280 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 00 0000 000 01 2677899999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=320.46 Aligned_cols=252 Identities=17% Similarity=0.249 Sum_probs=177.2
Q ss_pred hcCCcccceecCCCcEEEEEEEECCe---EEEEEE--------------Ec---ccCccchHHHHHHHHHHHhcCCCcee
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHHT---FAAVKV--------------LQ---SKGNIQNKQFLQELEVLSKIRHPHLL 506 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~~---~vavK~--------------l~---~~~~~~~~~~~~Ei~il~~l~Hpniv 506 (802)
..+|....+||+|+||.||+|.+... .+++|. +. .........|.+|+.+|.+++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 35788899999999999999876421 111110 00 01112235688999999999999999
Q ss_pred eecceecCCC--eEEEEEccCCCHHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC
Q 003694 507 LLLGACPDHG--CLVYEYMENGSLEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 582 (802)
Q Consensus 507 ~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~ 582 (802)
++++++.+.. ++|++++. ++|.+++..... ...........|+.||+.||.|||+.+ ||||||||+||||+.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 9999986544 89999985 577777654221 112334567789999999999999988 999999999999999
Q ss_pred CceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCC-Cccccc--hh
Q 003694 583 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP-AIAITH--KV 659 (802)
Q Consensus 583 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~-p~~~~~--~~ 659 (802)
++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+||||++|.. |+.... ..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-----FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCEEEEeCCCceecCccccc-----ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999876543211 1234579999999999999999999999999999999999874 443211 00
Q ss_pred hhhhc---------------hhhhHHHhhhhC-C----CCC-----hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 660 ETAID---------------EDNLAEILDAQA-G----DWP-----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 660 ~~~~~---------------~~~l~~~ld~~~-~----~~p-----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..... ...+...++... . ..+ ...+..+.+++.+|+..||.+||++.+
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~e 450 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAE 450 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHH
Confidence 00000 001111111100 0 000 012345778899999999999999985
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.11 Aligned_cols=234 Identities=20% Similarity=0.326 Sum_probs=188.7
Q ss_pred ceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCC--CeEEEEEccCCCHH
Q 003694 454 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGSLE 529 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~lV~Ey~~~gsL~ 529 (802)
.+||+|+||.||++... +..||||++..........+.+|+.+++.++|||++++++.+.+. .++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999884 568999988655555566789999999999999999999988544 48999999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccccc
Q 003694 530 DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 609 (802)
Q Consensus 530 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 609 (802)
+++.. ..+++.....++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........ .
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~------~ 172 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------R 172 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc------c
Confidence 87743 23788899999999999999999988 99999999999999999999999999876543221 1
Q ss_pred ccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC-CC--CChHHHHH
Q 003694 610 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-GD--WPIKETKE 686 (802)
Q Consensus 610 ~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~-~~--~p~~~~~~ 686 (802)
.....|++.|++||++.+..++.++|+||||+++|+|++|.+||........ ...+.... .. .....+..
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNLPPKLKNLHKVSPS 245 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhhCCcccCCcccCCHH
Confidence 1234688999999999888899999999999999999999999964322211 11111111 11 11234667
Q ss_pred HHHHHHHhhccccCCCCcccc
Q 003694 687 LAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 687 l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+.+++.+||..+|.+||++.+
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ 266 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAE 266 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHH
Confidence 899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=286.86 Aligned_cols=230 Identities=24% Similarity=0.262 Sum_probs=181.1
Q ss_pred ceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHHH-HhcCCCceeeecceecCCC--eEEEEEccC
Q 003694 454 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVL-SKIRHPHLLLLLGACPDHG--CLVYEYMEN 525 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~il-~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~ 525 (802)
+.||.|+||.||+|... +..||+|++...... ....+..|..++ ...+|||++++++++.+.. ++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999884 569999998654321 122345555544 4458999999999996544 899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++......
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 99999886543 4788899999999999999999988 999999999999999999999999998764321
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC----Ch
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW----PI 681 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~----p~ 681 (802)
....|++.|++||.+.+..++.++||||||+++|+|+||.+||....... +...+......+ +.
T Consensus 151 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 218 (260)
T cd05611 151 -----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRINWPEEVKE 218 (260)
T ss_pred -----ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccCCCCcccc
Confidence 23468899999999988888999999999999999999999996432211 111111111112 22
Q ss_pred HHHHHHHHHHHHhhccccCCCCccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
.++..+.+++.+||..+|.+||++.
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCC
Confidence 3568899999999999999999876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.46 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=191.7
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecC------CCe
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------HGC 517 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~------~~~ 517 (802)
.+|.....||.|+||.||+|... +..||+|++.... ......+.+|+.+|+.++||||+++++++.. ..+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888899999999999999875 5689999987542 2334567889999999999999999998742 238
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~ 597 (802)
+||||+. |+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 6898887543 23899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhh--------------
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-------------- 662 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~-------------- 662 (802)
...... .........|+..|+|||++.. ..++.++|||||||++|+|++|++||.........
T Consensus 158 ~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 158 SSSPTE--HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred cccCcC--CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 543211 1111234578999999998755 45889999999999999999999999643221110
Q ss_pred ---hchhhhHHHhhhhC--CCCC-----hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 663 ---IDEDNLAEILDAQA--GDWP-----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 663 ---~~~~~l~~~ld~~~--~~~p-----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+.+...++... ...+ ...+..+.+++.+||+.+|.+||++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 290 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 00111111111111 1111 224678999999999999999999884
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=303.39 Aligned_cols=246 Identities=19% Similarity=0.232 Sum_probs=189.8
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeecceecC-------
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------- 514 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~------- 514 (802)
....|.....||+|+||.||+|... +..||+|++... .......+.+|+.++++++||||++++++|..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467899999999999999999874 568999988643 22334567889999999999999999998742
Q ss_pred -CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 515 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 515 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
..|+||||+. ++|.+.+... ++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 2389999996 5888877432 778888999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhc--------h
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--------E 665 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~--------~ 665 (802)
++....... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||........... .
T Consensus 165 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 165 ARTAGTSFM-------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ceeCCCCCC-------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 987643211 2334688999999999989999999999999999999999999964332111000 0
Q ss_pred hhhHHH--------hhhhC--------------------CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 DNLAEI--------LDAQA--------------------GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 ~~l~~~--------ld~~~--------------------~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+... .+... ...+...+..+.+++.+||+.||.+||++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 307 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence 000000 00000 0001134567899999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=290.61 Aligned_cols=238 Identities=26% Similarity=0.321 Sum_probs=196.0
Q ss_pred CCcccceecCCCcEEEEEEEECCe--EEEEEEEcccCccchHH---HHHHHHHHHhc-CCCceeeecceec--CCCeEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKI-RHPHLLLLLGACP--DHGCLVY 520 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~~~~---~~~Ei~il~~l-~Hpniv~l~g~~~--~~~~lV~ 520 (802)
+|.....||+|+||.|.++..+++ .+|||+++.+...+.++ -+.|-.+|... +-|.+++|..+|+ +..|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 688889999999999999998876 89999998875444333 34677777655 4788999998885 5669999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
||+.||+|.-+++.-+. +.+....-++.+|+-||-|||+.| ||+||||.+|||||.+|++||+|||+++.---.
T Consensus 430 EyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999998887654 455577789999999999999999 999999999999999999999999999853322
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
. ......+|||.|+|||++...+|+..+|+|||||+|||||.|++||...+ ++.+...+....-.+|
T Consensus 504 ~------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD-------E~elF~aI~ehnvsyP 570 (683)
T KOG0696|consen 504 G------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-------EDELFQAIMEHNVSYP 570 (683)
T ss_pred C------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHHccCcCc
Confidence 1 12256799999999999999999999999999999999999999997543 2333333444445678
Q ss_pred hHHHHHHHHHHHHhhccccCCCCcc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDL 705 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~ 705 (802)
...+.+...+....+...|.+|-..
T Consensus 571 KslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 571 KSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred ccccHHHHHHHHHHhhcCCccccCC
Confidence 8888999999999999999999543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=293.32 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=194.1
Q ss_pred cccceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhc--CCCceeeecceecC------CCeEEEEE
Q 003694 451 SENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI--RHPHLLLLLGACPD------HGCLVYEY 522 (802)
Q Consensus 451 ~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l--~Hpniv~l~g~~~~------~~~lV~Ey 522 (802)
.....||+|.||.||||.++++.||||++.. ...+.|++|-+|.+.. +|+||++|+++-.. ...||++|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 3345699999999999999999999999975 3567799999988764 79999999998532 22699999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC------CCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP------KPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~------~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
-+.|||.++|... .++|....+|+..+++||+|||..-| ++|+|||||..||||..|+.+.|+|||||..
T Consensus 290 h~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred ccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 9999999999754 38999999999999999999997543 5899999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCccCcccCCccccccCC-CC-----CcccchhHHHHHHHHHhCCCCcc--ccchhhhhhc----
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL-IS-----PKSDVYAYGMVILQLLTAKPAIA--ITHKVETAID---- 664 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~-----~~sDv~SlGvil~elltg~~p~~--~~~~~~~~~~---- 664 (802)
+........ ..+.+||..|||||++.+.. +. .+.||||+|.+||||+++-..+. .....+..++
T Consensus 366 ~~p~~~~~d----~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 366 LEPGKPQGD----THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred ecCCCCCcc----hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 875543222 24479999999999886543 22 36899999999999999754441 1111111111
Q ss_pred ----hhhhHHHh--hhhCCCCChH-----HHHHHHHHHHHhhccccCCCCccccchhhHHHHHH
Q 003694 665 ----EDNLAEIL--DAQAGDWPIK-----ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 665 ----~~~l~~~l--d~~~~~~p~~-----~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
.+.+.+++ +...+.+|.. ....|.+.+..||..|+..|-|+. -+.+.+..|.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~-Cv~eR~~~l~ 504 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG-CVEERMAELM 504 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH-HHHHHHHHHh
Confidence 12222222 2223445542 356789999999999999999987 5555554443
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=278.18 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=196.9
Q ss_pred ceecCCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeecceecCCC--eEEEEEccCCCH
Q 003694 454 LRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYMENGSL 528 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~lV~Ey~~~gsL 528 (802)
..||+|.|+.|-.+.. .+..||||++.......+.+..+|++++...+ |+||+.|+.+|.+.. |||||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 3699999999998765 46689999998887788889999999999986 999999999997655 999999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCc---eeEEeeecccccccCCCCc-c
Q 003694 529 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL---VSKIGDVGLSTMLNSDPSF-V 604 (802)
Q Consensus 529 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~---~~kl~DFGla~~~~~~~~~-~ 604 (802)
..+|.+... ++..+..++..+|+.||.|||..| |.||||||+|||-.... -+|||||.|..-+....+- .
T Consensus 164 LshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRKH---FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999987554 888899999999999999999999 99999999999996653 4699999887654422211 1
Q ss_pred cccccccCCccCcccCCcccc-----ccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch--------hhhHHH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQ-----RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE--------DNLAEI 671 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~-----~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~--------~~l~~~ 671 (802)
.......+++|+..|||||+. ....|+.++|.||||||||-||.|.+||...--...+++. ..+.+.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 122234567999999999954 2345899999999999999999999999754333333332 234444
Q ss_pred hhhhCCCCCh----HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 672 LDAQAGDWPI----KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 672 ld~~~~~~p~----~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+.....++|. ..+.+..+|+...+-.++.+|-++..
T Consensus 318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~ 357 (463)
T KOG0607|consen 318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQ 357 (463)
T ss_pred HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhh
Confidence 4444444554 34677888999999999999988774
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=301.63 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=191.2
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhc-CCCceeeecceecCC----C
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH----G 516 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~----~ 516 (802)
..++|.....||+|+||.||+|.+. +..+|+|.+... .......+.+|+.++.++ +||||++++++|... .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3457888889999999999999874 578999987542 223345677899999999 999999999988532 3
Q ss_pred eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
++||||++ ++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 89999997 5898887543 4788899999999999999999988 99999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhh------------
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI------------ 663 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~------------ 663 (802)
+....... .........||+.|+|||++.+ ..++.++||||||+++|+|+||++||..........
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65433211 0111234568999999997754 557899999999999999999999996433221100
Q ss_pred -----chhhhHHHhhhhC-------CCCChHHHHHHHHHHHHhhccccCCCCccccc
Q 003694 664 -----DEDNLAEILDAQA-------GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 708 (802)
Q Consensus 664 -----~~~~l~~~ld~~~-------~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~ 708 (802)
.......+++... .......+..+.+++.+||+.+|.+||++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~i 292 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA 292 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHH
Confidence 0000011111100 00111246788999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=290.09 Aligned_cols=232 Identities=24% Similarity=0.316 Sum_probs=179.7
Q ss_pred eecCCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHH---HHhcCCCceeeecceecCCC--eEEEEEcc
Q 003694 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEV---LSKIRHPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~i---l~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
.||+|+||.||++... +..||+|++...... ....+..|..+ ++...||||+.+++++.+.. ++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999874 568999988654221 12234445443 44457999999999886544 89999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
||+|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999888643 35899999999999999999999988 9999999999999999999999999987654321
Q ss_pred cccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHH
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
.....|+..|+|||++.++ .++.++|||||||++|+|++|+.||........ .............+|...
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 222 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLTMAVELPDSF 222 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----HHHHHHhhccCCCCCCcC
Confidence 1234789999999998754 589999999999999999999999964422111 111112222223455556
Q ss_pred HHHHHHHHHHhhccccCCCCc
Q 003694 684 TKELAALGLSCAELRRKDRPD 704 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~ 704 (802)
+..+.+++.+|+..+|.+||.
T Consensus 223 s~~~~~li~~~l~~~p~~R~~ 243 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLG 243 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccC
Confidence 789999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=291.90 Aligned_cols=246 Identities=25% Similarity=0.373 Sum_probs=188.0
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcC-CCceeeecceecCCC--eEEEEEc
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
|.....||.|+||.||+|... +..|+||.+..... .......+|+..+.+++ |||++++++++.+.. ++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566788999999999999985 56899998865432 22334567999999999 999999999986544 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
+|+|.+++.... ...+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 789999886544 245899999999999999999999988 999999999999999999999999999876543211
Q ss_pred ccccccccCCccCcccCCccccc-cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhh---------h-----
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN---------L----- 668 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~---------l----- 668 (802)
....++..|+|||++. +..++.++|+||||+++|+|+||++||.............. +
T Consensus 156 -------~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 156 -------TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred -------CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 2346889999999774 45578999999999999999999999964433222110000 0
Q ss_pred -HHHhhhhC--------CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 669 -AEILDAQA--------GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 669 -~~~ld~~~--------~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
....+... .......+..+.+++.+||+.+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 276 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ 276 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHH
Confidence 00000000 0000112467999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=285.09 Aligned_cols=242 Identities=28% Similarity=0.444 Sum_probs=196.6
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|....+||.|+||.||++... +..+++|.+.... ......+.+|+.+++.++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999875 4589999886532 233456789999999999999999998876544 899999
Q ss_pred ccCCCHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 523 MENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 523 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|.||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999886532 2345889999999999999999999998 9999999999999999999999999998775431
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 681 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 681 (802)
.....+++.|++||++.+..++.++|+||||+++|+|++|+.||........ ...+.....+..+.
T Consensus 158 --------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~ 223 (256)
T cd08530 158 --------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL------RYKVQRGKYPPIPP 223 (256)
T ss_pred --------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhcCCCCCCch
Confidence 1224688999999999888899999999999999999999999964432110 11111222233445
Q ss_pred HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+.+++.+|+..+|.+||++.+
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 67788999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=294.53 Aligned_cols=252 Identities=23% Similarity=0.273 Sum_probs=191.0
Q ss_pred HhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecC------
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------ 514 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~------ 514 (802)
...++|....+||.|+||.||+|... +..||+|++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567888999999999999999985 5689999987543 2233567889999999999999999998854
Q ss_pred ------CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEE
Q 003694 515 ------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 588 (802)
Q Consensus 515 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl 588 (802)
..++|+||+++ +|.+.+... ...+++..+..|+.||+.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 23799999975 777776543 235899999999999999999999998 999999999999999999999
Q ss_pred eeecccccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhh
Q 003694 589 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 667 (802)
Q Consensus 589 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~ 667 (802)
+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++|++||...........-..
T Consensus 158 ~dfg~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 158 ADFGLARLYNSEESR-----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred CcccccccccCCccc-----ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999876543211 1122356888999998754 4578999999999999999999999975433221100000
Q ss_pred ---------hHHHh--------hhhC------CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 668 ---------LAEIL--------DAQA------GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 668 ---------l~~~l--------d~~~------~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+..+. +... .......+..+.+++.+||..+|.+||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 00000 0000 0001123678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=294.32 Aligned_cols=248 Identities=20% Similarity=0.294 Sum_probs=186.7
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
++|....+||.|+||.||+|.+. ++.||+|.+..... .....+.+|+.++++++||||+++++++.+.. ++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888889999999999999875 56899998764322 23456889999999999999999999996554 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC-CceeEEeeecccccccCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~-~~~~kl~DFGla~~~~~~ 600 (802)
|++ ++|.+++.... ...+++.....++.||+.||.|||+.+ |+||||+|+|||++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 58888775433 233677888899999999999999988 999999999999985 567999999999765432
Q ss_pred CCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchh-------------
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED------------- 666 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~------------- 666 (802)
... .....+++.|+|||++.+ ..++.++|||||||++|+|+||++||.............
T Consensus 157 ~~~------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 157 VRT------FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred ccc------cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 211 123467899999998765 457899999999999999999999996433221110000
Q ss_pred --hhHHHhhhhCCCC--------ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 667 --NLAEILDAQAGDW--------PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 667 --~l~~~ld~~~~~~--------p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+..... ....+ ....+..+.+++.+|+..+|.+||++.+
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~ 280 (294)
T PLN00009 231 VTSLPDYKS-AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA 280 (294)
T ss_pred cccchhhhh-hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHH
Confidence 0000000 00001 1123567899999999999999999885
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=289.43 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=190.8
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
|.....||.|++|.||+|... +..+++|.+...... ....+.+|+.+|++++||||+++++++.+.. ++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999874 668999988654332 3467889999999999999999999986554 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
++ +|.+++.... ..+++..+..++.+|+.||.|||..+ |+|+||||+|||++.++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 74 8888876543 35899999999999999999999988 99999999999999999999999999987754321
Q ss_pred ccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch---------hhhHHHhh
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLAEILD 673 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~---------~~l~~~ld 673 (802)
......++..|++||.+.+. .++.++||||||+++|+|+||++||...+..+..... ..+..+.+
T Consensus 154 -----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 154 -----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred -----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 11234688899999988766 7899999999999999999999999654432211000 00000000
Q ss_pred ---hh------CCC-----CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 674 ---AQ------AGD-----WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ---~~------~~~-----~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.. ... .....+..+.+++.+||..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 276 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHH
Confidence 00 000 01134678999999999999999999984
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=307.56 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=204.3
Q ss_pred cccceecCCCcEEEEEEEEC------CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecCCC-eEEEEE
Q 003694 451 SENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEY 522 (802)
Q Consensus 451 ~~~~~iG~G~~g~Vy~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~-~lV~Ey 522 (802)
...++||+|.||+||+|.|- +-+||+|++.... .....+|+.|+-+|.+++|||+++|+|+|.... .||++|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~ 778 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL 778 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence 34568999999999999883 2389999987653 445678999999999999999999999997655 789999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
|++|+|.|++..... .+..+..+.|..|||+|+.|||... +|||||-..|||+.....+||.|||+++.+..+..
T Consensus 779 mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999976443 4778899999999999999999988 99999999999999999999999999999887654
Q ss_pred cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhhh-CCCCC
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWP 680 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p 680 (802)
. |......-.+.|||=|.+....|+.++|||||||++|||+| |..|+.... ...+.+++... ....|
T Consensus 854 e----y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-------~~eI~dlle~geRLsqP 922 (1177)
T KOG1025|consen 854 E----YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-------AEEIPDLLEKGERLSQP 922 (1177)
T ss_pred c----ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-------HHHhhHHHhccccCCCC
Confidence 3 23344455778999999999999999999999999999999 888875321 22233333322 34567
Q ss_pred hHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
+.++..+..++.+||..|+..||++++ +...+.++
T Consensus 923 piCtiDVy~~mvkCwmid~~~rp~fke-l~~~fs~~ 957 (1177)
T KOG1025|consen 923 PICTIDVYMVMVKCWMIDADSRPTFKE-LAEEFSRM 957 (1177)
T ss_pred CCccHHHHHHHHHHhccCcccCccHHH-HHHHHHHH
Confidence 788999999999999999999999994 44444443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=285.91 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=190.2
Q ss_pred CcccceecCCCcEEEEEEEECCe--EEEEEEEccc-----CccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEE
Q 003694 450 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSK-----GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~~~--~vavK~l~~~-----~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
|....+||+|+||.||++.+... .+++|+++.. .......+..|+.+++.++||||+++++++.+.. ++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 66778899999999999987643 4566665432 1123345778999999999999999999986544 8999
Q ss_pred EEccCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 521 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999988642 23346899999999999999999999988 999999999999975 5699999999987643
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||....... ....+........
T Consensus 158 ~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 225 (260)
T cd08222 158 SCD------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIVEGPTPSL 225 (260)
T ss_pred Ccc------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHcCCCCCC
Confidence 321 1123468899999999988888999999999999999999999995332211 1112222223344
Q ss_pred ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+...+..+.+++.+||..+|.+||++.+
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 253 (260)
T cd08222 226 PETYSRQLNSIMQSMLNKDPSLRPSAAE 253 (260)
T ss_pred cchhcHHHHHHHHHHhcCChhhCcCHHH
Confidence 5567789999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=293.43 Aligned_cols=249 Identities=25% Similarity=0.285 Sum_probs=189.3
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeecceecCC----CeE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCL 518 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----~~l 518 (802)
..+|...+.||.|+||.||+|.+. +..||+|++...... ....+.+|+.++.+++||||+++++++.+. .++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457888999999999999999985 568999998654321 223467899999999999999999998543 389
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 58888876533 45899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch--------hhhH
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE--------DNLA 669 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~--------~~l~ 669 (802)
.... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||............ ..+.
T Consensus 160 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 160 LPAK------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred CccC------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 4321 1123356888999998765 45789999999999999999999999644332211000 0000
Q ss_pred HHhhh-------hCCCCC--------hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 670 EILDA-------QAGDWP--------IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 670 ~~ld~-------~~~~~p--------~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.-++. .....+ ...+..+.+++.+|+..||.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~ 286 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE 286 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHH
Confidence 00000 000000 013567889999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=301.64 Aligned_cols=241 Identities=22% Similarity=0.301 Sum_probs=199.1
Q ss_pred HhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeecceecC--CCeE
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCL 518 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~l 518 (802)
.....|....+||+|.|+.|..|++. ++.||+|++....-. ....+.+|+.+|..++|||||+|+.+... ..|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567899999999999999999875 669999998765322 23458899999999999999999999754 4499
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
||||..+|.+.++|.+.+. +.......++.|+.+|++|||+.+ |||||||++||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999987765 344677889999999999999998 9999999999999999999999999999887
Q ss_pred CCCCcccccccccCCccCcccCCccccccCCC-CCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh--
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-- 675 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~-- 675 (802)
...- ....+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||.+... .++-...
T Consensus 207 ~~~~-------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----------k~Lr~rvl~ 269 (596)
T KOG0586|consen 207 YGLM-------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----------KELRPRVLR 269 (596)
T ss_pred cccc-------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----------ccccchhee
Confidence 4431 245699999999999988775 5899999999999999999999964321 1111111
Q ss_pred -CCCCChHHHHHHHHHHHHhhccccCCCCccccc
Q 003694 676 -AGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 708 (802)
Q Consensus 676 -~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~ 708 (802)
.-..|.-...++.+|+.+++-++|.+|+++.+.
T Consensus 270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqi 303 (596)
T KOG0586|consen 270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQI 303 (596)
T ss_pred eeecccceeechhHHHHHHhhccCccccCCHHHh
Confidence 123455667788999999999999999998853
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=280.93 Aligned_cols=200 Identities=26% Similarity=0.432 Sum_probs=164.4
Q ss_pred cCCcccceecCCCcEEEEEEEECC------eEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCCC---
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--- 516 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~------~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--- 516 (802)
..|+...+||+|.||.||++.-.+ ..+|+|.++.... .......+|+.+++.|+||||+.|..+|....
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 457778889999999999996532 2689998875422 23345789999999999999999999886532
Q ss_pred eEEEEEccCCCHHHHhhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC----ceeEEee
Q 003694 517 CLVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN----LVSKIGD 590 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~----~~~kl~D 590 (802)
+|++||.+. +|...++- ......++...+..|++||+.|+.|||++- |+||||||+|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 799999985 88887753 233456888999999999999999999999 9999999999999877 9999999
Q ss_pred ecccccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCcc
Q 003694 591 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIA 654 (802)
Q Consensus 591 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~ 654 (802)
||+++++...-. ..+.....+-|..|.|||.+.+ ..||++.|||+.|||+.||||-.|.|.
T Consensus 180 lGlaR~~~~plk---pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLK---PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhcccc---ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 999999875432 2223345678999999998766 459999999999999999999988775
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-33 Score=322.02 Aligned_cols=252 Identities=29% Similarity=0.377 Sum_probs=185.7
Q ss_pred hhcCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeecceecC--------
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------- 514 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-------- 514 (802)
--.+|+....||+||||.||+++. +|+.||||++.... ......+.+|+.+|++|+|||||++|.+|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 345788888999999999999975 69999999987664 2234567899999999999999999864400
Q ss_pred ----------------------------------------------------------------------C---------
Q 003694 515 ----------------------------------------------------------------------H--------- 515 (802)
Q Consensus 515 ----------------------------------------------------------------------~--------- 515 (802)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 003694 516 ----------------------------------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 561 (802)
Q Consensus 516 ----------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH 561 (802)
.||-||||+..+|.+++..+.-.. .....++++++|+.||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 156789998877777765433210 23467889999999999999
Q ss_pred hcCCCCeEEcCCCCCCeEecCCceeEEeeeccccccc----C--------CCCcccccccccCCccCcccCCccccccCC
Q 003694 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN----S--------DPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 629 (802)
Q Consensus 562 ~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~----~--------~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 629 (802)
+.| ||||||||.||+||.+..+||+|||+|+... . ...........|+.+||.-|+|||++.+..
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998722 0 000111222457789999999999887654
Q ss_pred ---CCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 630 ---ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 630 ---~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
|+.|+|+|||||||+||+. ||+. .++++..-..+....-+...++.....+.-+.+|.++++.||.+||++.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 9999999999999999997 4642 2333222222211111111122334556678999999999999999998
Q ss_pred c
Q 003694 707 N 707 (802)
Q Consensus 707 ~ 707 (802)
+
T Consensus 867 e 867 (1351)
T KOG1035|consen 867 E 867 (1351)
T ss_pred H
Confidence 5
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=299.98 Aligned_cols=255 Identities=22% Similarity=0.272 Sum_probs=193.6
Q ss_pred ccCCHHHHHHhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecce
Q 003694 436 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGA 511 (802)
Q Consensus 436 ~~~~~~ei~~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~ 511 (802)
+.....++...+++|.....||+|+||.||+|... +..||+|++.... ......+.+|+.++.+++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 34455667778899999999999999999999864 5689999886532 2234568889999999999999999998
Q ss_pred ecCC--------CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC
Q 003694 512 CPDH--------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN 583 (802)
Q Consensus 512 ~~~~--------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~ 583 (802)
+... .+++++++ +++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 156 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 156 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence 7421 36777776 78998877532 3889999999999999999999998 9999999999999999
Q ss_pred ceeEEeeecccccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhh
Q 003694 584 LVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA 662 (802)
Q Consensus 584 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~ 662 (802)
+.+||+|||++...... .....|+..|+|||++.+ ..++.++|||||||++|+|++|++||.........
T Consensus 157 ~~~kl~dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 227 (345)
T cd07877 157 CELKILDFGLARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227 (345)
T ss_pred CCEEEeccccccccccc---------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999998764321 123468899999998765 56889999999999999999999999543221110
Q ss_pred h-----------------chhhhHHHhhh--hCCC-----CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 663 I-----------------DEDNLAEILDA--QAGD-----WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 663 ~-----------------~~~~l~~~ld~--~~~~-----~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. ........+.. ..+. ........+.+++.+|++.+|.+||+..+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 296 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 296 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHH
Confidence 0 00000000000 0000 00123567889999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=295.38 Aligned_cols=251 Identities=17% Similarity=0.241 Sum_probs=184.3
Q ss_pred eecCC--CcEEEEEEEE--CCeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCC
Q 003694 455 RIGMG--GYGTVYKGTF--HHTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 526 (802)
Q Consensus 455 ~iG~G--~~g~Vy~~~~--~~~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~g 526 (802)
.||.| +||+||++.+ .++.||+|++..... ...+.+.+|+.++..++||||++++++|.... ++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999988 467999999875432 23467889999999999999999999996554 8999999999
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+............
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999887543 234888899999999999999999988 999999999999999999999999876543322111110
Q ss_pred ccc-ccCCccCcccCCccccccC--CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch---hh--------h----
Q 003694 607 TYK-NTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---DN--------L---- 668 (802)
Q Consensus 607 ~~~-~~~~~gt~~Y~aPE~~~~~--~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~---~~--------l---- 668 (802)
.+. .....++..|++||++.+. .++.++|||||||++|+|++|++||............ .. .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 000 0112356779999998763 4789999999999999999999999643221111000 00 0
Q ss_pred H------------------------HHhhhh-CCCCChHHHHHHHHHHHHhhccccCCCCccccch
Q 003694 669 A------------------------EILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 669 ~------------------------~~ld~~-~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
. .+.... ....+......+.+|+.+||..+|.+||++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0 000000 0011224567899999999999999999998533
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=293.02 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=188.6
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeecceecCC-------
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 515 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------- 515 (802)
.++|....+||.|+||.||+|.+. +..+|+|++...... ....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999985 568999987654322 234578899999999999999999886321
Q ss_pred ---CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeec
Q 003694 516 ---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 592 (802)
Q Consensus 516 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFG 592 (802)
.++||||+. ++|...+... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 279999996 4677766543 235899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCccc-----ccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhc--
Q 003694 593 LSTMLNSDPSFVS-----TTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID-- 664 (802)
Q Consensus 593 la~~~~~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~-- 664 (802)
++........... .....+...|++.|+|||++.+ ..++.++|||||||++|+|++|++||.........-.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9987654322111 1111234577899999998754 4588999999999999999999999964433211100
Q ss_pred -------hhhh------HHHhh-hhCCCCC-------hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 665 -------EDNL------AEILD-AQAGDWP-------IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 665 -------~~~l------~~~ld-~~~~~~p-------~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+ ....+ ......+ ......+.+++.+|++.+|.+||++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e 304 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHH
Confidence 0000 00000 0000011 112357889999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=297.57 Aligned_cols=248 Identities=21% Similarity=0.296 Sum_probs=190.3
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeecceecCC-------
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 515 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------- 515 (802)
.+.|.....||+|+||.||+|... +..||||.+... .......+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 456888899999999999999875 568999988653 222345678899999999999999999987532
Q ss_pred CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccc
Q 003694 516 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~ 595 (802)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 389999996 7898887543 34889999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhh------------
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA------------ 662 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~------------ 662 (802)
....... ......++..|+|||.+.. ..++.++|||||||++|+|++|++||.........
T Consensus 157 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 157 TTSEKGD------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccCCCcc------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 7654321 1133467899999998764 46889999999999999999999999643221100
Q ss_pred -----hchhhhHHHhhhhC--C-----CCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 663 -----IDEDNLAEILDAQA--G-----DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 663 -----~~~~~l~~~ld~~~--~-----~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+........+.... . ......+..+.+++.+||+.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~e 287 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEE 287 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 00111111111000 0 011234677899999999999999999885
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=291.05 Aligned_cols=236 Identities=27% Similarity=0.397 Sum_probs=185.2
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
|....+||+|+||.||+|... +..|++|++..... .....+.+|+.+++.++|||++++++++.+.. ++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555667999999999999874 56899998864332 22346788999999999999999999986654 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+. |+|.+++.... .++++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 96 67888775433 35899999999999999999999988 999999999999999999999999998643221
Q ss_pred cccccccccCCccCcccCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
....|+..|+|||++. .+.++.++|||||||++|+|++|.+||......... ..+........
T Consensus 175 --------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~~~~~ 240 (313)
T cd06633 175 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNDSPTL 240 (313)
T ss_pred --------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcCCCCC
Confidence 2346889999999874 466889999999999999999999998643322111 11111111111
Q ss_pred -ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 680 -PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 680 -p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
....+..+.+|+.+||+.+|.+||++.+
T Consensus 241 ~~~~~~~~l~~li~~~l~~~P~~Rp~~~~ 269 (313)
T cd06633 241 QSNEWTDSFRGFVDYCLQKIPQERPASAE 269 (313)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 1223467899999999999999999884
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=294.09 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=190.1
Q ss_pred HHHhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecC---C
Q 003694 443 IESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD---H 515 (802)
Q Consensus 443 i~~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~---~ 515 (802)
+..++++|.....||.|+||.||++... +..||+|.+.... ......+.+|+.+++.++||||++++++|.. .
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 4457788999999999999999999865 5689999875432 2234668899999999999999999998843 2
Q ss_pred CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccc
Q 003694 516 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~ 595 (802)
.++||||+ +++|.+++.. .++++.....++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 48999998 5789887753 24778888899999999999999998 9999999999999999999999999987
Q ss_pred cccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhh------------
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA------------ 662 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~------------ 662 (802)
..... .....+++.|+|||++.+ ..++.++||||||+++|+|+||++||.........
T Consensus 157 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 157 IQDPQ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred ccCCC---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 54321 123467889999998765 56899999999999999999999999643321110
Q ss_pred -----hchhhhHHHhhhhC--CCCCh-----HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 663 -----IDEDNLAEILDAQA--GDWPI-----KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 663 -----~~~~~l~~~ld~~~--~~~p~-----~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+..+....++.... ...|. ..+..+.+++.+||+.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e 284 (328)
T cd07856 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284 (328)
T ss_pred HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 00000111111111 11111 23578999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=291.07 Aligned_cols=236 Identities=28% Similarity=0.419 Sum_probs=185.7
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEccc---CccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
|.....||.|+||.||+|... +..+++|.+... .......+.+|+.+++.++|||++++++++.+.. ++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 666678999999999999874 568999987642 2223356788999999999999999999986544 899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
+. |+|.+.+.... .++++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 97 CL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred cC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 96 68887775433 34888999999999999999999988 999999999999999999999999998765432
Q ss_pred cccccccccCCccCcccCCccccc---cCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCC-
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD- 678 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~- 678 (802)
....|++.|+|||++. .+.++.++|||||||++|+|++|..||........ +..+.......
T Consensus 169 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~ 234 (308)
T cd06634 169 --------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNESPAL 234 (308)
T ss_pred --------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHHHhhcCCCCc
Confidence 2346889999999874 35678899999999999999999999854322111 11111111111
Q ss_pred CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+...+..+.+|+.+||..+|.+||++.+
T Consensus 235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 263 (308)
T cd06634 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (308)
T ss_pred CcccccHHHHHHHHHHhhCCcccCCCHHH
Confidence 12345678999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=298.93 Aligned_cols=245 Identities=21% Similarity=0.293 Sum_probs=188.7
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCC------
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 515 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------ 515 (802)
..++|.....||+|+||.||+|... +..||||++.... ......+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4567888999999999999999874 5689999885432 22345688999999999999999999988532
Q ss_pred --CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 516 --GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 516 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
.++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 27999999 7799887753 24889999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch-------
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE------- 665 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~------- 665 (802)
+....... ....+++.|++||++.+ ..++.++|+|||||++|+|++|++||............
T Consensus 165 ~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 165 ARQTDSEM---------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ccccccCc---------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 98654321 23467899999998765 45889999999999999999999999644322111000
Q ss_pred -hhhH---------HHhhhhC-------CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 -DNLA---------EILDAQA-------GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 -~~l~---------~~ld~~~-------~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+. ..+.... ..........+.+++.+|+..+|.+||++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~ 294 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAE 294 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHH
Confidence 0000 0000000 0001123556889999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=298.43 Aligned_cols=243 Identities=23% Similarity=0.340 Sum_probs=185.2
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCC-------
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 515 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------- 515 (802)
..+|.....||+|+||.||+|... +..||||++.... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 367888899999999999999874 6789999886432 22335688999999999999999999988532
Q ss_pred -CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccc
Q 003694 516 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594 (802)
Q Consensus 516 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla 594 (802)
.++|+||+. ++|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 279999996 47766541 24888999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhh---c-----h
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI---D-----E 665 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~---~-----~ 665 (802)
+..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... . .
T Consensus 165 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 165 RHADAE---------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred cCCCCC---------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 765321 123467899999998765 468899999999999999999999997433211100 0 0
Q ss_pred hhhHHHhhh--------hCCCCC--------hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 DNLAEILDA--------QAGDWP--------IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 ~~l~~~ld~--------~~~~~p--------~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+...+.. ..+..+ ...+..+.+|+.+||+.+|.+||++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e 293 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATE 293 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 000000000 000000 123456889999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=279.37 Aligned_cols=233 Identities=29% Similarity=0.356 Sum_probs=191.4
Q ss_pred ecCCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCH
Q 003694 456 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 528 (802)
Q Consensus 456 iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL 528 (802)
||.|+||.||++... +..+++|++...... ....+..|+.++++++||||+++++.+.+.. ++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999985 579999998754322 3457889999999999999999999986555 899999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccc
Q 003694 529 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 608 (802)
Q Consensus 529 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 608 (802)
.+++.... .+++.....++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------ 148 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------ 148 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC------
Confidence 99986543 4889999999999999999999988 99999999999999999999999999987654321
Q ss_pred cccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHH
Q 003694 609 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 688 (802)
Q Consensus 609 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 688 (802)
......++..|++||...+...+.++|+||||+++|+|++|+.||...... .....+.. .....|...+..+.
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~~~~~l~ 221 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EIYEKILK-DPLRFPEFLSPEAR 221 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHhc-CCCCCCCCCCHHHH
Confidence 123457889999999998888899999999999999999999999643321 11111221 22344555578899
Q ss_pred HHHHHhhccccCCCCcccc
Q 003694 689 ALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 689 ~li~~Cl~~~p~~RP~~~~ 707 (802)
+++.+|+..+|.+||++.+
T Consensus 222 ~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHhcCCHhhCCCccc
Confidence 9999999999999999963
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=294.70 Aligned_cols=249 Identities=24% Similarity=0.288 Sum_probs=192.8
Q ss_pred CCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCC-------Ce
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------GC 517 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-------~~ 517 (802)
+|.....||.|+||.||+|... +..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+. .|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777889999999999999975 5689999887643 33456789999999999999999999998543 38
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~ 597 (802)
+||||++ ++|.+++.... .+++..+..++.+|+.||.|||+.+ |+||||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58888875433 5899999999999999999999998 999999999999999999999999999877
Q ss_pred cCCCCcccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhh-------------
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI------------- 663 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~------------- 663 (802)
...... ........+++.|+|||++.+. .++.++||||||+++|+|+||++||......+...
T Consensus 154 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccc---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 643211 0112344689999999998877 78999999999999999999999996443221100
Q ss_pred ----chhhhHHHhhhhCCCC-------ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 664 ----DEDNLAEILDAQAGDW-------PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 664 ----~~~~l~~~ld~~~~~~-------p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
........+....... ....+..+.+++.+||+.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 285 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE 285 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 0000001111000000 1123567899999999999999999884
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=275.37 Aligned_cols=242 Identities=24% Similarity=0.319 Sum_probs=191.8
Q ss_pred hcCCccc-ceecCCCcEEEEEEEECCe--EEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeecceecCC----C--
Q 003694 447 TLSFSEN-LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH----G-- 516 (802)
Q Consensus 447 ~~~f~~~-~~iG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~----~-- 516 (802)
+.+|.+. .+||-|-.|.|..+..+.+ .+|+|++.. .....+|+++--.. .|||||.++++|... .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 3344443 4699999999999988754 789998853 23456788875444 599999999988532 2
Q ss_pred eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC---CceeEEeeecc
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDVGL 593 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~---~~~~kl~DFGl 593 (802)
.+|||.|+||.|..++..++. ..+++.+...|+.||+.|+.|||+.+ |.||||||+|+|... |-.+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 479999999999999987654 46899999999999999999999998 999999999999954 57889999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhh
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld 673 (802)
|+...... ...+.+.||+|.|||++....|+..+|+||+|||+|-||+|.|||...+- .++..|.-..+..
T Consensus 211 AK~t~~~~-------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~ 281 (400)
T KOG0604|consen 211 AKETQEPG-------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRT 281 (400)
T ss_pred ccccCCCc-------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhc
Confidence 99755322 23556889999999999999999999999999999999999999986554 3344443333322
Q ss_pred hhCCCCCh----HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 674 AQAGDWPI----KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ~~~~~~p~----~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. .-.+|. ..++...++|.+.|..+|.+|-++.+
T Consensus 282 g-qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~ 318 (400)
T KOG0604|consen 282 G-QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEE 318 (400)
T ss_pred c-CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHH
Confidence 2 222332 45778899999999999999999874
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=284.55 Aligned_cols=240 Identities=26% Similarity=0.371 Sum_probs=187.0
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhc---CCCceeeecceecC--C-----
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKI---RHPHLLLLLGACPD--H----- 515 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~il~~l---~Hpniv~l~g~~~~--~----- 515 (802)
|.....||.|+||.||+|.+. +..+|+|++...... ....+.+|+.++.++ +|||+++++++|.+ .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566788999999999999985 579999998744322 234566788887766 59999999999853 2
Q ss_pred CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccc
Q 003694 516 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~ 595 (802)
.+++|||+. ++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 479999997 589888865432 35899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh-
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA- 674 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~- 674 (802)
....... .....++..|+|||++.+..++.++|||||||++|+|+||++||......+. +..+++.
T Consensus 156 ~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~------~~~~~~~~ 222 (287)
T cd07838 156 IYSFEMA-------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ------LDKIFDVI 222 (287)
T ss_pred eccCCcc-------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH------HHHHHHHc
Confidence 7653321 1233578899999999988899999999999999999999999964432221 1111110
Q ss_pred ---------------------hCCCC----ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 675 ---------------------QAGDW----PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 675 ---------------------~~~~~----p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..... .......+.+++.+||..+|.+||++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~ 280 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHH
Confidence 00000 1134577889999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=287.11 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=190.6
Q ss_pred CcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 450 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
|+...+||+|+||.||+|... +..+++|++.... ......+..|+.++++++|||++++++++.+.. ++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999986 5699999987653 333466888999999999999999999986544 8999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
+ ++|.+++.... ..+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58999987643 35899999999999999999999998 999999999999999999999999999876543211
Q ss_pred ccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhc---------hhhhHHHh-
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---------EDNLAEIL- 672 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~---------~~~l~~~l- 672 (802)
.....++..|+|||++.+. .++.++|||||||++|+|++|++||........... ...+..+.
T Consensus 155 ------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 155 ------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred ------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 1233567889999988766 789999999999999999999999965433221100 00000000
Q ss_pred ----hhhCCCCC--------hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 673 ----DAQAGDWP--------IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 673 ----d~~~~~~p--------~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+.....++ ...+..+.+++.+||..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 00001110 112567999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=295.32 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=187.8
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCC----------
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---------- 515 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~---------- 515 (802)
.+|...+.||.|+||.||+|... +..||+|++........+.+.+|+++|++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888899999999999999885 568999998766555667788999999999999999999876432
Q ss_pred ------CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEec-CCceeEE
Q 003694 516 ------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKI 588 (802)
Q Consensus 516 ------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~-~~~~~kl 588 (802)
.++||||++ ++|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 379999997 588887743 24888899999999999999999998 99999999999997 4668899
Q ss_pred eeecccccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch--
Q 003694 589 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-- 665 (802)
Q Consensus 589 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~-- 665 (802)
+|||+++.+....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||............
T Consensus 157 ~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 157 GDFGLARIVDPHYSHK---GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred CCcccceecCCccccc---cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999998764321110 01123367889999997644 55788999999999999999999999643322211000
Q ss_pred ----------hh----hHHHhh--hhCCCCC-----hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 ----------DN----LAEILD--AQAGDWP-----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 ----------~~----l~~~ld--~~~~~~p-----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.. +..... ......+ ......+.+|+.+||..+|.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 296 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHH
Confidence 00 000000 0001111 123467889999999999999999884
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=283.63 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=196.2
Q ss_pred hcCCcccceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHh--cCCCceeeecceecC------CCeE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSK--IRHPHLLLLLGACPD------HGCL 518 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~--l~Hpniv~l~g~~~~------~~~l 518 (802)
.......+.||+|.||.||+|.|+|..||||++.... ...+.+|.+|.+. |+|+||+.|+++-.. +.+|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 3455667789999999999999999999999997643 4457788888876 599999999987522 2379
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-----TKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-----~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
|.+|-++|||.|+|.+. .++....++++..+|+||++||. .|.+.|.|||||+.|||+..||.+.|+|+||
T Consensus 287 vTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999763 38888999999999999999995 3556799999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCC----C--CCcccchhHHHHHHHHHhC----------CCCccccc
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL----I--SPKSDVYAYGMVILQLLTA----------KPAIAITH 657 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~--~~~sDv~SlGvil~elltg----------~~p~~~~~ 657 (802)
|-......+.. .......+||..|||||++.... + -..+||||||.++||+.-. ++||....
T Consensus 363 Av~h~~~t~~i--di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 363 AVRHDSDTDTI--DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eEEecccCCcc--cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 98776553322 12335569999999999875432 1 1358999999999998753 46775322
Q ss_pred hhhhhhchhhhHHHhhh--hCCCCC-----hHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHHH
Q 003694 658 KVETAIDEDNLAEILDA--QAGDWP-----IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 658 ~~~~~~~~~~l~~~ld~--~~~~~p-----~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
..+. ..+.+.+++-. ..+..| ......+.+|+..||..+|..|-++- -+.+.|.++.+
T Consensus 441 p~DP--s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltAL-riKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSDP--SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTAL-RIKKTLAKLSN 505 (513)
T ss_pred CCCC--CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHH-HHHHHHHHHhc
Confidence 2111 11122222211 122222 25678899999999999999998876 46666665543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=291.64 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=185.9
Q ss_pred CCcccceecCCCcEEEEEEEECC----eEEEEEEEcccC--ccchHHHHHHHHHHHhc-CCCceeeecceecC------C
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH----TFAAVKVLQSKG--NIQNKQFLQELEVLSKI-RHPHLLLLLGACPD------H 515 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~----~~vavK~l~~~~--~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~------~ 515 (802)
+|...+.||+|+||.||++...+ ..||+|++.... ......+.+|+.++.++ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46777899999999999999864 489999886432 22345678899999999 59999999987521 2
Q ss_pred CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccc
Q 003694 516 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~ 595 (802)
.+++++|+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 367888885 6898888543 34889999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhh---h------ch
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA---I------DE 665 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~---~------~~ 665 (802)
.+...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||......... + ..
T Consensus 154 ~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGE--NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred eccccccc--ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 76543211 1111234578999999998765 46889999999999999999999999643311100 0 00
Q ss_pred hhhHHH--------hhhh--CCCCC-----hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 666 DNLAEI--------LDAQ--AGDWP-----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 ~~l~~~--------ld~~--~~~~p-----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+.+..+ .... .+..+ ......+.+++.+|++.+|.+||++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 288 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEE 288 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 000000 0000 00000 113567999999999999999999885
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=313.84 Aligned_cols=254 Identities=25% Similarity=0.472 Sum_probs=204.1
Q ss_pred CCcccceecCCCcEEEEEEEEC---------CeEEEEEEEcccCcc-chHHHHHHHHHHHhc-CCCceeeecceecCCC-
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKI-RHPHLLLLLGACPDHG- 516 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~---------~~~vavK~l~~~~~~-~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~- 516 (802)
+......||+|.||.|++|... ...||||.++..... ..+.+..|+++|+.+ +||||+.|+|+|....
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3344558999999999999754 347999998865443 556799999999998 4999999999997744
Q ss_pred -eEEEEEccCCCHHHHhhhcC-----CC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC
Q 003694 517 -CLVYEYMENGSLEDRLYRKN-----NT--------PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 582 (802)
Q Consensus 517 -~lV~Ey~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~ 582 (802)
++|+||+..|+|.++|.... .. ..++..+.+.++.|||.|+.||++.+ +|||||-..|||+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecC
Confidence 89999999999999998655 01 23888999999999999999999988 999999999999999
Q ss_pred CceeEEeeecccccccCCCCcccccccccCCcc--CcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchh
Q 003694 583 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG--TLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 659 (802)
Q Consensus 583 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~ 659 (802)
+..+||+|||+|+........ ......| ...|||||.+....|+.++|||||||+||||+| |..||.....
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y-----~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~- 527 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYY-----RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP- 527 (609)
T ss_pred CCEEEEccccceeccCCCCce-----EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence 999999999999976544322 2122233 344999999999999999999999999999999 7889864211
Q ss_pred hhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 660 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 660 ~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
..+-+..+-+......|..+..++.+++..||+.+|.+||++. ++...++.+
T Consensus 528 ----~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~-~~~~~~~~~ 579 (609)
T KOG0200|consen 528 ----TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFS-ECVEFFEKH 579 (609)
T ss_pred ----HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHH-HHHHHHHHH
Confidence 1111222333445677888899999999999999999999999 576777663
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=291.33 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=185.1
Q ss_pred CCc-ccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccc--------------hHHHHHHHHHHHhcCCCceeeecce
Q 003694 449 SFS-ENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ--------------NKQFLQELEVLSKIRHPHLLLLLGA 511 (802)
Q Consensus 449 ~f~-~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~--------------~~~~~~Ei~il~~l~Hpniv~l~g~ 511 (802)
.|. ....||.|+||.||+|.+. ++.||||++....... ...+.+|+++++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 443 3456999999999999875 5689999886432211 1247789999999999999999999
Q ss_pred ecCCC--eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEe
Q 003694 512 CPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 589 (802)
Q Consensus 512 ~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~ 589 (802)
+.... ++||||+. |+|.+++... ..+++.....++.|++.||.|||+.+ |+||||+|+|||++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence 86544 89999997 6899888643 24888899999999999999999988 9999999999999999999999
Q ss_pred eecccccccCCCCcc--------cccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhh
Q 003694 590 DVGLSTMLNSDPSFV--------STTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVE 660 (802)
Q Consensus 590 DFGla~~~~~~~~~~--------~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~ 660 (802)
|||++.......... ..........+++.|+|||++.+. .++.++|||||||++|+|+||++||.......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999998765211000 001112234578899999988654 46899999999999999999999997543322
Q ss_pred hhhchhhhHHHhh-hhCCCC-----------------------ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 661 TAIDEDNLAEILD-AQAGDW-----------------------PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 661 ~~~~~~~l~~~ld-~~~~~~-----------------------p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
... .+...+. +....| ....+..+.+++.+|+..+|.+||++.+
T Consensus 242 ~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 309 (335)
T PTZ00024 242 QLG---RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309 (335)
T ss_pred HHH---HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence 110 0000000 000000 0123567889999999999999999884
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=292.80 Aligned_cols=237 Identities=24% Similarity=0.305 Sum_probs=200.3
Q ss_pred cccceecCCCcEEEEEEEECCeE--EEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEc
Q 003694 451 SENLRIGMGGYGTVYKGTFHHTF--AAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 451 ~~~~~iG~G~~g~Vy~~~~~~~~--vavK~l~~~~---~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
.....||-||||.|=++..++.. +|+|+++... ..+.+.+..|-.||..++.|.||+||..|.+.. |+.||-|
T Consensus 423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence 33456999999999999887664 7888877653 334455788999999999999999999998776 7889999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 603 (802)
-||.|+..|..++. +...+..-++..+..|++|||+.+ ||+|||||+|.|||.+|.+||.|||+|+.+....
T Consensus 503 lGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-- 574 (732)
T KOG0614|consen 503 LGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-- 574 (732)
T ss_pred cCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC--
Confidence 99999999976654 666777788999999999999999 9999999999999999999999999999987653
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh-CCCCChH
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIK 682 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~ 682 (802)
+..+++|||.|.|||++.+..++.++|.|||||++||||||.|||...+.+... ..++... .-.||..
T Consensus 575 -----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY------n~ILkGid~i~~Pr~ 643 (732)
T KOG0614|consen 575 -----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY------NLILKGIDKIEFPRR 643 (732)
T ss_pred -----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH------HHHHhhhhhhhcccc
Confidence 235679999999999999999999999999999999999999999877766542 2233222 1457888
Q ss_pred HHHHHHHHHHHhhccccCCCCccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
......+|+.+.|..+|.+|-...
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG~~ 667 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLGYQ 667 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhccc
Confidence 889999999999999999998744
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=275.15 Aligned_cols=219 Identities=21% Similarity=0.174 Sum_probs=175.4
Q ss_pred CCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCHHHHhhh
Q 003694 459 GGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYR 534 (802)
Q Consensus 459 G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~ 534 (802)
|.||.||++.+. +..+|+|.+.... .+.+|...+....||||+++++++.+.. ++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999884 5689999986543 2344555566667999999999986544 899999999999998865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccccccCCc
Q 003694 535 KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 614 (802)
Q Consensus 535 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~ 614 (802)
.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....... ....
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---------~~~~ 143 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---------DGEA 143 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc---------ccCC
Confidence 43 3889999999999999999999988 9999999999999999999999999886654321 2235
Q ss_pred cCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHh
Q 003694 615 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSC 694 (802)
Q Consensus 615 gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~C 694 (802)
++..|+|||+..+..++.++||||||+++|+|++|+.|+...... +........|...+..+.+++.+|
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------INTHTTLNIPEWVSEEARSLLQQL 212 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------cccccccCCcccCCHHHHHHHHHH
Confidence 677899999998888999999999999999999999887432110 000001123444567899999999
Q ss_pred hccccCCCCccccc
Q 003694 695 AELRRKDRPDLKNQ 708 (802)
Q Consensus 695 l~~~p~~RP~~~~~ 708 (802)
++.||.+||++.+.
T Consensus 213 l~~dp~~R~~~~~~ 226 (237)
T cd05576 213 LQFNPTERLGAGVA 226 (237)
T ss_pred ccCCHHHhcCCCcc
Confidence 99999999998643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=299.20 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=206.2
Q ss_pred HHHHhhcCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeeccee------
Q 003694 442 EIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC------ 512 (802)
Q Consensus 442 ei~~~~~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~------ 512 (802)
.+..-+.-|.+...||.|.||.||+++. +++.+|+|++..... ..+++..|.++|+.. +|||++.++|++
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3344566788889999999999998865 567999999887654 345678899999887 599999999997
Q ss_pred -cCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeee
Q 003694 513 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 591 (802)
Q Consensus 513 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DF 591 (802)
.|...||||||.+||..|++..-. +..+.|..+.-|+.+++.||.+||.+. +||||||-.||||+.++.+||+||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeee
Confidence 345589999999999999887655 556899999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCccCcccCCccccccC-----CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchh
Q 003694 592 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 666 (802)
Q Consensus 592 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~ 666 (802)
|++..++... .+.....|||+|||||++... .|+..+|+|||||+..||--|.||+...|.+...+..
T Consensus 168 GvSaQldsT~------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I- 240 (953)
T KOG0587|consen 168 GVSAQLDSTV------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI- 240 (953)
T ss_pred eeeeeeeccc------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-
Confidence 9998876543 344567999999999987543 4788999999999999999999999888776653211
Q ss_pred hhHHHhhhhC--CCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 667 NLAEILDAQA--GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 667 ~l~~~ld~~~--~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..... ...|.....++.++|..|+..|..+||++.+
T Consensus 241 -----pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ 278 (953)
T KOG0587|consen 241 -----PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEE 278 (953)
T ss_pred -----CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhh
Confidence 11111 1235678899999999999999999999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=312.01 Aligned_cols=143 Identities=30% Similarity=0.366 Sum_probs=125.3
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeecceecCC--CeEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVY 520 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~lV~ 520 (802)
++|....+||+|+||.||+|.+. +..||||++..... .....+..|+.++..++||||+++++++... .||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999987 67999999875432 2235688999999999999999999888644 48999
Q ss_pred EEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
||+.+|+|.+++.... .+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999886543 3788889999999999999999988 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=294.96 Aligned_cols=246 Identities=22% Similarity=0.279 Sum_probs=189.0
Q ss_pred HhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeecceecCC-----
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----- 515 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~----- 515 (802)
...++|.....||+|+||.||+|... +..||+|++.... ......+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34668999999999999999999985 5689999876432 22345678899999999999999999876422
Q ss_pred ---CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeec
Q 003694 516 ---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 592 (802)
Q Consensus 516 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFG 592 (802)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 47999998 6799988754 34899999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhh--------
Q 003694 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI-------- 663 (802)
Q Consensus 593 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~-------- 663 (802)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|+||+.||..........
T Consensus 164 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence 99865432 133467889999998755 367899999999999999999999996433221100
Q ss_pred ---------chhhhHHHhhhhC----CCC---ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 664 ---------DEDNLAEILDAQA----GDW---PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 664 ---------~~~~l~~~ld~~~----~~~---p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
........+.... ..+ ....+..+.+++.+|+..+|.+||++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 0000000000000 000 0123578899999999999999999884
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=289.99 Aligned_cols=233 Identities=23% Similarity=0.301 Sum_probs=188.1
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~E 521 (802)
+..|.....+|.|+|+.|-.+... +...+||++.... .+-.+|+.++... .||||+.+.+.|.+.. ++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 556777778999999999999875 4588999987652 2234678777666 5999999999998776 89999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEe-cCCceeEEeeecccccccCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL-DHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl-~~~~~~kl~DFGla~~~~~~ 600 (802)
++.||-|.+.+..... +. ..+..|+.+|+.|+.|||..| ||||||||+|||+ +..++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988888765442 22 567789999999999999988 9999999999999 68899999999999987754
Q ss_pred CCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
....+-|..|.|||++....|+++|||||||++||+||+|+.||.....- ..+...+ ..+...
T Consensus 470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i--~~~~~s 532 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRI--QMPKFS 532 (612)
T ss_pred ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhh--cCCccc
Confidence 12347799999999999899999999999999999999999999633211 0111111 113333
Q ss_pred hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+...++|+.+||+.+|.+||++.+
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~ 559 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADE 559 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhh
Confidence 566788999999999999999999985
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=270.39 Aligned_cols=236 Identities=28% Similarity=0.362 Sum_probs=182.0
Q ss_pred ceecCCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeecceec-CCC-eEEEEEccCCC
Q 003694 454 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACP-DHG-CLVYEYMENGS 527 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~-~~~-~lV~Ey~~~gs 527 (802)
..||.|.||+|+|-.++ +...|||.+..... ....+|+.|.++..+- +.||||++||++- ++. ++.||.|. .|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 45999999999999886 56889999987654 4567789999876554 6999999999974 444 58899996 57
Q ss_pred HHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 528 LEDRLYRK--NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 528 L~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|+.+...- -....+++...-.|..-...||.||-..- .|||||+||+|||||..|.+||||||++-.+.++-
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---- 222 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---- 222 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH----
Confidence 76654321 12234888888889999999999998764 39999999999999999999999999998765432
Q ss_pred ccccccCCccCcccCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC---
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP--- 680 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p--- 680 (802)
..+.-+|-..|||||.+.. ..|+.+|||||||++|||+.||+-|+..-..+- +.+..+. .++.|
T Consensus 223 ---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf-----eql~~Vv---~gdpp~l~ 291 (361)
T KOG1006|consen 223 ---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF-----EQLCQVV---IGDPPILL 291 (361)
T ss_pred ---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH-----HHHHHHH---cCCCCeec
Confidence 2345589999999997743 348999999999999999999999985322211 1112221 12222
Q ss_pred -----hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 -----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 -----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
......+..++..|+-.|..+||.+.+
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~ 323 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDD 323 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhh
Confidence 236788999999999999999999984
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=266.02 Aligned_cols=246 Identities=23% Similarity=0.268 Sum_probs=198.1
Q ss_pred hcCCcccceecCCCcEEEEEEEECCe--EEEEEEEccc---CccchHHHHHHHHHHHhc-CCCceeeecceecCCC--eE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSK---GNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~~--~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~l 518 (802)
.++|.....||+|+|+.|..+.+..+ .+|+|+++.. .....+..+.|-.+.... +||.+|-|..+|+... ++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 34678888999999999999998765 8999998754 333455677888888776 6999999999997654 88
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
|.||++||+|.-++.+.. .+|.....-+..+|+.||.|||+.| ||+||||.+|+|||..|++||.|||+++.--
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999976665543 4888888889999999999999999 9999999999999999999999999998644
Q ss_pred CCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchh-hhhhchhhhHHHhhhhCC
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKV-ETAIDEDNLAEILDAQAG 677 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~-~~~~~~~~l~~~ld~~~~ 677 (802)
...+. ....+|||.|+|||++++..|+..+|+|+|||+++||+.|+.||.+...- .....++.+.+++-...-
T Consensus 403 ~~gd~------tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 403 GPGDT------TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred CCCcc------cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 33221 24579999999999999999999999999999999999999999854311 111123444455544444
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCc
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPD 704 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~ 704 (802)
..|...+.....++..-+..||+.|-.
T Consensus 477 riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 556666777788888899999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=262.45 Aligned_cols=229 Identities=29% Similarity=0.411 Sum_probs=187.9
Q ss_pred CcEEEEEEEECC--eEEEEEEEcccCccc-hHHHHHHHHHHHhcCCCceeeecceecCC--CeEEEEEccCCCHHHHhhh
Q 003694 460 GYGTVYKGTFHH--TFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGSLEDRLYR 534 (802)
Q Consensus 460 ~~g~Vy~~~~~~--~~vavK~l~~~~~~~-~~~~~~Ei~il~~l~Hpniv~l~g~~~~~--~~lV~Ey~~~gsL~~~l~~ 534 (802)
+||.||+|...+ ..+++|++....... .+.+.+|+.++++++|+|++++++++... .+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 689999999864 789999988765544 67899999999999999999999998654 4899999999999998865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccccccCCc
Q 003694 535 KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 614 (802)
Q Consensus 535 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~ 614 (802)
... +++..+..++.+++.+|.|||..+ |+|+||+|.||+++.++.++|+|||++....... ......
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~ 147 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFV 147 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-------cccccc
Confidence 432 788999999999999999999998 9999999999999999999999999998876532 123446
Q ss_pred cCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChH---HHHHHHHHH
Q 003694 615 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK---ETKELAALG 691 (802)
Q Consensus 615 gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~---~~~~l~~li 691 (802)
++..|++||++....++.++||||||+++|+|++|..||...... ..+...+.......... .+..+.+++
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 221 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPFPPPEWKISPEAKDLI 221 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCCccccccCCHHHHHHH
Confidence 888999999998888999999999999999999999999642211 11222222222221111 567899999
Q ss_pred HHhhccccCCCCcccc
Q 003694 692 LSCAELRRKDRPDLKN 707 (802)
Q Consensus 692 ~~Cl~~~p~~RP~~~~ 707 (802)
.+|+..+|.+||++.+
T Consensus 222 ~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 222 RKLLVKDPEKRLTAEE 237 (244)
T ss_pred HHHccCCchhccCHHH
Confidence 9999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=278.50 Aligned_cols=236 Identities=23% Similarity=0.355 Sum_probs=186.8
Q ss_pred cceecCCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeecceec--CCCeEEEEEccCC
Q 003694 453 NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEYMENG 526 (802)
Q Consensus 453 ~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~--~~~~lV~Ey~~~g 526 (802)
.+.||+|-||+||-|.++ |+.||||++..- ...+..++.+|+.||.+++||.||.|...|. +..++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 467999999999999886 569999998653 2334567899999999999999999999885 45589999996 5
Q ss_pred CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC---ceeEEeeecccccccCCCCc
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~---~~~kl~DFGla~~~~~~~~~ 603 (802)
+..+.+..... ..++.....-++.||+.||.|||-.+ |+|+||||+||||... -.+||||||+|++++... +
T Consensus 648 DMLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-F 722 (888)
T KOG4236|consen 648 DMLEMILSSEK-GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-F 722 (888)
T ss_pred hHHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh-h
Confidence 55555543322 24888877888999999999999988 9999999999999653 478999999999987532 2
Q ss_pred ccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCCh-H
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI-K 682 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~-~ 682 (802)
....+|||.|+|||+++...|+..-|+||.|||+|--|+|.-||.-...+...+.+..+. -+..|. +
T Consensus 723 ------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM------yPp~PW~e 790 (888)
T KOG4236|consen 723 ------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM------YPPNPWSE 790 (888)
T ss_pred ------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc------cCCCchhh
Confidence 245699999999999999999999999999999999999999997555444333322111 022222 4
Q ss_pred HHHHHHHHHHHhhccccCCCCccc
Q 003694 683 ETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 683 ~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
......+||...++..-++|-+..
T Consensus 791 is~~AidlIn~LLqVkm~kRysvd 814 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVD 814 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchH
Confidence 567788999999998888887765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-31 Score=260.87 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=187.2
Q ss_pred CCcccceecCCCcEEEEEEEECC--eEEEEEEEcc--cCccchHHHHHHHHHHHhcCCCceeeecceecC-----C----
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQS--KGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-----H---- 515 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~--~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~-----~---- 515 (802)
.|....+||+|.||.||+++..+ +.||+|++-. ....-.....+|+.+|..+.|+|++.|+..|.. .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 45666789999999999998764 4678775432 122223345789999999999999999998832 1
Q ss_pred -CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccc
Q 003694 516 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594 (802)
Q Consensus 516 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla 594 (802)
.||||.+|+. +|..+|.... ..++...+.+++.++..||.|+|..+ |+|||+||+|+||+.+|.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 2899999974 8888875432 34788899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccch---------------
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHK--------------- 658 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~--------------- 658 (802)
+.+......... +.+..+-|..|.+||.+.+ ..|+++.|||.-|||+.||+||.|.|.....
T Consensus 172 r~fs~~~n~~kp--rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 172 RAFSTSKNVVKP--RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cceecccccCCC--CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 877654432222 2466788999999997655 5699999999999999999999998864322
Q ss_pred --hhhhhchhhhHHHhhhh-CCC----------CChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 659 --VETAIDEDNLAEILDAQ-AGD----------WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 659 --~~~~~~~~~l~~~ld~~-~~~----------~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
++...++-.+.+.+... .+. .|..-.....+|+.+++.+||.+|++..+
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~ 311 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ 311 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence 22222222222222110 000 01112346789999999999999999885
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=281.88 Aligned_cols=254 Identities=20% Similarity=0.242 Sum_probs=177.1
Q ss_pred hhcCCcccceecCCCcEEEEEEEE------------------CCeEEEEEEEcccCccchHHH--------------HHH
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTF------------------HHTFAAVKVLQSKGNIQNKQF--------------LQE 493 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~------------------~~~~vavK~l~~~~~~~~~~~--------------~~E 493 (802)
..++|...++||+|+||.||+|.+ .++.||||.+........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 466899999999999999999964 235799999875543333333 346
Q ss_pred HHHHHhcCCCce-----eeecceecC----------CCeEEEEEccCCCHHHHhhhcCC---------------------
Q 003694 494 LEVLSKIRHPHL-----LLLLGACPD----------HGCLVYEYMENGSLEDRLYRKNN--------------------- 537 (802)
Q Consensus 494 i~il~~l~Hpni-----v~l~g~~~~----------~~~lV~Ey~~~gsL~~~l~~~~~--------------------- 537 (802)
+.++.+++|.++ +.++|+|.. ..+|||||+++|+|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677777642 23899999999999999874321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccccccCCccCc
Q 003694 538 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 617 (802)
Q Consensus 538 ~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~ 617 (802)
...++|..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-----~~~~g~~tp 374 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-----NPLYGMLDP 374 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-----CccccCCCc
Confidence 113467778899999999999999988 999999999999999999999999999765432211 112234588
Q ss_pred ccCCccccccCC----------------------CCCcccchhHHHHHHHHHhCCC-Cccccchhhhhhch--hhh--HH
Q 003694 618 CYIDPEYQRTGL----------------------ISPKSDVYAYGMVILQLLTAKP-AIAITHKVETAIDE--DNL--AE 670 (802)
Q Consensus 618 ~Y~aPE~~~~~~----------------------~~~~sDv~SlGvil~elltg~~-p~~~~~~~~~~~~~--~~l--~~ 670 (802)
.|+|||.+.... ...+.||||+||+||+|++|.. ||.........+.. ..+ +.
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 999999765322 1234799999999999999875 66432222211111 000 11
Q ss_pred HhhhhCCCCC--hHHHHHHHHHHHHhhcccc---CCCCcccc
Q 003694 671 ILDAQAGDWP--IKETKELAALGLSCAELRR---KDRPDLKN 707 (802)
Q Consensus 671 ~ld~~~~~~p--~~~~~~l~~li~~Cl~~~p---~~RP~~~~ 707 (802)
.......+++ ........+|+.+++..+| .+|+++.+
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 1111111121 1346778999999999766 68999884
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=237.30 Aligned_cols=196 Identities=24% Similarity=0.380 Sum_probs=160.8
Q ss_pred CCcccceecCCCcEEEEEEEECCe--EEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~~--~vavK~l~~~~~--~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
+|....+||+|.||+||+|+..++ .||+|..+.+.. .......+|+-+|+.++|.|||+|++...... -||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455567899999999999988654 899998876533 23456789999999999999999999875443 799999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
|. .+|..+....++ .++......++.|+++||.|+|+++ +.||||||.|+||+.||.+|++|||+++-++-..
T Consensus 83 cd-qdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hh-HHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 96 578887765443 4777888899999999999999998 9999999999999999999999999999776432
Q ss_pred cccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHh-CCCCcccc
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLT-AKPAIAIT 656 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~ellt-g~~p~~~~ 656 (802)
. .....+-|..|.+|.++-+. -|++..|+||-|||+.|+.. |+|.|...
T Consensus 156 ---r--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 156 ---R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred ---E--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 1 22445789999999987665 48899999999999999987 56656443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=263.83 Aligned_cols=246 Identities=25% Similarity=0.331 Sum_probs=188.6
Q ss_pred hcCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcC--CC----ceeeecceecC--CC
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIR--HP----HLLLLLGACPD--HG 516 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~il~~l~--Hp----niv~l~g~~~~--~~ 516 (802)
++.|.+..++|+|.||.|-.+.++. ..||||+++.-.. -.+..+-|+++|.+|. -| -+|.+.++|.- +.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6778888999999999999998865 4899999875432 2344567999999994 22 36778788754 44
Q ss_pred eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC--------------
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-------------- 582 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~-------------- 582 (802)
|+|+|.+ |-|+.++|..++ ..+++...+..|+.|++.++.|||+.+ ++|-||||+|||+-.
T Consensus 167 Civfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 569999986544 456899999999999999999999999 999999999999931
Q ss_pred ------CceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCcccc
Q 003694 583 ------NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT 656 (802)
Q Consensus 583 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~ 656 (802)
+..+||+|||.|+...... ...+.|..|.|||++.+-.++..+||||+||||+||.||...|...
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h---------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH---------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc---------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3467999999998865433 4458899999999999999999999999999999999999888644
Q ss_pred chhhh------hhc--------hhhhHHHhhhhCCCCC-------------------------hHHHHHHHHHHHHhhcc
Q 003694 657 HKVET------AID--------EDNLAEILDAQAGDWP-------------------------IKETKELAALGLSCAEL 697 (802)
Q Consensus 657 ~~~~~------~~~--------~~~l~~~ld~~~~~~p-------------------------~~~~~~l~~li~~Cl~~ 697 (802)
...+. .+. ...-.+.......+|| ..+..+|.+|+.+++..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 32221 110 0000000111111222 13456799999999999
Q ss_pred ccCCCCcccc
Q 003694 698 RRKDRPDLKN 707 (802)
Q Consensus 698 ~p~~RP~~~~ 707 (802)
||.+|+++.+
T Consensus 393 DP~~RiTl~E 402 (415)
T KOG0671|consen 393 DPARRITLRE 402 (415)
T ss_pred CccccccHHH
Confidence 9999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=289.67 Aligned_cols=259 Identities=27% Similarity=0.335 Sum_probs=194.1
Q ss_pred CCcccceecCCCcEE-EEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeecceecCCC--eEEEEEcc
Q 003694 449 SFSENLRIGMGGYGT-VYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~-Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
-|.....+|.|+-|+ ||+|.+.++.||||.+-... ..-..+||..|+.-+ |||||++||.-.+.. |+..|.|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 355666789998865 69999999999999875432 234578999998874 999999999876665 78999995
Q ss_pred CCCHHHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC-----CceeEEeeeccccccc
Q 003694 525 NGSLEDRLYRKNNT-PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-----NLVSKIGDVGLSTMLN 598 (802)
Q Consensus 525 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~-----~~~~kl~DFGla~~~~ 598 (802)
.+|.+++...... ....-.....+..|++.||++||+.+ ||||||||.||||+. ..+++|+|||+|+.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 7999999763111 11111345678899999999999999 999999999999965 3688999999999998
Q ss_pred CCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhC-CCCccccchhhhhhchhhhHHHhhhhCC
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHKVETAIDEDNLAEILDAQAG 677 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~l~~~ld~~~~ 677 (802)
.+...... ..+..||-+|+|||++....-+.++|||||||++|+.+|| ..||+..-..+..+-.+...-..-
T Consensus 663 ~~~sS~~r---~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L---- 735 (903)
T KOG1027|consen 663 GGKSSFSR---LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHL---- 735 (903)
T ss_pred CCcchhhc---ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeee----
Confidence 76644332 4678999999999999988888899999999999999996 899986544443332222111100
Q ss_pred CCChHHHHHHHHHHHHhhccccCCCCccccchh--------hHHHHHHHhhhcc
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKNQVL--------PVLERLKEVADRA 723 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~--------~~L~~l~~~~~~~ 723 (802)
.|... .+..+||.+|+.++|..||++.+++. +.|.-|+++.++.
T Consensus 736 -~~~~d-~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRv 787 (903)
T KOG1027|consen 736 -EPLPD-CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRV 787 (903)
T ss_pred -ccCch-HHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhh
Confidence 01111 17889999999999999999985442 2455555555543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=287.00 Aligned_cols=250 Identities=20% Similarity=0.211 Sum_probs=160.7
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecce--------
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA-------- 511 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~-------- 511 (802)
..++|...++||+|+||.||+|++. +..||||.+..... .+.+..+ .+....+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3568999999999999999999985 45899998764321 1111111 1222223333322222
Q ss_pred ecCCCeEEEEEccCCCHHHHhhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 003694 512 CPDHGCLVYEYMENGSLEDRLYRKNNT-----------------PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 574 (802)
Q Consensus 512 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLK 574 (802)
..+..+|||||+.+++|.+++...... .......+..|+.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 122348999999999999988643210 00112335578999999999999988 9999999
Q ss_pred CCCeEecC-CceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccC----------------------CCC
Q 003694 575 PGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG----------------------LIS 631 (802)
Q Consensus 575 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~~ 631 (802)
|+||||+. ++.+||+|||+++.+..... +......+|+.|+|||.+... .++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-----~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-----cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 99999986 68999999999986643322 122445789999999954322 234
Q ss_pred CcccchhHHHHHHHHHhCCCCccccch-hhhhhc-----hhhhHHHhhhhCC-CCC------hHHHHHHHHHHHHhhccc
Q 003694 632 PKSDVYAYGMVILQLLTAKPAIAITHK-VETAID-----EDNLAEILDAQAG-DWP------IKETKELAALGLSCAELR 698 (802)
Q Consensus 632 ~~sDv~SlGvil~elltg~~p~~~~~~-~~~~~~-----~~~l~~~ld~~~~-~~p------~~~~~~l~~li~~Cl~~~ 698 (802)
.++|||||||+||||+++..++..... ....+. ...+...+..... +.. ........+|+.+|++.|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 567999999999999997766532110 000000 0111111111100 000 001223458999999999
Q ss_pred cCCCCcccc
Q 003694 699 RKDRPDLKN 707 (802)
Q Consensus 699 p~~RP~~~~ 707 (802)
|.+||++.+
T Consensus 438 P~kR~ta~e 446 (566)
T PLN03225 438 GRQRISAKA 446 (566)
T ss_pred cccCCCHHH
Confidence 999999884
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=239.55 Aligned_cols=196 Identities=30% Similarity=0.404 Sum_probs=158.4
Q ss_pred CCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeecceecCCC--eEEEEE
Q 003694 449 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
.......||+|+||.|-+-++ .++..|+|.+..... +..++.++|+++..+. ..|.+|.+||..-+.+ .+.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 334445699999999877665 578999999876543 3456788899987655 6999999999875544 789999
Q ss_pred ccCCCHHHHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 523 MENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 523 ~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
|. .||+.+..+ -.....+++...-+|+..+..||.|||+.- .+||||+||+||||+.+|.+||||||++-.+.++.
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 96 688776543 123345888899999999999999999975 49999999999999999999999999998876543
Q ss_pred CcccccccccCCccCcccCCccccc----cCCCCCcccchhHHHHHHHHHhCCCCcc
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQR----TGLISPKSDVYAYGMVILQLLTAKPAIA 654 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~~sDv~SlGvil~elltg~~p~~ 654 (802)
. .+...|-..|||||.+. ...|+.++||||||+.+.||.+++.||.
T Consensus 204 A-------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 204 A-------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred H-------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 2 23347888999999764 3468999999999999999999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=250.33 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=200.0
Q ss_pred CcccceecCCCcEEEEEEEECC-------eEEEEEEEccc-CccchHHHHHHHHHHHhcCCCceeeecceecCC---CeE
Q 003694 450 FSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---GCL 518 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~~-------~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~---~~l 518 (802)
+.....+-+|.||.||+|.|.. ..|-||.++.. +..+...|+.|--.|..+.|||+..+.|.+.+. .++
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V 365 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV 365 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence 4444568899999999997642 24556655543 334556788999999999999999999998543 378
Q ss_pred EEEEccCCCHHHHhh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecc
Q 003694 519 VYEYMENGSLEDRLY-----RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGl 593 (802)
+|.++.-|+|..+|. .-.....+.-.+...++.|++.|+.|||+++ |||.||...|.+||+...+||+|=.+
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchh
Confidence 999999999999997 2233345677788899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHh
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 672 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~l 672 (802)
++.+-+.+-. .-.........||+||.+....|+.++|||||||+||||+| |+.|+...+..+. ..-+.
T Consensus 443 SRDLFP~DYh----cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm------~~ylk 512 (563)
T KOG1024|consen 443 SRDLFPGDYH----CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM------EHYLK 512 (563)
T ss_pred ccccCccccc----ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH------HHHHh
Confidence 9876654321 11233356778999999999999999999999999999998 8999975544332 12244
Q ss_pred hhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 673 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 673 d~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
|......|.+++.+|..++..||...|++||++.+ +..-|..
T Consensus 513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Q-lv~cLse 554 (563)
T KOG1024|consen 513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQ-LVICLSE 554 (563)
T ss_pred ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHH-HHHHHHH
Confidence 55556678999999999999999999999999984 5544443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=235.63 Aligned_cols=242 Identities=21% Similarity=0.392 Sum_probs=187.6
Q ss_pred hcCCcccceecCCCcEEEEEEE--ECCeEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeecceecCCC----eEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGT--FHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG----CLV 519 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~--~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~----~lV 519 (802)
..+|+..+++|+|.|+.||.|. .++..++||++++- ..+.+.+|+.||..|. ||||+.|++...+.. .||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678899999999999999998 45678999999863 4567899999999997 999999999986654 799
Q ss_pred EEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC-ceeEEeeeccccccc
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLN 598 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~-~~~kl~DFGla~~~~ 598 (802)
+||+.+.+...+. +.++...+...+.+++.||.|+|+.| |+|||+||.|++||.. -.++|+|+|||.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998887654 23667788889999999999999999 9999999999999975 678999999999987
Q ss_pred CCCCcccccccccCCccCcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhh-hh------hchhhhHH
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVE-TA------IDEDNLAE 670 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~-~~------~~~~~l~~ 670 (802)
+.... ...+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||...+... +. +....+..
T Consensus 185 p~~eY-------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 185 PGKEY-------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred CCcee-------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 65432 22366778899997754 458889999999999999999999996332211 11 11111222
Q ss_pred Hhhhh----------------CCCCCh--------HHHHHHHHHHHHhhccccCCCCcccc
Q 003694 671 ILDAQ----------------AGDWPI--------KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 671 ~ld~~----------------~~~~p~--------~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+... ...|.. -..++..+|+.+.+..|-.+|||+.+
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakE 318 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKE 318 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHH
Confidence 11111 111111 12477889999999999999999885
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-28 Score=242.86 Aligned_cols=198 Identities=25% Similarity=0.372 Sum_probs=160.3
Q ss_pred CCcccceecCCCcEEEEEEEE--CCeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeecceecCC-------Ce
Q 003694 449 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------GC 517 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-------~~ 517 (802)
+.+..+.||.|.||.||..++ +++.||+|++..- .-...+++.+|+.+|+-++|.|++.+++..+.. .|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 456678899999999999987 4779999987642 223456789999999999999999988875322 26
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~ 597 (802)
++.|.|. .+|...+..- ..++-..+.-++.||++||.|||+.+ |+||||||.|+|++.|..+||||||+++..
T Consensus 134 V~TELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 7888885 5777766432 24666677778899999999999999 999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccch
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHK 658 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~ 658 (802)
..+... .++..+-|-+|.|||.+.+. .|+.+.||||.|||+.|||..+..|.....
T Consensus 207 e~d~~~-----hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 207 DQRDRL-----NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred chhhhh-----hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 654432 34556789999999988764 589999999999999999998887764433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=231.55 Aligned_cols=203 Identities=37% Similarity=0.569 Sum_probs=176.4
Q ss_pred ecCCCcEEEEEEEEC--CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecC--CCeEEEEEccCCCHHH
Q 003694 456 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYMENGSLED 530 (802)
Q Consensus 456 iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~lV~Ey~~~gsL~~ 530 (802)
||+|++|.||++... +..+++|++...... ....+.+|+.++..+.|++++++++++.. ..+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999997 779999998765432 34678999999999999999999999876 4489999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC-CceeEEeeecccccccCCCCccccccc
Q 003694 531 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYK 609 (802)
Q Consensus 531 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 609 (802)
++.... ..+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~ 149 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------L 149 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------h
Confidence 886542 34888999999999999999999998 999999999999999 89999999999987654321 1
Q ss_pred ccCCccCcccCCccccccC-CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHH
Q 003694 610 NTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 688 (802)
Q Consensus 610 ~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 688 (802)
.....+...|++||.+... .++.+.|+|+||+++++| ..+.
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~ 191 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELK 191 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHH
Confidence 2334678899999998877 788999999999999998 5688
Q ss_pred HHHHHhhccccCCCCcccc
Q 003694 689 ALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 689 ~li~~Cl~~~p~~RP~~~~ 707 (802)
+++.+|+..+|.+||++.+
T Consensus 192 ~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred HHHHHHhhCCcccCcCHHH
Confidence 9999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=256.07 Aligned_cols=197 Identities=23% Similarity=0.297 Sum_probs=166.6
Q ss_pred HhhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcC------CCceeeecceec--C
Q 003694 445 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR------HPHLLLLLGACP--D 514 (802)
Q Consensus 445 ~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~------Hpniv~l~g~~~--~ 514 (802)
.....|.+....|+|-|++|.+|.+. +..||||++..+... .+.=+.|++||.+|+ --|+++|+..|. .
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 34556777777899999999999875 559999999876432 334468999999995 347889988774 5
Q ss_pred CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC-ceeEEeeecc
Q 003694 515 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGL 593 (802)
Q Consensus 515 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~-~~~kl~DFGl 593 (802)
+.|||+|-+. .+|.++|.+.+..-.|....+..++.|+..||..|-.++ |+|+||||+|||++.+ ..+||||||.
T Consensus 508 HLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence 6699999985 699999999888888999999999999999999999999 9999999999999875 6779999999
Q ss_pred cccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIA 654 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~ 654 (802)
|.......- +...-+..|.|||++.+-.|+...|+||.||+||||.||+..|.
T Consensus 584 A~~~~enei--------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 584 ASFASENEI--------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred ccccccccc--------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 988765431 22355678999999999999999999999999999999998885
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=242.93 Aligned_cols=129 Identities=27% Similarity=0.435 Sum_probs=106.8
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcC-----C---CceeeecceecC--
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----H---PHLLLLLGACPD-- 514 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-----H---pniv~l~g~~~~-- 514 (802)
...|-..++||.|.|++||++.+. .+.||+|+.+... .-.+..+.||.+|++++ | .+||+|++.|.-
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 357888999999999999999874 5799999987642 23345678999999984 2 479999999843
Q ss_pred ----CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEe
Q 003694 515 ----HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 580 (802)
Q Consensus 515 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl 580 (802)
+.|||+|++ |-+|..+|.... ...++...+..|+.||+.||.|||... +|||-||||+||||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 239999999 678888876544 455899999999999999999999876 59999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=262.30 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=201.7
Q ss_pred hcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceec--CCCeEEEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEY 522 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~--~~~~lV~Ey 522 (802)
..+|....++|.|.||.|||+++. +...|+|+++........-+++|+-+++..+|||||.++|.+. +...++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 346788889999999999999886 4589999999887777778899999999999999999999984 566899999
Q ss_pred ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~ 602 (802)
|.+|+|.+..+- ..+++..++....++.+.||.|||+.+ =+|||||-.|||+++.|.+|++|||.+-.+...
T Consensus 94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-- 165 (829)
T ss_pred cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence 999999997653 345888888889999999999999998 899999999999999999999999998766532
Q ss_pred cccccccccCCccCcccCCcccc---ccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCC
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQ---RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~---~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
..+...+.||++|||||+. +.+.|...||||++|+...|+---++|....+.+....--. ....++....-
T Consensus 166 ----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT--kS~~qpp~lkD 239 (829)
T KOG0576|consen 166 ----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT--KSGFQPPTLKD 239 (829)
T ss_pred ----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--ccCCCCCcccC
Confidence 3345678999999999954 56789999999999999999998898886555544311000 00011111122
Q ss_pred ChHHHHHHHHHHHHhhccccCCCCccccc
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKNQ 708 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~~ 708 (802)
+......|.+|+..|+..+|++||+....
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaekl 268 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKL 268 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhh
Confidence 33567889999999999999999998753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=231.49 Aligned_cols=196 Identities=31% Similarity=0.488 Sum_probs=167.2
Q ss_pred CcccceecCCCcEEEEEEEECC--eEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeecceecC--CCeEEEEEcc
Q 003694 450 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYME 524 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~Hpniv~l~g~~~~--~~~lV~Ey~~ 524 (802)
|.....||.|++|.||+|...+ ..+++|.+...... ..+.+.+|++.+.+++|+|++++++++.. ..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566789999999999999864 78999998866544 56788999999999999999999999864 4489999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 604 (802)
+++|.+++...... +++.....++.+++.+|.|||..+ ++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 99999988754321 788899999999999999999988 999999999999999999999999999887644200
Q ss_pred cccccccCCccCcccCCcccc-ccCCCCCcccchhHHHHHHHHHhCCCCccc
Q 003694 605 STTYKNTGPVGTLCYIDPEYQ-RTGLISPKSDVYAYGMVILQLLTAKPAIAI 655 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDv~SlGvil~elltg~~p~~~ 655 (802)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11234678899999988 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=250.36 Aligned_cols=193 Identities=24% Similarity=0.316 Sum_probs=162.1
Q ss_pred cCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccch--------HHHHHHHHHHHhcC---CCceeeecceecC
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQN--------KQFLQELEVLSKIR---HPHLLLLLGACPD 514 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~--------~~~~~Ei~il~~l~---Hpniv~l~g~~~~ 514 (802)
.+|.....+|+|+||.|+.|+++. ..|+||.+........ ...-.|+.||..++ |+||++++.+|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 357888899999999999999974 4788998765432111 12456999999997 9999999999987
Q ss_pred CC--eEEEEEc-cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeee
Q 003694 515 HG--CLVYEYM-ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 591 (802)
Q Consensus 515 ~~--~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DF 591 (802)
.. ||+||-- +|-+|.+++..+. .+++....-|+.||+.|+++||+.+ |||||||-+|+.++.+|.+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 76 6788763 5668888886543 4888999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCccCcccCCccccccCCC-CCcccchhHHHHHHHHHhCCCCcc
Q 003694 592 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIA 654 (802)
Q Consensus 592 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDv~SlGvil~elltg~~p~~ 654 (802)
|.+......+ ...++||..|.|||++.+..| +..-|||++||+||.++....||.
T Consensus 715 gsaa~~ksgp--------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP--------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC--------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998766443 234689999999999998775 567899999999999999999984
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=233.02 Aligned_cols=243 Identities=20% Similarity=0.237 Sum_probs=183.7
Q ss_pred cCCcccceecCCCcEEEEEEEE--CCeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeecceecCC--------
Q 003694 448 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------- 515 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~-------- 515 (802)
..|.....+|.|.- .|..+.+ .+.+||+|.+... .....++..+|..++..++|+||+.++.+|...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888888 5655544 4678999986543 223345678999999999999999999998433
Q ss_pred CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccc
Q 003694 516 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~ 595 (802)
.|+|||||. ++|...+... ++-.....|+.|++.|+.|||+.+ |+||||||+||++..++.+||+|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILME-----LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 289999996 6888877632 455677889999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhch---------h
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------D 666 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~---------~ 666 (802)
.-..+ +.++..+.|..|.|||++.+..|...+||||+|||+.||++|+--|.+...+.+...- .
T Consensus 167 ~e~~~-------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TEDTD-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccCcc-------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 75432 3567779999999999998888999999999999999999999887643322221100 0
Q ss_pred hhHHHhh------------------hhCC--CCC------hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 667 NLAEILD------------------AQAG--DWP------IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 667 ~l~~~ld------------------~~~~--~~p------~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
-+.++.. ...+ .|+ ......+.+++.+||-.+|++|.+..+
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~d 306 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDD 306 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHH
Confidence 0000000 0011 121 123456788999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=228.38 Aligned_cols=237 Identities=21% Similarity=0.284 Sum_probs=175.7
Q ss_pred cCCcccceecCCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeecce-ecCCC--eEEEE
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA-CPDHG--CLVYE 521 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~l~g~-~~~~~--~lV~E 521 (802)
+.|.+.+.||+|.||.+-++.+++ +.+++|.++... ....+|.+|...--.| .|.||+.-|.. |+... ++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 468888999999999999999975 588999876543 3567899998875556 49999988764 44433 68999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEec--CCceeEEeeecccccccC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--HNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~--~~~~~kl~DFGla~~~~~ 599 (802)
|++.|+|..-+... .+.+....+++.|+++||.|+|+.. +||||||.+||||- +..++||||||+.+..+.
T Consensus 103 ~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999998877543 3677778899999999999999988 99999999999993 346999999999987664
Q ss_pred CCCcccccccccCCccCcccCCccccccC-----CCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHH---
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG-----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI--- 671 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~--- 671 (802)
... ...-+..|.+||..... ...+.+|||.||||++.+|||++||.... +....+.+.
T Consensus 176 tV~---------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-----~~d~~Y~~~~~w 241 (378)
T KOG1345|consen 176 TVK---------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-----IMDKPYWEWEQW 241 (378)
T ss_pred eeh---------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-----ccCchHHHHHHH
Confidence 322 12346779999965432 25688999999999999999999996221 112222221
Q ss_pred hhhhCCCCCh---HHHHHHHHHHHHhhccccCCCCccc
Q 003694 672 LDAQAGDWPI---KETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 672 ld~~~~~~p~---~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
+....+..|. ..++.+..+..+-+..++++|-...
T Consensus 242 ~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~ 279 (378)
T KOG1345|consen 242 LKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIW 279 (378)
T ss_pred hcccCccCchhhcccCHHHHHHHHHhcCCcccccchhH
Confidence 1111122221 2356777888888888998884444
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=235.62 Aligned_cols=200 Identities=25% Similarity=0.381 Sum_probs=161.7
Q ss_pred HHhhcCCcccceecCCCcEEEEEEEECC-----eEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeecceec--CC
Q 003694 444 ESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACP--DH 515 (802)
Q Consensus 444 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~~-----~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~--~~ 515 (802)
....+.|....+||+|.|++||++++.. ..||+|.+... ....++.+|++.|..+. +.||+.+.+++. +.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3445678888999999999999998743 48999987654 34566899999999996 999999999985 45
Q ss_pred CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC-CceeEEeeeccc
Q 003694 516 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLS 594 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~-~~~~kl~DFGla 594 (802)
.++|+||++.....+++.. ++...+..+++.++.||.++|..| ||||||||+|||.+. .+.-.|+|||||
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 5999999999999998753 567788899999999999999999 999999999999975 477899999999
Q ss_pred ccccCCC------C-------c-----c----------c----------ccccccCCccCcccCCcccc-ccCCCCCccc
Q 003694 595 TMLNSDP------S-------F-----V----------S----------TTYKNTGPVGTLCYIDPEYQ-RTGLISPKSD 635 (802)
Q Consensus 595 ~~~~~~~------~-------~-----~----------~----------~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sD 635 (802)
....... . . . . ........+||++|.|||++ .....++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 8322110 0 0 0 0 00112345899999999976 4566899999
Q ss_pred chhHHHHHHHHHhCCCCcc
Q 003694 636 VYAYGMVILQLLTAKPAIA 654 (802)
Q Consensus 636 v~SlGvil~elltg~~p~~ 654 (802)
|||.|||++-+++++.||.
T Consensus 261 iws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred eeeccceeehhhccccccc
Confidence 9999999999999999996
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-25 Score=267.82 Aligned_cols=196 Identities=16% Similarity=0.173 Sum_probs=136.0
Q ss_pred hcCC-Cceeeecceec-------C--CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 003694 499 KIRH-PHLLLLLGACP-------D--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568 (802)
Q Consensus 499 ~l~H-pniv~l~g~~~-------~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 568 (802)
.++| +||+.++++|. + ..+++|||+ +++|.++|... ...+++..+..|+.||+.||.|||+.+ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4456 58888888771 1 225678887 57999999643 245899999999999999999999988 9
Q ss_pred EEcCCCCCCeEecCC-------------------ceeEEeeecccccccCCCCc----------ccccccccCCccCccc
Q 003694 569 IHRDMKPGNILLDHN-------------------LVSKIGDVGLSTMLNSDPSF----------VSTTYKNTGPVGTLCY 619 (802)
Q Consensus 569 vHrDLKp~NILl~~~-------------------~~~kl~DFGla~~~~~~~~~----------~~~~~~~~~~~gt~~Y 619 (802)
|||||||+||||+.. +.+||+|||+++........ ...........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 44556666665532210000 0000011224689999
Q ss_pred CCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhcccc
Q 003694 620 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRR 699 (802)
Q Consensus 620 ~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p 699 (802)
||||++.+..++.++|||||||+||||++|.+|+........ .+.....+..+.........++.+||..+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMS--------SLRHRVLPPQILLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHH--------HHHHhhcChhhhhcCHHHHHHHHHhCCCCh
Confidence 999999999999999999999999999999998742211111 110111111111223456788899999999
Q ss_pred CCCCccccc
Q 003694 700 KDRPDLKNQ 708 (802)
Q Consensus 700 ~~RP~~~~~ 708 (802)
.+||++.+.
T Consensus 254 ~~Rps~~ei 262 (793)
T PLN00181 254 SCRPSMSEL 262 (793)
T ss_pred hhCcChHHH
Confidence 999999853
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=208.83 Aligned_cols=160 Identities=21% Similarity=0.247 Sum_probs=123.5
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|||.+++...+ .++++..+..|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 78999987543 35999999999999999999999965 999999999999999 99998765321
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCC------C
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD------W 679 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~------~ 679 (802)
..||+.|+|||++.+..++.++|||||||++|||+||++||........ .+..++...... .
T Consensus 64 -------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 131 (176)
T smart00750 64 -------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-----ILEILLNGMPADDPRDRSN 131 (176)
T ss_pred -------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-----HHHHHHHHhccCCcccccc
Confidence 2689999999999999999999999999999999999999964332211 111111111111 1
Q ss_pred ChHHHH--HHHHHHHHhhccccCCCCccccchhhHHHH
Q 003694 680 PIKETK--ELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 680 p~~~~~--~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
+..... .+.+++.+||..+|.+||++. +++..+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~-~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAAN-HYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHH-HHHHHHHH
Confidence 222333 699999999999999999998 45554443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=222.05 Aligned_cols=259 Identities=22% Similarity=0.235 Sum_probs=190.9
Q ss_pred CCcccceecCCCcEEEEEEEECCe---EEEEEEEcccCccchHHHHHHHHHHHhcCC----Cceeeecceec-CC--CeE
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLLLGACP-DH--GCL 518 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~~---~vavK~l~~~~~~~~~~~~~Ei~il~~l~H----pniv~l~g~~~-~~--~~l 518 (802)
.|....+||+|+||.||.+..... .+|+|+...........+..|+.+|..+.. +++..++.... .. .++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999998653 689998776543333367889999998863 57888877773 33 389
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC-----ceeEEeeecc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-----LVSKIGDVGL 593 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~-----~~~kl~DFGl 593 (802)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|.+||+.| +|||||||+|++++.. ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 789999775544 456899999999999999999999999 9999999999999865 4689999999
Q ss_pred cc--cccCCCCccccccc--ccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhH
Q 003694 594 ST--MLNSDPSFVSTTYK--NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 669 (802)
Q Consensus 594 a~--~~~~~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~ 669 (802)
++ .+...........+ .....||..|+++..+.+...+.+.|+||++.++.+|+.|..||........ ...+.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence 98 43322211101111 2345799999999999999999999999999999999999999853332111 11111
Q ss_pred HHhhhhCCC-CChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHH
Q 003694 670 EILDAQAGD-WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 670 ~~ld~~~~~-~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
......... .....+..+..+...+-..+...+|+.. .+...|..+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~-~~~~~l~~~ 297 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYE-KLAELLKDV 297 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHH-HHHHHHHHH
Confidence 111111111 1222356777777777789999999998 455554433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=226.83 Aligned_cols=172 Identities=20% Similarity=0.199 Sum_probs=131.1
Q ss_pred HHHHhhcCCcccceecCCCcEEEEEEEEC---CeEEEEEEEcccC-----ccchHHHHHHHHHHHhcCCCceee-eccee
Q 003694 442 EIESATLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKG-----NIQNKQFLQELEVLSKIRHPHLLL-LLGAC 512 (802)
Q Consensus 442 ei~~~~~~f~~~~~iG~G~~g~Vy~~~~~---~~~vavK~l~~~~-----~~~~~~~~~Ei~il~~l~Hpniv~-l~g~~ 512 (802)
.+.....+|.....||+|+||.||+|.+. ++.+|||++.... ......|.+|+++|.+++|+|++. ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34455678999999999999999999874 5678999875331 123456899999999999999985 5432
Q ss_pred cCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCCeEecCCceeEEeee
Q 003694 513 PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDM-KPGNILLDHNLVSKIGDV 591 (802)
Q Consensus 513 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDL-Kp~NILl~~~~~~kl~DF 591 (802)
...+|||||++|++|.. +.. .. ...++.+++.+|.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 45699999999999963 211 11 1467889999999999988 999999 999999999999999999
Q ss_pred cccccccCCCCcccc-ccc-ccCCccCcccCCccccccC
Q 003694 592 GLSTMLNSDPSFVST-TYK-NTGPVGTLCYIDPEYQRTG 628 (802)
Q Consensus 592 Gla~~~~~~~~~~~~-~~~-~~~~~gt~~Y~aPE~~~~~ 628 (802)
|+|+.+........- .+. -+...+++.|++||++...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999987643211110 011 1456889999999987543
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=192.26 Aligned_cols=142 Identities=46% Similarity=0.685 Sum_probs=117.4
Q ss_pred eEEEEecCCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhhHHHH
Q 003694 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFR 95 (802)
Q Consensus 16 ~IlVaVD~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 95 (802)
+||||||+|+.|.+|++||++++...+. .++++||.+++.......+. .+....+.+..++.+++.|..+.
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~-~l~ll~v~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~~ 71 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQ-TIVLVHVHPPITSIPSSSGK--------LEVASAYKQEEDKEAKELLLPYR 71 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCC-cEEEEEeccCcccCCCCccc--------hHHHHHHHHHHHHHHHHHHHHHH
Confidence 5999999999999999999998776655 59999998764332221110 11234455666777889999999
Q ss_pred HHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCC-cccccccC-Cc--ceEEEEecC
Q 003694 96 NMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLS-SRISICVP-SF--CTVYGVEKG 170 (802)
Q Consensus 96 ~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lg-Sv~~~v~~-a~--cpVlvV~~~ 170 (802)
..|...|+.++..++.+|+|+++|+++|++.++|+||||+||++ ++.++++| |++.++++ ++ |||+||++|
T Consensus 72 ~~~~~~~~~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~----~l~~~~~gssva~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 72 CFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDN----HFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred HHHhhcCCeEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCC----ceeecccCCchhHHHHhcCCCCceEEEEeCc
Confidence 99988899999999986699999999999999999999999999 77778887 69999999 99 999999987
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-23 Score=205.29 Aligned_cols=263 Identities=21% Similarity=0.409 Sum_probs=204.6
Q ss_pred hcccccccccCCHHHHHHhhcCCcccceecCCCcEEEEEEEECCeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCce
Q 003694 428 LNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHL 505 (802)
Q Consensus 428 ~~~~~~~~~~~~~~ei~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~Hpni 505 (802)
.+.++.+|...+..++...| +|.+...|..|+|+|.+..+++|++.... .....+|..|.-.|+.+.||||
T Consensus 177 rdatlsr~~gid~~~lnl~t-------kl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpni 249 (448)
T KOG0195|consen 177 RDATLSRYTGIDVSSLNLIT-------KLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNI 249 (448)
T ss_pred cccccccccCcchhhhhhhh-------hhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCch
Confidence 34556667766666665554 58999999999999999988889887543 2234679999999999999999
Q ss_pred eeecceecCCC--eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc-CCCCCCeEecC
Q 003694 506 LLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR-DMKPGNILLDH 582 (802)
Q Consensus 506 v~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHr-DLKp~NILl~~ 582 (802)
+.++|+|.... .++..||+.|||...|+.... -.++-.+..+++.+|++|+.|||+..| +|-| -|....+++|+
T Consensus 250 lpvlgacnsppnlv~isq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmide 326 (448)
T KOG0195|consen 250 LPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDE 326 (448)
T ss_pred hhhhhhccCCCCceEeeeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecc
Confidence 99999996544 788999999999999986543 235566888999999999999999874 4444 78999999999
Q ss_pred CceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCC---CcccchhHHHHHHHHHhCCCCccccchh
Q 003694 583 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS---PKSDVYAYGMVILQLLTAKPAIAITHKV 659 (802)
Q Consensus 583 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~---~~sDv~SlGvil~elltg~~p~~~~~~~ 659 (802)
+.+++|+ +|-+++. +...+..-.|.||+||.++..+-+ ..+|+|||.|+||||.|..-||..-..+
T Consensus 327 dltaris-mad~kfs----------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm 395 (448)
T KOG0195|consen 327 DLTARIS-MADTKFS----------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM 395 (448)
T ss_pred hhhhhee-cccceee----------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence 9888773 1111111 112334567899999988766533 4789999999999999999999866666
Q ss_pred hhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccchhhHHHHHH
Q 003694 660 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 660 ~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
+.++. -.+.......|+..+..+.+|+.-|+..||.+||.+. .|++.|++++
T Consensus 396 ecgmk-----ialeglrv~ippgis~hm~klm~icmnedpgkrpkfd-mivpilekm~ 447 (448)
T KOG0195|consen 396 ECGMK-----IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFD-MIVPILEKMI 447 (448)
T ss_pred hhhhh-----hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcc-eehhhHHHhc
Confidence 55432 2233444567888899999999999999999999998 7999998864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-21 Score=206.34 Aligned_cols=255 Identities=30% Similarity=0.419 Sum_probs=193.3
Q ss_pred CcccceecCCCcEEEEEEEECCeEEEEEEEcccCcc---chHHHHHHHHHHHhcCCC-ceeeecceecCCC--eEEEEEc
Q 003694 450 FSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHP-HLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~---~~~~~~~Ei~il~~l~Hp-niv~l~g~~~~~~--~lV~Ey~ 523 (802)
|.....||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++.+++++.... +++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 566778999999999999988 78899988765443 366799999999999988 7999999986554 7999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCc-eeEEeeecccccccCCCC
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~-~~kl~DFGla~~~~~~~~ 602 (802)
.+++|.+++........+.......++.|++.+|.|+|..+ ++||||||+|||++..+ .++++|||+++.+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999966644321124788889999999999999999999 99999999999999988 799999999986654332
Q ss_pred cccccccccCCccCcccCCcccccc---CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCC--
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG-- 677 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~-- 677 (802)
............||..|++||.+.. ..++...|+||+|++++++++|..||...... .........+.....
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTPS 234 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCcc
Confidence 1110012356689999999999887 57889999999999999999999997544321 000111111111111
Q ss_pred ---CCCh----HHHHHHHHHHHHhhccccCCCCccccchhh
Q 003694 678 ---DWPI----KETKELAALGLSCAELRRKDRPDLKNQVLP 711 (802)
Q Consensus 678 ---~~p~----~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~ 711 (802)
.... .....+.+++.+|+..+|..|.+....+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111 113578999999999999999998754433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-21 Score=196.18 Aligned_cols=249 Identities=18% Similarity=0.211 Sum_probs=191.5
Q ss_pred hcCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeecceecCCC--eEEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~lV~E 521 (802)
--+|.+.++||+|+||.++.|+. ++.+||||.-...+. .-++.-|....+.|. .+.|...|.|-+++. .||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 34799999999999999999975 688999998654433 234566777777774 788877776655544 79999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC-----ceeEEeeeccccc
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-----LVSKIGDVGLSTM 596 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~-----~~~kl~DFGla~~ 596 (802)
.+ |-||+|++.-.+. .++..++..||.|++.-++|+|.+. +|.|||||+|+||+.. ..+-|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 98 7899998765544 3899999999999999999999998 9999999999999754 4678999999999
Q ss_pred ccCCCCccccccc-ccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhh
Q 003694 597 LNSDPSFVSTTYK-NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675 (802)
Q Consensus 597 ~~~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~ 675 (802)
+.+.......+|+ ..+..||..||+-....+...+.+.|+-|||-++.+.|-|..||...... -.+..+..+=+..
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~---tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD---TNKEKYEKIGETK 255 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc---chHHHHHHhcccc
Confidence 8876655555554 45678999999999999999999999999999999999999999633211 1122222222222
Q ss_pred CCCC----ChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 676 AGDW----PIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 676 ~~~~----p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
.... ....+.+++..+.-.-.++-.+-|+..
T Consensus 256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 1111 112366788888888888888999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=189.75 Aligned_cols=249 Identities=20% Similarity=0.216 Sum_probs=189.7
Q ss_pred hcCCcccceecCCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCC-CceeeecceecC--CCeEEEE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH-PHLLLLLGACPD--HGCLVYE 521 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H-pniv~l~g~~~~--~~~lV~E 521 (802)
..+|...++||.|+||.+|.|.. .+..||||+-..... ..++..|..+...|++ ..|..+.-+..+ ...|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 45789999999999999999976 467999999766543 3457788888888874 445555545443 4479999
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC---ceeEEeeeccccccc
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGLSTMLN 598 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~---~~~kl~DFGla~~~~ 598 (802)
.+ |-||++++.-... .++..+++-++-|++.-++|+|..+ +|||||||+|+|.+-+ ..+.++|||+++.+-
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 6899998764333 3888899999999999999999999 9999999999999754 467899999999887
Q ss_pred CCCCccccccc-ccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCC
Q 003694 599 SDPSFVSTTYK-NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 677 (802)
Q Consensus 599 ~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~ 677 (802)
+........++ .....||..|.+-..+.+...+.+.|+-|+|.+|..+.-|..||........ ......+......
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---KQKYEKISEKKMS 242 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH---HHHHHHHHHhhcC
Confidence 66544443433 4567899999999888888889999999999999999999999964432222 2223333332221
Q ss_pred CCC----hHHHHHHHHHHHHhhccccCCCCccc
Q 003694 678 DWP----IKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 678 ~~p----~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
..+ ...+.++.-.+.-|-.+.-.+-|+..
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 111 12356788888999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=186.78 Aligned_cols=138 Identities=17% Similarity=0.204 Sum_probs=106.6
Q ss_pred ceecCCCcEEEEEEEEC-CeEEEEEEEcccCcc--c-------hHHH-----------------HHHHHHHHhcCCCcee
Q 003694 454 LRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI--Q-------NKQF-----------------LQELEVLSKIRHPHLL 506 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~--~-------~~~~-----------------~~Ei~il~~l~Hpniv 506 (802)
..||+|+||.||+|... +..||||+++..... . ...| ..|+.+|.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 57999999999999874 779999998764221 0 1122 3499999999877664
Q ss_pred eecceecCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEcCCCCCCeEecCCce
Q 003694 507 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL-HNTKPKPIIHRDMKPGNILLDHNLV 585 (802)
Q Consensus 507 ~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~ivHrDLKp~NILl~~~~~ 585 (802)
..........+|||||++|++|...+... .+++......++.|++.+|.|| |+.+ |+||||||+|||++ ++.
T Consensus 83 ~p~~~~~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILLKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCc
Confidence 33322233448999999988776543322 3488889999999999999999 6888 99999999999998 578
Q ss_pred eEEeeeccccccc
Q 003694 586 SKIGDVGLSTMLN 598 (802)
Q Consensus 586 ~kl~DFGla~~~~ 598 (802)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=190.91 Aligned_cols=170 Identities=14% Similarity=0.082 Sum_probs=132.8
Q ss_pred hhcCCcccceecCCCcEEEEEEEECCeEEEEEEEcccCccchHH---------HHHHHHHHHhcCCCceeeecceec---
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ---------FLQELEVLSKIRHPHLLLLLGACP--- 513 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~---------~~~Ei~il~~l~Hpniv~l~g~~~--- 513 (802)
..++|...+.||.|+||.||....++..+|||++.......... |.+|+..+.++.||+|.....++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46789999999999999999987777799999997654333322 678999999999999988877643
Q ss_pred -------CCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCcee
Q 003694 514 -------DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 586 (802)
Q Consensus 514 -------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~ 586 (802)
...+|||||++|.+|.+... ++. ....+++.+|..||..| ++|||+||+|||++.+| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 12489999999999988631 222 34569999999999999 99999999999999998 9
Q ss_pred EEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh
Q 003694 587 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648 (802)
Q Consensus 587 kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt 648 (802)
+|+|||........... .-+.....|+.+.|+||||+.+..+..
T Consensus 174 ~liDfg~~~~~~e~~a~------------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK------------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEECCCcccccchhhH------------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99999988765322110 013444556789999999999876543
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.3e-20 Score=174.80 Aligned_cols=139 Identities=16% Similarity=0.106 Sum_probs=108.1
Q ss_pred CCceEEEEecCCc--cchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHh
Q 003694 13 PALSVAVAVKGNR--KSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRL 90 (802)
Q Consensus 13 ~~~~IlVaVD~S~--~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~ 90 (802)
+|++||||||||+ .|..|++||+..+. ..+ .|+++||+++...... .. +. .....+.+..++.+++.
T Consensus 1 m~~~ILv~vD~S~~~~s~~al~~A~~la~-~~~-~l~llhv~~~~~~~~~--~~--~~-----~~~~~~~~~~~~~~~~~ 69 (142)
T PRK15456 1 MYKTIIMPVDVFEMELSDKAVRHAEFLAQ-DDG-VIHLLHVLPGSASLSL--HR--FA-----ADVRRFEEHLQHEAEER 69 (142)
T ss_pred CCccEEEeccCCchhHHHHHHHHHHHHHh-cCC-eEEEEEEecCcccccc--cc--cc-----cchhhHHHHHHHHHHHH
Confidence 3789999999994 89999999998654 445 6999999976432111 00 00 01233445566677778
Q ss_pred hHHHHHHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC-CcceEEEEe
Q 003694 91 LLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGVE 168 (802)
Q Consensus 91 l~~~~~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~-a~cpVlvV~ 168 (802)
|..+...+...+++++..+.. |+|++.|+++|+++++|+||||+||++ +.+.++||++.++++ ++|||+||+
T Consensus 70 l~~~~~~~~~~~~~v~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~-----~~~~llGS~a~~v~~~a~~pVLvV~ 142 (142)
T PRK15456 70 LQTMVSHFTIDPSRIKQHVRF-GSVRDEVNELAEELGADVVVIGSRNPS-----ISTHLLGSNASSVIRHANLPVLVVR 142 (142)
T ss_pred HHHHHHHhCCCCcceEEEEcC-CChHHHHHHHHhhcCCCEEEEcCCCCC-----ccceecCccHHHHHHcCCCCEEEeC
Confidence 888877766667888888877 999999999999999999999999965 345789999999999 999999985
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=181.37 Aligned_cols=140 Identities=19% Similarity=0.142 Sum_probs=110.1
Q ss_pred cceecCCCcEEEEEEEEC-CeEEEEEEEcccCccc--------------------------hHHHHHHHHHHHhcCCCce
Q 003694 453 NLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQ--------------------------NKQFLQELEVLSKIRHPHL 505 (802)
Q Consensus 453 ~~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~--------------------------~~~~~~Ei~il~~l~Hpni 505 (802)
...||+|+||.||+|.+. ++.||||++....... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 357999999999999875 7899999988653210 1124578999999999887
Q ss_pred eeecceecCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEecCCc
Q 003694 506 LLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNL 584 (802)
Q Consensus 506 v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl~~~~ 584 (802)
.....+.....+|||||++|+++...+... ..++......++.+++.+|.+||+ .| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 544333334568999999988654432222 236777889999999999999999 88 99999999999999 89
Q ss_pred eeEEeeecccccccC
Q 003694 585 VSKIGDVGLSTMLNS 599 (802)
Q Consensus 585 ~~kl~DFGla~~~~~ 599 (802)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.7e-20 Score=182.70 Aligned_cols=188 Identities=16% Similarity=0.085 Sum_probs=139.7
Q ss_pred cccceecCCCcEEEEEEEECCeEEEEEEEcccCccc----hHHHHHHHHHHHhcC-CCceeeecceecCCCeEEEEEccC
Q 003694 451 SENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQ----NKQFLQELEVLSKIR-HPHLLLLLGACPDHGCLVYEYMEN 525 (802)
Q Consensus 451 ~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~----~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~lV~Ey~~~ 525 (802)
.....||+|+||+||.+...+..++.+.+....... ...|.+|+++|.+|. |++++.++++ +..+++|||+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence 445679999999999888878888877766543311 225789999999995 5888888886 445899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCCeEecCCceeEEeeecccccccCCCCc-
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDM-KPGNILLDHNLVSKIGDVGLSTMLNSDPSF- 603 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDL-Kp~NILl~~~~~~kl~DFGla~~~~~~~~~- 603 (802)
.+|...+.. ....++.+++.+|.++|..| |+|||| ||+|||++.++.++|+|||++.........
T Consensus 83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 998654311 11357789999999999999 999999 799999999999999999999865533210
Q ss_pred ---c----cccccccCCccCcccCCcccccc--CCCCCcccchhHHHHHHHHHhCCCCcc
Q 003694 604 ---V----STTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIA 654 (802)
Q Consensus 604 ---~----~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDv~SlGvil~elltg~~p~~ 654 (802)
. ..... .-...++.|++|+...- ..--...++++.|.-+|.++|++.++.
T Consensus 150 r~L~~rDl~~llk-~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 150 RLLAREDLRHLLK-HKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHH-HHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00000 11246888888884321 222256799999999999999997764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-20 Score=215.42 Aligned_cols=244 Identities=23% Similarity=0.299 Sum_probs=178.8
Q ss_pred CCcccceecCCCcEEEEEEEECCeEEEEEEEcccC-ccchHHHHHHHHH--HHhcCCCceeeecceecCC--CeEEEEEc
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG-NIQNKQFLQELEV--LSKIRHPHLLLLLGACPDH--GCLVYEYM 523 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~-~~~~~~~~~Ei~i--l~~l~Hpniv~l~g~~~~~--~~lV~Ey~ 523 (802)
+|.....||.+.|=.|.+|.++...|+||++-... ......|.++++- ...++|||.+.+.-+-... .|||-+|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 56666789999999999999998889999986554 4445555554443 3445899999987764332 38888998
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc--cCCC
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML--NSDP 601 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~--~~~~ 601 (802)
. -+|.|+|..+ +-+...+...|+.|++.||..+|..| |+|||||.+||||+.-..+.|+||..-+.. +.++
T Consensus 104 k-hnLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 K-HNLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred h-hhhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 6 4899988532 34667778889999999999999999 999999999999999989999999876432 2332
Q ss_pred CcccccccccCCccCcccCCccccccC----------C-CCCcccchhHHHHHHHHHh-CCCCccccchhhhhhc-hhhh
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTG----------L-ISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAID-EDNL 668 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------~-~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~-~~~l 668 (802)
....+.+ ..+...-.+|+|||.+..+ . ++++.||||+||++.||++ |+|||.+.+.....-. ....
T Consensus 177 Padf~fF-FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 177 PADFTFF-FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP 255 (1431)
T ss_pred cccceEE-EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence 2222222 2233455789999966431 2 7889999999999999998 7999987665544322 1112
Q ss_pred HHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 669 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 669 ~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..++... +...+..|++.|++.||.+|-++.+
T Consensus 256 e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAed 287 (1431)
T KOG1240|consen 256 EQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAED 287 (1431)
T ss_pred HHHHHhC-------cCccHHHHHHHHHccCchhccCHHH
Confidence 2222211 1236899999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-20 Score=207.06 Aligned_cols=222 Identities=26% Similarity=0.279 Sum_probs=178.0
Q ss_pred ecCCCcEEEEEE-----EECCeEEEEEEEcccCccch--HHHHHHHHHHHhcC-CCceeeecceecCCC--eEEEEEccC
Q 003694 456 IGMGGYGTVYKG-----TFHHTFAAVKVLQSKGNIQN--KQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYMEN 525 (802)
Q Consensus 456 iG~G~~g~Vy~~-----~~~~~~vavK~l~~~~~~~~--~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~lV~Ey~~~ 525 (802)
+|.|.||.|+.+ .+.+..+|+|+++....... .....|..++..++ ||.+|.+..++.... +++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 799999999964 44567889998775432211 14566888898887 999999999886544 899999999
Q ss_pred CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc
Q 003694 526 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 605 (802)
Q Consensus 526 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 605 (802)
|.|...+..... +...........++-+++++|..+ |+|||+|++||+++.+|++++.|||+++......
T Consensus 82 g~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 82 GDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred chhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999887755433 555666677889999999999999 9999999999999999999999999998765432
Q ss_pred ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHH
Q 003694 606 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 685 (802)
Q Consensus 606 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~ 685 (802)
..+||..|||||+++ .+....|+||||++++||+||-.||.. +.+..++ ......|.....
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il-~~~~~~p~~l~~ 212 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRIL-KAELEMPRELSA 212 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHh-hhccCCchhhhH
Confidence 128999999999998 567899999999999999999999964 1222222 223456777888
Q ss_pred HHHHHHHHhhccccCCCCccc
Q 003694 686 ELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 686 ~l~~li~~Cl~~~p~~RP~~~ 706 (802)
.+..++..++..+|..|-...
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~ 233 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAG 233 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccC
Confidence 899999999999999997664
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-19 Score=170.46 Aligned_cols=140 Identities=14% Similarity=0.131 Sum_probs=105.0
Q ss_pred CceEEEEecCCcc--chhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhh
Q 003694 14 ALSVAVAVKGNRK--SRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLL 91 (802)
Q Consensus 14 ~~~IlVaVD~S~~--S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l 91 (802)
|++||||||||+. +.+|++||++.+...++ .|+|+||+++...... .+. .... + . ......++.+.+.|
T Consensus 2 ~~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~-~l~ll~v~~~~~~~~~-~~~--~~~~---~-~-~~~~~~~~~~~~~l 72 (144)
T PRK15005 2 NRTILVPIDISDSELTQRVISHVEAEAKIDDA-EVHFLTVIPSLPYYAS-LGL--AYSA---E-L-PAMDDLKAEAKSQL 72 (144)
T ss_pred CccEEEecCCCchhHHHHHHHHHHHHHhccCC-eEEEEEEEccCccccc-ccc--cccc---c-c-hHHHHHHHHHHHHH
Confidence 7899999999988 57999999997766555 6999999976432211 110 0000 0 0 01123344455666
Q ss_pred HHHHHHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC-CcceEEEEe
Q 003694 92 LPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGVE 168 (802)
Q Consensus 92 ~~~~~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~-a~cpVlvV~ 168 (802)
..+...+...+++++..+.. |+|++.|+++|++.++|+||||+| ++ ++.+.++||++.++++ ++|||+||+
T Consensus 73 ~~~~~~~~~~~~~~~~~v~~-G~p~~~I~~~a~~~~~DLIV~Gs~-~~----~~~~~llGS~a~~vl~~a~cpVlvVr 144 (144)
T PRK15005 73 EEIIKKFKLPTDRVHVHVEE-GSPKDRILELAKKIPADMIIIASH-RP----DITTYLLGSNAAAVVRHAECSVLVVR 144 (144)
T ss_pred HHHHHHhCCCCCceEEEEeC-CCHHHHHHHHHHHcCCCEEEEeCC-CC----CchheeecchHHHHHHhCCCCEEEeC
Confidence 66666666667888888887 999999999999999999999999 45 5677899999999999 999999985
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-20 Score=211.76 Aligned_cols=247 Identities=18% Similarity=0.256 Sum_probs=173.6
Q ss_pred ccceecCCCcEEEEEEEEC--CeEEEEEEEccc--Cccch----HHHHHHHHHHHhcCCCceeeecceecCCC--eEEEE
Q 003694 452 ENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQN----KQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 452 ~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~----~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
....+|.|.||.|+..... ....+.|..... ..... ..+..|+.+-..+.|||++..+..+.+.. .-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4567999999977766542 223333322210 11111 11455777777889999987776664433 33499
Q ss_pred EccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCC
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~ 601 (802)
||++ +|..++.... .+....+..++.|++.||.|||..| |.||||||+|+|+..+|.+||+|||.+..+.-..
T Consensus 402 ~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9998 9999887642 3666788889999999999999999 9999999999999999999999999997765322
Q ss_pred CcccccccccCCccCcccCCccccccCCCCCc-ccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCC
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPK-SDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
. .......+.+|+..|+|||.+....|.+. .||||.||++..|++|+.||-....-+..........-.....+.++
T Consensus 475 e--~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 475 E--KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred c--hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 1 11233467899999999999999988864 79999999999999999999654433221100000000000001111
Q ss_pred --hHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 681 --IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 --~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+..-..++-++++.+|.+|.++.+
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~ 581 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQ 581 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHH
Confidence 134566788999999999999999984
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=174.71 Aligned_cols=135 Identities=16% Similarity=0.224 Sum_probs=104.7
Q ss_pred CcccceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhc-----CCCceeeecceecCCC---e---E
Q 003694 450 FSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-----RHPHLLLLLGACPDHG---C---L 518 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l-----~Hpniv~l~g~~~~~~---~---l 518 (802)
......||+|+||.||.-... ...+||++........+.+.+|+.++..+ .||||++++|++.+.. + +
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~-~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPED-AQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cCCcceecCCCceEEEECCCC-cCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 345568999999999962222 23479988765444567799999999999 5799999999997652 3 6
Q ss_pred EEEE--ccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEcCCCCCCeEecC----CceeEEeee
Q 003694 519 VYEY--MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL-AFLHNTKPKPIIHRDMKPGNILLDH----NLVSKIGDV 591 (802)
Q Consensus 519 V~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~~~~ivHrDLKp~NILl~~----~~~~kl~DF 591 (802)
|+|| +++|+|.+++... .++.. ..++.+++.++ .|||+++ ||||||||+|||++. ++.++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5679999999542 14443 35678888888 8999999 999999999999974 348999995
Q ss_pred ccc
Q 003694 592 GLS 594 (802)
Q Consensus 592 Gla 594 (802)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.6e-18 Score=164.43 Aligned_cols=137 Identities=15% Similarity=0.164 Sum_probs=100.4
Q ss_pred CCceEEEEecCCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhhH
Q 003694 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLL 92 (802)
Q Consensus 13 ~~~~IlVaVD~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~ 92 (802)
.|++||||||||+.|..|+++|+..+...+ ++|+|+||.++...... +.+++ . .....+..++.+++.|.
T Consensus 2 ~~k~ILvavD~S~~s~~al~~A~~lA~~~~-a~l~llhV~~~~~~~~~--~~~~~----~---~~~~~~~~~~~~~~~l~ 71 (142)
T PRK09982 2 AYKHIGVAISGNEEDALLVNKALELARHND-AHLTLIHIDDGLSELYP--GIYFP----A---TEDILQLLKNKSDNKLY 71 (142)
T ss_pred CceEEEEEecCCcchHHHHHHHHHHHHHhC-CeEEEEEEccCcchhch--hhhcc----c---hHHHHHHHHHHHHHHHH
Confidence 378999999999999999999999776554 46999999875422110 00000 0 12233444555566677
Q ss_pred HHHHHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC-CcceEEEEec
Q 003694 93 PFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGVEK 169 (802)
Q Consensus 93 ~~~~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~-a~cpVlvV~~ 169 (802)
.+...+.. ..++..+.. |+|++.|+++|++.++|+||||+| ++ ++.+++ | ++.++++ +.||||||+.
T Consensus 72 ~~~~~~~~--~~~~~~v~~-G~p~~~I~~~A~~~~aDLIVmG~~-~~----~~~~~~-~-va~~V~~~s~~pVLvv~~ 139 (142)
T PRK09982 72 KLTKNIQW--PKTKLRIER-GEMPETLLEIMQKEQCDLLVCGHH-HS----FINRLM-P-AYRGMINKMSADLLIVPF 139 (142)
T ss_pred HHHHhcCC--CcceEEEEe-cCHHHHHHHHHHHcCCCEEEEeCC-hh----HHHHHH-H-HHHHHHhcCCCCEEEecC
Confidence 76655432 345666666 999999999999999999999986 77 555555 4 9999999 9999999985
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-18 Score=189.73 Aligned_cols=205 Identities=25% Similarity=0.434 Sum_probs=152.9
Q ss_pred HHhcCCCceeeecceecCCC--eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EEcCC
Q 003694 497 LSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI-IHRDM 573 (802)
Q Consensus 497 l~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i-vHrDL 573 (802)
|+.+.|.|+.+|+|.|.+.. +.|.+||..|+|.|.+.... ..++|.-...++.+|+.||.|||+.. | .|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 35688999999999996655 78999999999999997633 34889888999999999999999876 4 99999
Q ss_pred CCCCeEecCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccC-------CCCCcccchhHHHHHHHH
Q 003694 574 KPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-------LISPKSDVYAYGMVILQL 646 (802)
Q Consensus 574 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-------~~~~~sDv~SlGvil~el 646 (802)
++.|.++|..+.+||+|||+........... ......-...|.|||.+... ..+.+.||||||++++|+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~----~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPE----AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccccccc----ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 9999999999999999999998875311100 11222345679999987653 146789999999999999
Q ss_pred HhCCCCccccchhhhhhchhhhHHHhh-hhCCCCC----h-HHHHHHHHHHHHhhccccCCCCccccchhhHH
Q 003694 647 LTAKPAIAITHKVETAIDEDNLAEILD-AQAGDWP----I-KETKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 647 ltg~~p~~~~~~~~~~~~~~~l~~~ld-~~~~~~p----~-~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
++...||......... .+.+..+.+ ...+..| . ...+.+..++..||..+|.+||++. .|-..+
T Consensus 152 ~~r~~~~~~~~~~~~~--~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~-~i~~~~ 221 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDP--DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE-QIRSKL 221 (484)
T ss_pred HhccCccccccccCCh--HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH-HHHhhh
Confidence 9999999864433322 111222222 1111111 1 3344799999999999999999988 344333
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.5e-18 Score=163.17 Aligned_cols=137 Identities=16% Similarity=0.152 Sum_probs=96.0
Q ss_pred CCceEEEEecCCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhhH
Q 003694 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLL 92 (802)
Q Consensus 13 ~~~~IlVaVD~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~ 92 (802)
.|++||||||+|+.|..||+||+..+...+ ++|+|+||..+..... .+. . +.....+.+...+...+.+.
T Consensus 2 ~~~~ILvavD~S~~s~~al~~a~~la~~~~-a~l~ll~v~~~~~~~~--~~~--~-----~~~~~~~~~~~~~~~~~~l~ 71 (144)
T PRK15118 2 AYKHILIAVDLSPESKVLVEKAVSMARPYN-AKVSLIHVDVNYSDLY--TGL--I-----DVNLGDMQKRISEETHHALT 71 (144)
T ss_pred CceEEEEEccCChhHHHHHHHHHHHHHhhC-CEEEEEEEccChhhhh--hhh--h-----hcchHHHHHHHHHHHHHHHH
Confidence 479999999999999999999999765554 4699999953321110 010 0 00112223333333444444
Q ss_pred HHHHHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC-CcceEEEEec
Q 003694 93 PFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGVEK 169 (802)
Q Consensus 93 ~~~~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~-a~cpVlvV~~ 169 (802)
. ++...|+.+...++..|+|+++|+++|++.++|+||||+|| + .+.. +||++.++++ ++||||||+.
T Consensus 72 ~---~~~~~~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~-~----~~~~--lgSva~~v~~~a~~pVLvv~~ 139 (144)
T PRK15118 72 E---LSTNAGYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQ-D----FWSK--LMSSARQLINTVHVDMLIVPL 139 (144)
T ss_pred H---HHHhCCCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCcc-c----HHHH--HHHHHHHHHhhCCCCEEEecC
Confidence 3 33456787655555459999999999999999999999996 3 2332 5799999999 9999999985
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=175.00 Aligned_cols=229 Identities=20% Similarity=0.277 Sum_probs=145.4
Q ss_pred CcccceecCCCcEEEEEEEECC--eEEEEEEEcccCcc---chHHHHHHHHHHHhcCC---C-------c------eeee
Q 003694 450 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNI---QNKQFLQELEVLSKIRH---P-------H------LLLL 508 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~---~~~~~~~Ei~il~~l~H---p-------n------iv~l 508 (802)
+.....||.|+|+.||.+++.. ..+|||+....... ..+.+.+|.-....+.+ | . ++++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3456679999999999999975 69999987654322 33556666544443322 1 1 1222
Q ss_pred cce---e---c-------CCCeEEEEEccCCCHHHHhh---hcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 003694 509 LGA---C---P-------DHGCLVYEYMENGSLEDRLY---RKNNT-PPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 571 (802)
Q Consensus 509 ~g~---~---~-------~~~~lV~Ey~~~gsL~~~l~---~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHr 571 (802)
-|- + . -+.+++|+-+. ++|.+++. ..... ..+....++.+..|+++.+++||..| +||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 110 0 1 12256777774 78888754 22221 22444566778899999999999999 9999
Q ss_pred CCCCCCeEecCCceeEEeeecccccccCCCCcccccccccCCccCcccCCcccccc--------CCCCCcccchhHHHHH
Q 003694 572 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--------GLISPKSDVYAYGMVI 643 (802)
Q Consensus 572 DLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~sDv~SlGvil 643 (802)
||+|+|+|++.+|.++|+||+.....+... .....+..|.+||.... -.++.+.|.|+||+++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~---------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY---------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE---------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee---------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 999999999999999999999877654311 11244578999996533 2478899999999999
Q ss_pred HHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCC
Q 003694 644 LQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDR 702 (802)
Q Consensus 644 ~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~R 702 (802)
|.|.+|+.||+........ .. ...... ..+..++.||..+++.+|.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~~--~~--------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADP--EW--------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGSTS--GG--------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCccccc--cc--------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999865322111 00 112223 678899999999999999987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.5e-17 Score=172.22 Aligned_cols=199 Identities=19% Similarity=0.219 Sum_probs=143.9
Q ss_pred CCCceeeecceecCC-----------------------------CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHH
Q 003694 501 RHPHLLLLLGACPDH-----------------------------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 551 (802)
Q Consensus 501 ~Hpniv~l~g~~~~~-----------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 551 (802)
+|||||+++++|.+. .||||...+ .+|..+|.... .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 599999999987321 178888775 58999886543 55567778999
Q ss_pred HHHHHHHHHHhcCCCCeEEcCCCCCCeEe--cCCc--eeEEeeecccccccCCCCcccccccccCCccCcccCCcccccc
Q 003694 552 EVASALAFLHNTKPKPIIHRDMKPGNILL--DHNL--VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627 (802)
Q Consensus 552 qia~aL~~LH~~~~~~ivHrDLKp~NILl--~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 627 (802)
|+++|+.|||.+| |.|||||.+|||| |+++ .+.|+|||.|---....-...........-|....||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 4443 5688999987533221111111112344568888999998764
Q ss_pred CC------CCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCC
Q 003694 628 GL------ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKD 701 (802)
Q Consensus 628 ~~------~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~ 701 (802)
.+ --.+.|.|+.|-+.||+++...||..... ..++..+ ......+..|..+++.+.+|+...++.+|.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~r~---Yqe~qLPalp~~vpp~~rqlV~~lL~r~psk 500 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDTRT---YQESQLPALPSRVPPVARQLVFDLLKRDPSK 500 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heechhh---hhhhhCCCCcccCChHHHHHHHHHhcCCccc
Confidence 33 12489999999999999999999964211 1111111 2233445667788899999999999999999
Q ss_pred CCccccchhhHH
Q 003694 702 RPDLKNQVLPVL 713 (802)
Q Consensus 702 RP~~~~~v~~~L 713 (802)
||+.. ....+|
T Consensus 501 Rvsp~-iAANvl 511 (598)
T KOG4158|consen 501 RVSPN-IAANVL 511 (598)
T ss_pred cCCcc-HHHhHH
Confidence 99986 444444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.7e-17 Score=166.38 Aligned_cols=132 Identities=23% Similarity=0.319 Sum_probs=109.9
Q ss_pred ceecCCCcEEEEEEEECCeEEEEEEEcccCcc--------chHHHHHHHHHHHhcCCCceeeecce--ecCCCeEEEEEc
Q 003694 454 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI--------QNKQFLQELEVLSKIRHPHLLLLLGA--CPDHGCLVYEYM 523 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~--------~~~~~~~Ei~il~~l~Hpniv~l~g~--~~~~~~lV~Ey~ 523 (802)
..||+|++|.||+|.+.+..+++|+....... ....+.+|+.++..+.|+++.....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 46999999999999999999999987654321 12457889999999999887655444 455568999999
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
+|++|.+++.... + .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999885421 2 77889999999999999998 99999999999999 78899999998875
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-17 Score=193.73 Aligned_cols=195 Identities=25% Similarity=0.299 Sum_probs=153.3
Q ss_pred HHHHhhcCCcccceecCCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCcee----eecce--ecC
Q 003694 442 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL----LLLGA--CPD 514 (802)
Q Consensus 442 ei~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv----~l~g~--~~~ 514 (802)
+++.....|.+...||+|+||.||+|... +..||+|+-++..... |.--.+++.+|+ |-+. .+..+ |.+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk-~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLK-PQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhc-hhhhcchHHHHHHHccCC
Confidence 44555667888899999999999999874 6799999977654322 223344555666 3333 33222 366
Q ss_pred CCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC-------CceeE
Q 003694 515 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-------NLVSK 587 (802)
Q Consensus 515 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~-------~~~~k 587 (802)
..+||+||.+.|+|.+++. ....++|..++.++.|++..+..||..+ ||||||||+|+||.. +.-++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 7789999999999999987 3445899999999999999999999999 999999999999942 45679
Q ss_pred EeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCC
Q 003694 588 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 650 (802)
Q Consensus 588 l~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~ 650 (802)
|+|||.+--+..-.+. .+.....+|-.+-.+|...+..++...|.|.|.-+++-||.|+
T Consensus 842 lIDfG~siDm~lfp~~----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDG----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred EEecccceeeeEcCCC----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 9999998655432221 1235567889999999999999999999999999999999986
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=8e-17 Score=163.17 Aligned_cols=128 Identities=26% Similarity=0.378 Sum_probs=105.5
Q ss_pred eecCCCcEEEEEEEECCeEEEEEEEcccCc--------cchHHHHHHHHHHHhcCCCce--eeecceecCCCeEEEEEcc
Q 003694 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGN--------IQNKQFLQELEVLSKIRHPHL--LLLLGACPDHGCLVYEYME 524 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~--------~~~~~~~~Ei~il~~l~Hpni--v~l~g~~~~~~~lV~Ey~~ 524 (802)
.||+|+||.||+|.+.+..+++|+...... ....++.+|+.++..++|+++ ..+++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 389999999999999999999998654321 112557789999999987754 4555555666699999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
|++|.+++.... ..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998874321 078999999999999998 99999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=150.33 Aligned_cols=131 Identities=15% Similarity=0.122 Sum_probs=107.8
Q ss_pred eEEEEecCCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhhHHHH
Q 003694 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFR 95 (802)
Q Consensus 16 ~IlVaVD~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 95 (802)
+||||||+++.+..|+++|...+... ++.|+++||++++..... . ......+..++.+..+.
T Consensus 1 ~ILv~vd~s~~~~~~l~~a~~la~~~-~~~v~ll~v~~~~~~~~~--------~---------~~~~~~~~~~~~~~~~~ 62 (132)
T cd01988 1 RILVPVANPNTARDLLELAAALARAQ-NGEIIPLNVIEVPNHSSP--------S---------QLEVNVQRARKLLRQAE 62 (132)
T ss_pred CEEEecCCchhHHHHHHHHHHHhhcC-CCeEEEEEEEecCCCCCc--------c---------hhHHHHHHHHHHHHHHH
Confidence 59999999999999999999866554 446999999876432110 0 01122345678888888
Q ss_pred HHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC-CcceEEEEe
Q 003694 96 NMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGVE 168 (802)
Q Consensus 96 ~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~-a~cpVlvV~ 168 (802)
..+...|++++..+..+|+|.++|+++++++++|+||||+++++ .+.+.++||++.++++ ++|||+||+
T Consensus 63 ~~~~~~g~~~~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~----~~~~~~lGs~~~~v~~~~~~pvlvv~ 132 (132)
T cd01988 63 RIAASLGVPVHTIIRIDHDIASGILRTAKERQADLIIMGWHGST----SLRDRLFGGVIDQVLESAPCDVAVVK 132 (132)
T ss_pred HHhhhcCCceEEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCC----CccceecCchHHHHHhcCCCCEEEeC
Confidence 88888899999888776899999999999999999999999999 6677889999999999 999999985
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.4e-17 Score=166.85 Aligned_cols=142 Identities=18% Similarity=0.150 Sum_probs=109.1
Q ss_pred CCcccceecCCCcEEEEEEE-E--CCeEEEEEEEcccCcc------------------------chHHHHHHHHHHHhcC
Q 003694 449 SFSENLRIGMGGYGTVYKGT-F--HHTFAAVKVLQSKGNI------------------------QNKQFLQELEVLSKIR 501 (802)
Q Consensus 449 ~f~~~~~iG~G~~g~Vy~~~-~--~~~~vavK~l~~~~~~------------------------~~~~~~~Ei~il~~l~ 501 (802)
.|.....||+|+||.||+|. . .++.||||++...... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37778899999999999998 2 5779999998754210 0123568999999997
Q ss_pred CC--ceeeecceecCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeE
Q 003694 502 HP--HLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 579 (802)
Q Consensus 502 Hp--niv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NIL 579 (802)
+. .+...+++ ...+|||||++|++|...+... ..+.......++.||+.+|.+||..+ .|+||||||+|||
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence 53 34445543 2358999999998887654222 23455567789999999999999976 3999999999999
Q ss_pred ecCCceeEEeeeccccccc
Q 003694 580 LDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 580 l~~~~~~kl~DFGla~~~~ 598 (802)
++ ++.++|+|||++....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 8899999999988644
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.4e-17 Score=187.54 Aligned_cols=144 Identities=23% Similarity=0.289 Sum_probs=114.3
Q ss_pred CHHHHHHhhcCCcccceecCCCcEEEEEEEECCeEEEEEEEcccC--------ccchHHHHHHHHHHHhcCCCceeeecc
Q 003694 439 TWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG--------NIQNKQFLQELEVLSKIRHPHLLLLLG 510 (802)
Q Consensus 439 ~~~ei~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~--------~~~~~~~~~Ei~il~~l~Hpniv~l~g 510 (802)
+|.........|...+.||+|+||.||+|.+.+..+++|+..... ......+.+|+.++..++|++++..+.
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 344444445556678899999999999999987766666533221 112356889999999999999887655
Q ss_pred eec--CCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEE
Q 003694 511 ACP--DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 588 (802)
Q Consensus 511 ~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl 588 (802)
++. +..++||||++|++|.+++. ....++.+++.+|.+||+.+ |+||||||+|||+ .++.++|
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence 553 45689999999999999874 34678999999999999998 9999999999999 6788999
Q ss_pred eeecccccc
Q 003694 589 GDVGLSTML 597 (802)
Q Consensus 589 ~DFGla~~~ 597 (802)
+|||+++..
T Consensus 469 iDFGla~~~ 477 (535)
T PRK09605 469 IDFGLGKYS 477 (535)
T ss_pred EeCcccccC
Confidence 999999763
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-17 Score=190.91 Aligned_cols=213 Identities=23% Similarity=0.298 Sum_probs=147.6
Q ss_pred hhcCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCCeEEEEEc
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYM 523 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~~lV~Ey~ 523 (802)
...+|+..+.|-.|+||-||..++. .+.+|+|+-+.+ . +.+- ||.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-l-----ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L-----ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccc-h-----hhhc--cccccCCccee-----------------
Confidence 4568899999999999999999887 447777442221 1 1110 22223333333
Q ss_pred cCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCC-
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS- 602 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~- 602 (802)
|+-.+.+... ++++. +++.+++|||+.+ |+|||+||+|.||..-|++|+.|||+++.......
T Consensus 136 --gDc~tllk~~---g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLKNI---GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhcccC---CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 4444444322 23433 2378999999998 99999999999999999999999999876432211
Q ss_pred --------cccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhh
Q 003694 603 --------FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 674 (802)
Q Consensus 603 --------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~ 674 (802)
.....+.....+||+.|+|||++....|+..+|+|++|+|+||.+.|.-||+....-+ -+..++..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~visd 273 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVISD 273 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhhhh
Confidence 1122333456799999999999998899999999999999999999999997542211 11111111
Q ss_pred hCCCCCh---HHHHHHHHHHHHhhccccCCCCccc
Q 003694 675 QAGDWPI---KETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 675 ~~~~~p~---~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
...||. ..+.+.++++.+.++.+|..|--..
T Consensus 274 -~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 274 -DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred -hccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 123332 3467899999999999999995543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.7e-18 Score=183.19 Aligned_cols=173 Identities=29% Similarity=0.388 Sum_probs=136.6
Q ss_pred CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccc
Q 003694 516 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~ 595 (802)
.++.|++|.-.+|.++|.+.......++.....++.|++.|+.| .+ .+|+|+||.||+...+..+||+|||+..
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhee
Confidence 47899999999999999876666678889999999999999999 56 9999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHh-CCCCccccchhhhhhchhhhHHHhhh
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA 674 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~ 674 (802)
...............+...||..||+||.+.+..|+.++||||||+||+||++ =..+|. ....+-|.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------r~~t~~d~ 472 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------RIATLTDI 472 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------HHHhhhhh
Confidence 87765532223334577799999999999999999999999999999999998 222221 11112222
Q ss_pred hCCCCChHH---HHHHHHHHHHhhccccCCCCccc
Q 003694 675 QAGDWPIKE---TKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 675 ~~~~~p~~~---~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
..+.+|+.. -+.-..|+++++.+.|.+||+..
T Consensus 473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 335555321 23446899999999999999543
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-16 Score=148.44 Aligned_cols=121 Identities=17% Similarity=0.138 Sum_probs=97.5
Q ss_pred eEEEEecCCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhhHHHH
Q 003694 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFR 95 (802)
Q Consensus 16 ~IlVaVD~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 95 (802)
+|+||||+|+.+..|++||+..+...+. .|+++||.++... . ..+..++.++.+.
T Consensus 1 ~Ilv~vd~s~~s~~al~~a~~la~~~~~-~l~ll~v~~~~~~----~--------------------~~~~~~~~l~~~~ 55 (124)
T cd01987 1 RILVCISGGPNAERLIRRAARLADRLKA-PWYVVYVETPRLN----R--------------------LSEAERRRLAEAL 55 (124)
T ss_pred CEEEEECCCcchHHHHHHHHHHHHHhCC-CEEEEEEecCccc----c--------------------CCHHHHHHHHHHH
Confidence 5999999999999999999987766555 5999999864211 0 0012345566666
Q ss_pred HHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC-C-cceEEEE
Q 003694 96 NMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-S-FCTVYGV 167 (802)
Q Consensus 96 ~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~-a-~cpVlvV 167 (802)
..+...++++ .++.+|+|+++|+++++++++|+||||+|+++ ++.++++||++.++++ + +|||+||
T Consensus 56 ~~~~~~~~~~--~~~~~~~~~~~I~~~~~~~~~dllviG~~~~~----~~~~~~~Gs~~~~v~~~a~~~~v~v~ 123 (124)
T cd01987 56 RLAEELGAEV--VTLPGDDVAEAIVEFAREHNVTQIVVGKSRRS----RWRELFRGSLVDRLLRRAGNIDVHIV 123 (124)
T ss_pred HHHHHcCCEE--EEEeCCcHHHHHHHHHHHcCCCEEEeCCCCCc----hHHHHhcccHHHHHHHhCCCCeEEEe
Confidence 6666666643 45555899999999999999999999999999 8888999999999999 8 9999997
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-16 Score=160.46 Aligned_cols=139 Identities=18% Similarity=0.101 Sum_probs=108.1
Q ss_pred hcCCcccceecCCCcEEEEEEEE-CCeEEEEEEEcccCcc----------------------chHHHHHHHHHHHhcCCC
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNI----------------------QNKQFLQELEVLSKIRHP 503 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~vavK~l~~~~~~----------------------~~~~~~~Ei~il~~l~Hp 503 (802)
...|.....||.|+||.||++.. +++.||||++...... ....+..|+.++..+.|+
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 33467778899999999999988 4789999987643210 112357789999999877
Q ss_pred c--eeeecceecCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEec
Q 003694 504 H--LLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 581 (802)
Q Consensus 504 n--iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~ 581 (802)
+ +...++. ...++||||++|++|...... .....++.+++.++.++|..+ |+||||||+|||++
T Consensus 94 ~i~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~ 159 (198)
T cd05144 94 GFPVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVD 159 (198)
T ss_pred CCCCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEc
Confidence 4 4444443 344899999999999765421 134578899999999999988 99999999999999
Q ss_pred CCceeEEeeecccccccC
Q 003694 582 HNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 582 ~~~~~kl~DFGla~~~~~ 599 (802)
.++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=151.48 Aligned_cols=137 Identities=12% Similarity=0.096 Sum_probs=101.6
Q ss_pred CCceEEEEecCCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhhH
Q 003694 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLL 92 (802)
Q Consensus 13 ~~~~IlVaVD~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~ 92 (802)
+|++||||+|+|+.+..||++|+..+...+. +|+++||++++.... + ......+.+.+...++..+.|.
T Consensus 2 ~~~~ILv~~D~s~~s~~al~~A~~lA~~~~a-~l~ll~v~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~l~ 70 (142)
T PRK10116 2 SYSNILVAVAVTPESQQLLAKAVSIARPVNG-KISLITLASDPEMYN---Q-------FAAPMLEDLRSVMQEETQSFLD 70 (142)
T ss_pred CCceEEEEccCCcchHHHHHHHHHHHHHhCC-EEEEEEEccCcccch---h-------hhHHHHHHHHHHHHHHHHHHHH
Confidence 4899999999999999999999997665544 699999986532211 0 0111223444444445555555
Q ss_pred HHHHHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC-CcceEEEEec
Q 003694 93 PFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGVEK 169 (802)
Q Consensus 93 ~~~~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~-a~cpVlvV~~ 169 (802)
.+ +...|+..+..++..|++.+.|+++|++.++|+||||+||++ ++.+++ |++.+++. ++||||||+-
T Consensus 71 ~~---~~~~~~~~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~----~~~~~~--s~a~~v~~~~~~pVLvv~~ 139 (142)
T PRK10116 71 KL---IQDADYPIEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHS----FFSRAS--CSAKRVIASSEVDVLLVPL 139 (142)
T ss_pred HH---HHhcCCCeEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcch----HHHHHH--HHHHHHHhcCCCCEEEEeC
Confidence 44 345677766555556999999999999999999999999998 555543 78999999 9999999974
|
|
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-16 Score=148.64 Aligned_cols=139 Identities=24% Similarity=0.231 Sum_probs=98.1
Q ss_pred CCceEEEEecCCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhhH
Q 003694 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLL 92 (802)
Q Consensus 13 ~~~~IlVaVD~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~ 92 (802)
++++|+||+|+++.+..|++||+..+...++ .|+++||.+....... . ...................
T Consensus 1 M~~~Ilv~~d~~~~~~~al~~a~~la~~~~~-~i~~l~v~~~~~~~~~--------~----~~~~~~~~~~~~~~~~~~~ 67 (140)
T PF00582_consen 1 MYKRILVAIDGSEESRRALRFALELAKRSGA-EITLLHVIPPPPQYSF--------S----AAEDEESEEEAEEEEQARQ 67 (140)
T ss_dssp -TSEEEEEESSSHHHHHHHHHHHHHHHHHTC-EEEEEEEEESCHCHHH--------H----HHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHHHHhhCC-eEEEEEeecccccccc--------c----cccccccccccchhhhhhh
Confidence 3789999999999999999999997776555 6999999976422111 0 0000000000000010011
Q ss_pred HHHHHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC-CcceEEEEe
Q 003694 93 PFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGVE 168 (802)
Q Consensus 93 ~~~~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~-a~cpVlvV~ 168 (802)
.....+...+.......+..|+++++|++++++.++|+||||+++++ ++.++++||++.+++. ++|||+||+
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~----~~~~~~~gs~~~~l~~~~~~pVlvv~ 140 (140)
T PF00582_consen 68 AEAEEAEAEGGIVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRS----GLERLLFGSVAEKLLRHAPCPVLVVP 140 (140)
T ss_dssp HHHHHHHHHTTSEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTT----STTTSSSHHHHHHHHHHTSSEEEEEE
T ss_pred HHHHHHhhhccceeEEEEEeeccchhhhhccccccceeEEEeccCCC----CccCCCcCCHHHHHHHcCCCCEEEeC
Confidence 11133444455555555556999999999999999999999999999 8888999999999999 999999986
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=165.15 Aligned_cols=145 Identities=14% Similarity=0.055 Sum_probs=112.1
Q ss_pred CCceEEEEecCCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhhH
Q 003694 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLL 92 (802)
Q Consensus 13 ~~~~IlVaVD~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~ 92 (802)
.|++||||+|+|+.|..|+.||+..+...+. .|+++||.++.... .+ +. ..........+...+...+.|+
T Consensus 2 ~~~~ILv~~D~s~~~~~al~~a~~lA~~~~a-~l~ll~v~~~~~~~-~~-~~------~~~~~~~~~~~~~~~~~~~~l~ 72 (305)
T PRK11175 2 KYQNILVVIDPNQDDQPALRRAVYLAQRNGG-KITAFLPIYDFSYE-MT-TL------LSPDEREAMRQGVISQRTAWIR 72 (305)
T ss_pred CcceEEEEcCCCccccHHHHHHHHHHHhcCC-CEEEEEeccCchhh-hh-cc------cchhHHHHHHHHHHHHHHHHHH
Confidence 3789999999999999999999997665555 59999997643211 10 10 0111122222333344566677
Q ss_pred HHHHHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC-CcceEEEEecC
Q 003694 93 PFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGVEKG 170 (802)
Q Consensus 93 ~~~~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~-a~cpVlvV~~~ 170 (802)
.+...+...|++++..+...|+|.++|+++|.+.++|+||||++|.+ ++.+.++||++.++++ ++||||||+.+
T Consensus 73 ~~~~~~~~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~----~~~~~~~gs~~~~l~~~~~~pvlvv~~~ 147 (305)
T PRK11175 73 EQAKPYLDAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHD----KLESVIFTPTDWHLLRKCPCPVLMVKDQ 147 (305)
T ss_pred HHHHHHhhcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCc----HHHhhccChhHHHHHhcCCCCEEEeccc
Confidence 77777777799999887755999999999999999999999999998 7888999999999999 99999999874
|
|
| >PF04564 U-box: U-box domain; InterPro: IPR003613 Quality control of intracellular proteins is essential for cellular homeostasis | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-16 Score=133.66 Aligned_cols=68 Identities=43% Similarity=0.885 Sum_probs=59.8
Q ss_pred CCCCccCccchhcccCCcccCCCcccchHHHHHHHhh-CCCCCCCCCCCCCCCCCCcHHHHHHHHHHhh
Q 003694 734 PPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKS 801 (802)
Q Consensus 734 ~P~~f~cPi~~evm~dp~iaadg~tye~~~I~~wl~~-~~~sP~T~~~l~~~~l~pn~~l~~~~~~w~~ 801 (802)
.|+.|+|||+.++|.||+++.+|+|||+.+|+.|+.. +.+||+|+.++.+.+|+||++||++|++|+.
T Consensus 1 iP~~f~CpIt~~lM~dPVi~~~G~tyer~~I~~~l~~~~~~~P~t~~~l~~~~l~pn~~Lk~~I~~~~~ 69 (73)
T PF04564_consen 1 IPDEFLCPITGELMRDPVILPSGHTYERSAIERWLEQNGGTDPFTRQPLSESDLIPNRALKSAIEEWCA 69 (73)
T ss_dssp SSGGGB-TTTSSB-SSEEEETTSEEEEHHHHHHHHCTTSSB-TTT-SB-SGGGSEE-HHHHHHHHHHHH
T ss_pred CCcccCCcCcCcHhhCceeCCcCCEEcHHHHHHHHHcCCCCCCCCCCcCCcccceECHHHHHHHHHHHH
Confidence 4889999999999999999999999999999999998 8999999999999999999999999999986
|
Molecular chaperones recognise and contribute to the refolding of misfolded or unfolded proteins, whereas the ubiquitin-proteasome system mediates the degradation of such abnormal proteins. Ubiquitin-protein ligases (E3s) determine the substrate specificity for ubiquitylation and have been classified into HECT and RING-finger families. More recently, however, U-box proteins, which contain a domain (the U box) of about 70 amino acids that is conserved from yeast to humans, have been identified as a new type of E3 []. Members of the U-box family of proteins constitute a class of ubiquitin-protein ligases (E3s) distinct from the HECT-type and RING finger-containing E3 families []. Using yeast two-hybrid technology, all mammalian U-box proteins have been reported to interact with molecular chaperones or co-chaperones, including Hsp90, Hsp70, DnaJc7, EKN1, CRN, and VCP. This suggests that the function of U box-type E3s is to mediate the degradation of unfolded or misfolded proteins in conjunction with molecular chaperones as receptors that recognise such abnormal proteins [, ]. Unlike the RING finger domain, IPR001841 from INTERPRO, that is stabilised by Zn2+ ions coordinated by the cysteines and a histidine, the U-box scaffold is probably stabilised by a system of salt-bridges and hydrogen bonds. The charged and polar residues that participate in this network of bonds are more strongly conserved in the U-box proteins than in classic RING fingers, which supports their role in maintaining the stability of the U box. Thus, the U box appears to have evolved from a RING finger domain by appropriation of a new set of residues required to stabilise its structure, concomitant with the loss of the original, metal-chelating residues [].; GO: 0004842 ubiquitin-protein ligase activity, 0016567 protein ubiquitination, 0000151 ubiquitin ligase complex; PDB: 1T1H_A 2C2L_D 2C2V_V 1WGM_A 2KR4_A 3L1Z_B 3L1X_A 2KRE_A 3M63_A 2QIZ_A .... |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.1e-15 Score=140.55 Aligned_cols=133 Identities=23% Similarity=0.211 Sum_probs=111.6
Q ss_pred cceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCC--CceeeecceecC--CCeEEEEEccCCCH
Q 003694 453 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH--PHLLLLLGACPD--HGCLVYEYMENGSL 528 (802)
Q Consensus 453 ~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H--pniv~l~g~~~~--~~~lV~Ey~~~gsL 528 (802)
...||.|+++.||++...+..+++|....... ...+.+|+.++..++| +++.++++++.. ..+++|||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 46799999999999999888999999866543 5678999999999976 588888887754 45899999998877
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccc
Q 003694 529 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 529 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~ 597 (802)
..+ +......++.+++.+|.+||.....+++|+||+|.|||++.++.++++|||++...
T Consensus 81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 653 44566788999999999999864445999999999999999999999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.7e-15 Score=147.98 Aligned_cols=137 Identities=18% Similarity=0.177 Sum_probs=96.9
Q ss_pred cceecCCCcEEEEEEEEC-CeEEEEEEEcccCccc--hHH----------------------HHHHHHHHHhcCCCc--e
Q 003694 453 NLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQ--NKQ----------------------FLQELEVLSKIRHPH--L 505 (802)
Q Consensus 453 ~~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~--~~~----------------------~~~Ei~il~~l~Hpn--i 505 (802)
.+.||+|+||.||+|... +..||||++....... ... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999986 7799999987542211 111 134566666664432 3
Q ss_pred eeecceecCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEecCCc
Q 003694 506 LLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNL 584 (802)
Q Consensus 506 v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl~~~~ 584 (802)
...+++ ...++||||++++++......... .. .....++.+++.++.++|. .+ |+||||||+|||++ ++
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 333332 345899999998554321111110 00 3567899999999999999 77 99999999999999 99
Q ss_pred eeEEeeecccccccC
Q 003694 585 VSKIGDVGLSTMLNS 599 (802)
Q Consensus 585 ~~kl~DFGla~~~~~ 599 (802)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.2e-14 Score=149.40 Aligned_cols=133 Identities=18% Similarity=0.198 Sum_probs=104.7
Q ss_pred cceec-CCCcEEEEEEEECCeEEEEEEEcccC-------------ccchHHHHHHHHHHHhcCCCce--eeecceecCC-
Q 003694 453 NLRIG-MGGYGTVYKGTFHHTFAAVKVLQSKG-------------NIQNKQFLQELEVLSKIRHPHL--LLLLGACPDH- 515 (802)
Q Consensus 453 ~~~iG-~G~~g~Vy~~~~~~~~vavK~l~~~~-------------~~~~~~~~~Ei~il~~l~Hpni--v~l~g~~~~~- 515 (802)
...|| .||.|+||.+...+..++||...... ......+.+|+.++.+|+|++| +..++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 34688 89999999999988899999775321 1223567889999999998775 5666654221
Q ss_pred -----CeEEEEEccC-CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEe
Q 003694 516 -----GCLVYEYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 589 (802)
Q Consensus 516 -----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~ 589 (802)
.++||||++| .+|.+++... +++.. .+.+|+.+|.+||..| |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2599999997 6898887432 24432 3678999999999999 9999999999999999999999
Q ss_pred eeccccc
Q 003694 590 DVGLSTM 596 (802)
Q Consensus 590 DFGla~~ 596 (802)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998875
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=2e-14 Score=155.78 Aligned_cols=145 Identities=12% Similarity=0.129 Sum_probs=101.3
Q ss_pred CCCceEEEEecCCccc-------hhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHH
Q 003694 12 SPALSVAVAVKGNRKS-------RYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEK 84 (802)
Q Consensus 12 ~~~~~IlVaVD~S~~S-------~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~ 84 (802)
..+++|+||+|+|+.+ ..|+++|+..+....++.|+|+||++....... .+ ++ ... ...+.+..+
T Consensus 150 ~~~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~-~~--~~--~~~---~~~~~~~~~ 221 (305)
T PRK11175 150 PEGGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIA-IE--LP--EFD---PSVYNDAIR 221 (305)
T ss_pred CCCCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhcc-cc--cc--ccc---hhhHHHHHH
Confidence 3578999999999754 679999998766651346999999865321110 00 01 001 112233333
Q ss_pred HHHHHhhHHHHHHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC-Ccce
Q 003694 85 WKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCT 163 (802)
Q Consensus 85 ~~~~~~l~~~~~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~-a~cp 163 (802)
+...+.+..+. ...|+..+..++..|+|+++|+++|++.++|+||||++|++ ++.++++||++.+++. ++||
T Consensus 222 ~~~~~~l~~~~---~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~----~~~~~llGS~a~~v~~~~~~p 294 (305)
T PRK11175 222 GQHLLAMKALR---QKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRT----GLSAAFLGNTAEHVIDHLNCD 294 (305)
T ss_pred HHHHHHHHHHH---HHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccC----CCcceeecchHHHHHhcCCCC
Confidence 33344444443 33466654344444999999999999999999999999999 8888999999999999 9999
Q ss_pred EEEEecCc
Q 003694 164 VYGVEKGK 171 (802)
Q Consensus 164 VlvV~~~~ 171 (802)
||||+...
T Consensus 295 VLvv~~~~ 302 (305)
T PRK11175 295 LLAIKPDG 302 (305)
T ss_pred EEEEcCCC
Confidence 99997543
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-13 Score=127.47 Aligned_cols=129 Identities=26% Similarity=0.312 Sum_probs=106.7
Q ss_pred eEEEEecCCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhhHHHH
Q 003694 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFR 95 (802)
Q Consensus 16 ~IlVaVD~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 95 (802)
+|+||+|+++.+..+++||.+.+...+. .|+++||.++....+. ...+....+.++.|..+.
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~-~i~~l~v~~~~~~~~~-----------------~~~~~~~~~~~~~l~~~~ 62 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGA-ELVLLHVVDPPPSSAA-----------------ELAELLEEEARALLEALR 62 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCC-EEEEEEEecCCCCcch-----------------hHHHHHHHHHHHHHHHHH
Confidence 5999999999999999999998777654 6999999865322110 122334455678888888
Q ss_pred HHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC-CcceEEEE
Q 003694 96 NMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGV 167 (802)
Q Consensus 96 ~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~-a~cpVlvV 167 (802)
..|...|+++...+.. |+++++|++++++.++|+||||+++++ .+.+.+.|+.+.+++. +.|||++|
T Consensus 63 ~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~dlvvig~~~~~----~~~~~~~~~~~~~ll~~~~~pvliv 130 (130)
T cd00293 63 EALAEAGVKVETVVLE-GDPAEAILEAAEELGADLIVMGSRGRS----GLRRLLLGSVAERVLRHAPCPVLVV 130 (130)
T ss_pred HHHhcCCCceEEEEec-CCCHHHHHHHHHHcCCCEEEEcCCCCC----ccceeeeccHHHHHHhCCCCCEEeC
Confidence 8887789998888877 888999999999999999999999998 6677889999999999 99999985
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.6e-13 Score=129.70 Aligned_cols=146 Identities=18% Similarity=0.168 Sum_probs=112.3
Q ss_pred CCceEEEEec-CCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhh
Q 003694 13 PALSVAVAVK-GNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLL 91 (802)
Q Consensus 13 ~~~~IlVaVD-~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l 91 (802)
.+++|++++| +++.+..|+.+|+..+...+. .+.++||.+........... ... ...............+.+
T Consensus 4 ~~~~il~~~d~~s~~~~~a~~~a~~~~~~~~~-~~~~~~v~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~~~~~~ 76 (154)
T COG0589 4 MYKKILVAVDVGSEAAEKALEEAVALAKRLGA-PLILLVVIDPLEPTALVSVA--LAD----APIPLSEEELEEEAEELL 76 (154)
T ss_pred ccceEEEEeCCCCHHHHHHHHHHHHHHHhcCC-eEEEEEEecccccccccccc--ccc----chhhhhHHHHHHHHHHHH
Confidence 4789999999 999999999999997766655 48899998764332221110 000 001122334455667788
Q ss_pred HHHHHHhhccCcee-EEEEEecCcH-HHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC-CcceEEEEe
Q 003694 92 LPFRNMCAQRRVEV-EVKVIESDDV-AKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGVE 168 (802)
Q Consensus 92 ~~~~~~~~~~~v~~-~~~v~~~g~~-~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~-a~cpVlvV~ 168 (802)
..+.....+.|+.. +..+.+ |+| .+.|++++.+.++|+||||++|++ ++.++++||++.+++. ++|||++|+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~-g~~~~~~i~~~a~~~~adliV~G~~g~~----~l~~~llGsvs~~v~~~~~~pVlvv~ 151 (154)
T COG0589 77 AEAKALAEAAGVPVVETEVVE-GSPSAEEILELAEEEDADLIVVGSRGRS----GLSRLLLGSVAEKVLRHAPCPVLVVR 151 (154)
T ss_pred HHHHHHHHHcCCCeeEEEEec-CCCcHHHHHHHHHHhCCCEEEECCCCCc----cccceeeehhHHHHHhcCCCCEEEEc
Confidence 88888888888885 677777 888 799999999999999999999999 7777999999999999 999999998
Q ss_pred cC
Q 003694 169 KG 170 (802)
Q Consensus 169 ~~ 170 (802)
..
T Consensus 152 ~~ 153 (154)
T COG0589 152 SE 153 (154)
T ss_pred cC
Confidence 53
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-14 Score=168.89 Aligned_cols=248 Identities=19% Similarity=0.249 Sum_probs=178.7
Q ss_pred hcCCcccceecCCCcEEEEEEEEC---CeEEEEEEEcccC--ccchHHHHHHHHHHHhcC-CCceeeecceecCCC--eE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~---~~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~l 518 (802)
...|.....||+|.|+.|-..... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.. ++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345677777999999999987652 2356666554432 222233445777777776 999999999875544 78
Q ss_pred EEEEccCCCHHHHhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEcCCCCCCeEecCCc-eeEEeeecccc
Q 003694 519 VYEYMENGSLEDRLY-RKNNTPPIPWFERYRIAWEVASALAFLH-NTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLST 595 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~ivHrDLKp~NILl~~~~-~~kl~DFGla~ 595 (802)
+++|..||++.+-+. ... ...+....-.++.|+..+|.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 999999999988773 222 12444466678999999999999 777 99999999999999999 99999999999
Q ss_pred cccCCCCcccccccccCCcc-CcccCCcccccc-CCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhh
Q 003694 596 MLNSDPSFVSTTYKNTGPVG-TLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~g-t~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld 673 (802)
.+....... ......+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+....... +.+.....
T Consensus 174 ~~~~~~g~~---~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-----~~~~~~~~ 245 (601)
T KOG0590|consen 174 AYRNKNGAE---RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-----GRYSSWKS 245 (601)
T ss_pred cccccCCcc---eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-----ccceeecc
Confidence 877622111 12234577 999999998876 456788999999999999999999997543322 11111111
Q ss_pred hh-C-CCC-ChHHHHHHHHHHHHhhccccCCCCcccc
Q 003694 674 AQ-A-GDW-PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ~~-~-~~~-p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.. . ... .........+++.+++..+|..|.+..+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~ 282 (601)
T KOG0590|consen 246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEE 282 (601)
T ss_pred cccccccCccccCChhhhhcccccccCCchhcccccc
Confidence 11 0 111 1234566788888999999999999874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=148.44 Aligned_cols=137 Identities=19% Similarity=0.199 Sum_probs=98.6
Q ss_pred ceecCCCcEEEEEEEE-CCeEEEEEEEcccCccch----------------------------------------HHHHH
Q 003694 454 LRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQN----------------------------------------KQFLQ 492 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~-~~~~vavK~l~~~~~~~~----------------------------------------~~~~~ 492 (802)
..||.|++|.||+|++ +|+.||||+.++...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999998 578999999876421110 02455
Q ss_pred HHHHHHhcC-----CCcee--eecceecCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 003694 493 ELEVLSKIR-----HPHLL--LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS-ALAFLHNTK 564 (802)
Q Consensus 493 Ei~il~~l~-----Hpniv--~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~~LH~~~ 564 (802)
|...+.+++ ++++. +.+..+....+|||||++|++|.+.+...... . .+..++..++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence 666666552 33322 23322334568999999999998876432211 2 23456666665 478889888
Q ss_pred CCCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 565 ~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
++|+|++|.||+++.++.++|+|||++..++
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.5e-12 Score=128.11 Aligned_cols=130 Identities=20% Similarity=0.121 Sum_probs=100.7
Q ss_pred ceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCc-eeeecceecCCCeEEEEEccCCCHHHHh
Q 003694 454 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH-LLLLLGACPDHGCLVYEYMENGSLEDRL 532 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-iv~l~g~~~~~~~lV~Ey~~~gsL~~~l 532 (802)
..|+.|.++.||+++..+..+++|+...... ....+..|+.++..+.+.+ +.+++++..+..++||||++|.++.+..
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~ 82 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTED 82 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccccc
Confidence 4689999999999999999999998765432 2234678999999886544 3456666666679999999998876530
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 533 YRKNNTPPIPWFERYRIAWEVASALAFLHNTK--PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 533 ~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
. ....++.+++.+|..||..+ +..++|+|++|.|||++ ++.++++|||.+..
T Consensus 83 --------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 83 --------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred --------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 1 11245679999999999987 33469999999999999 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.5e-13 Score=137.18 Aligned_cols=201 Identities=25% Similarity=0.336 Sum_probs=139.3
Q ss_pred HHHHhcCCCceeeecceecCCC-------eEEEEEccCCCHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 003694 495 EVLSKIRHPHLLLLLGACPDHG-------CLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPK 566 (802)
Q Consensus 495 ~il~~l~Hpniv~l~g~~~~~~-------~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 566 (802)
.-|-.+-|.|||++..++.+.. .++.|||..|+|..+|.+. .....+......+|+.||.+||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 3455567999999999986544 5899999999999999863 33345667777899999999999999998 5
Q ss_pred CeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccc-ccccccCCccCcccCCccccccCCCCCcccchhHHHHHHH
Q 003694 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS-TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 645 (802)
Q Consensus 567 ~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~e 645 (802)
+|+|+++..+-|++..+|-+||+--.-...- ..... .........+-++|.+||+-.....+..+|||+||.+.++
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h---~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH---PSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccc---hhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 7999999999999999999988432111110 00000 1111223456789999999888888899999999999999
Q ss_pred HHhCCCC-ccccchhhhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCccccch
Q 003694 646 LLTAKPA-IAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 709 (802)
Q Consensus 646 lltg~~p-~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v 709 (802)
|..|..- -.....+ ..+..+...+-... ...=+.++.+|++-.|..||+++..+
T Consensus 275 mailEiq~tnseS~~---~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 275 MAILEIQSTNSESKV---EVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHHheeccCCCccee---ehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhh
Confidence 9887532 1111111 11122222221111 11124578899999999999998644
|
|
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.3e-11 Score=132.13 Aligned_cols=109 Identities=17% Similarity=0.196 Sum_probs=79.9
Q ss_pred CCCCceEEEEecCCccchhhHHHHhhhcCCCC-CceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHH
Q 003694 11 NSPALSVAVAVKGNRKSRYAVLWALEKFIPEG-INLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDR 89 (802)
Q Consensus 11 ~~~~~~IlVaVD~S~~S~~Al~wA~~~~~~~~-~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ 89 (802)
...|++||||||||+.|++|+++|++.+...+ +++|++|||.+...... .. ....+..++
T Consensus 2 ~~~ykkILVavDGSe~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~--------~~-----------~~~~~~~ee 62 (357)
T PRK12652 2 MMAANRLLVPVADSVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDP--------EG-----------QDELAAAEE 62 (357)
T ss_pred CcccCeEEEEeCCCHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCccccc--------ch-----------hHHHHHHHH
Confidence 35689999999999999999999999776543 46799999987532111 00 011122334
Q ss_pred hhHHHHHHhhc------cCceeEEEEEec-------CcHHHHHHHHHHhcCCCEEEEcccCC
Q 003694 90 LLLPFRNMCAQ------RRVEVEVKVIES-------DDVAKAIADEVASCNINKLVIGAQSQ 138 (802)
Q Consensus 90 ~l~~~~~~~~~------~~v~~~~~v~~~-------g~~~~~I~~~a~~~~idlIVmGs~g~ 138 (802)
+++.+.+.+.. .|++++..++.. |+|++.|++||+++++|+||||-.-.
T Consensus 63 lle~~~~~~~~~l~~~~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~~~ 124 (357)
T PRK12652 63 LLERVEVWATEDLGDDASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPEYN 124 (357)
T ss_pred HHHHHHHHHHHhhhcccCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCCCC
Confidence 44444444433 589999888763 89999999999999999999997654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.9e-12 Score=139.16 Aligned_cols=243 Identities=22% Similarity=0.248 Sum_probs=170.4
Q ss_pred CCcccceecC--CCcEEEEEEEE----CCeEEEEEEEccc--CccchHHHHHHHHHHHhcC-CCceeeecceecCCC--e
Q 003694 449 SFSENLRIGM--GGYGTVYKGTF----HHTFAAVKVLQSK--GNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--C 517 (802)
Q Consensus 449 ~f~~~~~iG~--G~~g~Vy~~~~----~~~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~--~ 517 (802)
.|.....+|. |.+|.||.+.. ....+|+|.-+.. .......=.+|+....+++ |+|.++.+..+.+.. +
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566678999 99999999876 2447888873332 2233333356777777775 999999888887665 6
Q ss_pred EEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEcCCCCCCeEecCC-ceeEEeeec
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS----ALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVG 592 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~~LH~~~~~~ivHrDLKp~NILl~~~-~~~kl~DFG 592 (802)
+-+|++ +.+|..+...... -++......+..+... ||.++|+.. ++|-|+||.||++..+ ..++++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 667777 4788777654433 2555667777777777 999999988 9999999999999999 899999999
Q ss_pred ccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCcc-ccchhhhhhchhhhHHH
Q 003694 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIA-ITHKVETAIDEDNLAEI 671 (802)
Q Consensus 593 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~-~~~~~~~~~~~~~l~~~ 671 (802)
+...+....-. ..........|...|++||..+ +.++...|+|+||.++++..+|..... .....+..++...+..
T Consensus 269 ~v~~i~~~~~~-~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~- 345 (524)
T KOG0601|consen 269 LVSKISDGNFS-SVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL- 345 (524)
T ss_pred eeEEccCCccc-cceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch-
Confidence 99988765421 1111223447888999999876 567899999999999999988865542 2112222222221110
Q ss_pred hhhhCCCCChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 672 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 672 ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
++-..-...+...+..+++.+|..|++..
T Consensus 346 ------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q 374 (524)
T KOG0601|consen 346 ------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQ 374 (524)
T ss_pred ------hhhcCcchhhhhHHHHhcCcchhhhhHHH
Confidence 11111234555588889999999998876
|
|
| >smart00504 Ubox Modified RING finger domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.6e-12 Score=101.19 Aligned_cols=63 Identities=46% Similarity=0.962 Sum_probs=60.7
Q ss_pred CccCccchhcccCCcccCCCcccchHHHHHHHhhCCCCCCCCCCCCCCCCCCcHHHHHHHHHH
Q 003694 737 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDW 799 (802)
Q Consensus 737 ~f~cPi~~evm~dp~iaadg~tye~~~I~~wl~~~~~sP~T~~~l~~~~l~pn~~l~~~~~~w 799 (802)
.|.|||..++|.||++...|++|++..|..|+.++.+||+|+.++...+|+||++||++|++|
T Consensus 1 ~~~Cpi~~~~~~~Pv~~~~G~v~~~~~i~~~~~~~~~cP~~~~~~~~~~l~~~~~l~~~i~~~ 63 (63)
T smart00504 1 EFLCPISLEVMKDPVILPSGQTYERRAIEKWLLSHGTDPVTGQPLTHEDLIPNLALKSAIQEW 63 (63)
T ss_pred CcCCcCCCCcCCCCEECCCCCEEeHHHHHHHHHHCCCCCCCcCCCChhhceeCHHHHHHHHhC
Confidence 378999999999999999999999999999999888999999999999999999999999999
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.3e-11 Score=135.69 Aligned_cols=143 Identities=18% Similarity=0.151 Sum_probs=92.0
Q ss_pred cCCcccceecCCCcEEEEEEEEC--CeEEEEEEEcccCccc----------------------------------h----
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ----------------------------------N---- 487 (802)
Q Consensus 448 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~----------------------------------~---- 487 (802)
..|+. ..||.|++|.||+|++. |+.||||+.++..... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 67999999999999985 6899999998652110 0
Q ss_pred --HHHHHHHHHHHhcC----CCceeeecce---ecCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHH-HH
Q 003694 488 --KQFLQELEVLSKIR----HPHLLLLLGA---CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS-AL 557 (802)
Q Consensus 488 --~~~~~Ei~il~~l~----Hpniv~l~g~---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL 557 (802)
-+|.+|...+.+++ +.+.+.+-.. +....+|||||+.|+.|.+.-.-...+ .+.. .++...+. -+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~---~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMK---LLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHH---HHHHHHHHHHH
Confidence 12445555555542 3333333333 334558999999999998742211111 2111 12222111 12
Q ss_pred HHHHhcCCCCeEEcCCCCCCeEecCCc----eeEEeeecccccccC
Q 003694 558 AFLHNTKPKPIIHRDMKPGNILLDHNL----VSKIGDVGLSTMLNS 599 (802)
Q Consensus 558 ~~LH~~~~~~ivHrDLKp~NILl~~~~----~~kl~DFGla~~~~~ 599 (802)
.-++..| ++|+|+||.|||++.+| .++++|||++..++.
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3344566 99999999999999888 999999999988764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=6e-10 Score=111.39 Aligned_cols=136 Identities=18% Similarity=0.136 Sum_probs=96.2
Q ss_pred ceecCCCcEEEEEEEEC--------CeEEEEEEEcccCc----------------------cchHHH----HHHHHHHHh
Q 003694 454 LRIGMGGYGTVYKGTFH--------HTFAAVKVLQSKGN----------------------IQNKQF----LQELEVLSK 499 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~--------~~~vavK~l~~~~~----------------------~~~~~~----~~Ei~il~~ 499 (802)
..||.|-=+.||.|... +..+|||+.+.... .....+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754 36899998753210 001223 379999998
Q ss_pred cC--CCceeeecceecCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEcCCCCC
Q 003694 500 IR--HPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL-HNTKPKPIIHRDMKPG 576 (802)
Q Consensus 500 l~--Hpniv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~ivHrDLKp~ 576 (802)
+. .-++...+++ ...+|||||+.++.+..-..+. ..++......+..+++.+|..| |..+ ||||||+|.
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 85 2345555543 5668999999765442211111 1244445667889999999999 8888 999999999
Q ss_pred CeEecCCceeEEeeeccccccc
Q 003694 577 NILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 577 NILl~~~~~~kl~DFGla~~~~ 598 (802)
|||++ ++.+.|+|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.9e-11 Score=132.12 Aligned_cols=236 Identities=21% Similarity=0.208 Sum_probs=166.2
Q ss_pred hcCCcccceecCCCcEEEEEEEEC---CeEEEEEEEcccCccchHHH--HHHHHHHHhcC-CCceeeecceec--CCCeE
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQF--LQELEVLSKIR-HPHLLLLLGACP--DHGCL 518 (802)
Q Consensus 447 ~~~f~~~~~iG~G~~g~Vy~~~~~---~~~vavK~l~~~~~~~~~~~--~~Ei~il~~l~-Hpniv~l~g~~~--~~~~l 518 (802)
..+|.....||.|.|+.||....+ +..|++|-+.........++ ..|+-+...+. |.|++..+..|. ++.++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 456888899999999999987654 55888887765544333322 45676666664 888888766653 44588
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC-ceeEEeeecccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTML 597 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~-~~~kl~DFGla~~~ 597 (802)
-.|||.++++...+.... .+....++++..+++.++.++|+.. ++|+|+||+||++..+ +..+++|||+...+
T Consensus 344 p~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 899999999887663222 2555677889999999999999988 9999999999999886 88899999998753
Q ss_pred cCCCCcccccccccCCccCccc-CCccccccCCCCCcccchhHHHHHHHHHhCCCCccccchhhhhhchhhhHHHhhhhC
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCY-IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 676 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y-~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~ 676 (802)
.-.. .....++..| .+|.......+..+.|+||||.-+.+.++|.+--.... ....+....
T Consensus 418 ~~~~--------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~~i~~~~ 479 (524)
T KOG0601|consen 418 AFSS--------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSLTIRSGD 479 (524)
T ss_pred ceec--------ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----------cceeeeccc
Confidence 3111 1112334445 46667777778899999999999999999874321110 011111111
Q ss_pred CCCChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 677 GDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 677 ~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
..........+..+...+...++..||.+.
T Consensus 480 ~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~ 509 (524)
T KOG0601|consen 480 TPNLPGLKLQLQVLLKVMINPDRKRRPSAV 509 (524)
T ss_pred ccCCCchHHhhhhhhhhhcCCccccchhhh
Confidence 111223337778888889999999999876
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.4e-09 Score=122.83 Aligned_cols=161 Identities=19% Similarity=0.223 Sum_probs=119.6
Q ss_pred CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCCC--eEEEEEccCCCHHHHhhhcCCCCCCCHHHHHH
Q 003694 471 HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 548 (802)
Q Consensus 471 ~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~ 548 (802)
+.+|.|.+.............+-+.-|+.++||||++++..+.... |||+|-+. .|..+|...+ ......
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------~~~v~~ 108 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------KEEVCL 108 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------HHHHHH
Confidence 4577777766554433445677889999999999999999987666 99999984 5777776543 346677
Q ss_pred HHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccC
Q 003694 549 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628 (802)
Q Consensus 549 i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 628 (802)
.+.||+.||.|||..+. ++|++|.-+-|+++..|..||++|-++......... .....---.|..|+.+...
T Consensus 109 Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~------~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP------AKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc------cccchhhhcccChhhcCcc
Confidence 88999999999997653 999999999999999999999999998765543210 0111122235566543322
Q ss_pred CCCCcccchhHHHHHHHHHhC
Q 003694 629 LISPKSDVYAYGMVILQLLTA 649 (802)
Q Consensus 629 ~~~~~sDv~SlGvil~elltg 649 (802)
. -..|.|-|||++++++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 1 346999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.2e-10 Score=114.27 Aligned_cols=139 Identities=24% Similarity=0.287 Sum_probs=107.3
Q ss_pred ceecCCCcEEEEEEEECC-eEEEEEEEcccCc-cchHHHHHHHHHHHhcCC--CceeeecceecC-----CCeEEEEEcc
Q 003694 454 LRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRH--PHLLLLLGACPD-----HGCLVYEYME 524 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~-~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H--pniv~l~g~~~~-----~~~lV~Ey~~ 524 (802)
..||.|.++.||+++..+ ..+++|+...... .....+.+|+.++..+.+ .++.+++.++.+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998876 7899998765432 134568899999999975 345667777655 3489999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK---------------------------------------- 564 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------------- 564 (802)
|++|.+.+.. ..++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988775431 23566677788888888888888531
Q ss_pred -------------CCCeEEcCCCCCCeEecC--CceeEEeeeccccc
Q 003694 565 -------------PKPIIHRDMKPGNILLDH--NLVSKIGDVGLSTM 596 (802)
Q Consensus 565 -------------~~~ivHrDLKp~NILl~~--~~~~kl~DFGla~~ 596 (802)
+..++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 67789999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.1e-10 Score=106.43 Aligned_cols=128 Identities=28% Similarity=0.378 Sum_probs=101.0
Q ss_pred eecCCCcEEEEEEEECCeEEEEEEEcccC-c-------cchHHHHHHHHHHHhcC--CCceeeecceecCCCeEEEEEcc
Q 003694 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKG-N-------IQNKQFLQELEVLSKIR--HPHLLLLLGACPDHGCLVYEYME 524 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~~~vavK~l~~~~-~-------~~~~~~~~Ei~il~~l~--Hpniv~l~g~~~~~~~lV~Ey~~ 524 (802)
.|++|+=+.+|.+.+.+..+.+|.=.++. . ....+-.+|..+|.+++ --+...++.+.++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 47899999999998887777777533321 1 12244578999999885 34556677777888899999999
Q ss_pred CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
|-.|.+.+... ...++..+-.-+.-||..| |||+||.++||++..+. +.++||||+..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 98898888643 2456778888889999999 99999999999998765 89999999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.8e-11 Score=140.33 Aligned_cols=248 Identities=19% Similarity=0.240 Sum_probs=168.8
Q ss_pred hhcCCcccceecCCCcEEEEEEEECCe--EEEEEEEcccCccc---hHHHHHHHHHHHhcCCCceeeecce--ecCCCeE
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGA--CPDHGCL 518 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~---~~~~~~Ei~il~~l~Hpniv~l~g~--~~~~~~l 518 (802)
..+.|...+-+-+|.++.++.+.-.++ ..+.|+........ .+....+-.++-..+||-++..+-- |.+..+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 445677777888999999997654322 23344333221111 1222233333333456777766655 4566699
Q ss_pred EEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
|++|+.+++|...|+..+ +.+..-....+..+..+++|||... ++|+|++|.|+|...+|..+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999887654 2333333445677889999999987 9999999999999999999999998544332
Q ss_pred CCCC---c--------------------ccc--cccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCc
Q 003694 599 SDPS---F--------------------VST--TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 653 (802)
Q Consensus 599 ~~~~---~--------------------~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~ 653 (802)
.... . ... ........||+.|.+||...+.......|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 1100 0 000 01234568999999999999999999999999999999999999999
Q ss_pred cccchhhhhhchhhhHHHhhhhCCCC---ChHHHHHHHHHHHHhhccccCCCCccc
Q 003694 654 AITHKVETAIDEDNLAEILDAQAGDW---PIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 654 ~~~~~~~~~~~~~~l~~~ld~~~~~~---p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
.....-. .+..++. ....| |........+++.+.+..+|.+|-.+.
T Consensus 1036 na~tpq~------~f~ni~~-~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQ------IFENILN-RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhh------hhhcccc-CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 6432211 1111221 12233 345677889999999999999998766
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.7e-09 Score=112.77 Aligned_cols=259 Identities=19% Similarity=0.226 Sum_probs=169.5
Q ss_pred cccceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceee--------ecceecCC-CeEEE
Q 003694 451 SENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLL--------LLGACPDH-GCLVY 520 (802)
Q Consensus 451 ~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~Hpniv~--------l~g~~~~~-~~lV~ 520 (802)
..+..||+||-+.+|-.---...|| |+.+........+ -+..|... .||-+-. |+|.-... ..+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchhhchhh-eeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3456799999999996322222333 5555433322222 23333333 4654332 22222222 24677
Q ss_pred EEccCC-CHHHHhh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 521 EYMENG-SLEDRLY---RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 521 Ey~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
..+++. .+.+++. +....+...|.-.++.++.++.+...||..| .+-+|+.++|||+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 777654 2223322 2344566899999999999999999999999 89999999999999999999987543332
Q ss_pred ccCCCCcccccccccCCccCcccCCccccc-----cCCCCCcccchhHHHHHHHHHhC-CCCcccc-------chhhhhh
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTA-KPAIAIT-------HKVETAI 663 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDv~SlGvil~elltg-~~p~~~~-------~~~~~~~ 663 (802)
...+. .....+|...|.+||... +..-+...|.|.|||++++||.| +.||... ...+..+
T Consensus 167 ~~ng~-------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 167 NANGT-------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred ccCCc-------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 21111 124568999999999765 33456789999999999999887 9999632 3344444
Q ss_pred chhhhHHHhhhhC------CCCChHH-HHHHHHHHHHhhcc--ccCCCCccccchhhHHHHHHHhhhccc
Q 003694 664 DEDNLAEILDAQA------GDWPIKE-TKELAALGLSCAEL--RRKDRPDLKNQVLPVLERLKEVADRAR 724 (802)
Q Consensus 664 ~~~~l~~~ld~~~------~~~p~~~-~~~l~~li~~Cl~~--~p~~RP~~~~~v~~~L~~l~~~~~~~~ 724 (802)
..+.+...-+... ..||... ++.+..|..+|+.. .+.-||+.. ..+..|..+.+....|.
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~-aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK-AWVAALDALRQQLKKCT 308 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH-HHHHHHHHHHHhhhhhh
Confidence 4554444333322 3455543 67889999999985 356899998 67788888877666554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.9e-09 Score=99.42 Aligned_cols=141 Identities=24% Similarity=0.293 Sum_probs=102.5
Q ss_pred ccceecCCCcEEEEEEEECCeEEEEEEEccc--------CccchHHHHHHHHHHHhcCCCce--eeecceecCCCeEEEE
Q 003694 452 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSK--------GNIQNKQFLQELEVLSKIRHPHL--LLLLGACPDHGCLVYE 521 (802)
Q Consensus 452 ~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~--------~~~~~~~~~~Ei~il~~l~Hpni--v~l~g~~~~~~~lV~E 521 (802)
....|-+|+=+.|+++.+.+....||.-..+ ......+..+|..+|.+++--.| ..++-+-....+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4556889999999999999998888853222 12234567889999998853222 2333333455689999
Q ss_pred EccC-CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCC---ceeEEeeeccccc
Q 003694 522 YMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGLSTM 596 (802)
Q Consensus 522 y~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~---~~~kl~DFGla~~ 596 (802)
|++| .++.+++.........+ .....++..|-..+.-||..+ |||+||..+||+|..+ ..+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9986 47888887654433222 233578888999999999999 9999999999999654 3458999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=8.6e-08 Score=101.21 Aligned_cols=137 Identities=15% Similarity=0.029 Sum_probs=96.5
Q ss_pred ecCCCcEEEEEEEECCeEEEEEEEcccCcc-----------chHHHHHHHHHHHhcCCCce--eeecceec-------CC
Q 003694 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNI-----------QNKQFLQELEVLSKIRHPHL--LLLLGACP-------DH 515 (802)
Q Consensus 456 iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~-----------~~~~~~~Ei~il~~l~Hpni--v~l~g~~~-------~~ 515 (802)
+-......|++..+.+..+.||........ ....+.+|...+.++..-+| ...+++.. ..
T Consensus 30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 444444457788889999999976433211 11247789998888742222 22333321 12
Q ss_pred CeEEEEEccCC-CHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecC-------CceeE
Q 003694 516 GCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-------NLVSK 587 (802)
Q Consensus 516 ~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~-------~~~~k 587 (802)
.+||+|++++. +|.+++..... .+.+...+..++.+++..+.-||..| |+|+||++.|||++. ++.+.
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEE
Confidence 48999999976 89988753221 23445566789999999999999999 999999999999975 47889
Q ss_pred Eeeeccccc
Q 003694 588 IGDVGLSTM 596 (802)
Q Consensus 588 l~DFGla~~ 596 (802)
|+||+.+..
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.7e-08 Score=96.35 Aligned_cols=125 Identities=20% Similarity=0.188 Sum_probs=80.1
Q ss_pred EEEEEEE-CCeEEEEEEEcccCcc--------------------------chHHHHHHHHHHHhcCCC--ceeeecceec
Q 003694 463 TVYKGTF-HHTFAAVKVLQSKGNI--------------------------QNKQFLQELEVLSKIRHP--HLLLLLGACP 513 (802)
Q Consensus 463 ~Vy~~~~-~~~~vavK~l~~~~~~--------------------------~~~~~~~Ei~il~~l~Hp--niv~l~g~~~ 513 (802)
.||.|.. ++..+|||+.+..... ......+|...|.++..- ++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899987 5779999987642110 012357899999999754 45555544
Q ss_pred CCCeEEEEEcc--CCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEEcCCCCCCeEecCCceeEEee
Q 003694 514 DHGCLVYEYME--NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF-LHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 590 (802)
Q Consensus 514 ~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~-LH~~~~~~ivHrDLKp~NILl~~~~~~kl~D 590 (802)
...+|||||++ |..+..+.... ++......++.+++..+.. +|..| ||||||.+.|||++.+ .+.|+|
T Consensus 79 ~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 35689999998 65554433221 1112345677788885555 57888 9999999999999988 899999
Q ss_pred eccccccc
Q 003694 591 VGLSTMLN 598 (802)
Q Consensus 591 FGla~~~~ 598 (802)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.4e-07 Score=103.45 Aligned_cols=164 Identities=20% Similarity=0.267 Sum_probs=125.0
Q ss_pred cEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeecceecCC------CeEEEEEccC-CCHHHH
Q 003694 461 YGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------GCLVYEYMEN-GSLEDR 531 (802)
Q Consensus 461 ~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv~l~g~~~~~------~~lV~Ey~~~-gsL~~~ 531 (802)
-.+.|+++. +|..|++|.++.+..........-++.++++.|+|+|.|-.+|... .+|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357788875 5778999999655444443445568899999999999998887521 2799999986 578776
Q ss_pred hhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 532 LYRKN------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 532 l~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
.+... .....++...+.++.|+..||.++|+.| +..+-|.|.+||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 65321 1234677888999999999999999999 88899999999999999999998888776654
Q ss_pred CCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCC
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 650 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~ 650 (802)
+.. +-+. --.+-|.=.||.+++.|.||.
T Consensus 446 d~~--------------------~~le---~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 446 DPT--------------------EPLE---SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CCC--------------------cchh---HHhhhhHHHHHHHHHHHhhcc
Confidence 320 1111 123578889999999999995
|
|
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.9e-07 Score=113.61 Aligned_cols=125 Identities=14% Similarity=0.069 Sum_probs=95.3
Q ss_pred CCCceEEEEecCCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhh
Q 003694 12 SPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLL 91 (802)
Q Consensus 12 ~~~~~IlVaVD~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l 91 (802)
....+|||+|++++.+.+++++|.+.+.+.++. +++|||..+..... . .+ ..+.+
T Consensus 248 ~~~eriLV~v~~~~~~~~lIr~~~rlA~~~~a~-~~~l~V~~~~~~~~------------~--------~~----~~~~l 302 (895)
T PRK10490 248 HTRDAILLCIGHNTGSEKLVRTAARLAARLGSV-WHAVYVETPRLHRL------------P--------EK----KRRAI 302 (895)
T ss_pred CcCCeEEEEECCCcchHHHHHHHHHHHHhcCCC-EEEEEEecCCcCcC------------C--------HH----HHHHH
Confidence 346789999999999999999999988877664 99999985421100 0 00 12223
Q ss_pred HHHHHHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC--CcceEEEEec
Q 003694 92 LPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP--SFCTVYGVEK 169 (802)
Q Consensus 92 ~~~~~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~--a~cpVlvV~~ 169 (802)
.....+|.+.|.+ .+++.++|++++|++||++++|+.||||.++++ ++ +.-||++.++++ ....|+||..
T Consensus 303 ~~~~~lA~~lGa~--~~~~~~~dva~~i~~~A~~~~vt~IViG~s~~~----~~--~~~~s~~~~l~r~~~~idi~iv~~ 374 (895)
T PRK10490 303 LSALRLAQELGAE--TATLSDPAEEKAVLRYAREHNLGKIIIGRRASR----RW--WRRESFADRLARLGPDLDLVIVAL 374 (895)
T ss_pred HHHHHHHHHcCCE--EEEEeCCCHHHHHHHHHHHhCCCEEEECCCCCC----CC--ccCCCHHHHHHHhCCCCCEEEEeC
Confidence 3344577777776 456666899999999999999999999999998 43 446799999998 7799999964
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.8e-07 Score=90.67 Aligned_cols=107 Identities=21% Similarity=0.226 Sum_probs=79.7
Q ss_pred chHHHHHHHHHHHhcCCCc--eeeecceecC------CCeEEEEEccCC-CHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 003694 486 QNKQFLQELEVLSKIRHPH--LLLLLGACPD------HGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASA 556 (802)
Q Consensus 486 ~~~~~~~Ei~il~~l~Hpn--iv~l~g~~~~------~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~a 556 (802)
......+|...+..+..-. ....+++... ..+||+|++++. +|.+++..... ++......++.+++..
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARL 130 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHH
Confidence 3456788888887774222 2333333322 227999999974 79988865332 3445667899999999
Q ss_pred HHHHHhcCCCCeEEcCCCCCCeEecCCc---eeEEeeeccccccc
Q 003694 557 LAFLHNTKPKPIIHRDMKPGNILLDHNL---VSKIGDVGLSTMLN 598 (802)
Q Consensus 557 L~~LH~~~~~~ivHrDLKp~NILl~~~~---~~kl~DFGla~~~~ 598 (802)
+.-||..| |+|+|++|.|||++.++ .+.++||+.++...
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999 99999999999998887 89999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=7.8e-08 Score=109.27 Aligned_cols=150 Identities=23% Similarity=0.326 Sum_probs=103.2
Q ss_pred HHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccccc---ccCCccCcccCCcccccc
Q 003694 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK---NTGPVGTLCYIDPEYQRT 627 (802)
Q Consensus 551 ~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~ 627 (802)
.+++.||.|+|..- .+||++|.|++|.++.++..||+.|+++........+....|. .........|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 35559999999875 4999999999999999999999999998766543221111111 111245678999999998
Q ss_pred CCCCCcccchhHHHHHHHHH-hCCCCccccch-hhhhhchhhhHHHhhhhCCCCChHHHHHHHHHHHHhhccccCCCCcc
Q 003694 628 GLISPKSDVYAYGMVILQLL-TAKPAIAITHK-VETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDL 705 (802)
Q Consensus 628 ~~~~~~sDv~SlGvil~ell-tg~~p~~~~~~-~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~ 705 (802)
...++++|+||||+++|-+. .|++-+..... ........ ..+..........+.++.+=+.+.+..++.-||++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~----~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN----LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc----ccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 88899999999999999999 55554432211 11111110 11111122334567788888889999999999965
Q ss_pred c
Q 003694 706 K 706 (802)
Q Consensus 706 ~ 706 (802)
.
T Consensus 260 ~ 260 (700)
T KOG2137|consen 260 D 260 (700)
T ss_pred h
Confidence 4
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.9e-06 Score=83.26 Aligned_cols=107 Identities=22% Similarity=0.236 Sum_probs=85.3
Q ss_pred HHHHHHHHhcCC-CceeeecceecCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 003694 491 LQELEVLSKIRH-PHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569 (802)
Q Consensus 491 ~~Ei~il~~l~H-pniv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iv 569 (802)
..|.-+|..+.+ +++.+++|+|.. ++|.||...+++......-......+|..|.+|+.+++..+.+|+......+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 358888888875 699999999944 68999998776653210001112368999999999999999999987666799
Q ss_pred EcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 570 HRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 570 HrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
-+|++|+||-++++|.+|++|...+.....
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~~~ 114 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVEDK 114 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchhHH
Confidence 999999999999999999999988766543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=5.2e-06 Score=83.48 Aligned_cols=136 Identities=16% Similarity=0.048 Sum_probs=102.1
Q ss_pred ecCCCcEEEEEEEECCeEEEEEEEccc------CccchHHHHHHHHHHHhcCC--Cceeeecceec---CC----CeEEE
Q 003694 456 IGMGGYGTVYKGTFHHTFAAVKVLQSK------GNIQNKQFLQELEVLSKIRH--PHLLLLLGACP---DH----GCLVY 520 (802)
Q Consensus 456 iG~G~~g~Vy~~~~~~~~vavK~l~~~------~~~~~~~~~~Ei~il~~l~H--pniv~l~g~~~---~~----~~lV~ 520 (802)
-|+||.+.|++-.+.+..+-+|.-... .......|.+|+..|.++.. -.+...+ ++. .. .+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 488999999999988887888865421 13456789999999999852 2244444 332 11 27999
Q ss_pred EEccC-CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCce--eEEeeeccccc
Q 003694 521 EYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV--SKIGDVGLSTM 596 (802)
Q Consensus 521 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~--~kl~DFGla~~ 596 (802)
|-+.| -+|.+++..... .+.+...+..++.+|+..+.-||..| +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 488888754322 24566677889999999999999999 999999999999986666 89999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.5e-06 Score=99.24 Aligned_cols=138 Identities=20% Similarity=0.208 Sum_probs=92.6
Q ss_pred ceecCCCcEEEEEEEEC-CeEEEEEEEcccCccch----------------------------------------HHHHH
Q 003694 454 LRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQN----------------------------------------KQFLQ 492 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~----------------------------------------~~~~~ 492 (802)
..|+.++-|.||+|++. |..||||+.++...... -+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56999999999999998 79999999987532211 01344
Q ss_pred HHHHHHhcC-----CCcee--eecceecCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHH-HHHHHhcC
Q 003694 493 ELEVLSKIR-----HPHLL--LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA-LAFLHNTK 564 (802)
Q Consensus 493 Ei~il~~l~-----Hpniv--~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a-L~~LH~~~ 564 (802)
|...+.+++ .|++. +.+--+.....|+|||++|-.+.+....... .++. ..|+..++.+ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~---k~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDR---KELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCH---HHHHHHHHHHHHHHHHhcC
Confidence 555555542 33321 2222223455899999999999887533222 2442 2334333333 23333345
Q ss_pred CCCeEEcCCCCCCeEecCCceeEEeeecccccccC
Q 003694 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 565 ~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~ 599 (802)
++|+|..|.||+++.+|.+.+.|||+...++.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.9e-06 Score=88.57 Aligned_cols=134 Identities=18% Similarity=0.097 Sum_probs=90.8
Q ss_pred CcccceecCCCcEEEEEEEEC-CeEEEEEEEcccCcc----------------------chHHHHHHHHHHHhcCCC--c
Q 003694 450 FSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI----------------------QNKQFLQELEVLSKIRHP--H 504 (802)
Q Consensus 450 f~~~~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~----------------------~~~~~~~Ei~il~~l~Hp--n 504 (802)
...+.+||-|-=+.||.|... +..+|||.-+..... .+...++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 455678999999999999986 789999976532211 112346799999888533 3
Q ss_pred eeeecceecCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCc
Q 003694 505 LLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 584 (802)
Q Consensus 505 iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~ 584 (802)
+..-+++ +.-++||||++|-.|...-. .....-.|+..|+.-+.-+-..| |||||+++-|||++.+|
T Consensus 173 VP~P~~~--nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW--NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc--ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 4333332 22379999999866544211 11122334444555444444666 99999999999999999
Q ss_pred eeEEeeeccccc
Q 003694 585 VSKIGDVGLSTM 596 (802)
Q Consensus 585 ~~kl~DFGla~~ 596 (802)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999966544
|
|
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.8e-06 Score=98.15 Aligned_cols=128 Identities=19% Similarity=0.094 Sum_probs=101.1
Q ss_pred CCceEEEEecCCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhhH
Q 003694 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLL 92 (802)
Q Consensus 13 ~~~~IlVaVD~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~ 92 (802)
...+|+|+|++|+.|...+++|...+.+..+. ++.|||..+..... .+...+.+.
T Consensus 247 ~~e~ilvcI~~~~~~e~liR~a~RlA~~~~a~-~~av~v~~~~~~~~------------------------~~~~~~~l~ 301 (890)
T COG2205 247 ARERILVCISGSPGSEKLIRRAARLASRLHAK-WTAVYVETPELHRL------------------------SEKEARRLH 301 (890)
T ss_pred ccceEEEEECCCCchHHHHHHHHHHHHHhCCC-eEEEEEeccccccc------------------------cHHHHHHHH
Confidence 45799999999999999999999988777664 99999976432110 012244555
Q ss_pred HHHHHhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCCcccccccC--CcceEEEEecC
Q 003694 93 PFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP--SFCTVYGVEKG 170 (802)
Q Consensus 93 ~~~~~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lgSv~~~v~~--a~cpVlvV~~~ 170 (802)
....+|.+.| .+.+++.++|++++|++||..+++..||||.+.++ ++..++-|+.+.+.+. ....|.+|..+
T Consensus 302 ~~~~Lae~lG--ae~~~l~~~dv~~~i~~ya~~~~~TkiViG~~~~~----rw~~~~~~~l~~~L~~~~~~idv~ii~~~ 375 (890)
T COG2205 302 ENLRLAEELG--AEIVTLYGGDVAKAIARYAREHNATKIVIGRSRRS----RWRRLFKGSLADRLAREAPGIDVHIVALD 375 (890)
T ss_pred HHHHHHHHhC--CeEEEEeCCcHHHHHHHHHHHcCCeeEEeCCCcch----HHHHHhcccHHHHHHhcCCCceEEEeeCC
Confidence 6666777655 46677777999999999999999999999999998 7777777899999888 78888888765
Q ss_pred c
Q 003694 171 K 171 (802)
Q Consensus 171 ~ 171 (802)
.
T Consensus 376 ~ 376 (890)
T COG2205 376 A 376 (890)
T ss_pred C
Confidence 5
|
|
| >KOG4642 consensus Chaperone-dependent E3 ubiquitin protein ligase (contains TPR repeats) [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.27 E-value=6.8e-07 Score=88.94 Aligned_cols=71 Identities=35% Similarity=0.559 Sum_probs=66.4
Q ss_pred CCCCCCCccCccchhcccCCcccCCCcccchHHHHHHHhh-CCCCCCCCCCCCCCCCCCcHHHHHHHHHHhh
Q 003694 731 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKS 801 (802)
Q Consensus 731 ~~~~P~~f~cPi~~evm~dp~iaadg~tye~~~I~~wl~~-~~~sP~T~~~l~~~~l~pn~~l~~~~~~w~~ 801 (802)
...+|+...|-|+.++|++|+|...|.||++..|...|+. ++..|+|+.+|..-.++||++|+.+|..++.
T Consensus 205 ~rEvpd~lcgkIt~el~~~pvi~psgIty~ra~I~Ehl~rvghfdpvtr~~Lte~q~ipN~alkevIa~fl~ 276 (284)
T KOG4642|consen 205 KREVPDYLCGKITLELMREPVITPSGITYDRADIEEHLQRVGHFDPVTRWPLTEYQLIPNLALKEVIAAFLK 276 (284)
T ss_pred cccccchhhhhhhHHhhcCCccCccccchhHHHHHHHHHHhccCCchhcccCCHHhhccchHHHHHHHHHHH
Confidence 3577888899999999999999999999999999999998 8999999999999999999999999987764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.26 E-value=9.3e-06 Score=83.94 Aligned_cols=138 Identities=16% Similarity=0.176 Sum_probs=79.2
Q ss_pred ceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCc--eeeecceecC--CCeEEEEEccCCC-H
Q 003694 454 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH--LLLLLGACPD--HGCLVYEYMENGS-L 528 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--iv~l~g~~~~--~~~lV~Ey~~~gs-L 528 (802)
..||+|..+.||+.. +..+++|...... ......+|.+++..+..-. +.+.++++.+ ...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~~--~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTHK--TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEec--CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 468999999999842 4456788776533 3455788999998875322 3444555433 2368999999863 2
Q ss_pred HHHh--------------hh------cCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCCCeEEcCCCC
Q 003694 529 EDRL--------------YR------KNNTPPIPWFERYR-IAW----------EVAS-ALAFLHNT-KPKPIIHRDMKP 575 (802)
Q Consensus 529 ~~~l--------------~~------~~~~~~l~~~~~~~-i~~----------qia~-aL~~LH~~-~~~~ivHrDLKp 575 (802)
...+ .. .-.....+...... +.. .+.. ...+|... .+..++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1111 00 00001111111100 000 0111 12222211 123579999999
Q ss_pred CCeEecCCceeEEeeeccccc
Q 003694 576 GNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 576 ~NILl~~~~~~kl~DFGla~~ 596 (802)
.||+++.++ +.|+||+.+..
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CcEEEcCCC-cEEEechhcCc
Confidence 999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=5.7e-06 Score=83.49 Aligned_cols=136 Identities=21% Similarity=0.145 Sum_probs=93.3
Q ss_pred hhcCCcccceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHH---------HHHHHHHHhcCC---Cceeeeccee-
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF---------LQELEVLSKIRH---PHLLLLLGAC- 512 (802)
Q Consensus 446 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~---------~~Ei~il~~l~H---pniv~l~g~~- 512 (802)
..++|...+.+-......|.+-..++..+.+|...+......+.| .+.+..+.+++. -....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 345677777788888888999999999999999877654433332 234444444432 1222222221
Q ss_pred ------cCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCcee
Q 003694 513 ------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 586 (802)
Q Consensus 513 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~ 586 (802)
....+|+|||++|..|.+... ++. .++..|..++.-||..| ++|+|..|.|+++..++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 122358999999988876532 221 24566778899999999 99999999999999665 8
Q ss_pred EEeeeccccc
Q 003694 587 KIGDVGLSTM 596 (802)
Q Consensus 587 kl~DFGla~~ 596 (802)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 8999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.23 E-value=7.4e-06 Score=84.43 Aligned_cols=141 Identities=22% Similarity=0.227 Sum_probs=84.4
Q ss_pred ceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCC--ceeeecceecC---C--CeEEEEEccCC
Q 003694 454 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP--HLLLLLGACPD---H--GCLVYEYMENG 526 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hp--niv~l~g~~~~---~--~~lV~Ey~~~g 526 (802)
..|+.|..+.||+....+..+++|+.... .....+.+|..++..+... .+..++.++.. . .+++|+|++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 46899999999999998889999997654 4456778899998887522 34555554321 1 37899999998
Q ss_pred CHHH----------------Hhh---hc-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHhc-
Q 003694 527 SLED----------------RLY---RK-NNTPPIPWFER---------YRI------------AWEVAS-ALAFLHNT- 563 (802)
Q Consensus 527 sL~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~qia~-aL~~LH~~- 563 (802)
.+.. .+. .. ....++.+... ... ...+.. .+..++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8777 111 11 11111222110 000 011222 33344432
Q ss_pred ---CCCCeEEcCCCCCCeEec-CCceeEEeeeccccc
Q 003694 564 ---KPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTM 596 (802)
Q Consensus 564 ---~~~~ivHrDLKp~NILl~-~~~~~kl~DFGla~~ 596 (802)
.+..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 345699999999999999 667668999987754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.2e-05 Score=91.72 Aligned_cols=139 Identities=19% Similarity=0.160 Sum_probs=92.4
Q ss_pred ceecCCCcEEEEEEEEC-CeEEEEEEEcccCccch-------------------------------------HHHHHHHH
Q 003694 454 LRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQN-------------------------------------KQFLQELE 495 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~-------------------------------------~~~~~Ei~ 495 (802)
..||.-+.|.||+|+++ |..||||+-++...... -+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 46899999999999986 56899999876532210 12445554
Q ss_pred HHHhc----CCCc------eeeecceecCCCeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003694 496 VLSKI----RHPH------LLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565 (802)
Q Consensus 496 il~~l----~Hpn------iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 565 (802)
-..++ .|-+ |.++|-.+.....|+||||+|..+.|.-.-...+ ++...+..-+.++..-.-+ ..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~l~~~~~~qIf--~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILNKLVEAYLEQIF--KTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHHHHHHHHHHHHH--hcC-
Confidence 44433 3444 4555555666779999999999887764322221 4444433333333322222 334
Q ss_pred CCeEEcCCCCCCeEec----CCceeEEeeecccccccC
Q 003694 566 KPIIHRDMKPGNILLD----HNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 566 ~~ivHrDLKp~NILl~----~~~~~kl~DFGla~~~~~ 599 (802)
++|+|=.|.|||+. .++.+.+-|||+...+..
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999998 368899999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.6e-05 Score=80.54 Aligned_cols=138 Identities=17% Similarity=0.078 Sum_probs=82.7
Q ss_pred ecCCCc-EEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeecceecC--CCeEEEEEccCCCHHHH
Q 003694 456 IGMGGY-GTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPD--HGCLVYEYMENGSLEDR 531 (802)
Q Consensus 456 iG~G~~-g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~--~~~lV~Ey~~~gsL~~~ 531 (802)
|-.|.+ ..||+....+..+.||+..... ...+.+|+.++..+. +--+.++++++.. ..++||||++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444545 8899998777778888875543 335678999988874 3334566666654 35899999998877643
Q ss_pred h-------------------hhcCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----cCC
Q 003694 532 L-------------------YRKNN-TPPIPW--FERYRIAW--------------------EVASALAFLHN----TKP 565 (802)
Q Consensus 532 l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------qia~aL~~LH~----~~~ 565 (802)
. +.... ..++.. ........ .+...+..|-. ..+
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 11000 001110 00110000 01111222211 112
Q ss_pred CCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 566 ~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 4599999999999999988889999987754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.95 E-value=5.6e-05 Score=78.69 Aligned_cols=138 Identities=20% Similarity=0.226 Sum_probs=75.7
Q ss_pred ceecCCCcEE-EEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCC---ceeeecceecC-----CCeEEEEEcc
Q 003694 454 LRIGMGGYGT-VYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP---HLLLLLGACPD-----HGCLVYEYME 524 (802)
Q Consensus 454 ~~iG~G~~g~-Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hp---niv~l~g~~~~-----~~~lV~Ey~~ 524 (802)
..|+.||... ||+. +..+.+|+.+.. .....+.+|..+|..+... .+...++.+.. ..+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 4578777774 9975 234667765432 2345788999999877421 23333433322 2378999999
Q ss_pred CCCHHHH------------------hhhcCCCC-CC-------------CHHHHH--HHH-------HHHHHHH-H-HHH
Q 003694 525 NGSLEDR------------------LYRKNNTP-PI-------------PWFERY--RIA-------WEVASAL-A-FLH 561 (802)
Q Consensus 525 ~gsL~~~------------------l~~~~~~~-~l-------------~~~~~~--~i~-------~qia~aL-~-~LH 561 (802)
|.++.+. |+...... +. .|.... .+. .+....+ . +++
T Consensus 78 G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 157 (235)
T cd05155 78 GETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAALR 157 (235)
T ss_pred CCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHhc
Confidence 8776422 11110000 00 011110 000 0111111 1 111
Q ss_pred h--cCCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 562 N--TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 562 ~--~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
. ..+..++|+|+.|.|||++.++..-|+||+.+..
T Consensus 158 ~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 158 APWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 1 1334589999999999999877778999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=75.01 Aligned_cols=151 Identities=19% Similarity=0.192 Sum_probs=92.2
Q ss_pred CCHHHHHHhhcCCcccc---eecCCCcEEEEEEEE-CCeEEEEEEEcccCccch---------HH---------------
Q 003694 438 LTWEEIESATLSFSENL---RIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQN---------KQ--------------- 489 (802)
Q Consensus 438 ~~~~ei~~~~~~f~~~~---~iG~G~~g~Vy~~~~-~~~~vavK~l~~~~~~~~---------~~--------------- 489 (802)
.|++.+........... .|..|--+.||+|.. ++..+|||+......... .+
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34444444444433333 466788889999876 478999999875432111 11
Q ss_pred HHHHHHHHHhcC--CCceeeecceecCCCeEEEEEccCCCH-HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCC
Q 003694 490 FLQELEVLSKIR--HPHLLLLLGACPDHGCLVYEYMENGSL-EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKP 565 (802)
Q Consensus 490 ~~~Ei~il~~l~--Hpniv~l~g~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~ 565 (802)
...|+.-|.++. +-.+.+-+++ ....|||||+....+ .-.|. ..++.......+..+++..+.-|-. .+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~--~~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~- 187 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF--RNNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEAG- 187 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee--cCCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhcC-
Confidence 134666666553 2122222222 234799999954311 01111 1112222456677788888887777 56
Q ss_pred CCeEEcCCCCCCeEecCCceeEEeeeccccccc
Q 003694 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 566 ~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~ 598 (802)
+||+||+.-|||+. ++.+.|+|||-|....
T Consensus 188 --LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 --LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999887654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00012 Score=90.19 Aligned_cols=147 Identities=19% Similarity=0.223 Sum_probs=92.4
Q ss_pred cceecCCCcEEEEEEEECC----eEEEEEEEcccCc-cchHHHHHHHHHHHhcC-CCce--eeecceecCC-----CeEE
Q 003694 453 NLRIGMGGYGTVYKGTFHH----TFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHL--LLLLGACPDH-----GCLV 519 (802)
Q Consensus 453 ~~~iG~G~~g~Vy~~~~~~----~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~-Hpni--v~l~g~~~~~-----~~lV 519 (802)
...|+.|.++.+|+....+ ..+++|+...... .....+.+|+.+|+.+. |+++ .+.+++|.+. .|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4568999999999987754 3567776544322 23356889999999995 6665 7788888653 4899
Q ss_pred EEEccCCCHHH--------------------H---hhhcCC--------CCCCCHH--HHHHHH---------------H
Q 003694 520 YEYMENGSLED--------------------R---LYRKNN--------TPPIPWF--ERYRIA---------------W 551 (802)
Q Consensus 520 ~Ey~~~gsL~~--------------------~---l~~~~~--------~~~l~~~--~~~~i~---------------~ 551 (802)
|||++|..+.+ . |+.... ..+..+. .+..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 1 111110 0111111 111111 1
Q ss_pred HHHHHHHHHHhcCCC--------CeEEcCCCCCCeEecC--CceeEEeeecccccccC
Q 003694 552 EVASALAFLHNTKPK--------PIIHRDMKPGNILLDH--NLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 552 qia~aL~~LH~~~~~--------~ivHrDLKp~NILl~~--~~~~kl~DFGla~~~~~ 599 (802)
.+...+.+|..+-|. .+||+|++|.|||++. +..+-|.||+++..-++
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 233346677554442 4999999999999975 23467999999876543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.0001 Score=71.29 Aligned_cols=129 Identities=16% Similarity=0.145 Sum_probs=89.7
Q ss_pred ccceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCcee-eecceecCCCeEEEEEccCCCHHH
Q 003694 452 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL-LLLGACPDHGCLVYEYMENGSLED 530 (802)
Q Consensus 452 ~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpniv-~l~g~~~~~~~lV~Ey~~~gsL~~ 530 (802)
....||+|++|.||+|.+.+..+|+|+-..++ ....+..|.++|..+.--++- ++|.+ +..++.|||+.|-.|.+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y--g~~~i~me~i~G~~L~~ 101 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY--GEDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe--chhhhhhhhhcCcchhh
Confidence 34569999999999999999999999876654 456788999999988755543 33333 22346699999888877
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC-CCCeEecCCceeEEeeecccccc
Q 003694 531 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK-PGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 531 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLK-p~NILl~~~~~~kl~DFGla~~~ 597 (802)
.-... . .+-...++..-.-|-..| |-|+.|. |..++|-.++.+.|+||..|+..
T Consensus 102 ~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 102 LEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 54211 1 122334455544455556 8888886 55555555559999999988743
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.78 E-value=9.9e-05 Score=77.87 Aligned_cols=139 Identities=12% Similarity=0.039 Sum_probs=81.1
Q ss_pred eecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCce-eeecceecCCCeEEEEEccCCCHHHH--
Q 003694 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHL-LLLLGACPDHGCLVYEYMENGSLEDR-- 531 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpni-v~l~g~~~~~~~lV~Ey~~~gsL~~~-- 531 (802)
.+..|-.+.+|+...++..+.+|+.........-...+|..+|+.+..-.+ .++++.+ ..++||||++|..+...
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~~~v~e~i~G~~~~~~~~ 80 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EHWLLVEWLEGEVITLDQF 80 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CCEEEEEeccCcccccccc
Confidence 356788889999988887888887554322211235779999988853222 3344443 35799999998765321
Q ss_pred ---------------hhhcC-CCCCCCHHHHH-HHHHH---------HHHHHHHHHhc-----CCCCeEEcCCCCCCeEe
Q 003694 532 ---------------LYRKN-NTPPIPWFERY-RIAWE---------VASALAFLHNT-----KPKPIIHRDMKPGNILL 580 (802)
Q Consensus 532 ---------------l~~~~-~~~~l~~~~~~-~i~~q---------ia~aL~~LH~~-----~~~~ivHrDLKp~NILl 580 (802)
|+... ...+++....+ ....+ +...+..+-.. .+..++|+|+.|.|||+
T Consensus 81 ~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~ 160 (256)
T TIGR02721 81 VALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVV 160 (256)
T ss_pred cCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEE
Confidence 11111 11122222211 11111 11112222111 12358999999999999
Q ss_pred cCCceeEEeeeccccc
Q 003694 581 DHNLVSKIGDVGLSTM 596 (802)
Q Consensus 581 ~~~~~~kl~DFGla~~ 596 (802)
+.++ +.|+||+.+..
T Consensus 161 ~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 161 TPQG-LKLIDWEYASD 175 (256)
T ss_pred eCCC-CEEEeccccCc
Confidence 9887 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.75 E-value=6.2e-06 Score=92.99 Aligned_cols=178 Identities=17% Similarity=0.161 Sum_probs=124.2
Q ss_pred eecCCCcEEEEEEEECCe-EEEEEEEcccCccchHHHHHHHHHHHhcCCCc-eeeecceecCCC--eEEEEEccCC-CHH
Q 003694 455 RIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH-LLLLLGACPDHG--CLVYEYMENG-SLE 529 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~~-~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-iv~l~g~~~~~~--~lV~Ey~~~g-sL~ 529 (802)
-+++|+++.+||.+...+ ....+++.. .....-++++|.+++||| .+..++-+.... .++++|+.+| +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 478999999999865432 222333322 234556899999999999 666666654333 6889998877 222
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCccccccc
Q 003694 530 DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 609 (802)
Q Consensus 530 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 609 (802)
....... ..+...+...+.+.-..+|++||+.. =+|+| |||... +..|..|||....+.... .
T Consensus 324 ~~~~~se--~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-------~ 386 (829)
T KOG0576|consen 324 LEMTVSE--IALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-------K 386 (829)
T ss_pred ccCChhh--Hhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-------c
Confidence 1111000 01222344456677788999999864 48998 777765 678999999988776542 2
Q ss_pred ccCCccCcccCCccccccCCCCCcccchhHHHHHHHHHhCCCCcc
Q 003694 610 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIA 654 (802)
Q Consensus 610 ~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~ 654 (802)
.....+|+.+++||+...+.+....|+|++|+--.+|--|-+|-.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 356689999999999999999999999999987778877777654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00038 Score=75.10 Aligned_cols=73 Identities=15% Similarity=0.031 Sum_probs=53.5
Q ss_pred ceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCC---CceeeecceecC-----CCeEEEEEccC
Q 003694 454 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH---PHLLLLLGACPD-----HGCLVYEYMEN 525 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H---pniv~l~g~~~~-----~~~lV~Ey~~~ 525 (802)
..||.|..+.||+....+..+.+|+.+.. .....|..|...|+.|.- -.+.+.+++|.+ ..+||||+++|
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 45999999999998765556677775431 133578899999988852 356777877643 34999999998
Q ss_pred CCH
Q 003694 526 GSL 528 (802)
Q Consensus 526 gsL 528 (802)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00059 Score=76.01 Aligned_cols=74 Identities=15% Similarity=0.029 Sum_probs=55.7
Q ss_pred ceecCCCcEEEEEEEECCe--EEEEEEEcccC-------ccchHHHHHHHHHHHhcC---CCceeeecceecCCCeEEEE
Q 003694 454 LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKG-------NIQNKQFLQELEVLSKIR---HPHLLLLLGACPDHGCLVYE 521 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~~--~vavK~l~~~~-------~~~~~~~~~Ei~il~~l~---Hpniv~l~g~~~~~~~lV~E 521 (802)
..||.|.+..||++...+. .+.||.-.+.. ....+++..|.+.|..+. ..++.+++.+..+..++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 4689999999999988653 79999743211 234566788888888763 35678888888877899999
Q ss_pred EccCCC
Q 003694 522 YMENGS 527 (802)
Q Consensus 522 y~~~gs 527 (802)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998744
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00032 Score=72.78 Aligned_cols=140 Identities=19% Similarity=0.236 Sum_probs=81.1
Q ss_pred ceecCCCcEEEEEEEEC---CeEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeecceecCCCeEEEEEccCCCHH
Q 003694 454 LRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHGCLVYEYMENGSLE 529 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~---~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-Hpniv~l~g~~~~~~~lV~Ey~~~gsL~ 529 (802)
..|..|-...+|+.... +..|.+|+........ -...+|+.++..+. +.-..++++.+. ..++|||++|.++.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l~ 80 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTLE 80 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcCC
Confidence 45788888999998876 4678888765432221 22347888888884 323344555443 35899999987653
Q ss_pred HH-----------------hhhcCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH--
Q 003694 530 DR-----------------LYRKNNT--------PPIP-WFERYRIAW----------------------EVASALAF-- 559 (802)
Q Consensus 530 ~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------qia~aL~~-- 559 (802)
.. |+..... .... |..+..+.. .+...+..
T Consensus 81 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 160 (235)
T cd05157 81 PEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLK 160 (235)
T ss_pred HHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHH
Confidence 21 1111111 1111 111111111 11111111
Q ss_pred --HHhc-CCCCeEEcCCCCCCeEecC-CceeEEeeeccccc
Q 003694 560 --LHNT-KPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTM 596 (802)
Q Consensus 560 --LH~~-~~~~ivHrDLKp~NILl~~-~~~~kl~DFGla~~ 596 (802)
+-.. .+..++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 161 ~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 161 ELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2211 2345999999999999998 57899999987754
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=97.66 E-value=9.5e-05 Score=63.88 Aligned_cols=83 Identities=12% Similarity=0.067 Sum_probs=66.1
Q ss_pred EEEEecCCccchhhHHHHhhhcCCCCCceEEEEEecCCCCCCCCCCCCccccCccchHHHHHHHHHHHHHHHHhhHHHHH
Q 003694 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRN 96 (802)
Q Consensus 17 IlVaVD~S~~S~~Al~wA~~~~~~~~~~~l~LlHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 96 (802)
|+|+++|+..|..++.||.+.. .. ..+++.+|+.
T Consensus 1 ilv~~sgg~dS~~~l~~~~~~~-~~-~~~~~~~~~~-------------------------------------------- 34 (86)
T cd01984 1 ILVALSGGLDSSVLLHLAKRLK-SG-GPEVVALVVV-------------------------------------------- 34 (86)
T ss_pred CEEEeeCCHHHHHHHHHHHHHH-hc-CCCEEEEEeH--------------------------------------------
Confidence 6899999999999999998854 23 3357777763
Q ss_pred HhhccCceeEEEEEecCcHHHHHHHHHHhcCCCEEEEcccCCCcceeecccCCCC-cccccccC-CcceEEE
Q 003694 97 MCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLS-SRISICVP-SFCTVYG 166 (802)
Q Consensus 97 ~~~~~~v~~~~~v~~~g~~~~~I~~~a~~~~idlIVmGs~g~~~~~~~~~~~~lg-Sv~~~v~~-a~cpVlv 166 (802)
-....+.+++++.++++||+|+++.. .....+.| +++.+++. +.|||+.
T Consensus 35 -----------------~~~~~~~~~a~~~~~~~Iv~G~~~~d----~~~~~~~~~~~~~~~~~~~~~~vl~ 85 (86)
T cd01984 35 -----------------AFVRILKRLAAEEGADVIILGHNADD----VAGRRLGASANVLVVIKGAGIPVLT 85 (86)
T ss_pred -----------------HHHHHHHHHHHHcCCCEEEEcCCchh----hhhhccCchhhhhhcccccCCceeC
Confidence 35556778888899999999999988 55556666 88888888 9999974
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00079 Score=67.81 Aligned_cols=127 Identities=22% Similarity=0.279 Sum_probs=85.8
Q ss_pred ccceecCCCcEEEEEEEECCeEEEEEEEcccC----------------ccchHHHHHHHHHHHhcC------CCceeeec
Q 003694 452 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG----------------NIQNKQFLQELEVLSKIR------HPHLLLLL 509 (802)
Q Consensus 452 ~~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~----------------~~~~~~~~~Ei~il~~l~------Hpniv~l~ 509 (802)
....||+|+.-.||.-=. +....||+..... .....++.+|+.-...+. +.+|.+++
T Consensus 5 ~~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CCcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 345799999999997432 3456788887665 122355677776665555 88999999
Q ss_pred ceecCCC--eEEEEEccC------CCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEec
Q 003694 510 GACPDHG--CLVYEYMEN------GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 581 (802)
Q Consensus 510 g~~~~~~--~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl~ 581 (802)
|+..... .+|+|.+.+ -+|.+++.... ++. ...+. +-.-..||-.++ |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 9986654 688888643 36777774332 433 33333 333445666666 99999999999995
Q ss_pred CC---c-eeEEee
Q 003694 582 HN---L-VSKIGD 590 (802)
Q Consensus 582 ~~---~-~~kl~D 590 (802)
.+ . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 43 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00063 Score=68.11 Aligned_cols=123 Identities=21% Similarity=0.262 Sum_probs=89.5
Q ss_pred cCCcccceecCCCc-EEEEEEEECCeEEEEEEEcc---cCc------------------cchHHHHHHHHHHHhcC---C
Q 003694 448 LSFSENLRIGMGGY-GTVYKGTFHHTFAAVKVLQS---KGN------------------IQNKQFLQELEVLSKIR---H 502 (802)
Q Consensus 448 ~~f~~~~~iG~G~~-g~Vy~~~~~~~~vavK~l~~---~~~------------------~~~~~~~~Ei~il~~l~---H 502 (802)
.+++....||.|.- |.||++..++..+|+|++.. ... ....-|..|.....+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888889999999 99999999999999999432 110 01124778888877774 5
Q ss_pred Cce--eeecceec-C---------------C----CeEEEEEccCCCHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 003694 503 PHL--LLLLGACP-D---------------H----GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL 560 (802)
Q Consensus 503 pni--v~l~g~~~-~---------------~----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L 560 (802)
.++ |+.+||.. + . ..||.||++... .+. ..-+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHHH
Confidence 566 89999861 0 0 147888876543 111 23355778888999
Q ss_pred HhcCCCCeEEcCCCCCCeEecCCceeEEeeeccc
Q 003694 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594 (802)
Q Consensus 561 H~~~~~~ivHrDLKp~NILl~~~~~~kl~DFGla 594 (802)
|..| |+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9999 999999999975 3489999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0013 Score=71.73 Aligned_cols=158 Identities=16% Similarity=0.229 Sum_probs=85.1
Q ss_pred ccCCHHHHHHhhcCCcc-----cceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcC-----CCce
Q 003694 436 RNLTWEEIESATLSFSE-----NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----HPHL 505 (802)
Q Consensus 436 ~~~~~~ei~~~~~~f~~-----~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-----Hpni 505 (802)
..++..++...-..|.. ...|+.|....+|+....+..+.+|+.. . .....+..|+.++..|. -|.+
T Consensus 5 t~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 5 TDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred ccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 34445555444344433 2346677778999988776688999876 2 12233444555555552 3333
Q ss_pred eee-----cceecCCCeEEEEEccCCCHH-----------HH---hhhcCC--------CCCCCHH-HHHH---------
Q 003694 506 LLL-----LGACPDHGCLVYEYMENGSLE-----------DR---LYRKNN--------TPPIPWF-ERYR--------- 548 (802)
Q Consensus 506 v~l-----~g~~~~~~~lV~Ey~~~gsL~-----------~~---l~~~~~--------~~~l~~~-~~~~--------- 548 (802)
+.- +....+..+++++|++|..+. .. |+.... ...+.|. ....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 321 111223347899999986431 11 111111 0112121 1111
Q ss_pred ---HH-HHHHHHHHHHHhc----CCCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 549 ---IA-WEVASALAFLHNT----KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 549 ---i~-~qia~aL~~LH~~----~~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
.+ ..+...+..+... -|.++||+|+.|.|||++.+...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 11 1111122333211 345799999999999999777778999998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0014 Score=70.83 Aligned_cols=139 Identities=22% Similarity=0.228 Sum_probs=82.4
Q ss_pred eecCCCcEEEEEEEECC--------eEEEEEEEcccCccchHHHHHHHHHHHhcCCCc-eeeecceecCCCeEEEEEccC
Q 003694 455 RIGMGGYGTVYKGTFHH--------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH-LLLLLGACPDHGCLVYEYMEN 525 (802)
Q Consensus 455 ~iG~G~~g~Vy~~~~~~--------~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-iv~l~g~~~~~~~lV~Ey~~~ 525 (802)
.|..|-...+|+....+ ..+++|+...... ......+|..++..+.... ..++++++. ..+||||++|
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~~~v~e~i~G 81 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP--NGRIEEFIPS 81 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC--CCchhheeCC
Confidence 46667778999988653 6788898665432 2234567888888875222 335555554 3468999998
Q ss_pred CCHHHH-----------------hhhcCCCC------CCC--HHHHHH--------------------------HHHHHH
Q 003694 526 GSLEDR-----------------LYRKNNTP------PIP--WFERYR--------------------------IAWEVA 554 (802)
Q Consensus 526 gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~qia 554 (802)
..+... |+...... ..+ |..... +...+.
T Consensus 82 ~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (302)
T cd05156 82 RTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDEA 161 (302)
T ss_pred CcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHHH
Confidence 766431 11111110 111 111101 111222
Q ss_pred HHHHHHHh------cCCCCeEEcCCCCCCeEecCC----ceeEEeeeccccc
Q 003694 555 SALAFLHN------TKPKPIIHRDMKPGNILLDHN----LVSKIGDVGLSTM 596 (802)
Q Consensus 555 ~aL~~LH~------~~~~~ivHrDLKp~NILl~~~----~~~kl~DFGla~~ 596 (802)
..+.+|-. ..+..++|+|+.|.|||++.+ +.+.|+||..|..
T Consensus 162 ~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 162 KYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 23344432 234569999999999999874 8899999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0026 Score=68.49 Aligned_cols=140 Identities=17% Similarity=0.195 Sum_probs=85.4
Q ss_pred ceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCC--ceeeeccee--------cCCCeEEEEEc
Q 003694 454 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP--HLLLLLGAC--------PDHGCLVYEYM 523 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hp--niv~l~g~~--------~~~~~lV~Ey~ 523 (802)
..|..|....+|+...++..+++|+... .....+..|+.++..+.+- .+.+.+... .+..++||+|+
T Consensus 20 ~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 4577788889999887777889998764 2345567788888877432 234443321 22337899999
Q ss_pred cCCCHHH--------------HhhhcCC--C------CCCCHHHHHH----------HHHHHHHHHHHHHh----cCCCC
Q 003694 524 ENGSLED--------------RLYRKNN--T------PPIPWFERYR----------IAWEVASALAFLHN----TKPKP 567 (802)
Q Consensus 524 ~~gsL~~--------------~l~~~~~--~------~~l~~~~~~~----------i~~qia~aL~~LH~----~~~~~ 567 (802)
+|..+.. .|+.... . ....|..... ....+..++.++.. ..+..
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9876531 1111100 0 1112222110 11123334455543 22456
Q ss_pred eEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 568 ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 99999999999999988889999987754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0064 Score=65.97 Aligned_cols=141 Identities=15% Similarity=0.185 Sum_probs=81.4
Q ss_pred ceecCCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCC--ceeeeccee--------cCCCeEEEEEc
Q 003694 454 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP--HLLLLLGAC--------PDHGCLVYEYM 523 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hp--niv~l~g~~--------~~~~~lV~Ey~ 523 (802)
..++.|....+|+...++..+.+|+..... .......|++++..|... .+.+.+... .+..+++|+|+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 346677778999987766678888765432 233455677777766321 133333322 12237899999
Q ss_pred cCCCHH-----------H---HhhhcCCC--C-------CCCHHHHHH------------HHHHHHHHHHHHHh----cC
Q 003694 524 ENGSLE-----------D---RLYRKNNT--P-------PIPWFERYR------------IAWEVASALAFLHN----TK 564 (802)
Q Consensus 524 ~~gsL~-----------~---~l~~~~~~--~-------~l~~~~~~~------------i~~qia~aL~~LH~----~~ 564 (802)
+|..+. . .++..... . .-.|..... ....+...+.+|.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 985432 0 11111110 0 011211110 01123344555543 23
Q ss_pred CCCeEEcCCCCCCeEecCCceeEEeeeccccc
Q 003694 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 565 ~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~ 596 (802)
+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 46799999999999999998889999997753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.19 E-value=8.9e-05 Score=90.75 Aligned_cols=159 Identities=14% Similarity=0.080 Sum_probs=115.6
Q ss_pred HHHHHHHHHhcCCCceeeecceecCC----CeEEEEEccCCCHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 003694 490 FLQELEVLSKIRHPHLLLLLGACPDH----GCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTK 564 (802)
Q Consensus 490 ~~~Ei~il~~l~Hpniv~l~g~~~~~----~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~ 564 (802)
...|.+-++...|++++..+.-.++. .+.+++|+.+|.+.+.|.+.. ..+++...-+.....+...+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 34455556667899988766554432 278999999999999887643 2333433333333333355555555432
Q ss_pred --CCCeEEcCCCCCCeEecCCceeEEeeecccccccCCCCcccccccccCCccCcccCCccccccCCCCCcccchhHHHH
Q 003694 565 --PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMV 642 (802)
Q Consensus 565 --~~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvi 642 (802)
..--+|++||+.|.+|..+..+|++++|+.+......++. ....+++.|+.|+....-.++.++|+|..|+-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~------Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFF------GLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhhh------hhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 2457999999999999999999999999999555433322 23478889999999988889999999999999
Q ss_pred HHHHHhCCCCcc
Q 003694 643 ILQLLTAKPAIA 654 (802)
Q Consensus 643 l~elltg~~p~~ 654 (802)
+|.+--|.++|-
T Consensus 1430 ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHhcccHHHH
Confidence 999999988873
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.003 Score=70.23 Aligned_cols=73 Identities=14% Similarity=0.052 Sum_probs=53.8
Q ss_pred cceecCCCcEEEEEEEECCeEEEEEEEcccCc-------cchHHHHHHHHHHHhcC---CCceeeecceecCCCeEEEEE
Q 003694 453 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGN-------IQNKQFLQELEVLSKIR---HPHLLLLLGACPDHGCLVYEY 522 (802)
Q Consensus 453 ~~~iG~G~~g~Vy~~~~~~~~vavK~l~~~~~-------~~~~~~~~Ei~il~~l~---Hpniv~l~g~~~~~~~lV~Ey 522 (802)
...||.|....||+....+..+.||.-..... ....+-..|.+.|..+. ..++.+++.+|.+..+++|||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 34689999999999988777788987542111 23334445677776654 357889999999999999999
Q ss_pred ccC
Q 003694 523 MEN 525 (802)
Q Consensus 523 ~~~ 525 (802)
+++
T Consensus 117 L~~ 119 (418)
T PLN02756 117 LEP 119 (418)
T ss_pred cCC
Confidence 976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0049 Score=67.96 Aligned_cols=140 Identities=15% Similarity=0.184 Sum_probs=81.2
Q ss_pred ceecCCCcEEEEEEEEC------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCce-eeecceecCCCeEEEEEccCC
Q 003694 454 LRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHL-LLLLGACPDHGCLVYEYMENG 526 (802)
Q Consensus 454 ~~iG~G~~g~Vy~~~~~------~~~vavK~l~~~~~~~~~~~~~Ei~il~~l~Hpni-v~l~g~~~~~~~lV~Ey~~~g 526 (802)
..|-.|-...+|+.... +..+.+|+.........+ -.+|..++..+..-++ .++++.+..+ .|++|+++.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g~ 118 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHAR 118 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCCC
Confidence 34656888999998753 247888887654433322 2678888888753222 3455666443 789999876
Q ss_pred CHHHH-----------------hhhcC--CCC-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-cC
Q 003694 527 SLEDR-----------------LYRKN--NTP-PIPWFERYRIAWEV-----------------ASALAFL----HN-TK 564 (802)
Q Consensus 527 sL~~~-----------------l~~~~--~~~-~l~~~~~~~i~~qi-----------------a~aL~~L----H~-~~ 564 (802)
+|... ++... ... +..|....++..++ ...+..| .. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 66421 11111 001 11222222222111 1112222 22 22
Q ss_pred CCCeEEcCCCCCCeEecC-CceeEEeeeccccc
Q 003694 565 PKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTM 596 (802)
Q Consensus 565 ~~~ivHrDLKp~NILl~~-~~~~kl~DFGla~~ 596 (802)
+..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 345899999999999986 57899999987764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0095 Score=64.26 Aligned_cols=141 Identities=18% Similarity=0.247 Sum_probs=79.7
Q ss_pred CCcEEEEEEEECCeEEEEEEEcc--cCccchHHHHHHHHHHHhcCC--CceeeecceecCCC----eEEEEEccCCCHHH
Q 003694 459 GGYGTVYKGTFHHTFAAVKVLQS--KGNIQNKQFLQELEVLSKIRH--PHLLLLLGACPDHG----CLVYEYMENGSLED 530 (802)
Q Consensus 459 G~~g~Vy~~~~~~~~vavK~l~~--~~~~~~~~~~~Ei~il~~l~H--pniv~l~g~~~~~~----~lV~Ey~~~gsL~~ 530 (802)
|-.-.+|.....++.+.+. ... ..........+|+.+|..+.- --+...++.|.+.. +.||+|++|..+.+
T Consensus 36 G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 3334445555546667777 332 122233445678888887642 23446677886666 89999998843322
Q ss_pred HhhhcCC-----------------------CC-----------C-CCHHHHHHHH--------HHHHHHHHHHHhcCC--
Q 003694 531 RLYRKNN-----------------------TP-----------P-IPWFERYRIA--------WEVASALAFLHNTKP-- 565 (802)
Q Consensus 531 ~l~~~~~-----------------------~~-----------~-l~~~~~~~i~--------~qia~aL~~LH~~~~-- 565 (802)
.+..... .+ . ..|...++.+ -....-..||+.+.|
T Consensus 115 ~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~ 194 (321)
T COG3173 115 ALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPW 194 (321)
T ss_pred cCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCc
Confidence 1110000 00 0 0011111100 012222445554432
Q ss_pred ---CCeEEcCCCCCCeEecCCceeEEeeecccccccCC
Q 003694 566 ---KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 566 ---~~ivHrDLKp~NILl~~~~~~kl~DFGla~~~~~~ 600 (802)
..++|+|+.+.||+++.++-+=|.||+++..-++.
T Consensus 195 ~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 195 AGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred CCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 57999999999999999888999999999875543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 802 | ||||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-35 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-32 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-15 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-04 | ||
| 1t1h_A | 78 | Nmr Solution Structure Of The U Box Domain From Atp | 4e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-04 |
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1T1H|A Chain A, Nmr Solution Structure Of The U Box Domain From Atpub14, An Armadillo Repeat Containing Protein From Arabidopsis Thaliana Length = 78 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 2e-82
Identities = 102/294 (34%), Positives = 149/294 (50%), Gaps = 24/294 (8%)
Query: 436 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQEL 494
+ ++E AT +F IG G +G VYKG A+K + + ++F E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 495 EVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNN-TPPIPWFERYRIAW 551
E LS RHPHL+ L+G C + L+Y+YMENG+L+ LY + T + W +R I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 552 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYKN 610
A L +LH + IIHRD+K NILLD N V KI D G+S D + +ST K
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK- 202
Query: 611 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE---------T 661
GTL YIDPEY G ++ KSDVY++G+V+ ++L A+ AI + E
Sbjct: 203 ----GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 662 AIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714
+ + L +I+D A + ++ + C L +DRP + VL LE
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM-GDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 4e-80
Identities = 101/312 (32%), Positives = 167/312 (53%), Gaps = 29/312 (9%)
Query: 425 ERALNGTFQRYRNLTWEEIESATLSFSENL------RIGMGGYGTVYKGTFHHTFAAVKV 478
++L + R+ + ++ E+++ T +F E ++G GG+G VYKG ++T AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK 61
Query: 479 LQSKGNIQ----NKQFLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRL 532
L + +I +QF QE++V++K +H +L+ LLG D CLVY YM NGSL DRL
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 533 YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 592
+ TPP+ W R +IA A+ + FLH IHRD+K NILLD +KI D G
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFG 178
Query: 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 652
L+ + T + VGT Y+ PE G I+PKSD+Y++G+V+L+++T PA
Sbjct: 179 LARASEKF----AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 653 IAITHK----VETA----IDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPD 704
+ + ++ +E + + +D + D + + ++ C ++ RPD
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 705 LKNQVLPVLERL 716
+K +V +L+ +
Sbjct: 294 IK-KVQQLLQEM 304
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 3e-74
Identities = 100/296 (33%), Positives = 158/296 (53%), Gaps = 23/296 (7%)
Query: 436 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNK-QFLQE 493
+ + E++ A+ +FS +G GG+G VYKG T AVK L+ + + QF E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 494 LEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLY-RKNNTPPIPWFERYRIA 550
+E++S H +LL L G C P LVY YM NGS+ L R + PP+ W +R RIA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 610
A LA+LH+ IIHRD+K NILLD + +GD GL+ +++ + V+T +
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR- 196
Query: 611 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI-----------AITHKV 659
GT+ +I PEY TG S K+DV+ YG+++L+L+T + A + V
Sbjct: 197 ----GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 660 ETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714
+ + E L ++D G++ +E ++L + L C + +RP + +V+ +LE
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS-EVVRMLE 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 9e-62
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 14/213 (6%)
Query: 439 TWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLS 498
+ I+ + E +G G +G V K + A+K ++S+ K F+ EL LS
Sbjct: 1 SLHMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQIESESER--KAFIVELRQLS 56
Query: 499 KIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 558
++ HP+++ L GAC + CLV EY E GSL + L+ P + + +A
Sbjct: 57 RVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 559 FLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 617
+LH+ +PK +IHRD+KP N+LL V KI D G + + + T G+
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---------HMTNNKGSA 167
Query: 618 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 650
++ PE S K DV+++G+++ +++T +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 4e-61
Identities = 69/302 (22%), Positives = 120/302 (39%), Gaps = 44/302 (14%)
Query: 441 EEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI 500
E + ++ G +G V+K + + AVK+ + Q+ Q E+ L +
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIF-PIQDKQSWQNEYEVYSLPGM 75
Query: 501 RHPHLLLLLGAC--PDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 554
+H ++L +GA L+ + E GSL D L + W E IA +A
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMA 131
Query: 555 SALAFLHNTKPK-------PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607
LA+LH P I HRD+K N+LL +NL + I D GL+ + S T
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 608 YKNTGPVGTLCYIDPEYQRTGLI-----SPKSDVYAYGMVILQLLTAKPAIAITHKVETA 662
+ VGT Y+ PE + + D+YA G+V+ +L + A
Sbjct: 192 GQ----VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV----- 242
Query: 663 IDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLP--VLERLKEVA 720
++ + + +++ +E+ + +K RP L++ + L E
Sbjct: 243 --DEYMLPFEEEIGQHPSLEDMQEVV--------VHKKKRPVLRDYWQKHAGMAMLCETI 292
Query: 721 DR 722
+
Sbjct: 293 EE 294
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-60
Identities = 71/240 (29%), Positives = 123/240 (51%), Gaps = 13/240 (5%)
Query: 415 KHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA 474
H + N FQ + +I L+ E +IG G +GTV++ +H +
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDV 63
Query: 475 AVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLED 530
AVK+L + +FL+E+ ++ ++RHP+++L +GA P + +V EY+ GSL
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 531 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 590
L++ + R +A++VA + +LHN P PI+HR++K N+L+D K+ D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 591 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 650
GLS + ST + GT ++ PE R + KSDVY++G+++ +L T +
Sbjct: 183 FGLSRLKA------STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 4e-55
Identities = 69/296 (23%), Positives = 127/296 (42%), Gaps = 41/296 (13%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN--KQFLQELEVLSK 499
+I L E IG G +G VY G +H A++++ + + ++ K F +E+ +
Sbjct: 29 DIPFEQLEIGE--LIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQ 85
Query: 500 IRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 557
RH +++L +GAC P H ++ + +L + + + +IA E+ +
Sbjct: 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGM 143
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 617
+LH K I+H+D+K N+ D+ V I D GL ++ + K G L
Sbjct: 144 GYLHA---KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRRED-KLRIQNGWL 198
Query: 618 CYIDPEYQRTGLI---------SPKSDVYAYGMVILQLLTAK------PAIAITHKVETA 662
C++ PE R S SDV+A G + +L + PA AI ++
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG-- 256
Query: 663 IDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718
+ G KE++ + L C +++RP +++ +LE+L +
Sbjct: 257 --TGMKPNLSQIGMG-------KEISDILLFCWAFEQEERPTFT-KLMDMLEKLPK 302
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-54
Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 35/290 (12%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVL--QSKGNIQNKQFLQELEVL 497
WE I ++ + RIG G +GTVYKG +H AVK+L + Q + F E+ VL
Sbjct: 19 WE-IPDGQITVGQ--RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVL 74
Query: 498 SKIRHPHLLLLLGAC-PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 556
K RH ++LL +G +V ++ E SL L + + IA + A
Sbjct: 75 RKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARG 132
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
+ +LH K IIHRD+K NI L + KIGD GL+T + S +++ G+
Sbjct: 133 MDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW----SGSHQFEQLSGS 185
Query: 617 LCYIDPE---YQRTGLISPKSDVYAYGMVILQLLTAK-------PAIAITHKVETAIDED 666
+ ++ PE Q + S +SDVYA+G+V+ +L+T + I V
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG----RG 241
Query: 667 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716
+L+ L + P K + L C + +R +RP ++L +E L
Sbjct: 242 SLSPDLSKVRSNCP----KRMKRLMAECLKKKRDERPSFP-RILAEIEEL 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-53
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN----KQFLQELEVL 497
EI+ A L+ E IG+GG+G VY+ + AVK + + + QE ++
Sbjct: 3 EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 498 SKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 555
+ ++HP+++ L G C + CLV E+ G L L K IP A ++A
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIAR 116
Query: 556 ALAFLHNTKPKPIIHRDMKPGNILLD--------HNLVSKIGDVGLSTMLNSDPSFVSTT 607
+ +LH+ PIIHRD+K NIL+ N + KI D GL+ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----- 171
Query: 608 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 650
G ++ PE R + S SDV++YG+++ +LLT +
Sbjct: 172 ---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-53
Identities = 44/218 (20%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN--KQFLQELEVLSK 499
I+ L+F ++ G ++KG + VKVL+ + + F +E L
Sbjct: 6 GIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRI 63
Query: 500 IRHPHLLLLLGAC----PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 555
HP++L +LGAC H L+ +M GSL + L + + + + A ++A
Sbjct: 64 FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMAR 122
Query: 556 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 615
+AFLH +P I + ++++D ++ ++I + S G +
Sbjct: 123 GMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----------PGRMY 170
Query: 616 TLCYIDPE---YQRTGLISPKSDVYAYGMVILQLLTAK 650
++ PE + +D++++ +++ +L+T +
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-52
Identities = 55/227 (24%), Positives = 110/227 (48%), Gaps = 30/227 (13%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVL-------QSKGNIQNKQF 490
+ + + + +IG GG+G V+KG + A+K L +++ + ++F
Sbjct: 13 LPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 491 LQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA 550
+E+ ++S + HP+++ L G + +V E++ G L RL K + PI W + R+
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLM 128
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLD-----HNLVSKIGDVGLSTMLNSDPSFVS 605
++A + ++ N P PI+HRD++ NI L + +K+ D GLS
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--------- 178
Query: 606 TTYKNTGPVGTLCYIDPE--YQRTGLISPKSDVYAYGMVILQLLTAK 650
+ + +G +G ++ PE + K+D Y++ M++ +LT +
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-51
Identities = 66/320 (20%), Positives = 122/320 (38%), Gaps = 46/320 (14%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSK 499
+ L E +G G +G K T T +K L + FL+E++V+
Sbjct: 6 IFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 500 IRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 557
+ HP++L +G + EY++ G+L + K+ PW +R A ++AS +
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGM 121
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP---- 613
A+LH+ IIHRD+ N L+ N + D GL+ ++ + + P
Sbjct: 122 AYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 614 ----VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--- 666
VG ++ PE K DV+++G+V+ +++ A D D
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-----------DPDYLP 227
Query: 667 -NLAEILDAQAG-------DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718
+ L+ + + P + + C +L + RP ++ LE L+
Sbjct: 228 RTMDFGLNVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFV-KLEHWLETLRM 282
Query: 719 VADRARDTVPSVHPAPPNHF 738
P + +
Sbjct: 283 HLAGHLPLGPQLEQLDRGFW 302
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 7e-51
Identities = 59/243 (24%), Positives = 89/243 (36%), Gaps = 33/243 (13%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEV--LSK 499
++ L E IG G YG VYKG+ AVKV + F+ E + +
Sbjct: 9 SLDLDNLKLLE--LIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIYRVPL 63
Query: 500 IRHPHLLLLLGAC-------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 552
+ H ++ + LV EY NGSL L W R+A
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHS 119
Query: 553 VASALAFLHNTKPK------PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV-- 604
V LA+LH P+ I HRD+ N+L+ ++ I D GLS L +
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 605 STTYKNTGPVGTLCYIDPEY-------QRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 657
VGT+ Y+ PE + + D+YA G++ ++ +
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 658 KVE 660
V
Sbjct: 240 SVP 242
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEV--LSKIRHPHLLLLLGAC 512
+G G YG V++G++ AVK+ S+ K + +E E+ +RH ++L + +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 513 ------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN---- 562
L+ Y E GSL D L + RI +AS LA LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 563 TKPKP-IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
T+ KP I HRD+K NIL+ N I D+GL+ M S N VGT Y+
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH--SQSTNQLDVGNNPRVGTKRYMA 185
Query: 622 PE------YQRTGLISPKSDVYAYGMVILQLLT 648
PE + D++A+G+V+ ++
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 3e-49
Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 30/227 (13%)
Query: 441 EEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEV--LS 498
+ + + + +IG G YG V+ G + AVKV + + + +E E+
Sbjct: 32 QRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTV 86
Query: 499 KIRHPHLLLLLGAC------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 552
+RH ++L + A L+ +Y ENGSL D L + ++A+
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYS 142
Query: 553 VASALAFLHN----TKPKP-IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607
S L LH T+ KP I HRD+K NIL+ N I D+GL+ SD +
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN--EVD 200
Query: 608 YKNTGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLT 648
VGT Y+ PE + +D+Y++G+++ ++
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-48
Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 31/231 (13%)
Query: 437 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEV 496
L I + T+ E IG G +G V++G + AVK+ S+ + + + +E E+
Sbjct: 34 LLVQRTI-ARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEI 87
Query: 497 --LSKIRHPHLLLLLGACPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 548
+RH ++L + A LV +Y E+GSL D L R + +
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIK 143
Query: 549 IAWEVASALAFLH----NTKPKP-IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603
+A AS LA LH T+ KP I HRD+K NIL+ N I D+GL+ +S
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD- 202
Query: 604 VSTTYKNTGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLT 648
+ VGT Y+ PE + ++D+YA G+V ++
Sbjct: 203 -TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 58/288 (20%), Positives = 115/288 (39%), Gaps = 37/288 (12%)
Query: 455 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
+G GG+G V++ +A ++ + ++ ++E++ L+K+ HP ++ A
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 512 CPDHG--------------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 557
+ + + +L+D + + I ++A A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN------T 611
FLH+ ++HRD+KP NI + V K+GD GL T ++ D + T
Sbjct: 132 EFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 612 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 671
G VGT Y+ PE S K D+++ G+++ +LL P +V T L ++
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRT------LTDV 240
Query: 672 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL--PVLERLK 717
+ + ++ + +RP+ ++ V E L
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-INIIENAVFEDLD 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 66/291 (22%), Positives = 120/291 (41%), Gaps = 48/291 (16%)
Query: 406 QRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVY 465
Q + + + E E + + + +G F ++ IG G + TVY
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIE-----------------IGRGSFKTVY 43
Query: 466 KGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGACPDHG----- 516
KG T A LQ + ++ ++F +E E+L ++HP+++ +
Sbjct: 44 KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103
Query: 517 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKP 575
LV E M +G+L+ ++ I + ++ L FLH P PIIHRD+K
Sbjct: 104 IVLVTELMTSGTLKT-YLKRFKVMKIKVLRSW--CRQILKGLQFLHTRTP-PIIHRDLKC 159
Query: 576 GNILLDHNL-VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS 634
NI + KIGD+GL+T+ + +GT ++ PE
Sbjct: 160 DNIFITGPTGSVKIGDLGLATLKRAS--------FAKAVIGTPEFMAPEMYEEKY-DESV 210
Query: 635 DVYAYGMVILQLLTAKP-------AIAITHKVETAIDEDNLAEILDAQAGD 678
DVYA+GM +L++ T++ A I +V + + + ++ + +
Sbjct: 211 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 62/291 (21%), Positives = 116/291 (39%), Gaps = 50/291 (17%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
IG GG+G V+K +K + N++ +E++ L+K+ H +++ G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 513 PDHG------------------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 554
+ E+ + G+LE + ++ + + ++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALELFEQIT 132
Query: 555 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 614
+ ++H+ K +I+RD+KP NI L KIGD GL T L +D +
Sbjct: 133 KGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-------K 182
Query: 615 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 674
GTL Y+ PE + + D+YA G+++ +LL TA + D
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD---------TAFETSKF--FTDL 231
Query: 675 QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL---PVLERLKEVADR 722
+ G K+ L + +DRP+ +++L V ++ E +R
Sbjct: 232 RDGIISDIFDKKEKTLLQKLLSKKPEDRPNT-SEILRTLTVWKKSPEKNER 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 68/275 (24%), Positives = 111/275 (40%), Gaps = 40/275 (14%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLL 509
IG G YG K K L G++ + E+ +L +++HP+++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 510 GACPDHG----CLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTK 564
D +V EY E G L + + + R+ ++ AL H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 565 PKP--IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
++HRD+KP N+ LD K+GD GL+ +LN D SF T VGT Y+ P
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF------VGTPYYMSP 185
Query: 623 E------YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE-ILDAQ 675
E Y + KSD+++ G ++ +L P TA + LA I + +
Sbjct: 186 EQMNRMSY------NEKSDIWSLGCLLYELCALMPPF-------TAFSQKELAGKIREGK 232
Query: 676 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL 710
P + + EL + L+ RP + ++L
Sbjct: 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSV-EEIL 266
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 33/216 (15%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
+G G +G V K + A+K + + L E+ +L+ + H +++ A
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 513 PDHG---------------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 557
+ + EY ENG+L D ++ +N E +R+ ++ AL
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD--EYWRLFRQILEAL 129
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN------- 610
+++H+ IIHRD+KP NI +D + KIGD GL+ ++ + +N
Sbjct: 130 SYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 611 -TGPVGTLCYIDPE-YQRTGLISPKSDVYAYGMVIL 644
T +GT Y+ E TG + K D+Y+ G +I
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLG-IIF 221
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 64/269 (23%), Positives = 114/269 (42%), Gaps = 39/269 (14%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLLG 510
IG G +G +K + + + +K + +E+ VL+ ++HP+++
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 511 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
+ ++G L V +Y E G L R+ + + ++ AL +H+ K I
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHDRK---I 146
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE----- 623
+HRD+K NI L + ++GD G++ +LNS +GT Y+ PE
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC------IGTPYYLSPEICENK 200
Query: 624 -YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE-ILDAQAGDWPI 681
Y + KSD++A G V+ +L T K A A NL I+ +
Sbjct: 201 PY------NNKSDIWALGCVLYELCTLKHAF-------EAGSMKNLVLKIISGSFPPVSL 247
Query: 682 KETKELAALGLSCAELRRKDRPDLKNQVL 710
+ +L +L + +DRP + N +L
Sbjct: 248 HYSYDLRSLVSQLFKRNPRDRPSV-NSIL 275
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVL 497
WE +E ++ ++G G YG VY+G + + AVK L+ ++ ++FL+E V+
Sbjct: 215 WE-MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVM 270
Query: 498 SKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 555
+I+HP+L+ LLG C ++ E+M G+L D L R+ N + +A +++S
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISS 329
Query: 556 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 615
A+ +L IHR++ N L+ N + K+ D GLS ++ D TY G
Sbjct: 330 AMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHA--G 378
Query: 616 TLCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 648
I PE S KSDV+A+G+++ ++ T
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLL-- 509
+G G V++G T A+KV + ++ ++E EVL K+ H +++ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 510 --GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
H L+ E+ GSL L +N +P E + +V + L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 568 IIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
I+HR++KPGNI+ D V K+ D G + L D + Y GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY------GTEEYLHPD 185
Query: 624 -YQRTGLI-------SPKSDVYAYGMVILQLLTAKP 651
Y+R L D+++ G+ T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 70/319 (21%), Positives = 125/319 (39%), Gaps = 38/319 (11%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELE 495
E L + ++G G +G+V + AVK LQ G Q + F +E++
Sbjct: 19 IFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 496 VLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 551
+L + ++ G G LV EY+ +G L D L + + + +
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSS 134
Query: 552 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 611
++ + +L + + +HRD+ NIL++ KI D GL+ +L D Y
Sbjct: 135 QICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD----YYVVR 187
Query: 612 G----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-----AKPAIAITHKVETA 662
P+ + PE + S +SDV+++G+V+ +L T P+ +
Sbjct: 188 EPGQSPI---FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244
Query: 663 IDEDNLAEILDA-QAG---DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718
D L+ +L+ + G P E+ L C +DRP + P L+ L
Sbjct: 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFS-ALGPQLDMLWS 303
Query: 719 VADRARDTVPSVHPAPPNH 737
+ + HP +H
Sbjct: 304 GSRGCETHAFTAHPEGKHH 322
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 59/300 (19%), Positives = 104/300 (34%), Gaps = 40/300 (13%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
++G GG+ V H F A+K + ++ +E ++ HP++L L+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 513 PDHG------CLVYEYMENGSLEDRLY-RKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
L+ + + G+L + + K+ + + + + L +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK---NTGPVGTLCYIDP 622
K HRD+KP NILL + D+G T+ Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 623 E---YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679
E Q +I ++DV++ G V+ ++ + D++A + Q
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQKGDSVALAVQNQL-SI 266
Query: 680 PIKET--KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNH 737
P L L S + RP + +L LE L+ PAP H
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHI-PLLLSQLEALQ-------------PPAPGQH 312
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKI 500
EI +L ++G G +G V+ GT+ T A+K L+ G + + FLQE +V+ K+
Sbjct: 180 EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 236
Query: 501 RHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 559
RH L+ L + +V EYM GSL D L + + + +A ++AS +A+
Sbjct: 237 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
+ +HRD++ NIL+ NLV K+ D GL+ ++ + K P+ +
Sbjct: 296 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIK---W 347
Query: 620 IDPEYQRTGLISPKSDVYAYGMVILQLLT 648
PE G + KSDV+++G+++ +L T
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVL-QSKGNIQNKQFLQELEV 496
W + L E +IG G +G V+ G +T AVK ++ +FLQE +
Sbjct: 109 WV-LNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARI 165
Query: 497 LSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 554
L + HP+++ L+G C +V E ++ G L + + ++ + A
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAA 223
Query: 555 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 614
+ + +L + K IHRD+ N L+ V KI D G+S Y +G +
Sbjct: 224 AGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG------VYAASGGL 274
Query: 615 GTLCY--IDPEYQRTGLISPKSDVYAYGMVI 643
+ PE G S +SDV+++G+++
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 70/340 (20%), Positives = 137/340 (40%), Gaps = 41/340 (12%)
Query: 436 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVL-QSKGNIQNK 488
+ L + L + +G G +GTV+KG + +KV+ G +
Sbjct: 4 KVLARI-FKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60
Query: 489 QFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERY 547
+ + + H H++ LLG CP LV +Y+ GSL D + + + +
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLL 118
Query: 548 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 607
++A + +L ++HR++ N+LL ++ D G++ +L D
Sbjct: 119 NWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD----DKQ 171
Query: 608 YKNTG---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVET 661
+ P+ ++ E G + +SDV++YG+ + +L+T A+P + +V
Sbjct: 172 LLYSEAKTPIK---WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228
Query: 662 AIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP---DLKNQVLPVLERLKE 718
+++ E L P T ++ + + C + RP +L N+ +
Sbjct: 229 LLEKG---ERLAQ-----PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280
Query: 719 VADRARDTVPSVHPAP-PNHFICPILKEVMNEPCVAADGY 757
R++ P + P P P+ L+EV EP + D
Sbjct: 281 YLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLD 320
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-31
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKI 500
EI +L ++G G +G V+ GT+ T A+K L+ G + + FLQE +V+ K+
Sbjct: 263 EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 319
Query: 501 RHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 559
RH L+ L + +V EYM GSL D L + + + +A ++AS +A+
Sbjct: 320 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
+ +HRD++ NIL+ NLV K+ D GL+ ++ + K P+
Sbjct: 379 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTA- 432
Query: 620 IDPEYQRTGLISPKSDVYAYGMVILQLLT 648
PE G + KSDV+++G+++ +L T
Sbjct: 433 --PEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLLG 510
IG G + VY+ A+K +Q + K ++E+++L ++ HP+++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 511 ACPDHGCL--VYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAW--EVASALAFLHNTKP 565
+ + L V E + G L + + K IP ER + ++ SAL +H+ +
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP--ERTVWKYFVQLCSALEHMHSRR- 156
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-- 623
++HRD+KP N+ + V K+GD+GL +S + + VGT Y+ PE
Sbjct: 157 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL------VGTPYYMSPERI 208
Query: 624 ----YQRTGLISPKSDVYAYGMVILQLLTAKPA 652
Y + KSD+++ G ++ ++ +
Sbjct: 209 HENGY------NFKSDIWSLGCLLYEMAALQSP 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 29/215 (13%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFL-QELEVLSKIRHPHLLLLL--- 509
+G G V++G T A+KV + ++ +E EVL K+ H +++ L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 510 -GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
H L+ E+ GSL L +N +P E + +V + L I
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 569 IHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE- 623
+HR++KPGNI+ D V K+ D G + L D + Y GT Y+ P+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY------GTEEYLHPDM 186
Query: 624 YQRTGLI-------SPKSDVYAYGMVILQLLTAKP 651
Y+R L D+++ G+ T
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-30
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR 501
+ L + IG G +G V G + AVK + K + + FL E V++++R
Sbjct: 189 ALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLR 244
Query: 502 HPHLLLLLGACPDHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 558
H +L+ LLG + +Y EYM GSL D L R + + + +V A+
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
+L +HRD+ N+L+ + V+K+ D GL+ +S K T
Sbjct: 304 YLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA------ 354
Query: 619 YIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
PE R S KSDV+++G+++ ++ +
Sbjct: 355 ---PEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 Length = 78 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-30
Identities = 26/73 (35%), Positives = 38/73 (52%), Gaps = 1/73 (1%)
Query: 731 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPN 789
P P +F CPI E+M +P + + G TY+R +I++WL + P + L + L PN
Sbjct: 2 SPEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPN 61
Query: 790 YTLLSAILDWKSK 802
Y L S I W
Sbjct: 62 YVLKSLIALWCES 74
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 509
+G GG+ ++ + T A K++ K + ++ E+ + + H H++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIV-PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 510 G--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
G D +V E SL + R+ + E ++ +LH +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR--- 135
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+IHRD+K GN+ L+ +L KIGD GL+T + D GT YI PE
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL------CGTPNYIAPEVLSK 189
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
S + DV++ G ++ LL KP
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 52/220 (23%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQ-SKGNIQNKQFLQ 492
++ + +G G +GTVYKG + A+K L+ + NK+ L
Sbjct: 9 LRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 493 ELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 551
E V++ + +PH+ LLG C L+ + M G L D + + + I
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCV 124
Query: 552 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 611
++A + +L + + ++HRD+ N+L+ KI D GL+ +L ++ Y
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYHAE 177
Query: 612 G---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
G P+ ++ E + + +SDV++YG+ + +L+T
Sbjct: 178 GGKVPIK---WMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELE 495
+ E L F + ++G G +G+V + AVK LQ + F +E+E
Sbjct: 6 QFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 496 VLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 551
+L ++H +++ G C G L+ EY+ GSL D L + + I + +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 121
Query: 552 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 611
++ + +L K IHRD+ NIL+++ KIGD GL+ +L D F
Sbjct: 122 QICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 612 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
P+ + PE S SDV+++G+V+ +L T
Sbjct: 179 SPI---FWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVL 497
WE +E ++ ++G G YG VY+G + + AVK L+ + ++ ++FL+E V+
Sbjct: 8 WE-MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVM 63
Query: 498 SKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 555
+I+HP+L+ LLG C ++ E+M G+L D L R+ N + +A +++S
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISS 122
Query: 556 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG--- 612
A+ +L IHRD+ N L+ N + K+ D GLS ++ D TY
Sbjct: 123 AMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAK 173
Query: 613 -PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
P+ + PE S KSDV+A+G+++ ++ T
Sbjct: 174 FPIK---WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSK 499
W + L + IG G +G V G + AVK + K + + FL E V+++
Sbjct: 16 WA-LNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQ 70
Query: 500 IRHPHLLLLLGACPDHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 556
+RH +L+ LLG + +Y EYM GSL D L R + + + +V A
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEA 129
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG---P 613
+ +L +HRD+ N+L+ + V+K+ D GL+ + P
Sbjct: 130 MEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLP 177
Query: 614 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
V + PE R S KSDV+++G+++ ++ +
Sbjct: 178 V---KWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHP--HLLLL 508
IG GG V++ + A+K + + N+ + E+ L+K++ ++ L
Sbjct: 36 IGSGGSSKVFQV-LNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 509 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
+V E N L L +K I +ER + A+ +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG-- 147
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--- 623
I+H D+KP N L+ ++ K+ D G++ + D +T+ VGT+ Y+ PE
Sbjct: 148 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQPD----TTSVVKDSQVGTVNYMPPEAIK 201
Query: 624 --------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
+ ISPKSDV++ G ++ + K
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 26/222 (11%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQ-FLQE 493
S + F+E IG G +G VY GT AVK L +I FL E
Sbjct: 19 VIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 494 LEVLSKIRHPHLLLLLGACPDHG---CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA 550
++ HP++L LLG C +V YM++G L + + +N T +
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFG 134
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYK 609
+VA + +L + K +HRD+ N +LD K+ D GL+ M + + Y
Sbjct: 135 LQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY------YS 185
Query: 610 NTGPVGTLCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 648
G + E +T + KSDV+++G+++ +L+T
Sbjct: 186 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 509
+G GG+ ++ + T A K++ K + ++ E+ + + H H++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIV-PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 510 G--ACPDHGCLVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
G D +V E SL + RK T P E ++ +LH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYYLRQIVLGCQYLHR---N 160
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
+IHRD+K GN+ L+ +L KIGD GL+T + D GT YI PE
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL------CGTPNYIAPEVLS 214
Query: 627 TGLISPKSDVYAYGMVILQLLTAKP 651
S + DV++ G ++ LL KP
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKP 239
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQS-KGNIQNKQFLQEL 494
E L +G G +G V + AVK L+ G +E+
Sbjct: 17 HFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI 74
Query: 495 EVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA 550
E+L + H +++ G C + G L+ E++ +GSL++ L N I ++ + A
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYA 132
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 610
++ + +L + + +HRD+ N+L++ KIGD GL+ + +D + +
Sbjct: 133 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189
Query: 611 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
PV + PE SDV+++G+ + +LLT
Sbjct: 190 DSPV---FWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 509
+G G + VY+ HT A+K++ K + ++ E+++ +++HP +L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMI-DKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 510 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
D LV E NG + L + P E ++ + + +LH+
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHS---HG 132
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
I+HRD+ N+LL N+ KI D GL+T L T GT YI PE
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL------CGTPNYISPEIATR 186
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
+SDV++ G + LL +P
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRP 210
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 51/204 (25%), Positives = 77/204 (37%), Gaps = 21/204 (10%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSK--GNIQNKQFLQELEVLSKI-RHPHLLLLL 509
R+G G YG V+K AVK S G + L E+ K+ +HP + L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 510 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
A L E SL+ +P + + + ALA LH+
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG--- 177
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
++H D+KP NI L K+GD GL L + G Y+ PE +
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-AGAGEVQ------EGDPRYMAPELLQG 230
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
+DV++ G+ IL++
Sbjct: 231 SY-GTAADVFSLGLTILEVACNME 253
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELE 495
+ E L F + ++G G +G+V + AVK LQ + F +E+E
Sbjct: 37 QFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 496 VLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 551
+L ++H +++ G C G L+ EY+ GSL D L + + I + +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 152
Query: 552 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 611
++ + +L K IHRD+ NIL+++ KIGD GL+ +L D + YK
Sbjct: 153 QICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY----YKVK 205
Query: 612 G----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
P+ + PE S SDV+++G+V+ +L T
Sbjct: 206 EPGESPI---FWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 32/215 (14%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHP--HLLLLL 509
IG GG V++ + A+K L+ N + E+ L+K++ ++ L
Sbjct: 17 IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 510 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
+V E N L L +K I +ER + A+ +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---- 623
I+H D+KP N L+ ++ K+ D G++ + D +T+ VGT+ Y+ PE
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPD----TTSVVKDSQVGTVNYMPPEAIKD 183
Query: 624 -------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
+ ISPKSDV++ G ++ + K
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-AVKVLQSKGNIQNKQFLQELEVLS 498
W I+ + L+F + IG G +G V+ G + + A+K ++ +G + + F++E EV+
Sbjct: 3 WV-IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMM 58
Query: 499 KIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 556
K+ HP L+ L G C + CLV E+ME+G L D Y + + +V
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG 116
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
+A+L +IHRD+ N L+ N V K+ D G++ + D Y ++ GT
Sbjct: 117 MAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD------QYTSST--GT 165
Query: 617 LCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 648
+ PE S KSDV+++G+++ ++ +
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLS 498
WE + TL E R+G G +G V+ G + HT AVK L+ G++ FL E ++
Sbjct: 8 WE-VPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMK 63
Query: 499 KIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 557
+++H L+ L ++ EYMENGSL D L + + + + +A ++A +
Sbjct: 64 QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGM 122
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 617
AF+ IHRD++ NIL+ L KI D GL+ ++ + Y T G
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN------EY--TAREGAK 171
Query: 618 CYID---PEYQRTGLISPKSDVYAYGMVILQLLT 648
I PE G + KSDV+++G+++ +++T
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQ-FLQE 493
S + F+E IG G +G VY GT AVK L +I FL E
Sbjct: 83 VIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 494 LEVLSKIRHPHLLLLLGACPDHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIA 550
++ HP++L LLG C YM++G L + + +N T +
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFG 198
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYK 609
+VA + FL + K +HRD+ N +LD K+ D GL+ M + + + +
Sbjct: 199 LQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHN 252
Query: 610 NTG---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
TG PV ++ E +T + KSDV+++G+++ +L+T
Sbjct: 253 KTGAKLPV---KWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 70/336 (20%), Positives = 139/336 (41%), Gaps = 41/336 (12%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSK-GNIQNKQFLQ 492
++ + +G G +GTVYKG + A+K L+ NK+ L
Sbjct: 9 LRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 493 ELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 551
E V++ + +PH+ LLG C L+ + M G L D + + + I
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCV 124
Query: 552 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 611
++A + +L + + ++HRD+ N+L+ KI D GL+ +L ++ Y
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYHAE 177
Query: 612 G---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVETAIDE 665
G P+ ++ E + + +SDV++YG+ + +L+T +KP I ++ + +++
Sbjct: 178 GGKVPIK---WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
Query: 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARD 725
E L P T ++ + + C + RP + +++ ++ R
Sbjct: 235 G---ERLPQ-----PPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMARDPQRYLV 285
Query: 726 TVPSVHPAPPN----HFICPILKEVMNEPCVAADGY 757
P+ +F ++ E + V AD Y
Sbjct: 286 IQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEY 321
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 59/244 (24%), Positives = 109/244 (44%), Gaps = 22/244 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGA 511
+G G G V+K + + A K++ + Q ++EL+VL + P+++ GA
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 512 CPDHGCLVY--EYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 567
G + E+M+ GSL+ + +K IP E+ +++ V L +L
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ-VLKKAG--RIP--EQILGKVSIAVIKGLTYLREKHK-- 152
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
I+HRD+KP NIL++ K+ D G+S L ++ ++ VGT Y+ PE +
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF-----VGTRSYMSPERLQG 204
Query: 628 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687
S +SD+++ G+ ++++ + I E + E A+ P + L
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 688 AALG 691
G
Sbjct: 265 NKFG 268
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKI 500
EI +L + ++G G +G V+ T++ HT AVK ++ G++ + FL E V+ +
Sbjct: 184 EIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTL 240
Query: 501 RHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 559
+H L+ L ++ E+M GSL D L + + P + + ++A +AF
Sbjct: 241 QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
+ + IHRD++ NIL+ +LV KI D GL+ ++ + Y T G
Sbjct: 300 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN------EY--TAREGAKFP 348
Query: 620 ID---PEYQRTGLISPKSDVYAYGMVILQLLT 648
I PE G + KSDV+++G+++++++T
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 18/217 (8%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGNIQNKQ-FLQELE 495
I + + IG G +G VY G + + A+K L +Q + FL+E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 496 VLSKIRHPHLLLLLGACPDHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 552
++ + HP++L L+G L + YM +G L + ++ + +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQ 132
Query: 553 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYKNT 611
VA + +L K +HRD+ N +LD + K+ D GL+ +L+ + V
Sbjct: 133 VARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 612 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
PV + E +T + KSDV+++G+++ +LLT
Sbjct: 190 LPVK---WTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLS 498
E ++ ++ + +G G +G V G + AVK+++ +G++ +F QE + +
Sbjct: 3 ME-LKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMM 58
Query: 499 KIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 556
K+ HP L+ G C +V EY+ NG L + Y +++ + + + ++V
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
+AFL + IHRD+ N L+D +L K+ D G++ + D Y ++ GT
Sbjct: 117 MAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD------QYVSSV--GT 165
Query: 617 LCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 648
+ PE S KSDV+A+G+++ ++ +
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C Length = 179 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 34/162 (20%), Positives = 59/162 (36%), Gaps = 11/162 (6%)
Query: 645 QLLTAKPAI---AITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKD 701
L AK ++ + L + + + + + + ++ +
Sbjct: 18 ALRIAKKKRWNSIEEKRISQENELHAYLSKLILAEKERELDDRVKQSDDSQNGGDISKMK 77
Query: 702 RPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDR 761
++ L ++ L D R P++ I E+M EPC+ G TYDR
Sbjct: 78 --SKHDKYLMDMDELFSQVDEKRKKRE-----IPDYLCGKISFELMREPCITPSGITYDR 130
Query: 762 KAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 802
K IEE LQ P+T PL L+PN + I + +
Sbjct: 131 KDIEEHLQRVGHFDPVTRSPLTQDQLIPNLAMKEVIDAFIQE 172
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLS 498
WE I+ L+F + +G G +G V G + A+K+++ +G++ +F++E +V+
Sbjct: 19 WE-IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMM 74
Query: 499 KIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 556
+ H L+ L G C ++ EYM NG L + Y + + + +V A
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEA 132
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
+ +L + + +HRD+ N L++ V K+ D GLS + D Y T VG+
Sbjct: 133 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD------EY--TSSVGS 181
Query: 617 LCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 648
+ PE S KSD++A+G+++ ++ +
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 32/215 (14%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHP--HLLLLL 509
IG GG V++ + A+K L+ N + E+ L+K++ ++ L
Sbjct: 64 IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 510 GACPDHGCLVYEYME--NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
+ Y ME N L L +K I +ER + A+ +H
Sbjct: 123 DYEITDQYI-YMVMECGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---- 623
I+H D+KP N L+ ++ K+ D G++ + D +T+ VG + Y+ PE
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPD----TTSVVKDSQVGAVNYMPPEAIKD 230
Query: 624 -------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
+ ISPKSDV++ G ++ + K
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 71/299 (23%), Positives = 118/299 (39%), Gaps = 31/299 (10%)
Query: 438 LTWEEIESATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQS---KGNIQNKQ 489
LT I L E ++G G +G V +G + AVK L+
Sbjct: 11 LTCL-IGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 490 FLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 548
F++E+ + + H +L+ L G +V E GSL DRL + + R
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSR 125
Query: 549 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 608
A +VA + +L + K IHRD+ N+LL + KIGD GL L +
Sbjct: 126 YAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 609 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVETAIDE 665
P + PE +T S SD + +G+ + ++ T +P I + ++ ID+
Sbjct: 183 HRKVPFA---WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
Query: 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRAR 724
+ E L P +++ + + C + +DRP + L + RA
Sbjct: 240 EG--ERLPR-----PEDCPQDIYNVMVQCWAHKPEDRPTFV-ALRDFLLEAQPTDMRAE 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 58/288 (20%), Positives = 115/288 (39%), Gaps = 38/288 (13%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGAC 512
+ GG+ VY+ + A+K L S +N+ +QE+ + K+ HP+++ A
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 513 ---------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
L+ + G L + L + + P+ +I ++ A+ +H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP------VGTL 617
KP PIIHRD+K N+LL + K+ D G +T ++ P + + + T
Sbjct: 156 KP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 618 CYIDPE----YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673
Y PE Y I K D++A G ++ L + ++ I++
Sbjct: 215 MYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQ----------HPFEDGAKLRIVN 263
Query: 674 AQAGDWPIKET--KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 719
+ P +T +L + ++ ++R + +V+ L+ +
Sbjct: 264 GK-YSIPPHDTQYTVFHSLIRAMLQVNPEERLSI-AEVVHQLQEIAAA 309
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 47/230 (20%), Positives = 92/230 (40%), Gaps = 37/230 (16%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQN--KQFLQEL 494
I + +G G +G+V + AVK+L++ + ++FL+E
Sbjct: 19 LIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 495 EVLSKIRHPHLLLLLGACPDHG--------CLVYEYMENGSLED--RLYRKNNTPPIPWF 544
+ + HPH+ L+G ++ +M++G L R P
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 545 ER-YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPS 602
+ R ++A + +L + IHRD+ N +L ++ + D GLS + + D
Sbjct: 137 QTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-- 191
Query: 603 FVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
Y+ PV ++ E L + SDV+A+G+ + +++T
Sbjct: 192 ----YYRQGCASKLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 28/224 (12%)
Query: 433 QRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA------AVKVL-QSKGNI 485
Q T E I + ++ + IG G +G VYKG + A+K L
Sbjct: 32 QAVLKFTTE-IHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK 88
Query: 486 QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPW 543
Q FL E ++ + H +++ L G + ++ EYMENG+L+ + +
Sbjct: 89 QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSV 146
Query: 544 FERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603
+ + +A+ + +L N +HRD+ NIL++ NLV K+ D GLS +L DP
Sbjct: 147 LQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-- 201
Query: 604 VSTTYKNTG---PVG-TLCYIDPEYQRTGLISPKSDVYAYGMVI 643
TY +G P+ T PE + SDV+++G+V+
Sbjct: 202 -EATYTTSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVM 240
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 48/219 (21%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQ-FLQE 493
+ I + + +G G +G VY+G + + AVK + + NK+ F+ E
Sbjct: 7 YG-IAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 494 LEVLSKIRHPHLLLLLGACPDH-GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 552
++ + HPH++ L+G + ++ E G L L + N + + +
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQ 121
Query: 553 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 612
+ A+A+L + +HRD+ NIL+ K+GD GLS + + YK +
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----DYYKASV 173
Query: 613 ---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
P+ ++ PE + SDV+ + + + ++L+
Sbjct: 174 TRLPIK---WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA------AVKVLQSKGNIQNKQ-FLQEL 494
L +G G +G V + T AVK L++ Q++ + QE+
Sbjct: 27 VFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI 84
Query: 495 EVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA 550
++L + H H++ G C D G LV EY+ GSL D L +++ I + A
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHS---IGLAQLLLFA 140
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 610
++ +A+LH IHRD+ N+LLD++ + KIGD GL+ + + Y+
Sbjct: 141 QQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----YRV 193
Query: 611 TG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
PV + PE + SDV+++G+ + +LLT
Sbjct: 194 REDGDSPV---FWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 50/217 (23%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQNKQ-FLQELE 495
EI+ + IG G +G V++G + A+K ++ + ++ FLQE
Sbjct: 11 EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 496 VLSKIRHPHLLLLLGACPDH-GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 554
+ + HPH++ L+G ++ ++ E G L + + + A++++
Sbjct: 69 TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLS 126
Query: 555 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG-- 612
+ALA+L + + +HRD+ N+L+ N K+GD GLS + T YK +
Sbjct: 127 TALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGK 178
Query: 613 -PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
P+ ++ PE + SDV+ +G+ + ++L
Sbjct: 179 LPIK---WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 60/252 (23%), Positives = 110/252 (43%), Gaps = 48/252 (19%)
Query: 423 MLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQ 480
M+ + +N RY +I ++G GG TVY + A+K +
Sbjct: 4 MIGKIINE---RY------KIVD---------KLGGGGMSTVYLAEDTILNIKVAIKAIF 45
Query: 481 SKGNIQNKQFL----QELEVLSKIRHPHLLLLLGACPDHGC--LVYEYMENGSLEDRLYR 534
+ ++ L +E+ S++ H +++ ++ + C LV EY+E +L + +
Sbjct: 46 IPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES 104
Query: 535 KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594
P+ ++ + H+ + I+HRD+KP NIL+D N KI D G++
Sbjct: 105 HG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIA 158
Query: 595 TMLNSDPSFVSTTYKNTGPV-GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP-- 651
L+ T+ T V GT+ Y PE + +D+Y+ G+V+ ++L +P
Sbjct: 159 KALS------ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212
Query: 652 ------AIAITH 657
+IAI H
Sbjct: 213 NGETAVSIAIKH 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 27/223 (12%)
Query: 433 QRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVL-QSKGNIQ 486
+ R+ T E IE++ + + IG G G V G A+K L Q
Sbjct: 37 RAGRSFTRE-IEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 487 NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWF 544
+ FL E ++ + HP+++ L G +V EYMENGSL+ + + +
Sbjct: 94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIM 151
Query: 545 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604
+ + V + + +L + +HRD+ N+L+D NLV K+ D GLS +L DP
Sbjct: 152 QLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP--- 205
Query: 605 STTYKNTG---PVG-TLCYIDPEYQRTGLISPKSDVYAYGMVI 643
Y TG P+ T PE S SDV+++G+V+
Sbjct: 206 DAAYTTTGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVM 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 45/247 (18%), Positives = 91/247 (36%), Gaps = 22/247 (8%)
Query: 480 QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNN 537
++ + + + L L + +L+D + R+ +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 538 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597
I ++A A+ FLH+ ++HRD+KP NI + V K+GD GL T +
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 598 NSDPSFVST------TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 651
+ D + +TG VGT Y+ PE S K D+++ G+++ +LL +
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
Query: 652 AIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL- 710
++ T + + ++ + + +RP+ ++
Sbjct: 275 TQMERVRIITDVRNLKFPLL--------FTQKYPQEHMMVQDMLSPSPTERPEA-TDIIE 325
Query: 711 -PVLERL 716
+ E L
Sbjct: 326 NAIFENL 332
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA----AVKVLQSKGNIQNKQ-FLQELEV 496
++ L ++ + +G G +G+V +G + A+KVL+ + + ++E ++
Sbjct: 5 FLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 63
Query: 497 LSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 555
+ ++ +P+++ L+G C LV E G L L IP + +V+
Sbjct: 64 MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSM 121
Query: 556 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 615
+ +L K +HRD+ N+LL + +KI D GLS L +D S+ + P+
Sbjct: 122 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 616 TLCYIDPEYQRTGLISPKSDVYAYGMVI 643
+ PE S +SDV++YG+ +
Sbjct: 179 ---WYAPECINFRKFSSRSDVWSYGVTM 203
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 50/223 (22%), Positives = 96/223 (43%), Gaps = 34/223 (15%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FLQE 493
E+ ++ S +G G +G VY+G T A+K + +++ + FL E
Sbjct: 21 EVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 494 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED-------RLYRKNNTPPIPWF 544
V+ + H++ LLG ++ E M G L+ + P
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 545 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604
+ ++A E+A +A+L+ +HRD+ N ++ + KIGD G++ +
Sbjct: 139 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET---- 191
Query: 605 STTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 643
Y+ G PV ++ PE + G+ + SDV+++G+V+
Sbjct: 192 -DYYRKGGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVL 230
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 3e-27
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFL-QELEVLSKIRHPHLLLLL-- 509
R+G GG+G V + T A+K + + + +N++ E++++ K+ HP+++
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 510 ------GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
A D L EY E G L L + N + + +++SAL +LH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 564 KPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
+ IIHRD+KP NI+L L+ KI D+G + L+ + VGTL Y+
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEF------VGTLQYL 190
Query: 621 DPEYQRTGLISPKSDVYAYGMVILQLLTAKP 651
PE + D +++G + + +T
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 51/229 (22%), Positives = 95/229 (41%), Gaps = 36/229 (15%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQN--KQFLQEL 494
I+ L + +G G +G+V +G AVK ++ + Q ++FL E
Sbjct: 30 VIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEA 87
Query: 495 EVLSKIRHPHLLLLLGACPDHGC-------LVYEYMENGSLED--RLYR-KNNTPPIPWF 544
+ HP+++ LLG C + ++ +M+ G L R + IP
Sbjct: 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 545 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSF 603
+ ++A + +L N +HRD+ N +L ++ + D GLS + + D
Sbjct: 148 TLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD--- 201
Query: 604 VSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
Y+ PV +I E + + KSDV+A+G+ + ++ T
Sbjct: 202 ---YYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-27
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 433 QRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVL-QSKGNIQ 486
Q E +++ +S + +G G +G V G A+K L Q
Sbjct: 33 QTVHEFAKE-LDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 487 NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWF 544
+ FL E ++ + HP+++ L G +V EYMENGSL+ + + +
Sbjct: 90 RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVI 147
Query: 545 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604
+ + +AS + +L + +HRD+ NIL++ NLV K+ D GL +L DP
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 643
TT P+ + PE + SDV++YG+V+
Sbjct: 205 YTTRGGKIPIR---WTSPEAIAYRKFTSASDVWSYGIVL 240
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEV-LSKIRHPHLLLLLG 510
+G G YG V K + AVK +++ N Q K+ L +L++ + + P + G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 511 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 566
A G + E M + SL D+ Y++ E +IA + AL LH+ K
Sbjct: 74 ALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLS 130
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY-----ID 621
+IHRD+KP N+L++ K+ D G+S L V K+ G Y I+
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDID-AGCKPYMAPERIN 182
Query: 622 PEYQRTGLISPKSDVYAYGMVILQLLTAKP 651
PE + G S KSD+++ G+ +++L +
Sbjct: 183 PELNQKGY-SVKSDIWSLGITMIELAILRF 211
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-27
Identities = 55/297 (18%), Positives = 104/297 (35%), Gaps = 50/297 (16%)
Query: 455 RIGMGGYGTVYKGTFHHTFA---AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLL- 509
I GG G +Y + +K L G+ + + + E + L+++ HP ++ +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 510 -GACPDHGC-----LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
D +V EY+ SL+ + +P E E+ AL++LH+
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS- 200
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV-GTLCYIDP 622
+++ D+KP NI+L + K+ D+G + +NS G + GT + P
Sbjct: 201 --IGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS-----------FGYLYGTPGFQAP 246
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 682
E + +D+Y G + L P + D+ +K
Sbjct: 247 E-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDP-------------VLK 292
Query: 683 ETKELAALGLSCAELRRKDRP----DLKNQVLPVLERLKEVADRARDTVPSVHPAPP 735
L + + R ++ Q+ VL + S +P
Sbjct: 293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPS 349
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 39/227 (17%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQEL 494
I+ + +G G +G V+ + AVK L+ K F +E
Sbjct: 11 HIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREA 68
Query: 495 EVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFERYR-- 548
E+L+ ++H H++ G C D +V+EYM++G L R + + + R
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 549 ---------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599
IA ++AS + +L + +HRD+ N L+ NL+ KIGD G+S + S
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 600 DPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 642
Y+ G P+ ++ PE + +SDV+++G++
Sbjct: 186 TD-----YYRVGGHTMLPI---RWMPPESIMYRKFTTESDVWSFGVI 224
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 44/233 (18%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FL 491
WE LSF + +G G +G V + T + AVK+L+ ++ ++ +
Sbjct: 18 WE-FPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 492 QELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFER 546
EL+VLS + H +++ LLGAC G ++ EY G L + R R +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 547 YR-------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593
+++VA +AFL + IHRD+ NILL H ++KI D GL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGL 191
Query: 594 STMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 642
+ + +D Y G PV ++ PE + + +SDV++YG+
Sbjct: 192 ARDIKNDS-----NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIF 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-27
Identities = 51/229 (22%), Positives = 102/229 (44%), Gaps = 26/229 (11%)
Query: 430 GTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGN 484
T+ +E I+ + IG G +G V++G + A+K ++ +
Sbjct: 375 DTYTMPSTRDYE-IQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS 431
Query: 485 IQNKQ-FLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYMENGSLEDRLYRKNNTPPIP 542
++ FLQE + + HPH++ L+G ++ ++ E G L + + +
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRS--FLQVRKFSLD 489
Query: 543 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602
A+++++ALA+L + + +HRD+ N+L+ N K+GD GLS +
Sbjct: 490 LASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-- 544
Query: 603 FVSTTYKNTG---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
T YK + P+ ++ PE + SDV+ +G+ + ++L
Sbjct: 545 ---TYYKASKGKLPIK---WMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 436 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA----AVKVLQSKGNIQNKQ-- 489
R ++ L+ E+ +G G +GTV KG + AVK+L+++ N +
Sbjct: 7 RPKEVY-LDRKLLTL-EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 490 FLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 548
L E V+ ++ +P+++ ++G C LV E E G L L ++N
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI--IE 121
Query: 549 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 608
+ +V+ + +L +HRD+ N+LL +KI D GLS L +D ++
Sbjct: 122 LVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 178
Query: 609 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 648
PV + PE S KSDV+++G+++ + +
Sbjct: 179 HGKWPVK---WYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 509
+G G +G VY + A+KVL K ++ Q +E+E+ S +RHP++L L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 510 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
G D L+ EY G++ L + + E+A+AL++ H+ K
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHS---KR 129
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+IHRD+KP N+LL KI D G S S S + GTL Y+ PE
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDL------CGTLDYLPPEMIEG 181
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
+ K D+++ G++ + L KP
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 52/269 (19%), Positives = 96/269 (35%), Gaps = 30/269 (11%)
Query: 398 ASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLR-- 455
S + Q AK + L+R T L E+++ + E +
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60
Query: 456 -----IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+G G +G V++ T AVK ++ + +EL + + P ++ L
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPL 115
Query: 509 LGACPDHGCL--VYEYMENGSLEDRL--YRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
GA + + E +E GSL + ++ + L +LH +
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-----QALEGLEYLHTRR 170
Query: 565 PKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
I+H D+K N+LL + + D G + L D S + GT ++ PE
Sbjct: 171 ---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY-IPGTETHMAPE 226
Query: 624 -YQRTGLISPKSDVYAYGMVILQLLTAKP 651
K D+++ ++L +L
Sbjct: 227 VVMGKP-CDAKVDIWSSCCMMLHMLNGCH 254
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEVLSK-IRHPHLLLLLG 510
+G G G V+K F T AVK ++ GN + NK+ L +L+V+ K P+++ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 511 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 566
+ + E M E R PIP ER ++ + AL +L
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLKKRMQG--PIP--ERILGKMTVAIVKALYYLKEKHG- 145
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY-----ID 621
+IHRD+KP NILLD K+ D G+S L V K+ G Y ID
Sbjct: 146 -VIHRDVKPSNILLDERGQIKLCDFGISGRL------VDDKAKDRS-AGCAAYMAPERID 197
Query: 622 PEYQRTGLISPKSDVYAYGMVILQLLTAKP 651
P ++DV++ G+ +++L T +
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQFLQEL 494
I+ + +G G +G V+ H+ AVK L+ + F +E
Sbjct: 37 HIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94
Query: 495 EVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRL------------YRKNNTPP 540
E+L+ ++H H++ G C + +V+EYM +G L L P
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 541 IPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNS 599
+ + +A +VA+ + +L +HRD+ N L+ LV KIGD G+S + ++
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 600 DPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 642
D Y+ G P+ ++ PE + +SDV+++G+V
Sbjct: 212 D------YYRVGGRTMLPI---RWMPPESILYRKFTTESDVWSFGVV 249
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 513
+G G YG VY G A+K + + + ++ +E+ + ++H +++ LG+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 514 DHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPII 569
++G + E + GSL L ++ P+ E+ ++ L +LH+ + I+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 570 HRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--YQR 626
HRD+K N+L++ ++ V KI D G S L T GTL Y+ PE +
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF------TGTLQYMAPEIIDKG 198
Query: 627 TGLISPKSDVYAYGMVILQLLTAKP 651
+D+++ G I+++ T KP
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 43/233 (18%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FL 491
WE L + +G G +G V + AVK+L+ + +
Sbjct: 22 WE-FPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 78
Query: 492 QELEVLSKI-RHPHLLLLLGACPDHG---CLVYEYMENGSLED--RLYRKNNTPPIPWFE 545
EL++L I H +++ LLGAC G ++ E+ + G+L R R P E
Sbjct: 79 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 546 RYR-----------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594
+++VA + FL + K IHRD+ NILL V KI D GL+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 595 TMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 643
+ DP Y G P+ ++ PE + + +SDV+++G+++
Sbjct: 196 RDIYKDP-----DYVRKGDARLPL---KWMAPETIFDRVYTIQSDVWSFGVLL 240
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
IG G V A+K + K + L+E++ +S+ HP+++ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 512 --CPDHGCLVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTK 564
D LV + + GS+ D + + IA EV L +LH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE- 623
IHRD+K GNILL + +I D G+S L + + T VGT C++ PE
Sbjct: 142 ---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF-VGTPCWMAPEV 197
Query: 624 YQRTGLISPKSDVYAYGMVILQLLTAKP 651
++ K+D++++G+ ++L T
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 62/228 (27%), Positives = 97/228 (42%), Gaps = 41/228 (17%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQNKQ-FLQEL 494
+ ++ + F + IG G +G V K AA+K ++ + + + F EL
Sbjct: 19 YPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 76
Query: 495 EVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY---- 547
EVL K+ HP+++ LLGAC G L EY +G+L D L + P F
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 548 ---------RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598
A +VA + +L + IHRD+ NIL+ N V+KI D GLS
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--G 191
Query: 599 SDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 642
+ Y PV ++ E + + SDV++YG++
Sbjct: 192 QE------VYVKKTMGRLPV---RWMAIESLNYSVYTTNSDVWSYGVL 230
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 48/241 (19%), Positives = 91/241 (37%), Gaps = 51/241 (21%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELE 495
+ E+E +IG G +G+V+K A+K G++ + L+E+
Sbjct: 13 FHELE----------KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62
Query: 496 VLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAW 551
+ + +H H++ A + + EY GSL D + E +
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 552 EVASALAFLHNTKPKPIIHRDMKPGNILLDHN-------------------LVSKIGDVG 592
+V L ++H+ ++H D+KP NI + ++ KIGD+G
Sbjct: 123 QVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTGLISPKSDVYAYGMVILQLLTAKP 651
T ++S G ++ E Q PK+D++A + ++ A+P
Sbjct: 180 HVTRISSPQVE----------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229
Query: 652 A 652
Sbjct: 230 L 230
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 38/223 (17%)
Query: 456 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN------------------KQFLQELEVL 497
+ G + + + F A+K K ++ F EL+++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKY-EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 498 SKIRHPHLLLLLG--ACPDHGCLVYEYMENGSLEDRL-----YRKNNTPPIPWFERYRIA 550
+ I++ + L G D ++YEYMEN S+ KN T IP I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 610
V ++ +++HN K I HRD+KP NIL+D N K+ D G S + + +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGS--- 210
Query: 611 TGPVGTLCYIDPE--YQRTGLISPKSDVYAYGMVILQLLTAKP 651
GT ++ PE + K D+++ G+ + +
Sbjct: 211 ---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 60/238 (25%), Positives = 96/238 (40%), Gaps = 49/238 (20%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FL 491
WE L + +G G +G V K T H T AVK+L+ + + L
Sbjct: 18 WE-FPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL 74
Query: 492 QELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFERY 547
E VL ++ HPH++ L GAC G L+ EY + GSL R RK +
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 548 -------------------RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 588
AW+++ + +L K ++HRD+ NIL+ KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKI 191
Query: 589 GDVGLSTMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 642
D GLS + + +Y PV ++ E + + +SDV+++G++
Sbjct: 192 SDFGLSRDVYEED-----SYVKRSQGRIPV---KWMAIESLFDHIYTTQSDVWSFGVL 241
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 46/235 (19%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQ- 489
WE L+ + +G G +G V AVK+L+ ++
Sbjct: 30 WE-FPRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 86
Query: 490 FLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFER 546
+ E+E++ I +H +++ LLGAC G ++ EY G+L + L + ++
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 547 YR-------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593
R +++A + +L + K IHRD+ N+L+ N V KI D GL
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGL 203
Query: 594 S-TMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 643
+ + N D YK T PV ++ PE + + +SDV+++G+++
Sbjct: 204 ARDINNID------YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLM 249
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 51/234 (21%), Positives = 95/234 (40%), Gaps = 35/234 (14%)
Query: 431 TFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKG 483
+ E + ++ +G G +G VY+G AVK L
Sbjct: 16 GKTSSISDLKE-VPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 72
Query: 484 NIQNKQ-FLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNT 538
+ Q++ FL E ++SK H +++ +G ++ E M G L+ R R +
Sbjct: 73 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS 132
Query: 539 --PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGL 593
+ + +A ++A +L IHRD+ N LL V+KIGD G+
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 594 STMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 643
+ + + Y+ G PV ++ PE G+ + K+D +++G+++
Sbjct: 190 ARDIYRA-----SYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLL 235
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 448 LSFSENLRIGMGGYGT-VYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHL 505
+SF +G G GT VY+G F + AVK + + +E+++L + HP++
Sbjct: 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNV 80
Query: 506 LLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
+ D + E +L++ + +K+ E + + S LA LH+
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL--EPITLLQQTTSGLAHLHSL 137
Query: 564 KPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
I+HRD+KP NIL+ + + I D GL L + + +G GT
Sbjct: 138 N---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR---HSFSRRSGVPGTEG 191
Query: 619 YIDPEY---QRTGLISPKSDVYAYGMVILQLLT 648
+I PE + D+++ G V +++
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 51/228 (22%), Positives = 96/228 (42%), Gaps = 42/228 (18%)
Query: 438 LTWEEIESATLSFSENLRIGMGGYGTVYKGTF---------HHTFAAVKVLQSKGNIQNK 488
+ + I + L F+E +G G + ++KG H T +KVL ++
Sbjct: 1 VFHK-IRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE 57
Query: 489 QFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFER 546
F + ++SK+ H HL+L G C LV E+++ GSL+ L + N I W
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-- 115
Query: 547 YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--------HNLVSKIGDVGLSTMLN 598
+A ++A+A+ FL +IH ++ NILL + K+ D G+S +
Sbjct: 116 LEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 599 SDPSFVSTTYKNTGPVGTLCYIDPE---YQRTGLISPKSDVYAYGMVI 643
+ + ++ PE + ++ +D +++G +
Sbjct: 173 PK-----DILQ--ERIP---WVPPECIENPKN--LNLATDKWSFGTTL 208
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 38/233 (16%), Positives = 73/233 (31%), Gaps = 29/233 (12%)
Query: 441 EEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-------AVKVLQSKGNIQNKQFLQE 493
E + + + +G G + VY+ T +KV + + Q
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 494 LEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRL--YRKNNTPPIPWFERYRI 549
+E L + A + LV E G+L + + Y+ +P
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 550 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS-----------KIGDVGLSTMLN 598
A + + +H+ + IIH D+KP N +L + + + D+G S +
Sbjct: 178 AMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 651
P T T + E + + D + + +L
Sbjct: 235 LFPKGTIF----TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 40/230 (17%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQ-FL 491
WE L F + L G G +G V + T AVK+L+S + K+ +
Sbjct: 41 WE-FPRNNLQFGKTL--GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 492 QELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNT---------- 538
EL+++S + +H +++ LLGAC G ++ EY G L + L RK+
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 539 -PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597
+ + +VA +AFL + IHRD+ N+LL + V+KIGD GL+ +
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 598 NSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 643
+D Y G PV ++ PE + + +SDV++YG+++
Sbjct: 215 MNDS-----NYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILL 256
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 59/210 (28%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEV-LSKIRHPHLLLLLG 510
IG G YG+V K + AVK ++S + + KQ L +L+V + P+++ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 511 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 566
A G E M + S + + E +I AL L
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK- 146
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY-----ID 621
IIHRD+KP NILLD + K+ D G+S L + T G Y ID
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQL-------VDSIAKTRDAGCRPYMAPERID 198
Query: 622 PEYQRTGLISPKSDVYAYGMVILQLLTAKP 651
P R G +SDV++ G+ + +L T +
Sbjct: 199 PSASRQGY-DVRSDVWSLGITLYELATGRF 227
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 51/228 (22%), Positives = 100/228 (43%), Gaps = 40/228 (17%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-------AVKVLQSKGNIQNKQ-FLQE 493
EI + + F E +G +G VYKG A+K L+ K ++ F E
Sbjct: 5 EISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 494 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR--- 548
+ ++++HP+++ LLG +++ Y +G L + L ++ + + R
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 549 ----------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598
+ ++A+ + +L + ++H+D+ N+L+ L KI D+GL +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 599 SDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 642
+ + YK G P+ ++ PE G S SD+++YG+V
Sbjct: 180 A-----ADYYKLLGNSLLPI---RWMAPEAIMYGKFSIDSDIWSYGVV 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 34/225 (15%)
Query: 455 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 507
+G GG V+ H AVKVL + ++ F +E + + + HP ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 508 LLGACPDHGC------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 561
+ +V EY++ +L D ++ + P+ + + AL F H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH 133
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV-GTLCYI 620
IIHRD+KP NI++ K+ D G++ + + T V GT Y+
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS----GNSVTQTAAVIGTAQYL 186
Query: 621 DPEYQRTGLISPKSDVYAYGMVILQLLTAKP--------AIAITH 657
PE R + +SDVY+ G V+ ++LT +P ++A H
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 231
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 63/239 (26%), Positives = 107/239 (44%), Gaps = 49/239 (20%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FL 491
WE L F + +G G +G V T + AVK+L+ K + ++ +
Sbjct: 40 WE-FPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM 96
Query: 492 QELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFER 546
EL++++++ H +++ LLGAC G L++EY G L + R R+ + +E
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 547 YR------------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 588
+ A++VA + FL +HRD+ N+L+ H V KI
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKI 213
Query: 589 GDVGLSTMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 643
D GL+ + SD Y G PV ++ PE G+ + KSDV++YG+++
Sbjct: 214 CDFGLARDIMSDS-----NYVVRGNARLPV---KWMAPESLFEGIYTIKSDVWSYGILL 264
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 56/243 (23%), Positives = 104/243 (42%), Gaps = 44/243 (18%)
Query: 431 TFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQS 481
++ + WE + L + +G G +G V T AVK+L+S
Sbjct: 55 EYELPEDPRWE-LPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 111
Query: 482 KGNIQNKQ-FLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNN 537
++ + E+E++ I +H +++ LLGAC G ++ EY G+L + L +
Sbjct: 112 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 171
Query: 538 TPPIPWFERYR-------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 584
+ A++VA + +L + K IHRD+ N+L+ +
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDN 228
Query: 585 VSKIGDVGLSTMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYG 640
V KI D GL+ ++ YK T PV ++ PE + + +SDV+++G
Sbjct: 229 VMKIADFGLARDIHHID-----YYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFG 280
Query: 641 MVI 643
+++
Sbjct: 281 VLL 283
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 50/237 (21%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FLQE 493
E + + IG G +G V++ T AVK+L+ + + + F +E
Sbjct: 43 EYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 100
Query: 494 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRL------------------- 532
++++ +P+++ LLG C CL++EYM G L + L
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 533 --YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 590
PP+ E+ IA +VA+ +A+L K +HRD+ N L+ N+V KI D
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIAD 217
Query: 591 VGLS-TMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 642
GLS + ++D YK G P+ ++ PE + +SDV+AYG+V
Sbjct: 218 FGLSRNIYSAD------YYKADGNDAIPI---RWMPPESIFYNRYTTESDVWAYGVV 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 4e-25
Identities = 48/202 (23%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 453 NLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLL 507
++ +G G +G+V +G + A+KVL+ + + ++E +++ ++ +P+++
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 508 LLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
L+G C LV E G L + IP + +V+ + +L K
Sbjct: 401 LIGVCQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYLEE---K 455
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
+HR++ N+LL + +KI D GLS L +D S+ + P+ + PE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK---WYAPECIN 512
Query: 627 TGLISPKSDVYAYGMVILQLLT 648
S +SDV++YG+ + + L+
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALS 534
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 34/223 (15%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FLQE 493
E+ ++ +G G +G VY+G AVK L + Q++ FL E
Sbjct: 67 EVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 124
Query: 494 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFER--Y 547
++SK H +++ +G ++ E M G L+ R R + P
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 548 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNSDPSFV 604
+A ++A +L IHRD+ N LL V+KIGD G++ +
Sbjct: 185 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA---- 237
Query: 605 STTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 643
Y+ G PV ++ PE G+ + K+D +++G+++
Sbjct: 238 -GYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLL 276
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 4e-25
Identities = 30/296 (10%), Positives = 76/296 (25%), Gaps = 61/296 (20%)
Query: 401 EKEAAQRQEAEMKAKHEAKEK--EMLERALNGTFQRYRNLTWEEIESATLSFSENLR--- 455
+ +E + EA ++ M+E + + T ++S L+
Sbjct: 12 RDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETT---VDSLLSQGERKLKLVE 68
Query: 456 -IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLL 509
+ +G V+ A+KV ++ + +++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 510 GACP----------------------------DHGCLVYEYMENGSLEDRL----YRKNN 537
+ L+ LE +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187
Query: 538 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597
+ + ++ A L + K ++H P N+ + + +GDV +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 598 NSDPSFVSTTYKNTGPVGTLCYIDPEY--QRTGLISPKSDVYAYGMVILQLLTAKP 651
+ + + Y E+ T + + + G+ I ++
Sbjct: 245 GT---------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 46/235 (19%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQ- 489
WE L+ + +G G +G V AVK+L+ ++
Sbjct: 76 WE-FPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 132
Query: 490 FLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFER 546
+ E+E++ I +H +++ LLGAC G ++ EY G+L + L + ++
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 547 YR-------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593
R +++A + +L + K IHRD+ N+L+ N V KI D GL
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGL 249
Query: 594 S-TMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 643
+ + N D YK T PV ++ PE + + +SDV+++G+++
Sbjct: 250 ARDINNID------YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLM 295
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 47/222 (21%), Positives = 85/222 (38%), Gaps = 35/222 (15%)
Query: 455 RIGMGGYGTVYKGTFHHT----FAAVKVLQSKGNIQN-----KQFLQELEVLSKIRHPHL 505
+G GG G VY+ T A+K++ + + + +E +++ PH+
Sbjct: 41 LVGRGGMGDVYEA--EDTVRERIVALKLM--SETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 506 LLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
+ + G + + L L R+ P+ I ++ SAL H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA 153
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV-GTLCYIDP 622
HRD+KP NIL+ + + + D G+++ G GTL Y+ P
Sbjct: 154 G---ATHRDVKPENILVSADDFAYLVDFGIASATT------DEKLTQLGNTVGTLYYMAP 204
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAKP-------AIAITH 657
E + ++D+YA V+ + LT P ++ H
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH 246
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 54/204 (26%), Positives = 84/204 (41%), Gaps = 23/204 (11%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 509
+G G +G VY A+KVL K ++ Q +E+E+ S +RHP++L +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVL-FKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 510 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
D L+ E+ G L L + E+A AL + H +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ---RSATFMEELADALHYCHE---RK 134
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+IHRD+KP N+L+ + KI D G S + T GTL Y+ PE
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTM------CGTLDYLPPEMIEG 186
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
K D++ G++ + L P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 33/314 (10%), Positives = 79/314 (25%), Gaps = 53/314 (16%)
Query: 382 EKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWE 441
+ Y R + E+ + +A ++ E + + + E
Sbjct: 11 RENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVE 70
Query: 442 -EIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ--------- 489
E+ + +G + T T V V +
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 490 -------------------FLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENG 526
F+ +++ + ++ + D +Y M+
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-S 189
Query: 527 SLEDRL----YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 582
+L+ + + R ++ +V LA LH+ ++H ++P +I+LD
Sbjct: 190 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQ 246
Query: 583 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-----YQRTGLISPKSDVY 637
+ + L++ D +
Sbjct: 247 RGGVFLTGFEHLVRDGASAVSPIGR-----GFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 638 AYGMVILQLLTAKP 651
G+ I + A
Sbjct: 302 TLGLAIYWIWCADL 315
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 456 IGMGGYGTV-YKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC- 512
+G G GTV ++G+F AVK + L E+++L++ HP+++ +
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 513 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEV----ASALAFLHNTKPKP 567
+ E +L+D + KN + ++ + AS +A LH+ K
Sbjct: 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--- 135
Query: 568 IIHRDMKPGNILLDH-------------NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 614
IIHRD+KP NIL+ NL I D GL L+S S T P
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN--NPS 193
Query: 615 GTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLT 648
GT + PE Q ++ D+++ G V +L+
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 42/207 (20%), Positives = 76/207 (36%), Gaps = 19/207 (9%)
Query: 457 GMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA- 511
G TV + T + V+ L++ N EL V HP+++
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 512 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKP 567
+ +V +M GS +D L + + E IA+ V AL ++H+
Sbjct: 96 IADNELWVVTSFMAYGSAKD-LICTHFMDGMN--ELA-IAYILQGVLKALDYIHHMG--- 148
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP-VGTLCYIDPE--Y 624
+HR +K +IL+ + + + + + S + V L ++ PE
Sbjct: 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKP 651
Q KSD+Y+ G+ +L
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHV 235
|
| >2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B Length = 100 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-23
Identities = 20/90 (22%), Positives = 29/90 (32%), Gaps = 4/90 (4%)
Query: 713 LERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQEND 772
+E + RA P+ F P++ +M +P G DR I L +
Sbjct: 9 VEEIVAKNARAEIDYSDA----PDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLNSP 64
Query: 773 KSPITDLPLPNKNLLPNYTLLSAILDWKSK 802
P L L P L I W +
Sbjct: 65 TDPFNRQTLTESMLEPVPELKEQIQAWMRE 94
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK----QFLQELEVLSKIRHPHLLLLL 509
+G G +G V T AVKV+ SK ++ K L+E+++L ++ HP+++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 510 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKP 565
D G LV E G L D + + E RI +V S + ++H K
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-----EVDAARIIRQVLSGITYMHKNK- 146
Query: 566 KPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
I+HRD+KP N+LL + +I D GLST + +GT YI P
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-------KDKIGTAYYIAP 197
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAKP 651
E G K DV++ G+++ LL+ P
Sbjct: 198 EVLH-GTYDEKCDVWSTGVILYILLSGCP 225
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 27/207 (13%)
Query: 456 IGMGGYGTVYKGTFHHTFA--AVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
+G G YG V T A+K+++ N + L+E+ VL + HP+++ L
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 512 CPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 567
D LV E + G L D + + E I +V S + +LH
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFN-----EVDAAVIIKQVLSGVTYLHKHN--- 156
Query: 568 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
I+HRD+KP N+LL + + + KI D GLS + + +GT YI PE
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-------KERLGTAYYIAPEV 209
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKP 651
R K DV++ G+++ LL P
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 509
+IG G +G V+KG + T A+K++ +++ I++ Q QE+ VLS+ P++
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYY 86
Query: 510 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTK 564
G+ L + EY+ GS D L P E IA E+ L +LH+ K
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALD-LLEPG-----PLDETQ-IATILREILKGLDYLHSEK 139
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
IHRD+K N+LL + K+ D G++ L T K VGT ++ PE
Sbjct: 140 ---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT------DTQIKRNTFVGTPFWMAPEV 190
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKP 651
+ K+D+++ G+ ++L +P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEP 217
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 27/199 (13%)
Query: 456 IGMGGYGTVYKGTFHHTF----AAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLL 508
IG G + V H A+K++ K + ++ +E+ ++ + HP+++ L
Sbjct: 23 IGKGNFAKVKLAR--HILTGREVAIKII-DKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 509 LG--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
L+ EY G + D L + E ++ SA+ + H K
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ---K 133
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQ 625
I+HRD+K N+LLD ++ KI D G S + + G Y PE +Q
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAF------CGAPPYAAPELFQ 186
Query: 626 RTGLISPKSDVYAYGMVIL 644
P+ DV++ G VIL
Sbjct: 187 GKKYDGPEVDVWSLG-VIL 204
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 510
+G G + TV T A+K+L+ + I+ + +E +V+S++ HP + L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 511 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKP 567
D L Y +NG L + + + R E+ SAL +LH K
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE----TCTRFYTAEIVSALEYLHG---KG 150
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
IIHRD+KP NILL+ ++ +I D G + +L+ + N+ VGT Y+ PE
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA---NSF-VGTAQYVSPE---- 202
Query: 628 GLISPK-----SDVYAYGMVILQLLTAKP 651
L++ K SD++A G +I QL+ P
Sbjct: 203 -LLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} Length = 85 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-22
Identities = 17/68 (25%), Positives = 24/68 (35%)
Query: 735 PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLS 794
P+ F P++ +M +P G DR I L + P L L P L
Sbjct: 12 PDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLNSPTDPFNRQMLTESMLEPVPELKE 71
Query: 795 AILDWKSK 802
I W +
Sbjct: 72 QIQAWMRE 79
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 456 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 510
+G G +G V K T AVKV+ +K + +NK L+E+E+L K+ HP+++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 511 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 566
D +V E G L D + ++ E RI +V S + ++H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFS-----EHDAARIIKQVFSGITYMHKHN-- 141
Query: 567 PIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
I+HRD+KP NILL + + KI D GLST + +GT YI PE
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------KDRIGTAYYIAPE 193
Query: 624 YQRTGLISPKSDVYAYGMVIL-QLLTAKP 651
R G K DV++ G VIL LL+ P
Sbjct: 194 VLR-GTYDEKCDVWSAG-VILYILLSGTP 220
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG- 510
+G G YG V T AVK++ + + +E+ + + H +++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 511 -ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
+ L EY G L DR+ +P + R ++ + + +LH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---IT 127
Query: 570 HRDMKPGNILLDHNLVSKIGDVGLSTM--LNSDPSFVSTTYKNTGPVGTLCYIDPE-YQR 626
HRD+KP N+LLD KI D GL+T+ N+ ++ GTL Y+ PE +R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM------CGTLPYVAPELLKR 181
Query: 627 TGLISPKSDVYAYGMVIL 644
+ DV++ G ++L
Sbjct: 182 REFHAEPVDVWSCG-IVL 198
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 4e-22
Identities = 37/306 (12%), Positives = 82/306 (26%), Gaps = 66/306 (21%)
Query: 397 RASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEI---ESATLSFSEN 453
E+ + +A ++ E + + + E TL
Sbjct: 21 DVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGT- 79
Query: 454 LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ------------------------- 486
+G + T T V V
Sbjct: 80 -VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 487 ---NKQFLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYME--NGSLEDRLY-RKN 536
+ +F+ +++ + ++ + D +Y M+ + + L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 537 NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596
+ R ++ +V LA LH+ ++H ++P +I+LD +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEY-----------QRTGLISPKSDVYAYGMVILQ 645
+ + + PE R L++ D +A G+VI
Sbjct: 256 DGARVVS----------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 646 LLTAKP 651
+ A
Sbjct: 306 IWCADL 311
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
+G G +G VYK T AA KV+++K + + ++ E+E+L+ HP+++ LLGA
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 513 PDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKP 567
G L + E+ G+++ + + + +I ++ AL FLH+ +
Sbjct: 86 YHDGKLWIMIEFCPGGAVDA-IMLELDRG----LTEPQIQVVCRQMLEALNFLHSKR--- 137
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---- 623
IIHRD+K GN+L+ ++ D G+S T K +GT ++ PE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL------KTLQKRDSFIGTPYWMAPEVVMC 191
Query: 624 -YQRTGLISPKSDVYAYGMVILQLLTAKP 651
+ K+D+++ G+ ++++ +P
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 24/198 (12%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRHPHLLLLL 509
+G+G +G V G T AVK+L ++ I++ + E++ L RHPH++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKIL-NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 510 G--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
+ P +V EY+ G L D + + + E R+ ++ SA+ + H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHR---HM 131
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQR 626
++HRD+KP N+LLD ++ +KI D GLS M++ F+ T+ G+ Y PE
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS------CGSPNYAAPEVISG 184
Query: 627 TGLISPKSDVYAYGMVIL 644
P+ D+++ G VIL
Sbjct: 185 RLYAGPEVDIWSCG-VIL 201
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 47/203 (23%), Positives = 89/203 (43%), Gaps = 31/203 (15%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
+G G +G V+ + +K + + + +Q E+EVL + HP+++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 513 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY------RIAWEVASALAFLHNTK 564
D+ +V E E G L +R+ + + ++ +ALA+ H+
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARG-----KALSEGYVAELMKQMMNALAYFHSQH 144
Query: 565 PKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
++H+D+KP NIL + KI D GL+ + SD T GT Y+
Sbjct: 145 ---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-------TNAAGTALYMA 194
Query: 622 PEYQRTGLISPKSDVYAYGMVIL 644
PE + ++ K D+++ G V++
Sbjct: 195 PEVFK-RDVTFKCDIWSAG-VVM 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 53/226 (23%)
Query: 456 IGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQFL--------------------- 491
IG G YG V + +T+ A+KVL SK + +
Sbjct: 21 IGKGSYGVVKLAY-NENDNTYYAMKVL-SKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 492 ------QELEVLSKIRHPHLLLLL----GACPDHGCLVYEYMENGSLEDRLYRKNNTPPI 541
QE+ +L K+ HP+++ L+ DH +V+E + G + + K P+
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PL 134
Query: 542 PWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601
+ ++ + +LH K IIHRD+KP N+L+ + KI D G+S
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 602 SFVSTTYKNTGPVGTLCYIDPE---YQRTGLISPKSDVYAYGMVIL 644
+ +S T VGT ++ PE R DV+A G V L
Sbjct: 192 ALLSNT------VGTPAFMAPESLSETRKIFSGKALDVWAMG-VTL 230
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 25/203 (12%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKV-----LQSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
IG G + V + T AVK+ S + + +E + ++HPH++ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 509 LGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTK 564
L G +V+E+M+ L + ++ + + E ++ AL + H+
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF-VYSEAVASHYMRQILEALRYCHDNN 150
Query: 565 PKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
IIHRD+KP +LL +++ K+G G++ L VGT ++
Sbjct: 151 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR------VGTPHFMA 201
Query: 622 PEYQRTGLISPKSDVYAYGMVIL 644
PE + DV+ G VIL
Sbjct: 202 PEVVKREPYGKPVDVWGCG-VIL 223
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 450 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 507
++ +IG G GTVY T A++ + + + + + E+ V+ + ++P+++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 508 LLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 563
L + L V EY+ GSL D + + E + E AL FLH+
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTD-VVTET-----CMDEGQIAAVCRECLQALEFLHSN 135
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
+ +IHRD+K NILL + K+ D G + K + VGT ++ PE
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPE 186
Query: 624 YQRTGLISPKSDVYAYGMVILQLLTAKP 651
PK D+++ G++ ++++ +P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 40/206 (19%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 510
+G G +G V K T AVKV+ +K + +NK L+E+E+L K+ HP+++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 511 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 566
D +V E G L D + ++ + E RI +V S + ++H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 567 PIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
I+HRD+KP NILL + + KI D GLST + +GT YI PE
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------KDRIGTAYYIAPE 193
Query: 624 -----YQRTGLISPKSDVYAYGMVIL 644
Y K DV++ G VIL
Sbjct: 194 VLRGTY------DEKCDVWSAG-VIL 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 450 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 507
F ++G G YG+VYK T A+K + + ++Q +E+ ++ + PH++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII--KEISIMQQCDSPHVVK 88
Query: 508 LLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHN 562
G+ + L V EY GS+ D + R N IA L +LH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKT----LTEDEIATILQSTLKGLEYLHF 143
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
+ IHRD+K GNILL+ +K+ D G++ L T K +GT ++ P
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT------DTMAKRNTVIGTPFWMAP 194
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAKP 651
E + + +D+++ G+ +++ KP
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 38/204 (18%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC 512
IG G +G V T A K + K +++ F QE+E++ + HP+++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKI-PKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 513 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPI 568
D+ LV E G L +R+ K + E RI +V SA+A+ H +
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV-----FRESDAARIMKDVLSAVAYCHKLN---V 127
Query: 569 IHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-- 623
HRD+KP N L + K+ D GL+ VGT Y+ P+
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-------RTKVGTPYYVSPQVL 180
Query: 624 ---YQRTGLISPKSDVYAYGMVIL 644
Y P+ D ++ G V++
Sbjct: 181 EGLY------GPECDEWSAG-VMM 197
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG- 510
+G G YG V T AVK++ + + +E+ + + H +++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 511 -ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
+ L EY G L DR+ +P + R ++ + + +LH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---IT 127
Query: 570 HRDMKPGNILLDHNLVSKIGDVGLSTM--LNSDPSFVSTTYKNTGPVGTLCYIDPE-YQR 626
HRD+KP N+LLD KI D GL+T+ N+ ++ GTL Y+ PE +R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM------CGTLPYVAPELLKR 181
Query: 627 TGLISPKSDVYAYGMVIL 644
+ DV++ G ++L
Sbjct: 182 REFHAEPVDVWSCG-IVL 198
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 53/212 (25%), Positives = 83/212 (39%), Gaps = 28/212 (13%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 508
IG G + V K T A+K++ ++ + F +E +VL + L
Sbjct: 69 IGRGAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 509 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
A ++ LV EY G L L + P R+ +A E+ A+ +H
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVHR---L 181
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQ 625
+HRD+KP NILLD ++ D G L +D + S VGT Y+ PE Q
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-----AVGTPDYLSPEILQ 236
Query: 626 RTGLISPKS------DVYAYGMVILQLLTAKP 651
G D +A G+ ++ +
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 49/252 (19%), Positives = 105/252 (41%), Gaps = 31/252 (12%)
Query: 416 HEAKEKEMLERALNGTFQRYRNLTWEEIESA----------TLSFSENLRIGMGGYGTVY 465
H ++ + + +T E+ ++A L ++IG G G V
Sbjct: 3 HHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVC 62
Query: 466 KGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCL--VYE 521
H+ AVK++ + + + E+ ++ +H +++ + + L + E
Sbjct: 63 LAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122
Query: 522 YMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 579
+++ G+L D + + E + V ALA+LH +IHRD+K +IL
Sbjct: 123 FLQGGALTD-IVSQV-----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173
Query: 580 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAY 639
L + K+ D G ++ K VGT ++ PE L + + D+++
Sbjct: 174 LTLDGRVKLSDFGFCAQIS------KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSL 227
Query: 640 GMVILQLLTAKP 651
G+++++++ +P
Sbjct: 228 GIMVIEMVDGEP 239
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-21
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 456 IGMGGYGTVYKGTFHHTFA--AVKVL-------------QSKGNIQNKQFLQELEVLSKI 500
+G G YG V + + A+KV+ +++ E+ +L +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 501 RHPHLLLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASA 556
HP+++ L D LV E+ E G L +++ ++ E I ++ S
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD-----ECDAANIMKQILSG 158
Query: 557 LAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
+ +LH I+HRD+KP NILL + L KI D GLS+ + D
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-------RDR 208
Query: 614 VGTLCYIDPEYQRTGLISPKSDVYAYGMVIL-QLLTAKP 651
+GT YI PE + + K DV++ G VI+ LL P
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCG-VIMYILLCGYP 245
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 4e-21
Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 38/305 (12%)
Query: 370 LLEEKAIELAKQEKKKYETARREAECARASAEKEAAQR--------QEAEMKAKHEAKEK 421
+ + A+ + Y + + C+ AE A R Q +
Sbjct: 98 ADDALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQA 157
Query: 422 EMLERALNGTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTVYKGTFHHT--FAAVKV 478
E + F R+ W E + + + R +G GG+G V+ T A K
Sbjct: 158 PFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKK 217
Query: 479 LQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGA--CPDHGCLVYEYMENGSLEDRLY 533
L K + K + + E ++L+K+ ++ L A CLV M G + +Y
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 534 RKNNTPPIPWFERYRI---AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 590
+ P F+ R ++ S L LH II+RD+KP N+LLD + +I D
Sbjct: 278 NVDEDNPG--FQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISD 332
Query: 591 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQRTGLISPKS-DVYAYGMVILQL 646
+GL+ L + + GT ++ PE + S D +A G+ + ++
Sbjct: 333 LGLAVELKAGQTKTKGY------AGTPGFMAPELLLGEEYD----FSVDYFALGVTLYEM 382
Query: 647 LTAKP 651
+ A+
Sbjct: 383 IAARG 387
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA 511
+G G YG VYKG T AA+KV+ G+ + ++ QE+ +L K H ++ GA
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGA 89
Query: 512 --------CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFL 560
D LV E+ GS+ D L + + E + IA+ E+ L+ L
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLK--EEW-IAYICREILRGLSHL 145
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
H K +IHRD+K N+LL N K+ D G+S L+ T + +GT ++
Sbjct: 146 HQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD------RTVGRRNTFIGTPYWM 196
Query: 621 DPE-----YQRTGLISPKSDVYAYGMVILQLLTAKP 651
PE KSD+++ G+ +++ P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 Length = 98 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-21
Identities = 19/70 (27%), Positives = 28/70 (40%), Gaps = 1/70 (1%)
Query: 734 PPNHFICPILKEVMNEPCVAADG-YTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTL 792
+ F+ PI+ +M +P V T DR I L + P PL + PN L
Sbjct: 19 ACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRSPLTMDQIRPNTEL 78
Query: 793 LSAILDWKSK 802
I W ++
Sbjct: 79 KEKIQRWLAE 88
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 446 ATLSFSENLR---------IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQEL 494
+T SFS +G G + V T AVK+++ + + +E+
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 495 EVLSKIR-HPHLLLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--R 548
E+L + + H ++L L+ + LV+E M GS+ ++++ + F E
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH------FNELEASV 115
Query: 549 IAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVS 605
+ +VASAL FLHN K I HRD+KP NIL + KI D L + + +
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 606 TTYKN-TGPVGTLCYIDPEYQRTGLISPKS-----DVYAYGMVIL 644
+ P G+ Y+ PE D+++ G VIL
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VIL 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 52/196 (26%), Positives = 81/196 (41%), Gaps = 22/196 (11%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL--LGA 511
IG G +G T AVK + +G ++ +E+ +RHP+++ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 512 CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 571
P H ++ EY G L +R+ E ++ S +++ H+ + I HR
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLSGVSYCHSMQ---ICHR 140
Query: 572 DMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTG 628
D+K N LLD + KI D G S S +T VGT YI PE R
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST------VGTPAYIAPEVLLRQE 193
Query: 629 LISPKSDVYAYGMVIL 644
+DV++ G V L
Sbjct: 194 YDGKIADVWSCG-VTL 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 55/235 (23%), Positives = 95/235 (40%), Gaps = 41/235 (17%)
Query: 434 RYRNLTWEEIESATLSFSENLRI----GMGGYGTVYKGTFHHTFA--AVKVL-------- 479
+ +LT ++ + + + G G G V T A++++
Sbjct: 117 VFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG 176
Query: 480 QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNN 537
++ E+E+L K+ HP ++ + D+ +V E ME G L D++
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR 235
Query: 538 TPPIPWFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVG 592
E +++ A+ +LH IIHRD+KP N+LL + + + KI D G
Sbjct: 236 LK-----EATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQRTGLISPKSDVYAYGMVIL 644
S +L + S + T GT Y+ PE T + D ++ G VIL
Sbjct: 288 HSKILG-ETSLMRTL------CGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VIL 334
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 49/177 (27%), Positives = 75/177 (42%), Gaps = 21/177 (11%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 508
IG G +G V K A+K+L ++ + F +E +VL + L
Sbjct: 82 IGRGAFGEVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 509 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
A ++ LV +Y G L L + + P R+ +A E+ A+ +H
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMVIAIDSVHQ---L 194
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
+HRD+KP NIL+D N ++ D G L D + S+ VGT YI PE
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-----AVGTPDYISPE 246
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 26/198 (13%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA-- 511
+G G + V+ T A+K ++ ++ E+ VL KI+H +++ L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 512 CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPII 569
H LV + + G L DR+ + + E+ + +V SA+ +LH I+
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGV-----YTEKDASLVIQQVLSAVKYLHENG---IV 128
Query: 570 HRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
HRD+KP N+L + N I D GLS M +ST GT Y+ PE
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTA------CGTPGYVAPEVLA 180
Query: 627 TGLISPKSDVYAYGMVIL 644
S D ++ G VI
Sbjct: 181 QKPYSKAVDCWSIG-VIT 197
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 24/198 (12%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRHPHLLLLL 509
+G+G +G V G T AVK+L ++ I++ + E++ L RHPH++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKIL-NRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 510 G--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
+ P +V EY+ G L D + + E R+ ++ S + + H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK---ESRRLFQQILSGVDYCHRHM--- 136
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQR 626
++HRD+KP N+LLD ++ +KI D GLS M++ F+ T+ G+ Y PE
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS------CGSPNYAAPEVISG 189
Query: 627 TGLISPKSDVYAYGMVIL 644
P+ D+++ G VIL
Sbjct: 190 RLYAGPEVDIWSSG-VIL 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 45/206 (21%), Positives = 78/206 (37%), Gaps = 34/206 (16%)
Query: 456 IGMGGYGTVYKGTFHHTFA----AVKVLQSKGNIQNKQFL---------QELEVLSKIRH 502
+G G +G V+ VK + K + ++ E+ +LS++ H
Sbjct: 32 LGSGAFGFVWTAV--DKEKNKEVVVKFI-KKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 503 PHLLLLLG--ACPDHGCLVYEYMENGS-LEDRLYRKNNTPPIPWFERYRIAWEVASALAF 559
+++ +L LV E +G L + R I ++ SA+ +
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE---PLASYIFRQLVSAVGY 145
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
L K IIHRD+K NI++ + K+ D G + L T GT+ Y
Sbjct: 146 LRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTF------CGTIEY 195
Query: 620 IDPE-YQRTGLISPKSDVYAYGMVIL 644
PE P+ ++++ G V L
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLG-VTL 220
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 5e-20
Identities = 51/258 (19%), Positives = 102/258 (39%), Gaps = 27/258 (10%)
Query: 399 SAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRI-- 456
E++ + + + + K + + N F ++ + +E ++ I
Sbjct: 104 GDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHE 163
Query: 457 --GMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
G G +G V++ T T A K + + + +E++ +S +RHP L+ L A
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 513 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPI 568
+ ++YE+M G L +++ ++N E +V L +H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMHE---NNY 276
Query: 569 IHRDMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
+H D+KP NI+ + K+ D GL+ L+ S GT + PE
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-------KVTTGTAEFAAPEVAE 329
Query: 627 TGLISPKSDVYAYGMVIL 644
+ +D+++ G V+
Sbjct: 330 GKPVGYYTDMWSVG-VLS 346
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 5e-20
Identities = 55/247 (22%), Positives = 82/247 (33%), Gaps = 57/247 (23%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKV-----LQSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
IG G YG V + T A+K+ ++ ++ E+ ++ K+ HP++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 509 LGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE-------------- 552
D LV E G L D+L +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 553 -----------------------VASALAFLHNTKPKPIIHRDMKPGNILL--DHNLVSK 587
+ SAL +LHN + I HRD+KP N L + + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 588 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--YQRTGLISPKSDVYAYGMVIL- 644
+ D GLS Y T GT ++ PE PK D ++ G V+L
Sbjct: 211 LVDFGLSKEF--YKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLH 267
Query: 645 QLLTAKP 651
LL
Sbjct: 268 LLLMGAV 274
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 23/197 (11%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 513
+G G +G V++ T K + + + E+ +++++ HP L+ L A
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 514 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPII 569
D L+ E++ G L DR+ ++ E + L +H I+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYK----MSEAEVINYMRQACEGLKHMHE---HSIV 171
Query: 570 HRDMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
H D+KP NI+ + S KI D GL+T LN D T + PE
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV-------KVTTATAEFAAPEIVDR 224
Query: 628 GLISPKSDVYAYGMVIL 644
+ +D++A G V+
Sbjct: 225 EPVGFYTDMWAIG-VLG 240
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 38/211 (18%)
Query: 456 IGMGGYGTVYKGTFHHTFA--AVKV-------LQSKGNIQNKQ--FLQELEVLSKI-RHP 503
+G G V + T AVK+ S +Q + L+E+++L K+ HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 504 HLLLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAF 559
+++ L + LV++ M+ G L D L K E+ +I + +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVICA 139
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
LH I+HRD+KP NILLD ++ K+ D G S L+ GT Y
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-------REVCGTPSY 189
Query: 620 IDPE------YQRTGLISPKSDVYAYGMVIL 644
+ PE + D+++ G VI+
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTG-VIM 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ-----ELEVLSKIRHPHLLLL 508
+G G YG V + T AVK+L K ++ + E+++L ++RH +++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKIL-KKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 509 ----LGACPDHGCLVYEYMENGSLE--DRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
+V EY G E D + K P + + ++ L +LH+
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----RFPVCQAHGYFCQLIDGLEYLHS 127
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN--SDPSFVSTTYKNTGPVGTLCYI 620
+ I+H+D+KPGN+LL KI +G++ L+ + T+ G+ +
Sbjct: 128 ---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS------QGSPAFQ 178
Query: 621 DPEYQRTGLIS-------PKSDVYAYGMVILQLLTA 649
PE + + K D+++ G V L +T
Sbjct: 179 PPE-----IANGLDTFSGFKVDIWSAG-VTLYNITT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-20
Identities = 42/200 (21%), Positives = 83/200 (41%), Gaps = 26/200 (13%)
Query: 456 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFL-QELEVLSKIRHPHLLLLLGA 511
+G G + V + +AA+ + K + ++ Q L +E + ++HP+++ L +
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 512 CPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 567
+ G L+++ + G L + + + + E ++ A+ H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREY-----YSEADASHCIQQILEAVLHCHQMG--- 130
Query: 568 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
++HR++KP N+LL K+ D GL+ + + GT Y+ PE
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF------AGTPGYLSPEV 184
Query: 625 QRTGLISPKSDVYAYGMVIL 644
R D++A G VIL
Sbjct: 185 LRKDPYGKPVDLWACG-VIL 203
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 56/286 (19%), Positives = 106/286 (37%), Gaps = 35/286 (12%)
Query: 367 EIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLER 426
Q ++ + ++ + + A+ K A A +
Sbjct: 20 YFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVT 79
Query: 427 ALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGN 484
A G + ++ EI +G G +G V+K T A K+++++G
Sbjct: 80 AKQGAVNSFYTVSKTEI------------LGGGRFGQVHKCEETATGLKLAAKIIKTRGM 127
Query: 485 IQNKQFLQELEVLSKIRHPHLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIP 542
++ E+ V++++ H +L+ L A + LV EY++ G L DR+ ++
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT-- 185
Query: 543 WFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS--KIGDVGLSTMLN 598
E ++ + +H I+H D+KP NIL + KI D GL+
Sbjct: 186 --ELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240
Query: 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVIL 644
GT ++ PE +S +D+++ G VI
Sbjct: 241 PREKL-------KVNFGTPEFLAPEVVNYDFVSFPTDMWSVG-VIA 278
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 49/164 (29%), Positives = 73/164 (44%), Gaps = 19/164 (11%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 509
IG G +G VY A+K + + N + + ++E+ L K+RHP+ +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 510 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIA---WEVASALAFLHNTK 564
G V EY GS D L + P + IA LA+LH+
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASD-LLEVHKKP----LQEVEIAAVTHGALQGLAYLHSHN 174
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 608
+IHRD+K GNILL + K+GD G ++++ SFV T Y
Sbjct: 175 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 46/205 (22%), Positives = 87/205 (42%), Gaps = 32/205 (15%)
Query: 456 IGMGGYGTVYKGTFHHT---FAA-----VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 507
+G G + V K T +AA ++ S+ + ++ +E+ +L +IRHP+++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 508 LLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 563
L L+ E + G L D L K + E + ++ + +LH+
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLT-----EDEATQFLKQILDGVHYLHSK 127
Query: 564 KPKPIIHRDMKPGNILLDHNLVS----KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
+ I H D+KP NI+L V K+ D G++ + + F GT +
Sbjct: 128 R---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-------KNIFGTPEF 177
Query: 620 IDPEYQRTGLISPKSDVYAYGMVIL 644
+ PE + ++D+++ G VI
Sbjct: 178 VAPEIVNYEPLGLEADMWSIG-VIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 44/205 (21%), Positives = 81/205 (39%), Gaps = 32/205 (15%)
Query: 456 IGMGGYGTVYKGTFHHT---FAA-----VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 507
+G G + V K T +AA + S+ + ++ +E+ +L ++ H +++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 508 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 563
L L+ E + G L D L +K + E ++ + +LH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS-----EEEATSFIKQILDGVNYLHTK 134
Query: 564 KPKPIIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
K I H D+KP NI+L K+ D GL+ + F GT +
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-------KNIFGTPEF 184
Query: 620 IDPEYQRTGLISPKSDVYAYGMVIL 644
+ PE + ++D+++ G VI
Sbjct: 185 VAPEIVNYEPLGLEADMWSIG-VIT 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 42/300 (14%), Positives = 89/300 (29%), Gaps = 73/300 (24%)
Query: 455 RIGMGGYGTVYKG--TFHHTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLL 509
G ++ T A+ + +G + ++ L LS+I P + +L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 510 --GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
G +V E++ GSL++ +T P P R +A+A H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPV-GAIRAMQSLAAAADAAHRA---G 149
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+ P + + + + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPDA---- 179
Query: 628 GLISPKSDVYAYGMVILQLLTAKP-----------AIAITHKVETAIDEDNLAEILDAQA 676
+P+ D+ G + LL + A A I+ ++ +
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF-- 234
Query: 677 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPN 736
+++A+ + R + +L ++++ VADR P + AP +
Sbjct: 235 ---------QISAVAARSVQGDGGIRSA--STLLNLMQQATAVADRTEVLGP-IDEAPVS 282
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-19
Identities = 64/239 (26%), Positives = 98/239 (41%), Gaps = 37/239 (15%)
Query: 430 GTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ 486
F R+ W E + T + R +G GG+G V T A K L+ K +
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 224
Query: 487 NKQF---LQELEVLSKIRHPHLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPI 541
K L E ++L K+ ++ L A D CLV M G L+ +Y
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ---- 280
Query: 542 PWFERYRI---AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598
F R A E+ L LH + I++RD+KP NILLD + +I D+GL+ +
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 599 SDPSFVSTTYKNTGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
T G VGT+ Y+ PE Y + D +A G ++ +++ +
Sbjct: 338 EG----QTI---KGRVGTVGYMAPEVVKNERYTFS------PDWWALGCLLYEMIAGQS 383
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 45/200 (22%), Positives = 88/200 (44%), Gaps = 27/200 (13%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
+G G + V + T A K++ +K ++ +E + K++HP+++ L +
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 512 CPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 567
+ LV++ + G L + + + + E ++ ++A+ H+
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILESIAYCHSNG--- 125
Query: 568 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
I+HR++KP N+LL K+ D GL+ +N ++ G GT Y+ PE
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-------HGFAGTPGYLSPEV 178
Query: 625 QRTGLISPKSDVYAYGMVIL 644
+ S D++A G VIL
Sbjct: 179 LKKDPYSKPVDIWACG-VIL 197
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 30/200 (15%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGAC 512
+G G + K + AVK++ + +E+ L HP+++ L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 513 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNTKPKP 567
D LV E + G L +R+ +K + F E I ++ SA++ +H+
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMRKLVSAVSHMHD---VG 126
Query: 568 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
++HRD+KP N+L + NL KI D G + + D + T P TL Y PE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT------PCFTLHYAAPEL 180
Query: 625 QRTGLISPKSDVYAYGMVIL 644
D+++ G VIL
Sbjct: 181 LNQNGYDESCDLWSLG-VIL 199
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 32/205 (15%)
Query: 456 IGMGGYGTVYKGTFHHT---FAA-----VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 507
+G G + V K T +AA + S+ + ++ +E+ +L ++ HP+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 508 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 563
L L+ E + G L D L +K + E ++ + +LH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS-----EEEATSFIKQILDGVNYLHT- 133
Query: 564 KPKPIIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
K I H D+KP NI+L K+ D GL+ + F GT +
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-------KNIFGTPEF 184
Query: 620 IDPEYQRTGLISPKSDVYAYGMVIL 644
+ PE + ++D+++ G VI
Sbjct: 185 VAPEIVNYEPLGLEADMWSIG-VIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 38/199 (19%), Positives = 78/199 (39%), Gaps = 28/199 (14%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC- 512
+G G +G V++ + K + +E+ +L+ RH ++L L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 513 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFER--YRIAWEVASALAFLHNTKPKPII 569
+ +++E++ + +R+ ER +V AL FLH+ I
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELN----EREIVSYVHQVCEALQFLHS---HNIG 124
Query: 570 HRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
H D++P NI+ + KI + G + L +F Y PE
Sbjct: 125 HFDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNF-------RLLFTAPEYYAPEVH 175
Query: 626 RTGLISPKSDVYAYGMVIL 644
+ ++S +D+++ G ++
Sbjct: 176 QHDVVSTATDMWSLG-TLV 193
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 45/200 (22%), Positives = 88/200 (44%), Gaps = 27/200 (13%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
+G G + V + T A K++ +K ++ +E + K++HP+++ L +
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 512 CPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 567
+ LV++ + G L + + + + E ++ ++A+ H+
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILESIAYCHSNG--- 148
Query: 568 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
I+HR++KP N+LL K+ D GL+ +N ++ G GT Y+ PE
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-------HGFAGTPGYLSPEV 201
Query: 625 QRTGLISPKSDVYAYGMVIL 644
+ S D++A G VIL
Sbjct: 202 LKKDPYSKPVDIWACG-VIL 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 4e-19
Identities = 66/318 (20%), Positives = 122/318 (38%), Gaps = 32/318 (10%)
Query: 350 KVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQE 409
++ K + EEE + ++ + ++ + + E ++ +
Sbjct: 88 EIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQ 147
Query: 410 AEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIES---ATLSFSENLR-IGMGGYGTVY 465
++ + ++ ++ + R W+ +E T++ R IG GG+G VY
Sbjct: 148 PYIEEICQNLRGDVFQKFIESDKFT-RFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVY 206
Query: 466 KGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKI---RHPHLLLLLGA--CPDH 515
T A+K L K + L E +LS + P ++ + A PD
Sbjct: 207 GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266
Query: 516 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPIIHRDMK 574
+ + M G L L + R A E+ L +HN +++RD+K
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIILGLEHMHNRF---VVYRDLK 319
Query: 575 PGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS 634
P NILLD + +I D+GL+ + K VGT Y+ PE + G+ S
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 635 -DVYAYGMVILQLLTAKP 651
D ++ G ++ +LL
Sbjct: 372 ADWFSLGCMLFKLLRGHS 389
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 53/194 (27%), Positives = 80/194 (41%), Gaps = 28/194 (14%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 508
IG G +G V K T A+K+L I+ F +E ++++ P ++ L
Sbjct: 77 IGRGAFGEVQLVRHKST--RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 509 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
A + +V EYM G L + + + F Y EV AL +H+
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--Y--TAEVVLALDAIHS---M 187
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
IHRD+KP N+LLD + K+ D G +N + T VGT YI PE
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-----AVGTPDYISPE--- 239
Query: 627 TGLISPKSDVYAYG 640
++ + YG
Sbjct: 240 --VLKSQGGDGYYG 251
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 37/209 (17%)
Query: 456 IGMGGYGTVYKGTFHHTFA--AVKVL--------QSKGNIQNKQFLQELEVLSKIRHPHL 505
+G G G V T A+K++ ++ E+E+L K+ HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 506 LLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLH 561
+ + D+ +V E ME G L D++ E +++ A+ +LH
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK-----EATCKLYFYQMLLAVQYLH 131
Query: 562 NTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
IIHRD+KP N+LL + + + KI D G S +L + S + T GT
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTL------CGTPT 181
Query: 619 YIDPE---YQRTGLISPKSDVYAYGMVIL 644
Y+ PE T + D ++ G VIL
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLG-VIL 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 36/207 (17%)
Query: 456 IGMGGYGTVYKGTFHHT---FAA-----VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 507
+G G + V K T +AA + S+ + + +E+ +L +I+HP+++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 508 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 563
L L+ E + G L D L K + E ++ + + +LH+
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLT-----EEEATEFLKQILNGVYYLHSL 133
Query: 564 KPKPIIHRDMKPGNILL------DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 617
+ I H D+KP NI+L + KI D GL+ ++ F GT
Sbjct: 134 Q---IAHFDLKPENIMLLDRNVPKPRI--KIIDFGLAHKIDFGNEF-------KNIFGTP 181
Query: 618 CYIDPEYQRTGLISPKSDVYAYGMVIL 644
++ PE + ++D+++ G VI
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIG-VIT 207
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 67/298 (22%), Positives = 109/298 (36%), Gaps = 46/298 (15%)
Query: 377 ELAKQEKKKYETARREAECAR-ASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRY 435
+ K+ ++ R R + R + A A+ K++ + GT Y
Sbjct: 14 KFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLY 73
Query: 436 RNLTWEEIESATLSFSENLR--------IGMGGYGTVYKGTFHHT--FAAVKVL------ 479
E E + ++ IG G V + T AVK++
Sbjct: 74 FQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAER 133
Query: 480 --QSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHGC--LVYEYMENGSLEDRLYR 534
+ + +E +L ++ HPH++ L+ + LV++ M G L D L
Sbjct: 134 LSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE 193
Query: 535 KNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 592
K E+ I + A++FLH I+HRD+KP NILLD N+ ++ D G
Sbjct: 194 KVA-----LSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG 245
Query: 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVIL 644
S L GT Y+ PE + + D++A G VIL
Sbjct: 246 FSCHLEPGEKL-------RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG-VIL 295
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 29/200 (14%)
Query: 456 IGMGGYGTVYKGTFHHTF----AAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLL 507
+G G +G V T H A+K + S+ ++ + +E+ L +RHPH++
Sbjct: 17 LGEGSFGKVKLAT--HYKTQQKVALKFI-SRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 508 LLG--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
L P +V EY G L D + K E R ++ A+ + H K
Sbjct: 74 LYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED---EGRRFFQQIICAIEYCHRHK- 128
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-Y 624
I+HRD+KP N+LLD NL KI D GLS ++ +F+ T+ G+ Y PE
Sbjct: 129 --IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTS------CGSPNYAAPEVI 179
Query: 625 QRTGLISPKSDVYAYGMVIL 644
P+ DV++ G ++L
Sbjct: 180 NGKLYAGPEVDVWSCG-IVL 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 34/202 (16%)
Query: 456 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQELEVLSK-IRHPHLLLLLGAC 512
IG+G Y + T AVK++ K + E+E+L + +HP+++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKII-DKSKRDPTE---EIEILLRYGQHPNIITLKDVY 85
Query: 513 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNTKPKP 567
D +V E M+ G L D++ R+ F ER + + + + +LH +
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKF------FSEREASAVLFTITKTVEYLHA---QG 136
Query: 568 IIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
++HRD+KP NIL + +I D G + L ++ + T P T ++ PE
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT------PCYTANFVAPE 190
Query: 624 -YQRTGLISPKSDVYAYGMVIL 644
+R G D+++ G V+L
Sbjct: 191 VLERQGY-DAACDIWSLG-VLL 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 27/198 (13%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC- 512
+G G VY+ T A+KVL+ + + E+ VL ++ HP+++ L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 513 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPII 569
P LV E + G L DR+ K + ER ++ A+A+LH I+
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGY-----YSERDAADAVKQILEAVAYLHE---NGIV 170
Query: 570 HRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
HRD+KP N+L + KI D GLS ++ GT Y PE R
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM-------KTVCGTPGYCAPEILR 223
Query: 627 TGLISPKSDVYAYGMVIL 644
P+ D+++ G +I
Sbjct: 224 GCAYGPEVDMWSVG-IIT 240
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 58/261 (22%), Positives = 103/261 (39%), Gaps = 46/261 (17%)
Query: 409 EAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTVYKG 467
A K + KE L +A +++ +A L + ++ +G G +G V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWET---PSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 468 TFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGACPDHGCL--VY 520
+ A+K+L + ++ KQ L E +L + P L+ L + D+ L V
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 521 EYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPIIHRDMKPGNIL 579
EY+ G + L R R A ++ +LH+ +I+RD+KP N+L
Sbjct: 121 EYVAGGEMFSHLRRIGRFSE----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLL 173
Query: 580 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YIDPEYQRTGLISPKS- 634
+D ++ D G + + T+ TLC + PE +I K
Sbjct: 174 IDQQGYIQVTDFGFAKRVK------GRTW-------TLCGTPEALAPE-----IILSKGY 215
Query: 635 ----DVYAYGMVILQLLTAKP 651
D +A G++I ++ P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYP 236
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 36/204 (17%)
Query: 456 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 512
+G+G G V + T A+K+L + QE++ + PH++ +L
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVY 91
Query: 513 PDHGC------LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNT 563
+ ++ E ME G L R+ + + F ER I ++ +A+ FLH+
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----FTEREAAEIMRDIGTAIQFLHS- 146
Query: 564 KPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
I HRD+KP N+L + + V K+ D G + + + T P T Y+
Sbjct: 147 --HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT------PCYTPYYV 196
Query: 621 DPEYQRTGLISPKSDVYAYGMVIL 644
PE D+++ G VI+
Sbjct: 197 APEVLGPEKYDKSCDMWSLG-VIM 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 50/205 (24%), Positives = 81/205 (39%), Gaps = 32/205 (15%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ-------ELEVLSKIRH--PH 504
+G GG+G+VY G A+K + K I + L E+ +L K+
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHV-EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 505 LLLLLG--ACPDHGCLVYEYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 561
++ LL PD L+ E E L D + + W+V A+ H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE---LARSFFWQVLEAVRHCH 166
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
N ++HRD+K NIL+D N K+ D G +L + + GT Y
Sbjct: 167 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF------DGTRVYS 215
Query: 621 DPEY-QRTGLISPKSDVYAYGMVIL 644
PE+ + + V++ G ++L
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLG-ILL 239
|
| >3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A Length = 968 | Back alignment and structure |
|---|
Score = 87.1 bits (215), Expect = 1e-17
Identities = 23/97 (23%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 713 LERLKEVADRARDTVPSVHP------APPNHFICPILKEVMNEPCV-AADGYTYDRKAIE 765
+E+L A++A + + P+ F+ P++ +M +P + A DR I+
Sbjct: 861 IEKLLNFANKAEEQRKADEEEDLEYGDVPDEFLDPLMYTIMKDPVILPASKMNIDRSTIK 920
Query: 766 EWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 802
L + P +PL +++ PN L IL +K +
Sbjct: 921 AHLLSDSTDPFNRMPLKLEDVTPNEELRQKILCFKKQ 957
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ-------ELEVLSKIR----H 502
+G GG+GTV+ G A+KV+ + + L E+ +L K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVI-PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 503 PHLLLLLG--ACPDHGCLVYEYMENGS-LEDRLYRKNNTPPIPWFERYRIAWEVASALAF 559
P ++ LL + LV E L D + K + +V +A+
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQH 154
Query: 560 LHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
H+ + ++HRD+K NIL+D +K+ D G +L+ +P Y + GT
Sbjct: 155 CHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP------YTDF--DGTRV 203
Query: 619 YIDPEY-QRTGLISPKSDVYAYGMVIL 644
Y PE+ R + + V++ G ++L
Sbjct: 204 YSPPEWISRHQYHALPATVWSLG-ILL 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 56/182 (30%), Positives = 83/182 (45%), Gaps = 36/182 (19%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
+G G +G V+ + + A+KVL+ + ++ KQ E +LS + HP ++ +
Sbjct: 14 LGTGSFGRVHLIRSRHN--GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 509 LGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKP 565
G D + + +Y+E G L L + P + A EV AL +LH+
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN----PVAKFYAAEVCLALEYLHS--- 124
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YID 621
K II+RD+KP NILLD N KI D G + + TY TLC YI
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------DVTY-------TLCGTPDYIA 171
Query: 622 PE 623
PE
Sbjct: 172 PE 173
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 35/204 (17%)
Query: 456 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 512
+G+G G V + T A+K+LQ + +E+E+ + + PH++ ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 124
Query: 513 PDHGC------LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNT 563
+ +V E ++ G L R+ + + F ER I + A+ +LH+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHS- 179
Query: 564 KPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
I HRD+KP N+L N + K+ D G + S S T P T Y+
Sbjct: 180 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-------TTPCYTPYYV 230
Query: 621 DPEYQRTGLISPKSDVYAYGMVIL 644
PE D+++ G VI+
Sbjct: 231 APEVLGPEKYDKSCDMWSLG-VIM 253
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 510
IG G +G V + T A+K + + ++ + +EL+++ + HP L+ L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 511 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHNTKP 565
+ + +V + + G L L + + F E ++ E+ AL +L N
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNVH------FKEETVKLFICELVMALDYLQN--- 133
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
+ IIHRDMKP NILLD + I D ++ ML + TT GT Y+ PE
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTM-----AGTKPYMAPE 184
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 49/218 (22%)
Query: 456 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
+G G +G V K T + A+K+L+ + I + + E VL RHP L L
Sbjct: 13 LGKGTFGKVILVREKAT--GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 509 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKP 565
A D C V EY G L L R+ ER R E+ SAL +LH+
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYLHS--- 123
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC----Y 619
+ +++RD+K N++LD + KI D GL + + T T C Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-----TMK-------TFCGTPEY 171
Query: 620 IDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
+ PE Y R D + G+V+ +++ +
Sbjct: 172 LAPEVLEDNDYGRA------VDWWGLGVVMYEMMCGRL 203
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 45/207 (21%), Positives = 76/207 (36%), Gaps = 38/207 (18%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVL--QSKGNIQNKQFLQELEVLSKIRH-PHLLLLLG 510
+G G + V + T A K L + +G + L E+ VL + P ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 511 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY------RIAWEVASALAFLHN 562
L+ EY G + + E R+ ++ + +LH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPEL-------AEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 563 TKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 617
I+H D+KP NILL ++ KI D G+S + +GT
Sbjct: 150 NN---IVHLDLKPQNILLSSIYPLGDI--KIVDFGMSRKIGHACEL-------REIMGTP 197
Query: 618 CYIDPEYQRTGLISPKSDVYAYGMVIL 644
Y+ PE I+ +D++ G +I
Sbjct: 198 EYLAPEILNYDPITTATDMWNIG-IIA 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-17
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
+G G +G V K T + A+K+L+ + + + L E VL RHP L L
Sbjct: 156 LGKGTFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 509 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKP 565
+ D C V EY G L L R+ +R R E+ SAL +LH+
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHS--E 267
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-- 623
K +++RD+K N++LD + KI D GL D + + T GT Y+ PE
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF------CGTPEYLAPEVL 321
Query: 624 ----YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y R D + G+V+ +++ +
Sbjct: 322 EDNDYGRA------VDWWGLGVVMYEMMCGRL 347
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 49/224 (21%), Positives = 93/224 (41%), Gaps = 52/224 (23%)
Query: 456 IGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLL 508
G G +GTV G T +V KV+Q + +F LQ ++ L+ + HP+++ L
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 509 LGACPDHG---------CLVYEYMENGSLED-----RLYRKNNTPPIPWFERYRIAWEVA 554
G +V EY+ + R Y + P P + + +++
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFL-FQLI 139
Query: 555 SALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
++ LH + HRD+KP N+L++ + K+ D G + L+ V+ Y
Sbjct: 140 RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA--Y----- 191
Query: 614 VGTLCYIDPEYQRTGLI------SPKSDVYAYGMVILQLLTAKP 651
+ + Y PE LI + D+++ G + +++ +P
Sbjct: 192 ICSRYYRAPE-----LIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 447 TLSFSENLRIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQFLQELEVLSKIRHP 503
+S+++ IG G +G VY+ + V KVLQ K + +EL+++ K+ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHC 107
Query: 504 HLLLLLGACPDHG--------CLVYEYMENGSLED-----RLYRKNNTPPIPWFERYRIA 550
+++ L G LV +Y+ E R Y + + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYM- 162
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYK 609
+++ +LA++H+ I HRD+KP N+LLD + K+ D G + L VS Y
Sbjct: 163 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--Y- 216
Query: 610 NTGPVGTLCYIDPEYQRTGLI------SPKSDVYAYGMVILQLLTAKP 651
+ + Y PE LI + DV++ G V+ +LL +P
Sbjct: 217 ----ICSRYYRAPE-----LIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 53/221 (23%)
Query: 456 IGMGGYGTVY---KGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLL 507
+G G +G V+ K + A+KVL K ++ + E ++L ++ HP ++
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 508 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 562
L A L+ +++ G L RL ++ F E + E+A AL LH+
Sbjct: 91 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM------FTEEDVKFYLAELALALDHLHS 144
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC-- 618
II+RD+KP NILLD K+ D GLS ++ + Y + C
Sbjct: 145 LG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-----KAY-------SFCGT 189
Query: 619 --YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y+ PE + ++ +D +++G+++ ++LT
Sbjct: 190 VEYMAPEVVNRRGHTQS------ADWWSFGVLMFEMLTGTL 224
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 55/223 (24%)
Query: 456 IGMGGYGTVY---KGTFHHT--FAAVKVLQSKGNIQNKQF-----LQELEVLSKIRHPHL 505
+G GGYG V+ K T +T A+KVL+ K I E +L +++HP +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLK-KAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 506 LLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFL 560
+ L+ A L+ EY+ G L +L R+ F + E++ AL L
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI------FMEDTACFYLAEISMALGHL 137
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC 618
H II+RD+KP NI+L+H K+ D GL ++ + T+ T C
Sbjct: 138 HQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-----VTH-------TFC 182
Query: 619 ----YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y+ PE + R D ++ G ++ +LT P
Sbjct: 183 GTIEYMAPEILMRSGHNRA------VDWWSLGALMYDMLTGAP 219
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 79.5 bits (195), Expect = 4e-16
Identities = 40/254 (15%), Positives = 78/254 (30%), Gaps = 58/254 (22%)
Query: 438 LTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVL--------QSKGNIQNKQ 489
+ + T +IG G +G V++ HT A+K++ ++
Sbjct: 11 VPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 490 FLQELEVLSKI---------RHPHLLLLL------GACPDHGCLVYEYM--ENGSLEDRL 532
L E+ + ++ R + L G+ P +++ GS DR
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 533 -YRKNNTPPIP-------------------WFERYRIAWEVASALAFLHNTKPKPIIHRD 572
+ K++ I I ++ ++LA HRD
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRD 187
Query: 573 MKPGNILLDHNLVSKIGDVGLSTMLNSDPS---------FVSTTYKNTGPVGTLCYIDPE 623
+ GN+LL + K+ +S ++ V +D +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247
Query: 624 YQRTGLISPKSDVY 637
TG + D+Y
Sbjct: 248 L-FTGDGDYQFDIY 260
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 66/266 (24%), Positives = 107/266 (40%), Gaps = 36/266 (13%)
Query: 406 QRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTV 464
+ + A A + E+ L + E + E L+ +G G YG V
Sbjct: 11 EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKV 70
Query: 465 Y---KGTFHHT--FAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLLGAC--- 512
+ K + H T A+KVL+ +Q + E +VL IR L+ L
Sbjct: 71 FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130
Query: 513 PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHNTKPKPII 569
L+ +Y+ G L L ++ F +I E+ AL LH II
Sbjct: 131 ETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHK---LGII 181
Query: 570 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQR 626
+RD+K NILLD N + D GLS +D + + + GT+ Y+ P+
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-----CGTIEYMAPDIVRGGD 236
Query: 627 TGLISPKS-DVYAYGMVILQLLTAKP 651
+G K+ D ++ G+++ +LLT
Sbjct: 237 SG--HDKAVDWWSLGVLMYELLTGAS 260
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 47/234 (20%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVL 497
+ E ++++ IG G +G V++ + A KVLQ K + +EL+++
Sbjct: 32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIM 86
Query: 498 SKIRHPHLLLLLGACPDHGC--------LVYEYMENGSLED-----RLYRKNNTPPIPWF 544
++HP+++ L +G LV EY+ E R Y K
Sbjct: 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLL 142
Query: 545 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSF 603
+ + +++ +LA++H+ I HRD+KP N+LLD + V K+ D G + +L +
Sbjct: 143 IKLYM-YQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 604 VSTTYKNTGPVGTLCYIDPEYQRTGLI------SPKSDVYAYGMVILQLLTAKP 651
VS Y + + Y PE LI + D+++ G V+ +L+ +P
Sbjct: 199 VS--Y-----ICSRYYRAPE-----LIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVK--VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+IG G YG V+K T A+K + + K L+E+ +L +++HP+L+ LL
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 511 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
LV+EY ++ ++ +P I W+ A+ F H
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLH--ELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---C 123
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE----- 623
IHRD+KP NIL+ + V K+ D G + +L PS V T Y PE
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDE-----VATRWYRSPELLVGD 177
Query: 624 --YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y P DV+A G V +LL+ P
Sbjct: 178 TQY------GPPVDVWAIGCVFAELLSGVP 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVK--VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+G G YG V K T A+K + + K ++E+++L ++RH +L+ LL
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 511 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
C LV+E++++ ++ D + + + + +++ + + F H+ I
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILD--DLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---I 145
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE----- 623
IHRD+KP NIL+ + V K+ D G + L + P V V T Y PE
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDE-----VATRWYRAPELLVGD 199
Query: 624 --YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y DV+A G ++ ++ +P
Sbjct: 200 VKY------GKAVDVWAIGCLVTEMFMGEP 223
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 9e-16
Identities = 53/225 (23%), Positives = 96/225 (42%), Gaps = 40/225 (17%)
Query: 452 ENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 507
E ++G G YG VYK A+K ++ G + +E+ +L +++HP+++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVIS 82
Query: 508 LLGACPDHG----CLVYEYMEN---GSLEDRLYRKNNTPPIPWFERYRI---AWEVASAL 557
L H L+++Y E+ ++ K N P+ R + +++ +
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ-LPRGMVKSLLYQILDGI 141
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVS----KIGDVGLSTMLNSDPSFVSTTYKNTGP 613
+LH ++HRD+KP NIL+ KI D+G + + NS +
Sbjct: 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLADLDPV 195
Query: 614 VGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
V T Y PE Y + D++A G + +LLT++P
Sbjct: 196 VVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSEP 234
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 50/219 (22%)
Query: 456 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSK-IRHPHLLL 507
+G G +G V +K T + F A+K L+ + + + E VLS HP L
Sbjct: 25 LGKGSFGKVFLAEFKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 508 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 564
+ ++ V EY+ G L + + R A E+ L FLH+
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL----SRATFYAAEIILGLQFLHSKG 138
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC---- 618
I++RD+K NILLD + KI D G+ ML T T C
Sbjct: 139 ---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-----KTN-------TFCGTPD 183
Query: 619 YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
YI PE Y + D +++G+++ ++L +
Sbjct: 184 YIAPEILLGQKYNHSV------DWWSFGVLLYEMLIGQS 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 54/236 (22%), Positives = 88/236 (37%), Gaps = 54/236 (22%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
IG G Y V K T A+KV++ + ++ E V + + L+
Sbjct: 17 IGRGSYAKVLLVRLKKT--DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 509 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 562
L +C V EY+ G L + R+ E R + E++ AL +LH
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHE 128
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC-- 618
+ II+RD+K N+LLD K+ D G+ + D TT T C
Sbjct: 129 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-----TTS-------TFCGT 173
Query: 619 --YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 666
YI PE Y + D +A G+++ +++ + I +
Sbjct: 174 PNYIAPEILRGEDYGFS------VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 50/219 (22%)
Query: 456 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
+G G +G V KGT AVK+L+ IQ+ + E VL+ P L
Sbjct: 28 LGKGSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 509 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 564
L +C D V EY+ G L + + A E+A L FL +
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGLFFLQS-- 139
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC---- 618
K II+RD+K N++LD KI D G+ + + TT T C
Sbjct: 140 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-----TTK-------TFCGTPD 186
Query: 619 YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
YI PE Y ++ D +A+G+++ ++L +
Sbjct: 187 YIAPEIIAYQPYGKS------VDWWAFGVLLYEMLAGQA 219
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 69/221 (31%), Positives = 96/221 (43%), Gaps = 54/221 (24%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSK-IRHPHLLL 507
IG G +G V K F AVKVLQ K ++ K+ + E VL K ++HP L+
Sbjct: 46 IGKGSFGKVLLARHKAE--EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 508 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 562
L + D V +Y+ G L L R+ F R R A E+ASAL +LH+
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERC------FLEPRARFYAAEIASALGYLHS 157
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC-- 618
I++RD+KP NILLD + D GL + ++ TT T C
Sbjct: 158 LN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-----TTS-------TFCGT 202
Query: 619 --YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y+ PE Y RT D + G V+ ++L P
Sbjct: 203 PEYLAPEVLHKQPYDRT------VDWWCLGAVLYEMLYGLP 237
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 53/236 (22%), Positives = 88/236 (37%), Gaps = 54/236 (22%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
IG G Y V K T A++V++ + ++ E V + + L+
Sbjct: 60 IGRGSYAKVLLVRLKKT--DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 509 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 562
L +C V EY+ G L + R+ E R + E++ AL +LH
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHE 171
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC-- 618
+ II+RD+K N+LLD K+ D G+ + D TT T C
Sbjct: 172 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-----TTS-------TFCGT 216
Query: 619 --YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 666
YI PE Y + D +A G+++ +++ + I +
Sbjct: 217 PNYIAPEILRGEDYGFS------VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 4e-15
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 50/219 (22%)
Query: 456 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
+G G +G V KGT AVK+L+ IQ+ + E VL+ P L
Sbjct: 349 LGKGSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 509 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 564
L +C D V EY+ G L + + A E+A L FL +
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGLFFLQS-- 460
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC---- 618
K II+RD+K N++LD KI D G+ + + TT T C
Sbjct: 461 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-----TTK-------TFCGTPD 507
Query: 619 YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
YI PE Y ++ D +A+G+++ ++L +
Sbjct: 508 YIAPEIIAYQPYGKS------VDWWAFGVLLYEMLAGQA 540
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 63/219 (28%), Positives = 89/219 (40%), Gaps = 50/219 (22%)
Query: 456 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 508
+G G +G V K T AVKVL+ +Q+ + E +LS R+ L
Sbjct: 31 LGKGSFGKVMLARVKET--GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 509 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 564
L C PD V E++ G L + + R R A E+ SAL FLH+
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE----ARARFYAAEIISALMFLHD-- 142
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC---- 618
K II+RD+K N+LLDH K+ D G+ + N TT T C
Sbjct: 143 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-----TTA-------TFCGTPD 189
Query: 619 YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
YI PE Y D +A G+++ ++L
Sbjct: 190 YIAPEILQEMLYGPA------VDWWAMGVLLYEMLCGHA 222
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 49/249 (19%), Positives = 97/249 (38%), Gaps = 51/249 (20%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-----------H 502
+G G + TV+ A+K+++ + E+++L ++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 503 PHLLLLL------GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 556
H+L LL G H +V+E + +L L +K IP +I+ ++
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLA-LIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVS------KIGDVGLSTMLNSDPSFVSTTYKN 610
L ++H + IIH D+KP N+L++ KI D+G + + T
Sbjct: 144 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNS-- 195
Query: 611 TGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID 664
+ T Y PE + +D+++ +I +L+T D
Sbjct: 196 ---IQTREYRSPEVLLGAPW------GCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 665 EDNLAEILD 673
+D++A+I++
Sbjct: 247 DDHIAQIIE 255
|
| >2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 Length = 281 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 40/182 (21%), Positives = 69/182 (37%), Gaps = 5/182 (2%)
Query: 624 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683
QR ++ + + + L AK + + E L L +E
Sbjct: 95 LQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLTRLIAAERERE 154
Query: 684 TKEL--AALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICP 741
+E G R + ++ + + + E+ + + P++
Sbjct: 155 LEECQRNHEGHEDDGHIRAQQACIEAKHDKYMADMDELFSQVDEKR--KKRDIPDYLCGK 212
Query: 742 ILKEVMNEPCVAADGYTYDRKAIEEWLQENDK-SPITDLPLPNKNLLPNYTLLSAILDWK 800
I E+M EPC+ G TYDRK IEE LQ +P+T PL + L+PN + I +
Sbjct: 213 ISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFI 272
Query: 801 SK 802
S+
Sbjct: 273 SE 274
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 40/151 (26%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 507
++G G Y TVYKG T + A+K + + +++ ++E+ ++ +++H +++
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLMKELKHENIVR 67
Query: 508 LLGACPDHGC--LVYEYMEN--GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
L LV+E+M+N D N + W++ LAF H
Sbjct: 68 LYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594
K I+HRD+KP N+L++ K+GD GL+
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 39/146 (26%), Positives = 71/146 (48%), Gaps = 11/146 (7%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+IG G YG VYK T A+K L ++ ++E+ +L ++ HP+++ LL
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 511 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
LV+E++ L+ + + IP +++ LAF H+ + +
Sbjct: 70 VIHTENKLYLVFEFLHQ-DLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 124
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLS 594
+HRD+KP N+L++ K+ D GL+
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 36/147 (24%), Positives = 67/147 (45%), Gaps = 14/147 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+IG G YGTV+K T A+K L L+E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 511 ACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
LV+E+ + D + Y + + +++ L F H+
Sbjct: 69 VLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLS 594
++HRD+KP N+L++ N K+ + GL+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A Length = 61 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-13
Identities = 11/57 (19%), Positives = 29/57 (50%), Gaps = 1/57 (1%)
Query: 736 NHFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYT 791
+H +C I +V P ++ +++ +E+++++ PIT+ PL + ++
Sbjct: 2 SHMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVP 58
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 40/214 (18%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 507
++G G Y TVYKG T A+K + +++++ ++E+ +L ++H +++
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 508 LLGACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
L LV+EY++ D + Y + I +++ LA+ H K
Sbjct: 65 LHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE- 623
++HRD+KP N+L++ K+ D GL+ S P + TY V TL Y P+
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARAK-SIP---TKTY--DNEVVTLWYRPPDI 171
Query: 624 ------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y S + D++ G + ++ T +P
Sbjct: 172 LLGSTDY------STQIDMWGVGCIFYEMATGRP 199
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 56/222 (25%), Positives = 86/222 (38%), Gaps = 45/222 (20%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF----LQE---LEVLSKIRHPH 504
IG+G YGTVYK H+ V V G ++E L L HP+
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 505 LLLLLGACPDHGC-------LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVAS 555
++ L+ C LV+E+++ D K P +P + +
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 556 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 615
L FLH I+HRD+KP NIL+ K+ D GL+ + + + T V
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-------TPVVV 181
Query: 616 TLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
TL Y PE Y + D+++ G + ++ KP
Sbjct: 182 TLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRRKP 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 17/149 (11%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 507
+G G + TVYK +T A+K ++ + K L+E+++L ++ HP+++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 508 LLGACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
LL A LV+++ME D + K+N+ + L +LH
Sbjct: 77 LLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGL 593
I+HRD+KP N+LLD N V K+ D GL
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 56/275 (20%), Positives = 94/275 (34%), Gaps = 63/275 (22%)
Query: 456 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----HP---HL 505
+G G + TV+ F A+KV++S + + L E+ +L +R P +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH-YTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 506 LLLL------GACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASALA 558
+ LL G H C+V+E + G L K+N +P +I +V L
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLK-WIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 559 FLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTY------- 608
+LH IIH D+KP NILL + + + + P S
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 609 ------------------------------KNTGPVGTLCYIDPEYQRTGLISPKSDVYA 638
T + T Y E + +D+++
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWS 278
Query: 639 YGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673
+ +L T E DED++A I++
Sbjct: 279 TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ--F----LQELEVLSKIRHPHLL 506
+IG G +G V+K T A+K K ++N++ F L+E+++L ++H +++
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 507 LLLGACPDHGC----------LVYEYMEN---GSLEDRLYRKNNTPPIPWFERYRIAWEV 553
L+ C LV+++ E+ G L N E R+ +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRVMQML 133
Query: 554 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
+ L ++H K I+HRDMK N+L+ + V K+ D GL+ + + Y T
Sbjct: 134 LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--TNR 188
Query: 614 VGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
V TL Y PE Y P D++ G ++ ++ T P
Sbjct: 189 VVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRSP 227
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 15/147 (10%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
++G G YG VYK A+K L ++ ++E+ +L ++ HP+++ L+
Sbjct: 28 KVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 511 ACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
C LV+E+ME D + N + + +++ +A H +
Sbjct: 87 VIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--- 139
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLS 594
I+HRD+KP N+L++ + K+ D GL+
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 1e-12
Identities = 33/147 (22%), Positives = 69/147 (46%), Gaps = 15/147 (10%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+IG G YG VYK ++ A+K L+ + ++E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 511 ACPDHG--CLVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
LV+E+++ D + + ++ + +A+ H+ +
Sbjct: 68 VIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--- 120
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLS 594
++HRD+KP N+L++ KI D GL+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLA 147
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 27/153 (17%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 512
+G+G G V + T A+K+LQ + +E+E+ + + PH++ ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 80
Query: 513 PDHGC------LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNT 563
+ +V E ++ G L R+ + + F ER I + A+ +LH+
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHS- 135
Query: 564 KPKPIIHRDMKPGNILL---DHNLVSKIGDVGL 593
I HRD+KP N+L N + K+ D G
Sbjct: 136 --INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 37/203 (18%), Positives = 64/203 (31%), Gaps = 25/203 (12%)
Query: 435 YRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQ- 486
Y WE L + +G G +G V + AVK+L+
Sbjct: 12 YDASKWE-FPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 68
Query: 487 NKQFLQELEVLSKI-RHPHLLLLLGACPDHG---CLVYEYMENGSLEDRLYRKNNTPPIP 542
++ + EL++L I H +++ LLGAC G ++ E+ + G+L L K N
Sbjct: 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
Query: 543 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602
+ R I D+K + + S L+
Sbjct: 129 KTKGARFR----------QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178
Query: 603 FVSTTYKNTGPVGTLCYIDPEYQ 625
+ + I +Q
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQ 201
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.7 bits (167), Expect = 5e-12
Identities = 92/651 (14%), Positives = 180/651 (27%), Gaps = 205/651 (31%)
Query: 2 EVKDIVELPNSPALSVAVAVKGNRKSR-YAVLWAL--------EKFIPEGIN-----LFK 47
E+ I+ + S + W L +KF+ E + L
Sbjct: 50 EIDHIIMSK-------------DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS 96
Query: 48 LLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEV 107
+ R S+ T M +I +Q ++ D + N+ +
Sbjct: 97 PIKTEQRQPSMMTRM--YI-------------EQRDRLYNDNQVFAKYNVSRLQPYLKLR 141
Query: 108 KVIESDDVAKAI-------------ADEVASCNINKLVIGAQSQGIFTW-KFKKNNLSSR 153
+ + AK + A +V + V IF W K N
Sbjct: 142 QALLELRPAKNVLIDGVLGSGKTWVALDVCL---SYKVQCKMDFKIF-WLNLKNCNSPET 197
Query: 154 ISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGS 213
+ + N +S++D S
Sbjct: 198 VLEMLQKLLYQI------------------------------------DPNWTSRSDHSS 221
Query: 214 AVASYTHSSSPSLPTQRLQALSAVNKTLLHLKPSSTEINHSRC-QSFDVEEQ-----KDA 267
+ HS L +RL LL L + +++ +F++ + +
Sbjct: 222 NIKLRIHSIQAEL--RRLLKSKPYENCLLVLL----NVQNAKAWNAFNLSCKILLTTRFK 275
Query: 268 SSSCLSGPEVRQTVSRSSSYRSMETENQDWSDQASTTDVLPYDSSSESQVDVN-FEL--- 323
+ +S ++ T ++ S D P D E + N L
Sbjct: 276 QVTDFLSAATTTHISLDHHSMTL-TPDEVKSLLLKYLDCRPQDLPREV-LTTNPRRLSII 333
Query: 324 -EKLRIEL------RHVRGMYAIAQNEANDASRKVNDLNKCKLEEETR--------LSEI 368
E +R L +HV ++S +N L E R
Sbjct: 334 AESIRDGLATWDNWKHVNCD---KLTTIIESS--LNVLE----PAEYRKMFDRLSVFPPS 384
Query: 369 QLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAE---------MKAKHEAK 419
+ + L + K + + + S ++Q E ++ K + +
Sbjct: 385 AHIPTILLSLIWFDVIKSDVMVVVNKLHKYS----LVEKQPKESTISIPSIYLELKVKLE 440
Query: 420 EKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVL 479
+ L R++ + + +++ L Y + G HH L
Sbjct: 441 NEYALHRSIVDHYNIPKTFDSDDLIPPYLD----------QYFYSHIG--HH-------L 481
Query: 480 QSKGNIQ----------NKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLE 529
++ + + + +FL+ KIRH A G + +L+
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLE-----QKIRHDST-----AWNASGSI------LNTLQ 525
Query: 530 D-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 579
+ Y+ P +ER V + L FL + I + ++L
Sbjct: 526 QLKFYKPYICDNDPKYERL-----VNAILDFLPKIEENLICSKYT---DLL 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.3 bits (166), Expect = 6e-12
Identities = 77/556 (13%), Positives = 158/556 (28%), Gaps = 175/556 (31%)
Query: 206 SSQTDLGSAVASYTHSSSPSLP---TQRLQALSAVNKTLLHLKPSSTEINH--------- 253
S T + ++ + RLQ + + LL L+P+ +
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW 165
Query: 254 ---SRCQSFDVEEQKD-----ASSSCLSGPEVRQTVSRSSSYRSMETENQDWSDQASTTD 305
C S+ V+ + D + + PE + + Y+ +W+ ++ +
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID----PNWTSRSDHSS 221
Query: 306 VLPYDSSSESQVDVNFELEK-----LRIELRHVRGMYAIAQNEANDASRKVNDLN-KCKL 359
+ S K L + L +V+ +A + N N CK+
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLLV-LLNVQ-----------NA-KAWNAFNLSCKI 268
Query: 360 EEETRLSEI--QLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAK-- 415
TR ++ L ++ T E ++ + + + +
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLT----------PDEVKSLLLKYLDCRPQDL 318
Query: 416 -HEAKE---------KEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVY 465
E E + L T+ ++++ +++ + S L Y
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLA-TWDNWKHVNCDKLTTIIESSLNVL------EPAEY 371
Query: 466 KGTFHHTFAAVKVLQSKGNIQNK---------------QFLQELEVLSKI-RHP------ 503
+ F + V +I + +L S + + P
Sbjct: 372 RKMF-DRLS---VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427
Query: 504 -HLLLLLGACPD------HGCLVYEYMENGSLEDRLYRK--NNTPPIPWFERYRIAWEVA 554
+ L H +V Y + + ++ P+ ++Y
Sbjct: 428 IPSIYLELKVKLENEYALHRSIVDHY--------NIPKTFDSDDLIPPYLDQY-FYS--- 475
Query: 555 SALAFL--HNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSFVST----- 606
+ H + + + LD L KI + N+ S ++T
Sbjct: 476 ----HIGHHLKNIEHPERMTLFR-MVFLDFRFLEQKIRHDSTA--WNASGSILNTLQQLK 528
Query: 607 TYKNTGPVGTLCYI---DPEYQR-------------TGLI-SPKSDVYAYGMVILQLLTA 649
YK YI DP+Y+R LI S +D +L+
Sbjct: 529 FYKP--------YICDNDPKYERLVNAILDFLPKIEENLICSKYTD-------LLR---- 569
Query: 650 KPAIAITHKVETAIDE 665
IA+ + E +E
Sbjct: 570 ---IALMAEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 4e-08
Identities = 75/509 (14%), Positives = 157/509 (30%), Gaps = 157/509 (30%)
Query: 351 VNDLNKCK-LEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQE 409
V++ + CK +++ + +L ++ I+ K R +
Sbjct: 30 VDNFD-CKDVQDMPK----SILSKEEIDHIIMSKDAVSGTLRLFWTLLS----------- 73
Query: 410 AEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTF 469
K++EM+++ + + I++ S R+ Y
Sbjct: 74 ---------KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM--------YIEQR 116
Query: 470 HHTFAAVKVLQSKGNIQNKQFLQEL-EVLSKIRHPHLLLLLGACPDHG-------CLVYE 521
+ +V +K N+ Q +L + L ++R P +L+ G + +
Sbjct: 117 DRLYNDNQVF-AKYNVSRLQPYLKLRQALLELR-PAKNVLI-----DGVLGSGKTWVALD 169
Query: 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII-------HRDMK 574
+ ++ ++ ++I W L + P+ ++ ++
Sbjct: 170 VCLSYKVQCKMD-------------FKIFW-----LNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 575 PGNILLDH--NLVSKIGDV--GLSTMLNSDPSFVSTTYKNTGPVGTLCYI------DPEY 624
DH N+ +I + L +L S P Y+N C + + +
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKP------YEN-------CLLVLLNVQNAK- 257
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKPAIA--ITHKVETAIDEDNLAEILDAQAGDWPIK 682
+ + IL L T + ++ T I D+ + L
Sbjct: 258 ----AW----NAFNLSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSMTLTP-------D 301
Query: 683 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPN---HFI 739
E K L + R +D P P L +A+ RD A + H
Sbjct: 302 EVKSLLL---KYLDCRPQDLPREVLTTNPRR--LSIIAESIRD-----GLATWDNWKHVN 351
Query: 740 CPILKEVMNEPCVAA---DGY--TYDRKAI-EE------------WLQ--ENDKSPITDL 779
C L ++ E + Y +DR ++ W ++D + +
Sbjct: 352 CDKLTTII-ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 780 PLPNKNLL---PN---YTLLSAILDWKSK 802
L +L+ P ++ S L+ K K
Sbjct: 411 -LHKYSLVEKQPKESTISIPSIYLELKVK 438
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 4e-07
Identities = 96/642 (14%), Positives = 189/642 (29%), Gaps = 185/642 (28%)
Query: 243 HLKPSSTEINHSR-----------CQSFDVEEQKDASSSCLSGPEVRQTVSRSS----SY 287
H+ + E + +FD ++ +D S LS E+ + +
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTL 65
Query: 288 RSMET--ENQDWSDQASTTDVLPYDSSSESQVDVNFELEKLRIELRH---VRGMYAIAQN 342
R T Q+ Q +VL +++ F + ++ E R + MY ++
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVL--------RINYKFLMSPIKTEQRQPSMMTRMYIEQRD 117
Query: 343 EANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKK----------KYETARRE 392
+ ++ N +RL L + +EL + K K A
Sbjct: 118 RLYNDNQVFAKYNV------SRLQPYLKLRQALLEL-RPAKNVLIDGVLGSGKTWVA--- 167
Query: 393 AECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSE 452
+ + + + + K+ + +LE +Q N T + S
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT------SRSDHSS 221
Query: 453 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
N+++ H A ++ L +++K + L VL +++
Sbjct: 222 NIKL-----------RIHSIQAELRRL-----LKSKPYENCLLVLLNVQNAKAWNAF--- 262
Query: 513 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH---NTKPK- 566
+ C L+ + D L T + + + + L + +P+
Sbjct: 263 -NLSCKILLTT--RFKQVTDFL--SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD 317
Query: 567 ---------P----IIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNS-DPSFVSTTYK 609
P II ++ G D H K+ + + + LN +P+ +
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI-IESSLNVLEPAEYRKMFD 376
Query: 610 NTG--------PVGTLC-------YIDPE-----YQRTGLI--SPKSDVYAYGMVILQLL 647
P L D + L+ PK + + L+L
Sbjct: 377 RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK 436
Query: 648 TAKPAIAITHKVETAIDEDNLAEILD-----AQAGD--W------------PIKETKELA 688
H+ + +D N+ + D D + +
Sbjct: 437 VKLENEYALHR--SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR 494
Query: 689 ALGLSCAELRRKDRPD-----LKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPIL 743
+ L L +K R D +L L++LK +IC
Sbjct: 495 MVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKP----------------YICD-- 536
Query: 744 KEVMNEPCVAADGYTYDR--KAIEEWLQEND----KSPITDL 779
N+P Y+R AI ++L + + S TDL
Sbjct: 537 ----NDP-------KYERLVNAILDFLPKIEENLICSKYTDL 567
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 18/150 (12%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
++G G YG VYK T A+K L+ + ++E+ +L +++H +++ L
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 511 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
+ L++EY EN L+ + + P + +++ + + F H+ +
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHSRR---C 153
Query: 569 IHRDMKPGNILLDHNLVS-----KIGDVGL 593
+HRD+KP N+LL + S KIGD GL
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRH------PHLLL 507
IG G +G V K H A+K+++++ +Q +E+ +L +R +++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH-RQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 508 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
+L +H C+ +E + +L + L +KN + A + L LH +
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYE-LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR- 220
Query: 566 KPIIHRDMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
IIH D+KP NILL S K+ D G S + TY + + Y PE
Sbjct: 221 --IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY----TY-----IQSRFYRAPE 269
Query: 624 ------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y D+++ G ++ +LLT P
Sbjct: 270 VILGARY------GMPIDMWSLGCILAELLTGYP 297
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 42/177 (23%), Positives = 83/177 (46%), Gaps = 27/177 (15%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGA 511
++G G Y V++ VK+L+ ++ K+ +E+++L +R P+++ L
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADI 99
Query: 512 CPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
D LV+E++ N + +LY+ I R+ + +E+ AL + H+
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDI----RFYM-YEILKALDYCHS---MG 150
Query: 568 IIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
I+HRD+KP N+++DH + ++ D GL+ F + V + + PE
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLA-------EFYHPGQEYNVRVASRYFKGPE 200
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 57/273 (20%), Positives = 104/273 (38%), Gaps = 36/273 (13%)
Query: 395 CARASAEKEAAQRQ--EAEMKAKHEAKEKEMLERALNGTFQRY--RNLTWEEIESATLSF 450
C+ + + + A Q + ++ + AK M + ++ F + T+ +
Sbjct: 9 CSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFT----VLKRY 64
Query: 451 SENLRIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN-KQFLQELEVLSKIRHPHLL 506
IG G G V V K+ + N + K+ +EL ++ + H +++
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 507 LLLGA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 558
LL P LV E M+ L + Y + +++ +
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLL-YQMLCGIK 178
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
LH+ IIHRD+KP NI++ + KI D GL+ SF+ T Y V T
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY-----VVTRY 228
Query: 619 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 651
Y PE D+++ G ++ +++ K
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 94 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-11
Identities = 20/76 (26%), Positives = 30/76 (39%), Gaps = 10/76 (13%)
Query: 737 HFICPILKEVMNEPCVAAD-GYTYDRKAIEEWLQENDKS------PIT---DLPLPNKNL 786
F CPI KE M +P G+TY+ AI ++ K P + +L
Sbjct: 7 GFTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDL 66
Query: 787 LPNYTLLSAILDWKSK 802
+ + L AI + K
Sbjct: 67 IQDEALRRAIENHNKK 82
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 45/264 (17%), Positives = 98/264 (37%), Gaps = 82/264 (31%)
Query: 444 ESATLSFSENLRIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF-LQELEVLSK 499
E+++ +S +G G +G V + + KVLQ + ++ +EL+++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKV 56
Query: 500 IRHPHLLLLL----------------------------------GACPDHGC------LV 519
+ H +++ L+ + + ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 520 YEYMENGSLED-----RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 574
EY+ + + + ++ I +++ A+ F+H+ I HRD+K
Sbjct: 117 MEYVP----DTLHKVLKSFIRSGRSIPMNLISIYI-YQLFRAVGFIHSLG---ICHRDIK 168
Query: 575 PGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI--- 630
P N+L++ + K+ D G + L V+ Y + + Y PE L+
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA--Y-----ICSRFYRAPE-----LMLGA 216
Query: 631 ---SPKSDVYAYGMVILQLLTAKP 651
+P D+++ G V +L+ KP
Sbjct: 217 TEYTPSIDLWSIGCVFGELILGKP 240
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 30/210 (14%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLLG 510
IG G G V V K+ + N + K+ +EL ++ + H +++ LL
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 91
Query: 511 A-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAFLH 561
P +V E M+ +L ++ + ER + +++ + LH
Sbjct: 92 VFTPQKSLEEFQDVYIVMELMDA-NLC-QVIQMELDH-----ERMSYLLYQMLCGIKHLH 144
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
+ IIHRD+KP NI++ + KI D GL+ SF+ T Y V T Y
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY-----VVTRYYRA 194
Query: 622 PEYQRTGLISPKSDVYAYGMVILQLLTAKP 651
PE D+++ G ++ +++
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 16/155 (10%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHP------HLLL 507
IG G +G V K + A+K++++K Q E+ +L + +++
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 508 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
L +H CLV+E + +L D L R N + + A ++ +AL FL +
Sbjct: 121 LKRHFMFRNHLCLVFEMLSY-NLYD-LLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 178
Query: 566 KPIIHRDMKPGNILLDHNLVS--KIGDVGLSTMLN 598
IIH D+KP NILL + S KI D G S L
Sbjct: 179 S-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 57/227 (25%)
Query: 455 RIGMGGYGTVYKGT-FHHT--FAAVKVLQSKGNIQNKQ------------FLQELEVLSK 499
IG G YG V+K + F A+K + +Q + L+ L
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALK----RVRVQTGEEGMPLSTIREVAVLRHL---ET 70
Query: 500 IRHPHLLLLLGACPDHGC-------LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIA 550
HP+++ L C LV+E+++ D K P +P +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMM 126
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 610
+++ L FLH+ + ++HRD+KP NIL+ + K+ D GL+ + + +
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL------- 176
Query: 611 TGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
T V TL Y PE Y + D+++ G + ++ KP
Sbjct: 177 TSVVVTLWYRAPEVLLQSSY------ATPVDLWSVGCIFAEMFRRKP 217
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 50/225 (22%), Positives = 80/225 (35%), Gaps = 51/225 (22%)
Query: 456 IGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN----------KQFLQELEVLSKIRH 502
I G YG V G V +V + + + K+ L+E+ +L+ H
Sbjct: 30 ISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 503 PHLLLLLGA-CPDHGC------LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEV 553
P++L L LV E M D ++ P +Y + +
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQHIQY-FMYHI 143
Query: 554 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
L LH ++HRD+ PGNILL N I D L+ +D + T Y
Sbjct: 144 LLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KTHY----- 193
Query: 614 VGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
V Y PE + + D+++ G V+ ++ K
Sbjct: 194 VTHRWYRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRKA 232
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 47/217 (21%)
Query: 456 IGMGGYGTVYKGTFHHTFAAV------KVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLL 509
+G G YG+V + V + QS+ I K+ +EL +L ++H +++ LL
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE--IFAKRAYRELLLLKHMQHENVIGLL 89
Query: 510 GA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 561
P LV +M+ D L + +Y + +++ L ++H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEKIQY-LVYQMLKGLKYIH 143
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
+ ++HRD+KPGN+ ++ + KI D GL+ +++ T Y V T Y
Sbjct: 144 SAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGY-----VVTRWYRA 191
Query: 622 PE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
PE Y + D+++ G ++ ++LT K
Sbjct: 192 PEVILSWMHY------NQTVDIWSVGCIMAEMLTGKT 222
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 35/137 (25%), Positives = 60/137 (43%), Gaps = 15/137 (10%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRH-----PHLLLL 508
+G G +G V + AVKV+++ + E ++L KI++ +++
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKIEADILKKIQNDDINNNNIVKY 101
Query: 509 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
G DH CL++E + SL + + +NN + E+ AL +L
Sbjct: 102 HGKFMYYDHMCLIFEPLGP-SLYE-IITRNNYNGFHIEDIKLYCIEILKALNYLRKMS-- 157
Query: 567 PIIHRDMKPGNILLDHN 583
+ H D+KP NILLD
Sbjct: 158 -LTHTDLKPENILLDDP 173
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 32/141 (22%), Positives = 62/141 (43%), Gaps = 21/141 (14%)
Query: 456 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQN--KQFLQELEVLSKIR-----HPHL 505
+G G +G V + H AVK+++ N+ + E++VL +
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 506 LLLLGACPD---HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
+ + + H C+V+E + S D ++N P ++A+++ ++ FLH+
Sbjct: 79 CVQMLEWFEHHGHICIVFELLGL-STYD-FIKENGFLPFRLDHIRKMAYQICKSVNFLHS 136
Query: 563 TKPKPIIHRDMKPGNILLDHN 583
K + H D+KP NIL +
Sbjct: 137 NK---LTHTDLKPENILFVQS 154
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 40/268 (14%), Positives = 88/268 (32%), Gaps = 69/268 (25%)
Query: 388 TARREAECARASA---EKEAAQRQEAEMKAKHEAKEKEMLERALNGTF---QRYRNLTWE 441
++ A + ++ + +QE + + +H + + + + RY
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRH-- 59
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--------KQFL 491
IG G YG V + A+K I K+ L
Sbjct: 60 -------------LIGTGSYGHVCEAYDKLEKRVVAIK------KILRVFEDLIDCKRIL 100
Query: 492 QELEVLSKIRHPHLLLLLGACPDHGC-------LVYEYME---------NGSLEDRLYRK 535
+E+ +L+++ H H++ +L +V E + L + +
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK- 159
Query: 536 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595
+ + + + ++H+ I+HRD+KP N L++ + K+ D GL+
Sbjct: 160 ------------TLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204
Query: 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
++ + S + P
Sbjct: 205 TVDYPENGNSQLPISPREDDMNLVTFPH 232
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 39/173 (22%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 456 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFLQELEVLSKIRHP-----HLLL 507
+G G +G V + H A+K++++ + E+ VL KI+ L +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 508 LLGACPD---HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
L+ + H C+ +E + + + ++NN P P +A+++ AL FLH +
Sbjct: 86 LMSDWFNFHGHMCIAFELLGK-NTFE-FLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ 143
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS-------FVSTTYKN 610
+ H D+KP NIL ++ + + S S + F S T+ +
Sbjct: 144 ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 45/175 (25%), Positives = 73/175 (41%), Gaps = 19/175 (10%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLLLG 510
+IG G +G +Y GT V + ++ Q E ++ ++ P + G
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPT-IRWCG 74
Query: 511 ACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
A D+ +V E + G SLED + + +A ++ S + ++H+ K I
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHS---KNFI 127
Query: 570 HRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTLCY 619
HRD+KP N L+ NLV I D GL+ + Y+ N GT Y
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 38/180 (21%), Positives = 65/180 (36%), Gaps = 27/180 (15%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLLLG 510
RIG G +G +++GT V + Q E + P++ G
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF-G 75
Query: 511 ACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERY---RIAWEVASALAFLHNTKPK 566
H LV + + G SLED L F A ++ + + +H K
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHE---K 125
Query: 567 PIIHRDMKPGNILL------DHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTLCY 619
+++RD+KP N L+ + N++ + D G+ + Y+ GT Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVV-DFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 49/229 (21%), Positives = 95/229 (41%), Gaps = 55/229 (24%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLL 508
+G GG G V+ + A+K K + + Q L+E++++ ++ H +++ +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIK----KIVLTDPQSVKHALREIKIIRRLDHDNIVKV 73
Query: 509 LGA-CPDHGC---------------LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIA 550
P +V EYME D + + R
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEE--HARL-FM 126
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVS--TT 607
+++ L ++H+ ++HRD+KP N+ ++ +LV KIGD GL+ +++ S +
Sbjct: 127 YQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 608 YKNTGPVGTLCYIDPEYQRTGLISPKS-----DVYAYGMVILQLLTAKP 651
+ T Y P L+SP + D++A G + ++LT K
Sbjct: 184 G-----LVTKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 42/189 (22%), Positives = 74/189 (39%), Gaps = 26/189 (13%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVK----VLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
IG G YG VY +T A+K + + I K+ L+E+ +L++++ +++ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL--IDCKRILREITILNRLKSDYIIRL 90
Query: 509 LGACPDHGC-------LVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAF 559
+V E + D L + K + I + + F
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIAD----SD-LKKLFKTPIFLTEEHIKT-ILYNLLLGENF 144
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
+H + IIHRD+KP N LL+ + K+ D GL+ +NS+
Sbjct: 145 IHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 620 IDPEYQRTG 628
+ + Q T
Sbjct: 202 KNLKKQLTS 210
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 47/231 (20%), Positives = 83/231 (35%), Gaps = 61/231 (26%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNI-QNKQFLQ----ELEVLSKIRHPHLLL 507
+G G YG V T T A+K K F E+++L +H +++
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIK----KIEPFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 508 LLGACPDHGC-------LVYEYME--------NGSLEDRLYRKNNTPPIPWFERYR-IAW 551
+ ++ E M+ L D + + +
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD--------------DHIQYFIY 119
Query: 552 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN- 610
+ A+ LH + +IHRD+KP N+L++ N K+ D GL+ +++ + S
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 611 ---TGPVGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
V T Y PE Y S DV++ G ++ +L +P
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRRP 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 44/217 (20%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLLG 510
+G G YG+V T V V + Q+ +EL +L ++H +++ LL
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 511 A-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAFLH 561
P LV M L + + + T + + + +++ L ++H
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTD-----DHVQFLIYQILRGLKYIH 149
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
+ IIHRD+KP N+ ++ + KI D GL+ + T Y V T Y
Sbjct: 150 SAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGY-----VATRWYRA 197
Query: 622 PE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
PE Y + D+++ G ++ +LLT +
Sbjct: 198 PEIMLNWMHY------NQTVDIWSVGCIMAELLTGRT 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 44/184 (23%), Positives = 76/184 (41%), Gaps = 33/184 (17%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRHPHLLLLL 509
IG G YG V + A+K + +++ + Q E+++L + RH +++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 510 GACPDHGC-------LVYEYMENGSLEDRLYRKNNTPPI-PWFERYRIAWEVASALAFLH 561
+V + ME D LY+ T + Y +++ L ++H
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLME----TD-LYKLLKTQHLSNDHICY-FLYQILRGLKYIH 145
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL--STMLNSDPSFVSTTYKNTGPVGTLCY 619
+ ++HRD+KP N+LL+ KI D GL + D + T Y V T Y
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----VATRWY 197
Query: 620 IDPE 623
PE
Sbjct: 198 RAPE 201
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 48/219 (21%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVK----VLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+G G YG V T A+K QS+ + K+ +EL +L +RH +++ L
Sbjct: 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMRHENVIGL 89
Query: 509 LGA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAF 559
L PD LV +M L + + +R + + +++ L +
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGE-----DRIQFLVYQMLKGLRY 143
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
+H IIHRD+KPGN+ ++ + KI D GL+ +S+ T Y V T Y
Sbjct: 144 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGY-----VVTRWY 191
Query: 620 IDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 651
PE Y + D+++ G ++ +++T K
Sbjct: 192 RAPEVILNWMRY------TQTVDIWSVGCIMAEMITGKT 224
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 Length = 175 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 9e-08
Identities = 26/111 (23%), Positives = 42/111 (37%), Gaps = 7/111 (6%)
Query: 27 SRYAVLWALEKFIPEGINLFKL--LHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEK 84
+ A W LEK + + FK+ LHV+ + + + D+ + K +
Sbjct: 27 CKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAKGL 86
Query: 85 WKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGA 135
LL F N C + V E + D I EV + LV+G+
Sbjct: 87 ----HLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGS 132
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 25/178 (14%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLLLG 510
+IG G +G +Y GT T V + ++ Q L E ++ ++ P+ + G
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPN-VRWFG 72
Query: 511 ACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERY---RIAWEVASALAFLHNTKPK 566
D+ LV + + G SLED L+ + +A ++ + + F+H+ K
Sbjct: 73 VEGDYNVLVMDLL--GPSLED-LFNFCSRK----LSLKTVLMLADQMINRVEFVHS---K 122
Query: 567 PIIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTLCY 619
+HRD+KP N L+ N V I D GL+ + Y+ N GT Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 40/177 (22%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN-KQFLQELEVLSKIR-HPHLLLLL 509
++G G YG V+K T V K+ + N + ++ +E+ +L+++ H +++ LL
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 510 GAC-PDHGC---LVYEYME--------NGSLEDRLYRKNNTPPIPWFERYR-IAWEVASA 556
D+ LV++YME LE + + +++
Sbjct: 76 NVLRADNDRDVYLVFDYMETDLHAVIRANILEP--------------VHKQYVVYQLIKV 121
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 613
+ +LH+ ++HRDMKP NILL+ K+ D GLS + + +
Sbjct: 122 IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 41/186 (22%), Positives = 73/186 (39%), Gaps = 39/186 (20%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLL 508
+IG G +G + G +T + A+K+ + Q E ++ P +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLE--PMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 509 LGACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFER-------YRIAWEVASALAFL 560
G C + +V E + G SLED L+ + R IA ++ S + ++
Sbjct: 74 -GPCGKYNAMVLELL--GPSLED-LFDLCD--------RTFSLKTVLMIAIQLISRMEYV 121
Query: 561 HNTKPKPIIHRDMKPGNILL------DHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGP 613
H+ K +I+RD+KP N L+ ++ I D L+ + Y+ +
Sbjct: 122 HS---KNLIYRDVKPENFLIGRPGNKTQQVIHII-DFALAKEYIDPETKKHIPYREHKSL 177
Query: 614 VGTLCY 619
GT Y
Sbjct: 178 TGTARY 183
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 27/166 (16%), Positives = 51/166 (30%), Gaps = 32/166 (19%)
Query: 455 RIGMGGYGTVYKGTFHHTFA----------AVKVLQSKGNIQNKQ-FLQELEVLSKIRHP 503
G +Y+ T ++K+ G + N+Q F Q ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 504 HLLLLLGA------------CPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIA 550
L + LV + G SL+ + + ++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQVA 165
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI--GDVGLS 594
+ AL FLH +H ++ NI +D S++ G +
Sbjct: 166 CRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 31/166 (18%), Positives = 58/166 (34%), Gaps = 35/166 (21%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHP---------H 504
+IG GG+G +Y + K +N EL+ ++
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 505 LLLLLGACPDHGCLVYEYMENG-----------SLEDRLYRKNNTPPIPWFER---YRIA 550
L LG +G + E+ L+ + +N T F++ ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK-ISGQNGT-----FKKSTVLQLG 157
Query: 551 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI--GDVGLS 594
+ L ++H +H D+K N+LL + ++ D GLS
Sbjct: 158 IRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} Length = 138 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 9e-06
Identities = 19/119 (15%), Positives = 43/119 (36%), Gaps = 13/119 (10%)
Query: 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVA 76
+ A+ A + L+ F + L+HV P M + D++
Sbjct: 4 LLFAIDDTEACERAAQYILDMFGKDADCTLTLIHV------KPEFMLYGEAVLAAYDEIE 57
Query: 77 AAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGA 135
+++ K T + ++ + V + E + + + +E N+ L+IG+
Sbjct: 58 MKEEEKAKLLTQKF----STFFTEKGINPFVVIKE-GEPVEMVLEEAKDYNL--LIIGS 109
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 34/172 (19%), Positives = 58/172 (33%), Gaps = 44/172 (25%)
Query: 455 RIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP---- 503
IG GG+G +Y + VKV S N EL+ + P
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD----NGPLFTELKFYQRAAKPEQIQ 97
Query: 504 -----HLLLLLGACPDHGCLVYEYMENG-----------SLEDRLYRKNNTPPIPWFER- 546
L LG G +++ L+ +Y N F R
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKR----FSRK 152
Query: 547 --YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI--GDVGLS 594
+++ + L ++H +H D+K N+LL++ ++ D GL+
Sbjct: 153 TVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae} Length = 267 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 5e-05
Identities = 12/70 (17%), Positives = 25/70 (35%), Gaps = 5/70 (7%)
Query: 738 FICPILKEVMNEPCVAAD-GYTYDRKAIEEWLQENDKS--PIT--DLPLPNKNLLPNYTL 792
CPI + P ++ + +DR I+ +LQ P + ++ + + +
Sbjct: 182 LTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIM 241
Query: 793 LSAILDWKSK 802
K K
Sbjct: 242 ELRCKIAKMK 251
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 8e-05
Identities = 27/144 (18%), Positives = 49/144 (34%), Gaps = 9/144 (6%)
Query: 313 SESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVND---LNKCKLEEETRLSEIQ 369
+++ F L + V+ + + Q + R V + E + +
Sbjct: 620 PKARDQAVFPQNGLVVSSVDVQSVEPVDQRTRDALQRSVQLAIEITTNSQEAAAKHEAQR 679
Query: 370 LLEEKAIELAKQ---EKKKYETARR---EAECARASAEKEAAQRQEAEMKAKHEAKEKEM 423
L +E L +Q ++ + E AR+ E E + E + EAE +A+ E E
Sbjct: 680 LEQEARGRLERQKILDQSEAEKARKELLELEAMSMAVESTGNAKAEAESRAEAARIEGEG 739
Query: 424 LERALNGTFQRYRNLTWEEIESAT 447
Q T E+E
Sbjct: 740 SVLQAKLKAQALAIETEAELERVK 763
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 30/147 (20%), Positives = 47/147 (31%), Gaps = 6/147 (4%)
Query: 305 DVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKL----E 360
DV + + D +L IE+ A L + K+ E
Sbjct: 639 DVQSVEPVDQRTRDALQRSVQLAIEITTNSQEAAAKHEAQRLEQEARGRLERQKILDQSE 698
Query: 361 EETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQ-RQEAEMKAKHEAK 419
E E+ LE ++ + K E A AE AR E Q + +A+ A
Sbjct: 699 AEKARKELLELEAMSMAVESTGNAKAE-AESRAEAARIEGEGSVLQAKLKAQALAIETEA 757
Query: 420 EKEMLERALNGTFQRYRNLTWEEIESA 446
E E +++ R E+ A
Sbjct: 758 ELERVKKVREMELIYARAQLELEVSKA 784
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 8/58 (13%), Positives = 22/58 (37%), Gaps = 6/58 (10%)
Query: 372 EEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEA----KEKEMLE 425
EE+ L + + + +A + E ++++E K++ +K +
Sbjct: 92 EEQRKRLQELDAA--SKVMEQEWREKAKKDLEEWNQRQSEQVEKNKINNRIADKAFYQ 147
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 40.1 bits (93), Expect = 8e-04
Identities = 17/96 (17%), Positives = 36/96 (37%), Gaps = 20/96 (20%)
Query: 315 SQVD-VNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEE 373
+Q D + E E +R + R + + + DA+ K +E+E R E+
Sbjct: 75 AQADRLTQEPESIR-KWREEQR----KRLQELDAASK-------VMEQEWR-------EK 115
Query: 374 KAIELAKQEKKKYETARREAECARASAEKEAAQRQE 409
+L + +++ E + R + + Q
Sbjct: 116 AKKDLEEWNQRQSEQVEKNKINNRIADKAFYQQPDA 151
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 28/114 (24%), Positives = 50/114 (43%), Gaps = 8/114 (7%)
Query: 314 ESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEE 373
+ + E L+ +L+ +YA A+ + K +L + E E R+ E EE
Sbjct: 885 QKHTQLCEEKNLLQEKLQAETELYAEAEEMRVRLAAKKQELEEILHEMEARIEE----EE 940
Query: 374 KAIELAKQEKKKYETARREAECARASAEKEAAQRQEAE-MKAKHEAKEKEMLER 426
+ + + EKKK + + E E+E A RQ+ + K + K K+M +
Sbjct: 941 ERSQQLQAEKKKMQQQMLDLE---EQLEEEEAARQKLQLEKVTADGKIKKMEDD 991
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 24/104 (23%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 322 ELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQ 381
+ KL E + + + + K +L K K + E+ +SE+ E ++ ++
Sbjct: 998 QNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLKNKHESMISEL----EVRLKKEEK 1053
Query: 382 EKKKYETARR--EAECARASAEKEAAQRQEAEMKAKHEAKEKEM 423
+++ E +R E E + + Q Q AE+KA+ KE+E+
Sbjct: 1054 SRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEEL 1097
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 802 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-25 | |
| d1t1ha_ | 78 | g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cre | 5e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-15 | |
| d1wgma_ | 98 | g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Hu | 9e-10 | |
| d2c2la2 | 80 | g.44.1.2 (A:225-304) STIP1 homology and U box-cont | 1e-09 | |
| d1jm7a_ | 103 | g.44.1.1 (A:) brca1 RING domain {Human (Homo sapie | 2e-06 | |
| d2baya1 | 56 | g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 { | 3e-06 | |
| d2gm3a1 | 171 | c.26.2.4 (A:5-175) Putative ethylene-responsive pr | 5e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-61
Identities = 83/285 (29%), Positives = 130/285 (45%), Gaps = 21/285 (7%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN--KQFLQELEVL 497
WE I ++ + RIG G +GTVYKG +H A VK+L + F E+ VL
Sbjct: 3 WE-IPDGQITVGQ--RIGSGSFGTVYKGKWHGDVA-VKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 498 SKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 556
K RH ++LL +G +V ++ E SL L+ + IA + A
Sbjct: 59 RKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQG 116
Query: 557 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
+ +LH K IIHRD+K NI L +L KIGD GL+T+ + S +++ G+
Sbjct: 117 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW----SGSHQFEQLSGS 169
Query: 617 LCYIDPEY---QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673
+ ++ PE Q S +SDVYA+G+V+ +L+T + + + + I L
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-RGYLS 228
Query: 674 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718
K + L C + +R +RP Q+L +E L
Sbjct: 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-55
Identities = 72/275 (26%), Positives = 125/275 (45%), Gaps = 20/275 (7%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKI 500
E+ TL E R+G G +G V+ G ++ HT AVK L +G++ FL E ++ ++
Sbjct: 9 EVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 501 RHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 559
+H L+ L ++ EYMENGSL D L + + + +A ++A +AF
Sbjct: 66 QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAF 124
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
+ + IHRD++ NIL+ L KI D GL+ ++ + G + +
Sbjct: 125 IEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-----EYTAREGAKFPIKW 176
Query: 620 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679
PE G + KSDV+++G+++ +++T + + + +
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-----YPGMTNPEVIQNLERGYRMVR 231
Query: 680 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714
P +EL L C + R +DRP + VLE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFD-YLRSVLE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (478), Expect = 1e-54
Identities = 72/301 (23%), Positives = 132/301 (43%), Gaps = 37/301 (12%)
Query: 439 TWEEIESATLSFSENL---------RIGMGGYGTVYKGTFHHT-----FAAVKVLQSKGN 484
T+E+ A F++ + IG G +G V G F A+K L+S
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 485 IQN-KQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPI 541
+ + FL E ++ + HP+++ L G ++ E+MENGSL+ + + N
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQF 125
Query: 542 PWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601
+ + +A+ + +L + +HRD+ NIL++ NLV K+ D GLS L D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 661
S + T G + + PE + + SDV++YG+V+ ++++ E
Sbjct: 183 SDPTYT-SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG---------ER 232
Query: 662 AIDEDNLAEILDAQAGDW----PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717
+ ++++A D+ P+ L L L C + R RP Q++ L+++
Sbjct: 233 PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG-QIVNTLDKMI 291
Query: 718 E 718
Sbjct: 292 R 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-54
Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 20/267 (7%)
Query: 455 RIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 513
IG G +G V+ G + + A+K + +G + + F++E EV+ K+ HP L+ L G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 514 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 571
+ CLV+E+ME+G L D Y + + +V +A+L +IHR
Sbjct: 71 EQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHR 125
Query: 572 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 631
D+ N L+ N V K+ D G++ + D +TG + + PE S
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDD-----QYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 632 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALG 691
KSDV+++G+++ ++ + ++ +I P + + +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-----DISTGFRLYKPRLASTHVYQIM 235
Query: 692 LSCAELRRKDRPDLKNQVLPVLERLKE 718
C + R +DRP ++L L + E
Sbjct: 236 NHCWKERPEDRPAFS-RLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 4e-54
Identities = 58/268 (21%), Positives = 114/268 (42%), Gaps = 23/268 (8%)
Query: 455 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC- 512
+G G +G V G + A+K++ +G++ +F++E +V+ + H L+ L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 513 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 571
++ EYM NG L + L + + + +V A+ +L + K +HR
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFLHR 124
Query: 572 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 631
D+ N L++ V K+ D GLS + D + G + + PE S
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 632 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALG 691
KSD++A+G+++ ++ + E + + I P ++++ +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP-----YERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234
Query: 692 LSCAELRRKDRPDLKNQVLPVLERLKEV 719
SC + +RP K +L + +V
Sbjct: 235 YSCWHEKADERPTFKI----LLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-53
Identities = 63/266 (23%), Positives = 110/266 (41%), Gaps = 24/266 (9%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC-- 512
IG G +G V G + AVK +++ Q FL E V++++RH +L+ LLG
Sbjct: 14 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 513 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 571
+V EYM GSL D L + + + + +V A+ +L +HR
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 127
Query: 572 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 631
D+ N+L+ + V+K+ D GL+ +S + + PE R S
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASST---------QDTGKLPVKWTAPEALREKKFS 178
Query: 632 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALG 691
KSDV+++G+++ ++ + +D + + D P + +
Sbjct: 179 TKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233
Query: 692 LSCAELRRKDRPDLKNQVLPVLERLK 717
+C L RP Q+ LE +K
Sbjct: 234 KNCWHLDAAMRPSFL-QLREQLEHIK 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-52
Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 23/286 (8%)
Query: 452 ENLRIGMGGYGTVYKGTFHHT----FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLL 506
++ +G G +G+V +G + A+KVL Q ++ ++E +++ ++ +P+++
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 507 LLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
L+G C LV E G L L K IP + +V+ + +L
Sbjct: 73 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE--- 127
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
K +HRD+ N+LL + +KI D GLS L +D S+ + + L + PE
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGKWPLKWYAPECI 184
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 685
S +SDV++YG+ + + L+ + + +A I + + P +
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYG-----QKPYKKMKGPEVMAFIEQGKRMECPPECPP 239
Query: 686 ELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVH 731
EL AL C + +DRPD V +R++ V H
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLT----VEQRMRACYYSLASKVEGHH 281
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 6e-52
Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 21/279 (7%)
Query: 440 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLS 498
WE I +L ++G G +G V+ GT++ T A+K L G + + FLQE +V+
Sbjct: 12 WE-IPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMK 67
Query: 499 KIRHPHLLLLLGAC-PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 557
K+RH L+ L + +V EYM GSL + + + +A ++AS +
Sbjct: 68 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 617
A++ +HRD++ NIL+ NLV K+ D GL+ ++ + G +
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPI 178
Query: 618 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 677
+ PE G + KSDV+++G+++ +L T ++ + L ++
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-----YPGMVNREVLDQVERGYRM 233
Query: 678 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716
P + + L L C ++RP + + LE
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFE-YLQAFLEDY 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-51
Identities = 61/274 (22%), Positives = 112/274 (40%), Gaps = 25/274 (9%)
Query: 452 ENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHL 505
E+ +G G +GTV KG + AVK+L+++ N + L E V+ ++ +P++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 506 LLLLGAC-PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
+ ++G C + LV E E G L L + + + +V+ + +L
Sbjct: 71 VRMIGICEAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
+HRD+ N+LL +KI D GLS L +D ++ T + + PE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ---THGKWPVKWYAPEC 181
Query: 625 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684
S KSDV+++G+++ + + + A + + P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYG-----QKPYRGMKGSEVTAMLEKGERMGCPAGCP 236
Query: 685 KELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718
+E+ L C ++RP V RL+
Sbjct: 237 REMYDLMNLCWTYDVENRPGFAA----VELRLRN 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-51
Identities = 67/282 (23%), Positives = 120/282 (42%), Gaps = 23/282 (8%)
Query: 449 SFSENLRIGMGGYGTVYKGTFHHT------FAAVKVL-QSKGNIQNKQFLQELEVLSKIR 501
+ IG G +G VYKG + A+K L Q FL E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 502 HPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 559
H +++ L G + ++ EYMENG+L+ + + + + +A+ + +
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
L N +HRD+ NIL++ NLV K+ D GLS +L DP TT +G + +
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT---SGGKIPIRW 179
Query: 620 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679
PE + SDV+++G+V+ +++T + + + I D
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEVMKAINDGFRLPT 234
Query: 680 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 721
P+ + L + C + R RP ++ +L++L D
Sbjct: 235 PMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIRAPD 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 2e-50
Identities = 64/332 (19%), Positives = 128/332 (38%), Gaps = 45/332 (13%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGA 511
+G G G V+K + + A K++ + Q ++EL+VL + P+++ GA
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 512 C--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
+ E+M+ GSL+ L + IP +++ V L +L I+
Sbjct: 73 FYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IM 127
Query: 570 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 629
HRD+KP NIL++ K+ D G+S L + VGT Y+ PE +
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--------NSFVGTRSYMSPERLQGTH 179
Query: 630 ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAA 689
S +SD+++ G+ ++++ + I D L + Q +
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPI-------PPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 690 LGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNE 749
G + RP + + + V P P+ ++ +N+
Sbjct: 233 PGRPLSSYGMDSRPPMA------------IFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280
Query: 750 PCVAADGYTYDRKAIEE-----WLQENDKSPI 776
C+ + +R +++ +++ +D +
Sbjct: 281 -CLIKN--PAERADLKQLMVHAFIKRSDAEEV 309
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (447), Expect = 2e-50
Identities = 73/285 (25%), Positives = 132/285 (46%), Gaps = 24/285 (8%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSK 499
E+E ++ ++G G YG VY+G + AVK L + ++ ++FL+E V+ +
Sbjct: 13 EMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKE 69
Query: 500 IRHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 557
I+HP+L+ LLG C + E+M G+L D L N + +A +++SA+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAM 128
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 617
+L K IHRD+ N L+ N + K+ D GLS ++ D T + G +
Sbjct: 129 EYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPI 180
Query: 618 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QA 676
+ PE S KSDV+A+G+++ ++ T + ID + E+L+
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP------YPGIDLSQVYELLEKDYR 234
Query: 677 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 721
+ P +++ L +C + DRP ++ E + + +
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFA-EIHQAFETMFQESS 278
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 5e-50
Identities = 60/267 (22%), Positives = 106/267 (39%), Gaps = 24/267 (8%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 510
IG G YG K K L + + + E+ +L +++HP+++
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 511 ACPDHG----CLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLH--NT 563
D +V EY E G L + + + R+ ++ AL H +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
++HRD+KP N+ LD K+GD GL+ +LN D SF T Y+ PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG------TPYYMSPE 184
Query: 624 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683
+ KSD+++ G ++ +L P + E +I + + P +
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREGKFRRIPYRY 238
Query: 684 TKELAALGLSCAELRRKDRPDLKNQVL 710
+ EL + L+ RP ++ ++L
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVE-EIL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-49
Identities = 64/296 (21%), Positives = 108/296 (36%), Gaps = 40/296 (13%)
Query: 455 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD 514
IG G +G V++G + AVK+ S ++ E+ +RH ++L + A
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 515 HG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-----T 563
LV +Y E+GSL D L R + ++A AS LA LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
I HRD+K NIL+ N I D+GL+ +S + VGT Y+ PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD--TIDIAPNHRVGTKRYMAPE 182
Query: 624 Y------QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET-------------AID 664
+ ++D+YA G+V ++ I + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 665 EDNLAEILDAQAGDW--PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718
+ + L + + + +A + C R ++ L +L +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQLSQ 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-49
Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 24/286 (8%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHT-----FAAVKVLQSKGNIQN-KQFLQELE 495
S + F+E IG G +G VY GT AVK L +I QFL E
Sbjct: 23 GPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 80
Query: 496 VLSKIRHPHLLLLLGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 552
++ HP++L LLG C +V YM++G L + + +N T + +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQ 138
Query: 553 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 612
VA + FL + K +HRD+ N +LD K+ D GL+ + + + TG
Sbjct: 139 VAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF--DSVHNKTG 193
Query: 613 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 672
+ ++ E +T + KSDV+++G+++ +L+T D +L
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLL 248
Query: 673 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718
+ P L + L C + + RP +++ + +
Sbjct: 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIFS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (438), Expect = 6e-49
Identities = 71/295 (24%), Positives = 121/295 (41%), Gaps = 44/295 (14%)
Query: 455 RIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLL 506
IG G +G V++ T AVK+L+ + + F +E ++++ +P+++
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 507 LLLGAC--PDHGCLVYEYMENGSLEDRLYRKN---------------------NTPPIPW 543
LLG C CL++EYM G L + L + PP+
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 544 FERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603
E+ IA +VA+ +A+L K +HRD+ N L+ N+V KI D GLS + S
Sbjct: 140 AEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA--- 193
Query: 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI 663
+ + ++ PE + +SDV+AYG+V+ ++ +
Sbjct: 194 -DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG-----LQPYYGMA 247
Query: 664 DEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718
E+ + + D P EL L C DRP + +L+R+ E
Sbjct: 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC-SIHRILQRMCE 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 6e-48
Identities = 71/301 (23%), Positives = 134/301 (44%), Gaps = 40/301 (13%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FLQE 493
E LSF + +G G +G V + T + AVK+L+ ++ ++ + E
Sbjct: 19 EFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 494 LEVLSKI-RHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRK--------------- 535
L+VLS + H +++ LLGAC ++ EY G L + L RK
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 536 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595
++ + + +++VA +AFL + K IHRD+ NILL H ++KI D GL+
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI 655
+ +D ++V + ++ PE + + +SDV++YG+ + +L + +
Sbjct: 194 DIKNDSNYVVKGN----ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249
Query: 656 THKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 715
V++ + I + P E+ + +C + RP K Q++ ++E+
Sbjct: 250 GMPVDSKFYK----MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEK 304
Query: 716 L 716
Sbjct: 305 Q 305
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-47
Identities = 57/267 (21%), Positives = 111/267 (41%), Gaps = 29/267 (10%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
+G G +G VYK T AA KV+ +K + + ++ E+++L+ HP+++ LL A
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 513 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
++ E+ G+++ + P+ + + + AL +LH+ IIH
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 571 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY-----Q 625
RD+K GNIL + K+ D G+S + +GT ++ PE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ------RRDSFIGTPYWMAPEVVMCETS 187
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG--DWPIKE 683
+ K+DV++ G+ ++++ +P + + L +I ++ P +
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSEPPTLAQPSRW 241
Query: 684 TKELAALGLSCAELRRKDRPDLKNQVL 710
+ C E R Q+L
Sbjct: 242 SSNFKDFLKKCLEKNVDARWTTS-QLL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-47
Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 33/269 (12%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 510
IG G + TVYKG T A LQ + ++ ++F +E E+L ++HP+++
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 511 ACPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
+ LV E M +G+L+ L R + ++ L FLH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 565 PKPIIHRDMKPGNILL-DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
P PIIHRD+K NI + KIGD+GL+T+ + + +GT ++ PE
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--------KAVIGTPEFMAPE 183
Query: 624 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL--DAQAGDWPI 681
DVYA+GM +L++ T++ + + + + +
Sbjct: 184 MYEEK-YDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDK 236
Query: 682 KETKELAALGLSCAELRRKDRPDLKNQVL 710
E+ + C + +R +K +L
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIK-DLL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 5e-47
Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 29/276 (10%)
Query: 455 RIGMGGYGTVYKGTFHHT-----FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLL 506
++G G +G V +G + AVK L+ Q F++E+ + + H +L+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 507 LLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 565
L G +V E GSL DRL + R A +VA + +L +
Sbjct: 75 RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES--- 129
Query: 566 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 625
K IHRD+ N+LL + KIGD GL L + + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ---EHRKVPFAWCAPESL 186
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET- 684
+T S SD + +G+ + ++ T + ++ + +D + P E
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYG------QEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 685 -KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 719
+++ + + C + +DRP + + L E
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVA----LRDFLLEA 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-46
Identities = 74/306 (24%), Positives = 124/306 (40%), Gaps = 44/306 (14%)
Query: 434 RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKGNIQN-K 488
Y L W +I+ F + IG G +G V K AA+K ++ + + +
Sbjct: 3 IYPVLDWNDIK-----FQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 489 QFLQELEVLSKI-RHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTP------ 539
F ELEVL K+ HP+++ LLGAC + L EY +G+L D L +
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 540 -------PIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 592
+ + A +VA + +L K IHRD+ NIL+ N V+KI D G
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 172
Query: 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 652
LS K T + ++ E + + SDV++YG+++ ++++
Sbjct: 173 LS-------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 653 IAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPV 712
+ ++ + P+ E+ L C + +RP Q+L
Sbjct: 226 PYCGMTCAELYE-----KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVS 279
Query: 713 LERLKE 718
L R+ E
Sbjct: 280 LNRMLE 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-46
Identities = 72/313 (23%), Positives = 130/313 (41%), Gaps = 51/313 (16%)
Query: 437 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHT-------FAAVKVLQSKGNIQN-K 488
+L WE L F + +G G +G V T + AVK+L+ K + +
Sbjct: 29 DLKWE-FPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE 85
Query: 489 QFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKN--------- 536
+ EL++++++ H +++ LLGAC G L++EY G L + L K
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 537 -----------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 585
+ + + + A++VA + FL K +HRD+ N+L+ H V
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKV 202
Query: 586 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 645
KI D GL+ + SD S + ++ PE G+ + KSDV++YG+++ +
Sbjct: 203 VKICDFGLARDIMSD----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258
Query: 646 LLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPD 704
+ + + + N +++ D P T+E+ + SC + RP
Sbjct: 259 IFSLG-----VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS 313
Query: 705 LKNQVLPVLERLK 717
N + L
Sbjct: 314 FPN----LTSFLG 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-46
Identities = 65/309 (21%), Positives = 129/309 (41%), Gaps = 25/309 (8%)
Query: 450 FSENLRIGMGGYGTVYKGTFHHT------FAAVKVLQSKGNIQ-NKQFLQELEVLSKIRH 502
F + +G G +GTVYKG + A+K L+ + + NK+ L E V++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 503 PHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 561
PH+ LLG C L+ + M G L D + + I ++A + +L
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE 128
Query: 562 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
+ + ++HRD+ N+L+ KI D GL+ +L ++ Y G + ++
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYHAEGGKVPIKWMA 181
Query: 622 PEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGDWP 680
E + + +SDV++YG+ + +L+T K I ++ IL+ + P
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFG------SKPYDGIPASEISSILEKGERLPQP 235
Query: 681 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFIC 740
T ++ + + C + RP + +++ ++ R P+
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
Query: 741 PILKEVMNE 749
+ +M+E
Sbjct: 295 NFYRALMDE 303
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-45
Identities = 59/262 (22%), Positives = 110/262 (41%), Gaps = 26/262 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
+IG G GTVY T A++ + + + + + E+ V+ + ++P+++ L +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 513 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
D +V EY+ GSL D + + + + E AL FLH+ +IH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 571 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 630
RD+K NILL + K+ D G + + S ST VGT ++ PE
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------VGTPYWMAPEVVTRKAY 193
Query: 631 SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE--TKELA 688
PK D+++ G++ ++++ +P + + L I + E +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPELQNPEKLSAIFR 247
Query: 689 ALGLSCAELRRKDRPDLKNQVL 710
C ++ + R K ++L
Sbjct: 248 DFLNRCLDMDVEKRGSAK-ELL 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 4e-45
Identities = 60/277 (21%), Positives = 103/277 (37%), Gaps = 33/277 (11%)
Query: 448 LSFSENLR----IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN-KQFLQELEVLSKI 500
+ F E+ +G G YG V T AVK++ K + + +E+ + +
Sbjct: 1 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 501 RHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 558
H +++ G + L EY G L DR+ +P + R ++ + +
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVV 117
Query: 559 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 618
+LH I HRD+KP N+LLD KI D GL+T+ + + GTL
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN----NRERLLNKMCGTLP 170
Query: 619 YIDPEY-QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 677
Y+ PE +R + DV++ G+V+ +L + D+ E D +
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--------DQPSDSCQEYSDWKEK 222
Query: 678 DWPIKE----TKELAALGLSCAELRRKDRPDLKNQVL 710
+ AL R + +
Sbjct: 223 KTYLNPWKKIDSAPLALLHKILVENPSARITIP-DIK 258
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 8e-45
Identities = 66/275 (24%), Positives = 112/275 (40%), Gaps = 40/275 (14%)
Query: 450 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPH 504
FS+ IG G +G VY A+K + G N + ++E+ L K+RHP+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 505 LLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
+ G LV EY + + K P+ E + LA+LH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS 133
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
+IHRD+K GNILL + K+GD G ++++ SF VGT ++ P
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF----------VGTPYWMAP 180
Query: 623 EY---QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679
E G K DV++ G+ ++L KP + + + ++ + +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---------NMNAMSALYHIAQNES 231
Query: 680 PIKE----TKELAALGLSCAELRRKDRPDLKNQVL 710
P + ++ SC + +DRP + +L
Sbjct: 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSE-VLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-44
Identities = 69/263 (26%), Positives = 109/263 (41%), Gaps = 29/263 (11%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 509
+G G +G VY + A+KVL Q + Q +E+E+ S +RHP++L L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 510 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
G D L+ EY G++ L + + E+A+AL++ H+ K
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KR 126
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+IHRD+KP N+LL KI D G S S + T GTL Y+ PE
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--------RRTTLCGTLDYLPPEMIEG 178
Query: 628 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687
+ K D+++ G++ + L KP A + + +P T+
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFE-------ANTYQETYKRISRVEFTFPDFVTEGA 231
Query: 688 AALGLSCAELRRKDRPDLKNQVL 710
L + RP L+ +VL
Sbjct: 232 RDLISRLLKHNPSQRPMLR-EVL 253
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-43
Identities = 59/294 (20%), Positives = 118/294 (40%), Gaps = 32/294 (10%)
Query: 442 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-------AVKVL-QSKGNIQNKQFLQE 493
E+ ++ S +G G +G VY+G A+K + ++ + +FL E
Sbjct: 16 EVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 494 LEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKN-------NTPPIPWF 544
V+ + H++ LLG ++ E M G L+ L P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 545 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604
+ ++A E+A +A+L+ +HRD+ N ++ + KIGD G++ +
Sbjct: 134 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET---- 186
Query: 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID 664
K + + ++ PE + G+ + SDV+++G+V+ ++ T + +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSN 241
Query: 665 EDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718
E L +++ D P L L C + K RP +++ ++ E
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIKEEME 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-43
Identities = 59/277 (21%), Positives = 115/277 (41%), Gaps = 24/277 (8%)
Query: 455 RIGMGGYGTVYKGTFHHT-----FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
IG G +G V++G + A+K + ++FLQE + + HPH++ L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 509 LGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
+G ++ ++ E G L + + + A+++++ALA+L + K
Sbjct: 74 IGVITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+HRD+ N+L+ N K+GD GLS + T YK + + ++ PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPESINF 183
Query: 628 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687
+ SDV+ +G+ + ++L + + D + I + + P L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHG-----VKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238
Query: 688 AALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRAR 724
+L C RP ++ L + E ++A+
Sbjct: 239 YSLMTKCWAYDPSRRPRFT-ELKAQLSTILE-EEKAQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 155 bits (393), Expect = 2e-42
Identities = 55/268 (20%), Positives = 107/268 (39%), Gaps = 34/268 (12%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
+G G +G V++ T T A K + + + +E++ +S +RHP L+ L A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 513 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
D ++YE+M G L +++ ++N + E +V L +H +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 571 RDMKPGNILL--DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
D+KP NI+ + K+ D GL+ L+ S TT GT + PE
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-------GTAEFAAPEVAEGK 200
Query: 629 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE----- 683
+ +D+++ G++ LL+ E++ + + ++ DW + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFG---------GENDDETLRNVKSCDWNMDDSAFSG 251
Query: 684 -TKELAALGLSCAELRRKDRPDLKNQVL 710
+++ R + Q L
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIH-QAL 278
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (377), Expect = 6e-41
Identities = 61/273 (22%), Positives = 113/273 (41%), Gaps = 23/273 (8%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQ---SKGNIQNKQFLQELEVLSKIRHPHLLLLL 509
+G GG V+ AVKVL+ ++ +F +E + + + HP ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 510 GACPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
+V EY++ +L D ++ + P+ + + AL F H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ- 129
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
IIHRD+KP NI++ K+ D G++ + + V+ T +GT Y+ PE
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT---AAVIGTAQYLSPE 184
Query: 624 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683
R + +SDVY+ G V+ ++LT +P V A ++ E +
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--YQHVREDPIPPSARHE-GL 241
Query: 684 TKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716
+ +L A+ L ++R ++ L R+
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 151 bits (383), Expect = 7e-41
Identities = 58/268 (21%), Positives = 103/268 (38%), Gaps = 34/268 (12%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
+G G +G V++ T K + + + E+ +++++ HP L+ L A
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 513 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
D L+ E++ G L DR+ ++ + E + L +H I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 571 RDMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
D+KP NI+ + S KI D GL+T LN D T T + PE
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-------TATAEFAAPEIVDRE 203
Query: 629 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE----- 683
+ +D++A G++ LL+ A ED+L + + + DW E
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFA---------GEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 684 -TKELAALGLSCAELRRKDRPDLKNQVL 710
+ E + + + R + L
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLTVH-DAL 281
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 65/288 (22%), Positives = 121/288 (42%), Gaps = 39/288 (13%)
Query: 455 RIGMGGYGTVYKGTFHHT---------FAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHP 503
+G G +G V AVK+L+S ++ + E+E++ I +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 504 HLLLLLGACPDHG--CLVYEYMENGSLEDRLYRK-------------NNTPPIPWFERYR 548
+++ LLGAC G ++ EY G+L + L + N + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 549 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 608
A++VA + +L + K IHRD+ N+L+ + V KI D GL+ ++ + TT
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 609 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 668
+ ++ PE + + +SDV+++G+++ ++ T + VE
Sbjct: 197 GR----LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK---- 248
Query: 669 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716
+ + D P T EL + C RP K Q++ L+R+
Sbjct: 249 -LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-40
Identities = 64/259 (24%), Positives = 105/259 (40%), Gaps = 24/259 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLL 509
+G G + TV T A+K+L+ + I+ +E +V+S++ HP + L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 510 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
D Y +NG L + + E+ SAL +LH K
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KG 128
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
IIHRD+KP NILL+ ++ +I D G + +L+ + S + VGT Y+ PE
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----SKQARANSFVGTAQYVSPELLTE 184
Query: 628 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687
SD++A G +I QL+ P ++ +I+ + D+P K +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------FQKIIKLE-YDFPEKFFPKA 237
Query: 688 AALGLSCAELRRKDRPDLK 706
L L R +
Sbjct: 238 RDLVEKLLVLDATKRLGCE 256
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 37/289 (12%)
Query: 455 RIGMGGYGTVYKGTFHHT-------FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLL 506
+G G +G V + AVK+L + + +++ + EL++L I H +
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 507 LLL-GACPDHG---CLVYEYMENGSLEDRLYRKNNTP-------------PIPWFERYRI 549
+ L GAC G ++ E+ + G+L L K N +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 550 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 609
+++VA + FL + + IHRD+ NILL V KI D GL+ + DP +V
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK--- 193
Query: 610 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 669
L ++ PE + + +SDV+++G+++ ++ + + IDE+
Sbjct: 194 -GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----SPYPGVKIDEEFCR 248
Query: 670 EILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718
+ + P T E+ L C RP +++ L L +
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNLLQ 296
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (360), Expect = 3e-38
Identities = 59/264 (22%), Positives = 99/264 (37%), Gaps = 25/264 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
+G G + V T A+K + + + E+ VL KI+HP+++ L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 512 CPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
G L+ + + G L DR+ K + R+ ++V A+ +LH+ I+
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHD---LGIV 129
Query: 570 HRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
HRD+KP N+L D + I D GLS M + + GT Y+ PE
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-------VLSTACGTPGYVAPEVLA 182
Query: 627 TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686
S D ++ G++ LL P + + E L + + W +
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF--EQILKAEYEFDSPYWD-DISDS 239
Query: 687 LAALGLSCAELRRKDRPDLKNQVL 710
E + R + Q L
Sbjct: 240 AKDFIRHLMEKDPEKRFTCE-QAL 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 60/264 (22%), Positives = 98/264 (37%), Gaps = 27/264 (10%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSK-IRHPHLLLL 508
+G G +G V+ F T F A+K L+ + + + E VLS HP L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 509 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
V EY+ G L + + A E+ L FLH+ K
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---K 122
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 626
I++RD+K NILLD + KI D G+ + K GT YI PE
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 627 TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 686
+ D +++G+++ ++L + DE+ L + +P KE
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFH-------GQDEEELFHSIRMDNPFYPRWLEKE 229
Query: 687 LAALGLSCAELRRKDRPDLKNQVL 710
L + + R ++ +
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDIR 253
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 41/203 (20%), Positives = 85/203 (41%), Gaps = 19/203 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
+G G +G V++ + K ++ KG +E+ +L+ RH ++L L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF 70
Query: 513 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 570
+ +++E++ + +R+ + + E +V AL FLH+ I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 571 RDMKPGNILLDH--NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 628
D++P NI+ + KI + G + L +F Y PE +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-------TAPEYYAPEVHQHD 178
Query: 629 LISPKSDVYAYGMVILQLLTAKP 651
++S +D+++ G ++ LL+
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGIN 201
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 139 bits (352), Expect = 1e-37
Identities = 61/285 (21%), Positives = 110/285 (38%), Gaps = 41/285 (14%)
Query: 450 FSENLR----IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---------KQFLQEL 494
F EN +G G V + T AVK++ G + L+E+
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 495 EVLSKIR-HPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 551
++L K+ HP+++ L + LV++ M+ G L D L K + E +I
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMR 117
Query: 552 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 611
+ + LH I+HRD+KP NILLD ++ K+ D G S L+ K
Sbjct: 118 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-------KLR 167
Query: 612 GPVGTLCYIDPEYQRTGL------ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 665
GT Y+ PE + + D+++ G+++ LL P ++
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML--R 225
Query: 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL 710
++ + +W + + L ++ + R + + L
Sbjct: 226 MIMSGNYQFGSPEWD-DYSDTVKDLVSRFLVVQPQKRYTAE-EAL 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 3e-37
Identities = 52/264 (19%), Positives = 93/264 (35%), Gaps = 26/264 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
+IG G +G +Y GT A+K+ K ++ Q E ++ ++ + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 513 ---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
D+ +V E + + + +A ++ S + ++H+ K I
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFI 125
Query: 570 HRDMKPGNIL---LDHNLVSKIGDVGLSTMLNSDPSFVSTTY-KNTGPVGTLCYIDPEYQ 625
HRD+KP N L + I D GL+ + Y +N GT Y
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-----IDEDNLAEILDAQAGDWP 680
S + D+ + G V++ I E ++ ++ +P
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 681 IKETKELAALGLSCAELRRKDRPD 704
E A C LR D+PD
Sbjct: 246 ----SEFATYLNFCRSLRFDDKPD 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (350), Expect = 3e-37
Identities = 50/284 (17%), Positives = 90/284 (31%), Gaps = 27/284 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLLGA 511
RIG G +G +++GT A+K + + + + ++L+ + G
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 512 CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 571
H LV + + + A ++ + + +H K +++R
Sbjct: 72 EGLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYR 125
Query: 572 DMKPGNILLD-----HNLVSKIGDVGLSTMLNSDPSFVSTTY-KNTGPVGTLCYIDPEYQ 625
D+KP N L+ + + + D G+ + Y + GT Y+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-----IDEDNLAEILDAQAGDWP 680
S + D+ A G V + L I E + L +P
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245
Query: 681 IKETKELAALGLSCAELRRKDRPD---LKNQVLPVLERLKEVAD 721
+E L PD L+ VLERL D
Sbjct: 246 ----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-36
Identities = 68/299 (22%), Positives = 115/299 (38%), Gaps = 39/299 (13%)
Query: 455 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQN--KQFLQELEVLSKI---RHPHLL 506
IG G YG V+K F A+K ++ + + ++E+ VL + HP+++
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 507 LLLGACPD-------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 559
L C LV+E+++ K P +P + +++ L F
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 560 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 619
LH+ ++HRD+KP NIL+ + K+ D GL+ + + + S V TL Y
Sbjct: 132 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-------VVTLWY 181
Query: 620 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ---- 675
PE + D+++ G + ++ KP + D D L +ILD
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS------DVDQLGKILDVIGLPG 235
Query: 676 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSV--HP 732
DWP A A+ K D+ +L + R + S HP
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (337), Expect = 3e-35
Identities = 66/256 (25%), Positives = 110/256 (42%), Gaps = 29/256 (11%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLL 509
+G G +G V+ H + A+KVL+ + ++ KQ E +LS + HP ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 510 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
G D + + +Y+E G L L + P A EV AL +LH+ K
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHS---KD 124
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
II+RD+KP NILLD N KI D G + + GT YI PE T
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---------VTYTLCGTPDYIAPEVVST 175
Query: 628 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687
+ D +++G++I ++L ++ ++T +IL+A+ +P +++
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILNAEL-RFPPFFNEDV 228
Query: 688 AALGLSCAELRRKDRP 703
L R
Sbjct: 229 KDLLSRLITRDLSQRL 244
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (339), Expect = 6e-35
Identities = 60/260 (23%), Positives = 100/260 (38%), Gaps = 29/260 (11%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSK------GNIQNKQFLQELEVLSKIRHPHLL 506
IG GG+G VY T A+K L K G L ++S P ++
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 507 LLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
+ A PD + + M G L L + + A E+ L +HN
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN-- 125
Query: 565 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 624
+ +++RD+KP NILLD + +I D+GL+ + K VGT Y+ PE
Sbjct: 126 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTHGYMAPEV 176
Query: 625 QRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683
+ G+ +D ++ G ++ +LL + D+ + + A + P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 684 TKELAALGLSCAELRRKDRP 703
+ EL +L + R
Sbjct: 233 SPELRSLLEGLLQRDVNRRL 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 1e-34
Identities = 53/267 (19%), Positives = 104/267 (38%), Gaps = 35/267 (13%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 512
+G+G G V + T A+K+LQ + +E+E+ + + PH++ ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 513 PDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
+ +V E ++ G L R+ + + E I + A+ +LH+
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 567 PIIHRDMKPGNILLDH---NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 623
I HRD+KP N+L N + K+ D G + S S + Y T Y+ PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-------TPYYVAPE 183
Query: 624 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683
D+++ G+++ LL P H + + + + ++P E
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQYEFPNPE 240
Query: 684 ----TKELAALGLSCAELRRKDRPDLK 706
++E+ L + + R +
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTIT 267
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 1e-34
Identities = 45/203 (22%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 511
IG G YG V + A+K + + ++ L+E+++L + RH +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 512 C--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
P + Y+ + LY+ T + +++ L ++H+ ++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131
Query: 570 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 629
HRD+KP N+LL+ KI D GL+ + + D T T V T Y PE
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 630 I-SPKSDVYAYGMVILQLLTAKP 651
+ D+++ G ++ ++L+ +P
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRP 211
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 47/204 (23%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 510
+IG G YG VYK T A+K ++ + ++E+ +L ++ HP+++ LL
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 511 AC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
+ LV+E++ + + IP +++ LAF H+ +
Sbjct: 69 VIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRV 123
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRT 627
+HRD+KP N+L++ K+ D GL+ + V TL Y PE
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE------VVTLWYRAPEILLGC 177
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
S D+++ G + +++T +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-34
Identities = 59/299 (19%), Positives = 109/299 (36%), Gaps = 28/299 (9%)
Query: 448 LSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHL 505
+S+++ IG G +G VY+ + A+K + + +EL+++ K+ H ++
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNI 75
Query: 506 LLLLGACPDHG--------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 557
+ L G LV +Y+ + +P +++ +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
A++H+ I HRD+KP N+LLD + V K+ D G + L VS
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR------ 186
Query: 617 LCYIDP-EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675
Y P + DV++ G V+ +LL +P V+ ++ + +
Sbjct: 187 -YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 676 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSV--HP 732
E + + RP + + + RL E AR T H
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 456 IGMGGYGTVYKGTFHHT--FAAVKVL-----QSKGNIQNKQFLQELEVLSKIRHPHLLLL 508
+G G + TVYK +T A+K + + N+ L+E+++L ++ HP+++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 509 LGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 566
L A + LV+++ME + K+N+ + L +LH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---H 119
Query: 567 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQ 625
I+HRD+KP N+LLD N V K+ D GL+ S T V T Y PE
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------RAYTHQVVTRWYRAPELLF 173
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKP 651
+ D++A G ++ +LL P
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVP 199
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 7e-33
Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 510
+IG G +G V+K T A+K + + + L+E+++L ++H +++ L+
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 511 ACPDHG----------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL 560
C LV+++ E+ E R+ + + L ++
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYI 133
Query: 561 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
H K I+HRDMK N+L+ + V K+ D GL+ + + S + T V TL Y
Sbjct: 134 HRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN--SQPNRYTNRVVTLWYR 188
Query: 621 DPEYQRTG-LISPKSDVYAYGMVILQLLTAKP 651
PE P D++ G ++ ++ T P
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 54/270 (20%), Positives = 102/270 (37%), Gaps = 31/270 (11%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVL------QSKGNIQNKQFLQELEVLSKIRHPHLL 506
+G G + V K T A K + S+ + + +E+ +L +I+HP+++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 507 LLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 564
L + L+ E + G L D L K + E ++ + + +LH+
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 131
Query: 565 PKPIIHRDMKPGNILLDHNLVS----KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 620
I H D+KP NI+L V KI D GL+ ++ F GT ++
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-------KNIFGTPEFV 183
Query: 621 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680
PE + ++D+++ G++ LL+ K ET N++ + ++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVNYEFEDEYF 240
Query: 681 IKETKELAALGLSCAELRRKDRPDLKNQVL 710
+ K R ++ L
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQ-DSL 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-32
Identities = 57/270 (21%), Positives = 98/270 (36%), Gaps = 41/270 (15%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN------KQFLQELEVLSKIRHPH-- 504
+G GG+G+VY G A+K ++ + E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 505 LLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
++ LL PD L+ E E + + W+V A+ HN
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN 128
Query: 563 TKPKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 621
++HRD+K NIL+D N K+ D G +L T GT Y
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--------YTDFDGTRVYSP 177
Query: 622 PEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680
PE+ R + V++ G+++ ++ ++ EI+ Q +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF------------EHDEEIIRGQV-FFR 224
Query: 681 IKETKELAALGLSCAELRRKDRPDLKNQVL 710
+ + E L C LR DRP + ++
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTFE-EIQ 253
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (311), Expect = 5e-32
Identities = 41/203 (20%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 455 RIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGA 511
+IG G YG VYK ++ A+K ++ + + ++E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 512 CPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 569
LV+E+++ + + + ++ + +A+ H+ + ++
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 570 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTG 628
HRD+KP N+L++ KI D GL+ K T + TL Y P+ +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIP------VRKYTHEIVTLWYRAPDVLMGSK 176
Query: 629 LISPKSDVYAYGMVILQLLTAKP 651
S D+++ G + +++ P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTP 199
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 62/256 (24%), Positives = 99/256 (38%), Gaps = 26/256 (10%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLL 509
+G G +G V T + A+K+L+ + I + E VL RHP L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 510 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
A H C V EY G L L R+ E+ SAL +LH+ +
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RD 125
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
+++RD+K N++LD + KI D GL SD + GT Y+ PE
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA------TMKTFCGTPEYLAPEVLED 179
Query: 628 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687
D + G+V+ +++ + D + L E++ + +P + E
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF-------YNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 688 AALGLSCAELRRKDRP 703
+L + K R
Sbjct: 233 KSLLAGLLKKDPKQRL 248
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (307), Expect = 6e-31
Identities = 59/303 (19%), Positives = 115/303 (37%), Gaps = 33/303 (10%)
Query: 409 EAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTVYKG 467
A K + KE L +A +++ + +A L + ++ +G G +G V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQN---TAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 468 TFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLGACPDHGCL--VY 520
+ A+K+L + ++ KQ L E +L + P L+ L + D+ L V
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 580
EY+ G + L R A ++ +LH+ +I+RD+KP N+L+
Sbjct: 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 581 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYG 640
D ++ D G + + + GT + PE + + D +A G
Sbjct: 175 DQQGYIQVTDFGFAKRVKGRTWTL---------CGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 641 MVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRK 700
++I ++ P A + E + + +P + +L L + ++
Sbjct: 226 VLIYEMAAGYPPF-------FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 701 DRP 703
R
Sbjct: 279 KRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-30
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 510
+G G YG V T A+K L + K+ +EL +L +RH +++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 511 ACPDHG--------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
LV +M G+ +L + + + +++ L ++H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA 139
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
IIHRD+KPGN+ ++ + KI D GL+ +S + TG V T Y P
Sbjct: 140 ---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---------EMTGYVVTRWYRAP 187
Query: 623 E-YQRTGLISPKSDVYAYGMVILQLLTAKP 651
E + D+++ G ++ +++T K
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKT 217
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 3e-29
Identities = 51/275 (18%), Positives = 105/275 (38%), Gaps = 25/275 (9%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 510
+IG G YGTV+K T A+K ++ + + L+E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 511 ACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 568
LV+E+ + + + + +++ L F H+ + +
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHS---RNV 122
Query: 569 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRT 627
+HRD+KP N+L++ N K+ + GL+ + V TL Y P+
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIP------VRCYSAEVVTLWYRPPDVLFGA 176
Query: 628 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 687
L S D+++ G + +L A + D D+ + + G ++ +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPL------FPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 688 AALGLSCAELRRKDRPDLKNQVLPVLERLKEVADR 722
L L N V + +++
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (282), Expect = 7e-28
Identities = 40/206 (19%), Positives = 89/206 (43%), Gaps = 28/206 (13%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGA 511
++G G Y V++ VK+L+ ++ K+ +E+++L +R P+++ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADI 98
Query: 512 CPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
D LV+E++ N + + ++ +E+ AL + H+
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHS---MG 149
Query: 568 IIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQ 625
I+HRD+KP N+++DH + ++ D GL+ + + V + + PE
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-------EYNVRVASRYFKGPELLV 202
Query: 626 RTGLISPKSDVYAYGMVILQLLTAKP 651
+ D+++ G ++ ++ K
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 8e-27
Identities = 45/209 (21%), Positives = 78/209 (37%), Gaps = 28/209 (13%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 510
IG G G V A+K L Q K+ +EL ++ + H +++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 511 ACPDHG--------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
LV E M+ + + + +++ + LH+
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLHS 137
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
IIHRD+KP NI++ + KI D GL+ T++ T V T Y P
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA-------RTAGTSFMMTPYVVTRYYRAP 187
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAKP 651
E D+++ G ++ +++ K
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (269), Expect = 6e-26
Identities = 55/368 (14%), Positives = 124/368 (33%), Gaps = 70/368 (19%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 512
++G G + TV+ A+K++ + + E+++L ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 513 ---------------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 557
P+ +V + G L +K IP +I+ ++ L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 558 AFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 616
++H IIH D+KP N+L++ + + ++ + N+ T + T
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSIQT 192
Query: 617 LCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-- 674
Y PE +D+++ +I +L+T D+D++A+I++
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 675 ---QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVH 731
K T+ + + L++ + + K+ A D
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD------ 306
Query: 732 PAPPNHFICPIL----------KEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPL 781
F+ P+L ++N P WL++ + ++ +
Sbjct: 307 ------FLSPMLQLDPRKRADAGGLVNHP----------------WLKDT--LGMEEIRV 342
Query: 782 PNKNLLPN 789
P++ L +
Sbjct: 343 PDRELYGS 350
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-25
Identities = 41/204 (20%), Positives = 78/204 (38%), Gaps = 18/204 (8%)
Query: 455 RIGMGGYGTVYKGTFHHT--FAAVKVL--QSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 510
+G G YG+V T AVK L + I K+ +EL +L ++H +++ LL
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 511 ACPDHGCLVYE---YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 567
L Y+ + L + + +++ L ++H+
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 141
Query: 568 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 627
IIHRD+KP N+ ++ + KI D GL+ + +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--------TGYVATRWYRAPEIMLNW 193
Query: 628 GLISPKSDVYAYGMVILQLLTAKP 651
+ D+++ G ++ +LLT +
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRT 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 3e-25
Identities = 63/264 (23%), Positives = 100/264 (37%), Gaps = 30/264 (11%)
Query: 455 RIGMGGYGTVYKG---TFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRH-PH 504
+G G YG V+ + H T A+KVL+ +Q + E +VL IR P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 505 LLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 562
L+ L A L+ +Y+ G L L ++ E E+ AL LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK 147
Query: 563 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 622
II+RD+K NILLD N + D GLS +D + Y G + +
Sbjct: 148 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIV 202
Query: 623 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG---DW 679
+G D ++ G+++ +LLT + ++++ AEI +
Sbjct: 203 RGGDSG-HDKAVDWWSLGVLMYELLTGASPFTVDG------EKNSQAEISRRILKSEPPY 255
Query: 680 PIKETKELAALGLSCAELRRKDRP 703
P + + L K R
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRL 279
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 78 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 71.3 bits (174), Expect = 5e-16
Identities = 27/73 (36%), Positives = 39/73 (53%), Gaps = 1/73 (1%)
Query: 731 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKS-PITDLPLPNKNLLPN 789
P P +F CPI E+M +P + + G TY+R +I++WL K+ P + L + L PN
Sbjct: 2 SPEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPN 61
Query: 790 YTLLSAILDWKSK 802
Y L S I W
Sbjct: 62 YVLKSLIALWCES 74
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.1 bits (176), Expect = 5e-15
Identities = 24/155 (15%), Positives = 46/155 (29%), Gaps = 19/155 (12%)
Query: 455 RIGMGGYGTVYKGTFH-HTFAAVKVL----------QSKGNIQNKQFLQELEVLSKIRHP 503
+G G V+ VK + K + + F ++
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 504 HLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 563
L L G VY + N L + + K + + +A ++
Sbjct: 67 ALQKLQGLAVPK---VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFYH- 121
Query: 564 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598
+ I+H D+ N+L+ + I D S +
Sbjct: 122 --RGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.1 bits (129), Expect = 9e-10
Identities = 19/70 (27%), Positives = 28/70 (40%), Gaps = 1/70 (1%)
Query: 734 PPNHFICPILKEVMNEPCVAADGY-TYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTL 792
+ F+ PI+ +M +P V T DR I L + P PL + PN L
Sbjct: 19 ACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRSPLTMDQIRPNTEL 78
Query: 793 LSAILDWKSK 802
I W ++
Sbjct: 79 KEKIQRWLAE 88
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 80 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 53.3 bits (127), Expect = 1e-09
Identities = 27/69 (39%), Positives = 37/69 (53%), Gaps = 1/69 (1%)
Query: 735 PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKS-PITDLPLPNKNLLPNYTLL 793
P++ I E+M EPC+ G TYDRK IEE LQ P+T PL + L+PN +
Sbjct: 5 PDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMK 64
Query: 794 SAILDWKSK 802
I + S+
Sbjct: 65 EVIDAFISE 73
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (106), Expect = 2e-06
Identities = 9/64 (14%), Positives = 23/64 (35%), Gaps = 3/64 (4%)
Query: 736 NHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKS---PITDLPLPNKNLLPNYTL 792
CPI E++ EP + + + + + L + P+ + ++L +
Sbjct: 20 KILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRF 79
Query: 793 LSAI 796
+
Sbjct: 80 SQLV 83
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 56 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 42.8 bits (100), Expect = 3e-06
Identities = 10/54 (18%), Positives = 27/54 (50%), Gaps = 1/54 (1%)
Query: 739 ICPILKEVMNEPCVAA-DGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYT 791
+C I +V P ++ +++ +E+++++ PIT+ PL + ++
Sbjct: 2 LCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVP 55
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 171 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 42.2 bits (98), Expect = 5e-05
Identities = 32/121 (26%), Positives = 49/121 (40%), Gaps = 7/121 (5%)
Query: 27 SRYAVLWALEKFIPEGINLFKL--LHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEK 84
+ A W LEK + + FK+ LHV+ + + + D+ +Q K
Sbjct: 23 CKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDM----RQSNK 78
Query: 85 WKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWK 144
K LL F N C + V E I++ D I EV + LV+G++ G F
Sbjct: 79 AKGLHLLEFFVNKCHEIGVGCEA-WIKTGDPKDVICQEVKRVRPDFLVVGSRGLGRFQKV 137
Query: 145 F 145
F
Sbjct: 138 F 138
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 802 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.86 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.84 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.75 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.71 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.65 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.6 | |
| d1wgma_ | 98 | Ubiquitin conjugation factor E4A {Human (Homo sapi | 99.3 | |
| d1t1ha_ | 78 | E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsi | 99.11 | |
| d2c2la2 | 80 | STIP1 homology and U box-containing protein 1, STU | 99.1 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.2 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d2baya1 | 56 | Pre-mRNA splicing factor Prp19 {Baker's yeast (Sac | 97.78 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.26 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.13 | |
| d1jm7b_ | 97 | bard1 RING domain {Human (Homo sapiens) [TaxId: 96 | 96.67 | |
| d1jm7a_ | 103 | brca1 RING domain {Human (Homo sapiens) [TaxId: 96 | 95.69 | |
| d1rmda2 | 86 | V(D)J recombination activating protein 1 (RAG1), d | 93.86 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 91.24 | |
| d1fbva4 | 79 | CBL {Human (Homo sapiens) [TaxId: 9606]} | 88.84 | |
| d1ni5a1 | 227 | tRNA-Ile-lysidine synthetase, TilS, N-terminal dom | 82.24 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=377.68 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=208.7
Q ss_pred CCCCCCEECCCCCEEEEEEEECCE-----EEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEE
Q ss_conf 874450114777189999998993-----89999971568-300698999999998269991544414142887--2899
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHHT-----FAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 449 ~f~~~~~IG~G~~g~Vyk~~~~~~-----~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
+|.....||+|+||.||+|.+..+ .||||.+.... ....+.|.+|+.+|++++|||||+++|+|.+.. ++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 42785698027882999999957997889999999784459899999999999998579988861899996288779999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCC
Q ss_conf 97269997789641189999998999999999999999977049999587589999767628960279320341013699
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... ..++|..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 107 Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp ECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCEEEECCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECCCC
T ss_conf 7227985300210456--79999999999999999889885279---835761504489889991998884431575677
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHHHHHHCHHHHHHHHHHHCCCC
Q ss_conf 996434333568755755679521125987875540338999999972-8997432200244310002688753207999
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
..... ........||+.|+|||++.++.++.++|||||||++|||+| |++||......+ .+..+........
T Consensus 182 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 254 (299)
T d1jpaa_ 182 TSDPT-YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD------VINAIEQDYRLPP 254 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCCCCC
T ss_pred CCCCE-EEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH------HHHHHHCCCCCCC
T ss_conf 77653-6502566688300387888369978612144535789999867999999999999------9999973788999
Q ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 9689999999999953012689986211203578878974
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 719 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~ 719 (802)
|..++..+.+|+.+||+.+|.+||++. +++..|+++...
T Consensus 255 ~~~~~~~l~~li~~cl~~~P~~RPs~~-ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 255 PMDCPSALHQLMLDCWQKDRNHRPKFG-QIVNTLDKMIRN 293 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHHHS
T ss_pred CCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHCC
T ss_conf 742269999999997587976892999-999999998418
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.51 Aligned_cols=255 Identities=30% Similarity=0.457 Sum_probs=206.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCEEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC-EEEEEEC
Q ss_conf 2187445011477718999999899389999971568--300698999999998269991544414142887-2899972
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYM 523 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~-~lV~Ey~ 523 (802)
.++|....+||+|+||.||+|++++ .||||+++... ....+.|.+|+.+|++++|||||+++|++.+.. ++||||+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred CCCEEEEEEEEECCCCEEEEEEECC-EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCEEEEEEECC
T ss_conf 4518998898307885899999999-899999973469989999999999999847998786456797155899999658
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCCC
Q ss_conf 69997789641189999998999999999999999977049999587589999767628960279320341013699996
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~~ 603 (802)
++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+........
T Consensus 86 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 86 EGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCC
T ss_conf 9988899985235--78999999999999999988875099---951614789979818997887500221333556776
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHH-----H
Q ss_conf 434333568755755679521125---98787554033899999997289974322002443100026887532-----0
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-----Q 675 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~-----~ 675 (802)
.......||+.|+|||++.+ +.|+.++|||||||++|||+||+.||........ +...+.. .
T Consensus 161 ----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 161 ----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPD 230 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSCCCC
T ss_pred ----CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCCCC
T ss_conf ----312566557431799999505689999531516359999999978899899896999------9999965888986
Q ss_pred CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 7999968999999999995301268998621120357887897
Q 003694 676 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 676 ~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
....+..++..+.+|+.+||..+|.+||++. +++..|+.+..
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-~il~~Le~l~~ 272 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLAR 272 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CHHCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 0003655549999999997588976892999-99999999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.91 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=207.3
Q ss_pred CCCCCCC-EECCCCCEEEEEEEEC----CEEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCEEEECCEECCCC-EEEE
Q ss_conf 1874450-1147771899999989----93899999715683-00698999999998269991544414142887-2899
Q 003694 448 LSFSENL-RIGMGGYGTVYKGTFH----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVY 520 (802)
Q Consensus 448 ~~f~~~~-~IG~G~~g~Vyk~~~~----~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~-~lV~ 520 (802)
++|.... +||+|+||.||+|.+. +..||||++..... ...+.|.+|+.+|++++|||||+++|+|.+.. ++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCEEEEEE
T ss_conf 47188784873060809999999608976899999988203978999999999999867998880686560368079999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCC
Q ss_conf 97269997789641189999998999999999999999977049999587589999767628960279320341013699
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 88 E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp ECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 8078996899752125--69999999999999999878998688---105767646604546885420331342115543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHHHHHHCHHHHHHHHHHHCCCC
Q ss_conf 996434333568755755679521125987875540338999999972-8997432200244310002688753207999
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
... ........||+.|+|||++.++.++.++|||||||++|||+| |++||......+ .+..+........
T Consensus 163 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~------~~~~i~~~~~~~~ 233 (285)
T d1u59a_ 163 DSY---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMEC 233 (285)
T ss_dssp SCE---ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTCCCCC
T ss_pred CCC---CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH------HHHHHHCCCCCCC
T ss_conf 432---1135621137433586887279999541232201789999938999999979999------9999981899999
Q ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 96899999999999530126899862112035788789
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
|..++.++.+|+.+||..+|.+||++. ++...|+...
T Consensus 234 p~~~~~~l~~li~~cl~~~p~~RPs~~-~i~~~L~~~~ 270 (285)
T d1u59a_ 234 PPECPPELYALMSDCWIYKWEDRPDFL-TVEQRMRACY 270 (285)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 976789999999997577976890999-9999999999
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.13 Aligned_cols=241 Identities=23% Similarity=0.367 Sum_probs=203.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEEEC
Q ss_conf 18744501147771899999989--9389999971568300698999999998269991544414142887--2899972
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
..|....+||+|+||.||+|... +..||+|++........+.+.+|+.+|++++|||||++++++.+.. ++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCCC
Q ss_conf 69997789641189999998999999999999999977049999587589999767628960279320341013699996
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~~ 603 (802)
+||+|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC-
T ss_conf 798089886415----9999999999999999999999879---72267768886887899686425156413213666-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHC--CCCCH
Q ss_conf 4343335687557556795211259878755403389999999728997432200244310002688753207--99996
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPI 681 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~--~~~p~ 681 (802)
.....+||+.|+|||++.+..++.++|||||||++|+|+||++||........ +..+..... ...|.
T Consensus 172 -----~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~~~~~~~~ 240 (293)
T d1yhwa1 172 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPELQNPE 240 (293)
T ss_dssp -----CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSCCCSSGG
T ss_pred -----CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCCCCCCC
T ss_conf -----44444447773682664479988012031372999998048899899799999------9999857999888855
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 89999999999953012689986211
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+..+.+|+.+||..+|.+||++.+
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~e 266 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKE 266 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 37999999999986699668909999
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.90 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=208.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEECCC--CEEEEEECC
Q ss_conf 18744501147771899999989-938999997156830069899999999826999154441414288--728999726
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYME 524 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~--~~lV~Ey~~ 524 (802)
.+|....+||+|+||.||+|.+. +..||||++.... ...++|.+|+.++++++|||||+++|+|.+. .++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 9958888982088829999998899999999987886-768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCCCC
Q ss_conf 99977896411899999989999999999999999770499995875899997676289602793203410136999964
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++.... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE-
T ss_conf 991899752013--47889999999999999877653164---310443153266668877686553210023688733-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCHHHHHHCHHHHHHHHHHHCCCCCHHH
Q ss_conf 343335687557556795211259878755403389999999728-9974322002443100026887532079999689
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
......||+.|+|||++.+..++.++|||||||++|||+|+ ++||...... ..+..+........|..+
T Consensus 158 ----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~------~~~~~i~~~~~~~~p~~~ 227 (263)
T d1sm2a_ 158 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGFRLYKPRLA 227 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH------HHHHHHHHTCCCCCCTTS
T ss_pred ----EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHHCCCCCCCCCC
T ss_conf ----5043001766678578607999840332105999999987898887789999------999999806888995436
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 99999999995301268998621120357887897
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
+.++.+|+.+||+.+|.+||++. +++..|+++.+
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~-~il~~L~~i~e 261 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFS-RLLRQLAEIAE 261 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 79999999997657976891999-99999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.00 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=207.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC-EEEEEECC
Q ss_conf 218744501147771899999989-9389999971568300698999999998269991544414142887-28999726
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYME 524 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~-~lV~Ey~~ 524 (802)
..+|....+||+|+||.||+|.+. ++.||||++.... ...+.|.+|+.+|++++|||||+++|+|.+.. ++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECC
T ss_conf 89938867981079828999999999999999986476-88899999999998679998857873104597699999578
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCCCC
Q ss_conf 99977896411899999989999999999999999770499995875899997676289602793203410136999964
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++..... .++++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 91 ~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-- 164 (272)
T d1qpca_ 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-- 164 (272)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE--
T ss_pred CCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC--
T ss_conf 9828888751478-98878899999999999999997489---54675642251562024404234101477358864--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCHHHHHHCHHHHHHHHHHHCCCCCHHH
Q ss_conf 3433356875575567952112598787554033899999997289-974322002443100026887532079999689
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
.......||+.|+|||++.++.++.++|||||||++|||+||. +|+...... ..+..+........|...
T Consensus 165 ---~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~------~~~~~i~~~~~~~~p~~~ 235 (272)
T d1qpca_ 165 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGYRMVRPDNC 235 (272)
T ss_dssp ---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCCCCCTTC
T ss_pred ---CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHHCCCCCCCCCC
T ss_conf ---42035677444458289837999824564525799999996898888888999------999999706888896557
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 9999999999530126899862112035788789
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
+..+.+|+.+||+.+|.+||++. +++..|+.+-
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~-ei~~~L~~~f 268 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFD-YLRSVLEDFF 268 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 19999999997588976893999-9999861132
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.92 Aligned_cols=254 Identities=25% Similarity=0.427 Sum_probs=206.9
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC-------EEEEEEEECCCC-CCCHHHHHHHHHHHHHC-CCCCEEEECCEECCCC-
Q ss_conf 2187445011477718999999899-------389999971568-30069899999999826-9991544414142887-
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG- 516 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~~-------~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~Hpniv~l~g~~~~~~- 516 (802)
.++|....+||+|+||.||+|++.+ ..||+|.+.... ......|.+|+.+|.++ +|||||+++|+|.+..
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 89939701983078819999998578855420499999966335878999999999999971589968687788862995
Q ss_pred -EEEEEECCCCCHHHHHHHCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf -289997269997789641189--------------------99999899999999999999997704999958758999
Q 003694 517 -CLVYEYMENGSLEDRLYRKNN--------------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKP 575 (802)
Q Consensus 517 -~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp 575 (802)
++||||+++|+|.++|..... ...+++..++.|+.|++.||.|||+.+ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCH
T ss_conf 899997279995999998625777510221000012220012577899999999999999999997399---05052703
Q ss_pred CCEEECCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCC
Q ss_conf 9767628960279320341013699996434333568755755679521125987875540338999999972-899743
Q 003694 576 GNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIA 654 (802)
Q Consensus 576 ~NILld~~~~~KI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~ 654 (802)
+|||++.++.+||+|||+|+........ .......||+.|+|||++.++.++.++|||||||++|||+| |++||.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCE----EEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCC
T ss_conf 2144345982898514222204577861----562343578765783887279999633030003999999838999999
Q ss_pred CCCHHHHHHCHHHHHHHHHH-HCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHH
Q ss_conf 22002443100026887532-0799996899999999999530126899862112035788
Q 003694 655 ITHKVETAIDEDNLAEILDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 714 (802)
Q Consensus 655 ~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~ 714 (802)
...... .+..++.. ...+.|...+..+.+|+.+||+.+|.+||++. +++..|.
T Consensus 269 ~~~~~~------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~-ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDA------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP-NLTSFLG 322 (325)
T ss_dssp TCCCSH------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHH
T ss_pred CCCHHH------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHH
T ss_conf 989899------99999856998998876789999999997588966893999-9999974
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.85 Aligned_cols=255 Identities=23% Similarity=0.387 Sum_probs=210.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCE------EEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC-EEE
Q ss_conf 1874450114777189999998993------8999997156-8300698999999998269991544414142887-289
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHHT------FAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 519 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~~~------~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~-~lV 519 (802)
.+|....+||+|+||.||+|.+..+ .||+|.+... .....+.|.+|+.+|++++|||||+++|+|.+.. +++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
T ss_conf 99978319820899299999995899889899999996513497999999999999986799888158999961983699
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCC
Q ss_conf 99726999778964118999999899999999999999997704999958758999976762896027932034101369
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~ 599 (802)
+||+.+|+|.+.+.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 89 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEECCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 98426874010111334--57999999999999999999998769---50476212031167998758602552223354
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHHHHHHCHHHHHHHH-HHHCC
Q ss_conf 9996434333568755755679521125987875540338999999972-899743220024431000268875-32079
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL-DAQAG 677 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~l-d~~~~ 677 (802)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||...... .+...+ .....
T Consensus 164 ~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-------~~~~~i~~~~~~ 232 (317)
T d1xkka_ 164 EEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKGERL 232 (317)
T ss_dssp TCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-------GHHHHHHHTCCC
T ss_pred CCCC----CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHCCCCC
T ss_conf 4453----22365105864467088746999835654407999999997799999999989-------999999759989
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 999689999999999953012689986211203578878974
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 719 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~ 719 (802)
..|..++..+.+|+.+||..+|.+||++. +++..|..+...
T Consensus 233 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~l~~~~~~ 273 (317)
T d1xkka_ 233 PQPPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMARD 273 (317)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHC
T ss_conf 99855689999999984789934691999-999999998758
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.73 Aligned_cols=247 Identities=24% Similarity=0.388 Sum_probs=202.3
Q ss_pred CEECCCCCEEEEEEEECC----EEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCEEEECCEECCCC-EEEEEECCCC
Q ss_conf 011477718999999899----3899999715683--00698999999998269991544414142887-2899972699
Q 003694 454 LRIGMGGYGTVYKGTFHH----TFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENG 526 (802)
Q Consensus 454 ~~IG~G~~g~Vyk~~~~~----~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~-~lV~Ey~~~g 526 (802)
++||+|+||.||+|.+.. ..||||+++.... ...+.|.+|+.+|++++|||||+++|+|.+.. +|||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEECCCCC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775059779999747889
Q ss_pred CHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCCCCCC
Q ss_conf 97789641189999998999999999999999977049999587589999767628960279320341013699996434
Q 003694 527 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 606 (802)
Q Consensus 527 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~~~~~ 606 (802)
+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+........
T Consensus 93 ~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~- 165 (277)
T d1xbba_ 93 PLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 165 (277)
T ss_dssp EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE-
T ss_pred CHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC-
T ss_conf 6899975225---7899999999999999976687479---55677761131023567512341345331343234432-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHHHHHHCHHHHHHHHHHHCCCCCHHHHH
Q ss_conf 333568755755679521125987875540338999999972-8997432200244310002688753207999968999
Q 003694 607 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 685 (802)
Q Consensus 607 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~ 685 (802)
......||+.|+|||++.++.++.++|||||||++|||+| |++||......+ ....+........|..++.
T Consensus 166 --~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~------~~~~i~~~~~~~~p~~~~~ 237 (277)
T d1xbba_ 166 --AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMGCPAGCPR 237 (277)
T ss_dssp --C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCTTCCH
T ss_pred --CCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHH------HHHHHHCCCCCCCCCCCCH
T ss_conf --24456778420391665379998434430340313289658999999989999------9999982899999865679
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 9999999953012689986211203578878
Q 003694 686 ELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 686 ~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
.+.+|+.+||+.+|.+||++. +|...|+..
T Consensus 238 ~~~~li~~cl~~dp~~RPs~~-~i~~~L~~~ 267 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVENRPGFA-AVELRLRNY 267 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHH-HHHHHHHHH
T ss_pred HHHHHHHHHCCCCHHHCCCHH-HHHHHHHCH
T ss_conf 999999997588976890989-999985288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=364.62 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=207.8
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEEE
Q ss_conf 218744501147771899999989--9389999971568300698999999998269991544414142887--289997
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
..+|....+||+|+||.||+|.+. +..||||++.... ...++|.+|+.+|++++|||||+++|+|.+.. ++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEEC
T ss_conf 799398659820888089999999999699999977761-0399999999999867999882677527457854787631
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCC
Q ss_conf 26999778964118999999899999999999999997704999958758999976762896027932034101369999
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~ 602 (802)
+++|+|.+++.... ...+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred CCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 46760677753035-541579999999999999788898789---30576045768998999289832445465378872
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHH-HCCCCCH
Q ss_conf 643433356875575567952112598787554033899999997289974322002443100026887532-0799996
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGDWPI 681 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~-~~~~~p~ 681 (802)
. ......|++.|+|||++.++.|+.++|||||||++|||+||..|+...... ..+...+.. .....|.
T Consensus 171 ~-----~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i~~~~~~~~~~ 239 (287)
T d1opja_ 171 T-----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKDYRMERPE 239 (287)
T ss_dssp E-----EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCCCCCCT
T ss_pred E-----EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHHCCCCCCCCC
T ss_conf 2-----103556654666927872799981043021789999998679988774259------99999985588888874
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 89999999999953012689986211203578878
Q 003694 682 KETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 682 ~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
..+..+.+|+.+||+.+|.+||++. +++..|+.+
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~-ei~~~L~~~ 273 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFA-EIHQAFETM 273 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHT
T ss_pred CCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHH
T ss_conf 3309999999997577976893999-999999999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.64 Aligned_cols=259 Identities=26% Similarity=0.444 Sum_probs=209.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC------EEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EE
Q ss_conf 187445011477718999999899------3899999715683-00698999999998269991544414142887--28
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 518 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~~------~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~l 518 (802)
..|...+.||+|+||.||+|.+.. ..||||++..... .....|.+|+.+|++++|||||+++|+|.+.. ++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCC
Q ss_conf 99972699977896411899999989999999999999999770499995875899997676289602793203410136
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~ 598 (802)
||||+.+|++.+.+.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEECCCCCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf 997213574022210234--54208999999999998541212123---4257656442788899849984551030035
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHCCC
Q ss_conf 99996434333568755755679521125987875540338999999972899743220024431000268875320799
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 678 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~ 678 (802)
..... ........||+.|+|||++.++.++.++|||||||++|||+||..|+...... ...+..+.+.....
T Consensus 162 ~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 162 DDPEA---TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAINDGFRLP 233 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTCCCC
T ss_pred CCCCC---CEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHCCCCCC
T ss_conf 78765---26742677773434888870499997355634489899999679886556899-----99999986357899
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 996899999999999530126899862112035788789742
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVA 720 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~~ 720 (802)
.|..++..+.+|+.+||+.+|.+||++. +++..|+.+....
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~-eil~~L~~l~~~p 274 (283)
T d1mqba_ 234 TPMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIRAP 274 (283)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHHHSG
T ss_pred CCHHHHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHCC
T ss_conf 8504579999999997767976893999-9999999986695
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.49 Aligned_cols=239 Identities=28% Similarity=0.369 Sum_probs=202.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEE
Q ss_conf 18744501147771899999989--9389999971568---300698999999998269991544414142887--2899
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|.....||+|+||.||+|.+. +..||+|++.... ......+.+|+.+|++++|||||++++++.+.. ++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCC
Q ss_conf 97269997789641189999998999999999999999977049999587589999767628960279320341013699
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~ 600 (802)
||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 5047985898875048---9999999999999999999999889---465220234414668998711555633544888
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHCCCCC
Q ss_conf 99643433356875575567952112598787554033899999997289974322002443100026887532079999
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
. .....||+.|+|||++.+..++.++|||||||++|+|+||++||......+ +...+.......|
T Consensus 160 ~--------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~p 224 (263)
T d2j4za1 160 R--------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEFTFP 224 (263)
T ss_dssp C--------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCCCCC
T ss_pred C--------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHCCCCCCC
T ss_conf 5--------235578876349999758998931440467599999832999988899999-------9999971899998
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 689999999999953012689986211
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+.++.+|+.+||+.+|.+||++.+
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~e 251 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLRE 251 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 668999999999976479768909999
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.80 Aligned_cols=243 Identities=23% Similarity=0.368 Sum_probs=202.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEEEC
Q ss_conf 18744501147771899999989--9389999971568300698999999998269991544414142887--2899972
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
+.|....+||+|+||.||+|.+. +..||+|++........+.|.+|+++|++++|||||++++++.+.. ++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCCC
Q ss_conf 69997789641189999998999999999999999977049999587589999767628960279320341013699996
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~~ 603 (802)
++|+|.+++..... ++++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--- 163 (288)
T d2jfla1 92 AGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--- 163 (288)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH---
T ss_pred CCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCC---
T ss_conf 99818899986289--9999999999999999999999889---887140700314878999899716123035778---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHC--
Q ss_conf 43433356875575567952112-----59878755403389999999728997432200244310002688753207--
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-- 676 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~-- 676 (802)
........||+.|+|||++. ...|+.++|||||||++|+|+||++||......+ .+..+.....
T Consensus 164 ---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i~~~~~~~ 234 (288)
T d2jfla1 164 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPPT 234 (288)
T ss_dssp ---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHHSCCCC
T ss_pred ---CCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHCCCCCC
T ss_conf ---64100102562647999983202578888806657878999999820889999989999------999997079987
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 9999689999999999953012689986211
Q 003694 677 GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 677 ~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...|...+.++.+|+.+||+.+|.+||++.+
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e 265 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ 265 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 7765669999999999976699668919999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=361.88 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=214.2
Q ss_pred HHHHCCCCCCCEECCCCCEEEEEEEECC-------EEEEEEEECCCCCC-CHHHHHHHHHHHHHCCCCCEEEECCEECCC
Q ss_conf 9862187445011477718999999899-------38999997156830-069899999999826999154441414288
Q 003694 444 ESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDH 515 (802)
Q Consensus 444 ~~~~~~f~~~~~IG~G~~g~Vyk~~~~~-------~~vAvK~l~~~~~~-~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~ 515 (802)
+...++|....+||+|+||.||+|++.+ +.||||++...... ...+|.+|+.+|++++||||+.++++|.+.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCC
T ss_conf 38988938867982078839999998887657788299999988210857999999999999966899765524666059
Q ss_pred C--EEEEEECCCCCHHHHHHHCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECC
Q ss_conf 7--28999726999778964118---------------------999999899999999999999997704999958758
Q 003694 516 G--CLVYEYMENGSLEDRLYRKN---------------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRD 572 (802)
Q Consensus 516 ~--~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrD 572 (802)
. ++||||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ |+|||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EEEEE
T ss_conf 803899981589929999985275542100001110012103467889899999999999999855413578---68548
Q ss_pred CCCCCEEECCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-C
Q ss_conf 999976762896027932034101369999643433356875575567952112598787554033899999997289-9
Q 003694 573 MKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK-P 651 (802)
Q Consensus 573 LKp~NILld~~~~~KI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~-~ 651 (802)
|||+|||++.++.+||+|||+|+........ ...+...|++.|+|||++.+..+++++|||||||++|||+||. +
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCB----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ECCCCEEECCCCCEEECCCHHHEECCCCCCC----CCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 8401168989992898331442113677641----115777767676798997268898056302523629999806899
Q ss_pred CCCCCCHHHHHHCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 743220024431000268875320799996899999999999530126899862112035788789
Q 003694 652 AIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 652 p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
||......+ .+..+.+......|..++.++.+|+.+||+.+|.+||++. +|++.|+++.
T Consensus 242 p~~~~~~~e------~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~-ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEE------VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC-SIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHH------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHTT
T ss_pred CCCCCCHHH------HHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHC
T ss_conf 999989999------9999973997888732529999999997488965793999-9999999842
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.03 Aligned_cols=241 Identities=25% Similarity=0.283 Sum_probs=203.6
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEE
Q ss_conf 218744501147771899999989--9389999971568---300698999999998269991544414142887--289
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV 519 (802)
-++|.....||+|+||.||+|... +..||+|++.... ......+.+|+.+|++++||||+++++++.+.. |+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCC
Q ss_conf 99726999778964118999999899999999999999997704999958758999976762896027932034101369
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~ 599 (802)
|||++||+|.+++.+.+. +++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EECCCCCCHHHHHHCCCC---CCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 003579860555532567---759999999999965211343159---62246477784765899888820565200356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHCCCC
Q ss_conf 99964343335687557556795211259878755403389999999728997432200244310002688753207999
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
... .....+||+.|+|||++.+..|+.++|||||||++|+|+||++||......+ +...+......+
T Consensus 158 ~~~------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~~~ 224 (337)
T d1o6la_ 158 DGA------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIRF 224 (337)
T ss_dssp TTC------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC
T ss_pred CCC------CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCCCC
T ss_conf 786------2055100889966665048988833310223067889987899999969999-------999985289989
Q ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 968999999999995301268998621
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
|...+.++.+|+.+||+.+|.+||+..
T Consensus 225 p~~~s~~~~dli~~~L~~dP~~R~~~~ 251 (337)
T d1o6la_ 225 PRTLSPEAKSLLAGLLKKDPKQRLGGG 251 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCS
T ss_pred CCCCCHHHHHHHHHHCCCCCHHHCCCC
T ss_conf 866899999999866638934422565
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.05 Aligned_cols=248 Identities=26% Similarity=0.360 Sum_probs=199.1
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEE
Q ss_conf 6218744501147771899999989--9389999971568-300698999999998269991544414142887--2899
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 446 ~~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
..++|....+||+|+||.||+|.+. +..||+|+++... ......+.+|+.+|++++|||||+++++|.+.. ++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCC
Q ss_conf 972699977896411899999989999999999999999770-4999958758999976762896027932034101369
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~ 599 (802)
||+++|+|.+++.+.+ .+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 7679986899874249---99999999999999999999998599---97144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCH--------------
Q ss_conf 999643433356875575567952112598787554033899999997289974322002443100--------------
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-------------- 665 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~-------------- 665 (802)
.. ....+||+.|+|||++.+..|+.++|||||||++|||+||+.||............
T Consensus 158 ~~--------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 158 SM--------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp HT--------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred CC--------CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 86--------2111377141194687589989488899899999999988899899887899999988751775457742
Q ss_pred ------------------HHHHHHHHHH----CCCCC-HHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf ------------------0268875320----79999-689999999999953012689986211
Q 003694 666 ------------------DNLAEILDAQ----AGDWP-IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 ------------------~~l~~~ld~~----~~~~p-~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
....+.++.. .+..| ...+.++.+|+.+||..||.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e 294 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 12333221111222354134778876650268766764448999999999986899467908999
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.04 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=205.3
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEECCEECCC----CEEE
Q ss_conf 18744501147771899999989--9389999971568--30069899999999826999154441414288----7289
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLV 519 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~----~~lV 519 (802)
++|.....||+|+||.||+|... +..||+|++.... ......|.+|+.+|++++|||||++++++.+. .++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHHHC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCEEECCCCCCCEEECCCCEEEEEEECCCCC
Q ss_conf 9972699977896411-899999989999999999999999770499--9958758999976762896027932034101
Q 003694 520 YEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKP--KPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~--~~iiHrDLKp~NILld~~~~~KI~DFGla~~ 596 (802)
|||+++|+|.+++... .....+++..++.|+.|++.||.|||+.++ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHC
Q ss_conf 36999964343335687557556795211259878755403389999999728997432200244310002688753207
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 676 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~ 676 (802)
+..... ......||+.|+|||++.+..++.++|||||||++|+|+||++||......+ .+..+.....
T Consensus 164 ~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~~~i~~~~~ 231 (269)
T d2java1 164 LNHDTS------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGKF 231 (269)
T ss_dssp C-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCC
T ss_pred CCCCCC------CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH------HHHHHHCCCC
T ss_conf 245777------5566778823279999839999938988752789999801889989989999------9999971899
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 9999689999999999953012689986211
Q 003694 677 GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 677 ~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...|...+.++.+|+.+||+.+|.+||++.+
T Consensus 232 ~~~~~~~s~~l~~li~~~L~~dp~~Rps~~e 262 (269)
T d2java1 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEE 262 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 8897435999999999976799557918999
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=356.17 Aligned_cols=243 Identities=20% Similarity=0.278 Sum_probs=201.5
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEEE
Q ss_conf 218744501147771899999989--9389999971568300698999999998269991544414142887--289997
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
-++|.....||+|+||.||+|... +..||||++........+.+.+|+.+|++++|||||++++++.+.. ++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCEEEEEEECCCCCCCCC
Q ss_conf 26999778964118999999899999999999999997704999958758999976762--8960279320341013699
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--HNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld--~~~~~KI~DFGla~~~~~~ 600 (802)
++||+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 79988999997623--78999999999999999999997569---76000154673641688986999545210442565
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHCC---
Q ss_conf 99643433356875575567952112598787554033899999997289974322002443100026887532079---
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG--- 677 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~--- 677 (802)
.. .....||+.|+|||++.+..++.++|||||||++|+|+||++||......+ .+..+......
T Consensus 180 ~~-------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~~~ 246 (350)
T d1koaa2 180 QS-------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDWNMDD 246 (350)
T ss_dssp SC-------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCCSCC
T ss_pred CC-------CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHCCCCCCC
T ss_conf 43-------200068624218899758998726765546599999985989989979999------99999847889894
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 999689999999999953012689986211
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+...+..+.+|+.+||..+|.+||++.+
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 276 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 223589999999999975689667908999
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.43 Aligned_cols=246 Identities=22% Similarity=0.277 Sum_probs=199.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEE
Q ss_conf 218744501147771899999989--9389999971568-300698999999998269991544414142887--28999
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
.++|....+||+|+||.||+|.+. +..||+|++.... ....+.+.+|+.+|++++|||||++++++.+.. ++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCC
Q ss_conf 72699977896411899999989999999999999999770499995875899997676289602793203410136999
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~ 601 (802)
|+++|+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 458980899975379---9999999999999999999999759---8357546899788789987983231422404688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHC-CCC
Q ss_conf 96434333568755755679521125987-8755403389999999728997432200244310002688753207-999
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-GDW 679 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~-~~~ 679 (802)
. ....+..+||+.|+|||++.+..+ +.++|||||||++|+|+||++||......... +........ ...
T Consensus 158 ~----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~~~~~~~~~~~~~ 228 (271)
T d1nvra_ 158 R----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YSDWKEKKTYLNP 228 (271)
T ss_dssp E----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-----HHHHHTTCTTSTT
T ss_pred C----CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHH-----HHHHHCCCCCCCC
T ss_conf 6----531113255747428728618999997101617379999998299788889859999-----9998638887886
Q ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 9689999999999953012689986211
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
....+.++.+|+.+||+.+|.+||++.+
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~e 256 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPD 256 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 4469999999999976799668909999
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.51 Aligned_cols=243 Identities=25% Similarity=0.334 Sum_probs=203.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEE
Q ss_conf 18744501147771899999989--9389999971568---300698999999998269991544414142887--2899
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
.+|.....||+|+||.||+|... +..||||++.... ......+.+|+.+|++++||||+++++++.+.. ++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCC
Q ss_conf 97269997789641189999998999999999999999977049999587589999767628960279320341013699
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~ 600 (802)
||++||+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 7048987777653159---9999999999999999997621650---884767741236688853886032102422567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHCCCCC
Q ss_conf 99643433356875575567952112598787554033899999997289974322002443100026887532079999
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
... ......+||+.|+|||++.+..++.++|||||||++|+|+||++||...+..+. +..++ .....+|
T Consensus 162 ~~~----~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~-~~~~~~p 230 (288)
T d1uu3a_ 162 SKQ----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------FQKII-KLEYDFP 230 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-TTCCCCC
T ss_pred CCC----CCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-CCCCCCC
T ss_conf 764----333555677552584400268989666230456999998038899899599999------99997-1899998
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 689999999999953012689986211
Q 003694 681 IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+..+.+|+.+||+.+|.+||++.+
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e 257 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEE 257 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 547999999999985579768919789
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=356.32 Aligned_cols=243 Identities=21% Similarity=0.283 Sum_probs=202.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEEE
Q ss_conf 218744501147771899999989--9389999971568300698999999998269991544414142887--289997
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
.+.|.....||+|+||.||+|... +..||+|++..........+.+|+.+|++++|||||+++++|.+.. ++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCEEEEEEECCCCCCCCC
Q ss_conf 26999778964118999999899999999999999997704999958758999976762--8960279320341013699
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--HNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld--~~~~~KI~DFGla~~~~~~ 600 (802)
++||+|.+.+...+ .++++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 89980888898638--99899999999999999999999779---26513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHC---C
Q ss_conf 9964343335687557556795211259878755403389999999728997432200244310002688753207---9
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA---G 677 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~---~ 677 (802)
.. .....||+.|+|||++.+..++.++|||||||++|+|+||++||......+. +..+..... .
T Consensus 183 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~~~~~ 249 (352)
T d1koba_ 183 EI-------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWEFDE 249 (352)
T ss_dssp SC-------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHCCCCCCS
T ss_pred CC-------EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCCCC
T ss_conf 72-------0100476453489997479989763338989999999968899899799999------9999847889893
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 999689999999999953012689986211
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
..+...+.++.+|+.+||+.+|.+||++.+
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 279 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 279 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 002479999999999975699668918999
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.34 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=207.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEEECC
Q ss_conf 18744501147771899999989-9389999971568300698999999998269991544414142887--28999726
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 524 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~-~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 524 (802)
++|....+||+|+||.||+|+++ +..||||+++.... ..+.|.+|+.++++++||||++++|+|.+.. ++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 99799689820788399999988998999999874757-78999999999996689860158899850781699997048
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCCCC
Q ss_conf 99977896411899999989999999999999999770499995875899997676289602793203410136999964
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~~~ 604 (802)
+|+|..++..... .+++..+.+|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE-
T ss_conf 9938886410246--7768999999999999999875468---434665413588769984798861442023578722-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHHHHHHCHHHHHHHHHHHCCCCCHHH
Q ss_conf 34333568755755679521125987875540338999999972-89974322002443100026887532079999689
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
......||+.|+|||++.+..++.++||||||+++|||+| |+.||......+ ....+........|...
T Consensus 157 ----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~~~i~~~~~~~~p~~~ 226 (258)
T d1k2pa_ 157 ----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYRPHLA 226 (258)
T ss_dssp ----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTTCCCCCCTTC
T ss_pred ----EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH------HHHHHHHCCCCCCCCCC
T ss_conf ----52465788775780786379988521033643246739755999988999999------99999807978996546
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf 999999999953012689986211203578
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVL 713 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L 713 (802)
+..+.+|+.+||+.+|.+||++.+ ++..|
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~e-il~~L 255 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKI-LLSNI 255 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHH-HHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHH-HHHHH
T ss_conf 599999999976689768939999-99874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.87 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=207.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC-EEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC-EEEEEECC
Q ss_conf 2187445011477718999999899-389999971568300698999999998269991544414142887-28999726
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYME 524 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~~-~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~-~lV~Ey~~ 524 (802)
..+|....+||+|+||.||+|.+.+ ..||||++.... ...+.|.+|+.+|++++|||||+++|+|.+.. ++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEECC
T ss_conf 79979846993079809999999999999999988044-88899999999998666678868999982397599999447
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCCCC
Q ss_conf 99977896411899999989999999999999999770499995875899997676289602793203410136999964
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~~~ 604 (802)
+|+|..++..... ..++|..++.|+.+|+.||.|||..+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 95 ~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-- 168 (285)
T d1fmka3 95 KGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 168 (285)
T ss_dssp TCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC--
T ss_conf 9943542000035-53059999999999999999875411---43353123079998999299844255542568873--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHCCCCCHHHH
Q ss_conf 34333568755755679521125987875540338999999972899743220024431000268875320799996899
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 684 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 684 (802)
.......||+.|+|||++..+.++.++|||||||++|||+||..|+....... ..+..+........+..++
T Consensus 169 ---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-----~~~~~i~~~~~~~~~~~~~ 240 (285)
T d1fmka3 169 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVERGYRMPCPPECP 240 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHTTCCCCCCTTSC
T ss_pred ---EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHHCCCCCCCCCCC
T ss_conf ---35245455665458089837998917741323589999986899999888899-----9999998268999983237
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCCHHHHHHH
Q ss_conf 9999999995301268998621120357887
Q 003694 685 KELAALGLSCAELRRKDRPDLKNQVLPVLER 715 (802)
Q Consensus 685 ~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~ 715 (802)
.++.+|+.+||+.+|.+||++.+ |+..|+.
T Consensus 241 ~~l~~li~~cl~~dP~~Rps~~~-i~~~L~~ 270 (285)
T d1fmka3 241 ESLHDLMCQCWRKEPEERPTFEY-LQAFLED 270 (285)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHH-HHHHHHT
T ss_pred HHHHHHHHHHCCCCHHHCCCHHH-HHHHHHH
T ss_conf 99999999975669758919999-9998766
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=353.75 Aligned_cols=237 Identities=27% Similarity=0.400 Sum_probs=194.6
Q ss_pred CCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCC---CCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEE
Q ss_conf 8744501147771899999989--93899999715683---00698999999998269991544414142887--28999
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 449 ~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
.|+..++||+|+||.||+|... +..||||++..... ...+.+.+|+.+|++++|||||+++++|.+.. ++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCC
Q ss_conf 72699977896411899999989999999999999999770499995875899997676289602793203410136999
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~ 601 (802)
|+++|+|..++... .++++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCCC-
T ss_conf 06999457899737---99999999999999999999998689---766678842179879997898443653346778-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHCCC
Q ss_conf 96434333568755755679521125---987875540338999999972899743220024431000268875320799
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 678 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~ 678 (802)
....||+.|+|||++.+ +.|+.++|||||||++|+|++|++||......+ .+..+.......
T Consensus 169 ---------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~~~~~~~ 233 (309)
T d1u5ra_ 169 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNESPA 233 (309)
T ss_dssp ---------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCCC
T ss_pred ---------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHCCCCC
T ss_conf ---------73134766368899834678886721454558999999987889999979999------999998289998
Q ss_pred -CCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf -99689999999999953012689986211
Q 003694 679 -WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 679 -~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.+...+..+.+|+.+||+.+|.+||++.+
T Consensus 234 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 263 (309)
T d1u5ra_ 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (309)
T ss_dssp CSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 887888999999999977379657918999
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=349.21 Aligned_cols=234 Identities=21% Similarity=0.286 Sum_probs=198.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEE
Q ss_conf 18744501147771899999989--9389999971568---300698999999998269991544414142887--2899
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|....+||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+.++|||||++++++.+.. ++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCC
Q ss_conf 97269997789641189999998999999999999999977049999587589999767628960279320341013699
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~ 600 (802)
||+.+|+|..++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 2334662266675158---9899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHCCCCC
Q ss_conf 99643433356875575567952112598787554033899999997289974322002443100026887532079999
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||....... .+..+ .......|
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i-~~~~~~~p 258 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKI-VSGKVRFP 258 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHCCCCCC
T ss_pred ---------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HCCCCCCC
T ss_conf ---------643367635678899717998853311450078999975889989959999------99998-61798897
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 68999999999995301268998
Q 003694 681 IKETKELAALGLSCAELRRKDRP 703 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP 703 (802)
...+..+.+|+.+||..+|.+|+
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCT
T ss_pred CCCCHHHHHHHHHHHHHCHHHCC
T ss_conf 66899999999998340998606
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.88 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=203.7
Q ss_pred CCEECCCCCEEEEEEEECC-----EEEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEECCEECCC---CEEEEEEC
Q ss_conf 5011477718999999899-----38999997156-830069899999999826999154441414288---72899972
Q 003694 453 NLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---GCLVYEYM 523 (802)
Q Consensus 453 ~~~IG~G~~g~Vyk~~~~~-----~~vAvK~l~~~-~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~---~~lV~Ey~ 523 (802)
..+||+|+||+||+|++.. ..||||.+... ......+|.+|+.+|++++||||++++|+|.+. .++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCCC
Q ss_conf 69997789641189999998999999999999999977049999587589999767628960279320341013699996
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~~ 603 (802)
++|+|.+++.... ..+++..+++++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ECCCHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 0674144210134--54048999999999887652003367---625776687576779998899106523225566555
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHCCCCCHHH
Q ss_conf 43433356875575567952112598787554033899999997289974322002443100026887532079999689
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
.........||+.|+|||++.++.++.++||||||+++|||+||..||....... .....+........|..+
T Consensus 187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~~i~~g~~~~~p~~~ 259 (311)
T d1r0pa_ 187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRRLLQPEYC 259 (311)
T ss_dssp --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCCCCCCTTC
T ss_pred --CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHCCCCCCCCCCC
T ss_conf --3100256555645567688743799974574661999999997899998889999-----999999808988996447
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 99999999995301268998621120357887897
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
+..+.+|+.+||..+|.+||++. +|+..|+.+..
T Consensus 260 ~~~l~~li~~cl~~dP~~RPs~~-ei~~~L~~i~~ 293 (311)
T d1r0pa_ 260 PDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIFS 293 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 59999999997688976893999-99999999997
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.80 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=208.9
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC-----EEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC-EEE
Q ss_conf 2187445011477718999999899-----389999971568-300698999999998269991544414142887-289
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 519 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~~-----~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~-~lV 519 (802)
.++|.....||+|+||.||+|.+.. ..||||.+.... ......|.+|+.+|++++|||||+++|+|.+.. ++|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCEEEEE
T ss_conf 89969877993078829999999369964499999993656687999999999999986899998569889953747999
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCC
Q ss_conf 99726999778964118999999899999999999999997704999958758999976762896027932034101369
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~ 599 (802)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 98406980776542247--89999999999999987752302267---44141026553206789678765034213367
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHHHHHHCHHHHHHHHHHHCCC
Q ss_conf 9996434333568755755679521125987875540338999999972-899743220024431000268875320799
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 678 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~ 678 (802)
... ...+...||+.|+|||++.++.++.++|||||||++|||+| |.+||......+ .+..+.......
T Consensus 161 ~~~-----~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~------~~~~i~~~~~~~ 229 (273)
T d1mp8a_ 161 STY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLP 229 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCCCC
T ss_pred CCC-----EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH------HHHHHHCCCCCC
T ss_conf 762-----330540058310326675169988745244424789999826999988899999------999998189998
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 9968999999999995301268998621120357887897
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
.|..++..+.+|+.+||..+|.+||++. +++..|+.+.+
T Consensus 230 ~~~~~~~~~~~li~~cl~~dp~~Rps~~-ei~~~L~~i~~ 268 (273)
T d1mp8a_ 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFT-ELKAQLSTILE 268 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 9877799999999997687976892999-99999999977
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=358.92 Aligned_cols=243 Identities=23% Similarity=0.323 Sum_probs=200.1
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEE
Q ss_conf 6218744501147771899999989--9389999971568-300698999999998269991544414142887--2899
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 446 ~~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
..+.|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+|++++|||||++++++.+.. ++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCEEEEEEECCCCCC
Q ss_conf 9726999778964118999999899999999999999997704999958758999976762---8960279320341013
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTML 597 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld---~~~~~KI~DFGla~~~ 597 (802)
||++||+|.+++...+ .+++..+..|+.|++.||.|||+.+ |+||||||+|||+. .++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf 5268984888653036---7887899999999999987524130---556870463001104688824998315435872
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHC-
Q ss_conf 6999964343335687557556795211259878755403389999999728997432200244310002688753207-
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA- 676 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~- 676 (802)
..... ....+||+.|+|||++.+..|+.++|||||||++|+|+||++||......+ ....++....
T Consensus 161 ~~~~~-------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~~ 227 (307)
T d1a06a_ 161 DPGSV-------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAEYE 227 (307)
T ss_dssp -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTTCCC
T ss_pred CCCCE-------EEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHCCCCC
T ss_conf 58970-------440032842259188737999807873451599999985979999989999------99998616877
Q ss_pred --CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf --9999689999999999953012689986211
Q 003694 677 --GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 677 --~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
...+...++.+.+|+.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 260 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ 260 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 787666678999999999976089757918999
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.13 Aligned_cols=239 Identities=26% Similarity=0.394 Sum_probs=190.5
Q ss_pred CCCCEECCCCCEEEEEEEECC--EEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEECCEECC------CCEEEE
Q ss_conf 445011477718999999899--389999971568--3006989999999982699915444141428------872899
Q 003694 451 SENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------HGCLVY 520 (802)
Q Consensus 451 ~~~~~IG~G~~g~Vyk~~~~~--~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~------~~~lV~ 520 (802)
....+||+|+||.||+|.+.. ..||+|++.... ....+.|.+|+++|++++|||||+++++|.+ ..++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCEEEEEEECCCCCCCC
Q ss_conf 9726999778964118999999899999999999999997704999958758999976762-896027932034101369
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld-~~~~~KI~DFGla~~~~~ 599 (802)
||+++|+|.+++.+.. .+++..+..|+.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC
T ss_conf 5789894899975135---5469999999999999999999789-97996876743511667999889800576542368
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHC-CC
Q ss_conf 99964343335687557556795211259878755403389999999728997432200244310002688753207-99
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-GD 678 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~-~~ 678 (802)
.. ....+||+.|+|||++.+ .++.++|||||||++|+|+||++||......... +..+..... ..
T Consensus 168 ~~--------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~-----~~~i~~~~~~~~ 233 (270)
T d1t4ha_ 168 SF--------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVTSGVKPAS 233 (270)
T ss_dssp TS--------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHHTTTCCCGG
T ss_pred CC--------CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHCCCCCCC
T ss_conf 76--------677553813008988478-9998671100799999998788999876559999-----999973899865
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 99689999999999953012689986211
Q 003694 679 WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 679 ~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
++...++++.+|+.+||+.+|.+||++.+
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~R~s~~e 262 (270)
T d1t4ha_ 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKD 262 (270)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 67557899999999976379758929999
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=346.52 Aligned_cols=235 Identities=26% Similarity=0.337 Sum_probs=198.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEE
Q ss_conf 18744501147771899999989--9389999971568---300698999999998269991544414142887--2899
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 520 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~ 520 (802)
++|.....||+|+||.||+|... +..||||++.... ....+.+.+|+.+|++++|||||++++++.+.. ++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCC
Q ss_conf 97269997789641189999998999999999999999977049999587589999767628960279320341013699
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~ 600 (802)
||++||+|..++..... +++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EECCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 50378632234322221---110079999999987655412476---770556810503868998898317521671245
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHCCCCC
Q ss_conf 99643433356875575567952112598787554033899999997289974322002443100026887532079999
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||...+..+ .+..++. ....+|
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~-~~~~~p 221 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILN-AELRFP 221 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHH-CCCCCC
T ss_pred ---------CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHH------HHHHHHC-CCCCCC
T ss_conf ---------643457634359999838999804304653336899975989999969999------9999970-898899
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 689999999999953012689986
Q 003694 681 IKETKELAALGLSCAELRRKDRPD 704 (802)
Q Consensus 681 ~~~~~~l~~li~~Cl~~~p~~RP~ 704 (802)
...+..+.+++.+||..+|.+||.
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTT
T ss_pred CCCCHHHHHHHHHHHHHCHHHCCC
T ss_conf 778999999999995449976664
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=348.55 Aligned_cols=242 Identities=23% Similarity=0.300 Sum_probs=194.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHH---HHHHHHHCCCCCEEEECCEECCCC--
Q ss_conf 218744501147771899999989--9389999971568---300698999---999998269991544414142887--
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQ---ELEVLSKIRHPHLLLLLGACPDHG-- 516 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~~~~---Ei~iL~~l~Hpniv~l~g~~~~~~-- 516 (802)
-++|.....||+|+||.||+|... +..||+|++.... ......+.+ ++.+++.++|||||++++++.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCC
Q ss_conf 28999726999778964118999999899999999999999997704999958758999976762896027932034101
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~ 596 (802)
|+||||++||+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEE
T ss_conf 99999148983899987325---5327899999999999999999779---62204442216785889679822010233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHH
Q ss_conf 3699996434333568755755679521125-987875540338999999972899743220024431000268875320
Q 003694 597 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675 (802)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~ 675 (802)
+.... ....+||+.|+|||++.. ..|+.++|||||||++|+|+||++||........ ..+.......
T Consensus 157 ~~~~~--------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~~~~~~~~ 224 (364)
T d1omwa3 157 FSKKK--------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLTM 224 (364)
T ss_dssp CSSSC--------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH----HHHHHHSSSC
T ss_pred CCCCC--------CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHCCCC
T ss_conf 37886--------43311345542168760389998441046778999999859998888998999----9999860468
Q ss_pred CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 7999968999999999995301268998621
Q 003694 676 AGDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 676 ~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
....|...++++.+|+.+||..+|.+||+..
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 255 (364)
T d1omwa3 225 AVELPDSFSPELRSLLEGLLQRDVNRRLGCL 255 (364)
T ss_dssp CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTS
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHHCCCC
T ss_conf 8878877899999999998566988808874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.35 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=209.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEECCC---CEEEEEECC
Q ss_conf 18744501147771899999989938999997156830069899999999826999154441414288---728999726
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---GCLVYEYME 524 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~---~~lV~Ey~~ 524 (802)
++|....+||+|+||.||+|.+.++.||||+++... ..+.|.+|+.+|++++||||++++|+|.+. .++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHEEEEEEEECCCCEEEEEEEECCEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCC
T ss_conf 994885798207980899999999099999988577--799999999999867898985498788723892899996369
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCCCC
Q ss_conf 99977896411899999989999999999999999770499995875899997676289602793203410136999964
Q 003694 525 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 604 (802)
Q Consensus 525 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~~~ 604 (802)
+|+|.+++..... ..++|..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCCC---
T ss_conf 9989999874578-88899999999999985232113376---5536665676014689977632456003447877---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHHHHHHCHHHHHHHHHHHCCCCCHHH
Q ss_conf 34333568755755679521125987875540338999999972-89974322002443100026887532079999689
Q 003694 605 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 683 (802)
Q Consensus 605 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 683 (802)
....+++.|+|||++.++.+++++||||||+++|||+| |++||...... .....+......+.|...
T Consensus 158 ------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~------~~~~~i~~~~~~~~~~~~ 225 (262)
T d1byga_ 158 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKMDAPDGC 225 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------GHHHHHTTTCCCCCCTTC
T ss_pred ------CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHCCCCCCCCCCC
T ss_conf ------65566646778178727988858877757999999997899999999999------999999808999997657
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 99999999995301268998621120357887897
Q 003694 684 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 684 ~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
+..+.+|+.+||..+|.+||++. +++..|++++.
T Consensus 226 ~~~~~~li~~cl~~dP~~Rps~~-~l~~~L~~i~~ 259 (262)
T d1byga_ 226 PPAVYEVMKNCWHLDAAMRPSFL-QLREQLEHIKT 259 (262)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 99999999997566976893999-99999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.60 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=206.7
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEECC-------EEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCEEEECCEECCC-
Q ss_conf 62187445011477718999999899-------3899999715683-0069899999999826-999154441414288-
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH- 515 (802)
Q Consensus 446 ~~~~f~~~~~IG~G~~g~Vyk~~~~~-------~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l-~Hpniv~l~g~~~~~- 515 (802)
..++|....+||+|+||.||+|.+.+ +.||||++..... .....+.+|..++.++ +||||+.+++++.+.
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCC
T ss_conf 67997984498416783999999867775557839999998600171789999999999886149984997411540479
Q ss_pred --CEEEEEECCCCCHHHHHHHCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf --7289997269997789641189-------------9999989999999999999999770499995875899997676
Q 003694 516 --GCLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 580 (802)
Q Consensus 516 --~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl 580 (802)
.++||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEE
T ss_conf 7579999845899299999853666665322202332146899999999999999999887379---7178677310657
Q ss_pred CCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCHH
Q ss_conf 289602793203410136999964343335687557556795211259878755403389999999728-9974322002
Q 003694 581 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHKV 659 (802)
Q Consensus 581 d~~~~~KI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg-~~p~~~~~~~ 659 (802)
+.++.+||+|||+|+........ .......||+.|+|||++.++.++.++|||||||++|||+|| .+||......
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp CGGGCEEECC------CCSCTTS----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CCCCCEEECCCCCHHHCCCCCCC----CCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 79982898457520011356652----22475166721020368646889966322136789999986889999899989
Q ss_pred HHHHCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 44310002688753207999968999999999995301268998621120357887897
Q 003694 660 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 660 ~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
+. ....+........|...++.+.+|+.+||+.+|.+||++. +++..|+.+..
T Consensus 244 ~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-eil~~L~~ilq 296 (299)
T d1ywna1 244 EE-----FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNLLQ 296 (299)
T ss_dssp HH-----HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HH-----HHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 99-----9999963898888865789999999997677966791999-99999979986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.34 Aligned_cols=244 Identities=24% Similarity=0.305 Sum_probs=202.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHH-HCCCCCEEEECCEECCCC--EEE
Q ss_conf 18744501147771899999989--9389999971568---300698999999998-269991544414142887--289
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLS-KIRHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~~~~Ei~iL~-~l~Hpniv~l~g~~~~~~--~lV 519 (802)
++|.....||+|+||.||+|.+. +..||||++.... ......+..|..++. .++|||||++++++.+.. |+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCC
Q ss_conf 99726999778964118999999899999999999999997704999958758999976762896027932034101369
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~ 599 (802)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 75037980899864047---8999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHCCCC
Q ss_conf 99964343335687557556795211259878755403389999999728997432200244310002688753207999
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 679 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~ 679 (802)
... ..+...||+.|+|||++.+..++.++|||||||++|+|+||+.||......+ +...+......+
T Consensus 156 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~~ 222 (320)
T d1xjda_ 156 GDA------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPFY 222 (320)
T ss_dssp TTC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC
T ss_pred CCC------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCCCC
T ss_conf 653------3454578777689999827998832320112278989873889999989999-------999997189989
Q ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 9689999999999953012689986211203
Q 003694 680 PIKETKELAALGLSCAELRRKDRPDLKNQVL 710 (802)
Q Consensus 680 p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~ 710 (802)
|...+..+.+|+.+||..+|.+||++..+++
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 7567999999999965448987838899998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.22 Aligned_cols=241 Identities=21% Similarity=0.279 Sum_probs=199.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC------CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--
Q ss_conf 218744501147771899999989--9389999971568------300698999999998269991544414142887--
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG------NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 516 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~------~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~-- 516 (802)
.+.|.....||+|+||.||+|.+. +..||||++.... ....+.|.+|+.+|++++|||||+++++|.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----EEEEEEEC
Q ss_conf 28999726999778964118999999899999999999999997704999958758999976762896----02793203
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL----VSKIGDVG 592 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~----~~KI~DFG 592 (802)
++||||+++|+|.+++...+ .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEECCCCCCCCCHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 99998677864310010356---4215578999999999987666254---22113330127982589866646964334
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHH
Q ss_conf 41013699996434333568755755679521125987875540338999999972899743220024431000268875
Q 003694 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 672 (802)
Q Consensus 593 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~l 672 (802)
+|........ .....||+.|+|||++.+..++.++|||||||++|+|+||++||......+. +..+.
T Consensus 163 ~a~~~~~~~~-------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~ 229 (293)
T d1jksa_ 163 LAHKIDFGNE-------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVS 229 (293)
T ss_dssp TCEECTTSCB-------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH
T ss_pred HHHHCCCCCC-------CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHH------HHHHH
T ss_conf 4210577763-------1224777743099998189999766522140999999708899889999999------99998
Q ss_pred HHHCCCCCH----HHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 320799996----89999999999953012689986211
Q 003694 673 DAQAGDWPI----KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 673 d~~~~~~p~----~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. ....++. ..+..+.+|+.+||+.+|.+||++.+
T Consensus 230 ~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 267 (293)
T d1jksa_ 230 A-VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267 (293)
T ss_dssp T-TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred H-CCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 1-6888870104788999999999986389668919999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.88 Aligned_cols=254 Identities=28% Similarity=0.413 Sum_probs=207.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCE----EEEEEEECCCC-CCCHHHHHHHHHHHHHC-CCCCEEEECCEECCCC--EEE
Q ss_conf 1874450114777189999998993----89999971568-30069899999999826-9991544414142887--289
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 519 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~~~----~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l-~Hpniv~l~g~~~~~~--~lV 519 (802)
++|....+||+|+||.||+|.+.++ .||||.+.... ....+.|.+|+.+|+++ +|||||+++|+|.+.. ++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHHC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEE
Q ss_conf 9972699977896411-------------899999989999999999999999770499995875899997676289602
Q 003694 520 YEYMENGSLEDRLYRK-------------NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 586 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~ 586 (802)
|||+++|+|.++|... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCHHHHHHCH
Q ss_conf 7932034101369999643433356875575567952112598787554033899999997289-974322002443100
Q 003694 587 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDE 665 (802)
Q Consensus 587 KI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~-~p~~~~~~~~~~~~~ 665 (802)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|. +||......+
T Consensus 167 kl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~----- 234 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 234 (309)
T ss_dssp EECCTTCEESSCEEC-------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----
T ss_pred EECCCCCCCCCCCCC-------CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHH-----
T ss_conf 874344322444223-------45530137755553875269999622153138899999836899999999999-----
Q ss_pred HHHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 02688753207999968999999999995301268998621120357887897
Q 003694 666 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 666 ~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
.+..+........|...+.++.+|+.+||+.+|.+||++. +++..|+++..
T Consensus 235 -~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~L~~i~~ 285 (309)
T d1fvra_ 235 -LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRMLE 285 (309)
T ss_dssp -HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred -HHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf -9999982688888766789999999997678966894999-99999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.02 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=212.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC---------EEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCEEEECCEECCC
Q ss_conf 2187445011477718999999899---------3899999715683-0069899999999826-999154441414288
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH 515 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~~---------~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l-~Hpniv~l~g~~~~~ 515 (802)
.++|...+.||+|+||.||+|+..+ +.||||+++.... .....+.+|+..+.++ +|||||+++|+|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred C--EEEEEECCCCCHHHHHHHCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 7--289997269997789641189-------------9999989999999999999999770499995875899997676
Q 003694 516 G--CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 580 (802)
Q Consensus 516 ~--~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl 580 (802)
. ++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEE
T ss_conf 8689999736999099999860677643222334574346799999999999999998766379---7863022102245
Q ss_pred CCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHH
Q ss_conf 28960279320341013699996434333568755755679521125987875540338999999972-89974322002
Q 003694 581 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 659 (802)
Q Consensus 581 d~~~~~KI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~ 659 (802)
+.++.+||+|||+++......... ......|++.|+|||++.++.|+.++||||||+++|||+| |.+||......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTC----CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CCCCCEEECCCHHHCCCCCCCCCC----CCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHH
T ss_conf 478976762211101135555543----1466788846632667517988825554775888887401798989999999
Q ss_pred HHHHCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 443100026887532079999689999999999953012689986211203578878974
Q 003694 660 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 719 (802)
Q Consensus 660 ~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~ 719 (802)
..+..+........|...+..+.+|+.+||+.+|.+||++. +++..|+++..+
T Consensus 245 ------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~-eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 ------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRIVAL 297 (299)
T ss_dssp ------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred ------HHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHC
T ss_conf ------99999972888898743529999999997667976793999-999999888604
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.06 Aligned_cols=254 Identities=23% Similarity=0.334 Sum_probs=206.3
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-----EEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC-EE
Q ss_conf 187445011477718999999899-----389999971568---300698999999998269991544414142887-28
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CL 518 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~~-----~~vAvK~l~~~~---~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~-~l 518 (802)
.+|.....||+|+||.||+|.+.+ ..||||++.... ....+.|.+|+.+|++++||||++++|+|.+.. ++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCHHE
T ss_conf 89199789803888399999998899907999999998355579899999999999998689999878987774010011
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCC
Q ss_conf 99972699977896411899999989999999999999999770499995875899997676289602793203410136
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 598 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~ 598 (802)
||||+++|+|.+++..... ++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 4654238612544421268--9999999999999999998752178---7520566888156556543325611555303
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHHHHHHCHHHHHHHHHH-HC
Q ss_conf 99996434333568755755679521125987875540338999999972-89974322002443100026887532-07
Q 003694 599 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QA 676 (802)
Q Consensus 599 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~l~~~ld~-~~ 676 (802)
...... .......|+..|+|||++.+..++.++||||||+++|||+| |++||...+..+. +..+... ..
T Consensus 163 ~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~~~i~~~~~~ 233 (273)
T d1u46a_ 163 QNDDHY---VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGER 233 (273)
T ss_dssp C-CCEE---EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCCC
T ss_pred CCCCCC---EECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH------HHHHHHCCCC
T ss_conf 588752---6547632573107999983799994215661489999999689999999699999------9999847999
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 9999689999999999953012689986211203578878
Q 003694 677 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 677 ~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
.+.+...+..+.+|+.+||..+|.+||++. ++...|...
T Consensus 234 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-ei~~~L~~~ 272 (273)
T d1u46a_ 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFV-ALRDFLLEA 272 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHC
T ss_conf 998544539999999997688966792999-999999964
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.58 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=208.8
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-------CEEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCEEEECCEECCCC-
Q ss_conf 218744501147771899999989-------93899999715683-0069899999999826-9991544414142887-
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG- 516 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~-------~~~vAvK~l~~~~~-~~~~~~~~Ei~iL~~l-~Hpniv~l~g~~~~~~- 516 (802)
.++|....+||+|+||.||+|++. ++.||||+++.... .....|.+|+.++.++ +|||||+++|+|.+..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 89969854982068829999998066447788699999987424877999999999998762699988789989831997
Q ss_pred -EEEEEECCCCCHHHHHHHCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf -28999726999778964118---------------99999989999999999999999770499995875899997676
Q 003694 517 -CLVYEYMENGSLEDRLYRKN---------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 580 (802)
Q Consensus 517 -~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILl 580 (802)
++||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCC
T ss_conf 8999973799879999985356654444453322233458899999999999999999887579---2666241021000
Q ss_pred CCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHH
Q ss_conf 28960279320341013699996434333568755755679521125987875540338999999972-89974322002
Q 003694 581 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 659 (802)
Q Consensus 581 d~~~~~KI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~ellt-g~~p~~~~~~~ 659 (802)
+.++.+||+|||+++......... ......||+.|+|||++.++.++.++||||||+++|||+| |.+||......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYV----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSE----ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred CCCCCCCCCCCCHHEECCCCCCCE----EEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 025752102340102336788615----8620135968767788617999974001025899999985899887789989
Q ss_pred HHHHCHHHHHHHHHHH-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 4431000268875320-799996899999999999530126899862112035788789
Q 003694 660 ETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 660 ~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
..+..++... ....|...+..+.+|+.+||+.+|.+||++. +++.+|+++.
T Consensus 255 ------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~-~il~~L~~~i 306 (311)
T d1t46a_ 255 ------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEKQI 306 (311)
T ss_dssp ------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred ------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf ------999999866898898543659999999997577965792999-9999998765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.85 Aligned_cols=257 Identities=23% Similarity=0.367 Sum_probs=208.6
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEEC-------CEEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEECCEECC--C
Q ss_conf 6218744501147771899999989-------9389999971568-3006989999999982699915444141428--8
Q 003694 446 ATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--H 515 (802)
Q Consensus 446 ~~~~f~~~~~IG~G~~g~Vyk~~~~-------~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~--~ 515 (802)
..++|....+||+|+||.||+|.+. ++.||||+++... ......|.+|+.++++++||||++++|+|.. .
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 68991883598207881899999878644778968999998701286899999999999997699988412547842881
Q ss_pred CEEEEEECCCCCHHHHHHHC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEE
Q ss_conf 72899972699977896411-------89999998999999999999999977049999587589999767628960279
Q 003694 516 GCLVYEYMENGSLEDRLYRK-------NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 588 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI 588 (802)
.++||||+++|+|.+++... .....+++..+..|+.+++.||.|||..+ |+||||||+|||++.++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEE
T ss_conf 06777604899889998750332113444688799999999999999999876479---654328677540359964999
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCHHHHHHCHHH
Q ss_conf 32034101369999643433356875575567952112598787554033899999997289-97432200244310002
Q 003694 589 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDEDN 667 (802)
Q Consensus 589 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~ 667 (802)
+|||+++.+..... ........||+.|+|||.+.++.++.++||||||+++|||+||. +||...... ..
T Consensus 175 ~DFGla~~~~~~~~----~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~~ 244 (308)
T d1p4oa_ 175 GDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QV 244 (308)
T ss_dssp CCTTCCCGGGGGGC----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HH
T ss_pred EECCCCEECCCCCC----EEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH------HH
T ss_conf 42454202357763----031340231632378888736998833344437899999996899999998999------99
Q ss_pred HHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 6887532079999689999999999953012689986211203578878
Q 003694 668 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 716 (802)
Q Consensus 668 l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l 716 (802)
+..+.+......|...+..+.+|+.+||+.+|.+||++. +++..|+..
T Consensus 245 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~-~il~~L~~~ 292 (308)
T d1p4oa_ 245 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIKEE 292 (308)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHGGG
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHH
T ss_conf 999980888888633539999999997577965893999-999997876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.98 Aligned_cols=261 Identities=25% Similarity=0.359 Sum_probs=197.3
Q ss_pred CCCCCCEECCCCCEEEEEEEECCEEEEEEEECCCCCCCHHHHHHHHH--HHHHCCCCCEEEECCEECCC------CEEEE
Q ss_conf 87445011477718999999899389999971568300698999999--99826999154441414288------72899
Q 003694 449 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELE--VLSKIRHPHLLLLLGACPDH------GCLVY 520 (802)
Q Consensus 449 ~f~~~~~IG~G~~g~Vyk~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~--iL~~l~Hpniv~l~g~~~~~------~~lV~ 520 (802)
.|....+||+|+||.||+|++++..||||++.... ...+.+|.+ .+.+++|||||+++|+|.+. .++||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEEECCCEEEEEEEECCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 89998898207881999999999899999987200---467999999999962799868326889983798604899999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCEEEEEEECCCC
Q ss_conf 97269997789641189999998999999999999999977049-----9995875899997676289602793203410
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK-----PKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-----~~~iiHrDLKp~NILld~~~~~KI~DFGla~ 595 (802)
||+++|+|.++|.+. .++|..++.++.+++.||.|||... .++|+||||||+|||++.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ECCCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
T ss_conf 646698989998658----9998999999999999999988766520468986615317313578688776887638662
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHC-----
Q ss_conf 1369999643433356875575567952112598------78755403389999999728997432200244310-----
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL------ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID----- 664 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~----- 664 (802)
........ .........||+.|+|||++.... ++.++|||||||+||||+||.+||...........
T Consensus 157 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 157 RHDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EEETTTTE--ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CCCCCCCC--EECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCC
T ss_conf 34677762--0013552503547678221056545467776750122015999999962899887663112410122556
Q ss_pred ---HHHHHHHH-HHHC-CCCC-----HHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf ---00268875-3207-9999-----689999999999953012689986211203578878974
Q 003694 665 ---EDNLAEIL-DAQA-GDWP-----IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 719 (802)
Q Consensus 665 ---~~~l~~~l-d~~~-~~~p-----~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~~ 719 (802)
...+...+ +... +..| ......+.+|+.+||..+|.+||++. +++..|+++..-
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ei~~~L~~i~~~ 298 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHH
T ss_conf 4309999998750246888776557768999999999997606985895999-999999988886
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=342.67 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=206.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCC---CCHHHHHHHHHHHHHCCCCCEEEECCEECCC------
Q ss_conf 218744501147771899999989--93899999715683---0069899999999826999154441414288------
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 515 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~------ 515 (802)
.+.|.....||+|+||.||+|.+. +..||+|++..... .....|.+|+.+|+.++||||+++++++...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred CEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCC
Q ss_conf 72899972699977896411899999989999999999999999770499995875899997676289602793203410
Q 003694 516 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~ 595 (802)
.|+||||++||+|.+++...+ ++++..+..|+.|++.||.|||+.+ |+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 999997788987101120358---9999999999999999999998579---5276346755665754320100344432
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHH
Q ss_conf 13699996434333568755755679521125987875540338999999972899743220024431000268875320
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~ 675 (802)
........ .......+||+.|+|||++.+..+++++|||||||++|+|+||++||......+. +...+...
T Consensus 160 ~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~ 230 (277)
T d1o6ya_ 160 AIADSGNS---VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVRED 230 (277)
T ss_dssp ECC-------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCC
T ss_pred HHCCCCCC---CCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCC
T ss_conf 21235443---3334642576243699998399999663202652899999769799899699999------99998469
Q ss_pred CC---CCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 79---9996899999999999530126899862112035788789
Q 003694 676 AG---DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 676 ~~---~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
.. ..+...+..+.+|+.+|++.+|.+||+..++++..|.++.
T Consensus 231 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 999710034789999999999866797677739999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.61 Aligned_cols=242 Identities=21% Similarity=0.324 Sum_probs=192.8
Q ss_pred HCCCCCCC-EECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCEEEECCEECC------CC
Q ss_conf 21874450-1147771899999989--938999997156830069899999999826-99915444141428------87
Q 003694 447 TLSFSENL-RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPD------HG 516 (802)
Q Consensus 447 ~~~f~~~~-~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l-~Hpniv~l~g~~~~------~~ 516 (802)
.++|.... .||+|+||.||+|.+. +..||||++.. ...+.+|+.++.++ +|||||++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 14879810796545486999999889998999999897-----4779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCEEEEEEECC
Q ss_conf 289997269997789641189999998999999999999999977049999587589999767628---96027932034
Q 003694 517 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDVGL 593 (802)
Q Consensus 517 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~---~~~~KI~DFGl 593 (802)
|+|||||+||+|.+++...+. ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 999977899849999986278-77579999999999999999999769---86444100220113555566311354551
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHH
Q ss_conf 10136999964343335687557556795211259878755403389999999728997432200244310002688753
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld 673 (802)
|+....... .....||+.|+|||++.+..|+.++|||||||++|+|+||++||......... ..+...+.
T Consensus 161 a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~ 230 (335)
T d2ozaa1 161 AKETTSHNS-------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIR 230 (335)
T ss_dssp CEECCCCCC-------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCC
T ss_pred EEECCCCCC-------CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHH---HHHHHHHH
T ss_conf 233368886-------43226775637927774898888888876451677886588998898877889---99999985
Q ss_pred HHCCCCC----HHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 2079999----689999999999953012689986211
Q 003694 674 AQAGDWP----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 674 ~~~~~~p----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.....+| ...+.++.+|+.+||+.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 268 (335)
T d2ozaa1 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 268 (335)
T ss_dssp SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 38888898543469999999999975699657909999
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.33 Aligned_cols=241 Identities=19% Similarity=0.259 Sum_probs=197.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEEE
Q ss_conf 218744501147771899999989--9389999971568300698999999998269991544414142887--289997
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
.+.|.....||+|+||.||+|.+. +..||+|++..... ....+.+|+.+|..++|||||++++++.+.. |+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 0105887898317783999999989996999999757866-599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CEEEEEEECCCCCCCCC
Q ss_conf 2699977896411899999989999999999999999770499995875899997676289--60279320341013699
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN--LVSKIGDVGLSTMLNSD 600 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~--~~~KI~DFGla~~~~~~ 600 (802)
++||+|.+++...+ ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf 89980889987538--99999999999999999999998769---97513554443443788518997644111003467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHHCCCCC
Q ss_conf 99643433356875575567952112598787554033899999997289974322002443100026887532079999
Q 003694 601 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 680 (802)
Q Consensus 601 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~~~~~p 680 (802)
.. .....||+.|++||...+..++.++|||||||++|+|++|++||......+ .+..++.. ...++
T Consensus 158 ~~-------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~-~~~~~ 223 (321)
T d1tkia_ 158 DN-------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNA-EYTFD 223 (321)
T ss_dssp CE-------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHT-CCCCC
T ss_pred CC-------CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHC-CCCCC
T ss_conf 75-------321223322234021048777840113027999999982899999989999------99999838-99988
Q ss_pred H----HHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 6----89999999999953012689986211
Q 003694 681 I----KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 681 ~----~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. ..+.++.+|+.+|+..+|.+||++.+
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 254 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASE 254 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 0223678999999999986699668909999
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-45 Score=331.07 Aligned_cols=241 Identities=23% Similarity=0.332 Sum_probs=198.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCC---------CHHHHHHHHHHHHHCC-CCCEEEECCEECCC
Q ss_conf 18744501147771899999989--938999997156830---------0698999999998269-99154441414288
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---------QNKQFLQELEVLSKIR-HPHLLLLLGACPDH 515 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~---------~~~~~~~Ei~iL~~l~-Hpniv~l~g~~~~~ 515 (802)
.+|.....||+|+||.||+|+.. +..+|||++...... ..+.+.+|+.+|++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred C--EEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECC
Q ss_conf 7--28999726999778964118999999899999999999999997704999958758999976762896027932034
Q 003694 516 G--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 593 (802)
Q Consensus 516 ~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGl 593 (802)
. +|||||+++|+|.+++...+ ++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 60599997689866899998659---9999999999999999999998759---94323462548986899838712403
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHH
Q ss_conf 1013699996434333568755755679521125------9878755403389999999728997432200244310002
Q 003694 594 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT------GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 667 (802)
Q Consensus 594 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~ 667 (802)
++.+..... .+...||+.|++||++.+ ..++.++||||+||++|+|+||++||....... .
T Consensus 157 a~~~~~~~~-------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~ 223 (277)
T d1phka_ 157 SCQLDPGEK-------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------M 223 (277)
T ss_dssp CEECCTTCC-------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H
T ss_pred EEECCCCCC-------EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHH------H
T ss_conf 167268872-------134524678889888605344567889923318565602310322888988999999------9
Q ss_pred HHHHHHHHC---CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 688753207---9999689999999999953012689986211
Q 003694 668 LAEILDAQA---GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 668 l~~~ld~~~---~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+..++.... .......++++.+|+.+||+.+|.+||++.+
T Consensus 224 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~e 266 (277)
T d1phka_ 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 266 (277)
T ss_dssp HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 9999818988898543468999999999976589668919999
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=329.30 Aligned_cols=240 Identities=25% Similarity=0.303 Sum_probs=186.9
Q ss_pred CCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCC-----CHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEEEC
Q ss_conf 501147771899999989--938999997156830-----0698999999998269991544414142887--2899972
Q 003694 453 NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-----QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 523 (802)
Q Consensus 453 ~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~-----~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 523 (802)
..+||+|+||.||+|.+. +..||||++...... ....+.+|+.+|++++|||||++++++.+.. ++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCCC
Q ss_conf 69997789641189999998999999999999999977049999587589999767628960279320341013699996
Q 003694 524 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 603 (802)
Q Consensus 524 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~~ 603 (802)
.++++...+.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred CCHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 45077655412---667789999999999999998863163---55035776258853778411465761000578755-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHH--------
Q ss_conf 434333568755755679521125-98787554033899999997289974322002443100026887532--------
Q 003694 604 VSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-------- 674 (802)
Q Consensus 604 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~-------- 674 (802)
.....+||+.|+|||++.. ..|+.++|||||||++|+|+||++||......+.... +...+..
T Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~---i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR---IFETLGTPTEEQWPD 227 (299)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTTTSSS
T ss_pred -----CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHH---HHHHCCCCCHHHCCC
T ss_conf -----433020473336399972677888056436304289999859699999999999999---998518997254521
Q ss_pred -----------HCCCCC-----HHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf -----------079999-----689999999999953012689986211
Q 003694 675 -----------QAGDWP-----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 675 -----------~~~~~p-----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.....+ ...+..+.+|+.+||+.||.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e 276 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred HHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 0002134430347898867856568999999999976389456908999
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=326.87 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=192.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEE
Q ss_conf 18744501147771899999989--93899999715683--00698999999998269991544414142887--28999
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
++|....+||+|+||.||+|.+. ++.||+|++..... .....+.+|+.+|++++|||||++++++.+.. ++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCC
Q ss_conf 72699977896411899999989999999999999999770499995875899997676289602793203410136999
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~ 601 (802)
|+.+ ++.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCC-CHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 2377-4455544202-568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHH---------HHHHH
Q ss_conf 9643433356875575567952112598-7875540338999999972899743220024431000---------26887
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------NLAEI 671 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~---------~l~~~ 671 (802)
. ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+......... .+..+
T Consensus 157 ~------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 R------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp B------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred C------CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCC
T ss_conf 4------1001036521541122136657774221033331342796687998988999999999983289833314442
Q ss_pred --HHHHCCCCC-----------HHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf --532079999-----------689999999999953012689986211
Q 003694 672 --LDAQAGDWP-----------IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 672 --ld~~~~~~p-----------~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
........+ ...+.++.+|+.+|+..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~e 279 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 279 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 2242124345432222044416678999999999976399557918999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=321.15 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=186.9
Q ss_pred CCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEECCC--------CEE
Q ss_conf 8744501147771899999989--938999997156830069899999999826999154441414288--------728
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--------GCL 518 (802)
Q Consensus 449 ~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~--------~~l 518 (802)
.|...++||+|+||+||+|++. +..||||++...... +.+|+.+|++++||||++++++|... .+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 767516982176839999999999979999998816068----9999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-EEEEEEECCCCCC
Q ss_conf 999726999778964118999999899999999999999997704999958758999976762896-0279320341013
Q 003694 519 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTML 597 (802)
Q Consensus 519 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~-~~KI~DFGla~~~ 597 (802)
||||+++|.+............+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCH---------HH
Q ss_conf 69999643433356875575567952112-598787554033899999997289974322002443100---------02
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DN 667 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~---------~~ 667 (802)
..... .....||+.|+|||.+. ...++.++|||||||++|||++|++||......+..... ..
T Consensus 174 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 174 VRGEP-------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CTTSC-------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCCC-------CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHH
T ss_conf 47765-------32002555556827764046888210002465277855028799898799999999999748981776
Q ss_pred HHHHHHH----HCC---------CCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 6887532----079---------999689999999999953012689986211
Q 003694 668 LAEILDA----QAG---------DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 668 l~~~ld~----~~~---------~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+...... ... ......+.++.+|+.+||..||.+||++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 299 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 54306210110355445674444315689999999999976589557929999
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=326.95 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=190.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC---CEEEEEEEECCCCC--CCHHHHHHHHHHHHHC---CCCCEEEECCEECC----
Q ss_conf 218744501147771899999989---93899999715683--0069899999999826---99915444141428----
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGN--IQNKQFLQELEVLSKI---RHPHLLLLLGACPD---- 514 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~---~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l---~Hpniv~l~g~~~~---- 514 (802)
.++|....+||+|+||.||+|.+. +..||||++..... .....+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred ---CCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEE
Q ss_conf ---87289997269997789641189999998999999999999999977049999587589999767628960279320
Q 003694 515 ---HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 591 (802)
Q Consensus 515 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DF 591 (802)
..+++|||+.+|.+...... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCEEEEEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf 67469999974058714444430--3789998999999999999999997588---983579862789858997542100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHH
Q ss_conf 34101369999643433356875575567952112598787554033899999997289974322002443100026887
Q 003694 592 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 671 (802)
Q Consensus 592 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ 671 (802)
|+++..... .......||+.|+|||++.+..|+.++|||||||++|||+||++||......+.... +...
T Consensus 161 g~~~~~~~~-------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~---i~~~ 230 (305)
T d1blxa_ 161 GLARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDV 230 (305)
T ss_dssp CSCCCCCGG-------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHH
T ss_pred HHHHHHCCC-------CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHH
T ss_conf 010110023-------457776548511483100179888111000328999999878799899898999999---9984
Q ss_pred HH------------------HH-----CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 53------------------20-----79999689999999999953012689986211
Q 003694 672 LD------------------AQ-----AGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 672 ld------------------~~-----~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+. .. ...++...+..+.+|+.+||+.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e 289 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 07996110532111103330223456454404458999999999987489667918999
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=322.45 Aligned_cols=251 Identities=19% Similarity=0.264 Sum_probs=193.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEECCEECCC------CE
Q ss_conf 218744501147771899999989--9389999971568-30069899999999826999154441414288------72
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------GC 517 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~------~~ 517 (802)
+..|....+||+|+||.||+|... ++.||||++.... ....+.+.+|+.+|++++||||+++++++... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCC
Q ss_conf 89997269997789641189999998999999999999999977049999587589999767628960279320341013
Q 003694 518 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 597 (802)
Q Consensus 518 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~ 597 (802)
++++|+.+|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 999962598656644058----9999999999999999999999789---867778764378879997787545705650
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHH----------
Q ss_conf 6999964343335687557556795211-25987875540338999999972899743220024431000----------
Q 003694 598 NSDPSFVSTTYKNTGPVGTLCYIDPEYQ-RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------- 666 (802)
Q Consensus 598 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~---------- 666 (802)
...... .......+||+.|+|||++ ....++.++||||+||++|+|++|++||.............
T Consensus 160 ~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCB---CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCCCCC---CEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 477764---10101102652000387860478887410100467013377669799788888999998765206997566
Q ss_pred -------HHHHHHHHH--CCCCCH-----HHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf -------268875320--799996-----89999999999953012689986211
Q 003694 667 -------NLAEILDAQ--AGDWPI-----KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 667 -------~l~~~ld~~--~~~~p~-----~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
......... ....+. ..+.++.+|+.+|++.||..||++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 4234332222024467755778777837899999999999976489567908999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-44 Score=319.30 Aligned_cols=261 Identities=20% Similarity=0.227 Sum_probs=195.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEECCEE-CCC--CEEEEEE
Q ss_conf 18744501147771899999989--938999997156830069899999999826999154441414-288--7289997
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC-PDH--GCLVYEY 522 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~-~~~--~~lV~Ey 522 (802)
+.|....+||+|+||.||+|.+. +..||||++..... ...+.+|+++++.++|+|++.+++.| .+. .++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 889996898507880999999988998999999721005--888999999999703899601799999519877899987
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCEEEEEEECCCCCCCC
Q ss_conf 26999778964118999999899999999999999997704999958758999976762---896027932034101369
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNS 599 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld---~~~~~KI~DFGla~~~~~ 599 (802)
+ +|+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred C-CCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 3-871333244306--88768999999999999999999799---44266787660643357776156504675134255
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHH-HHHCC
Q ss_conf 9996434-333568755755679521125987875540338999999972899743220024431000268875-32079
Q 003694 600 DPSFVST-TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQAG 677 (802)
Q Consensus 600 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~l-d~~~~ 677 (802)
....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||................... .....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred CCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH
T ss_conf 44554100013577678735329999918998983218861778999984987665530577999999852356789835
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 9996899999999999530126899862112035788789
Q 003694 678 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 717 (802)
Q Consensus 678 ~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~ 717 (802)
..+...+.++.+++.+||..+|.+||++. .+...|+.+.
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~-~i~~~l~~~~ 277 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYS-YLRQLFRNLF 277 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHH-HHHHHHHHHH
T ss_pred HHCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 75347889999999998439955791999-9999999999
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=320.36 Aligned_cols=244 Identities=21% Similarity=0.285 Sum_probs=191.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEECCEECCC-------
Q ss_conf 218744501147771899999989--9389999971568--30069899999999826999154441414288-------
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 515 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~------- 515 (802)
...|....+||+|+||.||+|.+. +..||||++.... ....+.+.+|+.+|+.++|||||+++++|...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred -CEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCC
Q ss_conf -7289997269997789641189999998999999999999999977049999587589999767628960279320341
Q 003694 516 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 594 (802)
Q Consensus 516 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla 594 (802)
.|+||||+ +++|...+.. . .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-E---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHHH-C---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 599998405-5218999874-0---2269999999999999999987378---764566851111210012211343102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCH--------
Q ss_conf 013699996434333568755755679521125-98787554033899999997289974322002443100--------
Q 003694 595 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-------- 665 (802)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~-------- 665 (802)
+..... .+...||+.|+|||.+.+ ..++.++|||||||++|+|++|++||............
T Consensus 169 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 169 RQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp EECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ECCCCC---------CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 206876---------31024553335889981787899650103003899999978699888976899999985037884
Q ss_pred ---------HHHHHHHHHH----CC---CCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf ---------0268875320----79---999689999999999953012689986211
Q 003694 666 ---------DNLAEILDAQ----AG---DWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 666 ---------~~l~~~ld~~----~~---~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.......... .. ......+..+.+|+.+||..+|.+||++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 8888653000344331157866655667755689999999999977299557929999
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=326.87 Aligned_cols=234 Identities=23% Similarity=0.330 Sum_probs=190.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCC------CHHHHHHHHHHHHHCC--CCCEEEECCEECCCC
Q ss_conf 218744501147771899999989--938999997156830------0698999999998269--991544414142887
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI------QNKQFLQELEVLSKIR--HPHLLLLLGACPDHG 516 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~------~~~~~~~Ei~iL~~l~--Hpniv~l~g~~~~~~ 516 (802)
.+.|.....||+|+||.||+|... +..||||++...... ...++.+|+.+|++++ |||||++++++.+..
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred --EEEEEECCC-CCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CEEEEEEEC
Q ss_conf --289997269-9977896411899999989999999999999999770499995875899997676289-602793203
Q 003694 517 --CLVYEYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVG 592 (802)
Q Consensus 517 --~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~-~~~KI~DFG 592 (802)
++||||+.+ +++.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 68999983368622899986158---9999999999999999999998779---75566761114774478848977546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHH
Q ss_conf 41013699996434333568755755679521125987-87554033899999997289974322002443100026887
Q 003694 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 671 (802)
Q Consensus 593 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ 671 (802)
+|+...... .+...||+.|+|||++.+..+ +.++|||||||++|+|+||+.||.....+
T Consensus 157 ~a~~~~~~~--------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------------ 216 (273)
T d1xwsa_ 157 SGALLKDTV--------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------ 216 (273)
T ss_dssp TCEECCSSC--------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------
T ss_pred CCEECCCCC--------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHHH------------
T ss_conf 535324445--------566565877479999848997886533255403453675688998873677------------
Q ss_pred HHHHCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 532079999689999999999953012689986211
Q 003694 672 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 672 ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
+. ....++...+.++.+|+.+||..+|.+||++.+
T Consensus 217 ~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 251 (273)
T d1xwsa_ 217 IR-GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEE 251 (273)
T ss_dssp HH-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HH-CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 61-544778779999999999976089758939999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8e-43 Score=312.70 Aligned_cols=263 Identities=16% Similarity=0.180 Sum_probs=199.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-CCEEEECCEECCCC--EEEEE
Q ss_conf 218744501147771899999989--93899999715683006989999999982699-91544414142887--28999
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH-PHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~H-pniv~l~g~~~~~~--~lV~E 521 (802)
.++|....+||+|+||.||+|++. ++.||||++..... ...+.+|++++..+.| +|++.+++++.+.. ++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 9806997998417882999999988997999999750258--29999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCEEEEEEECCCCC
Q ss_conf 7269997789641189999998999999999999999977049999587589999767628-----96027932034101
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-----NLVSKIGDVGLSTM 596 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~-----~~~~KI~DFGla~~ 596 (802)
|+ +|+|.+.+...+. .+++.....|+.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EC-CCCHHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 64-8887999975203--1106899999999999999999779---6626677131523475434479568723660577
Q ss_pred CCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHHHH
Q ss_conf 3699996434-333568755755679521125987875540338999999972899743220024431000268875320
Q 003694 597 LNSDPSFVST-TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 675 (802)
Q Consensus 597 ~~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld~~ 675 (802)
.......... .......+||+.|+|||++.+..++.++||||||+++|+|+||+.||..............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 14676654111024676277510267989648888869998983199999986987678853021999999997056799
Q ss_pred -CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf -7999968999999999995301268998621120357887897
Q 003694 676 -AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 718 (802)
Q Consensus 676 -~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~~v~~~L~~l~~ 718 (802)
....+...++++.+++..|+..+|.+||++. .+...|+.+..
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~-~l~~~l~~~~~ 278 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYD-YLQGLFSKVLE 278 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH-HHHHHHHHHHH
T ss_pred CHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHHH
T ss_conf 95896579989999999998439930085999-99999999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-44 Score=320.15 Aligned_cols=248 Identities=19% Similarity=0.271 Sum_probs=191.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CEEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEEE
Q ss_conf 18744501147771899999989-93899999715683--00698999999998269991544414142887--289997
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 522 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~-~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey 522 (802)
++|....+||+|+||.||+|.+. +..||||++..... .....+.+|+.+|++++||||++++++|.+.. ++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCCC
Q ss_conf 26999778964118999999899999999999999997704999958758999976762896027932034101369999
Q 003694 523 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 602 (802)
Q Consensus 523 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~~ 602 (802)
+.++.+..+.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EHHHHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf 0045678998604---77514456899999999999860574---88267877505686899787323664301146765
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHH---------HHHHHH
Q ss_conf 6434333568755755679521125-987875540338999999972899743220024431000---------268875
Q 003694 603 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------NLAEIL 672 (802)
Q Consensus 603 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~---------~l~~~l 672 (802)
......|++.|++||.+.. ..++.++|||||||++|+|++|++||...+..+...... .+....
T Consensus 156 ------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHH
T ss_conf ------41010243110137887178888841002111758999977979989889899999999863899711042123
Q ss_pred H-----H-HC-------CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 3-----2-07-------9999689999999999953012689986211
Q 003694 673 D-----A-QA-------GDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 673 d-----~-~~-------~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
. . .. ...+...+..+.+|+.+|++.||++||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~e 277 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 332214333335676466651258999999999986689668909999
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=314.32 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=191.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCEEEECCEECC--------
Q ss_conf 218744501147771899999989--938999997156--83006989999999982699915444141428--------
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------- 514 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~-------- 514 (802)
.++|....+||+|+||+||+|.+. +..||||++... .......+.+|+.+|++++|||++.+++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred --CCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEEC
Q ss_conf --872899972699977896411899999989999999999999999770499995875899997676289602793203
Q 003694 515 --HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 592 (802)
Q Consensus 515 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFG 592 (802)
..++||||+.++.+...... ...++...+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEECCCCCCCCHHHHC---CCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECC
T ss_conf 7638999853578741012220---344330899999999999998852299---8856767222036689968763135
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHH----
Q ss_conf 410136999964343335687557556795211259-878755403389999999728997432200244310002----
Q 003694 593 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN---- 667 (802)
Q Consensus 593 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~---- 667 (802)
+++.+...... ........+||+.|+|||++.+. .++.++|||||||++|+|+||++||..............
T Consensus 163 ~~~~~~~~~~~--~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 163 LARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp TCEECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEEECCCCCCC--CCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCC
T ss_conf 00223554443--2113566024978742899707999891787006786466174487998998999999999984189
Q ss_pred -------------HHHHHHHHC-CCCCH-------HHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf -------------688753207-99996-------89999999999953012689986211
Q 003694 668 -------------LAEILDAQA-GDWPI-------KETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 668 -------------l~~~ld~~~-~~~p~-------~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
....+.... ...+. .....+.+|+.+||+.||.+||++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 9825534432034443320133445550334044459989999999987389658909999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=316.51 Aligned_cols=245 Identities=25% Similarity=0.309 Sum_probs=196.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEE-----CCEEEEEEEECCCC----CCCHHHHHHHHHHHHHCCC-CCEEEECCEECCCC-
Q ss_conf 1874450114777189999998-----99389999971568----3006989999999982699-91544414142887-
Q 003694 448 LSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKIRH-PHLLLLLGACPDHG- 516 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~-----~~~~vAvK~l~~~~----~~~~~~~~~Ei~iL~~l~H-pniv~l~g~~~~~~- 516 (802)
++|....+||+|+||.||+|.. .+..||+|++.... ....+.+.+|+.+|++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred -EEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCC
Q ss_conf -2899972699977896411899999989999999999999999770499995875899997676289602793203410
Q 003694 517 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 517 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~ 595 (802)
++||||+.+|+|.+++..... ++......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHHHCCC---CCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 0012312341179999873045---437888888999999998851499---8965477320124699988874132022
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHHHHHHHHH
Q ss_conf 136999964343335687557556795211259--878755403389999999728997432200244310002688753
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 673 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~~l~~~ld 673 (802)
.+..... .......|++.|++||.+.+. .++.++|||||||+||+|+||+.||......... ..+.....
T Consensus 178 ~~~~~~~-----~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~ 249 (322)
T d1vzoa_ 178 EFVADET-----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRIL 249 (322)
T ss_dssp ECCGGGG-----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHH
T ss_pred HHCCCCC-----CCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHCC
T ss_conf 2034444-----322122233333106876057768871325177779999997689998888777799---99998335
Q ss_pred HHCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 207999968999999999995301268998621
Q 003694 674 AQAGDWPIKETKELAALGLSCAELRRKDRPDLK 706 (802)
Q Consensus 674 ~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~ 706 (802)
......|...+.++.+|+.+||..+|.+||++.
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~ 282 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCC
T ss_conf 689988654799999999997445898819997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-43 Score=312.30 Aligned_cols=244 Identities=19% Similarity=0.218 Sum_probs=192.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEECCEECC--------C
Q ss_conf 18744501147771899999989--9389999971568--3006989999999982699915444141428--------8
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--------H 515 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~--------~ 515 (802)
+.|....+||+|+||+||+|.+. +..||||++.... ......+.+|+.+|++++|||||+++++|.. .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred CEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCC
Q ss_conf 72899972699977896411899999989999999999999999770499995875899997676289602793203410
Q 003694 516 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~ 595 (802)
.|+||||+.++.+ +.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEECCCHHHH-HHHH-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf 6999841446778-7650-----38999999999999999998865221---1245677632113654431320102321
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHC-----------
Q ss_conf 136999964343335687557556795211259878755403389999999728997432200244310-----------
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID----------- 664 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~----------- 664 (802)
...... ......||+.|+|||++.+..+++++||||+||++|+|++|++||...+.......
T Consensus 168 ~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 168 TAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCCCCC-------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHH
T ss_conf 146665-------5332214655558133147777877433356625789865989988897788999999720589879
Q ss_pred -----HHHHHHHHHHHC----------------C-C--CCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf -----002688753207----------------9-9--99689999999999953012689986211
Q 003694 665 -----EDNLAEILDAQA----------------G-D--WPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 665 -----~~~l~~~ld~~~----------------~-~--~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
............ . . .+...+..+.+|+.+|+..+|.+||++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~e 307 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 9987656677776417543566642126433354321013337999999999987699457908999
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-42 Score=308.38 Aligned_cols=241 Identities=19% Similarity=0.316 Sum_probs=188.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEECCEECCC----CEEEE
Q ss_conf 18744501147771899999989--9389999971568300698999999998269-99154441414288----72899
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDH----GCLVY 520 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-Hpniv~l~g~~~~~----~~lV~ 520 (802)
++|....+||+|+||.||+|++. +..||+|++... ...++.+|+.+|..+. ||||+++++++... .++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CEEEEEEECCCCCCCC
Q ss_conf 972699977896411899999989999999999999999770499995875899997676289-6027932034101369
Q 003694 521 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNS 599 (802)
Q Consensus 521 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~-~~~KI~DFGla~~~~~ 599 (802)
||+.+|+|.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ ..+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 631798589974------68999999999999999998876433---443456441237748998366415654266468
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHH-------CHHHHHHH
Q ss_conf 99964343335687557556795211259-87875540338999999972899743220024431-------00026887
Q 003694 600 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI-------DEDNLAEI 671 (802)
Q Consensus 600 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~-------~~~~l~~~ 671 (802)
... .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.......... ........
T Consensus 183 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 183 GQE-------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp TCC-------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CCC-------CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHH
T ss_conf 874-------4432248642476102688888845232335455587604889998876018999999998788415555
Q ss_pred HHHH------------------------CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 5320------------------------79999689999999999953012689986211
Q 003694 672 LDAQ------------------------AGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 672 ld~~------------------------~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.... ........+.++.+|+.+|+..+|.+||++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 315 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 542254447430000033343311211552112448999999999986699568908999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-42 Score=307.13 Aligned_cols=245 Identities=20% Similarity=0.271 Sum_probs=191.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCEEEECCEECCC-------
Q ss_conf 218744501147771899999989--93899999715683--0069899999999826999154441414288-------
Q 003694 447 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 515 (802)
Q Consensus 447 ~~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~------- 515 (802)
.+.|....+||+|+||+||+|.+. +..||||++..... ...+.+.+|+.+|++++|||+|++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred CEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCC
Q ss_conf 72899972699977896411899999989999999999999999770499995875899997676289602793203410
Q 003694 516 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 595 (802)
Q Consensus 516 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~ 595 (802)
.+++++|+.+|+|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEECCCCHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 49999962588623200224----5309999999999999999997388---7651667763345543220013210001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHC----------
Q ss_conf 136999964343335687557556795211259-878755403389999999728997432200244310----------
Q 003694 596 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---------- 664 (802)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~---------- 664 (802)
.... ......|++.|+|||...+. .++.++|||||||++|+|++|++||...+.......
T Consensus 170 ~~~~---------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 170 HTDD---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CCTG---------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCCC---------CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 2575---------4444345435558355337756785512432058999997688997889889999999973079975
Q ss_pred -------HHHHHHHHHHH--CCCCC-----HHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf -------00268875320--79999-----689999999999953012689986211
Q 003694 665 -------EDNLAEILDAQ--AGDWP-----IKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 665 -------~~~l~~~ld~~--~~~~p-----~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
........... ....+ ...+..+.+|+.+|+..||.+||++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 773200102445444303557875556626789999999999977588345938999
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=303.24 Aligned_cols=248 Identities=19% Similarity=0.254 Sum_probs=192.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEECCEECCCC--EEEEE
Q ss_conf 18744501147771899999989--9389999971568--300698999999998269991544414142887--28999
Q 003694 448 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 521 (802)
Q Consensus 448 ~~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~~~~Ei~iL~~l~Hpniv~l~g~~~~~~--~lV~E 521 (802)
+.|....+||+|+||+||+|++. +..||||+++... .....++.+|+.+|+.++||||++++++|.+.. ++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCCCCCCC
Q ss_conf 72699977896411899999989999999999999999770499995875899997676289602793203410136999
Q 003694 522 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 601 (802)
Q Consensus 522 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~~~~~~ 601 (802)
++.+++|..++... ..+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 02332221121235---65403678999999999987743399---8600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHCHH-H------------
Q ss_conf 9643433356875575567952112598-7875540338999999972899743220024431000-2------------
Q 003694 602 SFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED-N------------ 667 (802)
Q Consensus 602 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~~~-~------------ 667 (802)
.. .....+++.|++||++.... ++.++|||||||++|+|++|+.||.........+..- .
T Consensus 156 ~~------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 RC------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp SC------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred CC------CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 51------001034431014667506988880444026541889985189999889999999999986118997355134
Q ss_pred HHHHHHH----------HCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 6887532----------079999689999999999953012689986211
Q 003694 668 LAEILDA----------QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 707 (802)
Q Consensus 668 l~~~ld~----------~~~~~p~~~~~~l~~li~~Cl~~~p~~RP~~~~ 707 (802)
.....+. .....+...+..+.+|+.+|++.+|++||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e 279 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 43222113344454431043306568999999999986499668909999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-38 Score=280.98 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=186.3
Q ss_pred CCCCCCEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-----------CCCEEEECCEECCC
Q ss_conf 8744501147771899999989--9389999971568300698999999998269-----------99154441414288
Q 003694 449 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----------HPHLLLLLGACPDH 515 (802)
Q Consensus 449 ~f~~~~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-----------Hpniv~l~g~~~~~ 515 (802)
.|....+||+|+||.||+|+.. +..||||+++.... ..+.+.+|+.+++.++ ||||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 57998997507781899999999997999999834313-36899999999998401455555422767647899876312
Q ss_pred ----CEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCC------
Q ss_conf ----72899972699977896411899999989999999999999999770-4999958758999976762896------
Q 003694 516 ----GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNL------ 584 (802)
Q Consensus 516 ----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILld~~~------ 584 (802)
.+++++++..+..............+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCCC
T ss_conf 565202343200035420000012234678689999999999999888764058---64656770570563057656443
Q ss_pred EEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHHHHC
Q ss_conf 02793203410136999964343335687557556795211259878755403389999999728997432200244310
Q 003694 585 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID 664 (802)
Q Consensus 585 ~~KI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDv~SlGvil~elltg~~p~~~~~~~~~~~~ 664 (802)
.+|++|||.+...... ....+||+.|+|||++....++.++||||+||++++|++|+.||...........
T Consensus 170 ~~kl~dfg~s~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp EEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred EEEEEECCCCCCCCCC---------CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCH
T ss_conf 0567531442123445---------4223665210571321466777643201237899999878899898755432102
Q ss_pred HHHHHHHH-----------------------------------------HHHCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 00268875-----------------------------------------3207999968999999999995301268998
Q 003694 665 EDNLAEIL-----------------------------------------DAQAGDWPIKETKELAALGLSCAELRRKDRP 703 (802)
Q Consensus 665 ~~~l~~~l-----------------------------------------d~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP 703 (802)
...+...+ .......+...+..+.+|+.+|+..||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 68999999983799878862453220001320122024323577644421000156743589999999998779945790
Q ss_pred CCCC
Q ss_conf 6211
Q 003694 704 DLKN 707 (802)
Q Consensus 704 ~~~~ 707 (802)
|+.+
T Consensus 321 ta~e 324 (362)
T d1q8ya_ 321 DAGG 324 (362)
T ss_dssp CHHH
T ss_pred CHHH
T ss_conf 8999
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=7.2e-22 Score=166.46 Aligned_cols=163 Identities=14% Similarity=0.077 Sum_probs=119.0
Q ss_pred CCCCEECCCCCEEEEEEEE-CCEEEEEEEECCCCCC------------------CHHHHHHHHHHHHHCCCCCEEEECCE
Q ss_conf 4450114777189999998-9938999997156830------------------06989999999982699915444141
Q 003694 451 SENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNI------------------QNKQFLQELEVLSKIRHPHLLLLLGA 511 (802)
Q Consensus 451 ~~~~~IG~G~~g~Vyk~~~-~~~~vAvK~l~~~~~~------------------~~~~~~~Ei~iL~~l~Hpniv~l~g~ 511 (802)
....+||+|+||.||+|.. ++..||||+++..... ....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred ECCCCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCEEEEEEE
Q ss_conf 42887289997269997789641189999998999999999999999977049999587589999767628960279320
Q 003694 512 CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 591 (802)
Q Consensus 512 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiHrDLKp~NILld~~~~~KI~DF 591 (802)
. ..+++|||++++.+.. ++......++.|++.+|.|||..+ |+||||||+|||++.++ ++|+||
T Consensus 83 ~--~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 83 E--GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp E--TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCC
T ss_pred C--CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECCC-EEEEEC
T ss_conf 2--8889999504565420----------015789999999999999982688---89836890361142898-999877
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 341013699996434333568755755679------52112598787554033899999
Q 003694 592 GLSTMLNSDPSFVSTTYKNTGPVGTLCYID------PEYQRTGLISPKSDVYAYGMVIL 644 (802)
Q Consensus 592 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~a------PE~~~~~~~~~~sDv~SlGvil~ 644 (802)
|+|......... .|.. .+++ .+.|+.++|+||..--++
T Consensus 147 G~a~~~~~~~~~--------------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWR--------------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHH--------------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCH--------------HHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf 884308998709--------------99987799999997-578998446899999874
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.86 E-value=3.5e-21 Score=161.72 Aligned_cols=149 Identities=25% Similarity=0.320 Sum_probs=123.1
Q ss_pred CCEEEEEECCCC---------CCHHHHHHHHHHCCCCCCC--EEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 956999864995---------6043387885303878996--59999841799977899988656676556889999998
Q 003694 14 ALSVAVAVKGNR---------KSRYAVLWALEKFIPEGIN--LFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQE 82 (802)
Q Consensus 14 ~~~I~VaVD~s~---------~S~~Al~wA~~~~~~~~~~--~i~LvHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~ 82 (802)
..||+||||+|. +|++|++||++++.+.++. .|+++||.+........ .+......+......++
T Consensus 1 p~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 76 (171)
T d2gm3a1 1 PTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDD----VDSIYASPEDFRDMRQS 76 (171)
T ss_dssp CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC--------------CCCCSHHHHHHHTTS
T ss_pred CCEEEEEECCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCCCCCCC----CCCCCCCHHHHHHHHHH
T ss_conf 98899997698566778999999999999999998779997289999954565434344----44445677789999999
Q ss_pred HHHHHHHHHHHHHHHHHCCCCEEEEEEEECCCHHHHHHHHHHHCCCCEEEECCCCCCCCEEECCCCCCCCCCCCCCC-CC
Q ss_conf 89989886698999852058113799972276889999998853987799702689940000035898741012248-85
Q 003694 83 EKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SF 161 (802)
Q Consensus 83 ~~~~~~~~l~~~~~~c~~~~v~~~~~v~e~gd~~~~Iv~~a~~~~id~lViGs~~~~~~~~~~~~~~~gs~~~~~~~-~~ 161 (802)
..+.+.++|..+...|...+++++..+.+ |+++++|+++|.+.++|+||||++|++ .+.+.++||++.+++. +.
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~----~~~~~~lGSv~~~vi~~~~ 151 (171)
T d2gm3a1 77 NKAKGLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLG----RFQKVFVGTVSAFCVKHAE 151 (171)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC------------CHHHHHHHHCS
T ss_pred HHHHHHHHHHHHHHHHHHCCCCEEEEEEE-CCHHHHHHHHHHHCCCCEEEECCCCCC----CCCCCCCCCHHHHHHHCCC
T ss_conf 99999999999999988639944799982-786999999876447757974367753----5455744869999983899
Q ss_pred CEEEEEECCC
Q ss_conf 3499984691
Q 003694 162 CTVYGVEKGK 171 (802)
Q Consensus 162 c~V~vV~~~k 171 (802)
|||++|+++.
T Consensus 152 cpVlvV~~~~ 161 (171)
T d2gm3a1 152 CPVMTIKRNA 161 (171)
T ss_dssp SCEEEEECCG
T ss_pred CCEEEEECCC
T ss_conf 8989996898
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.84 E-value=2.2e-20 Score=156.15 Aligned_cols=153 Identities=10% Similarity=0.047 Sum_probs=122.8
Q ss_pred CCCEEEEEECCCCCCHHHHHHHHHHCCCCCCCEEEEEEECCCCCCCCCCC-CCCC---CCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 99569998649956043387885303878996599998417999778999-8865---6676556889999998899898
Q 003694 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPM-GNFI---PIEQVRDDVAAAYKQEEKWKTD 88 (802)
Q Consensus 13 ~~~~I~VaVD~s~~S~~Al~wA~~~~~~~~~~~i~LvHV~~~~~~~~~~~-g~~~---p~~~~~~~~~~~~~~~~~~~~~ 88 (802)
++++|+||||+|+.|++|++||++.+...+. +|+|+||+++........ .... ......++......+...+++.
T Consensus 2 m~~~ILvavD~s~~s~~al~~a~~la~~~~a-~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (160)
T d1mjha_ 2 MYKKILYPTDFSETAEIALKHVKAFKTLKAE-EVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAK 80 (160)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHTCCSSCC-EEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHH
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHHHHHCCC-EEEEEEECCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 8682999987998999999999999875399-799998305665443333222245332220078899999999999999
Q ss_pred HHHHHHHHHHHCCCCEEEEEEEECCCHHHHHHHHHHHCCCCEEEECCCCCCCCEEECCCCCCCCCCCCCCC-CCCEEEEE
Q ss_conf 86698999852058113799972276889999998853987799702689940000035898741012248-85349998
Q 003694 89 RLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGV 167 (802)
Q Consensus 89 ~~l~~~~~~c~~~~v~~~~~v~e~gd~~~~Iv~~a~~~~id~lViGs~~~~~~~~~~~~~~~gs~~~~~~~-~~c~V~vV 167 (802)
+.|..+...|...|++++..+.. |+|++.|+++|.+.++|+||||+|+++ .+.+.++||++.++++ ++|||+||
T Consensus 81 ~~l~~~~~~~~~~gv~~~~~~~~-G~~~~~I~~~a~~~~~dliV~G~~~~~----~~~~~~~GS~a~~vl~~s~~pVlvV 155 (160)
T d1mjha_ 81 NKMENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKT----NLKEILLGSVTENVIKKSNKPVLVV 155 (160)
T ss_dssp HHHHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSS----CCTTCSSCHHHHHHHHHCCSCEEEE
T ss_pred HHHHHHHHHHHHCCCEEEEEEEE-CCHHHHHHHHHHCCCCCEEEECCCCCC----CCCCCCCCCHHHHHHHCCCCCEEEE
T ss_conf 99999999987659769999994-558987766520242214776168998----6421410709999996299989998
Q ss_pred ECCC
Q ss_conf 4691
Q 003694 168 EKGK 171 (802)
Q Consensus 168 ~~~k 171 (802)
++..
T Consensus 156 ~~~~ 159 (160)
T d1mjha_ 156 KRKN 159 (160)
T ss_dssp CCCC
T ss_pred CCCC
T ss_conf 2899
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.75 E-value=3e-18 Score=141.20 Aligned_cols=134 Identities=18% Similarity=0.180 Sum_probs=104.6
Q ss_pred CCEEEEEECCCCCCHHHHHHHHHHCCCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH
Q ss_conf 95699986499560433878853038789965999984179997789998865667655688999999889989886698
Q 003694 14 ALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLP 93 (802)
Q Consensus 14 ~~~I~VaVD~s~~S~~Al~wA~~~~~~~~~~~i~LvHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~~ 93 (802)
|++|+||+|+|+.|+.|++||++.+...+. .|+|+||+++..... + ........++..+++++.+..
T Consensus 1 yk~Ilv~~D~s~~s~~a~~~a~~~a~~~~~-~l~ll~V~~~~~~~~---~---------~~~~~~~~~~~~~~~~~~l~~ 67 (135)
T d2z3va1 1 FKTILLAYDGSEHARRAAEVAKAEAEAHGA-RLIVVHAYEPVPDYL---G---------EPFFEEALRRRLERAEGVLEE 67 (135)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHHHHTC-EEEEEEEECCCCTTC---C---------TTHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHHHCCC-EEEEEEEECCCCCCC---C---------CCHHHHHHHHHHHHHHHHHHH
T ss_conf 998999978998999999999999998399-999999745775434---6---------502689999999999999999
Q ss_pred HHHHHHCCCCEEEEEEEECCCHHHHHHHHHHHCCCCEEEECCCCCCCCEEECCCCCCCCCCCCCCC-CCCEEEEE
Q ss_conf 999852058113799972276889999998853987799702689940000035898741012248-85349998
Q 003694 94 FRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGV 167 (802)
Q Consensus 94 ~~~~c~~~~v~~~~~v~e~gd~~~~Iv~~a~~~~id~lViGs~~~~~~~~~~~~~~~gs~~~~~~~-~~c~V~vV 167 (802)
+... .++.....++..|+|+++|+++|.+.++|+||||+++++ .+.+.++||++.++++ ++|||++|
T Consensus 68 ~~~~---~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~----~~~~~~~Gs~~~~ll~~~~~pVlvV 135 (135)
T d2z3va1 68 ARAL---TGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLG----ALGSLFLGSQSQRVVAEAPCPVLLV 135 (135)
T ss_dssp HHHH---HCCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSS----SCBCSSCBHHHHHHHHHCSSCEEEE
T ss_pred HHHH---CCCCEEEEEEECCCHHHHHHHHHHHHHEEEEEECCCCCC----CCCCCCCCCHHHHHHHHCCCCEEEC
T ss_conf 9986---699728999982776899998752000115775367998----5210413709999997099999959
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.71 E-value=1.4e-17 Score=136.65 Aligned_cols=142 Identities=13% Similarity=-0.012 Sum_probs=107.8
Q ss_pred CCCCEEEEEECCCCCCHHHHHHHHHHCCCCCCCEEEEEEECCCC-CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 99956999864995604338788530387899659999841799-97789998865667655688999999889989886
Q 003694 12 SPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRI-TSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRL 90 (802)
Q Consensus 12 ~~~~~I~VaVD~s~~S~~Al~wA~~~~~~~~~~~i~LvHV~~~~-~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~ 90 (802)
..|++|+||||+|+.|+.|++||+..+. ..+. .+++|++.+. ...+.... ...........+.+++.
T Consensus 3 ~~yk~ILv~vD~s~~s~~al~~A~~la~-~~~~-~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~ 70 (147)
T d1tq8a_ 3 SAYKTVVVGTDGSDSSMRAVDRAAQIAG-ADAK-LIIASAYLPQHEDARAADI----------LKDESYKVTGTAPIYEI 70 (147)
T ss_dssp CCCCEEEEECCSSHHHHHHHHHHHHHHT-TTSE-EEEEEECCC------------------------------CCTHHHH
T ss_pred CCCCEEEEEECCCHHHHHHHHHHHHHHH-CCCC-EEEEEEEECCCCCCCCCCC----------CHHHHHHHHHHHHHHHH
T ss_conf 6789799998899899999999999986-1898-7999999436665432110----------00246899999999999
Q ss_pred HHHHHHHHHCCCCEEEEEEEECCCHHHHHHHHHHHCCCCEEEECCCCCCCCEEECCCCCCCCCCCCCCC-CCCEEEEEEC
Q ss_conf 698999852058113799972276889999998853987799702689940000035898741012248-8534999846
Q 003694 91 LLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGVEK 169 (802)
Q Consensus 91 l~~~~~~c~~~~v~~~~~v~e~gd~~~~Iv~~a~~~~id~lViGs~~~~~~~~~~~~~~~gs~~~~~~~-~~c~V~vV~~ 169 (802)
+..++..+.+.|+......+..|++++.|++++.++++|+||||+++++ .+.+.++||++.+++. ++|||+||+.
T Consensus 71 l~~~~~~~~~~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~----~~~~~l~Gs~~~~ll~~~~~pVlvV~~ 146 (147)
T d1tq8a_ 71 LHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLS----TIAGRLLGSVPANVSRRAKVDVLIVHT 146 (147)
T ss_dssp HHHHHHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCC----SHHHHHTBBHHHHHHHHTTCEEEEECC
T ss_pred HHHHHHHHHHCCCCCEEEEEEECCHHHHHHHHHHCCCEEEEEECCCCCC----CCCCCCCCCHHHHHHHHCCCCEEEEEC
T ss_conf 9999999987599738999984276999987642351369985578998----633250264999999708998899946
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.65 E-value=1.2e-16 Score=129.96 Aligned_cols=137 Identities=16% Similarity=0.129 Sum_probs=100.1
Q ss_pred CCCEEEEEECCCCCCHHHHHHHHHHCCCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 99569998649956043387885303878996599998417999778999886566765568899999988998988669
Q 003694 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLL 92 (802)
Q Consensus 13 ~~~~I~VaVD~s~~S~~Al~wA~~~~~~~~~~~i~LvHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~ 92 (802)
+|++|+||+|+|+.|+.|+.||+..+...++ .|+++||++++....... .+...........+.+.+.+.
T Consensus 1 myk~ILv~vD~s~~s~~al~~A~~~a~~~~~-~v~~lhv~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~ 70 (140)
T d1jmva_ 1 MYKHILVAVDLSEESPILLKKAVGIAKRHDA-KLSIIHVDVNFSDLYTGL---------IDVNMSSMQDRISTETQKALL 70 (140)
T ss_dssp CCSEEEEEECCSTTHHHHHHHHHHHHHHHTC-EEEEEEEEECCGGGCCCC---------EEHHHHHHTTCCCCHHHHHHH
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHHHHHCCC-EEEEEEEEEECCCCCCCC---------CCCCHHHHHHHHHHHHHHHHH
T ss_conf 9870999987998999999999999987499-099999964044221233---------322358999999999999999
Q ss_pred HHHHHHHCCCCEEEEEEEECCCHHHHHHHHHHHCCCCEEEECCCCCCCCEEECCCCCCCCCCCCCCC-CCCEEEEEEC
Q ss_conf 8999852058113799972276889999998853987799702689940000035898741012248-8534999846
Q 003694 93 PFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYGVEK 169 (802)
Q Consensus 93 ~~~~~c~~~~v~~~~~v~e~gd~~~~Iv~~a~~~~id~lViGs~~~~~~~~~~~~~~~gs~~~~~~~-~~c~V~vV~~ 169 (802)
. .+...+......++..|+++++|+++++++++|+||||+|+++ .. .+||++.+++. +.|||++|+-
T Consensus 71 ~---~~~~~~~~~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~----~~---~lgs~~~~li~~~~~pVliVp~ 138 (140)
T d1jmva_ 71 D---LAESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDF----WS---KLMSSTRQVMNTIKIDMLVVPL 138 (140)
T ss_dssp H---HHHHSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCC----HH---HHHHHHHHHHTTCCSEEEEEEC
T ss_pred H---HHHHCCCCEEEEEEEECCHHHHHHHHHHHCHHHEEEECCCCCC----CC---CCCCHHHHHHHCCCCCEEEEEC
T ss_conf 9---9985588617999981688999998640031428884058999----77---7353999998616998999946
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.60 E-value=3.1e-16 Score=127.21 Aligned_cols=137 Identities=11% Similarity=0.011 Sum_probs=98.6
Q ss_pred CCCCEEEEEECCCCCCHHHHHHHHHHCCCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 99956999864995604338788530387899659999841799977899988656676556889999998899898866
Q 003694 12 SPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLL 91 (802)
Q Consensus 12 ~~~~~I~VaVD~s~~S~~Al~wA~~~~~~~~~~~i~LvHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l 91 (802)
...++|+||+|+|+.|+.|++||+..+...++ .|+++||.++......... .... .......++..+.+.+.+
T Consensus 2 ~~mk~ILv~~D~S~~s~~al~~A~~~a~~~~a-~l~llhv~~~~~~~~~~~~---~~~~---~~~~~~~e~~~~~~~~~l 74 (138)
T d1q77a_ 2 NAMKVLLVLTDAYSDCEKAITYAVNFSEKLGA-ELDILAVLEDVYNLERANV---TFGL---PFPPEIKEESKKRIERRL 74 (138)
T ss_dssp CCCEEEEEEESTTCCCHHHHHHHHHHHTTTCC-EEEEEEECHHHHHHHHHHH---HHCC---CCCTHHHHHHHHHHHHHH
T ss_pred CCCCEEEEEEECCHHHHHHHHHHHHHHHHCCC-EEEEEEECCCCCCCCCCCC---CCCC---CHHHHHHHHHHHHCCCCC
T ss_conf 87899999995999999999999996544054-3899997367433321023---3222---101345656543111200
Q ss_pred HHHHHHHHCCCCEEEEEEEECCCHHHHHHHHHHHCCCCEEEECCCCCCCCEEECCCCCCCCCCCCCCCCCCEEEEEE
Q ss_conf 98999852058113799972276889999998853987799702689940000035898741012248853499984
Q 003694 92 LPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVE 168 (802)
Q Consensus 92 ~~~~~~c~~~~v~~~~~v~e~gd~~~~Iv~~a~~~~id~lViGs~~~~~~~~~~~~~~~gs~~~~~~~~~c~V~vV~ 168 (802)
..+...+...++.++..+.. |+|++.|+++|.+.++|+||||+||++++.|.+ .| +.||+++|+
T Consensus 75 ~~~~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l----~g--------~~~~~livk 138 (138)
T d1q77a_ 75 REVWEKLTGSTEIPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPSAYLCKVI----DG--------LNLASLIVK 138 (138)
T ss_dssp HHHHHHHHSCCCCCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHH----HH--------SSSEEEECC
T ss_pred HHHCCCCCCCCEEEEEEEEC-CHHHHHHHHHHHHCCCCEEEEECCCCCHHHHHH----CC--------CCCCEEEEC
T ss_conf 22201122232147986402-304788887666426999999569976789985----59--------998879869
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=8.7e-13 Score=103.12 Aligned_cols=70 Identities=27% Similarity=0.494 Sum_probs=65.8
Q ss_pred CCCCCCCCCCCCHHCCCCCCCCCCC-CCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9999976673000001497425898-301348799998627999998999999998771999999999750
Q 003694 732 PAPPNHFICPILKEVMNEPCVAADG-YTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 801 (802)
Q Consensus 732 ~~~p~~f~cPi~~evm~dp~ia~dg-~tye~~aI~~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~i~~w~~ 801 (802)
...|+.|+|||.+++|.||++...| +||++.+|+.||..++++|+|+.+|...+|+||++||.+|++|+.
T Consensus 17 ~~~P~~f~CPI~~~lm~dPV~~~~~~~ty~r~~I~~~l~~~~~~P~~~~~l~~~~L~pN~~Lr~~I~~~~~ 87 (98)
T d1wgma_ 17 ADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRSPLTMDQIRPNTELKEKIQRWLA 87 (98)
T ss_dssp CSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTTSCBCTTTCSBCCTTTSEECHHHHHHHHHHHH
T ss_pred CCCCHHHCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHCCHHHHHHHHHHHHH
T ss_conf 59907748867346887777623553201499999998706876655566640112013999999999999
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.11 E-value=2e-11 Score=93.61 Aligned_cols=72 Identities=36% Similarity=0.711 Sum_probs=67.0
Q ss_pred CCCCCCCCCCCCCHHCCCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 9999997667300000149742589830134879999862-79999989999999987719999999997509
Q 003694 731 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 802 (802)
Q Consensus 731 ~~~~p~~f~cPi~~evm~dp~ia~dg~tye~~aI~~wl~~-~~~sP~t~~~l~~~~l~pn~~l~~~i~~w~~~ 802 (802)
.|..|+.|.|||.+++|.||++...|++|++..|+.|+.. +.++|.++.++...+++||++||++|++|+.+
T Consensus 2 ~peiP~~l~CpIc~~~m~dPV~~~cgh~fc~~ci~~~~~~~~~~cP~~~~~l~~~~l~pN~~L~~~I~~~~~~ 74 (78)
T d1t1ha_ 2 SPEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCES 74 (78)
T ss_dssp CCCCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHH
T ss_pred CCCCCCCCCCCCCCCHHHCCEECCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 7989962799171812108337267774339999999998888788655637756562469999999999999
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.10 E-value=5e-11 Score=90.81 Aligned_cols=71 Identities=38% Similarity=0.619 Sum_probs=66.2
Q ss_pred CCCCCCCCCCCCHHCCCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 999997667300000149742589830134879999862-79999989999999987719999999997509
Q 003694 732 PAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 802 (802)
Q Consensus 732 ~~~p~~f~cPi~~evm~dp~ia~dg~tye~~aI~~wl~~-~~~sP~t~~~l~~~~l~pn~~l~~~i~~w~~~ 802 (802)
...|+.|.|||..++|.||++...|+||++..|..|+.. +.++|+++.++...+|+||++||++|++|+.+
T Consensus 2 ~eiP~~l~CpIc~~l~~dPv~~~cGhtfc~~ci~~~l~~~~~~cP~c~~~l~~~~l~pN~~L~~~I~~~l~~ 73 (80)
T d2c2la2 2 RDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISE 73 (80)
T ss_dssp CCCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTT
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCEECHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 989700118583732340330588685638899999863776578756665423555199999999999998
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=8.8e-08 Score=68.20 Aligned_cols=146 Identities=14% Similarity=0.047 Sum_probs=95.9
Q ss_pred HHHHHCCCCCCCEECCCCCEEEEEEEECCEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEECCEECC--CCEEE
Q ss_conf 99862187445011477718999999899389999971568300698999999998269-9915444141428--87289
Q 003694 443 IESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPD--HGCLV 519 (802)
Q Consensus 443 i~~~~~~f~~~~~IG~G~~g~Vyk~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-Hpniv~l~g~~~~--~~~lV 519 (802)
+......|......+.++.+.||+....+..+.+|+...........+.+|...+..+. +--+.+++..+.+ ..++|
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHHHHCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEE
T ss_conf 99751352799767899877189999089869999848876532556999999999876069987289997508964999
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC----------------------------------
Q ss_conf 9972699977896411899999989999999999999999770499----------------------------------
Q 003694 520 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP---------------------------------- 565 (802)
Q Consensus 520 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~---------------------------------- 565 (802)
|++++|.++.+..... . ....++.+++..|..||+..+
T Consensus 89 ~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEECCCCCCCCCCCCC-----C---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 9860433435433440-----2---6999999899999998556842143576446565557789987765555430332
Q ss_pred ----------------------CCEEECCCCCCCEEECCCCEEEEEEECCCCC
Q ss_conf ----------------------9958758999976762896027932034101
Q 003694 566 ----------------------KPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 566 ----------------------~~iiHrDLKp~NILld~~~~~KI~DFGla~~ 596 (802)
..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 32005799999999844986781789860047642364996599960231441
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.20 E-value=1.5e-05 Score=52.61 Aligned_cols=75 Identities=12% Similarity=0.024 Sum_probs=51.6
Q ss_pred CEECCCCCEEEEEEEEC--CEEEEEEEECCCC-------CCCHHHHHHHHHHHHHCC---CCCEEEECCEECCCCEEEEE
Q ss_conf 01147771899999989--9389999971568-------300698999999998269---99154441414288728999
Q 003694 454 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-------NIQNKQFLQELEVLSKIR---HPHLLLLLGACPDHGCLVYE 521 (802)
Q Consensus 454 ~~IG~G~~g~Vyk~~~~--~~~vAvK~l~~~~-------~~~~~~~~~Ei~iL~~l~---Hpniv~l~g~~~~~~~lV~E 521 (802)
..||.|....||++... +..+.+|.-.+.. .....+...|.+.|..+. ...+..++++..+...+|||
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvmE 111 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVME 111 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEEC
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEECCCCCEEEEE
T ss_conf 98079852768999957998489996177130346777888778999999999986505798855289985988779871
Q ss_pred ECCCCCH
Q ss_conf 7269997
Q 003694 522 YMENGSL 528 (802)
Q Consensus 522 y~~~gsL 528 (802)
++.+..+
T Consensus 112 ~L~~~~~ 118 (392)
T d2pula1 112 DLSHLKI 118 (392)
T ss_dssp CCTTSEE
T ss_pred CCCCCCC
T ss_conf 3577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=7.2e-05 Score=47.87 Aligned_cols=128 Identities=18% Similarity=0.137 Sum_probs=77.9
Q ss_pred EECCCCC-EEEEEEEECCE-EEEEEEECCCCCCCHHHHHHHHHHHHHCC--CCCEEEECCEECCCC--EEEEEECCCCCH
Q ss_conf 1147771-89999998993-89999971568300698999999998269--991544414142887--289997269997
Q 003694 455 RIGMGGY-GTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIR--HPHLLLLLGACPDHG--CLVYEYMENGSL 528 (802)
Q Consensus 455 ~IG~G~~-g~Vyk~~~~~~-~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~--Hpniv~l~g~~~~~~--~lV~Ey~~~gsL 528 (802)
.+..|.. +.||+....+. .+.+|....... ..+..|...|..+. .-.+..+++++.+.. ++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 76786547758999938987899995896677---689999999999986599988613222456615999874413554
Q ss_pred HHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------------------
Q ss_conf 789641189999998999999999999999977049--------------------------------------------
Q 003694 529 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK-------------------------------------------- 564 (802)
Q Consensus 529 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------------- 564 (802)
.+.. .. ...++.++...|.-||...
T Consensus 94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred CCCC--------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 3221--------26---899999999999987368854488755412468899999987541101134011213799999
Q ss_pred -----------CCCEEECCCCCCCEEECCCCEEEEEEECCCCC
Q ss_conf -----------99958758999976762896027932034101
Q 003694 565 -----------PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 565 -----------~~~iiHrDLKp~NILld~~~~~KI~DFGla~~ 596 (802)
+..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 9998718765795678678887635773796589998533265
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.78 E-value=3.6e-06 Score=56.96 Aligned_cols=52 Identities=19% Similarity=0.530 Sum_probs=48.5
Q ss_pred CCCCCCHHCCCCCCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 6673000001497425-898301348799998627999998999999998771
Q 003694 738 FICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPN 789 (802)
Q Consensus 738 f~cPi~~evm~dp~ia-~dg~tye~~aI~~wl~~~~~sP~t~~~l~~~~l~pn 789 (802)
.+|||..++|.||++. ..|++|++..|..|+..++++|+|+.+|...+|+|.
T Consensus 1 l~C~Ic~~~~~~Pv~~~~cGh~fc~~cI~~~l~~~~~CP~c~~~l~~~dLipi 53 (56)
T d2baya1 1 MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEI 53 (56)
T ss_dssp CCCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHHHSBCTTTCCBCCGGGCEEC
T ss_pred CCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHCEEC
T ss_conf 99936785688657457899845599999987603679854781887753647
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.26 E-value=0.004 Score=35.66 Aligned_cols=159 Identities=16% Similarity=0.148 Sum_probs=80.6
Q ss_pred CCCCCCHHHHHHHHCCCC--CC---CEECCCCCEEEEEEEE-CCEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCC----
Q ss_conf 666679889998621874--45---0114777189999998-9938999997156830069899999999826999----
Q 003694 434 RYRNLTWEEIESATLSFS--EN---LRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP---- 503 (802)
Q Consensus 434 ~~~~~~~~ei~~~~~~f~--~~---~~IG~G~~g~Vyk~~~-~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~Hp---- 503 (802)
.|..++-+.|..+...+. .. ..|+ +--..||++.. ++..+++|+.++.. ....++..|...+..|...
T Consensus 4 ~f~~L~pd~i~~al~~~g~~~~~~~~~L~-s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv 81 (325)
T d1zyla1 4 TFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV 81 (325)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCCC-CCCCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCC
T ss_conf 71666979999999975999775723256-61202699983899979999847877-88999999999999998559987
Q ss_pred -CEEEECCE----ECCCCEEEEEECCCCCHH--------------HHHHHCCC------CCCCCHH--------------
Q ss_conf -15444141----428872899972699977--------------89641189------9999989--------------
Q 003694 504 -HLLLLLGA----CPDHGCLVYEYMENGSLE--------------DRLYRKNN------TPPIPWF-------------- 544 (802)
Q Consensus 504 -niv~l~g~----~~~~~~lV~Ey~~~gsL~--------------~~l~~~~~------~~~l~~~-------------- 544 (802)
..+..-|. .....+.++++++|..+. ..++.... ....++.
T Consensus 82 ~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~ 161 (325)
T d1zyla1 82 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 161 (325)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred CCCEECCCCEEEEEEEEEEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCC
T ss_conf 87520689805665347999986527768899999999998999999886303578655677897887665689998747
Q ss_pred --------HHHHHHHHHHHHHHHH-HHCCCCCEEECCCCCCCEEECCCCEEEEEEECCCCC
Q ss_conf --------9999999999999997-704999958758999976762896027932034101
Q 003694 545 --------ERYRIAWEVASALAFL-HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 545 --------~~~~i~~qia~aL~~L-H~~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~ 596 (802)
.....+..+...+.-+ ....+..+||+|+.|.|||++.+ ..++||+-|..
T Consensus 162 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 162 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 699889899999999999999984545687120247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.21 E-value=0.0011 Score=39.59 Aligned_cols=71 Identities=15% Similarity=0.186 Sum_probs=47.6
Q ss_pred CEECCCCCEEEEEEEECC---------EEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEECCEECCCCEEEEEEC
Q ss_conf 011477718999999899---------389999971568300698999999998269-9915444141428872899972
Q 003694 454 LRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHGCLVYEYM 523 (802)
Q Consensus 454 ~~IG~G~~g~Vyk~~~~~---------~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~-Hpniv~l~g~~~~~~~lV~Ey~ 523 (802)
..|+.|-.-.+|++.... ..+.+++... .. ..-...+|..+++.+. +.-..+++++|. ..+|+||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFS--GGRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET--TEEEECCC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC-CC-HHHHHHHHHHHHHHHHHCCCCCEEEEECC--CCEEEEEE
T ss_conf 9917853343489996887754457898179996599-61-16589999999999975799980899818--95699973
Q ss_pred CCCCH
Q ss_conf 69997
Q 003694 524 ENGSL 528 (802)
Q Consensus 524 ~~gsL 528 (802)
+|.+|
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred CCCCC
T ss_conf 45548
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.13 E-value=0.007 Score=33.98 Aligned_cols=158 Identities=12% Similarity=0.055 Sum_probs=81.9
Q ss_pred CCCHHHHHHHHCCCCCCCE-----ECCCCCEEEEEEEECCEEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-----CCEE
Q ss_conf 6798899986218744501-----14777189999998993899999715683006989999999982699-----9154
Q 003694 437 NLTWEEIESATLSFSENLR-----IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH-----PHLL 506 (802)
Q Consensus 437 ~~~~~ei~~~~~~f~~~~~-----IG~G~~g~Vyk~~~~~~~vAvK~l~~~~~~~~~~~~~Ei~iL~~l~H-----pniv 506 (802)
.++.+++...-.+|..... |..|--.+.|+...++..+.+|+...... ...+..|+.+|..+.. |..+
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 88999999999867999856852378885267389997897289998078999--8899999999875430255545564
Q ss_pred EEC-C----EECCCCEEEEEECCCCCHH--------------HHHHHCCCC----C---CCCH-----------------
Q ss_conf 441-4----1428872899972699977--------------896411899----9---9998-----------------
Q 003694 507 LLL-G----ACPDHGCLVYEYMENGSLE--------------DRLYRKNNT----P---PIPW----------------- 543 (802)
Q Consensus 507 ~l~-g----~~~~~~~lV~Ey~~~gsL~--------------~~l~~~~~~----~---~l~~----------------- 543 (802)
... | ........++.++.+.... ..++..... . ...+
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf 10489762134125502453114655333204678888899876454443202453101110120024567777653114
Q ss_pred HHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCEEEEEEECCCCC
Q ss_conf 9999999999999999770-4999958758999976762896027932034101
Q 003694 544 FERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 596 (802)
Q Consensus 544 ~~~~~i~~qia~aL~~LH~-~~~~~iiHrDLKp~NILld~~~~~KI~DFGla~~ 596 (802)
......+..+...+.-... .-|.++||+|+.++|||++.+...-|.||+.|..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 127999999987642048554545033378636564020454126742221236
|
| >d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: bard1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.67 E-value=0.0017 Score=38.30 Aligned_cols=62 Identities=16% Similarity=0.185 Sum_probs=55.2
Q ss_pred CCCCCCCHHCCCCCCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 76673000001497425-89830134879999862799999899999999877199999999975
Q 003694 737 HFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWK 800 (802)
Q Consensus 737 ~f~cPi~~evm~dp~ia-~dg~tye~~aI~~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~i~~w~ 800 (802)
.+.|||-.++|.+|+.. .=|++|-+..|..|+. .++|+.+.++...++.||++|..+|+.+.
T Consensus 22 ~l~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~--~~CP~Cr~~~~~~~l~~n~~l~~lv~~~~ 84 (97)
T d1jm7b_ 22 LLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIG--TGCPVCYTPAWIQDLKINRQLDSMIQLCS 84 (97)
T ss_dssp TTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTT--TBCSSSCCBCSCSSCCCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHCCCEECCCCCCHHHHHHHHHHH--CCCCCCCCCCCHHHCCCCHHHHHHHHHHH
T ss_conf 2899258722112746588999302999999985--36662278676551860589999999999
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.69 E-value=0.005 Score=35.04 Aligned_cols=64 Identities=14% Similarity=0.287 Sum_probs=57.3
Q ss_pred CCCCCCCHHCCCCCCCCCCCCCCCHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 76673000001497425898301348799998627---99999899999999877199999999975
Q 003694 737 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQEN---DKSPITDLPLPNKNLLPNYTLLSAILDWK 800 (802)
Q Consensus 737 ~f~cPi~~evm~dp~ia~dg~tye~~aI~~wl~~~---~~sP~t~~~l~~~~l~pn~~l~~~i~~w~ 800 (802)
.+.|||-.+++.+|+...=|++|=+..|..|+... ..+|+-+.++...+|.||+.|+..++.++
T Consensus 21 ~l~CpIC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~~ve~l~ 87 (103)
T d1jm7a_ 21 ILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELL 87 (103)
T ss_dssp HTSCSSSCCCCSSCCBCTTSCCCCSHHHHHHHHSSSSSCCCTTTSCCCCTTTCBCCCSSSHHHHHHH
T ss_pred CCCCCCCCCHHCCEEECCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHCCCCHHHHHHHHHHH
T ss_conf 8499721823189188379986416789999997799980969888387552875789999999999
|
| >d1rmda2 g.44.1.1 (A:1-86) V(D)J recombination activating protein 1 (RAG1), dimerization domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: V(D)J recombination activating protein 1 (RAG1), dimerization domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=93.86 E-value=0.038 Score=28.88 Aligned_cols=61 Identities=18% Similarity=0.301 Sum_probs=53.5
Q ss_pred CCCCCCCCHHCCCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCCCCCC-CCHHHHHHH
Q ss_conf 97667300000149742589830134879999862-79999989999999987-719999999
Q 003694 736 NHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLL-PNYTLLSAI 796 (802)
Q Consensus 736 ~~f~cPi~~evm~dp~ia~dg~tye~~aI~~wl~~-~~~sP~t~~~l~~~~l~-pn~~l~~~i 796 (802)
..+.|||-.+.|.+|.+..=|++|=+..|+.|+.. +.++|+-+.++...+|. |..++++.+
T Consensus 22 ~~l~C~IC~~~~~~pv~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~p~~~~~l~~P~~~~l~~l 84 (86)
T d1rmda2 22 KSISCQICEHILADPVETSCKHLFCRICILRCLKVMGSYCPSCRYPCFPTDLESPVKSFLNIL 84 (86)
T ss_dssp HHTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCBCCCHHHHHHH
T ss_pred CCCCCCCCCCCHHCCEECCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHCCCHHHHHHHHH
T ss_conf 675995678444155526788763199999999648790703699799666359899999986
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=91.24 E-value=0.3 Score=22.56 Aligned_cols=101 Identities=14% Similarity=0.061 Sum_probs=60.7
Q ss_pred CCCCCEEEEEECCCCCCHHHHHHHHHHCCCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 99995699986499560433878853038789965999984179997789998865667655688999999889989886
Q 003694 11 NSPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRL 90 (802)
Q Consensus 11 ~~~~~~I~VaVD~s~~S~~Al~wA~~~~~~~~~~~i~LvHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~ 90 (802)
-...++|+||+-|...|...|..+.......+...+.++||-.... ++ . ...
T Consensus 21 ~~~~~kv~Va~SGG~DS~~Ll~lL~~~~~~~~~~~i~~~~vdh~~r----------------~~---s---------~~~ 72 (216)
T d1wy5a1 21 FSGERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR----------------ES---A---------ERD 72 (216)
T ss_dssp CSSCCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS----------------TH---H---------HHH
T ss_pred CCCCCEEEEEECCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC----------------CC---H---------HHH
T ss_conf 6899869999678599999999999998766877088887511234----------------10---3---------321
Q ss_pred HHHHHHHHHCCCCEEEEEEEECC--------CH--------HHHHHHHHHHCCCCEEEECCCCCC
Q ss_conf 69899985205811379997227--------68--------899999988539877997026899
Q 003694 91 LLPFRNMCAQRRVEVEVKVIESD--------DV--------AKAIADEVASCNINKLVIGAQSQG 139 (802)
Q Consensus 91 l~~~~~~c~~~~v~~~~~v~e~g--------d~--------~~~Iv~~a~~~~id~lViGs~~~~ 139 (802)
....+.+|...|+++...-+... .. ...+.+++.+.+++.|+.|.|..-
T Consensus 73 ~~~~~~~~~~l~i~~~i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~dD 137 (216)
T d1wy5a1 73 EEFCKEFAKERNMKIFVGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLND 137 (216)
T ss_dssp HHHHHHHHHHHTCCEEEEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
T ss_conf 34789999862000102102101111377644578799999887641111223121576520241
|
| >d1fbva4 g.44.1.1 (A:356-434) CBL {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: CBL species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.84 E-value=0.47 Score=21.26 Aligned_cols=52 Identities=12% Similarity=0.250 Sum_probs=45.6
Q ss_pred CCCCCCCCHHCCCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCCCCCC
Q ss_conf 97667300000149742589830134879999862-79999989999999987
Q 003694 736 NHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLL 787 (802)
Q Consensus 736 ~~f~cPi~~evm~dp~ia~dg~tye~~aI~~wl~~-~~~sP~t~~~l~~~~l~ 787 (802)
....|||-.+.+.+|.+..=|++|-+..|..|+.. +.++|+.+..+.....+
T Consensus 22 ~~~~C~IC~~~~~~~~~~~CgH~fC~~Ci~~wl~~~~~~CP~Cr~~i~~~~~i 74 (79)
T d1fbva4 22 TFQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTEPI 74 (79)
T ss_dssp CTTBCTTTSSSBCCEECSSSCCEECHHHHHHHHHTTCCSCTTTCCCCCCCCCS
T ss_pred CCCCCCCCCCCCCCEEEECCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCEE
T ss_conf 98999358976899699589993529999999997858189979586477666
|
| >d1ni5a1 c.26.2.5 (A:0-226) tRNA-Ile-lysidine synthetase, TilS, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: tRNA-Ile-lysidine synthetase, TilS, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=82.24 E-value=0.96 Score=19.08 Aligned_cols=98 Identities=16% Similarity=0.135 Sum_probs=56.1
Q ss_pred CCCEEEEEECCCCCCHHHHHHHHHHCCCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 99569998649956043387885303878996599998417999778999886566765568899999988998988669
Q 003694 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPMGNFIPIEQVRDDVAAAYKQEEKWKTDRLLL 92 (802)
Q Consensus 13 ~~~~I~VaVD~s~~S~~Al~wA~~~~~~~~~~~i~LvHV~~~~~~~~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~~l~ 92 (802)
..++|+|||-|...|..++..+.+......+..++++||-.... + .......
T Consensus 12 ~~kkvlva~SGG~DS~~Ll~ll~~~~~~~~~~~l~~~~vdh~~r----------~------------------~s~~~~~ 63 (227)
T d1ni5a1 12 TSRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLS----------A------------------NADAWVT 63 (227)
T ss_dssp TCSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCC----------S------------------SHHHHHH
T ss_pred CCCCEEEEECCCHHHHHHHHHHHHHHHHCCCCEEEEEEECCCCC----------C------------------CHHHHHH
T ss_conf 89968999638499999999999998758895699998678987----------5------------------2144589
Q ss_pred HHHHHHHCCCCEEEEEEEECCC----------HHHHHHHHHHHCCCCEEEECCCCC
Q ss_conf 8999852058113799972276----------889999998853987799702689
Q 003694 93 PFRNMCAQRRVEVEVKVIESDD----------VAKAIADEVASCNINKLVIGAQSQ 138 (802)
Q Consensus 93 ~~~~~c~~~~v~~~~~v~e~gd----------~~~~Iv~~a~~~~id~lViGs~~~ 138 (802)
....+|...|+........... ............+.+.|+.|.|..
T Consensus 64 ~~~~~~~~~~i~~~i~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~i~~gH~~d 119 (227)
T d1ni5a1 64 HCENVCQQWQVPLVVERVQLAQEGLGIEAQARQARYQAFARTLLPGEVLVTAQHLD 119 (227)
T ss_dssp HHHHHHHHTTCCEEEECCCCCCSSSTTTTHHHHHHHHHHHHTCCTTEEEECCCCHH
T ss_pred HHHHHHHHCCCCCEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_conf 99999754157632663133334430366899999998887752038999998888
|